id,Start,End,Label
Ventricular,0,11,B-Multi-tissue_structure
fibrillation,12,24,O
long,32,36,O
QT,37,39,O
syndrome,40,48,O
probably,49,57,O
caused,58,64,O
clindamycin,68,79,O
Prolongation,81,93,O
QT,97,99,O
time,100,104,O
interval,105,113,O
provoked,121,129,O
limited,135,142,O
number,143,149,O
drugs,153,158,O
especially,160,170,O
macrolide,171,180,O
antibiotics,181,192,O
describe,197,205,O
case,208,212,O
QT,216,218,O
time,219,223,O
interval,224,232,O
prolongation,233,245,O
induced,246,253,O
clindamycin,257,268,O
subsequent,274,284,O
repeated,285,293,O
ventricular,294,305,B-Multi-tissue_structure
fibrillation,306,318,O
resuscitation,323,336,O
previous,350,358,O
report,359,365,O
literature,373,383,O
QT,387,389,O
time,390,394,O
prolongation,395,407,O
caused,408,414,O
lincosamides,418,430,O
Decontamination,0,15,O
medical,19,26,O
equipment,27,36,O
manufacturer,38,50,O
s,51,52,O
problems,53,61,O
1,63,64,O
Small,66,71,O
items,72,77,O
sent,78,82,O
post,91,95,O
present,96,103,O
greater,111,118,O
hidden,119,125,O
hazard,126,132,O
higher,139,145,O
potential,146,155,O
catching,160,168,O
people,169,175,O
unawares,176,184,O
2,186,187,O
Large,189,194,O
items,195,200,O
accompanied,201,212,O
Decontamination,218,233,O
Certificate,234,245,O
need,246,250,O
treated,257,264,O
caution,270,277,O
surfaces,297,305,O
accessible,316,326,O
cleaned,342,349,O
soon,354,358,O
engineers,362,371,O
start,372,377,O
dismantling,378,389,O
equipment,390,399,O
areas,401,406,O
soiled,423,429,O
exposed,437,444,O
3,446,447,O
Total,449,454,O
co,455,457,O
operation,458,467,O
hospital,476,484,O
staff,485,490,O
service,495,502,O
engineers,503,512,O
necessary,516,525,O
resolve,529,536,O
problems,543,551,O
work,564,568,O
safely,569,575,O
assistance,588,598,O
4,613,614,O
products,621,629,O
use,633,636,O
hospitals,640,649,O
20,663,665,O
years,666,671,O
old,672,675,O
clearly,680,687,O
designed,697,705,O
facilitate,709,719,O
decontamination,720,735,O
present,750,757,O
far,758,761,O
greater,762,769,O
risk,770,774,O
concerned,782,791,O
5,793,794,O
future,804,810,O
clearly,819,826,O
responsibility,829,843,O
manufacturers,849,862,O
thought,876,883,O
design,891,897,O
equipment,907,916,O
decontamination,925,940,O
achieved,948,956,O
effectively,962,973,O
Enterococci,0,11,O
crossroads,19,29,O
food,33,37,O
safety,38,44,O
Enterococci,46,57,O
gram,62,66,O
positive,67,75,O
bacteria,76,84,O
fit,89,92,O
general,104,111,O
definition,112,122,O
lactic,126,132,O
acid,133,137,O
bacteria,138,146,O
Modern,148,154,O
classification,155,169,O
techniques,170,180,O
resulted,181,189,O
transfer,197,205,O
members,214,221,O
genus,229,234,O
Streptococcus,235,248,O
notably,250,257,O
Lancefield,270,280,O
s,281,282,O
group,283,288,O
D,289,290,O
streptococci,291,303,O
new,312,315,O
genus,316,321,O
Enterococcus,322,334,O
Enterococci,336,347,O
indicators,363,373,O
faecal,377,383,B-Organism_substance
contamination,384,397,O
implicated,414,424,O
outbreaks,428,437,O
foodborne,441,450,O
illness,451,458,O
ascribed,479,487,O
beneficial,490,500,O
detrimental,504,515,O
role,516,520,O
foods,524,529,O
processed,534,543,O
meats,544,549,B-Organism_subdivision
enterococci,551,562,O
survive,567,574,O
heat,575,579,O
processing,580,590,O
cause,595,600,O
spoilage,601,609,O
certain,621,628,O
cheeses,629,636,O
growth,641,647,O
enterococci,651,662,O
contributes,663,674,O
ripening,678,686,O
development,691,702,O
product,706,713,O
flavour,714,721,O
enterococci,728,739,O
food,743,747,O
origin,748,754,O
produce,755,762,O
bacteriocins,763,775,O
exert,781,786,O
anti,787,791,O
Listeria,792,800,O
activity,801,809,O
Enterococci,811,822,O
probiotics,835,845,O
improve,849,856,O
microbial,861,870,O
balance,871,878,O
intestine,886,895,B-Organ
treatment,905,914,O
gastroenteritis,919,934,O
humans,938,944,O
animals,949,956,O
hand,971,975,O
enterococci,977,988,O
recognised,1001,1011,O
nosocomial,1023,1033,O
pathogens,1034,1043,O
causing,1044,1051,O
bacteraemia,1052,1063,O
endocarditis,1065,1077,O
urinary,1079,1086,B-Multi-tissue_structure
tract,1087,1092,I-Multi-tissue_structure
infections,1103,1113,O
explained,1131,1140,O
resistance,1148,1158,O
bacteria,1176,1184,O
antibiotics,1193,1204,O
currently,1214,1223,O
use,1227,1230,O
Resistance,1232,1242,O
acquired,1246,1254,O
gene,1258,1262,O
transfer,1263,1271,O
systems,1272,1279,O
conjugative,1289,1300,B-Cellular_component
nonconjugative,1304,1318,B-Cellular_component
plasmids,1319,1327,I-Cellular_component
transposons,1331,1342,O
Virulence,1344,1353,O
enterococci,1357,1368,O
understood,1381,1391,O
adhesins,1396,1404,O
haemolysin,1406,1416,O
hyaluronidase,1418,1431,O
aggregation,1433,1444,O
substance,1445,1454,O
gelatinase,1459,1469,O
putative,1474,1482,O
virulence,1483,1492,O
factors,1493,1500,O
appears,1505,1512,O
foods,1518,1523,O
source,1535,1541,O
vancomycin,1545,1555,O
resistant,1556,1565,O
enterococci,1566,1577,O
review,1584,1590,O
addresses,1591,1600,O
issue,1605,1610,O
health,1618,1624,O
risk,1625,1629,O
foods,1633,1638,O
containing,1639,1649,O
enterococci,1650,1661,O
Obstructive,0,11,O
nephropathy,12,23,O
lessons,25,32,O
cystic,38,44,O
kidney,45,51,B-Organ
disease,52,59,O
Obstructive,61,72,O
nephropathy,73,84,O
important,104,113,O
causes,114,120,O
renal,124,129,B-Organ
failure,130,137,O
infants,141,148,O
children,153,161,O
polycystic,169,179,O
kidney,180,186,B-Organ
disease,187,194,O
PKD,196,199,O
major,206,211,O
cause,212,217,O
renal,221,226,B-Organ
failure,227,234,O
adult,242,247,O
population,248,258,O
review,265,271,O
summarizes,272,282,O
evidence,287,295,O
number,316,322,O
mechanisms,326,336,O
common,337,343,O
pathophysiology,351,366,O
conditions,375,385,O
animal,390,396,O
models,397,403,O
obstructive,407,418,O
nephropathy,419,430,O
PKD,435,438,O
renal,444,449,B-Multi-tissue_structure
tubular,450,457,I-Multi-tissue_structure
expression,458,468,O
epidermal,472,481,O
growth,482,488,O
factor,489,495,O
suppressed,499,509,O
expression,515,525,O
clusterin,529,538,O
increased,542,551,O
suggest,567,574,O
arrested,575,583,O
maturation,584,594,O
dedifferentiation,598,615,O
tubular,623,630,B-Cell
cell,631,635,I-Cell
marked,648,654,O
increase,655,663,O
apoptosis,667,676,O
epithelial,680,690,B-Cell
cells,691,696,I-Cell
dilated,700,707,O
tubules,708,715,B-Multi-tissue_structure
associated,717,727,O
increase,736,744,O
apoptotic,748,757,O
stimuli,758,765,O
renin,771,776,O
angiotensin,777,788,O
system,789,795,O
activated,799,808,O
obstructive,817,828,O
nephropathy,829,840,O
PKD,845,848,O
contribute,860,870,O
tubular,874,881,B-Multi-tissue_structure
atrophy,882,889,O
interstitial,894,906,B-Immaterial_anatomical_entity
fibrosis,907,915,O
characterize,923,935,O
progression,940,951,O
conditions,960,970,O
Focal,972,977,O
cystic,978,984,O
dilatation,985,995,O
tubule,1003,1009,B-Multi-tissue_structure
found,1013,1018,O
obstructive,1022,1033,O
nephropathy,1034,1045,O
tubular,1053,1060,B-Multi-tissue_structure
obstruction,1061,1072,O
present,1076,1083,O
cystic,1087,1093,O
kidney,1094,1100,B-Organ
disease,1101,1108,O
likely,1126,1132,O
elucidation,1138,1149,O
effects,1157,1164,O
mechanical,1168,1178,O
stretch,1179,1186,O
renal,1190,1195,B-Cell
tubular,1196,1203,I-Cell
epithelial,1204,1214,I-Cell
cells,1215,1220,I-Cell
contribute,1226,1236,O
understanding,1244,1257,O
conditions,1266,1276,O
Genuine,0,7,O
monovalent,8,18,O
ligands,19,26,O
TrkA,30,34,O
nerve,35,40,O
growth,41,47,O
factor,48,54,O
receptors,55,64,O
reveal,65,71,O
novel,74,79,O
pharmacological,80,95,O
mechanism,96,105,O
action,109,115,O
Developing,117,127,O
small,128,133,O
molecule,134,142,O
agonistic,143,152,O
ligands,153,160,O
tyrosine,165,173,O
kinase,174,180,O
receptors,181,190,O
difficult,200,209,O
generally,221,230,O
thought,231,238,O
ligands,249,256,O
require,257,264,O
bivalency,265,274,O
multisubunit,286,298,O
receptors,299,308,O
difficult,313,322,O
target,326,332,O
subunit,347,354,O
contributes,355,366,O
ligand,370,376,O
affinity,377,385,O
subunit,396,403,O
distinct,413,421,O
opposing,436,444,O
functions,445,454,O
nerve,466,471,O
growth,472,478,O
factor,479,485,O
receptor,486,494,O
subunits,495,503,O
p75,504,507,O
tyrosine,516,524,O
kinase,525,531,O
TrkA,532,536,O
studied,542,549,O
artificial,556,566,O
ligands,567,574,O
bind,580,584,O
specifically,585,597,O
extracellular,607,620,B-Immaterial_anatomical_entity
domain,621,627,O
Bivalent,629,637,O
TrkA,638,642,O
ligands,643,650,O
afford,651,657,O
robust,658,664,O
signals,665,672,O
genuine,683,690,O
monomeric,691,700,O
monovalent,705,715,O
TrkA,716,720,O
ligands,721,728,O
afford,729,735,O
partial,736,743,O
agonism,744,751,O
activate,753,761,O
tyrosine,766,774,O
kinase,775,781,O
activity,782,790,O
cause,792,797,O
receptor,798,806,O
internalization,807,822,O
induce,828,834,O
survival,835,843,O
differentiation,848,863,O
cell,867,871,B-Cell
lines,872,877,I-Cell
primary,882,889,O
neurons,890,897,B-Cell
Monomeric,899,908,O
monovalent,913,923,O
TrkA,924,928,O
ligands,929,936,O
synergize,941,950,O
ligands,956,963,O
bind,969,973,O
p75,978,981,O
subunit,982,989,O
p75,1004,1007,O
ligands,1008,1015,O
study,1029,1034,O
bivalent,1043,1051,O
monovalent,1057,1067,O
p75,1068,1071,O
ligands,1072,1079,O
effect,1088,1094,O
findings,1102,1110,O
useful,1119,1125,O
designing,1129,1138,O
developing,1143,1153,O
screens,1154,1161,O
small,1165,1170,O
molecules,1171,1180,O
selective,1181,1190,O
tyrosine,1195,1203,O
kinase,1204,1210,O
receptors,1211,1220,O
indicate,1225,1233,O
strategies,1239,1249,O
designing,1254,1263,O
agonists,1264,1272,O
multisubunit,1276,1288,O
receptors,1289,1298,O
require,1299,1306,O
consideration,1307,1320,O
role,1328,1332,O
subunit,1341,1348,O
strategy,1360,1368,O
anti,1378,1382,O
receptor,1383,1391,O
mAbs,1392,1396,O
small,1401,1406,O
molecule,1407,1415,O
hormone,1416,1423,O
mimics,1424,1430,O
receptor,1434,1442,O
ligands,1443,1450,O
applied,1460,1467,O
study,1475,1480,O
heteromeric,1495,1506,O
cell,1507,1511,B-Cellular_component
surface,1512,1519,I-Cellular_component
receptors,1520,1529,O
Application,0,11,O
microsatellite,15,29,O
PCR,30,33,O
techniques,34,44,O
identification,52,66,O
mixed,70,75,O
tissue,79,85,B-Tissue
specimens,86,95,I-Tissue
surgical,99,107,O
pathology,108,117,O
fragment,121,129,B-Pathological_formation
tumour,133,139,B-Pathological_formation
erroneously,144,155,O
mixed,156,161,O
endometrial,173,184,B-Tissue
biopsy,185,191,I-Tissue
Micro,193,198,O
satellite,199,208,O
polymerase,209,219,O
chain,220,225,O
reaction,226,234,O
PCR,236,239,O
clearly,241,248,O
demonstrated,249,261,O
extraneous,266,276,O
nature,277,283,O
fragment,291,299,B-Pathological_formation
Micro,301,306,O
satellite,307,316,O
PCR,317,320,O
useful,328,334,O
identification,343,357,O
mis,361,364,O
labelled,365,373,O
mismatched,377,387,O
tissue,388,394,B-Tissue
fragments,395,404,I-Tissue
surgical,408,416,O
pathology,417,426,O
specimens,427,436,B-Tissue
Specific,0,8,O
subgroup,9,17,O
B,18,19,O
adenovirus,20,30,O
diagnosis,31,40,O
PCR,44,47,O
fibre,55,60,O
gene,61,65,O
OBJECTIVE,67,76,O
highly,80,86,O
sensitive,87,96,O
specific,101,109,O
PCR,110,113,O
assay,114,119,O
targeting,120,129,O
regions,130,137,O
fibre,145,150,O
gene,151,155,O
developed,160,169,O
identification,178,192,O
subgroup,196,204,O
B,205,206,O
adenovirus,207,217,O
strains,218,225,O
critical,235,243,O
adenovirus,257,267,O
strains,268,275,O
frequently,280,290,O
associated,291,301,O
severe,307,313,O
respiratory,314,325,B-Anatomical_system
infections,326,336,O
infants,340,347,O
new,352,355,O
borns,356,361,O
METHODS,363,370,O
Clinical,372,380,O
samples,381,388,B-Organism_substance
nasopharyngeal,394,408,B-Organism_substance
aspirates,409,418,I-Organism_substance
analysed,424,432,O
PCR,436,439,O
sets,454,458,O
primers,462,469,O
corresponding,470,483,O
sequences,487,496,O
gene,504,508,O
coding,509,515,O
fibre,524,529,O
protein,530,537,O
RESULTS,539,546,O
assay,552,557,O
allowed,558,565,O
detection,570,579,O
identification,584,598,O
genotypes,610,619,O
adenovirus,623,633,O
subgroup,634,642,O
B,643,644,O
based,646,651,O
size,659,663,O
amplified,671,680,O
product,681,688,O
analysed,694,702,O
polyacrilamide,706,720,O
gel,721,724,O
electrophoresis,725,740,O
Specifically,742,754,O
set,760,763,O
primers,767,774,O
able,779,783,O
amplify,787,794,O
DNA,795,798,O
subgroup,802,810,O
B,811,812,O
subgroup,821,829,O
C,830,831,O
E,836,837,O
viruses,838,845,O
CONCLUSION,847,857,O
detection,863,872,O
adenovirus,876,886,O
genotyping,895,905,O
routine,923,930,O
basis,931,936,O
PCR,942,945,O
assay,946,951,O
fibre,962,967,O
gene,968,972,O
target,978,984,O
assay,990,995,O
allows,996,1002,O
identification,1007,1021,O
ADV,1025,1028,O
subgroup,1029,1037,O
B,1038,1039,O
including,1041,1050,O
genotype,1051,1059,O
7h,1060,1062,O
single,1077,1083,O
important,1089,1098,O
viral,1099,1104,O
pathogen,1105,1113,O
associated,1114,1124,O
respiratory,1130,1141,B-Anatomical_system
diseases,1142,1150,O
infants,1154,1161,O
young,1166,1171,O
children,1172,1180,O
southern,1188,1196,O
South,1205,1210,O
America,1211,1218,O
Anesthetic,1,11,O
management,12,22,O
patient,28,35,O
Dyggve,41,47,O
Melchior,48,56,O
Clausen,57,64,O
syndrome,65,73,O
Dyggve,80,86,O
Melchior,87,95,O
Clausen,96,103,O
syndrome,104,112,O
DMCS,114,118,O
rare,125,129,O
autosomal,130,139,O
recessive,140,149,O
skeletal,150,158,B-Anatomical_system
dysplasia,159,168,O
characterized,169,182,O
short,186,191,O
trunk,192,197,B-Organism_subdivision
dwarfism,198,206,O
mental,211,217,O
retardation,218,229,O
49,233,235,O
year,236,240,O
old,241,244,O
male,245,249,O
DMCS,255,259,O
underwent,260,269,O
resection,270,279,O
arthroplasty,280,292,O
contracture,297,308,O
right,316,321,B-Multi-tissue_structure
hip,322,325,I-Multi-tissue_structure
joint,326,331,I-Multi-tissue_structure
general,338,345,O
anesthesia,346,356,O
thiamylal,363,372,O
nitrous,374,381,O
oxide,382,387,O
sevoflurane,389,400,O
vecuronium,406,416,O
assumed,434,441,O
difficult,450,459,O
airway,460,466,B-Multi-tissue_structure
short,474,479,O
neck,480,484,B-Organism_subdivision
macroglossia,486,498,O
disturbance,504,515,O
neck,519,523,B-Organism_subdivision
flexion,524,531,O
tracheal,533,541,B-Multi-tissue_structure
intubation,542,552,O
difficult,561,570,O
complications,575,588,O
including,589,598,O
malignant,599,608,O
hyperthermia,609,621,O
observed,627,635,O
95,647,649,O
min,650,653,O
operation,661,670,O
Assembly,0,8,O
strategies,9,19,O
GTPase,24,30,O
regulation,31,41,O
eukaryotic,49,59,O
Escherichia,64,75,O
coil,76,80,O
translocons,81,92,B-Cellular_component
translocation,98,111,O
proteins,120,128,O
endoplasmic,140,151,B-Cellular_component
reticulum,152,161,I-Cellular_component
bacterial,165,174,O
inner,175,180,B-Cellular_component
membrane,181,189,I-Cellular_component
occurs,190,196,O
aqueous,208,215,B-Cellular_component
pore,216,220,I-Cellular_component
spans,226,231,O
membrane,236,244,B-Cellular_component
Substrates,246,256,O
translocated,266,278,O
co,279,281,O
translationally,282,297,O
membrane,309,317,B-Cellular_component
directed,322,330,O
translocation,338,351,B-Cellular_component
pore,352,356,I-Cellular_component
interaction,364,375,O
cytosolic,388,397,B-Organism_substance
signal,398,404,O
recognition,405,416,O
particle,417,425,O
membrane,434,442,B-Cellular_component
bound,443,448,O
receptor,449,457,O
translocation,472,485,B-Cellular_component
pore,486,490,I-Cellular_component
receptor,499,507,O
referred,512,520,O
translocon,529,539,B-Cellular_component
studying,544,552,O
biogenesis,557,567,O
translocon,575,585,B-Cellular_component
number,588,594,O
alternate,598,607,O
targeting,608,617,O
membrane,622,630,B-Cellular_component
integration,631,642,O
pathways,643,651,O
discovered,662,672,O
operate,678,685,O
independently,686,699,O
signal,707,713,O
recognition,714,725,O
particle,726,734,O
SRP,736,739,O
pathway,741,748,O
novel,754,759,O
assembly,760,768,O
strategies,769,779,O
translocon,787,797,B-Cellular_component
ways,806,810,O
components,826,836,O
interact,837,845,O
ensure,849,855,O
fidelity,860,868,O
unidirectionality,873,890,O
targeting,898,907,O
translocation,912,925,O
process,926,933,O
reviewed,938,946,O
Phonology,0,9,O
review,13,19,O
proposals,24,33,O
connectionist,41,54,O
perspective,55,66,O
parallel,70,78,O
distributed,79,90,O
processing,91,101,O
PDP,103,106,O
model,108,113,O
phonological,117,129,O
processing,130,140,O
developed,144,153,O
including,155,164,O
components,165,175,O
support,179,186,O
repetition,187,197,O
auditory,199,207,O
processing,208,218,O
comprehension,220,233,O
language,239,247,O
production,248,258,O
performance,269,280,O
PDP,288,291,O
reading,292,299,O
model,300,305,O
Plaut,309,314,O
McClelland,316,326,O
Seidenberg,328,338,O
Patterson,344,353,O
1996,355,359,O
inferred,368,376,O
acoustic,386,394,O
articulatory,395,407,O
motor,408,413,O
pattern,414,421,O
associator,422,432,O
supports,438,446,O
repetition,447,457,O
provides,458,466,O
basis,471,476,O
phonological,481,493,O
sequence,494,502,O
knowledge,503,512,O
observation,523,534,O
patients,545,553,O
phonemic,559,567,O
paraphasic,568,578,O
errors,579,585,O
language,589,597,O
production,598,608,O
repetition,616,626,O
argued,634,640,O
direct,662,668,O
link,669,673,O
distributed,682,693,O
concept,694,701,O
representations,702,717,O
lexical,719,726,O
semantic,727,735,O
knowledge,736,745,O
network,756,763,O
representation,764,778,O
sequence,782,790,O
knowledge,791,800,O
way,810,813,O
lexical,820,827,O
semantic,828,836,O
phonotactic,841,852,O
constraints,853,864,O
brought,869,876,O
bear,880,884,O
language,888,896,O
production,897,907,O
literature,913,923,O
phonological,927,939,O
function,940,948,O
normal,952,958,O
subjects,959,967,O
slip,969,973,O
tongue,981,987,O
corpora,988,995,O
patients,1004,1012,O
aphasia,1018,1025,O
critically,1029,1039,O
reviewed,1040,1048,O
perspective,1059,1070,O
relationship,1076,1088,O
acoustic,1097,1105,O
articulatory,1110,1122,O
motor,1123,1128,O
representations,1129,1144,O
process,1152,1159,O
phonetic,1163,1171,O
perception,1172,1182,O
considered,1186,1196,O
Repetition,1198,1208,O
reproduction,1213,1225,O
conduction,1226,1236,O
aphasia,1237,1244,O
reviewed,1249,1257,O
detail,1261,1267,O
extended,1272,1280,O
consideration,1281,1294,O
given,1298,1303,O
representation,1311,1325,O
auditory,1329,1337,O
verbal,1338,1344,O
short,1345,1350,O
term,1351,1355,O
memory,1356,1362,O
model,1370,1375,O
Finally,1377,1384,O
PDP,1390,1393,O
model,1394,1399,O
reconciled,1403,1413,O
information,1419,1430,O
processing,1431,1441,O
models,1442,1448,O
phonological,1452,1464,O
processing,1465,1475,O
including,1477,1486,O
Lichtheim,1495,1504,O
current,1515,1522,O
knowledge,1523,1532,O
anatomic,1540,1548,O
localization,1549,1561,O
phonological,1565,1577,O
processing,1578,1588,O
simulations,1602,1613,O
model,1621,1626,O
run,1632,1635,O
number,1639,1645,O
simulation,1649,1659,O
studies,1660,1667,O
proposed,1672,1680,O
Male,0,4,O
role,5,9,O
fertility,13,22,O
decisions,23,32,O
Robertsport,36,47,O
Liberia,49,56,O
experimental,61,73,O
exercise,74,82,O
policy,87,93,O
formulation,94,105,O
tendency,118,126,O
believe,130,137,O
African,146,153,O
societies,154,163,O
men,164,167,O
dominant,176,184,O
decision,185,193,O
makers,194,200,O
family,208,214,O
Robertsport,220,231,O
Liberia,233,240,O
indications,252,263,O
respect,275,282,O
fertility,286,295,O
regulation,296,306,O
dominance,312,321,O
husband,329,336,O
fertility,340,349,O
decisions,350,359,O
exists,360,366,O
apparent,383,391,O
decisions,411,420,O
jointly,430,437,O
husband,446,453,O
wife,458,462,O
Education,465,474,O
particularly,478,490,O
influential,491,502,O
joint,510,515,O
fertility,516,525,O
decision,526,534,O
making,535,541,O
process,542,549,O
100,556,559,O
husbands,560,568,O
sampled,569,576,O
1982,580,584,O
desired,585,592,O
large,595,600,O
number,601,607,O
children,611,619,O
experience,628,638,O
infant,644,650,O
child,655,660,O
mortality,661,670,O
family,676,682,O
planning,683,691,O
programs,692,700,O
attain,708,714,O
goals,721,726,O
men,728,731,O
involved,747,755,O
present,765,772,O
aspect,783,789,O
programs,797,805,O
Equally,808,815,O
important,816,825,O
urgency,833,840,O
studies,845,852,O
related,853,860,O
role,868,872,O
men,876,879,O
fertility,883,892,O
regulation,893,903,O
adequately,911,921,O
large,922,927,O
samples,928,935,O
Act,0,3,O
16,8,10,O
045,11,14,O
2,19,20,O
June,21,25,O
1989,26,30,O
prohibiting,31,42,O
discrimination,47,61,O
violates,67,75,O
principle,80,89,O
equality,93,101,O
treatment,105,114,O
opportunities,119,132,O
sexes,142,147,O
sectors,155,162,O
labor,166,171,O
activity,172,180,O
Uruguayan,187,196,O
Act,197,200,O
prohibits,201,210,O
discrimination,211,225,O
employment,229,239,O
respect,245,252,O
following,260,269,O
areas,270,275,O
1,291,292,O
advertising,294,305,O
provision,314,323,O
positions,327,336,O
2,338,339,O
selection,341,350,O
criteria,351,359,O
3,361,362,O
recruitment,364,375,O
hiring,380,386,O
4,388,389,O
evaluation,391,401,O
performance,405,416,O
criteria,417,425,O
5,427,428,O
right,434,439,O
advancement,443,454,O
promotion,459,468,O
6,470,471,O
labour,473,479,O
stability,480,489,O
7,491,492,O
social,494,500,O
benefits,501,509,O
8,511,512,O
suspension,514,524,O
dismissal,529,538,O
particularly,540,552,O
cases,556,561,O
involving,562,571,O
change,574,580,O
civil,584,589,O
status,590,596,O
pregnancy,598,607,O
nursing,612,619,O
9,621,622,O
possibilities,624,637,O
professional,642,654,O
technical,659,668,O
education,669,678,O
retraining,682,692,O
10,698,700,O
remuneration,702,714,O
criteria,715,723,O
Reserving,725,734,O
places,735,741,O
sex,750,753,O
presence,769,777,O
activities,781,791,O
sex,805,808,O
employee,816,824,O
essential,828,837,O
performance,842,853,O
comply,860,866,O
international,872,885,O
labor,886,891,O
treaties,892,900,O
constitute,910,920,O
discrimination,921,935,O
compensatory,945,957,O
acts,958,962,O
designed,963,971,O
promote,975,982,O
equality,983,991,O
opportunities,995,1008,O
treatment,1013,1022,O
sexes,1031,1036,O
concrete,1040,1048,O
situations,1049,1059,O
cases,1064,1069,O
provisions,1080,1090,O
Act,1099,1102,O
violated,1113,1121,O
specially,1123,1132,O
designated,1133,1143,O
judges,1144,1150,O
parties,1165,1172,O
adopt,1190,1195,O
measures,1196,1204,O
designed,1205,1213,O
end,1217,1220,O
situation,1225,1234,O
complained,1235,1245,O
deem,1259,1263,O
necessary,1267,1276,O
judges,1282,1288,O
institute,1293,1302,O
formal,1308,1314,O
proceedings,1315,1326,O
measures,1336,1344,O
adopted,1345,1352,O
carried,1361,1368,O
person,1378,1384,O
violating,1385,1394,O
law,1399,1402,O
subject,1406,1413,O
daily,1419,1424,O
fine,1425,1429,O
administrative,1442,1456,O
penalties,1457,1466,O
set,1467,1470,O
Act,1478,1481,O
15,1482,1484,O
903,1485,1488,O
10,1492,1494,O
November,1495,1503,O
1987,1504,1508,O
Adverse,1511,1518,O
decisions,1519,1528,O
appealed,1536,1544,O
state,1551,1556,O
undertake,1568,1577,O
educative,1578,1587,O
campaigns,1588,1597,O
create,1601,1607,O
interest,1608,1616,O
understanding,1624,1637,O
problems,1645,1653,O
affecting,1654,1663,O
women,1664,1669,O
workers,1670,1677,O
promoting,1684,1693,O
awareness,1694,1703,O
workers,1712,1719,O
employers,1730,1739,O
situation,1749,1758,O
CXC,0,3,O
chemokine,4,13,O
receptors,14,23,O
central,31,38,B-Anatomical_system
nervous,39,46,I-Anatomical_system
system,47,53,I-Anatomical_system
Role,55,59,O
cerebellar,63,73,B-Multi-tissue_structure
neuromodulation,74,89,O
development,94,105,O
Chemokines,107,117,O
receptors,128,137,O
constitutively,142,156,O
present,157,164,O
central,172,179,B-Anatomical_system
nervous,180,187,I-Anatomical_system
system,188,194,I-Anatomical_system
CNS,196,199,B-Anatomical_system
expressed,202,211,O
neurons,215,222,B-Cell
glial,227,232,B-Cell
cells,233,238,I-Cell
evidence,245,253,O
suggests,254,262,O
involvement,282,293,O
neuroinflammation,297,314,O
proteins,322,330,O
play,331,335,O
role,338,342,O
neurodevelopment,346,362,O
neurophysiological,367,385,O
signaling,386,395,O
goal,401,405,O
review,414,420,O
summarize,427,436,O
recent,437,443,O
information,444,455,O
concerning,456,466,O
expression,467,477,O
signaling,479,488,O
function,494,502,O
CXC,506,509,O
chemokine,510,519,O
receptor,520,528,O
CNS,536,539,B-Anatomical_system
main,550,554,O
focus,555,560,O
developmental,568,581,O
neuromodulatory,586,601,O
actions,602,609,O
chemokines,613,623,O
cerebellum,631,641,B-Multi-tissue_structure
Combined,0,8,O
tracheal,9,17,B-Multi-tissue_structure
esophageal,22,32,B-Multi-tissue_structure
stenting,33,41,O
palliation,46,56,O
tracheoesophageal,60,77,B-Multi-tissue_structure
symptoms,78,86,O
mediastinal,92,103,B-Pathological_formation
lymphoma,104,112,I-Pathological_formation
Mediastinal,114,125,B-Pathological_formation
lymphoma,126,134,I-Pathological_formation
cause,140,145,O
tracheobronchial,149,165,B-Multi-tissue_structure
obstruction,166,177,O
uncommon,181,189,O
malignant,197,206,O
tracheoesophageal,207,224,B-Immaterial_anatomical_entity
fistula,225,232,I-Immaterial_anatomical_entity
setting,240,247,O
mediastinal,251,262,B-Pathological_formation
lymphoma,263,271,I-Pathological_formation
rare,275,279,O
Malignant,281,290,O
tracheoesophageal,291,308,B-Immaterial_anatomical_entity
fistulas,309,317,I-Immaterial_anatomical_entity
associated,322,332,O
pronounced,338,348,O
morbidity,349,358,O
mortality,363,372,O
describe,377,385,O
patient,388,395,O
mediastinal,401,412,B-Pathological_formation
lymphomatous,413,425,I-Pathological_formation
infiltration,426,438,O
resulting,439,448,O
tracheal,452,460,B-Multi-tissue_structure
obstruction,461,472,O
esophageal,474,484,B-Multi-tissue_structure
obstruction,485,496,O
tracheoesophageal,502,519,B-Immaterial_anatomical_entity
fistula,520,527,I-Immaterial_anatomical_entity
successfully,538,550,O
palliated,551,560,O
combined,566,574,O
airway,575,581,B-Multi-tissue_structure
esophageal,586,596,B-Multi-tissue_structure
stent,597,602,O
placement,603,612,O
Rural,0,5,O
urban,6,11,O
differences,12,23,O
access,27,33,O
utilization,41,52,O
services,56,64,O
people,71,77,O
Alabama,81,88,O
sickle,94,100,B-Cell
cell,101,105,I-Cell
disease,106,113,O
OBJECTIVE,115,124,O
study,131,136,O
examined,137,145,O
relationships,146,159,O
socioeconomic,168,181,O
factors,182,189,O
geographic,198,208,O
distribution,209,221,O
662,225,228,O
cases,229,234,O
sickle,238,244,B-Cell
cell,245,249,I-Cell
disease,250,257,O
Alabama,261,268,O
1999,272,276,O
2001,277,281,O
METHODS,283,290,O
Measures,292,300,O
community,304,313,O
distress,314,322,O
physical,324,332,O
functioning,333,344,O
medical,350,357,O
problems,358,366,O
analyzing,380,389,O
utilization,390,401,O
differences,402,413,O
individuals,422,433,O
sickle,439,445,B-Cell
cell,446,450,I-Cell
disease,451,458,O
living,459,465,O
urban,469,474,O
rural,479,484,O
areas,485,490,O
RESULTS,492,499,O
Utilization,501,512,O
comprehensive,516,529,O
sickle,530,536,B-Cell
cells,537,542,I-Cell
disease,543,550,O
services,551,559,O
lower,564,569,O
individuals,574,585,O
sickle,591,597,B-Cell
cell,598,602,I-Cell
disease,603,610,O
living,611,617,O
rural,621,626,O
areas,627,632,O
living,648,654,O
urban,658,663,O
areas,664,669,O
Rural,671,676,O
clients,677,684,O
reported,685,693,O
significantly,694,707,O
limitations,713,724,O
urban,730,735,O
clients,736,743,O
measures,755,763,O
physical,767,775,O
functioning,776,787,O
results,793,800,O
suggest,806,813,O
utilization,819,830,O
services,834,842,O
higher,847,853,O
medical,874,881,O
problems,882,890,O
lived,905,910,O
high,914,918,O
distress,919,927,O
areas,928,933,O
findings,950,958,O
meet,967,971,O
criterion,976,985,O
statistical,990,1001,O
significance,1002,1014,O
CONCLUSIONS,1016,1027,O
Conclusions,1029,1040,O
based,1041,1046,O
statistical,1050,1061,O
evidence,1062,1070,O
geographic,1076,1086,O
location,1087,1095,O
socioeconomic,1100,1113,O
factors,1114,1121,O
relate,1122,1128,O
significantly,1132,1145,O
different,1146,1155,O
health,1156,1162,O
care,1163,1167,O
service,1168,1175,O
experience,1176,1186,O
bear,1187,1191,O
important,1192,1201,O
implications,1202,1214,O
medical,1219,1226,O
health,1231,1237,O
care,1238,1242,O
support,1243,1250,O
systems,1251,1258,O
especially,1260,1270,O
community,1278,1287,O
level,1288,1293,O
Impact,0,6,O
technology,10,20,O
utilisation,28,39,O
positron,43,51,O
emission,52,60,O
tomography,61,71,O
lymphoma,75,83,B-Pathological_formation
current,85,92,O
future,97,103,O
perspectives,104,116,O
Positron,118,126,O
emission,127,135,O
tomography,136,146,O
PET,148,151,O
gained,161,167,O
place,170,175,O
management,183,193,O
patients,197,205,O
cancer,211,217,B-Pathological_formation
including,219,228,O
Hodgkin,240,247,O
s,248,249,O
disease,250,257,O
non,262,265,B-Pathological_formation
Hodgkin,266,273,I-Pathological_formation
s,274,275,I-Pathological_formation
lymphoma,276,284,I-Pathological_formation
Restaging,286,295,O
studies,296,303,O
addressing,314,324,O
monitoring,329,339,O
response,343,351,O
treatment,355,364,O
especially,369,379,O
focus,383,388,O
knowledge,402,411,O
gained,412,418,O
achieved,428,436,O
dedicated,442,451,O
BGO,452,455,O
based,456,461,O
PET,462,465,O
technology,466,476,O
number,494,500,O
developments,504,516,O
impact,527,533,O
use,541,544,O
metabolic,553,562,O
imaging,563,570,O
technique,571,580,O
investigation,588,601,O
patients,605,613,O
lymphoma,619,627,B-Pathological_formation
challenges,633,643,O
ahead,644,649,O
determined,654,664,O
need,672,676,O
high,681,685,O
quality,686,693,O
body,700,704,O
imaging,705,712,O
associated,713,723,O
increased,729,738,O
patient,739,746,O
throughput,747,757,O
need,766,770,O
investigate,774,785,O
role,790,794,O
new,798,801,O
labelled,802,810,O
ligands,811,818,O
likely,835,841,O
yield,845,850,O
new,851,854,O
insights,855,863,O
tumour,869,875,B-Cell
cell,876,880,I-Cell
characterisation,881,897,O
tumour,899,905,B-Pathological_formation
behaviour,906,915,O
tumour,920,926,B-Pathological_formation
outcome,927,934,O
assessment,935,945,O
study,951,956,O
new,960,963,O
radiolabelled,964,977,O
ligands,978,985,O
impose,991,997,O
demands,1006,1013,O
rapid,1018,1023,O
dynamic,1024,1031,O
data,1032,1036,O
acquisition,1037,1048,O
accurate,1053,1061,O
tracer,1062,1068,O
quantification,1069,1083,O
Current,1085,1092,O
future,1097,1103,O
developments,1104,1116,O
PET,1120,1123,O
technology,1124,1134,O
range,1135,1140,O
use,1150,1153,O
new,1157,1160,O
detector,1161,1169,O
materials,1170,1179,O
different,1183,1192,O
detector,1193,1201,O
geometries,1202,1212,O
data,1217,1221,O
acquisition,1222,1233,O
modes,1234,1239,O
search,1245,1251,O
alternatives,1256,1268,O
BGO,1272,1275,O
scintillation,1276,1289,O
materials,1290,1299,O
PET,1304,1307,O
led,1312,1315,O
development,1323,1334,O
PET,1338,1341,O
instruments,1342,1353,O
utilising,1354,1363,O
new,1364,1367,O
crystals,1368,1376,O
LSO,1385,1388,O
GSO,1393,1396,O
use,1402,1405,O
new,1415,1418,O
detectors,1419,1428,O
increased,1437,1446,O
sensitivity,1447,1458,O
achieved,1459,1467,O
3D,1473,1475,O
data,1476,1480,O
acquisitions,1481,1493,O
represent,1494,1503,O
significant,1513,1524,O
current,1525,1532,O
developments,1533,1545,O
field,1553,1558,O
increasing,1569,1579,O
demands,1580,1587,O
imposed,1588,1595,O
clinical,1603,1611,O
utilisation,1612,1623,O
PET,1627,1630,O
issues,1632,1638,O
study,1647,1652,O
cost,1653,1657,O
patient,1662,1669,O
throughput,1670,1680,O
emerge,1686,1692,O
significant,1696,1707,O
future,1708,1714,O
factors,1715,1722,O
consequence,1729,1740,O
low,1742,1745,O
cost,1746,1750,O
units,1751,1756,O
offered,1767,1774,O
manufacturers,1782,1795,O
utilisation,1808,1819,O
gamma,1823,1828,O
camera,1829,1835,O
based,1836,1841,O
SPET,1842,1846,O
systems,1847,1854,O
PET,1859,1862,O
coincidence,1863,1874,O
imaging,1875,1882,O
Unfortunately,1884,1897,O
clinical,1899,1907,O
studies,1908,1915,O
lymphoma,1919,1927,B-Pathological_formation
cancers,1938,1945,B-Pathological_formation
demonstrated,1959,1971,O
limitations,1976,1987,O
technology,1996,2006,O
20,2013,2015,O
lesions,2020,2027,B-Pathological_formation
15,2029,2031,O
mm,2032,2034,O
size,2038,2042,O
escaping,2043,2051,O
detection,2052,2061,O
hand,2076,2080,O
recent,2086,2092,O
development,2093,2104,O
combined,2108,2116,O
PET,2117,2120,O
CT,2121,2123,O
devices,2124,2131,O
attempts,2132,2140,O
address,2144,2151,O
lack,2156,2160,O
anatomical,2164,2174,O
information,2175,2186,O
inherent,2187,2195,O
PET,2201,2204,O
images,2205,2211,O
taking,2213,2219,O
advantage,2220,2229,O
improvement,2241,2252,O
patient,2256,2263,O
throughput,2264,2274,O
cost,2285,2289,O
effectiveness,2290,2303,O
Preliminary,2305,2316,O
studies,2317,2324,O
multimodality,2336,2349,O
imaging,2350,2357,O
approach,2358,2366,O
demonstrated,2380,2392,O
potential,2397,2406,O
technique,2414,2423,O
potential,2438,2447,O
exists,2448,2454,O
certain,2456,2463,O
technical,2464,2473,O
issues,2474,2480,O
PET,2486,2489,O
CT,2490,2492,O
require,2493,2500,O
refinement,2501,2511,O
methodology,2519,2530,O
issues,2537,2543,O
include,2544,2551,O
organ,2552,2557,B-Organ
movement,2558,2566,O
respiratory,2576,2587,B-Anatomical_system
motion,2588,2594,O
strongly,2603,2611,O
influences,2612,2622,O
image,2627,2632,O
fusion,2633,2639,O
rapidly,2645,2652,O
acquired,2653,2661,O
CT,2662,2664,O
scan,2665,2669,O
slower,2679,2685,O
acquisition,2686,2697,O
PET,2703,2706,O
dataset,2707,2714,O
derivation,2724,2734,O
CT,2738,2740,O
based,2741,2746,O
attenuation,2747,2758,O
coefficients,2759,2771,O
presence,2779,2787,O
contrast,2791,2799,O
agents,2800,2806,O
metallic,2810,2818,O
implants,2819,2827,O
application,2833,2844,O
technology,2852,2862,O
radiotherapy,2867,2879,O
planning,2880,2888,O
poses,2894,2899,O
number,2902,2908,O
associated,2912,2922,O
challenges,2923,2933,O
Finally,2935,2942,O
development,2948,2959,O
dedicated,2963,2972,O
PET,2973,2976,O
systems,2977,2984,O
based,2985,2990,O
planar,2994,3000,O
detector,3001,3009,O
arrangements,3010,3022,O
new,3028,3031,O
detector,3032,3040,O
components,3041,3051,O
potential,3060,3069,O
improve,3073,3080,O
clinical,3081,3089,O
throughput,3090,3100,O
100,3109,3112,O
clinical,3119,3127,O
trials,3128,3134,O
systems,3146,3153,O
carried,3171,3178,O
order,3186,3191,O
establish,3195,3204,O
associated,3209,3219,O
body,3226,3230,B-Organism_subdivision
image,3231,3236,O
quality,3237,3244,O
Stereoselective,0,15,O
synthesis,16,25,O
1,29,30,O
aminoalkanephosphonic,31,52,O
acids,53,58,O
chiral,68,74,O
centers,75,82,O
activity,93,101,O
leucine,110,117,O
aminopeptidase,118,132,O
stereoselective,138,153,O
synthesis,154,163,O
1,167,168,O
amino,169,174,O
2,175,176,O
alkylalkanephosphonic,177,198,O
acids,199,204,O
compounds,214,223,O
bearing,224,231,O
chiral,236,242,O
centers,243,250,O
achieved,256,264,O
condensation,272,284,O
hypophosphorous,288,303,O
acid,304,308,O
salts,309,314,O
R,319,320,O
S,329,330,O
N,335,336,O
alpha,337,342,O
methylbenzylamine,343,360,O
appropriate,370,381,O
aldehydes,382,391,O
isopropanol,395,406,O
Simultaneous,408,420,O
deprotection,421,433,O
oxidation,438,447,O
action,455,461,O
bromine,465,472,O
water,473,478,O
provided,479,487,O
equimolar,488,497,O
mixtures,498,506,O
RS,514,516,O
RR,517,519,O
SR,524,526,O
SS,527,529,O
diastereomers,530,543,O
desired,547,554,O
acids,555,560,O
appeared,567,575,O
act,579,582,O
moderate,586,594,O
inhibitors,595,605,O
kidney,609,615,B-Organ
leucine,616,623,O
aminopeptidase,624,638,O
potency,644,651,O
dependent,652,661,O
absolute,669,677,O
configuration,678,691,O
centers,700,707,O
chirality,711,720,O
Community,1,10,O
intervention,11,23,O
hypertension,27,39,O
stroke,44,50,O
OBJECTIVE,53,62,O
evaluate,67,75,O
community,80,89,O
based,90,95,O
intervention,96,108,O
reduction,112,121,O
hypertension,125,137,O
stroke,142,148,O
different,152,161,O
age,162,165,O
groups,166,172,O
subtypes,177,185,O
hypertension,186,198,O
METHODS,200,207,O
6,212,213,O
cities,214,220,O
2,222,223,O
geographically,224,238,O
separated,239,248,O
communities,249,260,O
registered,268,278,O
population,279,289,O
10,296,298,O
000,299,302,O
selected,316,324,O
intervention,335,347,O
control,351,358,O
communities,359,370,O
cohort,374,380,O
containing,381,391,O
2,392,393,O
700,394,397,O
subjects,398,406,O
35,408,410,O
years,411,416,O
older,420,425,O
free,431,435,O
stroke,439,445,O
sampled,451,458,O
community,469,478,O
baseline,484,492,O
survey,493,499,O
conducted,504,513,O
screen,517,523,O
subjects,528,536,O
intervention,541,553,O
city,563,567,O
program,571,578,O
control,583,590,O
hypertension,594,606,O
heart,608,613,B-Organ
diseases,614,622,O
diabetes,627,635,O
initiated,640,649,O
intervention,657,669,O
cohort,670,676,O
health,681,687,O
education,688,697,O
provided,702,710,O
intervention,724,736,O
community,737,746,O
follow,750,756,O
survey,760,766,O
conducted,771,780,O
3,781,782,O
years,783,788,O
later,789,794,O
RESULTS,796,803,O
3,812,813,O
years,814,819,O
prevalence,825,835,O
hypertension,839,851,O
increased,852,861,O
intervention,870,882,O
control,887,894,O
cohorts,895,902,O
middle,922,928,O
elderly,933,940,O
cohorts,941,948,O
especially,950,960,O
middle,968,974,O
aged,975,979,O
control,983,990,O
group,991,996,O
hypertensives,1004,1017,O
intervention,1025,1037,O
cohort,1038,1044,O
rates,1050,1055,O
awareness,1059,1068,O
treatment,1070,1079,O
control,1084,1091,O
hypertension,1095,1107,O
got,1108,1111,O
improved,1112,1120,O
incidence,1126,1135,O
stroke,1139,1145,O
29,1150,1152,O
lower,1154,1159,O
HR,1161,1163,O
0,1166,1167,O
71,1168,1170,O
95,1172,1174,O
CI,1176,1178,O
0,1180,1181,O
58,1182,1184,O
0,1187,1188,O
87,1189,1191,O
mortality,1197,1206,O
stroke,1210,1216,O
40,1221,1223,O
lower,1225,1230,O
HR,1232,1234,O
0,1237,1238,O
60,1239,1241,O
95,1243,1245,O
CI,1247,1249,O
0,1251,1252,O
42,1253,1255,O
0,1258,1259,O
86,1260,1262,O
intervention,1271,1283,O
cohort,1284,1290,O
control,1300,1307,O
cohort,1308,1314,O
intervention,1320,1332,O
effective,1342,1351,O
reduction,1355,1364,O
stroke,1368,1374,O
isolated,1390,1398,O
systolic,1399,1407,O
hypertension,1408,1420,O
combined,1425,1433,O
systolic,1434,1442,O
diastolic,1447,1456,O
hypertension,1457,1469,O
P,1475,1476,O
0,1479,1480,O
05,1481,1483,O
cause,1501,1506,O
mortality,1507,1516,O
11,1521,1523,O
lower,1525,1530,O
HR,1532,1534,O
0,1537,1538,O
89,1539,1541,O
95,1543,1545,O
CI,1547,1549,O
0,1551,1552,O
78,1553,1555,O
0,1558,1559,O
99,1560,1562,O
intervention,1571,1583,O
cohort,1584,1590,O
control,1603,1610,O
cohort,1611,1617,O
CONCLUSION,1619,1629,O
community,1635,1644,O
based,1645,1650,O
intervention,1651,1663,O
effective,1668,1677,O
controlling,1681,1692,O
development,1697,1708,O
hypertension,1712,1724,O
stroke,1729,1735,O
elderly,1747,1754,O
people,1755,1761,O
benefit,1762,1769,O
middle,1784,1790,O
aged,1791,1795,O
people,1796,1802,O
intervention,1812,1824,O
Laboratory,1,11,O
diagnostics,12,23,O
Crimean,27,34,O
hemorrhagic,35,46,O
fever,47,52,O
polymerase,56,66,O
chain,67,72,O
reaction,73,81,O
group,88,93,O
developed,94,103,O
present,116,123,O
case,124,128,O
study,129,134,O
techniques,140,150,O
variations,152,162,O
e,166,167,O
single,171,177,O
step,178,182,O
RT,183,185,O
PCR,186,189,O
nested,194,200,O
RT,201,203,O
PCR,204,207,O
assays,208,214,O
purpose,224,231,O
detecting,235,244,O
Crimean,249,256,O
Congo,257,262,O
hemorrhagic,263,274,O
fever,275,280,O
RNA,281,284,O
virus,285,290,O
human,294,299,O
samples,300,307,O
assays,319,325,O
previously,343,353,O
recommended,354,365,O
Ministry,373,381,O
Health,385,391,O
Russian,399,406,O
Federation,407,417,O
simultaneously,423,437,O
14,446,448,O
clinical,449,457,O
samples,458,465,O
obtained,466,474,O
patients,480,488,O
Crimean,494,501,O
hemorrhagic,502,513,O
fever,514,519,O
assessing,527,536,O
detection,541,550,O
accuracy,551,559,O
found,568,573,O
developed,583,592,O
test,599,603,O
system,604,610,O
displayed,611,620,O
better,638,644,O
diagnostic,645,655,O
values,656,662,O
versus,663,669,O
previously,674,684,O
recommended,685,696,O
nested,697,703,O
RT,704,706,O
PCR,707,710,O
1000,717,721,O
fold,722,726,O
advantage,727,736,O
previously,746,756,O
recommended,757,768,O
single,769,775,O
step,776,780,O
RT,781,783,O
PCA,784,787,O
single,793,799,O
step,800,804,O
RT,805,807,O
PCR,808,811,O
assay,812,817,O
variation,818,827,O
preferable,843,853,O
sense,857,862,O
technical,866,875,O
economic,880,888,O
motivations,889,900,O
Finally,902,909,O
test,915,919,O
system,920,926,O
developed,927,936,O
reason,953,959,O
method,974,980,O
choice,984,990,O
routine,994,1001,O
PCR,1002,1005,O
diagnosis,1006,1015,O
Crimean,1019,1026,O
hemorrhagic,1027,1038,O
fever,1039,1044,O
official,1055,1063,O
trials,1064,1070,O
approvals,1075,1084,O
duly,1089,1093,O
complied,1094,1102,O
Prognostic,0,10,O
significance,11,23,O
correlation,28,39,O
survival,45,53,O
bcl,57,60,O
2,61,62,O
TGF,67,70,O
beta,71,75,O
RII,76,79,O
colon,83,88,B-Pathological_formation
cancer,89,95,I-Pathological_formation
Bcl,97,100,O
2,101,102,O
TGF,107,110,O
beta,111,115,O
receptors,116,125,O
type,126,130,O
II,131,133,O
RII,135,138,O
colon,143,148,B-Pathological_formation
carcinomas,149,159,I-Pathological_formation
studied,165,172,O
series,178,184,O
113,188,191,O
patients,192,200,O
determine,205,214,O
prognostic,221,231,O
significance,232,244,O
correlate,252,261,O
expression,268,278,O
prognostic,290,300,O
indicators,301,311,O
Bcl,313,316,O
2,317,318,O
expression,319,329,O
tumor,337,342,B-Cell
cells,343,348,I-Cell
showed,349,355,O
reverse,358,365,O
relation,366,374,O
tumor,380,385,B-Pathological_formation
size,386,390,O
P,392,393,O
0,396,397,O
018,398,401,O
histological,404,416,O
grade,417,422,O
P,424,425,O
0,428,429,O
04,430,432,O
stage,439,444,O
P,446,447,O
0,450,451,O
013,452,455,O
Univariate,458,468,O
survival,469,477,O
analysis,478,486,O
log,497,500,O
rank,501,505,O
test,506,510,O
showed,511,517,O
survival,527,535,O
patients,539,547,O
bcl,553,556,B-Pathological_formation
2,557,558,I-Pathological_formation
positive,559,567,I-Pathological_formation
tumors,568,574,I-Pathological_formation
significantly,579,592,O
better,593,599,O
survival,609,617,O
patients,621,629,O
bcl,635,638,B-Pathological_formation
2,639,640,I-Pathological_formation
negative,641,649,I-Pathological_formation
tumors,650,656,I-Pathological_formation
P,658,659,O
0,662,663,O
02,664,666,O
entered,683,690,O
multivariate,698,710,O
analysis,711,719,O
model,720,725,O
found,738,743,O
independent,753,764,O
prognostic,765,775,O
significance,776,788,O
TGF,790,793,O
beta,794,798,O
RII,799,802,O
expression,803,813,O
correlated,818,828,O
stage,834,839,O
P,841,842,O
0,845,846,O
03,847,849,O
statistically,861,874,O
significant,875,886,O
correlation,887,898,O
found,903,908,O
TGF,917,920,O
beta,921,925,O
RII,926,929,O
expression,930,940,O
histological,945,957,O
grade,958,963,O
survival,967,975,O
conclusion,980,990,O
results,998,1005,O
provide,1006,1013,O
additional,1014,1024,O
evidence,1025,1033,O
role,1042,1046,O
bcl,1050,1053,O
2,1054,1055,O
TGF,1060,1063,O
beta,1064,1068,O
RII,1069,1072,O
carcinogenesis,1076,1090,O
colon,1098,1103,B-Organ
support,1123,1130,O
use,1135,1138,O
factors,1148,1155,O
prognostic,1159,1169,O
markers,1170,1177,O
patients,1181,1189,O
colon,1195,1200,B-Pathological_formation
cancer,1201,1207,I-Pathological_formation
Antibiotic,0,10,O
induced,11,18,O
persistence,19,30,O
cytotoxic,34,43,O
Staphylococcus,44,58,O
aureus,59,65,O
non,69,72,B-Cell
phagocytic,73,83,I-Cell
cells,84,89,I-Cell
OBJECTIVES,91,101,O
infection,109,118,O
non,122,125,B-Cell
phagocytic,126,136,I-Cell
cells,137,142,I-Cell
Staphylococcus,149,163,O
aureus,164,170,O
strains,171,178,O
able,183,187,O
survive,191,198,O
kill,203,207,O
host,214,218,O
cells,219,224,B-Cell
purpose,230,237,O
study,246,251,O
determine,259,268,O
action,273,279,O
antibiotics,291,302,O
survival,310,318,O
host,322,326,O
cells,327,332,B-Cell
intracellular,340,353,B-Immaterial_anatomical_entity
S,354,355,O
aureus,357,363,O
METHODS,365,372,O
Murine,374,380,O
keratinocyte,381,393,B-Cell
PAM212,395,401,B-Cell
fibroblast,407,417,B-Cell
mKSA,419,423,B-Cell
cell,425,429,I-Cell
lines,430,435,I-Cell
infected,441,449,O
cytotoxic,455,464,O
S,465,466,O
aureus,468,474,O
cultured,479,487,O
presence,495,503,O
antibiotics,515,526,O
graded,530,536,O
concentrations,537,551,O
viability,557,566,O
host,570,574,O
cells,575,580,B-Cell
measured,585,593,O
24,594,596,O
h,597,598,O
infection,605,614,O
determine,619,628,O
bacterial,633,642,O
viability,643,652,O
host,660,664,O
cells,665,670,B-Cell
cellular,672,680,B-Organism_substance
lysates,681,688,I-Organism_substance
prepared,694,702,O
colony,707,713,O
forming,714,721,O
units,722,727,O
quantified,733,743,O
spiral,752,758,O
plater,759,765,O
Host,767,771,O
cells,772,777,B-Cell
infected,778,786,O
fluorescein,792,803,O
isothiocyanate,804,818,O
FITC,820,824,O
labelled,826,834,O
S,835,836,O
aureus,838,844,O
analysed,850,858,O
flow,862,866,O
cytometry,867,876,O
microscopy,881,891,O
determine,895,904,O
subcellular,909,920,B-Cellular_component
localization,921,933,O
S,934,935,O
aureus,937,943,O
RESULTS,945,952,O
Oxacillin,954,963,O
vancomycin,965,975,O
gentamicin,977,987,O
ciprofloxacin,989,1002,O
trimethoprim,1007,1019,O
sulfamethoxazole,1020,1036,O
rescue,1045,1051,O
host,1052,1056,O
cells,1057,1062,B-Cell
cell,1068,1072,B-Cell
death,1073,1078,O
induced,1079,1086,O
intracellular,1090,1103,B-Immaterial_anatomical_entity
S,1104,1105,O
aureus,1107,1113,O
contrast,1118,1126,O
linezolid,1128,1137,O
rifampicin,1139,1149,O
azithromycin,1151,1163,O
clindamycin,1165,1176,O
erythromycin,1178,1190,O
quinupristin,1195,1207,O
dalfopristin,1208,1220,O
suppressed,1221,1231,O
cytotoxic,1236,1245,O
action,1246,1252,O
S,1256,1257,O
aureus,1259,1265,O
withdrawal,1273,1283,O
antibiotics,1287,1298,O
intracellular,1300,1313,B-Immaterial_anatomical_entity
S,1314,1315,O
aureus,1317,1323,O
regained,1324,1332,O
cytotoxic,1333,1342,O
activity,1343,1351,O
killed,1356,1362,O
host,1369,1373,O
cells,1374,1379,B-Cell
rifampicin,1386,1396,O
able,1401,1405,O
eliminate,1409,1418,O
intracellular,1419,1432,B-Immaterial_anatomical_entity
S,1433,1434,O
aureus,1436,1442,O
completely,1443,1453,O
72,1461,1463,O
h,1464,1465,O
contrast,1470,1478,O
clindamycin,1480,1491,O
azithromycin,1493,1505,O
linezolid,1510,1519,O
induced,1520,1527,O
state,1530,1535,O
intracellular,1539,1552,B-Immaterial_anatomical_entity
persistence,1553,1564,O
viable,1568,1574,O
S,1575,1576,O
aureus,1578,1584,O
CONCLUSIONS,1586,1597,O
Antibiotics,1599,1610,O
commonly,1611,1619,O
management,1633,1643,O
S,1647,1648,O
aureus,1650,1656,O
infections,1657,1667,O
appear,1668,1674,O
create,1678,1684,O
niche,1687,1692,O
invasive,1697,1705,O
intracellular,1706,1719,B-Immaterial_anatomical_entity
S,1720,1721,O
aureus,1723,1729,O
play,1741,1745,O
important,1749,1758,O
role,1759,1763,O
persistence,1768,1779,O
recurrence,1784,1794,O
infection,1798,1807,O
unique,1824,1830,O
ability,1831,1838,O
eliminate,1842,1851,O
intracellular,1852,1865,B-Immaterial_anatomical_entity
S,1866,1867,O
aureus,1869,1875,O
rifampicin,1877,1887,O
appears,1888,1895,O
valuable,1902,1910,O
treatment,1919,1928,O
invasive,1932,1940,O
S,1941,1942,O
aureus,1944,1950,O
infections,1951,1961,O
sequencing,5,15,O
analysis,16,24,O
estrogen,28,36,O
receptor,37,45,O
alpha,46,51,O
gene,52,56,O
polymorphism,57,69,O
association,78,89,O
breast,95,101,B-Pathological_formation
cancer,102,108,I-Pathological_formation
risk,109,113,O
BACKGROUND,115,125,O
estrogen,131,139,O
receptor,140,148,O
plays,149,154,O
critical,157,165,O
role,166,170,O
breast,174,180,B-Pathological_formation
cancer,181,187,I-Pathological_formation
development,188,199,O
progression,204,215,O
genetic,224,231,O
polymorphism,232,244,O
ER,248,250,O
alpha,251,256,O
gene,257,261,O
affect,268,274,O
cancer,275,281,B-Pathological_formation
risk,282,286,O
phenotype,291,300,O
MATERIALS,302,311,O
METHODS,316,323,O
fully,328,333,O
sequenced,334,343,O
ER,348,350,O
alpha,351,356,O
gene,357,361,O
investigate,365,376,O
single,381,387,O
nucleotide,388,398,O
polymorphisms,399,412,O
SNPs,414,418,O
100,423,426,O
breast,427,433,B-Pathological_formation
cancer,434,440,I-Pathological_formation
patients,441,449,O
100,454,457,O
controls,458,466,O
RESULTS,468,475,O
novel,481,486,O
polymorphism,487,499,O
control,507,514,O
11,519,521,O
cancer,525,531,B-Pathological_formation
patients,532,540,O
found,546,551,O
G,557,558,O
G,559,560,O
genotype,561,569,O
C975,573,577,O
G,578,579,O
genotype,588,596,O
G1782,600,605,O
protective,614,624,O
effect,625,631,O
breast,640,646,B-Pathological_formation
cancer,647,653,I-Pathological_formation
compared,659,667,O
genotypes,677,686,O
0,693,694,O
3,695,696,O
0,701,702,O
3,703,704,O
respectively,706,718,O
975 G,721,725,O
allele,726,732,O
associated,737,747,O
inversely,748,757,O
p53,767,770,O
expression,771,781,O
positively,786,796,O
bcl,806,809,O
2,810,811,O
expression,812,822,O
cancer,826,832,B-Pathological_formation
borderline,838,848,O
significance,849,861,O
Combining,863,872,O
result,878,884,O
previous,894,902,O
study,903,908,O
associations,916,928,O
significant,941,952,O
p,954,955,O
0,958,959,O
005,960,963,O
0,968,969,O
019,970,973,O
respectively,975,987,O
CONCLUSION,990,1000,O
Polymorphisms,1002,1015,O
ER,1019,1021,O
alpha,1022,1027,O
gene,1028,1032,O
affect,1037,1043,O
breast,1048,1054,B-Pathological_formation
cancer,1055,1061,I-Pathological_formation
susceptibility,1062,1076,O
related,1088,1095,O
protein,1105,1112,O
expression,1113,1123,O
p53,1133,1136,O
bcl,1141,1144,O
2,1145,1146,O
Covariance,0,10,O
structure,11,20,O
analysis,21,29,O
statistical,31,42,O
practice,43,51,O
theory,53,59,O
directions,65,75,O
covariance,86,96,O
structure,97,106,O
analysis,107,115,O
increasingly,124,136,O
analyze,140,147,O
nonexperimental,148,163,O
data,164,168,O
important,170,179,O
statistical,180,191,O
requirements,192,204,O
proper,213,219,O
use,220,223,O
frequently,228,238,O
ignored,239,246,O
Valid,248,253,O
conclusions,254,265,O
adequacy,276,284,O
model,290,295,O
acceptable,302,312,O
representation,313,327,O
data,331,335,O
based,347,352,O
goodness,356,364,O
fit,368,371,O
test,372,376,O
statistics,377,387,O
standard,392,400,O
errors,401,407,O
parameter,411,420,O
estimates,421,430,O
rely,432,436,O
model,444,449,O
estimation,450,460,O
procedure,461,470,O
appropriate,477,488,O
data,497,501,O
analogies,509,518,O
linear,522,528,O
regression,529,539,O
anova,544,549,O
review,556,562,O
examines,563,571,O
conditions,572,582,O
conclusions,595,606,O
drawn,607,612,O
estimation,626,636,O
methods,637,644,O
correct,653,660,O
consequences,669,681,O
ignoring,685,693,O
conditions,700,710,O
distinction,714,725,O
estimation,742,752,O
methods,753,760,O
correctly,777,786,O
incorrectly,790,801,O
specified,802,811,O
distribution,820,832,O
data,836,840,O
analyzed,847,855,O
shown,867,872,O
valid,878,883,O
conclusions,884,895,O
possible,900,908,O
misspecification,920,936,O
brief,940,945,O
example,946,953,O
illustrates,954,965,O
ideas,970,975,O
Internet,977,985,O
access,986,992,O
given,996,1001,O
computer,1007,1015,O
code,1016,1020,O
methods,1033,1040,O
available,1054,1063,O
programs,1067,1075,O
EQS,1084,1087,O
LISREL,1091,1097,O
Potent,0,6,O
antibacterial,7,20,O
activity,21,29,O
Y,33,34,O
754,35,38,O
novel,42,47,O
benzimidazole,48,61,O
compound,62,70,O
selective,76,85,O
action,86,92,O
Helicobacter,101,113,O
pylori,114,120,O
Y,122,123,O
754,124,127,O
novel,131,136,O
benzimidazole,137,150,O
compound,151,159,O
investigated,165,177,O
vitro,185,190,O
vivo,198,202,O
antibacterial,203,216,O
activity,217,225,O
Unlike,227,233,O
amoxicillin,234,245,O
clarithromycin,247,261,O
metronidazole,267,280,O
compound,286,294,O
activity,302,310,O
common,319,325,O
aerobic,326,333,O
anaerobic,338,347,O
bacteria,348,356,O
Helicobacter,368,380,O
pylori,381,387,O
minimum,393,400,O
inhibitory,401,411,O
concentration,412,425,O
Y,429,430,O
754,431,434,O
H,443,444,O
pylori,446,452,O
0,457,458,O
025,459,462,O
microg,463,469,O
ml,470,472,O
nearly,478,484,O
equal,485,490,O
amoxicillin,502,513,O
clarithromycin,518,532,O
respective,538,548,O
concentrations,549,563,O
Y,567,568,O
754,569,572,O
amoxicillin,574,585,O
clarithromycin,587,601,O
metronidazole,607,620,O
required,621,629,O
inhibit,633,640,O
90,641,643,O
39,648,650,O
isolates,651,659,O
H,663,664,O
pylori,666,672,O
0,678,679,O
05,680,682,O
0,684,685,O
39,686,688,O
6,690,691,O
25,692,694,O
25,700,702,O
microg,703,709,O
ml,710,712,O
indicating,714,724,O
potent,729,735,O
activity,736,744,O
Y,748,749,O
754,750,753,O
including,755,764,O
activity,765,773,O
clarithromycin,782,796,O
metronidazole,802,815,O
resistant,816,825,O
strains,826,833,O
anti,839,843,O
H,844,845,O
pylori,847,853,O
activity,854,862,O
Y,866,867,O
754,868,871,O
potent,876,882,O
pH,891,893,O
5,894,895,O
5,896,897,O
bactericidal,906,918,O
concentrations,922,936,O
0,940,941,O
1,942,943,O
microg,944,950,O
ml,951,953,O
Exposure,965,973,O
H,977,978,O
pylori,980,986,O
Y,990,991,O
754,992,995,O
result,1004,1010,O
induction,1018,1027,O
drug,1031,1035,O
resistant,1036,1045,O
mutation,1046,1054,O
Oral,1056,1060,O
administration,1061,1075,O
10,1077,1079,O
mg,1080,1082,O
kg,1083,1085,O
twice,1086,1091,O
day,1094,1097,O
7,1102,1103,O
days,1104,1108,O
Mongolian,1113,1122,O
gerbils,1123,1130,O
infected,1131,1139,O
strain,1145,1151,O
ATCC,1152,1156,O
43504,1157,1162,O
demonstrated,1163,1175,O
Y,1181,1182,O
754,1183,1186,O
effective,1191,1200,O
H,1204,1205,O
pylori,1207,1213,O
eradication,1214,1225,O
eradication,1239,1250,O
efficacy,1251,1259,O
increased,1260,1269,O
line,1273,1277,O
progress,1287,1295,O
damage,1299,1305,O
gastric,1313,1320,B-Multi-tissue_structure
mucosa,1321,1327,I-Multi-tissue_structure
caused,1328,1334,O
H,1338,1339,O
pylori,1341,1347,O
infection,1348,1357,O
Y,1359,1360,O
754,1361,1364,O
efficacious,1374,1385,O
treatment,1393,1402,O
infection,1406,1415,O
clarithromycin,1423,1437,O
resistant,1438,1447,O
strain,1448,1454,O
OIT,1455,1458,O
36,1459,1461,O
results,1467,1474,O
obtained,1475,1483,O
lead,1484,1488,O
expectation,1496,1507,O
new,1517,1520,O
benzimidazole,1521,1534,O
Y,1535,1536,O
754,1537,1540,O
near,1554,1558,O
future,1559,1565,O
H,1579,1580,O
pylori,1582,1588,O
eradication,1589,1600,O
therapy,1601,1608,O
peptic,1612,1618,B-Pathological_formation
ulcer,1619,1624,I-Pathological_formation
patients,1625,1633,O
Active,0,6,O
respiratory,7,18,O
syncytial,19,28,O
virus,29,34,O
purified,35,43,O
ion,47,50,O
exchange,51,59,O
chromatography,60,74,O
characterization,76,92,O
binding,96,103,O
elution,108,115,O
requirements,116,128,O
viruses,134,141,O
respiratory,143,154,O
syncytial,155,164,O
virus,165,170,O
RSV,172,175,O
vesicular,181,190,O
stomatitis,191,201,O
virus,202,207,O
VSV,209,212,O
evaluate,227,235,O
viral,236,241,O
purification,242,254,O
affinity,261,269,O
resin,270,275,O
column,276,282,O
Matrex,284,290,O
Cellufine,291,300,O
Sulfate,301,308,O
MCS,310,313,O
Amicon,316,322,O
Division,323,331,O
WR,333,335,O
Grace,336,341,O
Co,344,346,O
Viable,350,356,O
RSV,357,360,O
purified,365,373,O
significantly,374,387,O
crude,393,398,O
cell,399,403,B-Organism_substance
lysate,404,410,I-Organism_substance
single,416,422,O
pass,423,427,O
column,438,444,O
containing,445,455,O
anionic,460,467,O
MCS,468,471,O
resin,472,477,O
cell,484,488,B-Cell
protein,489,496,O
albumin,501,508,O
eluted,509,515,O
MCS,525,528,O
resin,529,534,O
phosphate,540,549,O
buffered,550,558,O
saline,559,565,O
PBS,567,570,O
RSV,576,579,O
eluted,580,586,O
high,590,594,O
ionic,595,600,O
strength,601,609,O
e,613,614,O
greater,617,624,O
equal,633,638,O
0,642,643,O
6,644,645,O
M,646,647,O
NaCl,648,652,O
purification,662,674,O
possible,679,687,O
sucrose,691,698,O
step,699,703,O
gradient,704,712,O
centrifugation,713,727,O
RSV,733,736,O
prepared,737,745,O
column,749,755,O
purification,756,768,O
column,775,781,O
plus,782,786,O
sucrose,787,794,O
gradient,795,803,O
separation,804,814,O
intact,824,830,O
infective,835,844,O
RSV,846,849,O
pure,854,858,O
samples,859,866,O
VSV,870,873,O
optimize,887,895,O
ionic,896,901,O
strength,902,910,O
salts,915,920,O
elution,925,932,O
MCS,942,945,O
column,946,952,O
0,954,955,O
8,956,957,O
M,958,959,O
NaCl,960,964,O
removed,965,972,O
viral,985,990,O
protein,991,998,O
capacity,1004,1012,O
MCS,1020,1023,O
gel,1024,1027,O
RSV,1032,1035,O
VSV,1039,1042,O
found,1047,1052,O
0,1065,1066,O
6,1067,1068,O
0,1069,1070,O
8,1071,1072,O
mg,1073,1075,O
viral,1076,1081,O
protein,1082,1089,O
ml,1094,1096,O
hydrated,1100,1108,O
resin,1109,1114,O
Detergent,1116,1125,O
solubilized,1126,1137,O
viral,1138,1143,O
membrane,1144,1152,B-Cellular_component
proteins,1153,1161,O
bound,1162,1167,O
MCS,1175,1178,O
resin,1179,1184,O
0,1188,1189,O
145,1190,1193,O
M,1194,1195,O
NaCl,1196,1200,O
eluted,1205,1211,O
higher,1217,1223,O
salt,1224,1228,O
concentrations,1229,1243,O
resin,1256,1261,O
useful,1276,1282,O
aid,1283,1286,O
relatively,1291,1301,O
gentle,1302,1308,O
purification,1309,1321,O
proteins,1331,1339,O
Novel,0,5,O
insights,6,14,O
pathogenesis,24,36,O
uric,40,44,O
acid,45,49,O
nephrolithiasis,50,65,O
PURPOSE,67,74,O
REVIEW,78,84,O
factors,90,97,O
involved,98,106,O
pathogenesis,114,126,O
uric,130,134,O
acid,135,139,O
nephrolithiasis,140,155,O
known,165,170,O
low,174,177,O
urinary,178,185,B-Organism_substance
pH,186,188,O
significant,201,212,O
element,213,220,O
generation,228,238,O
stones,242,248,B-Organism_substance
hyperuricosuria,255,270,O
common,284,290,O
finding,291,298,O
underlying,304,314,O
mechanism,315,324,O
s,325,326,O
responsible,328,339,O
disturbances,350,362,O
remain,363,369,O
poorly,370,376,O
characterized,377,390,O
review,397,403,O
summarizes,404,414,O
previous,415,423,O
knowledge,424,433,O
highlights,438,448,O
recent,454,460,O
developments,461,473,O
pathophysiology,481,496,O
low,500,503,O
urine,504,509,B-Organism_substance
pH,510,512,O
hyperuricosuria,517,532,O
RECENT,534,540,O
FINDINGS,541,549,O
Epidemiological,551,566,O
metabolic,571,580,O
studies,581,588,O
indicated,594,603,O
association,607,618,O
uric,627,631,O
acid,632,636,O
nephrolithiasis,637,652,O
insulin,657,664,O
resistance,665,675,O
potential,682,691,O
mechanisms,692,702,O
include,703,710,O
impaired,711,719,O
ammoniagenesis,720,734,O
caused,735,741,O
resistance,745,755,O
insulin,759,766,O
action,767,773,O
renal,781,786,B-Multi-tissue_structure
proximal,787,795,I-Multi-tissue_structure
tubule,796,802,I-Multi-tissue_structure
substrate,807,816,O
competition,817,828,O
free,832,836,O
fatty,837,842,O
acids,843,848,O
evaluation,854,864,O
large,870,875,O
Sicilian,876,884,O
kindred,885,892,O
recently,893,901,O
revealed,902,910,O
putative,913,921,O
genetic,922,929,O
locus,930,935,O
linked,936,942,O
uric,946,950,B-Organism_substance
acid,951,955,I-Organism_substance
stone,956,961,I-Organism_substance
disease,962,969,O
identification,975,989,O
novel,993,998,O
complementary,999,1012,O
DNA,1013,1016,O
provided,1021,1029,O
interesting,1033,1044,O
insight,1045,1052,O
renal,1062,1067,B-Organ
handling,1068,1076,O
uric,1080,1084,O
acid,1085,1089,O
including,1091,1100,O
genetic,1105,1112,O
cause,1113,1118,O
renal,1122,1127,B-Organ
uric,1128,1132,O
acid,1133,1137,O
wasting,1138,1145,O
SUMMARY,1147,1154,O
recognition,1160,1171,O
metabolic,1175,1184,O
molecular,1186,1195,O
genetic,1201,1208,O
factors,1209,1216,O
influence,1222,1231,O
urinary,1232,1239,B-Organism_substance
pH,1240,1242,O
uric,1248,1252,O
acid,1253,1257,O
metabolism,1258,1268,O
excretion,1273,1282,O
provide,1289,1296,O
novel,1297,1302,O
insights,1303,1311,O
pathogenesis,1321,1333,O
uric,1337,1341,B-Organism_substance
acid,1342,1346,I-Organism_substance
stones,1347,1353,I-Organism_substance
open,1359,1363,O
way,1368,1371,O
new,1376,1379,O
therapeutic,1380,1391,O
strategies,1392,1402,O
Flow,0,4,O
dynamics,5,13,O
internal,21,29,B-Multi-tissue_structure
thoracic,30,38,I-Multi-tissue_structure
radial,43,49,B-Multi-tissue_structure
artery,50,56,I-Multi-tissue_structure
T,57,58,O
graft,59,64,O
BACKGROUND,66,76,O
Complex,78,85,O
use,86,89,O
arterial,93,101,B-Multi-tissue_structure
conduits,102,110,I-Multi-tissue_structure
resurrected,115,126,O
concerns,127,135,O
adequacy,146,154,O
conduit,158,165,B-Multi-tissue_structure
flow,166,170,O
T,176,177,O
graft,178,183,O
extreme,191,198,O
example,199,206,O
trend,215,220,O
purpose,226,233,O
identify,241,249,O
limitation,254,264,O
single,268,274,O
source,275,281,O
inflow,282,288,O
compare,296,303,O
flow,304,308,O
capacity,309,317,O
completion,323,333,O
coronary,334,342,B-Multi-tissue_structure
flow,343,347,O
METHODS,349,356,O
February,366,374,O
1999,375,379,O
November,384,392,O
2001,393,397,O
372,399,402,O
patients,403,411,O
underwent,412,421,O
total,422,427,O
arterial,428,436,B-Multi-tissue_structure
revascularization,437,454,O
T,464,465,O
graft,466,471,O
Intraoperative,479,493,O
flows,494,499,O
recorded,505,513,O
limb,523,527,B-Multi-tissue_structure
T,535,536,O
graft,537,542,O
distal,560,566,O
anastomoses,567,578,O
204,582,585,O
patients,586,594,O
Independent,596,607,O
predictors,608,618,O
T,622,623,O
graft,624,629,O
flow,630,634,O
identified,640,650,O
multivariate,654,666,O
analysis,667,675,O
RESULTS,677,684,O
Free,686,690,O
flow,691,695,O
radial,704,710,B-Multi-tissue_structure
arterial,711,719,I-Multi-tissue_structure
RA,721,723,I-Multi-tissue_structure
limb,725,729,I-Multi-tissue_structure
161,734,737,O
81,742,744,O
mL,745,747,O
min,748,751,O
internal,757,765,B-Multi-tissue_structure
thoracic,766,774,I-Multi-tissue_structure
artery,775,781,I-Multi-tissue_structure
ITA,783,786,I-Multi-tissue_structure
limb,788,792,I-Multi-tissue_structure
137,793,796,O
57,801,803,O
mL,804,806,O
min,807,810,O
combined,812,820,O
298,821,824,O
101,829,832,O
mL,833,835,O
min,836,839,O
versus,841,847,O
simultaneous,848,860,O
limb,861,865,B-Multi-tissue_structure
flow,866,870,O
226,874,877,O
84,882,884,O
mL,885,887,O
min,888,891,O
giving,892,898,O
flow,901,905,O
restriction,906,917,O
24,921,923,O
14,929,931,O
Completion,934,944,O
coronary,945,953,B-Multi-tissue_structure
flow,954,958,O
88,963,965,O
49,970,972,O
mL,973,975,O
min,976,979,O
RA,988,990,B-Multi-tissue_structure
60,992,994,O
45,999,1001,O
mL,1002,1004,O
min,1005,1008,O
ITA,1017,1020,B-Multi-tissue_structure
140,1026,1029,O
70,1034,1036,O
mL,1037,1039,O
min,1040,1043,O
limbs,1053,1058,B-Multi-tissue_structure
simultaneously,1059,1073,O
flow,1084,1088,O
reserve,1089,1096,O
vs,1098,1100,O
simultaneous,1101,1113,O
free,1114,1118,O
flow,1119,1123,O
160,1128,1131,O
1,1136,1137,O
6,1138,1139,O
Independent,1141,1152,O
predictors,1153,1163,O
completion,1167,1177,O
RA,1178,1180,B-Multi-tissue_structure
limb,1181,1185,I-Multi-tissue_structure
flow,1186,1190,O
RA,1195,1197,B-Multi-tissue_structure
proximal,1198,1206,O
diameter,1207,1215,O
p,1217,1218,O
0,1221,1222,O
005,1223,1226,O
number,1229,1235,O
anastomoses,1239,1250,O
p,1252,1253,O
0,1256,1257,O
018,1258,1261,O
target,1268,1274,O
stenosis,1275,1283,O
p,1285,1286,O
0,1289,1290,O
005,1291,1294,O
CONCLUSIONS,1297,1308,O
flow,1312,1316,O
reserve,1317,1324,O
1,1328,1329,O
6,1330,1331,O
compares,1332,1340,O
favorably,1341,1350,O
ITA,1359,1362,B-Multi-tissue_structure
flow,1363,1367,O
reserve,1368,1375,O
1,1379,1380,O
8,1381,1382,O
1,1386,1387,O
month,1388,1393,O
postoperatively,1394,1409,O
1,1414,1415,O
8,1416,1417,O
ITA,1431,1434,B-Multi-tissue_structure
T,1435,1436,O
graft,1437,1442,O
ITA,1451,1454,B-Multi-tissue_structure
RA,1455,1457,I-Multi-tissue_structure
T,1458,1459,O
graft,1460,1465,O
1,1469,1470,O
week,1471,1475,O
postoperatively,1476,1491,O
reported,1495,1503,O
Proximal,1515,1523,O
RA,1524,1526,B-Multi-tissue_structure
diameter,1527,1535,O
competitive,1540,1551,O
coronary,1552,1560,B-Multi-tissue_structure
flow,1561,1565,O
influence,1566,1575,O
completion,1576,1586,O
T,1587,1588,O
graft,1589,1594,O
flow,1595,1599,O
data,1607,1611,O
quantitate,1612,1622,O
limitation,1627,1637,O
single,1641,1647,O
source,1648,1654,O
inflow,1655,1661,O
T,1669,1670,O
graft,1671,1676,O
configuration,1677,1690,O
support,1695,1702,O
continued,1707,1716,O
use,1717,1720,O
Thiazole,0,8,O
orange,9,15,O
positive,16,24,O
platelets,25,34,B-Cell
dog,40,43,O
Evans,49,54,O
syndrome,56,64,O
examined,69,77,O
transition,78,88,O
percentage,97,107,O
reticulated,111,122,B-Cell
platelets,123,132,I-Cell
RP,134,136,B-Cell
platelet,143,151,B-Cell
count,152,157,O
canine,163,169,O
case,170,174,O
Evans,178,183,O
syndrome,185,193,O
result,199,205,O
demonstrated,206,218,O
measurement,224,235,O
RP,243,245,B-Cell
useful,254,260,O
evaluating,264,274,O
platelet,275,283,B-Cell
production,284,294,O
bone,302,306,B-Multi-tissue_structure
marrow,307,313,I-Multi-tissue_structure
response,318,326,O
treatment,330,339,O
Human,0,5,O
cytomegalovirus,6,21,O
5,22,23,O
kilobase,24,32,O
immediate,33,42,O
early,43,48,O
RNA,49,52,O
stable,58,64,O
intron,65,71,O
Immediate,73,82,O
early,83,88,O
viral,89,94,O
gene,95,99,O
products,100,108,O
human,112,117,O
cytomegalovirus,118,133,O
HCMV,135,139,O
derived,145,152,O
genomic,166,173,O
loci,174,178,O
largely,183,190,O
serve,191,196,O
establish,200,209,O
cellular,212,220,B-Cell
environment,221,232,O
conducive,233,242,O
viral,246,251,O
replication,252,263,O
examined,281,289,O
unusual,293,300,O
immediate,301,310,O
early,311,316,O
transcript,317,327,O
known,328,333,O
5,341,342,O
kb,343,345,O
RNA,346,349,O
concluding,351,361,O
stable,375,381,O
intron,382,388,O
encoded,389,396,O
HCMV,400,404,O
5,410,411,O
kb,412,414,O
RNA,415,418,O
highly,422,428,O
rich,432,436,O
sequence,440,448,O
lacks,453,458,O
open,459,463,O
reading,464,471,O
frames,472,478,O
likely,479,485,O
translated,492,502,O
protein,508,515,O
confirmed,520,529,O
absence,534,541,O
polyadenylation,545,560,O
transcript,568,578,O
showed,583,589,O
primarily,601,610,O
nuclear,611,618,B-Cellular_component
localized,619,628,O
viral,636,641,O
infection,642,651,O
mapped,656,662,O
5,667,668,O
end,670,673,O
5,681,682,O
kb,683,685,O
RNA,686,689,O
consensus,695,704,O
splice,705,711,O
donor,712,717,O
site,718,722,O
localized,727,736,O
3,741,742,O
end,744,747,O
vicinity,755,763,O
splice,769,775,O
acceptor,776,784,O
site,785,789,O
transfection,794,806,O
studies,807,814,O
showed,819,825,O
5,835,836,O
kb,837,839,O
RNA,840,843,O
spliced,851,858,O
heterologous,866,878,O
primary,879,886,O
transcript,887,897,O
bacterial,905,914,O
artificial,915,925,O
chromosome,926,936,B-Cellular_component
technology,937,947,O
constructed,952,963,O
viral,966,971,O
recombinant,972,983,O
containing,984,994,O
mutation,997,1005,O
5,1013,1014,O
splice,1016,1022,O
donor,1023,1028,O
site,1029,1033,O
defines,1039,1046,O
5,1051,1052,O
end,1054,1057,O
RNA,1065,1068,O
found,1073,1078,O
mutation,1089,1097,O
eliminates,1098,1108,O
expression,1109,1119,O
5,1127,1128,O
kb,1129,1131,O
RNA,1132,1135,O
viral,1143,1148,O
infection,1149,1158,O
mutant,1165,1171,O
grows,1172,1177,O
human,1181,1186,O
fibroblasts,1187,1198,B-Cell
complementation,1207,1222,O
Taken,1224,1229,O
data,1246,1250,O
support,1251,1258,O
conclusion,1263,1273,O
5,1283,1284,O
kb,1285,1287,O
RNA,1288,1291,O
stable,1297,1303,O
intron,1304,1310,O
expressed,1311,1320,O
HCMV,1324,1328,O
Reduced,0,7,O
prognostic,8,18,O
power,19,24,O
ventricular,28,39,B-Multi-tissue_structure
late,40,44,O
potentials,45,55,O
post,59,63,O
infarction,64,74,O
patients,75,83,O
reperfusion,91,102,O
era,103,106,O
AIMS,108,112,O
test,117,121,O
prognostic,126,136,O
value,137,142,O
ventricular,146,157,B-Multi-tissue_structure
late,158,162,O
potentials,163,173,O
LPs,175,178,O
large,185,190,O
cohort,191,197,O
post,201,205,O
infarction,206,216,O
patients,217,225,O
modern,233,239,O
reperfusion,240,251,O
era,252,255,O
METHODS,257,264,O
RESULTS,269,276,O
1800,278,282,O
consecutive,283,294,O
survivors,295,304,O
acute,308,313,O
myocardial,314,324,B-Multi-tissue_structure
infarction,325,335,O
sinus,339,344,B-Immaterial_anatomical_entity
rhythm,345,351,O
76,362,364,O
years,365,370,O
age,374,377,O
enrolled,383,391,O
99,399,401,O
patients,411,419,O
received,420,428,O
reperfusion,429,440,O
revascularization,441,458,O
therapy,459,466,O
91,468,470,O
percutaneous,472,484,O
coronary,485,493,B-Multi-tissue_structure
intervention,494,506,O
date,518,522,O
pharmacological,523,538,O
treatment,539,548,O
99,550,552,O
aspirin,554,561,O
93,563,565,O
beta,567,571,O
blockers,572,580,O
90,582,584,O
ACE,586,589,O
inhibitors,590,600,O
85,606,608,O
statins,610,617,O
LPs,620,623,O
calculated,629,639,O
968,643,646,O
patients,647,655,O
found,660,665,O
present,672,679,O
90,683,685,O
9,687,688,O
3,689,690,O
primary,698,705,O
endpoint,706,714,O
composite,723,732,O
cardiac,736,743,B-Organ
death,744,749,O
arrhythmic,762,772,O
events,773,779,O
secondary,785,794,O
endpoint,795,803,O
composite,812,821,O
sudden,825,831,O
cardiac,832,839,B-Organ
death,840,845,O
arrhythmic,858,868,O
events,869,875,O
follow,884,890,O
median,895,901,O
34,902,904,O
months,905,911,O
26,914,916,O
patients,917,925,O
reached,926,933,O
primary,938,945,O
endpoint,946,954,O
presence,960,968,O
LPs,972,975,O
significantly,984,997,O
associated,998,1008,O
primary,1018,1025,O
endpoint,1026,1034,O
univariable,1038,1049,O
multivariable,1053,1066,O
analysis,1067,1075,O
contrast,1080,1088,O
low,1090,1093,O
30,1102,1104,O
left,1107,1111,B-Multi-tissue_structure
ventricular,1112,1123,I-Multi-tissue_structure
ejection,1124,1132,O
fraction,1133,1141,O
hazard,1143,1149,O
ratio,1150,1155,O
9,1156,1157,O
6,1158,1159,O
95,1161,1163,O
confidence,1165,1175,O
interval,1176,1184,O
4,1185,1186,O
1,1187,1188,O
22,1189,1191,O
4,1192,1193,O
heart,1196,1201,B-Organ
rate,1202,1206,O
turbulence,1207,1217,O
category,1218,1226,O
2,1227,1228,O
7,1230,1231,O
5,1232,1233,O
2,1235,1236,O
4,1237,1238,O
23,1239,1241,O
9,1242,1243,O
category,1249,1257,O
1,1258,1259,O
5,1261,1262,O
3,1263,1264,O
1,1266,1267,O
9,1268,1269,O
14,1270,1272,O
9,1273,1274,O
significant,1281,1292,O
predictors,1293,1303,O
univariable,1312,1323,O
multivariable,1328,1341,O
analysis,1342,1350,O
CONCLUSION,1352,1362,O
Ventricular,1364,1375,B-Multi-tissue_structure
LPs,1376,1379,O
limited,1387,1394,O
use,1395,1398,O
risk,1403,1407,O
stratification,1408,1422,O
unselected,1426,1436,O
post,1437,1441,O
infarction,1442,1452,O
patients,1453,1461,O
modern,1469,1475,O
reperfusion,1476,1487,O
era,1488,1491,O
Bcl,0,3,O
2,4,5,O
decreases,6,15,O
cell,16,20,B-Cell
proliferation,21,34,O
promotes,39,47,O
accumulation,48,60,O
cells,64,69,B-Cell
S,73,74,O
phase,75,80,O
affecting,89,98,O
rate,103,107,O
apoptosis,111,120,O
human,124,129,O
ovarian,130,137,B-Cell
carcinoma,138,147,I-Cell
cells,148,153,I-Cell
OBJECTIVES,155,165,O
Bcl,171,174,O
2,175,176,O
protein,177,184,O
important,191,200,O
regulator,201,210,O
apoptotic,218,227,O
cascade,228,235,O
promotes,240,248,O
cell,249,253,B-Cell
survival,254,262,O
Bcl,264,267,O
2,268,269,O
delay,279,284,O
entry,285,290,O
cell,300,304,B-Cell
cycle,305,310,O
quiescence,316,326,O
present,335,342,O
study,343,348,O
isogenic,362,370,O
human,371,376,O
ovarian,377,384,B-Cell
carcinoma,385,394,I-Cell
cell,395,399,I-Cell
lines,400,405,I-Cell
expressed,413,422,O
differential,423,435,O
levels,436,442,O
Bcl,446,449,O
2,450,451,O
proteins,452,460,O
demonstrate,465,476,O
Bcl,482,485,O
2,486,487,O
regulate,492,500,O
growth,505,511,O
rates,512,517,O
adenocarcinoma,521,535,B-Cell
cells,536,541,I-Cell
METHODS,543,550,O
growth,556,562,O
rates,563,568,O
isogenic,576,584,O
ovarian,585,592,B-Cell
cancer,593,599,I-Cell
cell,600,604,I-Cell
lines,605,610,I-Cell
determined,616,626,O
XTT,630,633,O
assays,634,640,O
flow,645,649,O
cytometry,650,659,O
combined,660,668,O
PI,674,676,O
staining,677,685,O
Bcl,687,690,B-Cell
2,691,692,I-Cell
overexpressing,693,707,I-Cell
SKOV3,708,713,I-Cell
cells,714,719,I-Cell
modified,725,733,O
express,737,744,O
doxycycline,747,758,O
inducible,759,768,O
anti,769,773,O
Bcl,774,777,O
2,778,779,O
single,780,786,O
chain,787,792,O
antibody,793,801,O
effects,810,817,O
Bcl,821,824,O
2,825,826,O
protein,827,834,O
inhibition,835,845,O
cell,849,853,B-Cell
proliferation,854,867,O
apoptosis,872,881,O
assessed,887,895,O
RESULTS,897,904,O
demonstrate,909,920,O
Bcl,926,929,O
2,930,931,O
promotes,932,940,O
accumulation,945,957,O
proliferating,961,974,O
carcinoma,975,984,B-Cell
cells,985,990,I-Cell
S,994,995,O
phase,996,1001,O
Bcl,1007,1010,B-Cell
2,1011,1012,I-Cell
overexpressing,1013,1027,I-Cell
SKOV3,1028,1033,I-Cell
cell,1034,1038,I-Cell
line,1039,1043,I-Cell
proliferates,1044,1056,O
markedly,1057,1065,O
faster,1066,1072,O
shows,1077,1082,O
delayed,1083,1090,O
progression,1091,1102,O
G2 M,1106,1109,O
phase,1110,1115,O
compared,1116,1124,O
low,1132,1135,O
Bcl,1136,1139,B-Cell
2,1140,1141,I-Cell
expressing,1142,1152,I-Cell
counterpart,1153,1164,I-Cell
SKOV3,1165,1170,I-Cell
ip1,1171,1174,I-Cell
cell,1175,1179,I-Cell
line,1180,1184,I-Cell
Single,1186,1192,O
chain,1193,1198,O
antibody,1199,1207,O
mediated,1208,1216,O
inhibition,1217,1227,O
Bcl,1231,1234,O
2,1235,1236,O
SKOV3,1240,1245,B-Cell
cells,1246,1251,I-Cell
associated,1256,1266,O
increased,1272,1281,O
growth,1282,1288,O
rates,1289,1294,O
rapid,1304,1309,O
cell,1310,1314,B-Cell
cycle,1315,1320,O
progression,1321,1332,O
Treatment,1334,1343,O
cisplatin,1349,1358,O
resulted,1359,1367,O
cells,1376,1381,B-Cell
accumulating,1382,1394,O
S,1398,1399,O
phase,1400,1405,O
Bcl,1409,1412,B-Cell
2,1413,1414,I-Cell
overexpressing,1415,1429,I-Cell
SKOV3,1430,1435,I-Cell
cells,1436,1441,I-Cell
inhibition,1453,1463,O
Bcl,1467,1470,O
2,1471,1472,O
abolished,1473,1482,O
delayed,1483,1490,O
entry,1491,1496,O
G2 M,1502,1505,O
phase,1506,1511,O
affecting,1520,1529,O
cisplatin,1530,1539,O
induced,1540,1547,O
apoptosis,1548,1557,O
CONCLUSIONS,1559,1570,O
results,1576,1583,O
suggest,1584,1591,O
ovarian,1601,1608,B-Cell
cancer,1609,1615,I-Cell
cells,1616,1621,I-Cell
Bcl,1623,1626,O
2,1627,1628,O
delays,1629,1635,O
cell,1636,1640,B-Cell
cycle,1641,1646,O
progression,1647,1658,O
promoting,1662,1671,O
accumulation,1672,1684,O
cells,1688,1693,B-Cell
S,1697,1698,O
phase,1699,1704,O
affecting,1713,1722,O
rate,1727,1731,O
apoptosis,1735,1744,O
addition,1755,1763,O
known,1771,1776,O
role,1777,1781,O
G0,1789,1791,O
G1,1792,1794,O
checkpoint,1795,1805,O
demonstrate,1810,1821,O
time,1836,1840,O
Bcl,1846,1849,O
2,1850,1851,O
regulates,1857,1866,O
S,1871,1872,O
phase,1873,1878,O
novel,2,7,O
conotoxin,8,17,O
Conus,23,28,O
delessertii,29,40,O
posttranslationally,46,65,O
modified,66,74,O
lysine,75,81,O
residues,82,90,O
major,94,99,O
peptide,100,107,O
de13a,109,114,O
crude,124,129,O
venom,130,135,B-Organism_substance
Conus,139,144,O
delessertii,145,156,O
collected,157,166,O
Yucatan,174,181,O
Channel,182,189,O
Mexico,191,197,O
purified,203,211,O
peptide,217,224,O
high,231,235,O
content,236,243,O
posttranslationally,247,266,O
modified,267,275,O
amino,276,281,O
acids,282,287,O
including,289,298,O
6,299,300,O
bromotryptophan,301,316,O
nonstandard,323,334,O
amino,335,340,O
acid,341,345,O
proved,351,357,O
5,364,365,O
hydroxylysine,366,379,O
report,399,405,O
5,409,410,O
hydroxylysine,411,424,O
residues,425,433,O
conotoxins,437,447,O
sequence,453,461,O
analysis,462,470,O
cDNA,486,490,O
cloning,491,498,O
mass,505,509,O
determination,510,523,O
monoisotopic,525,537,O
mass,538,542,O
3486,546,550,O
76,551,553,O
Da,554,556,O
established,559,570,O
mature,580,586,O
toxin,587,592,O
sequence,601,609,O
DCOTSCOTTCANGWECCKGYOCVNKACSGCTH,610,642,O
O,650,651,O
4,655,656,O
hydroxyproline,657,671,O
W,673,674,O
6,675,676,O
bromotryptophan,677,692,O
K,698,699,O
5,700,701,O
hydroxylysine,702,715,O
asterisk,721,729,O
represents,730,740,O
amidated,745,753,O
C,754,755,O
terminus,756,764,O
calculated,774,784,O
monoisotopic,785,797,O
mass,798,802,O
3487,806,810,O
09,811,813,O
Da,814,816,O
Cys,828,831,O
residues,832,840,O
arranged,845,853,O
pattern,859,866,O
C,868,869,O
C,870,871,O
C,872,873,O
CC,874,876,O
C,877,878,O
C,879,880,O
C,881,882,O
described,888,897,O
previously,898,908,O
conotoxins,912,922,O
arrangement,929,940,O
propose,955,962,O
designation,967,978,O
framework,982,991,O
13,993,995,O
XIII,999,1003,O
differs,1005,1012,O
ones,1022,1026,O
C,1028,1029,O
C,1030,1031,O
CC,1032,1034,O
CC,1035,1037,O
C,1038,1039,O
C,1040,1041,O
C,1046,1047,O
C,1048,1049,O
C,1050,1051,O
C,1052,1053,O
CC,1054,1056,O
C,1057,1058,O
C,1059,1060,O
present,1062,1069,O
conotoxins,1079,1089,O
contain,1101,1108,O
Cys,1115,1118,O
residues,1119,1127,O
peptide,1134,1141,O
defines,1147,1154,O
novel,1157,1162,O
class,1163,1168,O
conotoxins,1172,1182,O
new,1191,1194,O
posttranslational,1195,1212,O
modification,1213,1225,O
previously,1230,1240,O
found,1241,1246,O
Conus,1256,1261,O
peptide,1262,1269,O
families,1270,1278,O
Enhancement,0,11,O
skin,15,19,B-Organ
permeation,20,30,O
ketotifen,34,43,O
supersaturation,47,62,O
generated,63,72,O
amorphous,76,85,O
form,86,90,O
drug,98,102,O
Pressure,104,112,O
sensitive,113,122,O
adhesive,123,131,O
PSA,133,136,O
matrices,138,146,O
containing,147,157,O
amorphous,158,167,O
ketotifen,168,177,O
prepared,183,191,O
evaluated,196,205,O
enhanced,210,218,O
skin,219,223,B-Organ
permeability,224,236,O
drug,244,248,O
solvent,252,259,O
casting,260,267,O
method,268,274,O
silicone,281,289,O
typed,290,295,O
PSA,296,299,O
employed,304,312,O
n,318,319,O
hexane,320,326,O
original,331,339,O
solvent,340,347,O
PSA,356,359,O
solvent,373,380,O
dichloromethane,382,397,O
tetrahydrofuran,399,414,O
acetone,416,423,O
ethyl,425,430,O
acetate,431,438,O
toluene,442,449,O
complete,465,473,O
dissolution,474,485,O
ketotifen,489,498,O
high,503,507,O
dispersion,508,518,O
amorphous,525,534,O
state,535,540,O
drug,548,552,O
Presence,554,562,O
amorphous,570,579,O
form,580,584,O
judged,589,595,O
based,596,601,O
vitro,612,617,O
drug,618,622,O
release,623,630,O
rate,631,635,O
matrix,645,651,O
result,658,664,O
dichloromethane,666,681,O
tetrahudrofuran,686,701,O
selected,707,715,O
appropriate,719,730,O
dilution,731,739,O
solvents,740,748,O
vitro,753,758,O
permeation,759,769,O
experiments,770,781,O
excised,790,797,O
hairless,798,806,O
mouse,807,812,O
skin,813,817,B-Organ
revealed,818,826,O
steady,836,842,O
state,843,848,O
flux,849,853,O
amorphous,863,872,O
ketotifen,873,882,O
dispersed,883,892,O
matrices,893,901,O
times,917,922,O
greater,923,930,O
crystalline,948,959,O
ketotifen,960,969,O
dispersed,970,979,O
matrices,980,988,O
enhancement,1003,1014,O
ratio,1015,1020,O
good,1028,1032,O
agreement,1033,1042,O
solubility,1052,1062,O
ratio,1063,1068,O
amorphous,1076,1085,O
crystalline,1089,1100,O
form,1101,1105,O
drug,1113,1117,O
Comparison,1119,1129,O
skin,1137,1141,B-Organ
permeation,1142,1152,O
profiles,1153,1161,O
amorphous,1165,1174,O
ketotifen,1175,1184,O
dispersed,1185,1194,O
matrices,1195,1203,O
different,1216,1225,O
drug,1226,1230,O
contents,1231,1239,O
suggested,1240,1249,O
steady,1259,1265,O
state,1266,1271,O
flux,1272,1276,O
influenced,1285,1295,O
drug,1303,1307,O
content,1308,1315,O
addition,1320,1328,O
drug,1338,1342,O
contents,1343,1351,O
period,1357,1363,O
steady,1371,1377,O
state,1378,1383,O
permeation,1384,1394,O
coincided,1395,1404,O
time,1414,1418,O
amorphous,1429,1438,O
drug,1439,1443,O
depleted,1448,1456,O
matrix,1466,1472,O
results,1480,1487,O
suggest,1488,1495,O
increase,1505,1513,O
skin,1517,1521,B-Organ
permeation,1522,1532,O
ketotifen,1536,1545,O
PSA,1551,1554,O
matrix,1555,1561,O
supersaturation,1577,1592,O
generated,1593,1602,O
amorphous,1606,1615,O
form,1616,1620,O
amorphous,1635,1644,O
form,1645,1649,O
stable,1654,1660,O
application,1672,1683,O
period,1684,1690,O
Polybrominated,0,14,O
diphenyl,15,23,O
ethers,24,30,O
indoor,34,40,O
dust,41,45,O
Ottawa,49,55,O
Canada,57,63,O
implications,65,77,O
sources,82,89,O
exposure,94,102,O
Polybrominated,104,118,O
diphenyl,119,127,O
ethers,128,134,O
PBDEs,136,141,O
widely,147,153,O
additive,162,170,O
flame,171,176,O
retardants,177,187,O
plastics,191,199,O
soft,201,205,O
furnishings,206,217,O
electrical,219,229,O
electronic,234,244,O
equipment,245,254,O
insulation,260,270,O
indoor,278,284,O
environment,285,296,O
released,309,317,O
indoors,318,325,O
volatilization,330,344,O
dusts,351,356,O
penta,362,367,O
octa,372,376,O
brominated,377,387,O
mixes,388,393,O
banned,402,408,O
parts,417,422,O
Europe,426,432,O
phasing,438,445,O
use,459,462,O
recently,467,475,O
begun,476,481,O
North,485,490,O
America,491,498,O
study,505,510,O
follows,511,518,O
previous,521,529,O
investigation,530,543,O
indoor,549,555,O
air,556,559,O
levels,560,566,O
PBDEs,570,575,O
House,577,582,O
dust,583,587,O
analyzed,592,600,O
family,610,616,O
vacuum,617,623,O
cleaners,624,632,O
68,636,638,O
74,651,653,O
randomly,654,662,O
selected,663,671,O
homes,672,677,O
Ottawa,682,688,O
Canada,690,696,O
winter,708,714,O
2002,718,722,O
2003,723,727,O
PBDEs,729,734,O
comprising,736,746,O
average,750,757,O
42,758,760,O
BDE,762,765,O
209,766,769,O
found,776,781,O
samples,789,796,O
levels,802,808,O
log,814,817,O
normally,818,826,O
distributed,827,838,O
geometric,846,855,O
mean,856,860,O
sigmaPBDE,861,870,O
2000,874,878,O
ng,879,881,O
g,882,883,O
1,885,886,O
median,895,901,O
1800,905,909,O
ng,910,912,O
g,913,914,O
1,916,917,O
dust,919,923,O
levels,929,935,O
dust,939,943,O
correlate,952,961,O
questionnaire,967,980,O
information,981,992,O
house,996,1001,O
characteristics,1002,1017,O
Correlations,1019,1031,O
found,1037,1042,O
pentamix,1051,1059,O
congener,1060,1068,O
levels,1069,1075,O
dust,1079,1083,O
air,1091,1094,O
homes,1109,1114,O
congeners,1128,1137,O
highly,1150,1156,O
brominated,1157,1167,O
mixes,1168,1173,O
Exposure,1175,1183,O
scenarios,1184,1193,O
presented,1198,1207,O
mean,1212,1216,O
high,1221,1225,O
dust,1226,1230,O
ingestion,1231,1240,O
rates,1241,1246,O
compared,1252,1260,O
exposures,1269,1278,O
pathways,1290,1298,O
adults,1309,1315,O
toddlers,1320,1328,O
6,1330,1331,O
months,1332,1338,O
2,1339,1340,O
years,1341,1346,O
Assuming,1349,1357,O
mean,1360,1364,O
dust,1365,1369,O
ingestion,1370,1379,O
rate,1380,1384,O
median,1389,1395,O
dust,1396,1400,O
air,1405,1408,O
concentrations,1409,1423,O
adults,1425,1431,O
exposed,1441,1448,O
7,1456,1457,O
5,1458,1459,O
ng,1460,1462,O
sigmaPBDE,1463,1472,O
d,1473,1474,O
1,1476,1477,O
dust,1487,1491,O
ingestion,1492,1501,O
pathway,1502,1509,O
represents,1517,1527,O
approximately,1528,1541,O
14,1542,1544,O
total,1549,1554,O
daily,1555,1560,O
exposure,1561,1569,O
compared,1575,1583,O
diet,1587,1591,O
82,1593,1595,O
inhalation,1602,1612,O
4,1614,1615,O
toddlers,1632,1640,O
equivalent,1645,1655,O
intakes,1656,1663,O
99,1673,1675,O
ng,1676,1678,O
d,1679,1680,O
1,1682,1683,O
representing,1686,1698,O
80,1699,1701,O
daily,1712,1717,O
PBDE,1718,1722,O
exposure,1723,1731,O
high,1736,1740,O
dust,1741,1745,O
ingestion,1746,1755,O
rates,1756,1761,O
values,1768,1774,O
increase,1775,1783,O
180,1787,1790,O
ng,1791,1793,O
d,1794,1795,O
1,1797,1798,O
80,1801,1803,O
daily,1805,1810,O
intake,1811,1817,O
adults,1823,1829,O
360,1834,1837,O
ng,1838,1840,O
d,1841,1842,O
1,1844,1845,O
89,1848,1850,O
daily,1852,1857,O
intake,1858,1864,O
toddlers,1870,1878,O
data,1884,1888,O
clearer,1896,1903,O
picture,1904,1911,O
sources,1915,1922,O
PBDE,1926,1930,O
exposure,1931,1939,O
home,1947,1951,O
environment,1952,1963,O
suggest,1968,1975,O
dust,1981,1985,O
significant,1997,2008,O
exposure,2009,2017,O
pathway,2018,2025,O
individuals,2035,2046,O
particularly,2048,2060,O
children,2061,2069,O
Pathogenesis,0,12,O
thrombosis,16,26,O
essential,30,39,O
thrombocythemia,40,55,O
polycythemia,60,72,O
vera,73,77,O
role,83,87,O
neutrophils,91,102,B-Cell
Thrombotic,104,114,O
complications,115,128,O
frequently,133,143,O
observed,144,152,O
patients,156,164,O
polycythemia,170,182,O
vera,183,187,O
PV,189,191,O
essential,197,206,O
thrombocythemia,207,222,O
ET,224,226,O
Abnormalities,229,242,O
red,246,249,B-Cell
blood,250,255,I-Cell
cells,256,261,I-Cell
platelets,266,275,B-Cell
arising,276,283,O
clonal,293,299,O
rearrangement,300,313,O
hematopoietic,317,330,B-Cell
cells,331,336,I-Cell
considered,347,357,O
causal,368,374,O
relationships,375,388,O
specific,410,418,O
abnormalities,419,432,O
thrombosis,437,447,O
clearly,462,469,O
established,470,481,O
involvement,487,498,O
neutrophils,502,513,B-Cell
macrophages,518,529,B-Cell
participate,537,548,O
thrombosis,552,562,O
hemostasis,567,577,O
insufficiently,588,602,O
explored,603,611,O
PV,615,617,O
ET,622,624,O
Persistent,626,636,O
activation,637,647,O
circulating,651,662,O
neutrophils,663,674,B-Cell
recently,679,687,O
demonstrated,688,700,O
ET,704,706,O
PV,711,713,O
patients,714,722,O
parallel,727,735,O
increase,744,752,O
plasma,756,762,B-Organism_substance
concentrations,763,777,O
endothelial,781,792,B-Tissue
damage,793,799,O
derived,800,807,O
prothrombotic,812,825,O
substances,826,836,O
studies,844,851,O
explored,857,865,O
augmentation,878,890,O
adhesion,894,902,O
neutrophils,906,917,B-Cell
affect,922,928,O
neutrophil,929,939,B-Cell
platelet,940,948,B-Cell
interaction,949,960,O
significant,969,980,O
increase,981,989,O
circulating,993,1004,O
neutrophil,1005,1015,B-Cell
platelet,1016,1024,B-Cell
aggregates,1025,1035,O
found,1039,1044,O
ET,1048,1050,O
PV,1055,1057,O
review,1064,1070,O
summarizes,1071,1081,O
current,1086,1093,O
knowledge,1094,1103,O
pathogenesis,1111,1123,O
thrombosis,1127,1137,O
PV,1141,1143,O
ET,1148,1150,O
emphasis,1157,1165,O
role,1173,1177,O
neutrophils,1181,1192,B-Cell
hemostasis,1196,1206,O
possible,1217,1225,O
involvement,1226,1237,O
mechanisms,1245,1255,O
acquired,1263,1271,O
thrombophilia,1272,1285,O
patients,1295,1303,O
Available,1305,1314,O
data,1315,1319,O
suggest,1320,1327,O
hemostatic,1339,1349,O
markers,1350,1357,O
deserve,1358,1365,O
included,1372,1380,O
prospective,1384,1395,O
clinical,1396,1404,O
studies,1405,1412,O
aimed,1413,1418,O
identifying,1422,1433,O
predictive,1440,1450,O
role,1451,1455,O
vascular,1463,1471,B-Multi-tissue_structure
complications,1472,1485,O
patients,1489,1497,O
ET,1503,1505,O
PV,1510,1512,O
Sensitivity,0,11,O
variation,12,21,O
center,29,35,O
holographic,36,47,O
recording,48,57,O
experimental,62,74,O
study,75,80,O
variation,84,93,O
sensitivity,97,108,O
recording,114,123,O
sensitizing,128,139,O
intensities,140,151,O
center,159,165,O
recording,166,175,O
presented,179,188,O
experimental,194,206,O
results,207,214,O
good,222,226,O
agreement,227,236,O
theoretical,246,257,O
predictions,258,269,O
shown,277,282,O
experimentally,283,297,O
knowledge,318,327,O
time,338,342,O
sensitivity,353,364,O
function,370,378,O
ratio,386,391,O
recording,395,404,O
sensitizing,408,419,O
intensities,420,431,O
absolute,444,452,O
intensities,453,464,O
ratio,476,481,O
recording,485,494,O
sensitizing,498,509,O
intensities,510,521,O
small,532,537,O
obtain,541,547,O
high,548,552,O
sensitivity,553,564,O
values,565,571,O
report,581,587,O
highest,592,599,O
sensitivity,600,611,O
S,613,614,O
0,615,616,O
15,617,619,O
cm,620,622,O
J,623,624,O
achieved,640,648,O
date,652,656,O
LiNbO3,663,669,O
Fe,670,672,O
Mn,673,675,O
crystal,676,683,O
Recent,0,6,O
advances,7,15,O
minisatellite,19,32,O
biology,33,40,O
Highly,42,48,O
polymorphic,49,60,O
tandemly,61,69,O
repeated,70,78,O
minisatellite,80,93,O
loci,95,99,O
abundant,109,117,O
human,125,130,O
genome,131,137,O
considerable,146,158,O
utility,159,166,O
human,170,175,O
genetic,176,183,O
analysis,184,192,O
review,199,205,O
describes,206,215,O
use,220,223,O
ordered,230,237,O
array,238,243,O
Charomid,244,252,O
library,253,260,O
systematic,268,278,O
efficient,283,292,O
cloning,293,300,O
regions,310,317,O
analysis,330,338,O
relative,346,354,O
overlap,355,362,O
different,375,384,O
probes,385,391,O
screen,400,406,O
hypervariable,411,424,O
loci,425,429,O
Recent,431,437,O
work,438,442,O
process,450,457,O
mutation,461,469,O
leading,470,477,O
generation,485,495,O
new,499,502,O
length,503,509,O
alleles,510,517,O
discussed,526,535,O
including,537,546,O
observation,551,562,O
mutations,582,591,O
unequal,606,613,O
exchanges,614,623,O
ictal,4,9,O
bradycardia,10,21,O
syndrome,22,30,O
localization,32,44,O
lateralization,49,63,O
PURPOSE,65,72,O
Previous,74,82,O
studies,83,90,O
established,96,107,O
importance,112,122,O
insular,130,137,B-Multi-tissue_structure
cortex,138,144,I-Multi-tissue_structure
temporal,149,157,B-Multi-tissue_structure
lobe,158,162,I-Multi-tissue_structure
cardiovascular,166,180,B-Anatomical_system
autonomic,181,190,O
modulation,191,201,O
investigators,208,221,O
based,223,228,O
results,236,243,O
cortical,247,255,B-Multi-tissue_structure
stimulation,256,267,O
response,268,276,O
functional,278,288,O
imaging,289,296,O
EEG,298,301,O
recordings,302,312,O
seizures,316,324,O
lesional,330,338,O
studies,339,346,O
suggested,353,362,O
cardiac,368,375,B-Organ
sympathetic,376,387,O
parasympathetic,392,407,O
function,408,416,O
lateralized,424,435,O
sympathetic,442,453,O
representation,454,468,O
lateralized,469,480,O
right,488,493,B-Multi-tissue_structure
insula,494,500,I-Multi-tissue_structure
parasympathetic,506,521,O
left,530,534,B-Multi-tissue_structure
studies,542,549,O
suggested,555,564,O
ictal,570,575,O
bradycardia,576,587,O
commonly,596,604,O
manifestation,607,620,O
activation,624,634,O
left,642,646,B-Multi-tissue_structure
temporal,647,655,I-Multi-tissue_structure
insular,660,667,B-Multi-tissue_structure
cortex,668,674,I-Multi-tissue_structure
evidence,689,697,O
inconsistent,710,722,O
sought,727,733,O
assess,737,743,O
critically,744,754,O
predictable,759,770,O
value,771,776,O
ictal,780,785,O
bradycardia,786,797,O
seizure,802,809,O
localization,810,822,O
lateralization,827,841,O
METHODS,843,850,O
study,860,865,O
reviewed,870,878,O
localization,883,895,O
seizure,899,906,O
activity,907,915,O
13,919,921,O
consecutive,922,933,O
patients,934,942,O
ictal,948,953,O
bradycardia,954,965,O
diagnosed,966,975,O
prolonged,983,992,O
video,993,998,O
EEG,999,1002,O
monitoring,1003,1013,O
Mayo,1017,1021,O
Clinic,1022,1028,O
Rochester,1029,1038,O
localization,1044,1056,O
electrographic,1060,1074,O
seizure,1075,1082,O
activity,1083,1091,O
seizure,1095,1102,O
onset,1103,1108,O
bradycardia,1113,1124,O
onset,1125,1130,O
identified,1135,1145,O
patients,1153,1161,O
addition,1166,1174,O
performed,1179,1188,O
comprehensive,1191,1204,O
review,1205,1211,O
ictal,1219,1224,O
bradycardia,1225,1236,O
literature,1237,1247,O
focusing,1248,1256,O
localization,1260,1272,O
seizure,1276,1283,O
activity,1284,1292,O
ictal,1296,1301,O
bradycardia,1302,1313,O
cases,1314,1319,O
RESULTS,1321,1328,O
occurrences,1334,1345,O
ictal,1349,1354,O
bradycardia,1355,1366,O
13,1374,1376,O
identified,1377,1387,O
patients,1388,1396,O
associated,1402,1412,O
temporal,1418,1426,O
lobe,1427,1431,O
onset,1432,1437,O
seizures,1438,1446,O
consistent,1460,1470,O
lateralization,1471,1485,O
seizure,1489,1496,O
activity,1497,1505,O
found,1510,1515,O
onset,1519,1524,O
seizure,1528,1535,O
activity,1536,1544,O
onset,1551,1556,O
bradycardia,1560,1571,O
population,1580,1590,O
Seizure,1592,1599,O
activity,1600,1608,O
bilateral,1613,1622,O
bradycardia,1626,1637,O
onset,1638,1643,O
13,1655,1657,O
patients,1658,1666,O
results,1672,1679,O
literature,1689,1699,O
review,1700,1706,O
showed,1712,1718,O
predominance,1726,1738,O
patients,1742,1750,O
bilateral,1755,1764,O
activity,1765,1773,O
bradycardia,1777,1788,O
onset,1789,1794,O
ictal,1817,1822,O
bradycardia,1823,1834,O
cases,1835,1840,O
literature,1850,1860,O
left,1865,1869,B-Multi-tissue_structure
hemispheric,1870,1881,I-Multi-tissue_structure
localization,1882,1894,O
seizure,1898,1905,O
onset,1906,1911,O
CONCLUSIONS,1913,1924,O
Ictal,1926,1931,O
bradycardia,1932,1943,O
occurs,1955,1961,O
association,1965,1976,O
bilateral,1982,1991,O
hemispheric,1992,2003,O
seizure,2004,2011,O
activity,2012,2020,O
consistent,2034,2044,O
lateralizing,2045,2057,O
sign,2058,2062,O
localizing,2066,2076,O
seizure,2077,2084,O
onset,2085,2090,O
data,2096,2100,O
support,2108,2115,O
existence,2120,2129,O
strictly,2135,2143,O
unilateral,2144,2154,O
parasympathetic,2155,2170,O
cardiomotor,2171,2182,O
representation,2183,2197,O
left,2205,2209,O
hemisphere,2210,2220,O
suggested,2234,2243,O
Dendrimer,0,9,O
templated,10,19,O
Fe,20,22,O
nanoparticles,23,36,O
growth,45,51,O
single,55,61,O
wall,62,66,O
carbon,67,73,O
nanotubes,74,83,O
plasma,87,93,O
enhanced,94,102,O
CVD,103,106,O
fourth,110,116,O
generation,117,127,O
G4,129,131,O
poly,133,137,O
amidoamine,138,148,O
PAMAM,151,156,O
dendrimer,158,167,O
G4,169,171,O
NH2,172,175,O
template,196,204,O
deliver,208,215,O
nearly,216,222,O
monodispersed,223,236,O
catalyst,237,245,O
nanoparticles,246,259,O
SiO2,263,267,O
Si,268,270,O
Ti,272,274,O
Si,275,277,O
sapphire,279,287,O
porous,293,299,O
anodic,300,306,O
alumina,307,314,O
PAA,316,319,O
substrates,321,331,O
Fe2O3,333,338,O
nanoparticles,339,352,O
obtained,353,361,O
calcination,368,379,O
immobilized,387,398,O
Fe3,399,402,O
G4,404,406,O
NH2,407,410,O
composite,411,420,O
served,421,427,O
catalytic,431,440,O
seeds,442,447,O
growth,457,463,O
single,467,473,O
wall,474,478,O
carbon,479,485,O
nanotubes,486,495,O
SWNTs,497,502,O
microwave,507,516,O
plasma,517,523,O
enhanced,524,532,O
CVD,533,536,O
PECVD,538,543,O
surmount,549,557,O
difficulty,562,572,O
associated,573,583,O
SWNT,589,593,O
growth,594,600,O
PECVD,605,610,O
reaction,612,620,O
conditions,621,631,O
promote,637,644,O
stabilization,649,662,O
Fe,666,668,O
nanoparticles,669,682,O
resulting,684,693,O
enhanced,697,705,O
SWNT,706,710,O
selectivity,711,722,O
quality,727,734,O
identified,746,756,O
particular,761,771,O
situ,776,780,O
annealing,781,790,O
Fe,794,796,O
catalyst,797,805,O
N2,812,814,O
atmosphere,815,825,O
found,830,835,O
improve,839,846,O
SWNT,847,851,O
selectivity,852,863,O
quality,868,875,O
H2,877,879,O
prereduction,880,892,O
900,896,899,O
degrees,900,907,O
C,908,909,O
5,914,915,O
min,916,919,O
found,929,934,O
enhance,938,945,O
SWNT,946,950,O
selectivity,951,962,O
quality,967,974,O
SiO2,979,983,O
Si,984,986,O
supported,987,996,O
catalyst,997,1005,O
albeit,1007,1013,O
lower,1017,1022,O
quality,1023,1030,O
sapphire,1035,1043,O
supported,1044,1053,O
catalyst,1054,1062,O
application,1068,1079,O
positive,1083,1091,O
dc,1092,1094,O
bias,1095,1099,O
voltage,1100,1107,O
200,1110,1113,O
V,1114,1115,O
SWNT,1124,1128,O
growth,1129,1135,O
shown,1140,1145,O
effective,1157,1166,O
removing,1170,1178,O
amorphous,1179,1188,O
carbon,1189,1195,O
impurities,1196,1206,O
enhancing,1213,1222,O
graphitization,1223,1237,O
SWNT,1239,1243,O
selectivity,1244,1255,O
vertical,1261,1269,O
alignment,1270,1279,O
results,1285,1292,O
study,1301,1306,O
promote,1314,1321,O
use,1326,1329,O
exposed,1333,1340,O
Fe,1341,1343,O
nanoparticles,1344,1357,O
supported,1358,1367,O
different,1371,1380,O
substrates,1381,1391,O
growth,1400,1406,O
high,1410,1414,O
quality,1415,1422,O
SWNTs,1423,1428,O
PECVD,1432,1437,O
Fluoro,0,6,O
Jade,7,11,O
B,12,13,O
staining,14,22,O
following,23,32,O
zymosan,33,40,O
microinjection,41,55,O
spinal,65,71,B-Multi-tissue_structure
cord,72,76,I-Multi-tissue_structure
white,77,82,I-Multi-tissue_structure
matter,83,89,I-Multi-tissue_structure
1,91,92,O
fluorescein,98,109,O
derivate,110,118,O
Fluoro,119,125,O
Jade,126,130,O
B,131,132,O
FJB,134,137,O
primarily,146,155,O
labels,156,162,O
dead,163,167,O
dying,171,176,O
neurons,177,184,B-Cell
study,198,203,O
acute,208,213,O
focal,214,219,O
inflammation,220,232,O
spinal,240,246,B-Multi-tissue_structure
cord,247,251,I-Multi-tissue_structure
white,252,257,I-Multi-tissue_structure
matter,258,264,I-Multi-tissue_structure
Inflammation,266,278,O
induced,283,290,O
microinjection,294,308,O
yeast,316,321,O
particulate,322,333,O
zymosan,334,341,O
evaluate,345,353,O
biological,358,368,O
effects,369,376,O
intraspinal,380,391,B-Cell
macrophages,392,403,I-Cell
activation,404,414,O
confounding,427,438,O
effects,439,446,O
physical,450,458,O
trauma,459,465,O
2,467,468,O
single,472,478,O
bolus,479,484,O
zymosan,488,495,O
Sigma,497,502,O
75,504,506,O
nL,507,509,O
stereotaxically,515,530,O
injected,531,539,O
thoracic,547,555,B-Multi-tissue_structure
level,556,561,O
lateral,571,578,B-Multi-tissue_structure
white,579,584,I-Multi-tissue_structure
matter,585,591,I-Multi-tissue_structure
rat,595,598,O
spinal,599,605,B-Organ
cord,606,610,I-Organ
standard,614,622,O
Fluoro,623,629,O
Jade,630,634,O
B,635,636,O
staining,637,645,O
protocol,646,654,O
applied,659,666,O
spinal,670,676,B-Organ
cord,677,681,I-Organ
sections,682,690,O
6,694,695,O
12,697,699,O
24,701,703,O
h,704,705,O
2,710,711,O
4,713,714,O
days,715,719,O
postinjection,720,733,O
Neutral,735,742,O
Red,743,746,O
NADPH,748,753,O
diaphorase,754,764,O
Iba1,766,770,O
IR,771,773,O
DAPI,779,783,O
staining,784,792,O
protocols,793,802,O
accomplished,803,815,O
examination,816,827,O
cells,835,840,B-Cell
participating,841,854,O
acute,862,867,O
inflammatory,868,880,O
response,881,889,O
3,891,892,O
Zymosan,894,901,O
caused,902,908,O
formation,909,918,O
clearly,922,929,O
delineated,930,940,O
inflammation,941,953,B-Pathological_formation
lesions,954,961,I-Pathological_formation
localized,962,971,O
lateral,979,986,B-Multi-tissue_structure
white,987,992,I-Multi-tissue_structure
matter,993,999,I-Multi-tissue_structure
spinal,1007,1013,B-Organ
cord,1014,1018,I-Organ
Fluoro,1020,1026,O
Jade,1027,1031,O
B,1032,1033,O
stained,1034,1041,O
cells,1042,1047,B-Cell
area,1055,1059,O
inflammation,1063,1075,B-Pathological_formation
observed,1085,1093,O
12,1097,1099,O
h,1100,1101,O
postinjection,1102,1115,O
mild,1122,1126,O
FJB,1127,1130,O
staining,1131,1139,O
appeared,1140,1148,O
24,1152,1154,O
h,1155,1156,O
intense,1161,1168,O
staining,1169,1177,O
observed,1182,1190,O
2,1194,1195,O
4,1200,1201,O
days,1202,1206,O
postinjection,1207,1220,O
4,1222,1223,O
study,1230,1235,O
shows,1236,1241,O
acute,1251,1256,O
response,1257,1265,O
zymosan,1269,1276,O
induced,1277,1284,O
inflammation,1285,1297,O
rat,1305,1308,O
spinal,1309,1315,B-Multi-tissue_structure
cord,1316,1320,I-Multi-tissue_structure
white,1321,1326,I-Multi-tissue_structure
matter,1327,1333,I-Multi-tissue_structure
causes,1334,1340,O
gradual,1343,1350,O
appearance,1351,1361,O
phagocytic,1365,1375,B-Cell
microglia,1376,1385,I-Cell
macrophages,1386,1397,B-Cell
delayed,1402,1409,O
FJB,1410,1413,O
staining,1414,1422,O
inflammatory,1430,1442,B-Cell
cells,1443,1448,I-Cell
5,1450,1451,O
FJB,1453,1456,O
reliable,1460,1468,O
marker,1469,1475,O
dying,1479,1484,O
neurons,1485,1492,B-Cell
universal,1504,1513,O
agent,1514,1519,O
believed,1534,1542,O
possible,1548,1556,O
explanation,1557,1568,O
gradual,1577,1584,O
appearance,1585,1595,O
FJB,1599,1602,O
stained,1603,1610,O
cells,1611,1616,B-Cell
area,1624,1628,O
inflammation,1632,1644,B-Pathological_formation
specific,1653,1661,O
time,1662,1666,O
required,1670,1678,O
sufficient,1683,1693,O
levels,1694,1700,O
proteins,1704,1712,O
myelin,1720,1726,O
debris,1727,1733,O
axonal,1737,1743,O
origin,1744,1750,O
appear,1754,1760,O
cytoplasm,1768,1777,B-Organism_substance
phagocytic,1781,1791,B-Cell
microglia,1792,1801,I-Cell
macrophages,1802,1813,B-Cell
Changes,0,7,O
lymphocyte,11,21,B-Cell
subsets,22,29,O
leukemia,33,41,O
patients,42,50,O
received,55,63,O
allogenic,64,73,O
bone,74,78,B-Multi-tissue_structure
marrow,79,85,I-Multi-tissue_structure
transplantation,86,101,O
Proportional,103,115,O
changes,116,123,O
lymphocyte,127,137,B-Cell
subsets,138,145,O
peripheral,153,163,B-Organism_substance
blood,164,169,I-Organism_substance
monitored,175,184,O
color,192,197,O
flow,198,202,O
cytometry,203,212,O
seven,216,221,O
leukemia,222,230,O
patients,231,239,O
received,248,256,O
allogenic,257,266,O
bone,267,271,B-Multi-tissue_structure
marrow,272,278,I-Multi-tissue_structure
transplantation,279,294,O
BMT,296,299,O
Lymphocyte,302,312,B-Cell
counts,313,319,O
proportions,325,336,O
T,340,341,B-Cell
B,346,347,B-Cell
cells,348,353,I-Cell
returned,354,362,O
normal,366,372,O
ranges,373,379,O
2nd,392,395,O
12th,400,404,O
months,405,411,O
BMT,418,421,O
Activated,423,432,O
T,433,434,B-Cell
cells,435,440,I-Cell
prominently,441,452,O
increased,453,462,O
BMT,469,472,O
values,482,488,O
gradually,489,498,O
returned,499,507,O
normal,515,521,O
lymphocyte,529,539,B-Cell
subsets,540,547,O
proportions,553,564,O
CD,568,570,B-Cell
4,571,572,I-Cell
cells,574,579,I-Cell
remained,584,592,O
low,593,596,O
CD,613,615,B-Cell
8,616,617,I-Cell
cells,619,624,I-Cell
high,625,629,O
observation,642,653,O
period,654,660,O
BMT,667,670,O
changes,676,683,O
CD,687,689,B-Cell
4,690,691,I-Cell
cells,693,698,I-Cell
caused,704,710,O
decrease,718,726,O
suppressor,730,740,B-Cell
inducer,741,748,I-Cell
T,749,750,I-Cell
cells,751,756,I-Cell
CD,758,760,O
4,761,762,O
Leu,764,767,O
8,768,769,O
High,773,777,O
proportion,778,788,O
CD,792,794,B-Cell
8,795,796,I-Cell
cells,798,803,I-Cell
mainly,808,814,O
associated,815,825,O
increased,831,840,O
suppressor,841,851,B-Cell
T,852,853,I-Cell
cells,854,859,I-Cell
CD,861,863,O
8,864,865,O
CD,867,869,O
11,870,872,O
natural,882,889,B-Cell
killer,890,896,I-Cell
NK,898,900,I-Cell
cells,902,907,I-Cell
highly,909,915,O
active,916,922,O
NK,923,925,B-Cell
cells,926,931,I-Cell
CD,933,935,O
16,936,938,O
CD,940,942,O
57,943,945,O
markedly,948,956,O
increased,957,966,O
shortly,967,974,O
BMT,981,984,O
gradually,990,999,O
returned,1000,1008,O
normal,1012,1018,O
CD,1020,1022,B-Cell
16,1023,1025,I-Cell
CD,1027,1029,I-Cell
57,1030,1032,I-Cell
NK,1034,1036,I-Cell
cells,1037,1042,I-Cell
increased,1043,1052,O
normal,1060,1066,O
ranges,1067,1073,O
2nd,1084,1087,O
month,1088,1093,O
incidence,1099,1108,O
degree,1112,1118,O
acute,1122,1127,O
chronic,1132,1139,O
graft,1140,1145,B-Multi-tissue_structure
versus,1146,1152,O
host,1153,1157,O
diseases,1158,1166,O
GVHD,1168,1172,O
correlate,1182,1191,O
changes,1201,1208,O
lymphocyte,1216,1226,B-Cell
subsets,1227,1234,O
present,1240,1247,O
results,1248,1255,O
suggest,1256,1263,O
increase,1273,1281,O
activated,1285,1294,O
T,1295,1296,B-Cell
cells,1297,1302,I-Cell
shortly,1303,1310,O
BMT,1317,1320,O
reflects,1321,1329,O
lymphocyte,1330,1340,B-Cell
reconstitution,1341,1355,O
prolonged,1361,1370,O
immune,1371,1377,O
deficiency,1378,1388,O
BMT,1395,1398,O
related,1408,1415,O
deficient,1426,1435,O
expression,1436,1446,O
homing,1450,1456,O
receptor,1457,1465,O
Leu,1467,1470,O
8,1471,1472,O
antigen,1473,1480,O
CD,1485,1487,B-Cell
4,1488,1489,I-Cell
cells,1491,1496,I-Cell
increased,1500,1509,O
suppressor,1510,1520,B-Cell
T,1521,1522,I-Cell
cells,1523,1528,I-Cell
CD,1530,1532,O
8,1533,1534,O
CD,1536,1538,O
11,1539,1541,O
addition,1548,1556,O
early,1562,1567,O
increase,1568,1576,O
NK,1580,1582,B-Cell
cells,1583,1588,I-Cell
BMT,1595,1598,O
compensate,1603,1613,O
immune,1622,1628,O
deficiency,1629,1639,O
BMT,1643,1646,O
patients,1647,1655,O
Fluoroscopically,0,16,O
guided,17,23,O
cervical,24,32,B-Organism_subdivision
prolotherapy,33,45,O
instability,50,61,O
blinded,67,74,O
pre,75,78,O
post,83,87,O
radiographic,88,100,O
reading,101,108,O
BACKGROUND,110,120,O
authors,130,137,O
postulated,143,153,O
cervical,159,167,B-Organism_subdivision
instability,168,179,O
major,185,190,O
cause,191,196,O
traumatic,200,209,O
spinal,210,216,B-Organism_subdivision
pain,217,221,O
OBJECTIVE,223,232,O
purpose,238,245,O
prospective,254,265,O
case,266,270,O
series,271,277,O
study,278,283,O
n,285,286,O
6,289,290,O
determine,299,308,O
proliferant,312,323,O
injections,324,334,O
effect,343,349,O
cervical,353,361,B-Organism_subdivision
translation,362,373,O
measured,377,385,O
blinded,391,398,O
reader,399,405,O
DESIGN,407,413,O
study,420,425,O
prospective,432,443,O
case,444,448,O
series,449,455,O
Study,457,462,O
participants,463,475,O
selected,481,489,O
patients,495,503,O
seen,504,508,O
primary,517,524,O
complaint,525,534,O
Motor,538,543,O
Vehicle,544,551,O
Collision,552,561,O
related,562,569,O
neck,570,574,B-Organism_subdivision
pain,575,579,O
private,585,592,O
sub,593,596,O
specialty,597,606,O
pain,607,611,O
clinic,612,618,O
METHODS,620,627,O
Flexion,629,636,O
extension,641,650,O
views,651,656,O
obtained,662,670,O
standard,674,682,O
radiographs,683,694,O
taken,695,700,O
C,708,709,O
Arm,710,713,O
fluoroscope,714,725,O
Valium,732,738,O
sedation,739,747,O
Patients,749,757,O
2,773,774,O
7,775,776,O
mm,777,779,O
absolute,783,791,O
cervical,792,800,B-Organism_subdivision
translation,801,812,O
50,826,828,O
reduction,830,839,O
cervical,843,851,B-Organism_subdivision
referred,856,864,O
pain,865,869,O
day,881,884,O
rigid,885,890,O
cervical,891,899,B-Organism_subdivision
immobilization,900,914,O
test,915,919,O
admitted,925,933,O
study,943,948,O
Participants,950,962,O
underwent,963,972,O
3,973,974,O
prolotherapy,975,987,O
injections,988,998,O
sites,1006,1011,O
demonstrated,1017,1029,O
translation,1030,1041,O
difference,1047,1057,O
means,1061,1066,O
pre,1075,1078,O
test,1079,1083,O
post,1088,1092,O
test,1093,1097,O
measurements,1098,1110,O
flexion,1112,1119,O
translation,1120,1131,O
extension,1133,1142,O
translation,1143,1154,O
pain,1160,1164,O
VAS,1165,1168,O
scores,1169,1175,O
assessed,1182,1190,O
Wilcoxon,1196,1204,O
signed,1205,1211,O
ranks,1212,1217,O
test,1218,1222,O
alpha,1224,1229,O
0,1232,1233,O
05,1234,1236,O
RESULTS,1239,1246,O
mean,1252,1256,O
post,1257,1261,O
test,1262,1266,O
VAS,1267,1270,O
score,1271,1276,O
M,1278,1279,O
3,1281,1282,O
83,1283,1285,O
SD,1287,1289,O
2,1290,1291,O
3,1292,1293,O
t,1295,1296,O
2,1297,1298,O
889,1299,1302,O
significantly,1308,1321,O
p,1328,1329,O
0,1330,1331,O
04,1332,1334,O
mean,1345,1349,O
pre,1350,1353,O
test,1354,1358,O
VAS,1359,1362,O
score,1363,1368,O
M,1370,1371,O
5,1372,1373,O
75,1374,1376,O
SD,1378,1380,O
1,1381,1382,O
94,1383,1385,O
correlation,1392,1403,O
difference,1412,1422,O
mean,1426,1430,O
extension,1431,1440,O
C2,1444,1446,O
3,1447,1448,O
C5,1453,1455,O
6,1456,1457,O
difference,1462,1472,O
mean,1476,1480,O
extension,1481,1490,O
significant,1495,1506,O
rho,1508,1511,O
0,1512,1513,O
89,1514,1516,O
p,1518,1519,O
0,1520,1521,O
02,1522,1524,O
rho,1529,1532,O
0,1533,1534,O
85,1535,1537,O
p,1539,1540,O
0,1541,1542,O
03,1543,1545,O
respectively,1546,1558,O
Difference,1561,1571,O
mean,1575,1579,O
flexion,1580,1587,O
C3,1591,1593,O
4,1594,1595,O
C4,1600,1602,O
5,1603,1604,O
significantly,1609,1622,O
correlated,1623,1633,O
difference,1639,1649,O
mean,1653,1657,O
flexion,1658,1665,O
rho,1667,1670,O
0,1671,1672,O
88,1673,1675,O
p,1677,1678,O
0,1679,1680,O
02,1681,1683,O
rho,1688,1691,O
0,1692,1693,O
941,1694,1697,O
p,1699,1700,O
0,1702,1703,O
01,1704,1706,O
respectively,1707,1719,O
CONCLUSIONS,1722,1733,O
results,1739,1746,O
study,1755,1760,O
demonstrate,1761,1772,O
statistically,1773,1786,O
significant,1787,1798,O
correlations,1799,1811,O
proliferant,1820,1831,O
injections,1832,1842,O
reduction,1846,1855,O
cervical,1864,1872,B-Organism_subdivision
flexion,1873,1880,O
extension,1885,1894,O
translation,1895,1906,O
reduction,1921,1930,O
pain,1934,1938,O
VAS,1939,1942,O
score,1943,1948,O
patients,1956,1964,O
traumatic,1970,1979,O
cervical,1980,1988,B-Organism_subdivision
instability,1989,2000,O
viable,2010,2016,O
treatment,2017,2026,O
options,2027,2034,O
surgical,2046,2054,O
fusion,2055,2061,O
cervical,2063,2071,B-Organism_subdivision
proliferant,2072,2083,O
injections,2084,2094,O
C,2101,2102,O
Arm,2103,2106,O
fluoroscope,2107,2118,O
viable,2128,2134,O
treatment,2135,2144,O
option,2145,2151,O
prevalence,5,15,O
ADHD,19,23,O
attention,28,37,O
problems,38,46,O
preschool,50,59,O
aged,60,64,O
children,65,73,O
comparison,77,87,O
diagnostic,95,105,O
instruments,106,117,O
OBJECTIVES,120,130,O
order,135,140,O
analyse,144,151,O
prevalence,156,166,O
ADHD,170,174,O
attention,179,188,O
problems,189,197,O
preschool,201,210,O
aged,211,215,O
children,216,224,O
mothers,226,233,O
asked,239,244,O
rate,248,252,O
children,259,267,O
measuring,278,287,O
instruments,288,299,O
METHODS,301,308,O
analysis,314,322,O
prospective,336,347,O
randomised,349,359,O
control,360,367,O
study,368,373,O
N,377,378,O
280,381,384,O
children,385,393,O
aged,394,398,O
years,412,417,O
mothers,425,432,O
rated,433,438,O
Child,454,459,O
Behaviour,460,469,O
Checklist,470,479,O
CBCL,480,484,O
1,485,486,O
1,487,488,O
2,489,490,O
5,491,492,O
Parent,501,507,O
Rating,508,514,O
Scale,515,520,O
Attention,525,534,O
Deficit,535,542,O
Hyperactivity,543,556,O
Disorder,557,565,O
ADHD,567,571,O
RESULTS,574,581,O
prevalence,587,597,O
rates,598,603,O
ranged,604,610,O
2,616,617,O
7,618,619,O
9,624,625,O
9,626,627,O
significant,643,654,O
gender,655,661,O
effect,662,668,O
age,677,680,O
group,681,686,O
CONCLUSIONS,688,699,O
study,705,710,O
delivers,711,719,O
initial,720,727,O
findings,728,736,O
provides,741,749,O
support,750,757,O
decisions,762,771,O
implement,775,784,O
Germany,788,795,O
new,796,799,O
assessment,800,810,O
methods,811,818,O
preschool,823,832,O
aged,833,837,O
children,838,846,O
ADHD,852,856,O
hyperkinetic,860,872,O
syndrome,873,881,O
Finally,883,890,O
different,896,905,O
rates,906,911,O
prevalence,915,925,O
implications,934,946,O
findings,954,962,O
epidemiology,967,979,O
prevention,988,998,O
ADHD,1002,1006,O
attention,1011,1020,O
problems,1021,1029,O
preschool,1036,1045,O
aged,1046,1050,O
children,1051,1059,O
discussed,1064,1073,O
Medical,0,7,O
adherence,8,17,O
childhood,22,31,O
chronic,32,39,O
illness,40,47,O
family,49,55,O
daily,56,61,O
management,62,72,O
skills,73,79,O
emotional,84,93,O
climate,94,101,O
emerging,105,113,O
contributors,114,126,O
PURPOSE,128,135,O
REVIEW,139,145,O
describe,150,158,O
recent,159,165,O
research,166,174,O
examines,180,188,O
family,189,195,O
factors,196,203,O
promote,209,216,O
derail,220,226,O
adherence,227,236,O
medical,240,247,O
regimens,248,256,O
children,261,269,O
chronic,275,282,O
health,283,289,O
conditions,290,300,O
primarily,302,311,O
asthma,312,318,O
diabetes,320,328,O
cystic,334,340,O
fibrosis,341,349,O
past,360,364,O
2,365,366,O
years,367,372,O
correlational,380,393,O
studies,394,401,O
identified,407,417,O
specifically,424,436,O
examined,437,445,O
links,450,455,O
family,464,470,O
management,471,481,O
strategies,482,492,O
family,494,500,O
climate,501,508,O
medical,513,520,O
adherence,521,530,O
RECENT,532,538,O
FINDINGS,539,547,O
Findings,549,557,O
studies,567,574,O
suggest,575,582,O
team,588,592,O
based,593,598,O
management,599,609,O
strategies,610,620,O
cohesive,625,633,O
family,634,640,O
climate,641,648,O
promote,649,656,O
adherence,657,666,O
medical,670,677,O
treatments,678,688,O
time,694,698,O
Family,700,706,O
interactions,707,719,O
characterized,729,742,O
conflict,746,754,O
disengagement,759,772,O
tend,773,777,O
disrupt,781,788,O
adherence,789,798,O
inevitably,803,813,O
cause,814,819,O
decline,822,829,O
child,833,838,O
health,839,845,O
findings,863,871,O
moderated,883,892,O
child,896,901,O
age,902,905,O
poorer,914,920,O
adherence,921,930,O
occurs,937,943,O
child,951,956,O
reaches,957,964,O
adolescence,965,976,O
searching,984,993,O
greater,998,1005,O
autonomy,1006,1014,O
SUMMARY,1016,1023,O
Future,1025,1031,O
research,1032,1040,O
consider,1048,1056,O
challenges,1061,1071,O
measuring,1075,1084,O
medical,1085,1092,O
adherence,1093,1102,O
family,1110,1116,O
context,1117,1124,O
incorporating,1136,1149,O
naturalistic,1155,1167,O
studies,1168,1175,O
family,1179,1185,O
interactions,1186,1198,O
Randomized,1200,1210,O
controlled,1211,1221,O
trials,1222,1228,O
family,1235,1241,O
based,1242,1247,O
interventions,1248,1261,O
consider,1266,1274,O
focusing,1275,1283,O
medical,1287,1294,O
adherence,1295,1304,O
important,1311,1320,O
mediator,1321,1329,O
family,1338,1344,O
process,1345,1352,O
child,1357,1362,O
health,1363,1369,O
outcomes,1370,1378,O
relationship,4,16,O
brain,25,30,B-Organ
activity,31,39,O
peak,44,48,O
grip,49,53,O
force,54,59,O
modulated,63,72,O
corticospinal,76,89,B-Anatomical_system
system,90,96,I-Anatomical_system
integrity,97,106,O
subcortical,113,124,B-Multi-tissue_structure
stroke,125,131,O
healthy,136,143,O
human,144,149,O
subjects,150,158,O
relative,164,172,O
contribution,173,185,O
cortical,189,197,B-Multi-tissue_structure
regions,198,205,I-Multi-tissue_structure
motor,209,214,O
performance,215,226,O
varies,227,233,O
task,243,247,O
parameters,248,258,O
Additionally,260,272,O
stroke,280,286,O
recruitment,288,299,O
cortical,303,311,B-Multi-tissue_structure
areas,312,317,I-Multi-tissue_structure
simple,327,333,O
motor,334,339,O
task,340,344,O
varies,345,351,O
corticospinal,357,370,B-Anatomical_system
system,371,377,I-Anatomical_system
integrity,378,387,O
investigated,392,404,O
pattern,417,424,O
motor,428,433,O
system,434,440,O
recruitment,441,452,O
task,458,462,O
involving,463,472,O
increasingly,473,485,O
forceful,486,494,O
hand,495,499,B-Organism_subdivision
grips,500,505,O
influenced,509,519,O
degree,527,533,O
corticospinal,537,550,B-Anatomical_system
system,551,557,I-Anatomical_system
damage,558,564,O
chronic,571,578,O
subcortical,579,590,B-Multi-tissue_structure
stroke,591,597,O
patients,598,606,O
age,616,619,O
matched,620,627,O
controls,628,636,O
underwent,637,646,O
functional,647,657,O
magnetic,658,666,O
brain,667,672,B-Organ
imaging,673,680,O
whilst,681,687,O
performing,688,698,O
repetitive,699,709,O
isometric,710,719,O
hand,720,724,B-Organism_subdivision
grips,725,730,O
Target,732,738,O
grip,739,743,O
forces,744,750,O
varied,756,762,O
15,771,773,O
45,779,781,O
individual,786,796,O
maximum,797,804,O
grip,805,809,O
force,810,815,O
Corticospinal,817,830,O
system,831,837,O
functional,838,848,O
integrity,849,858,O
assessed,863,871,O
transcranial,877,889,O
magnetic,890,898,O
stimulation,899,910,O
Averaged,912,920,O
forces,932,938,O
task,955,959,O
related,960,967,O
activation,968,978,O
compared,979,987,O
rest,993,997,O
secondary,1005,1014,O
motor,1015,1020,O
areas,1021,1026,O
patients,1030,1038,O
greater,1044,1051,O
corticospinal,1052,1065,B-Anatomical_system
system,1066,1072,I-Anatomical_system
damage,1073,1079,O
confirming,1081,1091,O
previous,1092,1100,O
reports,1101,1108,O
primarily,1132,1141,O
interested,1142,1152,O
regional,1156,1164,O
brain,1165,1170,B-Organ
activation,1171,1181,O
covaried,1189,1197,O
force,1217,1222,O
generated,1223,1232,O
implying,1234,1242,O
prominent,1245,1254,O
executive,1255,1264,O
role,1265,1269,O
force,1273,1278,O
production,1279,1289,O
found,1294,1299,O
control,1308,1315,O
subjects,1316,1324,O
patients,1329,1337,O
lesser,1343,1349,O
corticospinal,1350,1363,B-Anatomical_system
system,1364,1370,I-Anatomical_system
damage,1371,1377,O
signal,1379,1385,O
change,1386,1392,O
increased,1393,1402,O
linearly,1403,1411,O
increasing,1417,1427,O
force,1428,1433,O
output,1434,1440,O
contralateral,1444,1457,O
primary,1458,1465,O
motor,1466,1471,B-Multi-tissue_structure
cortex,1472,1478,I-Multi-tissue_structure
supplementary,1480,1493,O
motor,1494,1499,O
area,1500,1504,O
ipsilateral,1509,1520,O
cerebellum,1521,1531,B-Multi-tissue_structure
contrast,1536,1544,O
patients,1549,1557,O
greater,1563,1570,O
corticospinal,1571,1584,B-Anatomical_system
system,1585,1591,I-Anatomical_system
damage,1592,1598,O
force,1600,1605,O
related,1606,1613,O
signal,1614,1620,O
changes,1621,1628,O
seen,1634,1638,O
mainly,1639,1645,O
contralesional,1649,1663,B-Multi-tissue_structure
dorsolateral,1664,1676,I-Multi-tissue_structure
premotor,1677,1685,I-Multi-tissue_structure
cortex,1686,1692,I-Multi-tissue_structure
bilateral,1694,1703,B-Multi-tissue_structure
ventrolateral,1704,1717,I-Multi-tissue_structure
premotor,1718,1726,I-Multi-tissue_structure
cortices,1727,1735,I-Multi-tissue_structure
contralesional,1740,1754,B-Multi-tissue_structure
cerebellum,1755,1765,I-Multi-tissue_structure
ipsilesional,1775,1787,B-Multi-tissue_structure
primary,1788,1795,I-Multi-tissue_structure
motor,1796,1801,I-Multi-tissue_structure
cortex,1802,1808,I-Multi-tissue_structure
findings,1816,1824,O
suggest,1825,1832,O
premotor,1842,1850,B-Multi-tissue_structure
cortices,1851,1859,I-Multi-tissue_structure
play,1866,1870,O
new,1873,1876,O
functionally,1881,1893,O
relevant,1894,1902,O
role,1903,1907,O
controlling,1911,1922,O
force,1923,1928,O
production,1929,1939,O
patients,1943,1951,O
severe,1962,1968,O
corticospinal,1969,1982,B-Anatomical_system
system,1983,1989,I-Anatomical_system
disruption,1990,2000,O
Characterization,0,16,O
transferrin,20,31,O
glycoforms,32,42,O
human,46,51,O
serum,52,57,B-Organism_substance
CE,61,63,O
UV,64,66,O
CE,71,73,O
ESI,74,77,O
MS,78,80,O
Human,82,87,O
transferrin,88,99,O
Tf,101,103,O
model,110,115,O
glycoprotein,116,128,O
congenital,133,143,O
disorders,144,153,O
glycosylation,157,170,O
CDG,172,175,O
diagnosis,177,186,O
years,204,209,O
new,211,214,O
CE,215,217,O
UV,218,220,O
methods,221,228,O
intact,233,239,O
Tf,240,242,O
glycoforms,243,253,O
analysis,254,262,O
developed,273,282,O
nonvolatile,289,300,O
BGEs,301,305,O
organic,310,317,O
modifiers,318,327,O
use,342,345,O
BGEs,355,359,O
allow,369,374,O
coupling,379,387,O
procedures,397,407,O
electrospray,413,425,O
MS,426,428,O
ESI,430,433,O
MS,434,436,O
study,447,452,O
new,456,459,O
CE,460,462,O
UV,463,465,O
separation,466,476,O
method,477,483,O
Tf,487,489,O
glycoforms,490,500,O
developed,504,513,O
double,523,529,O
layer,530,535,O
stable,536,542,O
coating,543,550,O
volatile,557,565,O
BGE,566,569,O
based,570,575,O
ammonium,579,587,O
acetate,588,595,O
separation,601,611,O
method,612,618,O
optimized,622,631,O
standard,638,646,O
Tf,647,649,O
potential,660,669,O
demonstrated,673,685,O
applying,686,694,O
method,699,705,O
analysis,713,721,O
sera,725,729,B-Organism_substance
Tf,730,732,O
healthy,738,745,O
individuals,746,757,O
CDG,762,765,O
patients,766,774,O
CE,780,782,O
UV,783,785,O
separation,786,796,O
method,797,803,O
coupled,813,820,O
ESI,824,827,O
MS,828,830,O
detection,831,840,O
Main,842,846,O
parameters,847,857,O
sheath,866,872,O
liquid,873,879,O
composition,880,891,O
optimized,896,905,O
order,909,914,O
obtain,918,924,O
good,927,931,O
sensitivity,932,943,O
CE,949,951,O
ESI,952,955,O
MS,956,958,O
method,959,965,O
serum,988,993,B-Organism_substance
samples,994,1001,I-Organism_substance
obtaining,1002,1011,O
separation,1016,1026,O
different,1034,1043,O
proteins,1044,1052,O
present,1053,1060,O
serum,1064,1069,B-Organism_substance
partial,1074,1081,O
separation,1082,1092,O
Tf,1096,1098,O
glycoforms,1099,1109,O
Different,1111,1120,O
mass,1121,1125,O
spectra,1126,1133,O
deconvoluted,1138,1150,O
molecular,1151,1160,O
masses,1161,1167,O
obtained,1173,1181,O
sialoform,1191,1200,O
allowing,1202,1210,O
unequivocal,1211,1222,O
glycoform,1223,1232,O
identification,1233,1247,O
Selective,0,9,O
activation,10,20,O
mast,24,28,B-Cell
cells,29,34,I-Cell
rheumatoid,38,48,B-Tissue
synovial,49,57,I-Tissue
tissue,58,64,I-Tissue
results,65,72,O
production,76,86,O
TNF,90,93,O
alpha,94,99,O
IL,101,103,O
1beta,104,109,O
IL,114,116,O
1Ra,117,120,O
OBJECTIVES,122,132,O
DESIGN,137,143,O
study,148,153,O
consequences,158,170,O
mast,174,178,B-Cell
cell,179,183,I-Cell
activation,184,194,O
human,198,203,O
synovial,204,212,B-Tissue
tissue,213,219,I-Tissue
METHODS,221,228,O
Synovial,230,238,B-Tissue
tissue,239,245,I-Tissue
obtained,250,258,O
18,264,266,O
RA,267,269,O
patients,270,278,O
mast,283,287,B-Cell
cells,288,293,I-Cell
selectively,298,309,O
activated,310,319,O
synovial,323,331,B-Tissue
tissue,332,338,I-Tissue
explant,339,346,O
cultures,347,355,O
Expression,357,367,O
TNF,371,374,O
alpha,375,380,O
IL,382,384,O
1beta,385,390,O
IL,395,397,O
1Ra,398,401,O
determined,407,417,O
tissue,422,428,B-Tissue
distribution,429,441,O
IL,445,447,O
1beta,448,453,O
studied,458,465,O
RESULTS,467,474,O
Compared,476,484,O
untreated,488,497,O
synovia,498,505,B-Tissue
selective,507,516,O
activation,517,527,O
synovial,531,539,B-Cell
mast,540,544,I-Cell
cells,545,550,I-Cell
increased,551,560,O
significantly,561,574,O
production,579,589,O
TNF,593,596,O
alpha,597,602,O
0,604,605,O
49,606,608,O
0,613,614,O
88,615,617,O
vs,618,620,O
4,622,623,O
56,624,626,O
3,631,632,O
18,633,635,O
pg,636,638,O
mg,639,641,O
wet,642,645,O
tissue,646,652,O
p,654,655,O
0,658,659,O
001,660,663,O
IL,669,671,O
1beta,672,677,O
0,679,680,O
058,681,684,O
0,689,690,O
032,691,694,O
vs,695,697,O
2,699,700,O
55,701,703,O
1,708,709,O
98,710,712,O
pg,713,715,O
mg,716,718,O
wet,719,722,O
tissue,723,729,O
p,731,732,O
0,735,736,O
013,737,740,O
expression,747,757,O
TNF,761,764,O
alpha,765,770,O
IL,775,777,O
1beta,778,783,O
mRNA,784,788,O
increased,789,798,O
significantly,799,812,O
19,814,816,O
fold,817,821,O
p,823,824,O
0,827,828,O
009,829,832,O
13,838,840,O
fold,841,845,O
p,847,848,O
0,851,852,O
031,853,856,O
respectively,859,871,O
Mast,874,878,B-Cell
cell,879,883,I-Cell
activation,884,894,O
induced,895,902,O
IL,903,905,O
1beta,906,911,O
expression,912,922,O
particular,926,936,O
nearby,940,946,O
CD68,947,951,B-Cell
positive,952,960,I-Cell
synovial,961,969,I-Cell
macrophages,970,981,I-Cell
Secretion,983,992,O
IL,996,998,O
1Ra,999,1002,O
increased,1012,1021,O
lesser,1031,1037,O
degree,1038,1044,O
IL,1058,1060,O
1beta,1061,1066,O
CONCLUSIONS,1068,1079,O
Synovial,1081,1089,B-Cell
mast,1090,1094,I-Cell
cells,1095,1100,I-Cell
produce,1101,1108,O
proinflammmatory,1109,1125,O
cytokines,1126,1135,O
contribute,1149,1159,O
inflammation,1167,1179,O
RA,1183,1185,O
Rapid,0,5,O
mixing,6,12,O
old,21,24,O
new,29,32,O
C,33,34,O
pools,35,40,O
canopy,48,54,O
mature,58,64,O
forest,65,71,O
trees,72,77,O
Stable,79,85,O
C,86,87,O
isotope,88,95,O
signals,96,103,O
plant,107,112,O
tissues,113,120,B-Tissue
key,130,133,O
tool,134,138,O
explaining,142,152,O
growth,153,159,O
responses,160,169,O
environment,177,188,O
technique,194,203,O
based,207,212,O
fundamental,220,231,O
assumption,232,242,O
isotopic,252,260,O
composition,261,272,O
given,278,283,O
unit,284,288,O
tissue,292,298,B-Tissue
e,300,301,O
g,302,303,O
tree,307,311,B-Tissue
ring,312,316,I-Tissue
reflects,318,326,O
specific,331,339,O
C,340,341,O
uptake,342,348,O
conditions,349,359,O
leaf,367,371,B-Organ
given,377,382,O
time,383,387,O
methodological,400,414,O
implications,415,427,O
deviation,435,444,O
assumption,455,465,O
physiological,476,489,O
interest,490,498,O
new,507,510,O
C,511,512,O
transferred,516,527,O
directly,528,536,O
sources,542,549,O
photosynthesizing,553,570,O
leaf,571,575,B-Organ
structural,580,590,O
sinks,591,596,O
e,598,599,O
g,600,601,O
adjacent,603,611,O
stem,612,616,B-Tissue
tissue,617,623,I-Tissue
inherently,629,639,O
passes,640,646,O
existing,655,663,O
mobile,665,671,O
C,673,674,O
pools,675,680,O
variable,698,706,O
older,708,713,O
age,715,718,O
explore,729,736,O
fate,741,745,O
13,750,752,O
C,753,754,O
labelled,755,763,O
photosynthates,764,778,O
crowns,786,792,B-Organism_subdivision
30,798,800,O
35,801,803,O
m,804,805,O
tall,806,810,O
mixed,812,817,O
forest,818,824,O
canopy,833,839,O
crane,840,845,O
study,859,864,O
species,865,872,O
labelled,873,881,O
C,882,883,O
reached,884,891,O
woody,892,897,B-Tissue
tissue,898,904,I-Tissue
2,912,913,O
9,914,915,O
h,916,917,O
labelling,924,933,O
months,940,946,O
later,947,952,O
small,959,964,O
signals,965,972,O
left,978,982,O
branch,986,992,O
wood,993,997,O
Tilia,1001,1006,O
suggesting,1007,1017,O
low,1023,1026,O
mixing,1027,1033,O
new,1037,1040,O
labelled,1042,1050,O
C,1051,1052,O
old,1058,1061,O
C,1062,1063,O
taken,1068,1073,O
place,1074,1079,O
contrast,1084,1092,O
signals,1094,1101,O
Fagus,1105,1110,O
Quercus,1115,1122,O
increased,1127,1136,O
indicating,1138,1148,O
intense,1154,1161,O
mixing,1162,1168,O
species,1175,1182,O
specific,1183,1191,O
mixing,1192,1198,O
new,1202,1205,O
old,1211,1214,O
C,1215,1216,O
pools,1217,1222,O
likely,1226,1232,O
mask,1236,1240,O
year,1241,1245,O
season,1250,1256,O
specific,1257,1265,O
linkages,1266,1274,O
tree,1283,1287,B-Tissue
ring,1288,1292,I-Tissue
formation,1293,1302,O
climate,1307,1314,O
considerable,1323,1335,O
implications,1336,1348,O
climate,1353,1360,O
reconstruction,1361,1375,O
stable,1382,1388,O
isotopes,1389,1397,O
proxies,1401,1408,O
past,1413,1417,O
climatic,1418,1426,O
conditions,1427,1437,O
M,0,1,O
leprae,3,9,O
BCG,15,18,O
induced,19,26,O
chemiluminescence,27,44,O
response,45,53,O
monocytes,57,66,B-Cell
leprosy,72,79,O
patients,80,88,O
healthy,93,100,O
subjects,101,109,O
effects,111,118,O
gamma,122,127,O
interferon,128,138,O
GM,143,145,O
CSF,146,149,O
Mycobacterium,151,164,O
leprae,165,171,O
contrast,176,184,O
BCG,188,191,O
failed,193,199,O
trigger,203,210,O
chemiluminescence,215,232,O
CL,234,236,O
response,238,246,O
mononuclear,250,261,B-Cell
cells,262,267,I-Cell
leprosy,280,287,O
patients,288,296,O
healthy,300,307,O
subjects,308,316,O
deficit,320,327,O
reversed,332,340,O
interferon,351,361,O
gamma,362,367,O
GM,371,373,O
CSF,374,377,O
Chemiluminescence,379,396,O
responses,397,406,O
induced,407,414,O
mycobacteria,423,435,O
BCG,444,447,O
found,453,458,O
lower,465,470,O
leprosy,474,481,O
patients,482,490,O
controls,499,507,O
M,509,510,O
leprae,512,518,O
phagocytosed,539,551,O
BCG,557,560,O
significant,583,594,O
difference,595,605,O
phagocytosis,609,621,O
healthy,630,637,O
tuberculoid,642,653,O
leprosy,654,661,O
subjects,662,670,O
Phagocytosis,672,684,O
altered,693,700,O
addition,708,716,O
lymphokine,727,737,O
major,746,751,O
differences,752,763,O
healthy,772,779,O
subjects,780,788,O
patients,793,801,O
observed,807,815,O
Preincubating,817,830,O
mononuclear,831,842,B-Cell
cells,843,848,I-Cell
anti,854,858,O
mycobacteria,859,871,O
antibodies,872,882,O
lepromatous,884,895,O
patients,896,904,O
sera,906,910,B-Organism_substance
increase,920,928,O
CL,933,935,O
response,936,944,O
phagocytosis,953,965,O
M,969,970,O
leprae,972,978,O
BCG,982,985,O
practical,2,11,O
interface,12,21,O
microfluidics,26,39,O
nanoelectrospray,44,60,O
mass,61,65,O
spectrometry,66,78,O
report,83,89,O
new,92,95,O
method,96,102,O
fabricating,107,118,O
nanospray,119,128,O
ionization,129,139,O
tips,140,144,O
MS,149,151,O
formed,153,159,O
glass,165,170,O
substrates,171,181,O
inert,190,195,O
polymer,196,203,O
parylene,205,213,O
C,214,215,O
single,225,231,O
photolithography,232,248,O
step,249,253,O
emitters,259,267,O
formed,272,278,O
contiguously,279,291,O
microchannels,297,310,O
dead,325,329,O
volumes,330,337,O
observed,342,350,O
addition,355,363,O
devices,377,384,O
thin,394,398,O
approximately,400,413,O
0,414,415,O
3,416,417,O
mm,418,420,O
tips,430,434,O
formed,439,445,O
rectangular,449,460,O
corners,461,468,O
Taylor,474,480,O
cone,481,485,O
volumes,486,493,O
small,498,503,O
makes,511,516,O
method,521,527,O
attractive,528,538,O
future,543,549,O
integration,550,561,O
microfluidic,567,579,O
separations,580,591,O
Device,593,599,O
performance,600,611,O
demonstrated,616,628,O
evaluating,632,642,O
diverse,643,650,O
analytes,651,659,O
ranging,661,668,O
synthetic,674,683,O
polymers,684,692,O
peptides,697,705,O
nucleic,710,717,O
acids,718,723,O
analytes,733,741,O
performance,743,754,O
similar,759,766,O
conventional,778,790,O
emitters,791,799,O
pulled,801,807,O
glass,808,813,O
capillaries,814,825,O
Agilent,834,841,O
HPLC,842,846,O
Chip,847,851,O
advantage,862,871,O
rapid,875,880,O
batch,882,887,O
fabrication,888,899,O
identical,903,912,O
devices,913,920,O
Intraoperative,0,14,O
handling,15,23,O
wound,28,33,B-Pathological_formation
healing,34,41,O
arthroscopic,45,57,O
portal,58,64,O
wounds,65,71,B-Pathological_formation
clinical,75,83,O
study,84,89,O
comparing,90,99,O
nylon,100,105,O
suture,106,112,O
wound,118,123,B-Pathological_formation
closure,124,131,O
strips,132,138,O
prospective,145,156,O
single,158,164,O
centre,165,171,O
study,172,177,O
compared,178,186,O
wound,187,192,B-Pathological_formation
closure,193,200,O
methods,201,208,O
patients,212,220,O
undergoing,221,231,O
arthroscopy,232,243,O
Closure,245,252,O
arthroscopic,256,268,O
portal,269,275,O
wounds,276,282,B-Pathological_formation
sterile,288,295,O
adhesive,296,304,O
strips,305,311,O
effective,315,324,O
convenient,329,339,O
wound,344,349,B-Pathological_formation
management,350,360,O
method,366,372,O
associated,377,387,O
reduced,395,402,O
potential,403,412,O
infection,417,426,O
faster,428,434,O
renewal,435,442,O
tensile,446,453,O
strength,454,462,O
greater,464,471,O
cost,472,476,O
effectiveness,477,490,O
better,496,502,O
cosmetic,503,511,O
effects,512,519,O
comparing,520,529,O
suture,535,541,O
closure,542,549,O
method,556,562,O
wound,566,571,B-Pathological_formation
closure,572,579,O
reduce,589,595,O
incidence,600,609,O
needle,613,619,O
stick,620,625,O
injury,626,632,O
theatre,640,647,O
environment,648,659,O
incidence,673,682,O
percutaneous,686,698,O
exposure,699,707,O
following,708,717,O
surgical,720,728,O
procedure,729,738,O
facilitate,747,757,O
transmission,758,770,O
blood,774,779,B-Organism_substance
borne,780,785,O
pathogens,786,795,O
human,804,809,O
immunodeficiency,810,826,O
virus,827,832,O
HIV,834,837,O
hepatitis,840,849,O
C,850,851,O
virus,852,857,O
hepatitis,862,871,O
B,872,873,O
virus,874,879,O
result,886,892,O
reduce,900,906,O
litigation,907,917,O
today,921,926,O
s,927,928,O
changing,929,937,O
healthcare,938,948,O
climate,949,956,O
Investigation,0,13,O
effect,21,27,O
kaolin,31,37,O
tissue,42,48,B-Tissue
factor,49,55,O
activated,56,65,O
citrated,66,74,O
blood,81,86,I-Organism_substance
clot,91,95,B-Organism_substance
forming,96,103,O
variables,104,113,O
evaluated,118,127,O
thromboelastography,131,150,O
BACKGROUND,152,162,O
Thrombelastograph,168,185,O
TEG,187,190,O
Haemoscope,192,202,O
Corp,203,207,O
analyzes,210,218,O
clot,219,223,B-Organism_substance
formation,224,233,O
blood,243,248,I-Organism_substance
WB,250,252,B-Organism_substance
treatment,258,267,O
based,268,273,O
analysis,282,290,O
shown,300,305,O
reduce,309,315,O
transfusion,316,327,O
requirements,328,340,O
liver,344,349,B-Organ
cardiac,354,361,B-Organ
surgery,362,369,O
compared,375,383,O
conventional,387,399,O
coagulation,400,411,O
analysis,412,420,O
Implementing,422,434,O
TEG,435,438,O
routine,444,451,O
laboratory,452,462,O
based,463,468,O
analysis,469,477,O
requires,488,496,O
validation,497,507,O
activators,515,525,O
employed,526,534,O
effect,543,549,O
storage,553,560,O
WB,568,570,B-Organism_substance
sample,571,577,O
citrate,581,588,O
analysis,596,604,O
STUDY,606,611,O
DESIGN,612,618,O
METHODS,623,630,O
effect,636,642,O
kaolin,646,652,O
tissue,654,660,B-Tissue
factor,661,667,O
TF,669,671,O
1,673,674,O
17,675,677,O
000,678,681,O
TF,686,688,O
1,689,690,O
42,691,693,O
500,694,697,O
TEG,701,704,O
clotting,705,713,O
time,714,718,O
R,720,721,O
Angle,724,729,O
velocity,731,739,O
clot,743,747,B-Organism_substance
formation,748,757,O
maximum,764,771,O
clot,772,776,B-Organism_substance
strength,777,785,O
amplitude,787,796,O
MA,798,800,O
evaluated,808,817,O
day,833,836,O
day,840,843,O
variation,844,853,O
coefficient,859,870,O
variance,874,882,O
CV,884,886,O
effect,898,904,O
citrate,908,915,O
storage,916,923,O
time,924,928,O
RESULTS,930,937,O
Clot,939,943,B-Organism_substance
formation,944,953,O
variables,954,963,O
equally,969,976,O
affected,977,985,O
TF,989,991,O
1,992,993,O
17,994,996,O
000,997,1000,O
kaolin,1005,1011,O
activation,1012,1022,O
R,1032,1033,O
significantly,1038,1051,O
longer,1052,1058,O
TF,1064,1066,O
1,1067,1068,O
42,1069,1071,O
500,1072,1075,O
CV,1090,1092,O
different,1101,1110,O
variables,1111,1120,O
varied,1121,1127,O
3,1133,1134,O
13,1138,1140,O
percent,1141,1148,O
significant,1157,1168,O
differences,1169,1180,O
assays,1189,1195,O
Storage,1197,1204,O
citrated,1208,1216,O
WB,1217,1219,B-Organism_substance
significantly,1220,1233,O
affected,1234,1242,O
TEG,1247,1250,O
variables,1251,1260,O
hypercoagulable,1266,1281,O
direction,1282,1291,O
R,1302,1303,O
significantly,1318,1331,O
affected,1332,1340,O
12,1342,1344,O
samples,1352,1359,O
rested,1360,1366,O
0,1371,1372,O
30,1377,1379,O
minutes,1380,1387,O
evaluated,1393,1402,O
kaolin,1408,1414,O
activator,1422,1431,O
CONCLUSION,1433,1443,O
TEG,1449,1452,O
assays,1453,1459,O
evaluated,1460,1469,O
reproducible,1475,1487,O
present,1492,1499,O
acceptable,1508,1518,O
CV,1519,1521,O
routine,1527,1534,O
clinical,1535,1543,O
practice,1544,1552,O
Kaolin,1554,1560,O
TF,1565,1567,O
1,1568,1569,O
17,1570,1572,O
000,1573,1576,O
equally,1577,1584,O
affected,1585,1593,O
clot,1598,1602,B-Organism_substance
formation,1603,1612,O
variables,1613,1622,O
Storage,1624,1631,O
WB,1635,1637,B-Organism_substance
30,1648,1650,O
minutes,1651,1658,O
citrate,1662,1669,O
R,1690,1691,O
affect,1693,1699,O
clot,1700,1704,B-Organism_substance
formation,1705,1714,O
variables,1715,1724,O
kaolin,1730,1736,O
activator,1749,1758,O
allowing,1759,1767,O
immediate,1772,1781,O
analysis,1782,1790,O
sample,1800,1806,O
arrives,1807,1814,O
laboratory,1822,1832,O
TESE,1,5,O
mTESE,10,15,O
Therapeutic,17,28,O
options,29,36,O
male,40,44,O
infertility,45,56,O
testicular,64,74,B-Organ
azoospermia,75,86,O
Modern,89,95,O
techniques,96,106,O
testicular,110,120,B-Cell
sperm,121,126,I-Cell
extraction,127,137,O
TESE,139,143,O
possible,153,161,O
infertile,169,178,O
man,179,182,O
father,186,192,O
child,195,200,O
operations,206,216,O
standardized,221,233,O
large,239,244,O
extent,245,251,O
underlying,260,270,O
morphological,271,284,O
alterations,285,296,O
spermatogenesis,300,315,O
appear,321,327,O
sufficiently,334,346,O
known,347,352,O
Current,354,361,O
research,362,370,O
focused,374,381,O
prognostic,385,395,O
factors,396,403,O
testicular,412,422,B-Organ
material,423,431,O
determine,437,446,O
sperm,451,456,B-Cell
retrieval,457,466,O
rate,467,471,O
success,476,483,O
rates,484,489,O
vitro,499,504,O
fertilization,505,518,O
intracytoplasmic,519,535,O
sperm,536,541,B-Cell
injection,542,551,O
IVF,553,556,O
ICSI,557,561,O
TESE,563,567,O
microTESE,572,581,O
accepted,586,594,O
standard,595,603,O
operations,604,614,O
testicular,619,629,B-Cell
sperm,630,635,I-Cell
retrieval,636,645,O
IVF,650,653,O
ICSI,654,658,O
Predictions,660,671,O
effective,676,685,O
sperm,686,691,B-Cell
recovery,692,700,O
addressed,705,714,O
Quantitative,0,12,O
retention,13,22,O
biological,23,33,O
activity,34,42,O
relationship,43,55,O
study,56,61,O
micellar,65,73,O
liquid,74,80,O
chromatography,81,95,O
previous,102,110,O
paper,111,116,O
usefulness,122,132,O
micellar,136,144,O
liquid,145,151,O
chromatography,152,166,O
MLC,168,171,O
predicting,176,186,O
octanol,187,194,O
water,195,200,O
partition,201,210,O
coefficients,211,223,O
organic,227,234,O
compounds,235,244,O
reported,249,257,O
paper,264,269,O
successful,283,293,O
report,294,300,O
quantitative,306,318,O
retention,319,328,O
activity,329,337,O
relationship,338,350,O
study,351,356,O
retention,367,376,O
factor,377,383,O
MLC,387,390,O
predicting,395,405,O
biological,410,420,O
activity,421,429,O
group,435,440,O
phenolic,444,452,O
compounds,453,462,O
Excellent,464,473,O
correlation,474,485,O
obtained,490,498,O
capacity,511,519,O
factor,520,526,O
MLC,530,533,O
bioactivity,542,553,O
measured,555,563,O
log,567,570,O
1,571,572,O
C,573,574,O
C,582,583,O
50,591,593,O
inhibitory,595,605,O
growth,606,612,O
concentration,613,626,O
26,631,633,O
para,634,638,O
substituted,639,650,O
phenols,651,658,O
single,662,668,O
MLC,669,672,O
retention,673,682,O
parameter,683,692,O
capable,696,703,O
describing,707,717,O
bioactivity,722,733,O
phenols,737,744,O
conventional,758,770,O
molecular,771,780,O
descriptors,781,792,O
log,794,797,O
P,798,799,O
ow,800,802,O
pKa,805,808,O
R,814,815,O
needed,821,827,O
achieve,831,838,O
similar,841,848,O
correlation,849,860,O
indicates,867,876,O
hydrophobic,887,898,O
electronic,903,913,O
interactions,914,926,O
incorporated,931,943,O
single,949,955,O
MLC,956,959,O
retention,960,969,O
parameter,970,979,O
amphiphilic,1001,1012,O
nature,1013,1019,O
surfactants,1023,1034,O
system,1042,1048,O
situations,1053,1063,O
like,1064,1068,O
QRAR,1075,1079,O
suitable,1085,1093,O
alternative,1094,1105,O
QSAR,1109,1113,O
measuring,1120,1129,O
MLC,1130,1133,O
retention,1134,1143,O
easier,1152,1158,O
measuring,1164,1173,O
different,1174,1183,O
molecular,1184,1193,O
descriptors,1194,1205,O
needed,1206,1212,O
build,1216,1221,O
QSAR,1226,1230,O
model,1231,1236,O
Addition,1238,1246,O
10,1250,1252,O
2,1254,1255,O
propanol,1256,1264,O
micellar,1270,1278,O
system,1279,1285,O
hybrid,1287,1293,O
system,1294,1300,O
proved,1302,1308,O
best,1319,1323,O
chromatographic,1324,1339,O
system,1340,1346,O
best,1355,1359,O
estimation,1360,1370,O
phenols,1378,1385,O
bioactivity,1386,1397,O
chromatographic,1405,1420,O
factors,1421,1428,O
pH,1437,1439,O
stationary,1444,1454,O
phase,1455,1460,O
showed,1466,1472,O
significant,1473,1484,O
effect,1485,1491,O
correlation,1499,1510,O
capacity,1519,1527,O
factor,1528,1534,O
k,1535,1536,O
log,1542,1545,O
1,1546,1547,O
C,1548,1549,O
Atypical,0,8,O
mycobacteriosis,9,24,O
larynx,32,38,B-Multi-tissue_structure
unusual,43,50,O
clinical,51,59,O
presentation,60,72,O
secondary,73,82,O
steroids,86,94,O
inhalation,95,105,O
Vocal,107,112,O
cords,113,118,O
stiffness,119,128,O
associated,136,146,O
variety,154,161,O
etiologic,165,174,O
agents,175,181,O
rarely,193,199,O
seen,200,204,O
atypical,210,218,O
mycobacteria,219,231,O
example,237,244,O
Mycobacterium,246,259,O
avium,260,265,O
complex,266,273,O
report,278,284,O
case,287,291,O
35,297,299,O
year,300,304,O
old,305,308,O
white,309,314,O
woman,315,320,O
maintained,336,346,O
inhaled,350,357,O
steroids,358,366,O
presented,372,381,O
hoarseness,387,397,O
low,402,405,O
grade,406,411,O
fever,412,417,O
medical,427,434,O
history,435,442,O
unremarkable,457,469,O
Laryngoscopy,471,483,O
revealed,484,492,O
bilateral,493,502,O
scarring,503,511,O
vocal,519,524,B-Multi-tissue_structure
cords,525,530,I-Multi-tissue_structure
Vocal,532,537,B-Multi-tissue_structure
cord,538,542,I-Multi-tissue_structure
biopsies,543,551,O
performed,557,566,O
Histologic,568,578,O
examination,579,590,O
revealed,591,599,O
unremarkable,600,612,O
laryngeal,613,622,B-Multi-tissue_structure
mucosa,623,629,I-Multi-tissue_structure
abundant,642,650,O
subepithelial,651,664,B-Pathological_formation
non,665,668,I-Pathological_formation
necrotizing,669,680,I-Pathological_formation
granulomata,681,692,I-Pathological_formation
differential,698,710,O
diagnosis,711,720,O
included,721,729,O
sarcoid,730,737,B-Pathological_formation
Klebsiella,739,749,B-Pathological_formation
scleroma,750,758,I-Pathological_formation
tuberculosis,764,776,O
Special,778,785,O
stains,786,792,O
reviewed,793,801,O
abundant,802,810,O
acid,811,815,O
fast,816,820,O
bacilli,821,828,O
later,830,835,O
confirmed,836,845,O
DNA,851,854,O
assay,855,860,O
induced,864,871,O
deep,872,876,O
sputum,877,883,B-Organism_substance
consistent,885,895,O
M,901,902,O
avium,903,908,O
complex,909,916,O
Subsequently,918,930,O
steroids,932,940,O
withdrawn,946,955,O
patient,965,972,O
treated,977,984,O
multiple,992,1000,O
drug,1001,1005,O
antituberculous,1006,1021,O
regimen,1022,1029,O
recovery,1045,1053,O
unusual,1060,1067,O
clinical,1068,1076,O
presentation,1077,1089,O
atypical,1097,1105,O
mycobacteriosis,1106,1121,O
encountered,1129,1140,O
otolaryngologists,1144,1161,O
pathologists,1166,1178,O
critical,1190,1198,O
recognize,1202,1211,O
patients,1218,1226,O
immunocompromised,1227,1244,O
steroids,1256,1264,O
female,11,17,O
elite,18,23,O
athletes,24,32,O
likely,38,44,O
experience,48,58,O
urinary,59,66,B-Organism_substance
incontinence,67,79,O
later,80,85,O
life,89,93,O
non,99,102,O
athletes,103,111,O
aim,117,120,O
present,128,135,O
study,136,141,O
investigate,149,160,O
female,176,182,O
elite,183,188,O
athletes,189,197,O
likely,207,213,O
experience,217,227,O
urinary,228,235,B-Organism_substance
incontinence,236,248,O
UI,250,252,O
later,254,259,O
life,263,267,O
non,273,276,O
athletes,277,285,O
assess,293,299,O
possible,300,308,O
risk,309,313,O
factors,314,321,O
UI,326,328,O
athletes,332,340,O
thirty,360,366,O
elite,378,383,O
athletes,384,392,O
response,394,402,O
rate,403,407,O
81,408,410,O
640,417,420,O
controls,421,429,O
replied,430,437,O
postal,443,449,O
questionnaire,450,463,O
including,464,473,O
validated,474,483,O
questions,484,493,O
UI,497,499,O
competing,507,516,O
sport,520,525,O
10,527,529,O
9,530,531,O
2,537,538,O
7,539,540,O
elite,556,561,O
athletes,562,570,O
reported,571,579,O
stress,580,586,O
urinary,587,594,B-Organism_substance
incontinence,595,607,O
SUI,609,612,O
urge,618,622,O
incontinence,623,635,O
respectively,637,649,O
Presently,651,660,O
36,662,664,O
5,665,666,O
elite,682,687,O
athletes,688,696,O
36,701,703,O
9,704,705,O
controls,714,722,O
reported,723,731,O
SUI,732,735,O
9,737,738,O
1,739,740,O
9,746,747,O
4,748,749,O
reported,751,759,O
urge,760,764,O
incontinence,765,777,O
elite,792,797,O
athletes,798,806,O
children,832,840,O
likely,851,857,O
nulliparous,863,874,O
women,875,880,O
UI,889,891,O
athletes,916,924,O
UI,926,928,O
common,938,944,O
women,948,953,O
vs,959,961,O
UI,976,978,O
competing,985,994,O
odds,996,1000,O
ratio,1001,1006,O
8,1007,1008,O
57,1009,1011,O
95,1013,1015,O
confidence,1017,1027,O
interval,1028,1036,O
3,1038,1039,O
55,1040,1042,O
20,1043,1045,O
71,1046,1048,O
Age,1051,1054,O
menopause,1056,1065,O
regularly,1076,1085,O
physically,1086,1096,O
active,1097,1103,O
associated,1117,1127,O
UI,1133,1135,O
group,1146,1151,O
Based,1153,1158,O
study,1167,1172,O
prevalence,1178,1188,O
UI,1192,1194,O
higher,1215,1221,O
athletes,1232,1240,O
controls,1249,1257,O
results,1272,1279,O
indicate,1280,1288,O
UI,1294,1296,O
early,1297,1302,O
life,1306,1310,O
reported,1315,1323,O
elite,1331,1336,O
sport,1337,1342,O
strong,1349,1355,O
predictor,1356,1365,O
UI,1369,1371,O
later,1372,1377,O
life,1381,1385,O
Handling,0,8,O
run,16,19,O
retention,20,29,O
time,30,34,O
shifts,35,41,O
dimensional,49,60,O
chromatography,61,75,O
data,76,80,O
shift,87,92,O
correction,93,103,O
modeling,108,116,O
use,122,125,O
PARAFAC,129,136,O
modeling,141,149,O
GC,150,152,O
x,153,154,O
GC,155,157,O
TOFMS,158,163,O
peaks,164,169,O
documented,178,188,O
success,195,202,O
trilinear,217,226,O
structure,227,236,O
data,246,250,O
ideal,257,262,O
sufficiently,267,279,O
close,280,285,O
ideal,289,294,O
chromatographic,296,311,O
conditions,312,322,O
temperature,339,350,O
programming,351,362,O
cope,366,370,O
general,380,387,O
elution,388,395,O
problem,396,403,O
deviations,405,415,O
trilinearity,421,433,O
run,443,446,O
likely,456,462,O
seen,469,473,O
following,482,491,O
cases,498,503,O
1,506,507,O
compounds,509,518,O
e,522,523,O
analytes,526,534,O
severely,536,544,O
broadened,545,554,O
column,568,574,O
defined,581,588,O
modulation,597,607,O
periods,608,615,O
2,618,619,O
analytes,621,629,O
high,642,646,O
retention,647,656,O
factor,657,663,O
second,671,677,O
column,678,684,O
likely,689,695,O
wrapped,696,703,O
dimension,719,728,O
3,734,735,O
fast,742,746,O
temperature,747,758,O
program,759,766,O
rates,767,772,O
deviation,779,788,O
trilinearity,794,806,O
seen,810,814,O
retention,818,827,O
time,828,832,O
shifted,833,840,O
peak,841,845,O
profiles,846,854,O
subsequent,858,868,O
modulation,869,879,O
periods,880,887,O
column,895,901,O
fractions,902,911,O
report,922,928,O
relaxed,932,939,O
powerful,944,952,O
version,953,960,O
PARAFAC,964,971,O
known,973,978,O
PARAFAC2,982,990,O
applied,1000,1007,O
handle,1011,1017,O
shift,1023,1028,O
model,1040,1045,O
step,1046,1050,O
allowing,1054,1062,O
generation,1063,1073,O
individual,1077,1087,O
peak,1088,1092,O
profiles,1093,1101,O
subsequent,1105,1115,O
column,1122,1128,O
fractions,1129,1138,O
alternative,1143,1154,O
approach,1155,1163,O
studied,1173,1180,O
utilizing,1182,1191,O
standard,1194,1202,O
retention,1203,1212,O
time,1213,1217,O
shift,1218,1223,O
correction,1224,1234,O
restore,1238,1245,O
data,1250,1254,O
trilinearity,1255,1267,O
structure,1268,1277,O
followed,1278,1286,O
PARAFAC,1290,1297,O
approaches,1309,1319,O
compared,1324,1332,O
identifying,1338,1349,O
quantifying,1354,1365,O
known,1368,1373,O
analyte,1374,1381,O
large,1389,1394,O
concentration,1395,1408,O
series,1409,1415,O
certain,1424,1431,O
shift,1432,1437,O
simulated,1441,1450,O
successive,1458,1468,O
column,1475,1481,O
fractions,1482,1491,O
Finally,1493,1500,O
methods,1506,1513,O
applied,1518,1525,O
real,1529,1533,O
chromatographic,1534,1549,O
data,1550,1554,O
showing,1555,1562,O
severely,1563,1571,O
shifted,1572,1579,O
peak,1580,1584,O
profiles,1585,1593,O
pros,1599,1603,O
cons,1608,1612,O
presented,1620,1629,O
approaches,1630,1640,O
discussed,1645,1654,O
relation,1658,1666,O
model,1674,1679,O
parameters,1680,1690,O
signal,1696,1702,O
noise,1706,1711,O
ratio,1712,1717,O
degree,1726,1732,O
shift,1736,1741,O
Incidence,1,10,O
fungal,14,20,O
infection,21,30,O
surgical,34,42,O
diseases,43,51,O
pancreas,59,67,B-Organ
Recently,70,78,O
number,83,89,O
mycotic,93,100,O
infections,101,111,O
increased,116,125,O
significantly,126,139,O
Authors,141,148,O
observed,154,162,O
13,163,165,O
mycotic,166,173,O
infections,174,184,O
operated,188,196,O
patients,197,205,O
suffering,206,215,O
pancreatic,216,226,B-Organ
diseases,227,235,O
1984,244,248,O
1990,253,257,O
9,259,260,O
13,264,266,O
patients,267,275,O
pancreatic,280,290,B-Pathological_formation
abscesses,291,300,I-Pathological_formation
risk,314,318,O
factors,319,326,O
fungal,330,336,O
infections,337,347,O
analysed,352,360,O
important,368,377,O
differentiation,386,401,O
fungal,410,416,O
colonisation,417,429,O
septicaemia,434,445,O
caused,446,452,O
yeasts,456,462,O
Repeated,464,472,O
microbiological,473,488,O
examinations,489,501,O
promote,506,513,O
recognising,514,525,O
fungal,533,539,O
invasion,540,548,O
base,554,558,O
therapy,566,573,O
avoid,580,585,O
risk,586,590,O
factors,591,598,O
infections,602,612,O
use,620,623,O
antifungal,624,634,O
medication,635,645,O
time,649,653,O
Quantitative,1,13,O
analysis,14,22,O
regional,26,34,O
cerebral,35,43,B-Organ
blood,44,49,B-Organism_substance
flow,50,54,O
elderly,58,65,O
white,71,76,B-Pathological_formation
matter,77,83,I-Pathological_formation
lesions,84,91,I-Pathological_formation
OBJECTIVE,94,103,O
observe,108,115,O
severity,128,136,O
white,140,145,B-Pathological_formation
matter,146,152,I-Pathological_formation
lesions,153,160,I-Pathological_formation
WML,162,165,B-Pathological_formation
related,170,177,O
ischemia,181,189,O
elderly,193,200,O
METHODS,202,209,O
WML,211,214,B-Pathological_formation
divided,220,227,O
2,233,234,O
categories,235,245,O
centrum,247,254,B-Multi-tissue_structure
semiovale,255,264,I-Multi-tissue_structure
periventricular,269,284,B-Multi-tissue_structure
regions,285,292,I-Multi-tissue_structure
grades,303,309,O
grade,311,316,O
0,317,318,O
grade,320,325,O
1,326,327,O
grade,329,334,O
2,335,336,O
grade,341,346,O
3,347,348,O
according,350,359,O
severity,367,375,O
WML,379,382,B-Pathological_formation
showing,383,390,O
FLAIR,398,403,O
sequence,404,412,O
MRI,416,419,O
modified,426,434,O
Fazekas,435,442,O
scale,443,448,O
values,454,460,O
regional,464,472,O
cerebral,473,481,B-Organ
blood,482,487,B-Organism_substance
flow,488,492,O
rCBF,494,498,O
WML,507,510,B-Pathological_formation
brain,521,526,B-Organ
regions,527,534,O
measured,540,548,O
Xenon,555,560,O
contrast,561,569,O
CT,570,572,O
RESULTS,574,581,O
Mean,583,587,O
rCBF,588,592,O
ml,594,596,O
x,597,598,O
100,599,602,O
g,603,604,O
1,606,607,O
x,609,610,O
min,611,614,O
1,616,617,O
lesions,627,634,B-Pathological_formation
periventricular,642,657,B-Multi-tissue_structure
areas,658,663,I-Multi-tissue_structure
right,668,673,O
left,678,682,O
centrum,683,690,B-Multi-tissue_structure
semiovale,691,700,I-Multi-tissue_structure
20,706,708,O
8,709,710,O
2,715,716,O
8,717,718,O
22,720,722,O
3,723,724,O
1,729,730,O
9,731,732,O
22,737,739,O
2,740,741,O
2,746,747,O
1,748,749,O
grade,753,758,O
0,759,760,O
20,762,764,O
3,765,766,O
2,771,772,O
5,773,774,O
21,776,778,O
3,779,780,O
1,785,786,O
0,787,788,O
21,793,795,O
0,796,797,O
1,802,803,O
8,804,805,O
grade1,809,815,O
16,817,819,O
3,820,821,O
2,826,827,O
0,828,829,O
15,831,833,O
6,834,835,O
1,840,841,O
7,842,843,O
15,848,850,O
9,851,852,O
0,857,858,O
9,859,860,O
grade,864,869,O
2,870,871,O
14,873,875,O
1,876,877,O
2,882,883,O
6,884,885,O
14,887,889,O
5,890,891,O
2,896,897,O
2,898,899,O
14,904,906,O
2,907,908,O
1,913,914,O
9,915,916,O
grade,920,925,O
3,926,927,O
respectively,928,940,O
severity,946,954,O
WML,958,961,B-Pathological_formation
associated,965,975,O
significantly,976,989,O
reduction,995,1004,O
rCBF,1008,1012,O
lesions,1020,1027,B-Pathological_formation
centrum,1036,1043,B-Multi-tissue_structure
semiovale,1044,1053,I-Multi-tissue_structure
periventricular,1058,1073,B-Multi-tissue_structure
regions,1074,1081,I-Multi-tissue_structure
P,1087,1088,O
0,1091,1092,O
05,1093,1095,O
significant,1111,1122,O
difference,1123,1133,O
rCBF,1137,1141,O
values,1142,1148,O
grade,1157,1162,O
0,1163,1164,O
1,1169,1170,O
significant,1176,1187,O
differences,1188,1199,O
existed,1200,1207,O
grade,1216,1221,O
0,1222,1223,O
grades,1228,1234,O
2,1235,1236,O
3,1241,1242,O
grade,1252,1257,O
1,1258,1259,O
grades,1264,1270,O
2,1271,1272,O
3,1277,1278,O
P,1284,1285,O
0,1288,1289,O
05,1290,1292,O
Statistical,1295,1306,O
significance,1307,1319,O
existed,1325,1332,O
severity,1345,1353,O
white,1357,1362,B-Pathological_formation
matter,1363,1369,I-Pathological_formation
lesions,1370,1377,I-Pathological_formation
rCBF,1382,1386,O
bilateral,1390,1399,O
temporal,1400,1408,B-Multi-tissue_structure
lobes,1409,1414,I-Multi-tissue_structure
lentiform,1419,1428,O
nucleases,1429,1438,O
P,1440,1441,O
0,1444,1445,O
05,1446,1448,O
CONCLUSIONS,1451,1462,O
severity,1468,1476,O
WML,1480,1483,B-Pathological_formation
centrum,1492,1499,B-Multi-tissue_structure
semiovale,1500,1509,I-Multi-tissue_structure
periventricular,1514,1529,B-Pathological_formation
regions,1530,1537,I-Pathological_formation
associated,1541,1551,O
significantly,1552,1565,O
reduction,1571,1580,O
rCBF,1584,1588,O
lesions,1596,1603,B-Pathological_formation
Aging,0,5,O
affects,6,13,O
cardiovascular,18,32,B-Anatomical_system
responses,33,42,O
cold,46,50,O
stress,51,57,O
humans,61,67,O
Cardiovascular,69,83,B-Anatomical_system
related,84,91,O
mortality,92,101,O
peaks,102,107,O
cold,115,119,O
winter,120,126,O
months,127,133,O
particularly,135,147,O
older,151,156,O
adults,157,163,O
Acute,165,170,O
physiological,171,184,O
responses,185,194,O
increases,204,213,O
blood,217,222,B-Organism_substance
pressure,223,231,O
response,236,244,O
cold,248,252,O
exposure,253,261,O
contribute,266,276,O
associations,286,298,O
determine,303,312,O
blood,325,330,B-Organism_substance
pressure,331,339,O
raising,340,347,O
effect,348,354,O
pressor,356,363,O
response,364,372,O
non,377,380,O
internal,381,389,O
body,390,394,B-Organism_subdivision
temperature,395,406,O
reducing,407,415,O
cold,416,420,O
stress,421,427,O
greater,431,438,O
age,444,447,O
measured,452,460,O
physiological,461,474,O
responses,475,484,O
20,488,490,O
min,491,494,O
superficial,498,509,O
skin,510,514,B-Organ
cooling,515,522,O
water,528,533,O
perfused,534,542,O
suit,543,547,O
12,552,554,O
younger,555,562,O
25,564,566,O
1,571,572,O
SE,574,576,O
yr,578,580,O
old,581,584,O
12,590,592,O
older,593,598,O
65,600,602,O
2,607,608,O
yr,609,611,O
old,612,615,O
adults,617,623,O
found,628,633,O
superficial,639,650,O
skin,651,655,B-Organ
cooling,656,663,O
elicited,664,672,O
increase,676,684,O
blood,688,693,B-Organism_substance
pressure,694,702,O
resting,708,715,O
levels,716,722,O
pressor,724,731,O
response,732,740,O
P,742,743,O
0,746,747,O
05,748,750,O
younger,755,762,O
older,767,772,O
adults,773,779,O
magnitude,794,803,O
pressor,812,819,O
response,820,828,O
systolic,830,838,O
mean,843,847,O
blood,848,853,B-Organism_substance
pressure,854,862,O
twofold,878,885,O
higher,886,892,O
older,896,901,O
adults,902,908,O
P,910,911,O
0,914,915,O
05,916,918,O
vs,919,921,O
younger,923,930,O
adults,931,937,O
magnitude,944,953,O
pressor,961,968,O
response,969,977,O
similar,982,989,O
peripheral,993,1003,O
brachial,1005,1013,B-Organism_subdivision
central,1019,1026,O
estimated,1028,1037,O
aorta,1045,1050,B-Multi-tissue_structure
measurement,1052,1063,O
sites,1064,1069,O
Regression,1071,1081,O
analysis,1082,1090,O
revealed,1091,1099,O
aortic,1105,1111,B-Multi-tissue_structure
pulse,1112,1117,O
wave,1118,1122,O
velocity,1123,1131,O
measure,1135,1142,O
central,1146,1153,O
arterial,1154,1162,B-Multi-tissue_structure
stiffness,1163,1172,O
obtained,1173,1181,O
cooling,1189,1196,O
best,1206,1210,O
predictor,1211,1220,O
increased,1228,1237,O
pressor,1238,1245,O
response,1246,1254,O
superficial,1258,1269,O
skin,1270,1274,B-Organ
cooling,1275,1282,O
older,1286,1291,O
adults,1292,1298,O
explaining,1300,1310,O
approximately,1311,1324,O
63,1325,1327,O
variability,1336,1347,O
results,1355,1362,O
indicate,1363,1371,O
greater,1388,1395,O
pressor,1396,1403,O
response,1404,1412,O
non,1416,1419,O
internal,1420,1428,O
body,1429,1433,B-Organism_subdivision
temperature,1434,1445,O
reducing,1446,1454,O
cold,1455,1459,O
stress,1460,1466,O
age,1472,1475,O
humans,1479,1485,O
mediated,1498,1506,O
increased,1510,1519,O
levels,1520,1526,O
central,1530,1537,O
arterial,1538,1546,B-Multi-tissue_structure
stiffness,1547,1556,O
Magnesium,0,9,O
treatment,14,23,O
asthma,27,33,O
children,37,45,O
QUESTION,47,55,O
Magnesium,57,66,O
considered,70,80,O
adjuvant,81,89,O
therapy,90,97,O
moderate,102,110,O
severe,114,120,O
asthma,121,127,O
exacerbations,128,141,O
adults,145,151,O
treat,175,180,O
children,181,189,O
ANSWER,191,197,O
Magnesium,199,208,O
beneficial,221,231,O
treatment,239,248,O
moderate,252,260,O
severe,264,270,O
asthma,271,277,O
children,281,289,O
safe,299,303,O
drug,304,308,O
administer,312,322,O
minor,344,349,O
effects,355,362,O
reported,363,371,O
epigastric,381,391,B-Organism_subdivision
facial,395,401,B-Organism_subdivision
warmth,402,408,O
flushing,410,418,O
pain,420,424,O
numbness,429,437,O
infusion,445,453,O
site,454,458,O
dry,460,463,O
mouth,464,469,B-Organism_subdivision
malaise,471,478,O
hypotension,484,495,O
Owing,497,502,O
bronchodilating,510,525,O
anti,530,534,O
inflammatory,535,547,O
effects,548,555,O
magnesium,557,566,O
encouraging,573,584,O
adjuvant,585,593,O
therapy,594,601,O
pediatric,606,615,O
patients,616,624,O
respond,636,643,O
conventional,647,659,O
treatment,660,669,O
acute,673,678,O
severe,679,685,O
exacerbations,686,699,O
Future,701,707,O
studies,708,715,O
focus,723,728,O
establishing,732,744,O
optimal,749,756,O
dosage,757,763,O
maximal,768,775,O
benefits,776,784,O
best,793,797,O
route,798,803,O
administration,807,821,O
Magnesium,823,832,O
considered,848,858,O
prophylactic,864,876,O
treatment,877,886,O
Effectiveness,0,13,O
different,17,26,O
approaches,27,37,O
establishing,42,54,O
cisplatin,55,64,O
induced,65,72,O
cochlear,73,81,B-Pathological_formation
lesions,82,89,I-Pathological_formation
mice,93,97,O
CONCLUSIONS,99,110,O
Mouse,112,117,O
cochleae,118,126,B-Multi-tissue_structure
highly,131,137,O
resistant,138,147,O
systemically,151,163,O
administered,164,176,O
cisplatin,177,186,O
cochlear,197,205,B-Pathological_formation
lesions,206,213,I-Pathological_formation
produced,221,229,O
effectively,230,241,O
mice,245,249,O
cisplatin,255,264,O
applied,268,275,O
locally,276,283,O
round,296,301,B-Immaterial_anatomical_entity
window,302,308,I-Immaterial_anatomical_entity
niche,309,314,I-Immaterial_anatomical_entity
tympanum,318,326,B-Multi-tissue_structure
OBJECTIVE,328,337,O
explore,342,349,O
optimal,354,361,O
approach,362,370,O
creating,375,383,O
cisplatin,384,393,O
induced,394,401,O
cochlear,402,410,B-Pathological_formation
lesions,411,418,I-Pathological_formation
mice,422,426,O
MATERIALS,428,437,O
METHODS,442,449,O
Cisplatin,451,460,O
administered,465,477,O
adult,481,486,O
C57BL,487,492,O
6J,493,495,O
mice,496,500,O
approaches,510,520,O
1,523,524,O
transtympanic,526,539,O
injection,540,549,O
2,552,553,O
round,555,560,B-Immaterial_anatomical_entity
window,561,567,I-Immaterial_anatomical_entity
niche,568,573,I-Immaterial_anatomical_entity
injection,574,583,O
3,586,587,O
intraperitoneal,589,604,O
injection,605,614,O
p,618,619,O
4,625,626,O
mg,627,629,O
kg,630,632,O
day,633,636,O
4,641,642,O
consecutive,643,654,O
days,655,659,O
4,666,667,O
15,673,675,O
mg,676,678,O
kg,679,681,O
dose,682,686,O
p,689,690,O
hearing,696,703,O
monitored,708,717,O
frequency,724,733,O
specific,734,742,O
auditory,743,751,O
brainstem,752,761,B-Multi-tissue_structure
responses,762,771,O
ABRs,773,777,O
distortion,783,793,O
product,794,801,O
otoacoustic,802,813,O
emissions,814,823,O
DPOAEs,825,831,O
Cochlear,834,842,B-Multi-tissue_structure
pathology,843,852,O
observed,857,865,O
cochleograms,869,881,O
Harris,887,893,O
hematoxylin,895,906,O
staining,907,915,O
RESULTS,917,924,O
Cisplatin,926,935,O
applied,936,943,O
systemically,944,956,O
cause,965,970,O
significant,975,986,O
ABR,987,990,O
threshold,991,1000,O
elevation,1001,1010,O
frequencies,1022,1033,O
tested,1034,1040,O
2,1042,1043,O
32,1044,1046,O
kHz,1047,1050,O
local,1061,1066,O
application,1067,1078,O
cisplatin,1082,1091,O
round,1104,1109,B-Immaterial_anatomical_entity
window,1110,1116,I-Immaterial_anatomical_entity
niche,1117,1122,I-Immaterial_anatomical_entity
tympanum,1126,1134,B-Multi-tissue_structure
resulted,1135,1143,O
significant,1147,1158,O
ABR,1159,1162,O
threshold,1163,1172,O
elevations,1173,1183,O
high,1189,1193,O
medium,1197,1203,O
frequencies,1204,1215,O
functional,1221,1231,O
changes,1232,1239,O
consistent,1245,1255,O
cochlear,1265,1273,B-Multi-tissue_structure
pathology,1274,1283,O
groups,1291,1297,O
Characterization,8,24,O
Activin,28,35,O
induced,38,45,O
IgA,46,49,O
Response,50,58,O
Murine,62,68,O
B,69,70,B-Cell
Lymphocytes,71,82,I-Cell
recently,92,100,O
shown,101,106,O
activin,112,119,O
member,125,131,O
TGF,135,138,O
beta,139,143,O
superfamily,144,155,O
stimulates,157,167,O
mouse,168,173,O
B,174,175,B-Cell
cells,176,181,I-Cell
express,185,192,O
IgA,193,196,O
isotype,197,204,O
isotypes,215,223,O
present,232,239,O
study,240,245,O
characterized,258,271,O
effects,272,279,O
activin,283,290,O
B,296,297,B-Cell
cell,298,302,I-Cell
growth,303,309,O
IgA,314,317,O
expression,318,328,O
found,333,338,O
activin,344,351,O
effect,367,373,O
LPS,377,380,O
stimulated,381,391,O
cell,392,396,B-Cell
viability,397,406,O
parallel,411,419,O
CFSE,421,425,O
staining,426,434,O
analysis,435,443,O
revealed,444,452,O
activin,458,465,O
alter,476,481,O
cell,482,486,B-Cell
division,487,495,O
increase,500,508,O
IgA,512,515,O
secretion,516,525,O
activin,529,536,O
completely,543,553,O
abrogated,554,563,O
anti,567,571,O
activin,572,579,O
Ab,582,584,O
anti,596,600,O
TGFbeta1,601,609,O
Ab,610,612,O
conditions,626,636,O
isotypes,647,655,O
significantly,660,673,O
affected,674,682,O
antibody,691,699,O
treatment,700,709,O
Finally,711,718,O
activin,720,727,O
similar,734,741,O
TGF,745,748,O
beta1,749,754,O
increased,756,765,O
IgA,766,769,O
secretion,770,779,O
mesenteric,783,793,O
lymph,794,799,B-Cell
node,800,804,I-Cell
cells,805,810,I-Cell
results,818,825,O
suggest,826,833,O
activin,839,846,O
specifically,853,865,O
stimulate,866,875,O
IgA,876,879,O
response,880,888,O
independent,890,901,O
TGF,905,908,O
beta,909,913,O
gut,921,924,B-Organism_subdivision
Posterior,0,9,O
stabilization,10,23,O
cervical,31,39,B-Organism_subdivision
spine,40,45,I-Organism_subdivision
hook,51,55,O
plates,56,62,O
Hook,64,68,O
plate,69,74,O
fixation,75,83,O
designed,87,95,O
posterior,100,109,O
cervical,110,118,B-Organism_subdivision
stabilization,119,132,O
C2,138,140,O
C7,144,146,O
Indications,148,159,O
remain,160,166,O
standard,183,191,O
posterior,192,201,O
fixations,202,211,O
prime,217,222,O
indications,223,234,O
discoligamentous,239,255,O
injuries,256,264,O
plates,270,276,O
hooked,281,287,O
lower,298,303,B-Multi-tissue_structure
laminas,304,311,I-Multi-tissue_structure
attached,316,324,O
articular,332,341,B-Multi-tissue_structure
masses,342,348,I-Multi-tissue_structure
upper,356,361,O
vertebra,362,370,B-Organ
oblique,374,381,O
screws,382,388,O
H,393,394,O
graft,395,400,O
placed,404,410,O
spinous,423,430,O
processes,431,440,O
vertebrae,446,455,B-Organ
compressed,460,470,O
plates,487,493,O
points,503,509,O
facet,515,520,O
joints,521,527,O
graft,533,538,O
resulting,544,553,O
pre,554,557,O
stressed,558,566,O
system,567,573,O
stable,577,583,O
directions,591,601,O
protocol,605,613,O
safe,618,622,O
reduction,623,632,O
cervical,636,644,B-Organism_subdivision
dislocations,645,657,O
observed,661,669,O
70,674,676,O
patients,677,685,O
treated,686,693,O
1979,699,703,O
1986,707,711,O
51,713,715,O
examined,721,729,O
12,730,732,O
54,733,735,O
months,736,742,O
surgery,749,756,O
fusions,762,769,O
consolidated,770,782,O
neurologic,788,798,B-Anatomical_system
complications,799,812,O
attributable,817,829,O
fixation,837,845,O
occurred,846,854,O
major,862,867,O
complications,868,881,O
seen,891,895,O
elimination,7,18,O
HIV,22,25,O
infection,26,35,O
reach,43,48,O
United,56,62,O
States,63,69,O
Lessons,71,78,O
epidemiologic,87,100,O
transmission,101,113,O
model,114,119,O
Recent,121,127,O
estimates,128,137,O
transmission,152,164,O
rate,165,169,O
human,173,178,O
immunodeficiency,179,195,O
virus,196,201,O
HIV,203,206,O
U,215,216,O
S,217,218,O
substantially,224,237,O
decreased,238,247,O
raises,254,260,O
question,265,273,O
elimination,278,289,O
HIV,293,296,O
infection,297,306,O
nation,314,320,O
feasible,321,329,O
foreseeable,337,348,O
future,349,355,O
demonstrate,360,371,O
HIV,384,387,O
transmission,388,400,O
rate,401,405,O
reduced,411,418,O
50,422,424,O
reproductive,436,448,O
rate,449,453,O
HIV,457,460,O
infection,461,470,O
drop,477,481,O
unity,488,493,O
lead,498,502,O
eventual,506,514,O
elimination,515,526,O
infection,530,539,O
recent,544,550,O
congressional,551,564,O
testimony,565,574,O
director,580,588,O
Centers,596,603,O
Disease,608,615,O
Control,616,623,O
Prevention,628,638,O
asserted,650,658,O
HIV,668,671,O
transmission,672,684,O
rate,685,689,O
halved,697,703,O
2020,707,711,O
earlier,720,727,O
provided,729,737,O
sufficient,738,748,O
investment,749,759,O
achieving,775,784,O
goal,790,794,O
assert,799,805,O
adequate,814,822,O
investment,823,833,O
transmission,850,862,O
rate,863,867,O
fact,874,878,O
lowered,879,886,O
50,890,892,O
HIV,904,907,O
reproductive,908,920,O
rate,921,925,O
fall,932,936,O
unity,943,948,O
setting,950,957,O
stage,962,967,O
eventual,972,980,O
elimination,981,992,O
HIV,996,999,O
infection,1000,1009,O
U,1017,1018,O
S,1019,1020,O
Pain,0,4,O
assessment,5,15,O
continuous,19,29,O
EEG,30,33,O
association,35,46,O
subjective,55,65,O
perception,66,76,O
tonic,80,85,O
pain,86,90,O
peak,95,99,O
frequency,100,109,O
alpha,113,118,O
oscillations,119,131,O
stimulation,139,150,O
rest,158,162,O
Recordings,164,174,O
neurophysiological,178,196,O
brain,197,202,B-Organ
responses,203,212,O
noxious,216,223,O
stimuli,224,231,O
traditionally,242,255,O
based,256,261,O
short,265,270,O
stimuli,271,278,O
order,287,292,O
milliseconds,296,308,O
induce,316,322,O
distinct,323,331,O
event,332,337,O
related,338,345,O
potentials,346,356,O
ERPs,358,362,O
stimuli,385,392,O
experimental,400,412,O
setting,413,420,O
disadvantageous,424,439,O
brief,456,461,O
faithfully,465,475,O
simulate,476,484,O
clinical,485,493,O
pain,494,498,O
aimed,503,508,O
utilizing,512,521,O
continuous,522,532,O
EEG,533,536,O
investigate,540,551,O
properties,556,566,O
peak,570,574,O
alpha,575,580,O
frequency,581,590,O
PAF,592,595,O
objective,603,612,O
cortical,613,621,B-Multi-tissue_structure
measure,622,629,O
associated,630,640,O
subjective,646,656,O
perception,657,667,O
tonic,671,676,O
pain,677,681,O
minute,688,694,O
long,695,699,O
continuous,700,710,O
EEG,711,714,O
recorded,719,727,O
18,731,733,O
healthy,734,741,O
volunteers,742,752,O
resting,764,771,O
state,772,777,O
ii,780,782,O
innocuous,784,793,O
temperature,794,805,O
iii,812,815,O
psychophysically,817,833,O
anchored,834,842,O
noxious,843,850,O
temperature,851,862,O
Numerical,864,873,O
pain,874,878,O
scores,879,885,O
NPSs,887,891,O
collected,893,902,O
application,914,925,O
tonic,929,934,O
noxious,935,942,O
stimuli,943,950,O
tested,956,962,O
correlation,967,978,O
peak,984,988,O
frequencies,989,1000,O
alpha,1004,1009,O
power,1010,1015,O
curves,1016,1022,O
derived,1023,1030,O
central,1036,1043,O
temporal,1045,1053,O
frontal,1058,1065,O
electrodes,1066,1076,O
NPSs,1078,1082,O
PAFs,1087,1091,O
remained,1092,1100,O
stable,1101,1107,O
recording,1123,1132,O
conditions,1133,1143,O
RM,1145,1147,O
ANOVAs,1148,1154,O
Ps,1156,1158,O
0,1159,1160,O
51,1161,1163,O
noxious,1173,1180,O
condition,1181,1190,O
PAFs,1192,1196,O
obtained,1197,1205,O
bilateral,1213,1222,O
temporal,1223,1231,B-Multi-tissue_structure
scalp,1232,1237,I-Multi-tissue_structure
correlated,1243,1253,O
NPSs,1259,1263,O
Ps,1265,1267,O
0,1268,1269,O
001,1270,1273,O
resting,1286,1293,O
state,1294,1299,O
PAFs,1300,1304,O
recorded,1305,1313,O
bilateral,1321,1330,O
temporal,1331,1339,B-Multi-tissue_structure
scalp,1340,1345,I-Multi-tissue_structure
correlated,1351,1361,O
NPSs,1367,1371,O
reported,1372,1380,O
noxious,1392,1399,O
condition,1400,1409,O
Ps,1411,1413,O
0,1414,1415,O
01,1416,1418,O
psychophysical,1427,1441,O
neurophysiological,1442,1460,O
relations,1461,1470,O
attest,1471,1477,O
properties,1485,1495,O
PAF,1499,1502,O
novel,1508,1513,O
cortical,1514,1522,B-Multi-tissue_structure
objective,1523,1532,O
measure,1533,1540,O
subjective,1544,1554,O
perception,1555,1565,O
tonic,1569,1574,O
pain,1575,1579,O
resting,1591,1598,O
state,1599,1604,O
PAFs,1605,1609,O
hold,1616,1620,O
inherent,1621,1629,O
pain,1630,1634,O
modulation,1635,1645,O
attributes,1646,1656,O
possibly,1658,1666,O
enabling,1667,1675,O
prediction,1680,1690,O
individual,1694,1704,O
responsiveness,1705,1719,O
prolonged,1723,1732,O
pain,1733,1737,O
relevance,1743,1752,O
PAF,1756,1759,O
neural,1767,1773,B-Cell
processing,1774,1784,O
tonic,1788,1793,O
pain,1794,1798,O
indicate,1803,1811,O
potential,1816,1825,O
advance,1829,1836,O
pain,1837,1841,O
research,1842,1850,O
clinical,1862,1870,O
pain,1871,1875,O
characterization,1876,1892,O
Acoustic,0,8,O
trauma,9,15,O
evokes,16,22,O
hyperactivity,23,36,O
changes,41,48,O
gene,52,56,O
expression,57,67,O
guinea,71,77,O
pig,78,81,O
auditory,82,90,O
brainstem,91,100,B-Multi-tissue_structure
Hearing,102,109,O
loss,110,114,O
acoustic,120,128,O
trauma,129,135,O
risk,141,145,O
factor,146,152,O
tinnitus,157,165,O
Animal,167,173,O
models,174,180,O
acoustic,187,195,O
trauma,196,202,O
demonstrated,208,220,O
hyperactivity,221,234,O
central,238,245,O
auditory,246,254,O
pathways,255,263,O
suggested,280,289,O
substrate,295,304,O
tinnitus,309,317,O
guinea,329,335,O
pig,336,339,O
model,340,345,O
unilateral,349,359,O
acoustic,360,368,O
trauma,369,375,O
animals,393,400,O
measurements,402,414,O
peripheral,418,428,O
hearing,429,436,O
loss,437,441,O
spontaneous,443,454,O
activity,455,463,O
single,467,473,O
neurons,474,481,B-Cell
inferior,489,497,B-Multi-tissue_structure
colliculus,498,508,I-Multi-tissue_structure
gene,513,517,O
expression,518,528,O
cochlear,532,540,B-Multi-tissue_structure
nucleus,541,548,I-Multi-tissue_structure
inferior,553,561,B-Multi-tissue_structure
colliculus,562,572,I-Multi-tissue_structure
combined,578,586,O
acutely,588,595,O
recovery,606,614,O
acoustic,620,628,O
trauma,629,635,O
Genes,637,642,O
investigated,643,655,O
related,656,663,O
inhibitory,667,677,O
GABA,679,683,O
receptor,686,694,O
subunit,695,702,O
alpha,703,708,O
1,709,710,O
glycine,712,719,O
receptor,720,728,O
subunit,729,736,O
alpha,737,742,O
1,743,744,O
excitatory,750,760,O
neurotransmission,761,778,O
glutamate,780,789,O
decarboxylase,790,803,O
1,804,805,O
glutamate,807,816,O
receptor,817,825,O
AMPA,826,830,O
subunit,831,838,O
alpha,839,844,O
2,845,846,O
glutamate,848,857,O
receptor,858,866,O
NMDA,867,871,O
subunit,872,879,O
1,880,881,O
regulation,884,894,O
transmitter,898,909,O
release,910,917,O
member,919,925,O
RAB,929,932,O
family,933,939,O
small,943,948,O
GTPase,949,955,O
RAB3,957,961,O
GTPase,962,968,O
activating,969,979,O
protein,980,987,O
subunit,988,995,O
1,996,997,O
neuronal,1003,1011,B-Cell
excitability,1012,1024,O
potassium,1026,1035,O
channel,1036,1043,O
subfamily,1044,1053,O
K,1054,1055,O
member,1056,1062,O
15,1063,1065,O
Acoustic,1068,1076,O
trauma,1077,1083,O
resulted,1084,1092,O
unilateral,1096,1106,O
hearing,1107,1114,O
loss,1115,1119,O
hyperactivity,1124,1137,O
bilaterally,1138,1149,O
inferior,1153,1161,B-Multi-tissue_structure
colliculus,1162,1172,I-Multi-tissue_structure
Changes,1174,1181,O
expression,1185,1195,O
different,1199,1208,O
mRNAs,1209,1214,O
observed,1220,1228,O
ipsilateral,1232,1243,O
cochlear,1244,1252,B-Multi-tissue_structure
nucleus,1253,1260,I-Multi-tissue_structure
ipsi,1268,1272,O
contralateral,1278,1291,O
inferior,1292,1300,B-Multi-tissue_structure
colliculus,1301,1311,I-Multi-tissue_structure
immediately,1313,1324,O
acoustic,1331,1339,O
trauma,1340,1346,O
2,1358,1359,O
4,1364,1365,O
weeks,1366,1371,O
recovery,1373,1381,O
Gene,1383,1387,O
expression,1388,1398,O
generally,1403,1412,O
reduced,1413,1420,O
immediately,1421,1432,O
trauma,1439,1445,O
followed,1447,1455,O
return,1461,1467,O
near,1471,1475,O
normal,1476,1482,O
levels,1483,1489,O
expression,1498,1508,O
recovery,1512,1520,O
time,1521,1525,O
increased,1526,1535,O
Different,1537,1546,O
mechanisms,1547,1557,O
appear,1558,1564,O
underlie,1568,1576,O
spontaneous,1581,1592,O
hyperactivity,1593,1606,O
observed,1607,1615,O
evidence,1626,1634,O
regulation,1643,1653,O
genes,1657,1662,O
associated,1663,1673,O
neuronal,1679,1687,B-Cell
inhibition,1688,1698,O
contralateral,1706,1719,O
inferior,1720,1728,B-Multi-tissue_structure
colliculus,1729,1739,I-Multi-tissue_structure
ipsilateral,1752,1763,O
cochlear,1764,1772,B-Multi-tissue_structure
nucleus,1773,1780,I-Multi-tissue_structure
competing,1782,1791,O
actions,1792,1799,O
inhibitory,1803,1813,O
excitatory,1818,1828,O
systems,1829,1836,O
play,1845,1849,O
major,1852,1857,O
role,1858,1862,O
determining,1866,1877,O
overall,1878,1885,O
excitability,1886,1898,O
Yellow,0,6,O
green,7,12,O
52,13,15,O
3W,16,18,O
laser,19,24,O
556 nm,28,33,O
based,34,39,O
frequency,43,52,O
doubling,53,61,O
diode,67,72,O
pumped,78,84,O
Q,85,86,O
switched,87,95,O
Nd,96,98,O
YAG,99,102,O
laser,103,108,O
demonstrate,113,124,O
high,127,131,O
power,132,137,O
556 nm,138,143,O
yellow,144,150,O
green,151,156,O
laser,157,162,O
generated,163,172,O
intracavity,176,187,O
frequency,188,197,O
doubling,198,206,O
diode,212,217,O
pumped,223,229,O
Nd,230,232,O
YAG,233,236,O
laser,237,242,O
1112 nm,246,252,O
symmetrical,256,267,O
L,268,269,O
shaped,270,276,O
flat,277,281,O
flat,282,286,O
cavity,287,293,O
employed,298,306,O
implement,310,319,O
efficient,320,329,O
operation,330,339,O
low,347,350,O
gain,351,355,O
1112 nm,356,362,O
transition,363,373,O
achieve,381,388,O
good,389,393,O
power,394,399,O
scalability,400,411,O
coatings,417,425,O
cavity,433,439,O
mirrors,440,447,O
carefully,453,462,O
designed,463,471,O
optimize,475,483,O
performance,488,499,O
laser,507,512,O
92W,520,523,O
continuous,524,534,O
wave,535,539,O
laser,540,545,O
output,546,552,O
1112 nm,556,562,O
achieved,567,575,O
pumping,585,592,O
power,593,598,O
laser,606,611,O
diodes,612,618,O
reached,619,626,O
960W,627,631,O
intracavity,636,647,O
frequency,648,657,O
doubling,658,666,O
fundamental,674,685,O
laser,686,691,O
lithium,697,704,O
triborate,705,714,O
crystal,715,722,O
maximum,728,735,O
power,736,741,O
frequency,749,758,O
doubled,759,766,O
output,767,773,O
556 nm,777,782,O
found,787,792,O
high,802,806,O
52,810,812,O
3W,813,815,O
pulse,823,828,O
repetition,829,839,O
frequency,840,849,O
10kHz,853,858,O
corresponds,865,876,O
optical,883,890,O
optical,894,901,O
conversion,902,912,O
efficiency,913,923,O
5,933,934,O
4,935,936,O
Ventral,0,7,B-Multi-tissue_structure
dorsal,12,18,B-Multi-tissue_structure
striatal,19,27,I-Multi-tissue_structure
dopamine,28,36,O
efflux,37,43,O
behavior,48,56,O
rats,60,64,O
simple,70,76,O
vs,77,79,O
co,81,83,O
morbid,84,90,O
histories,91,100,O
cocaine,104,111,O
sensitization,112,125,O
neonatal,130,138,B-Pathological_formation
ventral,139,146,I-Pathological_formation
hippocampal,147,158,I-Pathological_formation
lesions,159,166,I-Pathological_formation
UNLABELLED,168,178,O
RATIONAL,180,188,O
Exposing,190,198,O
animal,199,205,O
models,206,212,O
mental,216,222,O
illness,223,230,O
addictive,234,243,O
drugs,244,249,O
provides,250,258,O
approach,262,270,O
understanding,274,287,O
neural,292,298,B-Multi-tissue_structure
etiology,299,307,O
dual,311,315,O
diagnosis,316,325,O
disorders,326,335,O
Previous,337,345,O
studies,346,353,O
shown,359,364,O
neonatal,370,378,B-Pathological_formation
ventral,379,386,I-Pathological_formation
hippocampal,387,398,I-Pathological_formation
lesions,399,406,I-Pathological_formation
NVHL,408,412,B-Pathological_formation
rats,417,421,O
produce,422,429,O
features,430,438,O
schizophrenia,447,460,O
addiction,465,474,O
vulnerability,475,488,O
OBJECTIVE,490,499,O
study,506,511,O
investigated,512,524,O
ventral,525,532,B-Multi-tissue_structure
dorsal,537,543,B-Multi-tissue_structure
striatal,544,552,I-Multi-tissue_structure
dopamine,553,561,O
DA,563,565,O
efflux,567,573,O
NVHL,577,581,B-Pathological_formation
rats,582,586,O
combined,587,595,O
behavioral,601,611,O
sensitization,612,625,O
cocaine,629,636,O
METHODS,638,645,O
Adult,647,652,O
NVHL,653,657,B-Pathological_formation
vs,658,660,O
SHAM,662,666,O
operated,667,675,O
rats,676,680,O
underwent,681,690,O
5,693,694,O
day,695,698,O
injection,699,708,O
series,709,715,O
cocaine,719,726,O
15,728,730,O
mg,731,733,O
kg,734,736,O
day,737,740,O
vs,742,744,O
saline,746,752,O
week,758,762,O
later,763,768,O
rats,770,774,O
cannulated,780,790,O
nucleus,794,801,B-Multi-tissue_structure
accumbens,802,811,I-Multi-tissue_structure
SHELL,812,817,O
CORE,819,823,O
caudate,828,835,B-Multi-tissue_structure
putamen,836,843,I-Multi-tissue_structure
week,853,857,O
later,858,863,O
vivo,868,872,O
microdialysis,873,886,O
sampled,887,894,O
DA,895,897,O
locomotor,905,914,O
testing,915,922,O
single,934,940,O
cocaine,941,948,O
injection,949,958,O
15,960,962,O
mg,963,965,O
kg,966,968,O
delivered,974,983,O
RESULTS,985,992,O
NVHLs,994,999,B-Pathological_formation
cocaine,1004,1011,O
history,1012,1019,O
significantly,1020,1033,O
increased,1034,1043,O
behavioral,1044,1054,O
activation,1055,1065,O
approximately,1066,1079,O
2,1080,1081,O
fold,1082,1086,O
SHAM,1092,1096,O
saline,1097,1103,O
history,1104,1111,O
rats,1112,1116,O
DA,1118,1120,O
efflux,1121,1127,O
curves,1128,1134,O
corresponded,1135,1147,O
time,1148,1152,O
dependently,1153,1164,O
cocaine,1174,1181,O
injection,1182,1191,O
locomotor,1196,1205,O
curves,1206,1212,O
varied,1217,1223,O
significantly,1224,1237,O
striatal,1241,1249,B-Multi-tissue_structure
region,1250,1256,I-Multi-tissue_structure
Baseline,1258,1266,O
DA,1267,1269,O
levels,1270,1276,O
increased,1277,1286,O
5,1287,1288,O
fold,1289,1293,O
cocaine,1300,1307,O
stimulated,1308,1318,O
DA,1319,1321,O
efflux,1322,1328,O
decreased,1329,1338,O
half,1342,1346,O
ventral,1356,1363,B-Multi-tissue_structure
dorsal,1367,1373,B-Multi-tissue_structure
striatal,1374,1382,I-Multi-tissue_structure
gradient,1383,1391,O
NVHLs,1402,1407,B-Pathological_formation
prior,1409,1414,O
cocaine,1415,1422,O
history,1423,1430,O
individual,1436,1446,O
differences,1447,1458,O
behavior,1462,1470,O
underpinned,1480,1491,O
differential,1495,1507,O
DA,1508,1510,O
efflux,1511,1517,O
overall,1518,1525,O
striatal,1540,1548,B-Multi-tissue_structure
region,1549,1555,I-Multi-tissue_structure
CONCLUSION,1557,1567,O
Differences,1569,1580,O
ventral,1584,1591,B-Multi-tissue_structure
dorsal,1592,1598,B-Multi-tissue_structure
striatal,1599,1607,I-Multi-tissue_structure
DA,1608,1610,O
efflux,1611,1617,O
present,1626,1633,O
required,1649,1657,O
producing,1662,1671,O
differential,1672,1684,O
levels,1685,1691,O
acute,1695,1700,O
cocaine,1701,1708,O
induced,1709,1716,O
behavioral,1717,1727,O
activation,1728,1738,O
NVHLs,1742,1747,B-Pathological_formation
behaviorally,1767,1779,O
sensitizing,1780,1791,O
cocaine,1792,1799,O
history,1800,1807,O
findings,1815,1823,O
suggest,1824,1831,O
neurotransmitter,1838,1854,O
systems,1855,1862,O
alterations,1868,1879,O
striatal,1883,1891,B-Multi-tissue_structure
network,1892,1899,O
function,1900,1908,O
post,1909,1913,O
synaptic,1914,1922,O
DA,1926,1928,O
transmission,1929,1941,O
important,1951,1960,O
understanding,1964,1977,O
interactive,1982,1993,O
effects,1994,2001,O
addictive,2005,2014,O
drugs,2015,2020,O
mental,2025,2031,O
illness,2032,2039,O
Predictive,0,10,O
value,11,16,O
serum,20,25,B-Organism_substance
carbohydrate,26,38,O
antigen,39,46,O
19,47,49,O
9,50,51,O
malignant,55,64,O
intraductal,65,76,O
papillary,77,86,B-Pathological_formation
mucinous,87,95,I-Pathological_formation
neoplasms,96,105,I-Pathological_formation
BACKGROUND,107,117,O
goal,123,127,O
present,135,142,O
study,143,148,O
evaluate,156,164,O
predictive,169,179,O
value,180,185,O
serum,189,194,B-Organism_substance
carbohydrate,195,207,O
antigen,208,215,O
19,216,218,O
9,219,220,O
19,225,227,O
9,228,229,O
diagnosis,238,247,O
malignant,251,260,O
intraductal,261,272,B-Pathological_formation
papillary,273,282,I-Pathological_formation
mucinous,283,291,I-Pathological_formation
neoplasms,292,301,I-Pathological_formation
pancreas,305,313,B-Organ
IPMNs,315,320,B-Pathological_formation
METHODS,323,330,O
Eighty,332,338,O
patients,343,351,O
pathological,357,369,O
diagnosis,370,379,O
IPMNs,383,388,B-Pathological_formation
Zhongshan,392,401,O
Hospital,402,410,O
March,419,424,O
1999,425,429,O
November,434,442,O
2008,443,447,O
retrospectively,453,468,O
reviewed,469,477,O
Data,479,483,O
reflecting,484,494,O
clinical,495,503,O
characteristics,504,519,O
tumor,521,526,B-Pathological_formation
marker,527,533,O
level,534,539,O
prognosis,545,554,O
collected,560,569,O
potential,575,584,O
predictive,585,595,O
value,596,601,O
19,608,610,O
9,611,612,O
analyzed,617,625,O
receiver,629,637,O
operating,638,647,O
characteristic,648,662,O
ROC,664,667,O
curve,669,674,O
RESULTS,676,683,O
Eighty,685,691,O
consecutive,696,707,O
patients,708,716,O
IPMNs,722,727,B-Pathological_formation
underwent,732,741,O
surgical,742,750,O
intervention,751,763,O
high,767,771,O
level,772,777,O
19,784,786,O
9,787,788,O
carcinoembryonic,792,808,O
antigen,809,816,O
CEA,818,821,O
associated,827,837,O
advanced,848,856,O
stage,857,862,O
malignant,866,875,O
IPMNs,876,881,B-Pathological_formation
Carbohydrate,883,895,O
antigen,896,903,O
19,904,906,O
9,907,908,O
significant,913,924,O
judging,929,936,O
malignant,937,946,O
IPMNs,947,952,B-Pathological_formation
binary,960,966,O
logistic,967,975,O
regression,976,986,O
model,987,992,O
p,994,995,O
0,996,997,O
047,998,1001,O
hazard,1008,1014,O
ratio,1015,1020,O
1,1025,1026,O
014,1027,1030,O
95,1038,1040,O
0,1041,1042,O
confidence,1044,1054,O
interval,1055,1063,O
0,1068,1069,O
91,1070,1072,O
1,1073,1074,O
028,1075,1078,O
Receiver,1080,1088,O
operating,1089,1098,O
characteristic,1099,1113,O
analysis,1114,1122,O
showed,1123,1129,O
serum,1139,1144,B-Organism_substance
19,1148,1150,O
9,1151,1152,O
level,1153,1158,O
good,1163,1167,O
predictive,1168,1178,O
value,1179,1184,O
malignant,1189,1198,O
invasive,1202,1210,O
IPMNs,1211,1216,B-Pathological_formation
postoperative,1218,1231,O
survival,1232,1240,O
disease,1246,1253,O
specific,1254,1262,O
recurrence,1263,1273,O
area,1279,1283,O
curve,1294,1299,O
AUC,1301,1304,O
0,1310,1311,O
856,1312,1315,O
0,1317,1318,O
893,1319,1322,O
0,1324,1325,O
815,1326,1329,O
0,1335,1336,O
857,1337,1340,O
p,1342,1343,O
0,1344,1345,O
05,1346,1348,O
respectively,1351,1363,O
According,1365,1374,O
follow,1382,1388,O
mean,1393,1397,O
survival,1398,1406,O
time,1407,1411,O
groups,1416,1422,O
19,1431,1433,O
9,1434,1435,O
63,1436,1438,O
60,1439,1441,O
U,1442,1443,O
ml,1444,1446,O
dramatically,1451,1463,O
shorter,1464,1471,O
groups,1486,1492,O
19,1501,1503,O
9,1504,1505,O
63,1507,1509,O
60,1510,1512,O
U,1513,1514,O
ml,1515,1517,O
57,1519,1521,O
38,1522,1524,O
2,1527,1528,O
85,1529,1531,O
versus,1532,1538,O
29,1539,1541,O
24,1542,1544,O
5,1547,1548,O
82,1549,1551,O
months,1553,1559,O
p,1562,1563,O
0,1564,1565,O
01,1566,1568,O
CONCLUSIONS,1571,1582,O
Serum,1584,1589,B-Organism_substance
19,1593,1595,O
9,1596,1597,O
level,1598,1603,O
good,1608,1612,O
predictive,1613,1623,O
value,1624,1629,O
malignant,1634,1643,O
invasive,1647,1655,O
IPMNs,1656,1661,B-Pathological_formation
Patients,1663,1671,O
19,1680,1682,O
9,1683,1684,O
63,1687,1689,O
60,1690,1692,O
U,1693,1694,O
ml,1695,1697,O
poor,1702,1706,O
postoperative,1707,1720,O
prognosis,1721,1730,O
IPMNs,1734,1739,B-Pathological_formation
Preoperative,1741,1753,O
abnormal,1754,1762,O
serum,1763,1768,B-Organism_substance
19,1772,1774,O
9,1775,1776,O
predictive,1786,1796,O
aggressive,1804,1814,O
surgical,1815,1823,O
intervention,1824,1836,O
IPMNs,1840,1845,B-Pathological_formation
Saliva,0,6,O
proteins,7,15,O
vector,19,25,O
Culicoides,26,36,O
modify,37,43,O
structure,44,53,O
infectivity,58,69,O
bluetongue,73,83,O
virus,84,89,O
particles,90,99,O
Bluetongue,101,111,O
virus,112,117,O
BTV,119,122,O
epizootic,128,137,O
haemorrhagic,138,150,O
disease,151,158,O
virus,159,164,O
EHDV,166,170,O
related,176,183,O
orbiviruses,184,195,O
transmitted,197,208,O
ruminant,223,231,O
hosts,232,237,O
primarily,238,247,O
certain,251,258,O
haematophagous,259,273,O
midge,274,279,O
vectors,280,287,O
Culicoides,289,299,O
spp,300,303,O
larger,311,317,O
BTV,325,328,O
outer,329,334,O
capsid,335,341,O
proteins,342,350,O
VP2,353,356,O
cleaved,366,373,O
proteases,377,386,O
including,388,397,O
trypsin,398,405,O
chymotrypsin,409,421,O
forming,424,431,O
infectious,432,442,O
subviral,443,451,O
particles,452,461,O
ISVP,463,467,O
enhanced,480,488,O
infectivity,489,500,O
adult,505,510,O
Culicoides,511,521,O
KC,526,528,B-Cell
cells,529,534,I-Cell
cell,538,542,B-Cell
line,543,547,I-Cell
derived,548,555,O
C,561,562,O
sonorensis,564,574,O
demonstrate,580,591,O
VP2,597,600,O
present,601,608,O
purified,612,620,O
virus,621,626,O
particles,627,636,O
3,642,643,O
different,644,653,O
BTV,654,657,O
strains,658,665,O
cleaved,678,685,O
treatment,689,698,O
saliva,704,710,O
adult,716,721,O
Culicoides,722,732,O
saliva,738,744,O
proteins,745,753,O
C,759,760,O
sonorensis,762,772,O
competent,776,785,O
BTV,786,789,O
vector,790,796,O
cleaved,799,806,O
BTV,807,810,O
VP2,811,814,O
efficiently,820,831,O
C,848,849,O
nubeculosus,851,862,O
competent,871,880,O
non,881,884,O
vector,885,891,O
species,892,899,O
Electrophoresis,902,917,O
mass,922,926,O
spectrometry,927,939,O
identified,940,950,O
trypsin,953,960,O
like,961,965,O
protease,966,974,O
C,978,979,O
sonorensis,981,991,O
saliva,992,998,O
significantly,1010,1023,O
reduced,1024,1031,O
absent,1035,1041,O
C,1047,1048,O
nubeculosus,1050,1061,O
saliva,1062,1068,O
Incubating,1070,1080,O
purified,1081,1089,O
BTV,1090,1093,O
1,1094,1095,O
C,1101,1102,O
sonorensis,1104,1114,O
saliva,1115,1121,O
proteins,1122,1130,O
increased,1136,1145,O
infectivity,1152,1163,O
KC,1168,1170,B-Cell
cells,1171,1176,I-Cell
10,1178,1180,O
fold,1181,1185,O
infectivity,1193,1204,O
BHK,1209,1212,B-Cell
cells,1213,1218,I-Cell
reduced,1223,1230,O
2,1234,1235,O
6,1236,1237,O
fold,1238,1242,O
Treatment,1244,1253,O
eastern,1261,1268,O
strain,1270,1276,O
EHDV,1280,1284,O
2,1285,1286,O
saliva,1292,1298,O
proteins,1299,1307,O
C,1318,1319,O
sonorensis,1321,1331,O
C,1335,1336,O
nubeculosus,1338,1349,O
cleaved,1350,1357,O
VP2,1358,1361,O
western,1370,1377,O
strain,1379,1385,O
EHDV,1389,1393,O
2,1394,1395,O
remained,1396,1404,O
unmodified,1405,1415,O
results,1423,1430,O
indicate,1431,1439,O
temperature,1445,1456,O
strain,1458,1464,O
virus,1468,1473,O
protein,1478,1485,O
composition,1486,1497,O
Culicoides,1501,1511,O
saliva,1512,1518,O
particularly,1520,1532,O
protease,1537,1545,O
content,1546,1553,O
dependent,1563,1572,O
vector,1578,1584,O
species,1585,1592,O
play,1603,1607,O
significant,1610,1621,O
role,1622,1626,O
efficiency,1634,1644,O
VP2,1648,1651,O
cleavage,1652,1660,O
influencing,1662,1673,O
virus,1674,1679,O
infectivity,1680,1691,O
Saliva,1693,1699,O
arthropod,1717,1726,O
species,1727,1734,O
previously,1739,1749,O
shown,1755,1760,O
increase,1764,1772,O
transmission,1773,1785,O
infectivity,1787,1798,O
virulence,1803,1812,O
certain,1816,1823,O
arboviruses,1824,1835,O
modulating,1840,1850,O
suppressing,1858,1869,O
mammalian,1874,1883,O
immune,1884,1890,O
response,1891,1899,O
findings,1905,1913,O
presented,1914,1923,O
demonstrate,1939,1950,O
novel,1953,1958,O
mechanism,1959,1968,O
proteases,1978,1987,O
Culicoides,1991,2001,O
saliva,2002,2008,O
directly,2018,2026,O
modify,2027,2033,O
orbivirus,2038,2047,O
particle,2048,2056,O
structure,2057,2066,O
leading,2068,2075,O
increased,2079,2088,O
infectivity,2089,2100,O
specifically,2101,2113,O
Culicoides,2118,2128,O
cells,2129,2134,B-Cell
turn,2143,2147,O
efficiency,2149,2159,O
transmission,2163,2175,O
insect,2183,2189,O
vector,2190,2196,O
mirAct,0,6,O
web,10,13,O
tool,14,18,O
evaluating,23,33,O
microRNA,34,42,O
activity,43,51,O
based,52,57,O
gene,61,65,O
expression,66,76,O
data,77,81,O
MicroRNAs,83,92,O
miRNAs,94,100,O
critical,106,114,O
regulators,115,125,O
complex,133,140,O
cellular,141,149,B-Cell
networks,150,158,O
mirAct,164,170,O
web,171,174,O
server,175,181,O
http,183,187,O
sysbio,190,196,O
ustc,197,201,O
edu,202,205,O
cn,206,208,O
software,209,217,O
mirAct,218,224,O
tool,231,235,O
designed,236,244,O
investigate,248,259,O
miRNA,260,265,O
activity,266,274,O
based,275,280,O
gene,284,288,O
expression,289,299,O
data,300,304,O
negative,318,326,O
regulation,327,337,O
relationship,338,350,O
miRNAs,359,365,O
target,376,382,O
genes,383,388,O
mirAct,390,396,O
supports,397,405,O
multiple,406,414,O
class,415,420,O
data,421,425,O
enables,430,437,O
clustering,438,448,O
analysis,449,457,O
based,458,463,O
computationally,467,482,O
determined,483,493,O
miRNA,494,499,O
activity,500,508,O
describe,519,527,O
framework,532,541,O
mirAct,545,551,O
demonstrate,553,564,O
performance,569,580,O
comparing,584,593,O
similar,605,612,O
programs,613,621,O
exemplify,626,635,O
applications,640,652,O
case,659,663,O
studies,664,671,O
Non,0,3,O
heart,4,9,B-Organ
beating,10,17,O
organ,18,23,B-Organ
donation,24,32,O
Italy,36,41,O
2007,46,50,O
non,55,58,O
heart,59,64,B-Organ
beating,65,72,O
organ,73,78,B-Organ
donation,79,87,O
NHBD,89,93,O
Programma,96,105,O
Alba,106,110,O
Sunrise,113,120,O
Programme,121,130,O
started,132,139,O
Pavia,143,148,O
Italy,150,155,O
initial,161,168,O
plan,169,173,O
cut,181,184,O
waiting,190,197,O
list,198,202,O
kidney,207,213,B-Organ
transplantation,214,229,O
final,241,246,O
aim,247,250,O
shorten,257,264,O
organ,265,270,B-Organ
transplantation,271,286,O
waiting,287,294,O
lists,295,300,O
compared,307,315,O
European,319,327,O
countries,328,337,O
USA,346,349,O
Italian,355,362,O
NHBD,363,367,O
program,368,375,O
taken,380,385,O
longer,386,392,O
established,400,411,O
Initially,413,422,O
Italian,423,430,O
physicians,431,441,O
entirely,451,459,O
aware,460,465,O
NHBD,473,477,O
organ,478,483,B-Organ
viability,484,493,O
transplantation,498,513,O
furthermore,515,526,O
ethical,527,534,O
issues,535,541,O
need,550,554,O
regulate,558,566,O
medical,567,574,O
requirements,575,587,O
Italian,591,598,O
law,599,602,O
slowed,603,609,O
NHBD,619,623,O
program,624,631,O
particular,636,646,O
Italian,648,655,O
legislation,656,667,O
provides,668,676,O
death,681,686,O
ascertainment,687,700,O
irreversible,707,719,O
cardiac,720,727,B-Organ
arrest,728,734,O
20,736,738,O
minute,739,745,O
flat,746,750,O
electrocardiogram,751,768,O
touch,778,783,O
period,784,790,O
longer,794,800,O
compared,806,814,O
worldwide,818,827,O
legislation,828,839,O
organ,845,850,B-Organ
viability,851,860,O
main,872,876,O
concern,877,884,O
Italian,889,896,O
transplant,897,907,O
doctors,908,915,O
years,925,930,O
recent,941,947,O
data,948,952,O
let,953,956,O
40,963,965,O
minute,966,972,O
warm,973,977,O
ischemia,978,986,O
time,987,991,O
preserve,995,1003,O
organ,1004,1009,B-Organ
viability,1010,1019,O
encouraged,1030,1040,O
Pavia,1041,1046,O
s,1047,1048,O
group,1049,1054,O
establish,1058,1067,O
NHBD,1072,1076,O
Programma,1078,1087,O
Alba,1088,1092,O
designed,1102,1110,O
according,1111,1120,O
Italian,1124,1131,O
legislation,1132,1143,O
death,1149,1154,O
diagnosis,1155,1164,O
graft,1168,1173,B-Organ
placement,1174,1183,O
perspective,1195,1206,O
significant,1216,1227,O
role,1228,1232,O
Transplant,1240,1250,O
coordinator,1251,1262,O
recognized,1266,1276,O
2007,1284,1288,O
seven,1289,1294,O
kidneys,1295,1302,B-Organ
gathered,1313,1321,O
seven,1327,1332,O
NHBD,1333,1337,O
NHBD,1353,1357,O
kidneys,1358,1365,B-Organ
transplanted,1376,1388,O
Currently,1390,1399,O
patients,1406,1414,O
dialysis,1426,1434,O
report,1441,1447,O
detailed,1453,1461,O
description,1462,1473,O
NHBD,1477,1481,O
Programma,1483,1492,O
Alba,1493,1497,O
preliminary,1507,1518,O
results,1519,1526,O
Massive,0,7,O
osteolysis,8,18,O
dog,24,27,O
resembling,28,38,O
Gorham,39,45,O
s,46,47,O
disease,48,55,O
humans,59,65,O
month,76,81,O
old,82,85,O
mixed,86,91,O
breed,92,97,O
dog,98,101,O
presented,106,115,O
history,123,130,O
sudden,134,140,O
onset,141,146,O
pelvic,147,153,B-Organism_subdivision
limb,154,158,I-Organism_subdivision
lameness,159,167,O
Radiographic,169,181,O
computed,186,194,O
tomographic,195,206,O
examinations,207,219,O
demonstrated,220,232,O
osteolytic,236,246,O
process,247,254,O
involving,255,264,O
lumbar,269,275,B-Organ
spine,276,281,I-Organ
pelvis,286,292,B-Organ
comprehensive,296,309,O
work,310,314,O
including,318,327,O
serial,328,334,O
radiographic,335,347,O
skeletal,348,356,B-Anatomical_system
survey,357,363,O
biopsy,365,371,O
routine,373,380,O
laboratory,381,391,O
investigation,392,405,O
evaluation,410,420,O
parathyroid,424,435,O
hormone,436,443,O
PTH,445,448,O
25,454,456,O
hydroxy,457,464,O
vitamin,465,472,O
D,473,474,O
levels,475,481,O
failed,482,488,O
reveal,492,498,O
underlying,503,513,O
cause,514,519,O
osteolysis,528,538,O
Conservative,540,552,O
treatment,553,562,O
bisphosphonate,573,587,O
drug,588,592,O
alendronate,593,604,O
oral,609,613,O
analgesic,614,623,O
medications,624,635,O
resulted,636,644,O
return,650,656,O
nearly,660,666,O
normal,667,673,O
long,674,678,O
term,679,683,O
function,684,692,O
despite,694,701,O
massive,702,709,O
lumbar,710,716,O
pelvic,721,727,O
osteolysis,728,738,O
clinical,744,752,O
radiological,754,766,O
histopathological,771,788,O
features,789,797,O
dog,806,809,O
reported,814,822,O
similarities,828,840,O
human,850,855,O
condition,856,865,O
known,866,871,O
Gorham,875,881,O
s,882,883,O
disease,884,891,O
discussed,896,905,O
Rubella,1,8,O
Poland,12,18,O
2009,22,26,O
Poland,32,38,O
7,40,41,O
587,42,45,O
cases,46,51,O
rubella,55,62,O
registered,68,78,O
2009,82,86,O
incidence,88,97,O
19,98,100,O
9,101,102,O
100,107,110,O
000,111,114,O
population,115,125,O
According,128,137,O
new,143,146,O
rubella,147,154,O
case,155,159,O
definition,160,170,O
introduced,172,182,O
2009,186,190,O
7,192,193,O
0,195,196,O
1,197,198,O
cases,201,206,O
classified,212,222,O
confirmed,226,235,O
cases,236,241,O
30,243,245,O
0,247,248,O
4,249,250,O
probable,256,264,O
case,270,274,O
congenital,278,288,O
rubella,289,296,O
syndrome,297,305,O
reported,310,318,O
incidence,324,333,O
men,337,340,O
26,342,344,O
6,345,346,O
1,352,353,O
9,354,355,O
times,356,361,O
higher,362,368,O
women,377,382,O
13,384,386,O
6,387,388,O
highest,395,402,O
incidence,403,412,O
observed,417,425,O
children,429,437,O
aged,438,442,O
7,443,444,O
8,449,450,O
years,451,456,O
180,458,461,O
3,462,463,O
175,468,471,O
6,472,473,O
respectively,475,487,O
rubella,493,500,O
deaths,501,507,O
registered,513,523,O
improvement,528,539,O
laboratory,543,553,O
diagnosis,554,563,O
reported,567,575,O
cases,576,581,O
necessary,585,594,O
assess,598,604,O
impact,609,615,O
2,619,620,O
dose,621,625,O
immunization,626,638,O
implemented,639,650,O
2003,654,658,O
rubella,662,669,O
epidemiology,670,682,O
Poland,686,692,O
Burns,0,5,O
hot,11,14,O
wheat,15,20,O
bags,21,25,O
public,29,35,O
safety,36,42,O
issue,43,48,O
Introduction,50,62,O
Wheat,64,69,O
bags,70,74,O
therapeutic,79,90,O
devices,91,98,O
heated,108,114,O
microwaves,118,128,O
commonly,133,141,O
provide,150,157,O
relief,158,164,O
muscle,170,176,B-Organ
joint,181,186,B-Multi-tissue_structure
pain,187,191,O
Royal,197,202,O
Adelaide,203,211,O
Hospital,212,220,O
Burns,221,226,O
Unit,227,231,O
observed,236,244,O
number,247,253,O
patients,257,265,O
significant,271,282,O
burn,283,287,O
injuries,288,296,O
resulting,297,306,O
use,318,321,O
Despite,323,330,O
dangers,337,344,O
products,350,358,O
come,359,363,O
limited,369,376,O
safety,377,383,O
information,384,395,O
Methods,397,404,O
Data,406,410,O
collected,416,425,O
Burns,435,440,O
Unit,441,445,O
database,446,454,O
patients,463,471,O
admitted,472,480,O
burns,486,491,O
hot,499,502,O
wheat,503,508,O
bags,509,513,O
2004,519,523,O
2009,527,531,O
analyzed,542,550,O
determine,554,563,O
severity,568,576,O
burn,584,588,O
injury,589,595,O
identify,600,608,O
predisposing,613,625,O
factors,626,633,O
experimental,638,650,O
study,651,656,O
performed,661,670,O
measure,674,681,O
temperature,686,697,O
wheat,701,706,O
bags,707,711,O
heated,717,723,O
determine,727,736,O
potential,743,752,O
causing,757,764,O
thermal,765,772,O
injury,773,779,O
Results,781,788,O
11,790,792,O
patients,793,801,O
admitted,807,815,O
burns,821,826,O
hot,834,837,O
wheat,838,843,O
bags,844,848,O
median,854,860,O
age,861,864,O
52,869,871,O
years,872,877,O
mean,886,890,O
total,891,896,O
body,897,901,B-Organism_subdivision
surface,902,909,I-Organism_subdivision
area,910,914,I-Organism_subdivision
1,919,920,O
1,921,922,O
burns,929,934,O
deep,947,951,O
dermal,952,958,B-Multi-tissue_structure
45,960,962,O
5,963,964,O
thickness,975,984,O
54,986,988,O
5,989,990,O
patients,998,1006,O
required,1007,1015,O
operative,1016,1025,O
management,1026,1036,O
Predisposing,1038,1050,O
factors,1051,1058,O
eg,1060,1062,O
neuropathy,1064,1074,O
thermal,1079,1086,O
injury,1087,1093,O
identified,1099,1109,O
7,1113,1114,O
patients,1115,1123,O
experimental,1129,1141,O
study,1142,1147,O
showed,1148,1154,O
hot,1160,1163,O
wheat,1164,1169,O
bags,1170,1174,O
reached,1175,1182,O
temperatures,1183,1195,O
57,1199,1201,O
3degreesC,1202,1211,O
135,1213,1216,O
1degreesF,1217,1226,O
heated,1233,1239,O
according,1240,1249,O
instructions,1253,1265,O
63,1267,1269,O
3degreesC,1270,1279,O
145,1281,1284,O
9degreesF,1285,1294,O
1000,1301,1305,O
W,1306,1307,O
microwave,1308,1317,O
69,1322,1324,O
6degreesC,1325,1334,O
157,1336,1339,O
3degreesF,1340,1349,O
reheating,1354,1363,O
Conclusions,1365,1376,O
Hot,1378,1381,O
wheat,1382,1387,O
bags,1388,1392,O
cause,1393,1398,O
burn,1407,1411,O
injury,1412,1418,O
heated,1425,1431,O
improperly,1432,1442,O
reach,1453,1458,O
temperatures,1459,1471,O
high,1472,1476,O
cause,1487,1492,O
epidermal,1493,1502,B-Multi-tissue_structure
necrosis,1503,1511,O
short,1517,1522,O
period,1523,1529,O
time,1533,1537,O
Patients,1539,1547,O
impaired,1553,1561,O
temperature,1562,1573,O
sensation,1574,1583,O
particularly,1588,1600,O
risk,1604,1608,O
greater,1626,1633,O
public,1634,1640,O
awareness,1641,1650,O
dangers,1658,1665,O
wheat,1669,1674,O
bag,1675,1678,O
use,1679,1682,O
specific,1692,1700,O
safety,1701,1707,O
warnings,1708,1716,O
products,1724,1732,O
enlarging,4,13,O
clinical,14,22,O
spectrum,23,31,O
Lyme,35,39,O
disease,40,47,O
Lyme,49,53,O
cerebral,54,62,B-Organ
vasculitis,63,73,O
new,77,80,O
disease,81,88,O
entity,89,95,O
case,101,105,O
patient,111,118,O
cerebral,124,132,B-Organ
vasculitis,133,143,O
right,151,156,B-Multi-tissue_structure
thalamic,157,165,I-Multi-tissue_structure
infarct,166,173,O
associated,174,184,O
cerebral,190,198,B-Organism_substance
spinal,199,205,I-Organism_substance
fluid,206,211,I-Organism_substance
Lyme,212,216,O
disease,217,224,O
presented,228,237,O
entity,244,250,O
described,264,273,O
United,281,287,O
States,288,294,O
similar,309,316,O
case,317,321,O
world,329,334,O
literature,335,345,O
found,355,360,O
patient,366,373,O
presented,374,383,O
progressive,391,402,O
headache,403,411,O
subsequent,416,426,O
development,427,438,O
grand,442,447,O
mal,448,451,O
seizure,452,459,O
activity,460,468,O
Lyme,470,474,O
disease,475,482,O
associated,492,502,O
cranial,508,515,B-Multi-tissue_structure
nerve,516,521,I-Multi-tissue_structure
palsies,522,529,O
peripheral,531,541,O
cranial,546,553,B-Organism_subdivision
radiculopathies,554,569,O
aseptic,571,578,O
meningitis,579,589,O
encephalitic,591,603,O
symptoms,604,612,O
chorea,614,620,O
demyelinating,626,639,O
polyneuropathy,640,654,O
presenting,655,665,O
like,666,670,O
Guillain,671,679,O
Barre,680,685,O
syndrome,686,694,O
syndromes,702,711,O
occur,716,721,O
separately,722,732,O
combination,739,750,O
Stroke,752,758,O
strokelike,763,773,O
syndromes,774,783,O
attributed,794,804,O
Lyme,808,812,O
disease,813,820,O
literature,826,836,O
concerning,837,847,O
neurologic,852,862,B-Anatomical_system
manifestations,863,877,O
Lyme,881,885,O
disease,886,893,O
reviewed,897,905,O
Gastric,0,7,B-Organ
microcirculatory,8,24,O
change,25,31,O
development,36,47,O
acute,51,56,O
gastric,57,64,B-Pathological_formation
mucosal,65,72,I-Pathological_formation
lesions,73,80,I-Pathological_formation
stress,82,88,B-Pathological_formation
ulcer,89,94,I-Pathological_formation
Concerning,97,107,O
pathogenesis,112,124,O
acute,128,133,O
gastric,134,141,B-Pathological_formation
mucosal,142,149,I-Pathological_formation
lesions,150,157,I-Pathological_formation
gastric,159,166,B-Organ
microcirculatory,167,183,O
change,184,190,O
drawn,195,200,O
attention,201,210,O
important,217,226,O
factor,227,233,O
view,238,242,O
fact,251,255,O
gastric,257,264,B-Multi-tissue_structure
mucosal,265,272,I-Multi-tissue_structure
blood,273,278,B-Organism_substance
flow,279,283,O
microvascular,288,301,B-Tissue
structure,302,311,O
investigated,317,329,O
normal,333,339,O
burn,347,351,O
stressed,352,360,O
rats,361,365,O
alterations,377,388,O
acid,392,396,O
pepsin,401,407,O
activities,408,418,O
morphological,425,438,O
biochemical,443,454,O
procedures,455,465,O
order,469,474,O
evaluate,478,486,O
relationship,491,503,O
defensive,512,521,O
aggressive,526,536,O
factors,537,544,O
gastric,552,559,B-Multi-tissue_structure
mucosa,560,566,I-Multi-tissue_structure
Gastric,568,575,B-Multi-tissue_structure
mucosal,576,583,I-Multi-tissue_structure
blood,584,589,B-Organism_substance
flow,590,594,O
decreased,595,604,O
significantly,605,618,O
early,622,627,O
period,628,634,O
induction,641,650,O
stress,654,660,O
p,662,663,O
0,674,675,O
01,676,678,O
incidence,685,694,O
ulceration,698,708,O
showed,709,715,O
correlative,718,729,O
relation,730,738,O
decrease,748,756,O
mucosal,760,767,B-Multi-tissue_structure
blood,768,773,B-Organism_substance
flow,774,778,O
Reduction,780,789,O
blood,793,798,B-Organism_substance
flow,799,803,O
burn,807,811,O
opening,823,830,O
arteriovenular,834,848,B-Multi-tissue_structure
shunt,849,854,O
appeared,862,870,O
responsible,885,896,O
mucosal,901,908,B-Multi-tissue_structure
ischemia,909,917,O
congestion,922,932,O
Following,934,943,O
decrease,948,956,O
blood,960,965,B-Organism_substance
flow,966,970,O
acid,972,976,O
output,977,983,O
lower,988,993,O
stress,997,1003,O
control,1017,1024,O
Finally,1026,1033,O
results,1039,1046,O
studies,1056,1063,O
demonstrated,1064,1076,O
importance,1081,1091,O
defensive,1095,1104,O
factors,1105,1112,O
reduction,1118,1127,O
mucosal,1131,1138,B-Multi-tissue_structure
blood,1139,1144,B-Organism_substance
flow,1145,1149,O
resulted,1150,1158,O
sequence,1166,1174,O
events,1178,1184,O
led,1190,1193,O
formation,1197,1206,O
acute,1210,1215,O
gastric,1216,1223,B-Pathological_formation
mucosal,1224,1231,I-Pathological_formation
lesion,1232,1238,I-Pathological_formation
Type,0,4,O
cholecystokinin,7,22,O
receptors,23,32,O
CHP212,36,42,B-Cell
neuroblastoma,43,56,I-Cell
cells,57,62,I-Cell
evidence,64,72,O
association,77,88,O
G,94,95,O
protein,96,103,O
activation,108,118,O
phosphoinositide,122,138,O
hydrolysis,139,149,O
125I,151,155,O
Bolton,156,162,O
Hunter,163,169,O
cholecystokinin,170,185,O
octapeptide,186,197,O
BH,199,201,O
CCK8,202,206,O
3H,217,219,O
L,220,221,O
364718,222,228,O
membrane,229,237,B-Cellular_component
binding,238,245,O
assays,246,252,O
identify,266,274,O
characterize,279,291,O
cholecystokinin,292,307,O
CCK,309,312,O
receptors,314,323,O
CHP212,327,333,B-Cell
human,334,339,O
neuroblastoma,340,353,B-Cell
cells,354,359,I-Cell
ligand,365,371,O
binding,372,379,O
properties,380,390,O
CCK,394,397,O
receptors,398,407,O
cells,417,422,B-Cell
similar,427,434,O
found,444,449,O
pancreas,453,461,B-Organ
CCK,463,466,O
sites,469,474,O
differ,480,486,O
predominant,496,507,O
type,508,512,O
CCK,516,519,O
binding,520,527,O
site,528,532,O
found,533,538,O
brain,542,547,B-Organ
CCK,549,552,O
B,553,554,O
sites,555,560,O
specific,567,575,O
binding,576,583,O
125I,587,591,O
BH,592,594,O
CCK8,595,599,O
3H,613,615,O
L,616,617,O
364718,618,624,O
reduced,629,636,O
metabolically,644,657,O
stable,658,664,O
GTP,665,668,O
analog,669,675,O
guanosine,676,685,O
5,686,687,O
beta,690,694,O
delta,695,700,O
imido,701,706,O
trisphosphate,707,720,O
substantial,724,735,O
difference,736,746,O
Bmax,754,758,O
radiolabeled,767,779,O
agonist,780,787,O
125I,789,793,O
BH,794,796,O
CCK8,797,801,O
antagonist,807,817,O
3H,824,826,O
L,827,828,O
364718,829,835,O
noted,841,846,O
observations,854,866,O
consistent,871,881,O
CCK,887,890,O
receptors,891,900,O
existing,901,909,O
guanine,913,920,O
nucleotide,921,931,O
binding,932,939,O
protein,940,947,O
coupled,948,955,O
uncoupled,961,970,O
states,971,977,O
Similar,979,986,O
action,994,1000,O
pancreatic,1004,1014,B-Cell
acinar,1015,1021,I-Cell
cells,1022,1027,I-Cell
CCK8,1029,1033,O
S,1034,1035,O
stimulated,1037,1047,O
accumulation,1052,1064,O
3H,1069,1071,O
inositol,1072,1080,O
phosphates,1081,1091,O
cells,1095,1100,B-Cell
prelabeled,1101,1111,O
3H,1118,1120,O
myo,1121,1124,O
inositol,1125,1133,O
EC50,1135,1139,O
3,1142,1143,O
2,1144,1145,O
0,1150,1151,O
4,1152,1153,O
nM,1154,1156,O
maximum,1158,1165,O
response,1166,1174,O
4,1177,1178,O
5,1179,1180,O
0,1185,1186,O
4,1187,1188,O
x,1189,1190,O
basal,1191,1196,O
intrinsic,1203,1212,O
activity,1213,1221,O
CCK,1225,1228,O
analogues,1229,1238,O
stimulating,1242,1253,O
phosphoinositide,1254,1270,O
hydrolysis,1271,1281,O
substantially,1286,1299,O
reported,1316,1324,O
intrinsic,1325,1334,O
activity,1335,1343,O
stimulating,1347,1358,O
phosphoinositide,1359,1375,O
hydrolysis,1376,1386,O
pancreatic,1390,1400,B-Cell
acinar,1401,1407,I-Cell
cells,1408,1413,I-Cell
CHP212,1419,1425,B-Cell
neuroblastoma,1426,1439,I-Cell
cell,1440,1444,I-Cell
serve,1449,1454,O
useful,1460,1466,O
model,1467,1472,O
recently,1481,1489,O
reported,1490,1498,O
CCK,1499,1502,O
binding,1505,1512,O
site,1513,1517,O
found,1518,1523,O
central,1531,1538,B-Anatomical_system
nervous,1539,1546,I-Anatomical_system
system,1547,1553,I-Anatomical_system
Screening,0,9,O
method,10,16,O
insecticidal,21,33,O
activity,34,42,O
instars,55,62,O
black,66,71,O
blow,72,76,O
fly,77,80,O
Diptera,82,89,O
Calliphoridae,91,104,O
bioassay,109,117,O
method,118,124,O
suitable,125,133,O
rapid,138,143,O
mass,144,148,O
screening,149,158,O
fermentation,162,174,O
synthetic,179,188,O
organic,189,196,O
compounds,197,206,O
insecticidal,211,223,O
activity,224,232,O
described,236,245,O
test,251,255,O
uses,263,267,O
instars,274,281,O
susceptible,285,296,O
black,297,302,O
blow,303,307,O
fly,308,311,O
Phormia,313,320,O
regina,321,327,O
Meigen,329,335,O
bovine,343,349,O
serum,350,355,B-Organism_substance
medium,356,362,O
detects,364,371,O
insecticidal,372,384,O
activity,385,393,O
reproducible,399,411,O
results,412,419,O
capable,427,434,O
selecting,438,447,O
active,457,463,O
compound,464,472,O
structure,476,485,O
activity,486,494,O
relationships,495,508,O
minimum,512,519,O
effective,520,529,O
dose,530,534,O
concentration,535,548,O
studies,549,556,O
bioassay,562,570,O
system,571,577,O
easy,581,585,O
operate,589,596,O
requires,601,609,O
minute,617,623,O
quantity,624,632,O
chemical,636,644,O
compound,645,653,O
Early,0,5,O
post,6,10,O
mortem,11,17,O
metabolism,18,28,O
muscle,33,39,B-Organ
shortening,40,50,O
Pectoralis,58,68,O
major,69,74,O
muscle,75,81,B-Organ
broiler,85,92,O
chickens,93,101,O
experiments,109,120,O
conducted,126,135,O
examine,139,146,O
effects,151,158,O
sodium,162,168,O
pentobarbital,169,182,O
SP,184,186,O
iodoacetate,189,200,O
IO,202,204,O
tubocurarine,207,219,O
TC,221,223,O
surgical,230,238,O
denervation,239,250,O
DN,252,254,O
early,259,264,O
rigor,265,270,O
development,271,282,O
broiler,286,293,O
breast,294,300,B-Organ
muscle,301,307,I-Organ
Experiment,312,322,O
1,323,324,O
birds,326,331,O
anesthetized,344,356,O
SP,369,371,O
receiving,379,388,O
injection,392,401,O
IO,405,407,O
TC,411,413,O
maintained,417,427,O
noninjected,431,442,O
controls,443,451,O
Experiment,453,463,O
2,464,465,O
identical,470,479,O
treatment,494,503,O
denervation,507,518,O
breast,526,532,B-Organ
muscle,533,539,I-Organ
added,544,549,O
Experiment,551,561,O
3,562,563,O
conducted,568,577,O
contrast,581,589,O
birds,590,595,O
1,599,600,O
day,601,604,O
DN1,606,609,O
3,615,616,O
days,617,621,O
DN3,623,626,O
denervation,628,639,O
prior,640,645,O
slaughter,649,658,O
nonoperated,662,673,O
controls,674,682,O
Measurements,684,696,O
muscle,700,706,B-Organ
lactate,707,714,O
ATP,716,719,O
R,721,722,O
value,723,728,O
ratio,730,735,O
inosine,739,746,O
adenine,750,757,O
nucleotides,758,769,O
pH,772,774,O
sarcomere,776,785,B-Tissue
lengths,786,793,O
shear,799,804,O
evaluate,818,826,O
treatment,827,836,O
effects,837,844,O
Results,846,853,O
Experiment,858,868,O
1,869,870,O
showed,871,877,O
significant,881,892,O
differences,893,904,O
treatment,911,920,O
control,925,932,O
groups,933,939,O
ATP,944,947,O
lactate,952,959,O
contents,960,968,O
R,970,971,O
values,972,978,O
sarcomere,983,992,B-Tissue
lengths,993,1000,O
significantly,1011,1024,O
lower,1025,1030,O
pH,1031,1033,O
higher,1038,1044,O
shear,1045,1050,O
values,1051,1057,O
observed,1063,1071,O
control,1076,1083,O
birds,1084,1089,O
Experiment,1094,1104,O
2,1105,1106,O
significant,1111,1122,O
differences,1123,1134,O
observed,1140,1148,O
treatment,1159,1168,O
groups,1169,1175,O
ATP,1180,1183,O
R,1185,1186,O
values,1187,1193,O
sarcomere,1198,1207,B-Tissue
lengths,1208,1215,O
lactate,1226,1233,O
shear,1238,1243,O
values,1244,1250,O
significantly,1256,1269,O
lower,1270,1275,O
pH,1281,1283,O
higher,1284,1290,O
DN,1300,1302,O
SP,1307,1309,O
treated,1310,1317,O
birds,1318,1323,O
Experiment,1325,1335,O
3,1336,1337,O
resulted,1338,1346,O
lower,1350,1355,O
lactate,1356,1363,O
higher,1368,1374,O
pH,1375,1377,O
values,1378,1384,O
DN3,1393,1396,O
treatment,1397,1406,O
comparison,1410,1420,O
DN1,1431,1434,O
control,1439,1446,O
groups,1447,1453,O
Results,1455,1462,O
studies,1472,1479,O
indicate,1480,1488,O
use,1498,1501,O
SP,1505,1507,O
DN,1512,1514,O
alter,1530,1535,O
early,1540,1545,O
profiles,1546,1554,O
rigor,1558,1563,O
development,1564,1575,O
Anaplastic,0,10,B-Pathological_formation
sarcomatoid,15,26,I-Pathological_formation
carcinoma,27,36,I-Pathological_formation
small,44,49,B-Organ
intestine,50,59,I-Organ
clinicopathologic,63,80,O
study,81,86,O
Carcinomas,88,98,B-Pathological_formation
involving,99,108,O
jejunum,113,120,B-Multi-tissue_structure
ileum,125,130,B-Multi-tissue_structure
rare,135,139,O
tumors,140,146,B-Pathological_formation
review,157,163,O
small,167,172,B-Pathological_formation
intestinal,173,183,I-Pathological_formation
neoplasms,184,193,I-Pathological_formation
primary,199,206,O
carcinomas,207,217,B-Pathological_formation
jejunum,221,228,B-Multi-tissue_structure
ileum,232,237,B-Multi-tissue_structure
anaplastic,246,256,O
sarcomatoid,261,272,B-Pathological_formation
histology,273,282,O
identified,288,298,O
presentation,303,315,O
patients,330,338,O
symptoms,343,351,O
related,352,359,O
metastatic,363,373,O
disease,374,381,O
symptoms,396,404,O
referable,405,414,O
local,422,427,O
tumor,428,433,B-Pathological_formation
tumors,439,445,B-Pathological_formation
large,451,456,O
greater,458,465,O
4,471,472,O
5,473,474,O
cm,475,477,O
diameter,481,489,O
usually,492,499,O
endophytic,500,510,O
masses,511,517,O
composed,518,526,O
large,530,535,O
cells,536,541,B-Cell
eosinophilic,547,559,B-Organism_substance
cytoplasm,560,569,I-Organism_substance
anaplastic,571,581,O
nuclei,582,588,B-Cellular_component
prominent,594,603,O
nucleoli,604,612,B-Cellular_component
areas,622,627,O
cells,633,638,B-Cell
spindled,645,653,O
configuration,654,667,O
Mucin,669,674,O
positivity,675,685,O
identified,690,700,O
cases,712,717,O
Electron,719,727,O
microscopic,728,739,O
findings,740,748,O
cases,756,761,O
indicative,767,777,O
epithelial,781,791,B-Tissue
differentiation,792,807,O
tumors,813,819,B-Pathological_formation
behaved,820,827,O
aggressively,828,840,O
patients,851,859,O
clinical,879,887,O
follow,888,894,O
died,898,902,O
metastases,906,916,B-Pathological_formation
40,924,926,O
months,927,933,O
anaplastic,943,953,B-Pathological_formation
sarcomatoid,958,969,I-Pathological_formation
carcinomas,970,980,I-Pathological_formation
compared,986,994,O
29,1000,1002,O
typical,1003,1010,O
adenocarcinomas,1011,1026,B-Pathological_formation
arising,1027,1034,O
jejunum,1042,1049,B-Multi-tissue_structure
ileum,1053,1058,B-Multi-tissue_structure
group,1083,1088,O
symptoms,1093,1101,O
referable,1102,1111,O
distant,1115,1122,O
metastases,1123,1133,B-Pathological_formation
presentation,1137,1149,O
tumors,1157,1163,B-Pathological_formation
tended,1169,1175,O
smaller,1182,1189,O
presentation,1193,1205,O
11,1207,1209,O
tumors,1210,1216,B-Pathological_formation
4,1232,1233,O
cm,1234,1236,O
greatest,1240,1248,O
dimension,1249,1258,O
25,1264,1266,O
patients,1267,1275,O
typical,1281,1288,O
adenocarcinomas,1289,1304,B-Pathological_formation
acceptable,1313,1323,O
follow,1324,1330,O
18,1335,1337,O
72,1339,1341,O
died,1344,1348,O
disease,1352,1359,O
20,1370,1372,O
alive,1380,1385,O
evidence,1394,1402,O
disease,1406,1413,O
5,1420,1421,O
years,1422,1427,O
conclude,1432,1440,O
anaplastic,1446,1456,B-Pathological_formation
sarcomatoid,1461,1472,I-Pathological_formation
carcinoma,1473,1482,I-Pathological_formation
rare,1488,1492,O
variant,1493,1500,O
small,1504,1509,B-Pathological_formation
intestinal,1510,1520,I-Pathological_formation
carcinoma,1521,1530,I-Pathological_formation
aggressive,1539,1549,O
clinical,1550,1558,O
course,1559,1565,O
Time,0,4,O
course,5,11,O
transmitter,15,26,O
action,27,33,O
sympathetic,41,52,B-Tissue
neuroeffector,53,66,I-Tissue
junction,67,75,I-Tissue
rodent,79,85,O
vascular,86,94,B-Organ
non,99,102,B-Organ
vascular,103,111,I-Organ
smooth,112,118,I-Organ
muscle,119,125,I-Organ
1,127,128,O
Transmitter,130,141,O
release,142,149,O
sympathetic,155,166,B-Multi-tissue_structure
postganglionic,167,181,I-Multi-tissue_structure
nerve,182,187,I-Multi-tissue_structure
terminals,188,197,O
innervating,198,209,O
guinea,214,220,O
pig,221,224,O
mouse,229,234,O
vas,235,238,B-Multi-tissue_structure
deferens,239,247,I-Multi-tissue_structure
rat,256,259,O
tail,260,264,B-Multi-tissue_structure
artery,265,271,I-Multi-tissue_structure
studied,281,288,O
vitro,292,297,O
focal,301,306,O
extracellular,307,320,B-Immaterial_anatomical_entity
recording,321,330,O
particular,336,346,O
emphasis,347,355,O
time,363,367,O
course,368,374,O
transmitter,378,389,O
action,390,396,O
underlying,397,407,O
intracellular,412,425,B-Immaterial_anatomical_entity
potential,426,435,O
changes,436,443,O
2,445,446,O
absence,455,462,O
stimulation,466,477,O
spontaneous,479,490,O
excitatory,491,501,B-Tissue
junction,502,510,I-Tissue
currents,511,519,O
SEJCs,521,526,O
recorded,533,541,O
amplitudes,547,557,O
500,564,567,O
microV,568,574,O
durations,579,588,O
40,597,599,O
100,604,607,O
ms,608,610,O
SEJCs,612,617,O
unaffected,623,633,O
competitive,641,652,O
alpha,653,658,O
adrenoceptor,659,671,O
antagonist,672,682,O
prazosin,683,691,O
blocked,696,703,O
alpha,707,712,O
beta,714,718,O
methylene,719,728,O
ATP,729,732,O
desensitizes,739,751,O
P2,752,754,O
purinoceptors,755,768,O
3,770,771,O
trains,780,786,O
supramaximal,790,802,O
stimuli,803,810,O
0,814,815,O
1,816,817,O
4,818,819,O
Hz,820,822,O
stimulus,823,831,O
locked,832,838,O
excitatory,839,849,B-Tissue
junction,850,858,I-Tissue
currents,859,867,O
EJCs,869,873,O
evoked,880,886,O
intermittently,887,901,O
population,911,921,O
varicosities,925,937,O
located,938,945,O
suction,956,963,O
electrode,964,973,O
4,975,976,O
SEJCs,978,983,O
similar,989,996,O
amplitude,1000,1009,O
time,1014,1018,O
course,1019,1025,O
EJCs,1029,1033,O
evoked,1034,1040,O
low,1044,1047,O
frequency,1048,1057,O
stimulation,1058,1069,O
attachment,1082,1092,O
tissues,1106,1113,B-Tissue
5,1115,1116,O
SEJCs,1118,1123,O
recorded,1124,1132,O
conventional,1148,1160,O
AC,1161,1163,O
amplifier,1164,1173,O
patch,1179,1184,O
clamp,1185,1190,O
amplifier,1191,1200,O
time,1214,1218,O
course,1219,1225,O
6,1227,1228,O
studies,1236,1243,O
time,1258,1262,O
course,1263,1269,O
current,1277,1284,O
underlying,1285,1295,O
excitatory,1300,1310,B-Tissue
junction,1311,1319,I-Tissue
potential,1320,1329,O
brief,1333,1338,O
essentially,1343,1354,O
different,1373,1382,O
tissues,1383,1390,B-Tissue
prolonged,1396,1405,O
time,1406,1410,O
course,1411,1417,O
excitatory,1425,1435,B-Tissue
junction,1436,1444,I-Tissue
potential,1445,1454,O
different,1458,1467,O
tissues,1468,1475,B-Tissue
accounted,1483,1492,O
passive,1504,1511,O
membrane,1512,1520,B-Multi-tissue_structure
properties,1521,1531,O
Differential,0,12,O
secretion,13,22,O
proteins,26,34,O
glycoproteins,39,52,O
livers,56,62,B-Organ
immature,66,74,O
adult,79,84,O
rats,85,89,O
Effect,91,97,O
antimicrotubule,101,116,B-Cellular_component
drugs,117,122,O
study,129,134,O
initiated,139,148,O
examine,155,162,O
reported,163,171,O
differences,172,183,O
action,191,197,O
antimicrotubule,201,216,B-Cellular_component
agents,217,223,O
plasma,227,233,B-Organism_substance
protein,234,241,O
secretion,242,251,O
livers,257,263,B-Organ
immature,267,275,O
versus,276,282,O
adult,283,288,O
rats,289,293,O
aim,299,302,O
1,308,309,O
determine,314,323,O
composition,328,339,O
monitor,347,354,O
secretion,359,368,O
plasma,380,386,B-Organism_substance
proteins,387,395,O
glycoproteins,400,413,O
liver,419,424,B-Multi-tissue_structure
slices,425,431,I-Multi-tissue_structure
labeled,432,439,O
vitro,443,448,O
specific,454,462,O
amino,463,468,O
acids,469,474,O
sugar,479,484,O
residues,485,493,O
2,500,501,O
correlate,506,515,O
observed,516,524,O
differences,525,536,O
secretion,540,549,O
proteins,559,567,O
structural,573,583,O
changes,584,591,O
hepatocytes,599,610,B-Cell
different,618,627,O
aged,628,632,O
animals,633,640,O
slices,661,667,B-Multi-tissue_structure
liver,671,676,B-Organ
fetal,682,687,B-Developing_anatomical_structure
term,689,693,O
neonatal,696,704,O
4,706,707,O
5,712,713,O
days,714,718,O
old,719,722,O
adult,729,734,O
rats,735,739,O
70,741,743,O
days,744,748,O
old,749,752,O
incubated,759,768,O
radioactive,774,785,O
amino,786,791,O
acids,792,797,O
tritiated,809,818,O
sugars,819,825,O
specific,826,834,O
N,839,840,O
linked,841,847,O
core,848,852,O
oligosaccharide,853,868,O
N,876,877,O
linked,878,884,O
terminal,885,893,O
oligosaccharide,894,909,O
chains,910,916,O
findings,922,930,O
indicate,931,939,O
liver,945,950,B-Multi-tissue_structure
slices,951,957,I-Multi-tissue_structure
fetal,961,966,B-Developing_anatomical_structure
neonatal,971,979,O
rats,980,984,O
efficient,989,998,O
synthesizing,1002,1014,O
plasma,1015,1021,B-Organism_substance
proteins,1022,1030,O
including,1031,1040,O
fully,1041,1046,O
glycosylated,1047,1059,O
glycoproteins,1060,1073,O
secretion,1079,1088,O
glycosylated,1092,1104,O
nonglycosylated,1109,1124,O
proteins,1125,1133,O
believed,1134,1142,O
processed,1149,1158,O
Golgi,1167,1172,B-Cellular_component
complexes,1173,1182,I-Cellular_component
inhibited,1187,1196,O
extent,1209,1215,O
approximately,1217,1230,O
70,1231,1233,O
80,1234,1236,O
antimicrotubule,1242,1257,B-Cellular_component
agents,1258,1264,O
regardless,1266,1276,O
age,1284,1287,O
host,1295,1299,O
animal,1300,1306,O
proteins,1323,1331,O
glycoproteins,1336,1349,O
secreted,1350,1358,O
livers,1362,1368,B-Organ
immature,1372,1380,O
rats,1381,1385,O
found,1391,1396,O
relatively,1403,1413,O
insensitive,1414,1425,O
e,1429,1430,O
inhibited,1432,1441,O
30,1450,1452,O
40,1453,1455,O
action,1465,1471,O
antimicrotubule,1483,1498,B-Cellular_component
drugs,1499,1504,O
glycoproteins,1510,1523,O
found,1529,1534,O
lack,1538,1542,O
N,1543,1544,O
linked,1545,1551,O
terminal,1552,1560,O
sugars,1561,1567,O
glycoproteins,1582,1595,O
contain,1600,1607,O
N,1608,1609,O
linked,1610,1616,O
core,1617,1621,O
sugars,1622,1628,O
likely,1641,1647,O
drug,1657,1661,O
insensitive,1662,1673,O
proteins,1674,1682,O
bypassed,1683,1691,O
critical,1692,1700,O
glycosylating,1701,1714,O
sites,1715,1720,O
Golgi,1728,1733,B-Cellular_component
compartment,1734,1745,I-Cellular_component
prior,1746,1751,O
release,1755,1762,O
Overall,1764,1771,O
findings,1779,1787,O
support,1788,1795,O
earlier,1796,1803,O
data,1804,1808,O
showing,1809,1816,O
antimicrotubule,1822,1837,B-Cellular_component
drugs,1838,1843,O
special,1851,1858,O
impact,1859,1865,O
Golgi,1869,1874,B-Cellular_component
associated,1875,1885,O
events,1886,1892,O
liver,1896,1901,B-Cell
cells,1902,1907,I-Cell
extent,1917,1923,O
findings,1930,1938,O
related,1943,1950,O
action,1958,1964,O
microtubules,1968,1980,B-Cellular_component
remains,1981,1988,O
seen,1995,1999,O
Torsade,0,7,O
de,8,10,O
pointes,11,18,O
loading,26,33,O
amiodarone,39,49,O
Torsade,51,58,O
de,59,61,O
pointes,62,69,O
represents,70,80,O
potential,83,92,O
complication,93,105,O
chronic,109,116,O
amiodarone,117,127,O
therapy,128,135,O
reports,145,152,O
emphasized,158,168,O
need,173,177,O
loading,184,191,O
dose,192,196,O
order,200,205,O
achieve,209,216,O
therapeutic,217,228,O
blood,229,234,B-Organism_substance
levels,235,241,O
rapidly,242,249,O
report,254,260,O
case,263,267,O
torsade,271,278,O
de,279,281,O
pointes,282,289,O
following,290,299,O
single,302,308,O
oral,309,313,O
dose,314,318,O
amiodarone,322,332,O
1400,334,338,O
mg,339,341,O
30,345,347,O
mg,348,350,O
kg,351,353,O
1,354,355,O
administered,357,369,O
short,376,381,O
intravenous,382,393,B-Multi-tissue_structure
loading,394,401,O
prevention,406,416,O
paroxysmal,420,430,O
atrial,431,437,B-Multi-tissue_structure
flutter,438,445,O
Torsades,447,455,O
de,456,458,O
pointes,459,466,O
preceded,472,480,O
associated,485,495,O
marked,501,507,O
QT,508,510,O
prolongation,511,523,O
bradycardia,528,539,O
report,546,552,O
suggests,553,561,O
careful,567,574,O
monitoring,575,585,O
patients,589,597,O
undergoing,598,608,O
oral,609,613,O
amiodarone,614,624,O
loading,625,632,O
necessary,636,645,O
Unsatisfactory,0,14,O
forehead,15,23,B-Pathological_formation
scar,24,28,I-Pathological_formation
following,29,38,O
face,39,43,B-Organism_subdivision
lift,44,48,O
W,54,55,O
plasty,56,62,O
scar,63,67,B-Pathological_formation
revision,68,76,O
technique,77,86,O
found,96,101,O
effective,108,117,O
repair,125,131,O
difficult,139,148,O
cosmetically,153,165,O
unsatisfactory,166,180,O
hairline,181,189,B-Pathological_formation
scar,190,194,I-Pathological_formation
following,195,204,O
ill,209,212,O
advised,213,220,O
face,221,225,B-Organism_subdivision
lift,226,230,O
technique,231,240,O
excises,246,253,O
forehead,254,262,B-Multi-tissue_structure
skin,263,267,I-Multi-tissue_structure
Clinical,0,8,O
evaluation,9,19,O
radiotherapy,23,35,O
Graves,40,46,O
ophthalmopathy,48,62,O
Seventeen,64,73,O
patients,74,82,O
moderately,88,98,O
severe,99,105,O
ophthalmopathy,106,120,O
Graves,128,134,O
disease,136,143,O
treated,149,156,O
cobalt,160,166,O
supervoltage,170,182,O
radiotherapy,183,195,O
patients,201,209,O
complained,210,220,O
diplopia,224,232,O
mean,238,242,O
proptosis,243,252,O
value,253,258,O
21,263,265,O
4,266,267,O
mm,268,270,O
patients,278,286,O
18,288,290,O
showed,293,299,O
good,300,304,O
response,305,313,O
7,315,316,O
41,318,320,O
moderate,323,331,O
7,336,337,O
minimal,338,345,O
response,352,360,O
Improvement,362,373,O
noted,378,383,O
mainly,384,390,O
soft,394,398,B-Tissue
tissue,399,405,I-Tissue
changes,406,413,O
diplopia,418,426,O
proptosis,434,443,O
decreased,444,453,O
5,462,463,O
patients,464,472,O
patient,489,496,O
marked,505,511,O
extraocular,512,523,B-Multi-tissue_structure
muscle,524,530,I-Multi-tissue_structure
involvement,531,542,O
revealed,543,551,O
computed,555,563,O
tomography,564,574,O
responded,575,584,O
treatment,588,597,O
data,605,609,O
indicate,610,618,O
radiotherapy,624,636,O
indicated,644,653,O
patients,657,665,O
progressive,671,682,O
ophthalmopathy,683,697,O
especially,699,709,O
associated,727,737,O
extraocular,743,754,B-Multi-tissue_structure
muscle,755,761,I-Multi-tissue_structure
enlargement,762,773,O
Management,0,10,O
tortuous,18,26,B-Multi-tissue_structure
internal,27,35,I-Multi-tissue_structure
carotid,36,43,I-Multi-tissue_structure
artery,44,50,I-Multi-tissue_structure
tortuous,56,64,B-Multi-tissue_structure
internal,65,73,I-Multi-tissue_structure
carotid,74,81,I-Multi-tissue_structure
artery,82,88,I-Multi-tissue_structure
basis,96,101,O
cerebral,105,113,B-Multi-tissue_structure
vascular,114,122,I-Multi-tissue_structure
insufficiency,123,136,O
controversial,142,155,O
entity,156,162,O
lesions,172,179,B-Pathological_formation
frequently,180,190,O
occur,191,196,O
neurologic,205,215,B-Anatomical_system
symptoms,216,224,O
tortuous,240,248,B-Multi-tissue_structure
vessels,249,256,I-Multi-tissue_structure
associated,261,271,O
significant,277,288,O
carotid,289,296,B-Multi-tissue_structure
atherosclerotic,297,312,O
disease,313,320,O
requiring,321,330,O
specific,333,341,O
surgical,342,350,O
approach,351,359,O
formed,366,372,O
basis,377,382,O
report,390,396,O
Symptoms,398,406,O
cerebrovascular,410,425,B-Multi-tissue_structure
insufficiency,426,439,O
association,443,454,O
tortuous,462,470,B-Multi-tissue_structure
internal,471,479,I-Multi-tissue_structure
carotid,480,487,I-Multi-tissue_structure
artery,488,494,I-Multi-tissue_structure
encountered,499,510,O
27,514,516,O
853,520,523,O
carotid,524,531,B-Multi-tissue_structure
endarterectomies,532,548,O
22,556,558,O
year,559,563,O
period,564,570,O
Stenosis,572,580,O
hemodynamic,584,595,O
significance,596,608,O
noted,613,618,O
patients,627,635,O
irregularities,640,654,O
ulceration,658,668,O
noted,674,679,O
rest,687,691,O
standard,702,710,O
technique,711,720,O
carotid,724,731,B-Multi-tissue_structure
endarterectomy,732,746,O
removal,748,755,O
plaque,759,765,B-Cell
tortuous,773,781,B-Multi-tissue_structure
vessel,782,788,I-Multi-tissue_structure
leads,789,794,O
loss,798,802,O
stenting,810,818,O
effect,819,825,O
provided,826,834,O
plaque,842,848,B-Cell
angulation,859,869,O
occlusion,870,879,O
likely,883,889,O
occur,893,898,O
optimal,904,911,O
reconstruction,912,926,O
experience,934,944,O
eversion,948,956,O
endarterectomy,957,971,O
transection,975,986,O
lower,991,996,O
reimplantation,997,1011,O
internal,1019,1027,B-Multi-tissue_structure
carotid,1028,1035,I-Multi-tissue_structure
artery,1036,1042,I-Multi-tissue_structure
common,1050,1056,B-Multi-tissue_structure
carotid,1057,1064,I-Multi-tissue_structure
artery,1065,1071,I-Multi-tissue_structure
experience,1077,1087,O
17,1093,1095,O
procedures,1101,1111,O
15,1115,1117,O
patients,1118,1126,O
presented,1136,1145,O
Rapid,0,5,O
enzyme,6,12,O
analysis,13,21,O
amniotic,25,33,B-Organism_substance
fluid,34,39,I-Organism_substance
phospholipids,40,53,O
containing,54,64,O
choline,65,72,O
comparison,76,86,O
lecithin,96,104,O
sphingomyelin,108,121,O
ratio,122,127,O
prenatal,131,139,O
assessment,140,150,O
fetal,154,159,B-Organ
lung,160,164,I-Organ
maturity,165,173,O
relation,179,187,O
choline,200,207,O
containing,208,218,O
surfactant,219,229,O
phospholipids,230,243,O
lecithin,244,252,O
sphingomyelin,257,270,O
amniotic,274,282,B-Organism_substance
fluid,283,288,I-Organism_substance
fetal,293,298,B-Organ
lung,299,303,I-Organ
maturity,304,312,O
established,321,332,O
enzymatic,337,346,O
method,347,353,O
automated,368,377,O
optimised,382,391,O
use,396,399,O
centrifugal,405,416,O
analyser,417,425,O
measure,438,445,O
total,450,455,O
choline,456,463,O
containing,464,474,O
phospholipids,475,488,O
amniotic,492,500,B-Organism_substance
fluid,501,506,I-Organism_substance
total,512,517,O
time,518,522,O
taken,523,528,O
assay,538,543,O
10,548,550,O
minutes,551,558,O
results,564,571,O
obtained,572,580,O
100,586,589,O
patient,590,597,O
samples,598,605,O
procedure,618,627,O
compared,629,637,O
favourably,638,648,O
results,658,665,O
obtained,666,674,O
thin,682,686,O
layer,687,692,O
chromatography,693,707,O
procedure,708,717,O
determine,726,735,O
lecithin,740,748,O
sphingomyelin,752,765,O
ratio,766,771,O
r,773,774,O
0,777,778,O
93,779,781,O
clinical,786,794,O
study,795,800,O
60,804,806,O
patients,807,815,O
showed,816,822,O
assay,833,838,O
predicted,839,848,O
prenatal,849,857,O
respiratory,858,869,B-Anatomical_system
distress,870,878,O
syndrome,879,887,O
lecithin,903,911,O
sphingomyelin,915,928,O
ratios,929,935,O
advantage,941,950,O
assay,959,964,O
existing,970,978,O
procedures,979,989,O
requires,1001,1009,O
minimum,1010,1017,O
preparation,1018,1029,O
specimen,1037,1045,B-Organism_substance
extraction,1053,1063,O
quick,1068,1073,O
shows,1079,1084,O
high,1087,1091,O
degree,1092,1098,O
precision,1102,1111,O
Differences,0,11,O
arterial,24,32,B-Multi-tissue_structure
venous,41,47,B-Multi-tissue_structure
pathomorphology,48,63,O
Buerger,67,74,O
s,75,76,O
disease,77,84,O
Morphological,86,99,O
lesions,100,107,B-Pathological_formation
found,113,118,O
different,125,134,O
arteries,138,146,B-Multi-tissue_structure
veins,154,159,B-Multi-tissue_structure
9,164,165,O
cases,166,171,O
Buerger,175,182,O
s,183,184,O
disease,185,192,O
arterial,198,206,B-Pathological_formation
lesions,207,214,I-Pathological_formation
characteristic,224,238,O
consisted,243,252,O
non,256,259,O
specific,260,268,O
inflammation,269,281,O
thrombosis,283,293,O
obliteration,298,310,O
occur,322,327,O
disease,342,349,O
contrast,354,362,O
addition,367,375,O
wall,379,383,B-Multi-tissue_structure
infiltration,384,396,O
thrombosis,401,411,O
veins,417,422,B-Multi-tissue_structure
showed,423,429,O
microabscesses,430,444,B-Pathological_formation
giant,449,454,B-Pathological_formation
cell,455,459,I-Pathological_formation
granulomas,460,470,I-Pathological_formation
believe,481,488,O
absent,495,501,O
known,515,520,O
diseases,521,529,O
affected,535,543,O
venous,544,550,B-Multi-tissue_structure
segment,551,558,O
exhibited,559,568,O
variety,571,578,O
lesions,582,589,B-Pathological_formation
earliest,598,606,O
period,607,613,O
morphological,619,632,O
aspect,633,639,O
inflammation,643,655,O
arteries,659,667,B-Multi-tissue_structure
veins,672,677,B-Multi-tissue_structure
fairly,682,688,O
similar,689,696,O
late,703,707,O
periods,708,715,O
vascular,734,742,B-Multi-tissue_structure
obliteration,743,755,O
arteries,761,769,B-Multi-tissue_structure
veins,774,779,B-Multi-tissue_structure
distinguishing,797,811,O
morphological,812,825,O
differences,826,837,O
Phosphorylation,0,15,O
induced,16,23,O
mobility,24,32,O
shift,33,38,O
phospholamban,42,55,O
sodium,59,65,O
dodecyl,66,73,O
sulfate,74,81,O
polyacrylamide,82,96,O
gels,97,101,O
Evidence,103,111,O
protein,118,125,O
structure,126,135,O
consisting,136,146,O
multiple,150,158,O
identical,159,168,O
phosphorylatable,169,185,O
subunits,186,194,O
Phosphorylation,196,211,O
purified,215,223,O
phospholamban,224,237,O
isolated,238,246,O
canine,252,258,O
cardiac,259,266,B-Cellular_component
sarcoplasmic,267,279,I-Cellular_component
reticulum,280,289,I-Cellular_component
vesicles,290,298,I-Cellular_component
decreased,299,308,O
electrophoretic,313,328,O
mobility,329,337,O
protein,345,352,O
sodium,356,362,O
dodecyl,363,370,O
sulfate,371,378,O
SDS,380,383,O
polyacrylamide,385,399,O
gels,400,404,O
Different,406,415,O
mobility,416,424,O
forms,425,430,O
phospholamban,434,447,O
SDS,451,454,O
gels,455,459,O
visualized,465,475,O
direct,484,490,O
protein,491,498,O
staining,499,507,O
autoradiography,515,530,O
Unphosphorylated,532,548,O
phospholamban,549,562,O
migrated,563,571,O
apparent,580,588,O
Mr,589,591,O
25,594,596,O
000,597,600,O
SDS,604,607,O
gels,608,612,O
maximal,614,621,O
phosphorylation,622,637,O
phospholamban,641,654,O
cAMP,658,662,O
Ca2,667,670,O
calmodulin,672,682,O
dependent,683,692,O
protein,693,700,O
kinase,701,707,O
increased,708,717,O
apparent,722,730,O
Mr,731,733,O
27,737,739,O
000,740,743,O
Partial,745,752,O
phosphorylation,753,768,O
phospholamban,772,785,O
protein,796,803,O
kinase,804,810,O
gave,811,815,O
intermediate,816,828,O
mobility,829,837,O
forms,838,843,O
molecular,847,856,O
weights,857,864,O
25,873,875,O
000,876,879,O
27,884,886,O
000,887,890,O
suggesting,892,902,O
phosphorylation,922,937,O
site,938,942,O
present,947,954,O
holoprotein,962,973,O
activity,983,991,O
Boiling,993,1000,O
phospholamban,1004,1017,O
SDS,1021,1024,O
dissociated,1025,1036,O
holoprotein,1041,1052,O
apparently,1061,1071,O
homogeneous,1072,1083,O
class,1084,1089,O
low,1093,1096,O
molecular,1097,1106,O
weight,1107,1113,O
monomers,1115,1123,O
mobility,1135,1143,O
forms,1144,1149,O
monomeric,1153,1162,O
phospholamban,1163,1176,O
observed,1182,1190,O
SDS,1194,1197,O
gels,1198,1202,O
phosphorylation,1209,1224,O
cAMP,1228,1232,O
dependent,1233,1242,O
protein,1243,1250,O
kinase,1251,1257,O
corresponding,1259,1272,O
9,1276,1277,O
kDa,1278,1281,O
dephospho,1282,1291,O
11,1297,1299,O
kDa,1300,1303,O
phosphoproteins,1304,1319,O
9,1332,1333,O
kDa,1334,1337,O
protein,1338,1345,O
phosphorylated,1355,1369,O
converted,1374,1383,O
11,1393,1395,O
kDa,1396,1399,O
mobility,1400,1408,O
form,1409,1413,O
suggesting,1415,1425,O
presence,1430,1438,O
site,1451,1455,O
phosphorylation,1459,1474,O
single,1480,1486,O
type,1487,1491,O
monomer,1495,1502,O
cAMP,1507,1511,O
dependent,1512,1521,O
protein,1522,1529,O
kinase,1530,1536,O
Simultaneous,1538,1550,O
phosphorylation,1551,1566,O
monomeric,1570,1579,O
phospholamban,1580,1593,O
cAMP,1597,1601,O
dependent,1602,1611,O
protein,1612,1619,O
kinase,1620,1626,O
Ca2,1631,1634,O
calmodulin,1636,1646,O
dependent,1647,1656,O
protein,1657,1664,O
kinase,1665,1671,O
gave,1672,1676,O
additional,1680,1690,O
mobility,1691,1699,O
form,1700,1704,O
protein,1712,1719,O
suggesting,1721,1731,O
different,1737,1746,O
sites,1747,1752,O
phosphorylation,1756,1771,O
present,1777,1784,O
activity,1794,1802,O
monomer,1811,1818,O
Incomplete,1820,1830,O
dissociation,1831,1843,O
holoprotein,1851,1862,O
boiling,1866,1873,O
relatively,1882,1892,O
low,1893,1896,O
concentration,1897,1910,O
SDS,1914,1917,O
facilitated,1918,1929,O
detection,1934,1943,O
major,1952,1957,O
mobility,1958,1966,O
forms,1967,1972,O
protein,1980,1987,O
SDS,1991,1994,O
gels,1995,1999,O
mobilities,2009,2019,O
forms,2036,2041,O
decreased,2047,2056,O
phosphorylation,2060,2075,O
propose,2080,2087,O
high,2097,2101,O
molecular,2102,2111,O
weight,2112,2118,O
form,2119,2123,O
phospholamban,2127,2140,O
multimer,2146,2154,O
electrophoretically,2158,2177,O
indistinguishable,2178,2195,O
monomers,2196,2204,O
contains,2220,2228,O
different,2231,2240,O
phosphorylation,2241,2256,O
site,2257,2261,O
cAMP,2266,2270,O
dependent,2271,2280,O
protein,2281,2288,O
kinase,2289,2295,O
activity,2296,2304,O
Ca2,2309,2312,O
calmodulin,2314,2324,O
dependent,2325,2334,O
protein,2335,2342,O
kinase,2343,2349,O
activity,2350,2358,O
Phosphorylation,2360,2375,O
phospholamban,2379,2392,O
multiple,2396,2404,O
sites,2405,2410,O
responsible,2414,2425,O
mobility,2442,2450,O
forms,2451,2456,O
holoprotein,2464,2475,O
detected,2476,2484,O
SDS,2488,2491,O
polyacrylamide,2492,2506,O
gels,2507,2511,O
Preliminary,0,11,O
evidence,12,20,O
pyridine,27,35,O
nucleotide,36,46,O
cycle,47,52,O
Bordetella,56,66,O
pertussis,67,76,O
Preliminary,78,89,O
evidence,90,98,O
Bordetella,104,114,O
pertussis,115,124,O
functional,131,141,O
pyridine,142,150,O
nucleotide,151,161,O
cycle,162,167,O
observation,176,187,O
14C,194,197,O
nicotinic,199,208,O
acid,209,213,O
rapidly,218,225,O
metabolized,226,237,O
uptake,249,255,O
bacteria,263,271,O
pyridine,275,283,O
nucleotides,284,295,O
nicotinamide,300,312,O
Nicotinamide,314,326,O
deamidase,327,336,O
activity,337,345,O
necessary,347,356,O
completion,365,375,O
cycle,383,388,O
conversion,392,402,O
nicotinamide,406,418,O
nicotinic,422,431,O
acid,432,436,O
found,442,447,O
soluble,453,460,O
extract,461,468,O
20,470,472,O
000,473,476,O
X,477,478,O
g,479,480,O
supernatant,481,492,O
B,497,498,O
pertussis,500,509,O
cell,510,514,B-Organism_substance
lysates,515,522,I-Organism_substance
Use,0,3,O
monoclonal,7,17,O
antibodies,18,28,O
investigate,32,43,O
possible,46,54,O
role,55,59,O
thyroglobulin,63,76,O
pathogenesis,84,96,O
Graves,100,106,O
ophthalmopathy,108,122,O
possible,128,136,O
mechanism,137,146,O
Graves,151,157,O
ophthalmopathy,159,173,O
progressive,186,197,O
orbital,198,205,B-Immaterial_anatomical_entity
inflammation,206,218,O
initiated,222,231,O
formation,235,244,O
thyroglobulin,248,261,O
Tg,263,265,O
anti,267,271,O
Tg,272,274,O
immune,275,281,O
complexes,282,291,O
sites,295,300,O
Tg,304,306,O
binding,307,314,O
extraocular,318,329,B-Tissue
muscle,330,336,I-Tissue
membranes,337,346,I-Tissue
study,356,361,O
monoclonal,362,372,O
antibodies,373,383,O
MCAB,385,389,O
human,399,404,O
Tg,405,407,O
probes,421,427,O
1,429,430,O
identify,435,443,O
Tg,444,446,O
eye,450,453,B-Tissue
muscle,454,460,I-Tissue
membranes,461,470,I-Tissue
prepared,471,479,O
normal,485,491,O
subjects,492,500,O
2,506,507,O
measure,512,519,O
binding,520,527,O
human,531,536,O
Tg,537,539,O
Tg,544,546,O
anti,547,551,O
Tg,552,554,O
immune,555,561,O
complexes,562,571,O
eye,575,578,B-Tissue
muscle,579,585,I-Tissue
membranes,586,595,I-Tissue
Reactivity,597,607,O
anti,611,615,O
Tg,616,618,O
MCAB,619,623,O
Tg,629,631,O
thyroid,633,640,B-Tissue
eye,646,649,B-Tissue
muscle,650,656,I-Tissue
membranes,657,666,I-Tissue
determined,671,681,O
binding,685,692,O
125I,697,701,O
anti,702,706,O
Tg,707,709,O
monoclonal,710,720,O
antibody,721,729,O
enzyme,734,740,O
linked,741,747,O
immunosorbent,748,761,O
assay,762,767,O
ELISA,769,774,O
indirect,785,793,O
immunofluorescence,794,812,O
technique,813,822,O
Seven,824,829,O
membrane,830,838,B-Tissue
fractions,839,848,I-Tissue
prepared,850,858,O
differential,862,874,O
sucrose,875,882,O
gradient,883,891,O
centrifugation,892,906,O
125I,928,932,O
anti,933,937,O
Tg,938,940,O
MCAB,941,945,O
bound,946,951,O
thyroid,959,966,B-Tissue
membrane,967,975,I-Tissue
fractions,976,985,I-Tissue
tested,986,992,O
125I,998,1002,O
anti,1003,1007,O
Tg,1008,1010,O
bound,1011,1016,O
eye,1020,1023,B-Tissue
muscle,1024,1030,I-Tissue
membranes,1031,1040,I-Tissue
Similarly,1042,1051,O
reactivity,1053,1063,O
anti,1067,1071,O
Tg,1072,1074,O
MCAB,1075,1079,O
eye,1085,1088,B-Tissue
muscle,1089,1095,I-Tissue
membranes,1096,1105,I-Tissue
demonstrated,1114,1126,O
ELISA,1130,1135,O
immunofluorescence,1139,1157,O
tests,1158,1163,O
Tg,1174,1176,O
anti,1177,1181,O
Tg,1182,1184,O
immune,1185,1191,O
complexes,1192,1201,O
bound,1202,1207,O
thyroid,1211,1218,B-Tissue
membranes,1219,1228,I-Tissue
complexes,1235,1244,O
bind,1253,1257,O
eye,1261,1264,B-Tissue
muscle,1265,1271,I-Tissue
membranes,1272,1281,I-Tissue
Significant,1283,1294,O
binding,1295,1302,O
125I,1307,1311,O
human,1312,1317,O
Tg,1318,1320,O
eye,1324,1327,B-Tissue
muscle,1328,1334,I-Tissue
thyroid,1338,1345,B-Tissue
membranes,1346,1355,I-Tissue
demonstrated,1364,1376,O
membrane,1385,1393,B-Tissue
preparation,1394,1405,I-Tissue
hand,1420,1424,O
moderate,1425,1433,O
significant,1439,1450,O
binding,1452,1459,O
skeletal,1463,1471,B-Organ
muscle,1472,1478,I-Organ
shown,1483,1488,O
Similar,1490,1497,O
results,1498,1505,O
found,1511,1516,O
ELISA,1526,1531,O
Binding,1533,1540,O
125I,1545,1549,O
anti,1550,1554,O
Tg,1555,1557,O
Tg,1558,1560,O
complexes,1561,1570,O
125I,1575,1579,O
Tg,1580,1582,O
thyroid,1586,1593,B-Tissue
eye,1598,1601,B-Tissue
muscle,1602,1608,I-Tissue
membranes,1609,1618,I-Tissue
affected,1627,1635,O
presence,1643,1651,O
normal,1655,1661,O
human,1662,1667,O
serum,1668,1673,B-Organism_substance
phosphate,1675,1684,O
ions,1685,1689,O
pH,1691,1693,O
incubation,1698,1708,O
temperature,1709,1720,O
conditions,1722,1732,O
claimed,1733,1740,O
critical,1757,1765,O
Tg,1770,1772,O
Tg,1777,1779,O
anti,1780,1784,O
Tg,1785,1787,O
immune,1788,1794,O
complex,1795,1802,O
binding,1803,1810,O
Tg,1818,1820,O
present,1828,1835,O
normal,1839,1845,O
human,1846,1851,O
eye,1852,1855,B-Tissue
muscle,1856,1862,I-Tissue
major,1865,1870,O
role,1871,1875,O
Tg,1879,1881,O
Tg,1886,1888,O
anti,1889,1893,O
Tg,1894,1896,O
immune,1897,1903,O
complexes,1904,1913,O
pathogenesis,1922,1934,O
Graves,1938,1944,O
ophthalmopathy,1946,1960,O
appears,1961,1968,O
excluded,1982,1990,O
findings,2000,2008,O
Purification,0,12,O
characterization,17,33,O
esterases,45,54,O
rat,60,63,O
liver,64,69,B-Organ
major,75,80,O
rat,81,84,O
liver,85,90,B-Cellular_component
microsomal,91,101,I-Cellular_component
esterases,102,111,O
acting,112,118,O
o,122,123,O
nitrophenylacetate,124,142,O
isoelectric,148,159,O
points,160,166,O
5,167,168,O
0,169,170,O
5,172,173,O
5,174,175,O
6,177,178,O
1,179,180,O
6,185,186,O
4,187,188,O
resolved,194,202,O
isoelectric,206,217,O
focusing,218,226,O
Molecular,228,237,O
weights,238,245,O
determined,251,261,O
sedimentation,265,278,O
analysis,279,287,O
isokinetic,291,301,O
gradients,302,311,O
sucrose,315,322,O
purification,334,346,O
sodium,351,357,O
dodecyl,358,365,O
sulphate,366,374,O
polyacrylamide,375,389,O
gel,390,393,O
electrophoresis,394,409,O
subunit,417,424,O
molecular,425,434,O
weights,435,442,O
57,456,458,O
000,459,462,O
60,467,469,O
000,470,473,O
behaved,480,487,O
monomers,491,499,O
pI,511,513,O
6,514,515,O
1,516,517,O
enzyme,518,524,O
behaved,531,538,O
trimer,544,550,O
Esterases,552,561,O
pI,565,567,O
5,568,569,O
0,570,571,O
pI,573,575,O
6,576,577,O
1,578,579,O
pI,584,586,O
6,587,588,O
4,589,590,O
behaved,591,598,O
like,599,603,O
glycoproteins,604,617,O
polymannose,625,636,O
type,637,641,O
presence,649,657,O
125I,661,665,O
labelled,666,674,O
concanavalin,675,687,O
Preparations,691,703,O
pI,711,713,O
5,714,715,O
0,716,717,O
enzyme,718,724,O
contained,725,734,O
esterases,739,748,O
highly,752,758,O
homologous,759,769,O
structure,770,779,O
Antibodies,781,791,O
directed,792,800,O
preparation,814,825,O
inhibit,834,841,O
precipitated,846,858,O
pI,859,861,O
5,862,863,O
0,864,865,O
esterase,866,874,O
activity,875,883,O
quantitatively,884,898,O
react,913,918,O
pI,928,930,O
6,931,932,O
1,933,934,O
pI,939,941,O
6,942,943,O
4,944,945,O
esterases,946,955,O
precipitated,960,972,O
nonimmunologically,981,999,O
related,1000,1007,O
esterases,1008,1017,O
enzymes,1032,1039,O
inducible,1045,1054,O
phenobarbital,1058,1071,O
Total,1073,1078,O
activity,1079,1087,O
low,1097,1100,O
3,1104,1105,O
day,1106,1109,O
old,1110,1113,O
animals,1114,1121,O
Individual,1123,1133,O
esterase,1134,1142,O
activities,1143,1153,O
rose,1154,1158,O
different,1162,1171,O
rates,1172,1177,O
development,1185,1196,O
enzyme,1202,1208,O
focusing,1209,1217,O
near,1218,1222,O
pI,1223,1225,O
5,1226,1227,O
0,1228,1229,O
times,1246,1251,O
active,1257,1263,O
adult,1267,1272,O
females,1273,1280,O
males,1289,1294,O
microsomal,1300,1310,O
esterases,1311,1320,O
located,1325,1332,O
luminal,1340,1347,O
endoplasmic,1360,1371,B-Cellular_component
reticulum,1372,1381,I-Cellular_component
Hippocampal,0,11,B-Multi-tissue_structure
afterdischarge,12,26,O
interferes,27,37,O
storage,43,50,O
spatial,54,61,O
information,62,73,O
working,79,86,O
memory,87,93,O
test,94,98,O
attempt,106,113,O
impair,117,123,O
spatial,124,131,O
working,132,139,O
memory,140,146,O
reversible,150,160,O
functional,161,171,O
blockade,172,180,O
irreversible,196,208,O
lesion,209,215,B-Pathological_formation
hippocampus,223,234,B-Multi-tissue_structure
male,242,246,O
hooded,247,253,O
rats,254,258,O
trained,264,271,O
asymptotic,275,285,O
performance,286,297,O
1,301,302,O
2,303,304,O
1,308,309,O
4,310,311,O
errors,312,318,O
trial,323,328,O
spatial,336,343,O
12,344,346,O
choice,347,353,O
apparatus,354,363,O
Bure,366,370,O
s,371,372,O
et,373,375,O
al,376,378,O
1982,380,384,O
formally,387,395,O
similar,396,403,O
radial,411,417,O
maze,418,422,O
rats,428,432,O
implanted,438,447,O
hippocampal,453,464,B-Multi-tissue_structure
stimulating,465,476,O
recording,481,490,O
electrodes,491,501,O
eliciting,523,532,O
monitoring,537,547,O
hippocampal,548,559,B-Multi-tissue_structure
afterdischarge,560,574,O
lasting,581,588,O
20,602,604,O
s,605,606,O
Experiment,611,621,O
1,622,623,O
elicited,629,637,O
1,638,639,O
10,643,645,O
min,646,649,O
testing,657,664,O
increased,665,674,O
incidence,679,688,O
errors,692,698,O
2,702,703,O
75,704,706,O
2,710,711,O
50,712,714,O
trial,719,724,O
respectively,726,738,O
performance,748,759,O
remained,766,774,O
chance,781,787,O
level,788,793,O
4,795,796,O
18,797,799,O
Experiment,805,815,O
2,816,817,O
interruption,819,831,O
trial,839,844,O
1,848,849,O
10,851,853,O
20,855,857,O
30,862,864,O
min,865,868,O
intervals,869,878,O
inserted,879,887,O
choices,896,903,O
6,904,905,O
7,910,911,O
increased,912,921,O
incidence,926,935,O
errors,939,945,O
choices,949,956,O
7,957,958,O
12,962,964,O
1,968,969,O
0,970,971,O
1,973,974,O
5,975,976,O
2,978,979,O
1,980,981,O
2,986,987,O
5,988,989,O
respectively,991,1003,O
elicited,1009,1017,O
immediately,1018,1029,O
choice,1036,1042,O
6,1043,1044,O
increased,1045,1054,O
error,1055,1060,O
incidence,1061,1070,O
subsequent,1078,1088,O
6,1089,1090,O
choices,1091,1098,O
performed,1099,1108,O
1,1115,1116,O
min,1117,1120,O
10,1124,1126,O
min,1127,1130,O
intervals,1131,1140,O
3,1144,1145,O
1,1146,1147,O
2,1151,1152,O
75,1153,1155,O
respectively,1157,1169,O
e,1173,1174,O
chance,1183,1189,O
level,1190,1195,O
3,1199,1200,O
errors,1201,1207,O
6,1211,1212,O
choices,1213,1220,O
concluded,1228,1237,O
elicits,1247,1254,O
transient,1255,1264,O
shortening,1265,1275,O
memory,1283,1289,O
span,1290,1294,O
newly,1299,1304,O
acquired,1305,1313,O
spatial,1314,1321,O
information,1322,1333,O
anterograde,1335,1346,O
effect,1347,1353,O
erases,1359,1365,O
current,1370,1377,O
spatial,1378,1385,O
working,1386,1393,O
memory,1394,1400,O
record,1401,1407,O
retrograde,1409,1419,O
effect,1420,1426,O
vitro,4,9,O
studies,10,17,O
thyroid,25,32,B-Organ
gland,33,38,I-Organ
regulation,39,49,O
principles,50,60,O
evaluation,71,81,O
free,88,92,O
fractions,93,102,O
thyroid,110,117,O
hormone,118,125,O
metabolism,138,148,O
body,156,160,B-Cell
cells,161,166,I-Cell
regulate,171,179,O
synthesis,184,193,O
thyroid,201,208,O
hormone,209,216,O
level,227,232,O
FT3,236,239,O
FT4,244,247,O
decreases,248,257,O
help,268,272,O
liberation,278,288,O
hormone,296,303,O
stimulating,304,315,O
thyroid,320,327,B-Organ
gland,328,333,I-Organ
anterior,343,351,B-Multi-tissue_structure
lobe,352,356,I-Multi-tissue_structure
pituitary,364,373,B-Organ
gland,374,379,I-Organ
lack,384,388,O
thyroid,392,399,O
hormone,400,407,O
corrected,411,420,O
synthesis,426,435,O
secretion,440,449,O
thyroid,457,464,B-Organ
gland,465,470,I-Organ
stimulating,471,482,O
hormone,483,490,O
induced,494,501,O
thyreotropin,509,521,O
releasing,522,531,O
hormone,532,539,O
given,549,554,O
hypothalamus,562,574,B-Multi-tissue_structure
organism,590,598,O
able,602,606,O
needed,610,616,O
carry,620,625,O
monodiodation,634,647,O
LT4,651,654,O
biologically,658,670,O
active,671,677,O
LT3,678,681,O
biologically,685,697,O
inactive,698,706,O
called,710,716,O
revers,717,723,O
T3,724,726,O
RT3,728,731,O
estimation,738,748,O
thyroid,752,759,B-Organ
gland,760,765,I-Organ
stimulating,766,777,O
hormone,778,785,O
30,797,799,O
minutes,800,807,O
intravenous,814,825,B-Multi-tissue_structure
application,826,837,O
thyreotropin,841,853,O
releasing,854,863,O
hormone,864,871,O
main,880,884,O
importance,885,895,O
early,904,909,O
recognition,910,921,O
disturbance,927,938,O
regulating,946,956,O
circle,957,963,O
hypophysis,964,974,O
thyroid,975,982,B-Organ
gland,983,988,I-Organ
diagnosis,1007,1016,O
clinically,1020,1030,O
manifest,1039,1047,O
clinical,1048,1056,O
pictures,1057,1065,O
latent,1079,1085,O
hypothyreosis,1086,1099,O
latent,1108,1114,O
hyperthyreosis,1115,1129,O
respectively,1131,1143,O
Basedow,1145,1152,O
hyperthyreosis,1153,1167,O
thyroidal,1172,1181,O
autonomy,1182,1190,O
According,1193,1202,O
questioning,1210,1221,O
estimations,1226,1237,O
levels,1245,1251,O
thyroid,1259,1266,O
hormones,1267,1275,O
thyroid,1287,1294,B-Organ
gland,1295,1300,I-Organ
stimulating,1301,1312,O
hormone,1313,1320,O
stepwise,1336,1344,O
Relationship,0,12,O
self,16,20,O
concept,21,28,O
late,36,40,O
pregnancy,41,50,O
neonatal,54,62,O
perception,63,73,O
parenting,78,87,O
profile,88,95,O
Thirty,97,103,O
gravidas,108,116,O
studied,122,129,O
examine,133,140,O
relationship,145,157,O
woman,168,173,O
s,174,175,O
feelings,176,184,O
late,206,210,O
pregnancy,211,220,O
perception,226,236,O
newborn,244,251,O
profile,261,268,O
parenting,272,281,O
Tennessee,287,296,O
Self,297,301,O
Concept,302,309,O
Scale,310,315,O
completed,320,329,O
trimester,347,356,O
pregnancy,360,369,O
Neonatal,375,383,O
Perception,384,394,O
Inventory,395,404,O
days,421,425,O
postpartum,426,436,O
Neonatal,446,454,O
Perception,455,465,O
Inventory,466,475,O
II,476,478,O
Michigan,487,495,O
Screening,496,505,O
Profile,506,513,O
Parenting,517,526,O
weeks,542,547,O
postpartum,548,558,O
considered,565,575,O
separately,576,586,O
positive,591,599,O
significant,600,611,O
relationships,612,625,O
found,631,636,O
scores,645,651,O
variables,661,670,O
subjects,685,693,O
negative,699,707,O
scores,708,714,O
self,723,727,O
concept,728,735,O
neonatal,740,748,O
perception,749,759,O
negative,764,772,O
scores,773,779,O
subscales,796,805,O
parenting,813,822,O
profile,823,830,O
Verrucous,0,9,B-Pathological_formation
carcinoma,10,19,I-Pathological_formation
endometrium,27,38,B-Multi-tissue_structure
unique,42,48,O
neoplasm,49,57,B-Pathological_formation
long,63,67,O
survival,68,76,O
case,80,84,O
verrucous,88,97,B-Pathological_formation
carcinoma,98,107,I-Pathological_formation
endometrium,115,126,B-Multi-tissue_structure
long,132,136,O
survival,137,145,O
described,149,158,O
represents,163,173,O
type,191,195,O
recorded,202,210,O
site,219,223,O
literature,229,239,O
verrucous,243,252,B-Pathological_formation
carcinoma,253,262,I-Pathological_formation
cases,276,281,O
squamous,285,293,B-Pathological_formation
carcinoma,294,303,I-Pathological_formation
endometrium,311,322,B-Multi-tissue_structure
briefly,326,333,O
reviewed,334,342,O
Organization,1,13,O
pectoral,17,25,B-Cell
muscle,26,32,I-Cell
motor,33,38,I-Cell
neurons,39,46,I-Cell
rat,54,57,O
Contribution,59,71,O
study,79,84,O
axillary,92,100,B-Multi-tissue_structure
arch,101,105,I-Multi-tissue_structure
Achselbogen,107,118,O
spite,125,130,O
role,140,144,O
forelimb,152,160,B-Organism_subdivision
activity,161,169,O
organization,175,187,O
mammalian,195,204,O
pectoral,205,213,B-Organ
muscles,214,221,I-Organ
remains,222,229,O
unclear,230,237,O
order,242,247,O
information,260,271,O
studied,281,288,O
qualitatively,290,303,O
quantitatively,308,322,O
motor,328,333,O
pools,334,339,O
pectoral,355,363,B-Organ
muscles,364,371,I-Organ
rat,379,382,O
musculus,384,392,B-Organ
pectoralis,393,403,I-Organ
major,404,409,I-Organ
musculus,411,419,B-Organ
pectoralis,420,430,I-Organ
minor,431,436,I-Organ
musculus,441,449,B-Organ
panniculus,450,460,I-Organ
carnosus,461,469,I-Organ
method,476,482,O
applied,483,490,O
retrograde,499,509,O
transport,510,519,O
horseradish,523,534,O
peroxidase,535,545,O
peripheral,553,563,B-Multi-tissue_structure
nerves,564,570,I-Multi-tissue_structure
supplying,571,580,O
muscles,593,600,B-Organ
results,606,613,O
provided,614,622,O
precise,627,634,O
localization,635,647,O
ventral,659,666,B-Cellular_component
horn,667,671,I-Cellular_component
motor,679,684,B-Cell
neurons,685,692,I-Cell
pectoral,702,710,B-Organ
muscles,711,718,I-Organ
ventral,746,753,B-Multi-tissue_structure
gray,766,770,B-Multi-tissue_structure
matter,771,777,I-Multi-tissue_structure
distinct,785,793,O
motor,794,799,O
pools,800,805,O
observed,811,819,O
confirms,827,835,O
functional,840,850,O
identity,851,859,O
muscle,868,874,B-Organ
motor,880,885,B-Cell
neurons,886,893,I-Cell
m,897,898,O
panniculus,900,910,O
carnosus,911,919,O
exhibited,920,929,O
particularities,935,950,O
4,962,963,O
times,964,969,O
numerous,975,983,O
m,1000,1001,O
pectoralis,1003,1013,O
major,1014,1019,O
occupied,1026,1034,O
ventral,1045,1052,B-Cellular_component
edge,1053,1057,I-Cellular_component
ventral,1065,1072,B-Cellular_component
horn,1073,1077,I-Cellular_component
medial,1088,1094,O
lateral,1107,1114,O
tip,1115,1118,O
cell,1124,1128,B-Cell
size,1129,1133,O
different,1138,1147,O
muscles,1171,1178,B-Organ
results,1186,1193,O
discussed,1199,1208,O
according,1210,1219,O
role,1227,1231,O
muscle,1240,1246,B-Organ
links,1254,1259,O
forelimb,1264,1272,B-Organism_subdivision
trunk,1286,1291,B-Organism_subdivision
mammals,1296,1303,O
m,1305,1306,O
panniculus,1308,1318,O
carnosus,1319,1327,O
constitutes,1328,1339,O
musculus,1346,1354,B-Organ
latissimus,1355,1365,I-Organ
dorsi,1366,1371,I-Organ
axillary,1377,1385,B-Multi-tissue_structure
arch,1386,1390,I-Multi-tissue_structure
Achselbogen,1392,1403,O
small,1408,1413,O
area,1414,1418,O
overlapping,1422,1433,O
motor,1446,1451,O
pools,1452,1457,O
muscles,1471,1478,B-Organ
observed,1483,1491,O
suggested,1500,1509,O
muscular,1519,1527,B-Cell
fibers,1528,1534,I-Cell
axillary,1544,1552,B-Multi-tissue_structure
arch,1553,1557,I-Multi-tissue_structure
innervated,1563,1573,O
defined,1592,1599,O
spinal,1600,1606,B-Organism_subdivision
area,1607,1611,I-Organism_subdivision
independent,1613,1624,O
muscle,1632,1638,B-Organ
originate,1655,1664,O
Additional,0,10,O
tests,11,16,O
interest,20,28,O
dermatologist,36,49,O
carcinoid,55,64,O
syndrome,65,73,O
clinical,82,90,O
manifestations,91,105,O
discussed,116,125,O
standard,131,139,O
laboratory,140,150,O
test,151,155,O
making,160,166,O
diagnosis,172,181,O
urinary,185,192,B-Organism_substance
5,193,194,O
HIAA,195,199,O
levels,200,206,O
newer,211,216,O
sensitive,223,232,O
tests,233,238,O
available,251,260,O
Central,0,7,B-Anatomical_system
nervous,8,15,I-Anatomical_system
system,16,22,I-Anatomical_system
infection,23,32,O
Eikenella,38,47,O
corrodens,48,57,O
report,59,65,O
cases,73,78,O
cases,84,89,O
central,93,100,B-Anatomical_system
nervous,101,108,I-Anatomical_system
system,109,115,I-Anatomical_system
infections,116,126,O
E,138,139,O
corrodens,141,150,O
isolated,160,168,O
reported,173,181,O
portals,187,194,O
entry,198,203,O
clinical,205,213,O
course,214,220,O
antimicrobial,226,239,O
responses,240,249,O
conform,250,257,O
reports,267,274,O
literature,282,292,O
importance,298,308,O
obtaining,312,321,O
careful,322,329,O
anaerobic,330,339,O
cultures,340,348,O
emphasized,352,362,O
Comparative,0,11,O
immunohistochemical,12,31,O
study,32,37,O
primary,41,48,B-Pathological_formation
metastatic,53,63,B-Pathological_formation
carcinomas,64,74,I-Pathological_formation
liver,82,87,B-Organ
Distinguishing,89,103,O
primary,104,111,B-Pathological_formation
hepatocellular,112,126,I-Pathological_formation
carcinoma,127,136,I-Pathological_formation
HCC,138,141,B-Pathological_formation
metastatic,148,158,B-Pathological_formation
carcinomas,159,169,I-Pathological_formation
liver,177,182,B-Organ
difficult,192,201,O
impossible,210,220,O
particularly,222,234,O
needle,238,244,B-Multi-tissue_structure
biopsy,245,251,I-Multi-tissue_structure
fine,256,260,B-Multi-tissue_structure
needle,261,267,I-Multi-tissue_structure
aspiration,268,278,I-Multi-tissue_structure
specimens,279,288,I-Multi-tissue_structure
attempt,296,303,O
identify,307,315,O
specific,318,326,O
immunohistochemical,327,346,O
profile,347,354,O
distinguish,366,377,O
HCC,378,381,B-Pathological_formation
metastatic,387,397,B-Pathological_formation
carcinomas,398,408,I-Pathological_formation
studied,413,420,O
56,421,423,O
HCCs,424,428,O
8,430,431,O
cholangiocarcinomas,432,451,B-Pathological_formation
24,457,459,O
metastatic,460,470,B-Pathological_formation
adenocarcinomas,471,486,I-Pathological_formation
monoclonal,492,502,O
antibodies,503,513,O
alpha,517,522,O
fetoprotein,523,534,O
AFP,536,539,O
keratin,542,549,O
AE1,551,554,O
AE3,556,559,O
CAM5,565,569,O
2,570,571,O
Leu,574,577,O
M1,578,580,O
human,582,587,O
milk,588,592,O
fat,593,596,O
globule,597,604,O
HMFG,606,610,O
2,611,612,O
tumor,615,620,B-Pathological_formation
associated,621,631,O
glycoprotein,632,644,O
72,645,647,O
B72,648,651,O
3,652,653,O
epithelial,656,666,B-Tissue
specific,667,675,O
membrane,676,684,B-Cellular_component
antigen,685,692,O
Ber,694,697,O
EP4,698,701,O
BCA,708,711,O
225,712,715,O
CU,717,719,O
18,720,722,O
monoclonal,730,740,O
polyclonal,745,755,O
mCEA,757,761,O
pCEA,766,770,O
antibodies,772,782,O
carcinoembryonic,786,802,O
antigen,803,810,O
Metastatic,827,837,B-Pathological_formation
adenocarcinomas,838,853,I-Pathological_formation
positive,865,873,O
CU,878,880,O
18,881,883,O
71,884,886,O
Leu,890,893,O
M1,894,896,O
75,898,900,O
B72,904,907,O
3,908,909,O
50,911,913,O
HMFG,917,921,O
2,922,923,O
67,925,927,O
Ber,931,934,O
EP4,935,938,O
83,939,941,O
mCEA,948,952,O
71,953,955,O
antibodies,971,981,O
frequency,987,996,O
positivity,1000,1010,O
HCC,1015,1018,B-Pathological_formation
9,1023,1024,O
16,1027,1029,O
11,1032,1034,O
20,1037,1039,O
36,1042,1044,O
11,1051,1053,O
respectively,1056,1068,O
CU,1070,1072,O
18,1073,1075,O
monoclonal,1089,1099,O
antibody,1100,1108,O
significant,1130,1141,O
difference,1142,1152,O
positive,1156,1164,O
rates,1165,1170,O
HCC,1179,1182,B-Pathological_formation
metastatic,1187,1197,B-Pathological_formation
adenocarcinomas,1198,1213,I-Pathological_formation
HCCs,1220,1224,B-Pathological_formation
71,1226,1228,O
revealed,1231,1239,O
bile,1242,1246,B-Multi-tissue_structure
canalicular,1247,1258,I-Multi-tissue_structure
staining,1259,1267,O
pattern,1268,1275,O
pCEA,1281,1285,O
staining,1300,1308,O
pattern,1309,1316,O
absent,1321,1327,O
metastatic,1331,1341,B-Pathological_formation
carcinomas,1342,1352,I-Pathological_formation
pCEA,1354,1358,O
appears,1359,1366,O
useful,1373,1379,O
confirming,1383,1393,O
diagnosis,1396,1405,O
HCC,1409,1412,O
AE1,1414,1417,O
AE3,1419,1422,O
CAM5,1427,1431,O
2,1432,1433,O
antibodies,1434,1444,O
useful,1454,1460,O
distinguishing,1464,1478,O
HCC,1479,1482,B-Pathological_formation
metastatic,1488,1498,B-Pathological_formation
carcinomas,1499,1509,I-Pathological_formation
cholangiocarcinoma,1516,1534,B-Pathological_formation
shared,1535,1541,O
staining,1544,1552,O
profile,1553,1560,O
similar,1561,1568,O
metastatic,1580,1590,B-Pathological_formation
carcinomas,1591,1601,I-Pathological_formation
Differential,0,12,O
effects,13,20,O
carbachol,24,33,O
calcium,37,44,O
entry,45,50,O
release,55,62,O
CHO,66,69,B-Cell
cells,70,75,I-Cell
expressing,76,86,O
m3,91,93,O
muscarinic,94,104,O
receptor,105,113,O
Calcium,115,122,O
signalling,123,133,O
examined,138,146,O
CHO,150,153,B-Cell
k1,154,156,I-Cell
cells,157,162,I-Cell
stably,168,174,O
express,175,182,O
m3,187,189,O
subtype,190,197,O
muscarinic,205,215,O
receptor,216,224,O
calcium,230,237,O
indicator,238,247,O
Fura,248,252,O
2,253,254,O
retained,259,267,O
cells,277,282,B-Cell
presence,295,303,O
probenecid,307,317,O
1,319,320,O
mM,321,323,O
suggesting,326,336,O
Fura,342,346,O
2,347,348,O
efflux,349,355,O
mediated,360,368,O
organic,375,382,O
anion,383,388,O
transporter,389,400,O
addition,406,414,O
carbachol,418,427,O
CCh,429,432,O
Fura,437,441,O
2,442,443,O
loaded,444,450,O
cells,451,456,B-Cell
suspension,460,470,O
caused,471,477,O
rapid,480,485,O
transient,486,495,O
increase,496,504,O
intracellular,508,521,B-Immaterial_anatomical_entity
calcium,522,529,O
followed,536,544,O
smaller,550,557,O
sustained,558,567,O
plateau,568,575,O
phase,576,581,O
transient,587,596,O
rise,597,601,O
dose,615,619,O
dependent,620,629,O
threshold,637,646,O
response,647,655,O
89,659,661,O
18,666,668,O
nM,669,671,O
baseline,678,686,O
10,692,694,O
nM,695,697,O
CCh,698,701,O
maximum,708,715,O
stimulation,716,727,O
734,731,734,O
46,739,741,O
nM,742,744,O
10,750,752,O
microM,753,759,O
CCh,760,763,O
phase,770,775,O
accompanied,780,791,O
similar,797,804,O
dose,805,809,O
dependent,810,819,O
stimulation,820,831,O
total,835,840,O
inositol,841,849,O
phosphate,850,859,O
production,860,870,O
assumed,879,886,O
generated,893,902,O
release,906,913,O
intracellular,919,932,B-Immaterial_anatomical_entity
stores,933,939,O
endoplasmic,947,958,B-Cellular_component
reticulum,959,968,I-Cellular_component
ER,970,972,B-Cellular_component
sustained,979,988,O
increase,989,997,O
generated,1011,1020,O
entry,1024,1029,O
extracellular,1039,1052,B-Immaterial_anatomical_entity
bath,1053,1057,O
blocked,1071,1078,O
pretreatment,1082,1094,O
La3,1100,1103,O
1,1106,1107,O
microM,1108,1114,O
absent,1124,1130,O
bath,1136,1140,O
calcium,1141,1148,O
chelated,1153,1161,O
EGTA,1167,1171,O
phase,1178,1183,O
dependent,1192,1201,O
CCh,1205,1208,O
dose,1209,1213,O
stimulation,1221,1232,O
approximately,1245,1258,O
90,1259,1261,O
nM,1262,1264,O
baseline,1271,1279,O
observed,1284,1292,O
CCh,1298,1301,O
concentrations,1302,1316,O
50,1325,1327,O
nM,1328,1330,O
10,1335,1337,O
microM,1338,1344,O
dose,1356,1360,O
range,1361,1366,O
rate,1372,1376,O
Mn2,1380,1383,O
quenching,1385,1394,O
Fura,1398,1402,O
2,1403,1404,O
insensitive,1415,1426,O
excitation,1427,1437,O
wavelength,1438,1448,O
360,1452,1455,O
nm,1456,1458,O
likewise,1463,1471,O
maximally,1472,1481,O
stimulated,1482,1492,O
lower,1497,1502,O
CCh,1503,1506,O
concentrations,1507,1521,O
10,1523,1525,O
50,1526,1528,O
nM,1529,1531,O
clear,1541,1546,O
activation,1556,1566,O
entry,1573,1578,O
dissociated,1592,1603,O
threshold,1611,1620,O
release,1621,1628,O
intracellular,1640,1653,B-Immaterial_anatomical_entity
stores,1654,1660,O
phorbol,1666,1673,O
ester,1674,1679,O
PMA,1680,1683,O
uncouples,1691,1700,O
muscarinic,1705,1715,O
receptor,1716,1724,O
phospholipase,1730,1743,O
C,1744,1745,O
reduced,1747,1754,O
transient,1759,1768,O
rise,1769,1773,O
approximately,1786,1799,O
50,1800,1802,O
little,1809,1815,O
effect,1822,1828,O
entry,1835,1840,O
higher,1844,1850,O
CCh,1851,1854,O
levels,1855,1861,O
1,1870,1871,O
microM,1872,1878,O
lower,1884,1889,O
CCh,1890,1893,O
concentrations,1894,1908,O
100,1917,1920,O
nM,1921,1923,O
pretreatment,1934,1946,O
PMA,1952,1955,O
completely,1956,1966,O
blocked,1967,1974,O
mobilization,1982,1994,O
supports,1999,2007,O
contention,2012,2022,O
entry,2031,2036,O
coupled,2040,2047,O
release,2054,2061,O
stores,2067,2073,O
store,2080,2085,O
depletion,2086,2095,O
emptying,2101,2109,O
inositol,2113,2121,O
trisphosphate,2122,2135,O
sensitive,2136,2145,O
stores,2146,2152,O
thapsigargin,2158,2170,O
10,2172,2174,O
nM,2175,2177,O
stimulated,2179,2189,O
entry,2193,2198,O
rate,2212,2216,O
Mn2,2220,2223,O
quenching,2225,2234,O
Store,2236,2241,O
depletion,2242,2251,O
incubation,2255,2265,O
free,2272,2276,O
media,2277,2282,O
likewise,2283,2291,O
stimulated,2292,2302,O
Mn2,2303,2306,O
uptake,2308,2314,O
rise,2325,2329,O
data,2344,2348,O
consistent,2363,2373,O
capacitative,2382,2394,O
coupling,2396,2404,O
model,2405,2410,O
activation,2424,2434,O
plasma,2442,2448,B-Cellular_component
membrane,2449,2457,I-Cellular_component
receptor,2458,2466,O
leads,2467,2472,O
InsP3,2479,2484,O
induced,2485,2492,O
change,2493,2499,O
degree,2507,2513,O
filling,2517,2524,O
ER,2532,2534,B-Cellular_component
pool,2538,2542,O
ABSTRACT,2544,2552,O
TRUNCATED,2553,2562,O
400,2566,2569,O
WORDS,2570,2575,O
Appetite,0,8,O
regulation,9,19,O
serotoninergic,23,37,O
mechanisms,38,48,O
effects,53,60,O
d,64,65,O
fenfluramine,66,78,O
literature,88,98,O
review,99,105,O
evidence,107,115,O
presented,119,128,O
theory,137,143,O
neurotransmitter,153,169,O
serotonin,171,180,O
5,182,183,O
hydroxytryptamine,184,201,O
5HT,203,206,O
medial,212,218,B-Multi-tissue_structure
hypothalamic,219,231,I-Multi-tissue_structure
centres,232,239,I-Multi-tissue_structure
important,246,255,O
regulator,256,265,O
appetite,270,278,O
selection,291,300,O
major,304,309,O
food,310,314,O
constituents,315,327,O
High,329,333,O
local,334,339,O
levels,340,346,O
5HT,350,353,O
cause,354,359,O
reduction,362,371,O
appetite,375,383,O
preference,390,400,O
protein,405,412,O
low,414,417,O
levels,418,424,O
opposite,429,437,O
main,443,447,O
antagonistic,448,460,O
system,461,467,O
noradrenergic,471,484,O
drug,490,494,O
d,495,496,O
fenfluramine,497,509,O
mimics,510,516,O
effects,521,528,O
5HT,532,535,O
releasing,539,548,O
5HT,549,552,O
serotoninergic,558,572,O
nerve,573,578,B-Multi-tissue_structure
endings,579,586,O
inhibiting,591,601,O
neuronal,606,614,B-Cell
uptake,618,624,O
experimental,634,646,O
data,647,651,O
prove,652,657,O
high,665,669,O
carbohydrate,670,682,O
low,684,687,O
protein,688,695,O
diet,696,700,O
promotes,701,709,O
uptake,710,716,O
serum,720,725,B-Organism_substance
tryptophan,726,736,O
brain,744,749,B-Organ
conversion,758,768,O
5HT,774,777,O
serotoninergic,791,805,O
system,806,812,O
function,817,825,O
self,831,835,O
regulatory,836,846,O
mechanism,847,856,O
patients,861,869,O
decreased,875,884,O
peripheral,885,895,O
insulin,896,903,O
sensitivity,904,915,O
system,921,927,O
disturbed,935,944,O
causing,946,953,O
overconsumption,954,969,O
carbohydrates,973,986,O
compulsive,1006,1016,O
carbohydrate,1019,1031,O
craving,1032,1039,O
presumed,1053,1061,O
treatment,1074,1083,O
obesity,1087,1094,O
addition,1099,1107,O
use,1115,1118,O
serotoninergic,1122,1136,O
drugs,1137,1142,O
successes,1144,1153,O
reducing,1159,1167,O
diets,1168,1173,O
enhanced,1181,1189,O
including,1193,1202,O
periods,1203,1210,O
high,1214,1218,O
carbohydrate,1219,1231,O
low,1233,1236,O
protein,1237,1244,O
intake,1245,1251,O
worthwhile,1265,1275,O
explore,1279,1286,O
similar,1295,1302,O
alimentary,1303,1313,O
self,1314,1318,O
regulatory,1319,1329,O
mechanisms,1330,1340,O
neurotransmitter,1344,1360,O
function,1361,1369,O
exist,1370,1375,O
regulatory,1385,1395,O
systems,1396,1403,O
Preliminary,1,12,O
results,13,20,O
observing,24,33,O
18,34,36,O
cases,37,42,O
retinoblastoma,46,60,B-Pathological_formation
carried,61,68,O
international,80,93,O
research,94,102,O
program,103,110,O
RICS,111,115,O
years,125,130,O
1988,131,135,O
1989,136,140,O
Ophthalmological,146,162,O
Clinic,163,169,O
Cracow,173,179,O
took,180,184,O
International,197,210,O
Research,211,219,O
Programme,220,229,O
Retinoblastoma,233,247,B-Pathological_formation
28,258,260,O
clinical,261,269,O
centres,270,277,O
14,281,283,O
countries,284,293,O
study,299,304,O
included,305,313,O
18,314,316,O
children,317,325,O
retinoblastoma,331,345,B-Pathological_formation
cases,355,360,O
advanced,368,376,O
stadium,377,384,O
disease,392,399,O
rule,406,410,O
eyes,416,420,B-Organ
filled,421,427,O
tumours,433,440,B-Pathological_formation
enucleated,446,456,O
advanced,471,479,O
cases,480,485,O
treated,491,498,O
combined,504,512,O
methods,513,520,O
applying,521,529,O
radiation,530,539,O
60Co,545,549,O
plaques,550,557,O
xenon,563,568,O
arc,569,572,O
photocoagulation,573,589,O
cryopexy,591,599,O
chemotherapy,605,617,O
18,622,624,O
treated,625,632,O
children,633,641,O
23,642,644,O
eyes,645,649,B-Organ
enucleated,655,665,O
5,670,671,O
children,672,680,O
eyes,686,690,B-Organ
6,695,696,O
children,697,705,O
bilateral,711,720,O
retinoblastoma,721,735,B-Pathological_formation
1,736,737,O
eye,738,741,B-Organ
7,747,748,O
eyes,749,753,B-Organ
unilateral,761,771,O
cases,772,777,O
eyes,784,788,B-Organ
advanced,799,807,O
lesions,808,815,B-Pathological_formation
treated,821,828,O
combined,834,842,O
methods,843,850,O
child,856,861,O
died,862,866,O
metastases,878,888,B-Pathological_formation
brain,896,901,B-Organ
obtained,907,915,O
data,916,920,O
reveal,921,927,O
retinoblastoma,933,947,B-Pathological_formation
diagnosed,951,960,O
late,965,969,O
decreases,977,986,O
chance,991,997,O
cure,1001,1005,O
causes,1010,1016,O
great,1017,1022,O
danger,1023,1029,O
life,1038,1042,O
child,1050,1055,O
Epilepsy,0,8,O
syndrome,17,25,O
clinical,27,35,O
aspects,36,43,O
possible,48,56,O
mechanisms,57,67,O
epilepsy,78,86,O
common,95,101,O
persons,105,112,O
trisomy,118,125,O
21,126,128,O
syndrome,135,143,O
general,157,164,O
population,165,175,O
mechanisms,181,191,O
seizures,201,209,O
generated,214,223,O
population,232,242,O
received,248,256,O
little,257,263,O
attention,264,273,O
likely,281,287,O
increased,298,307,O
seizure,308,315,O
susceptibility,316,330,O
combination,343,354,O
medical,358,365,O
risk,366,370,O
factors,371,378,O
inherent,383,391,O
neurologic,392,402,B-Anatomical_system
abnormalities,403,416,O
characteristic,417,431,O
syndrome,440,448,O
review,458,464,O
clinical,465,473,O
aspects,474,481,O
seizures,485,493,O
individuals,500,511,O
syndrome,522,530,O
described,536,545,O
possible,550,558,O
mechanisms,559,569,O
trisomy,583,590,O
21,591,593,O
brain,594,599,B-Organ
generate,604,612,O
seizures,613,621,O
explored,627,635,O
Chelation,0,9,O
treatment,10,19,O
neurological,23,35,B-Anatomical_system
Wilson,36,42,O
s,43,44,O
disease,45,52,O
results,58,65,O
chelation,69,78,O
treatment,79,88,O
137,92,95,O
patients,96,104,O
presenting,105,115,O
neurological,121,133,B-Anatomical_system
Wilson,134,140,O
s,141,142,O
disease,143,150,O
described,155,164,O
commonly,189,197,O
observed,198,206,O
toxic,207,212,O
reactions,213,222,O
drugs,238,243,O
employed,244,252,O
seven,260,265,O
patients,266,274,O
excellent,283,292,O
response,293,301,O
treatment,305,314,O
symptom,326,333,O
free,334,338,O
Thirty,340,346,O
patients,351,359,O
good,367,371,O
recovery,372,380,O
left,391,395,O
minor,406,411,O
neurological,412,424,B-Anatomical_system
deficit,425,432,O
patients,446,454,O
poor,461,465,O
response,466,474,O
disease,489,496,O
process,497,504,O
arrested,509,517,O
left,528,532,O
disabled,546,554,O
patients,563,571,O
died,572,576,O
little,587,593,O
treatment,600,609,O
11,615,617,O
died,618,622,O
despite,623,630,O
apparently,631,641,O
adequate,642,650,O
chelation,651,660,O
therapy,661,668,O
obvious,683,690,O
reason,691,697,O
failure,707,714,O
liver,720,725,B-Organ
copper,726,732,O
level,733,738,O
estimated,743,752,O
patients,769,777,O
significantly,792,805,O
elevated,806,814,O
possible,859,867,O
determination,880,893,O
concentration,899,912,O
copper,916,922,O
basal,930,935,B-Multi-tissue_structure
ganglia,936,943,I-Multi-tissue_structure
excess,951,957,O
45,961,963,O
micrograms,964,974,O
g,975,976,O
wet,977,980,O
weight,981,987,O
apparent,1000,1008,O
adequate,1013,1021,O
therapy,1022,1029,O
failed,1030,1036,O
remove,1040,1046,O
copper,1047,1053,O
brains,1063,1069,B-Organ
patients,1079,1087,O
obvious,1102,1109,O
clinical,1110,1118,O
histological,1120,1132,O
biochemical,1136,1147,O
indicator,1148,1157,O
failure,1161,1168,O
respond,1172,1179,O
treatment,1183,1192,O
Initial,1194,1201,O
deterioration,1202,1215,O
improvement,1223,1234,O
seen,1239,1243,O
30,1247,1249,O
patients,1250,1258,O
prognosis,1264,1273,O
useful,1280,1286,O
recovery,1287,1295,O
necessarily,1304,1315,O
worse,1316,1321,O
patients,1335,1343,O
phenomenon,1366,1376,O
Prehospital,1,12,O
service,13,20,O
Denmark,24,31,O
Denmark,37,44,O
emergency,46,55,O
ambulances,56,66,O
dispatched,71,81,O
41,85,87,O
centres,88,95,O
manned,96,102,O
trained,113,120,O
firemen,121,128,O
Copenhagen,133,143,O
policemen,148,157,O
outside,159,166,O
Copenhagen,167,177,O
1990,183,187,O
emergency,189,198,O
ambulance,199,208,O
calls,209,214,O
totalled,215,223,O
284,224,227,O
000,228,231,O
Utilisation,233,244,O
emergency,248,257,O
ambulance,258,267,O
services,268,276,O
increases,277,286,O
urbanisation,292,304,O
doctor,308,314,O
manned,315,321,O
ambulance,322,331,O
operation,338,347,O
Copenhagen,351,361,O
large,381,386,O
towns,387,392,O
anaesthesiology,393,408,O
intensive,413,422,O
care,423,427,O
teams,428,433,O
dispatched,441,451,O
hospital,457,465,O
spot,481,485,O
care,486,490,O
populated,500,509,O
areas,510,515,O
general,522,529,O
practitioners,530,543,O
advanced,549,557,O
life,558,562,O
support,563,570,O
areas,586,591,O
serviced,596,604,O
ambulances,608,618,O
equipped,619,627,O
defibrillators,633,647,O
majority,653,661,O
patients,665,673,O
receive,674,681,O
basic,687,692,O
life,693,697,O
support,698,705,O
ambulance,711,720,O
personnel,721,730,O
New,732,735,O
initiatives,736,747,O
resulting,748,757,O
recent,765,771,O
report,772,778,O
commission,784,794,O
appointed,795,804,O
central,808,815,O
authorities,816,827,O
focused,833,840,O
prehospital,844,855,O
treatment,856,865,O
expected,871,879,O
improve,883,890,O
service,895,902,O
raising,906,913,O
level,918,923,O
training,927,935,O
given,936,941,O
ambulance,945,954,O
personnel,955,964,O
Cell,0,4,B-Cellular_component
surface,5,12,I-Cellular_component
binding,13,20,O
characteristics,21,36,O
correlate,37,46,O
consensus,52,61,O
type,62,66,O
interferon,69,79,O
enhanced,80,88,O
activity,89,97,O
binding,103,110,O
characteristics,111,126,O
genetically,132,143,O
engineered,144,154,O
consensus,155,164,O
interferon,165,175,O
unusually,181,190,O
high,191,195,O
biologic,196,204,O
activity,205,213,O
compared,219,227,O
characteristics,235,250,O
recombinant,254,265,O
interferon,266,276,O
alpha,277,282,O
2,283,284,O
interferon,291,301,O
alpha,302,307,O
2,308,309,O
consensus,318,327,O
interferon,328,338,O
produced,339,347,O
typical,348,355,O
biphasic,356,364,O
Scatchard,365,374,O
plots,375,380,O
indicating,382,392,O
multiple,393,401,O
independent,402,413,O
binding,414,421,O
sites,422,427,O
consensus,433,442,O
interferon,443,453,O
exhibited,461,470,O
biologic,473,481,O
potency,482,489,O
10,500,502,O
fold,503,507,O
greater,508,515,O
type,531,535,O
interferons,538,549,O
exhibited,556,565,O
binding,566,573,O
site,574,578,O
affinities,579,589,O
greater,590,597,O
IFN,613,616,O
alpha,617,622,O
2b,623,625,O
addition,630,638,O
larger,642,648,O
number,649,655,O
high,659,663,O
low,669,672,O
affinity,673,681,O
cell,682,686,B-Cellular_component
surface,687,694,I-Cellular_component
sites,695,700,O
recognized,706,716,O
consensus,724,733,O
interferon,734,744,O
resulting,746,755,O
equivalent,759,769,O
numbers,770,777,O
sites,781,786,O
reduced,790,797,O
molar,798,803,O
concentrations,804,818,O
compared,819,827,O
IFN,831,834,O
a2b,835,838,O
given,853,858,O
biologic,859,867,O
activity,868,876,O
similar,878,885,O
numbers,886,893,O
sites,897,902,O
bound,908,913,O
consensus,921,930,O
interferon,931,941,O
IFN,946,949,O
alpha,950,955,O
2,956,957,O
despite,959,966,O
differences,967,978,O
molar,988,993,O
concentrations,994,1008,O
differences,1013,1024,O
internalization,1028,1043,O
kinetics,1044,1052,O
identified,1058,1068,O
interferons,1085,1096,O
indicating,1098,1108,O
differences,1118,1129,O
cell,1133,1137,B-Cellular_component
surface,1138,1145,I-Cellular_component
binding,1146,1153,O
sufficient,1161,1171,O
produce,1175,1182,O
differences,1187,1198,O
biologic,1202,1210,O
activity,1211,1219,O
Human,0,5,O
immunodeficiency,6,22,O
virus,23,28,O
type,29,33,O
1,34,35,O
viral,36,41,O
background,42,52,O
plays,53,58,O
major,61,66,O
role,67,71,O
development,75,86,O
resistance,90,100,O
protease,104,112,O
inhibitors,113,123,O
observed,129,137,O
vitro,141,146,O
vivo,154,158,O
benefit,159,166,O
combination,170,181,O
treatment,182,191,O
anti,197,201,O
human,202,207,O
immunodeficiency,208,224,O
virus,225,230,O
HIV,232,235,O
agents,237,243,O
prompted,244,252,O
examine,259,266,O
potential,271,280,O
resistance,284,294,O
development,295,306,O
protease,316,324,O
inhibitors,325,335,O
concurrently,345,357,O
Recombinant,359,370,O
HIV,371,374,O
1,375,376,O
NL4,378,381,O
3,382,383,O
proteases,385,394,O
containing,395,405,O
combined,406,414,O
resistance,415,425,O
mutations,426,435,O
associated,436,446,O
BMS,452,455,O
186318,456,462,O
77003,469,474,O
saquinavir,479,489,O
inactive,503,511,O
impaired,519,527,O
enzyme,528,534,O
activity,535,543,O
Subsequent,545,555,O
construction,556,568,O
HIV,572,575,O
1,576,577,O
NL4,579,582,O
3,583,584,O
proviral,586,594,O
clones,595,601,O
containing,602,612,O
mutations,622,631,O
yielded,632,639,O
viruses,640,647,O
severely,658,666,O
impaired,667,675,O
growth,679,685,O
nonviable,689,698,O
confirming,700,710,O
combination,716,727,O
therapy,728,735,O
advantageous,743,755,O
passage,766,773,O
BMS,777,780,O
186318,781,787,O
resistant,788,797,O
HIV,798,801,O
1,802,803,O
RF,805,807,O
presence,816,824,O
saquinavir,835,845,O
SC52151,849,856,O
represented,864,875,O
sequential,876,886,O
drug,887,891,O
treatment,892,901,O
produced,903,911,O
viable,912,918,O
viruses,919,926,O
resistant,927,936,O
BMS,945,948,O
186318,949,955,O
second,964,970,O
compound,971,979,O
predominant,985,996,O
breakthrough,997,1009,O
virus,1010,1015,O
contained,1016,1025,O
G48V,1030,1034,O
A71 T,1035,1039,O
V82A,1040,1044,O
protease,1045,1053,O
mutations,1054,1063,O
clone,1069,1074,O
purified,1075,1083,O
RF,1084,1086,O
G48V,1088,1092,O
A71 T,1093,1097,O
V82A,1098,1102,O
virus,1104,1109,O
unlike,1111,1117,O
corresponding,1122,1135,O
defective,1136,1145,O
NL4,1146,1149,O
3,1150,1151,O
triple,1152,1158,O
mutant,1159,1165,O
grew,1167,1171,O
displayed,1181,1190,O
cross,1191,1196,O
resistance,1197,1207,O
distinct,1216,1224,O
protease,1225,1233,O
inhibitors,1234,1244,O
Chimeric,1246,1254,O
virus,1255,1260,O
vitro,1268,1273,O
mutagenesis,1274,1285,O
studies,1286,1293,O
indicated,1294,1303,O
RF,1313,1315,O
specific,1316,1324,O
protease,1325,1333,O
sequence,1334,1342,O
specifically,1344,1356,O
Ile,1361,1364,O
residue,1368,1375,O
10,1376,1378,O
enabled,1380,1387,O
NL4,1392,1395,O
3,1396,1397,O
strain,1398,1404,O
triple,1414,1420,O
mutant,1421,1427,O
grow,1431,1435,O
results,1441,1448,O
clearly,1449,1456,O
indicate,1457,1465,O
viral,1471,1476,O
genetic,1477,1484,O
background,1485,1495,O
play,1501,1505,O
key,1508,1511,O
role,1512,1516,O
determining,1520,1531,O
cross,1540,1545,O
resistance,1546,1556,O
variants,1557,1565,O
arise,1571,1576,O
Referral,0,8,O
bias,9,13,O
health,20,26,O
workers,27,34,O
studies,38,45,O
hospitalization,52,67,O
proxy,73,78,O
measure,79,86,O
underlying,94,104,O
incidence,105,114,O
rate,115,119,O
Contacts,121,129,O
health,135,141,O
services,142,150,O
like,151,155,O
hospitals,156,165,O
general,169,176,O
practitioners,177,190,O
usually,195,202,O
available,212,221,O
proxy,222,227,O
measure,228,235,O
incidence,239,248,O
disease,252,259,O
studies,263,270,O
based,271,276,O
secondary,280,289,O
data,290,294,O
differential,299,311,O
referrals,312,321,O
care,325,329,O
seeking,330,337,O
behavior,338,346,O
bias,353,357,O
proxy,363,368,O
measures,369,377,O
analyses,389,397,O
based,398,403,O
Occupational,411,423,O
Hospitalization,424,439,O
Register,440,448,O
Denmark,452,459,O
assisting,460,469,O
nurses,470,476,O
high,481,485,O
Standardized,486,498,O
Hospitalization,499,514,O
Ratios,515,521,O
diseases,531,539,O
suspected,558,567,O
fully,576,581,O
partly,585,591,O
referral,605,613,O
bias,614,618,O
self,622,626,O
selection,627,636,O
hospital,640,648,O
treatment,649,658,O
exposures,671,680,O
occupational,684,696,O
hazards,697,704,O
aim,710,713,O
present,721,728,O
study,729,734,O
evaluate,741,749,O
referral,754,762,O
bias,763,767,O
hypothesis,768,778,O
comparing,782,791,O
hospitalization,792,807,O
mortality,812,821,O
data,822,826,O
health,831,837,O
workers,838,845,O
disease,852,859,O
category,860,868,O
high,876,880,O
mortality,881,890,O
Cohorts,892,899,O
gainfully,907,916,O
employed,917,925,O
20,926,928,O
59,933,935,O
year,936,940,O
old,941,944,O
Danes,945,950,O
formed,956,962,O
order,966,971,O
compare,975,982,O
Standardized,983,995,O
Mortality,996,1005,O
Ratios,1006,1012,O
Standardized,1017,1029,O
Hospitalization,1030,1045,O
Ratios,1046,1052,O
ischemic,1056,1064,O
heart,1065,1070,B-Organ
disease,1071,1078,O
IHD,1080,1083,O
occupational,1088,1100,O
groups,1101,1107,O
follow,1113,1119,O
period,1123,1129,O
10,1134,1136,O
years,1137,1142,O
investigated,1160,1172,O
occupational,1173,1185,O
groups,1186,1192,O
similar,1195,1202,O
disease,1203,1210,O
pattern,1211,1218,O
found,1223,1228,O
hospitalization,1237,1252,O
death,1256,1261,O
outcome,1278,1285,O
measure,1286,1293,O
nurse,1299,1304,O
assistants,1305,1315,O
statistically,1319,1332,O
significant,1333,1344,O
higher,1345,1351,O
risk,1352,1356,O
found,1371,1376,O
hospitalization,1383,1398,O
IHD,1406,1409,O
end,1417,1420,O
point,1421,1426,O
mortality,1439,1448,O
Additional,1450,1460,O
analysis,1461,1469,O
support,1478,1485,O
hypothesis,1490,1500,O
finding,1510,1517,O
explained,1527,1536,O
differentiated,1540,1554,O
hospitalization,1555,1570,O
social,1578,1584,O
factors,1585,1592,O
true,1598,1602,O
incidence,1603,1612,O
rates,1613,1618,O
disease,1626,1633,O
need,1634,1638,O
equally,1646,1653,O
described,1659,1668,O
proxy,1672,1677,O
measures,1678,1686,O
hospitalization,1695,1710,O
diagnosis,1711,1720,O
death,1724,1729,O
diagnosis,1730,1739,O
occupational,1747,1759,O
groups,1760,1766,O
Differential,1768,1780,O
access,1781,1787,O
medical,1791,1798,O
treatment,1799,1808,O
groups,1817,1823,O
lead,1828,1832,O
bias,1836,1840,O
hospital,1846,1854,O
data,1855,1859,O
proxy,1872,1877,O
measures,1878,1886,O
underlying,1895,1905,O
incidence,1906,1915,O
rates,1916,1921,O
Induction,0,9,O
p18INK4c,13,21,O
predominant,30,41,O
association,42,53,O
CDK4,59,63,O
CDK6,68,72,O
myogenic,80,88,O
differentiation,89,104,O
Terminal,106,114,O
cell,115,119,B-Cell
differentiation,120,135,O
involves,136,144,O
permanent,145,154,O
withdrawal,155,165,O
cell,175,179,B-Cell
division,180,188,O
cycle,189,194,O
inhibitors,200,210,O
cyclin,214,220,O
dependent,221,230,O
kinases,231,238,O
CDKs,240,244,O
potential,250,259,O
molecules,260,269,O
functioning,270,281,O
couple,285,291,O
cell,292,296,B-Cell
cycle,297,302,O
arrest,303,309,O
cell,314,318,B-Cell
differentiation,319,334,O
murine,339,345,O
C2C12,346,351,B-Cell
myoblast,352,360,I-Cell
cells,361,366,I-Cell
G1,368,370,O
CDK,371,374,O
enzymes,375,382,O
CDK2,384,388,O
CDK4,390,394,O
CDK6,400,404,O
associate,406,415,O
CDK,426,429,O
inhibitors,430,440,O
p18INK4c,442,450,O
p19INK4d,452,460,O
p21,462,465,O
p27Kip1,471,478,O
induced,487,494,O
myogenesis,495,505,O
p21,507,510,O
associated,519,529,O
CDK,530,533,O
proteins,534,542,O
underwent,543,552,O
initial,556,563,O
increase,564,572,O
followed,573,581,O
decrease,587,595,O
cells,599,604,B-Cell
terminally,612,622,O
differentiated,623,637,O
level,643,648,O
p27,652,655,O
protein,656,663,O
gradually,664,673,O
increased,674,683,O
total,703,708,O
associated,709,719,O
CDK,720,723,O
proteins,724,732,O
remained,733,741,O
unchanged,742,751,O
p19,753,756,O
protein,757,764,O
decreased,765,774,O
gradually,775,784,O
differentiation,792,807,O
associated,820,830,O
CDK4,831,835,O
protein,836,843,O
contrast,848,856,O
p18,858,861,O
protein,862,869,O
increased,870,879,O
50,880,882,O
fold,883,887,O
negligible,894,904,O
levels,905,911,O
proliferating,915,928,O
myoblasts,929,938,B-Cell
clearly,942,949,O
detectable,950,960,O
levels,961,967,O
8,975,976,O
12,977,979,O
h,980,981,O
myogenic,985,993,O
induction,994,1003,O
initial,1010,1017,O
rise,1018,1022,O
followed,1027,1035,O
precipitous,1041,1052,O
increase,1053,1061,O
12,1070,1072,O
24,1077,1079,O
h,1080,1081,O
postinduction,1082,1095,O
p18,1102,1105,O
protein,1106,1113,O
finally,1114,1121,O
accumulating,1122,1134,O
highest,1142,1149,O
level,1150,1155,O
terminally,1159,1169,O
differentiated,1170,1184,O
cells,1185,1190,B-Cell
Induction,1192,1201,O
p18,1205,1208,O
correlated,1209,1219,O
increased,1225,1234,O
sequential,1239,1249,O
complex,1250,1257,O
formation,1258,1267,O
increasing,1275,1285,O
association,1286,1297,O
CDK6,1303,1307,O
CDK4,1322,1326,O
course,1336,1342,O
myogenic,1346,1354,O
differentiation,1355,1370,O
CDK6,1383,1387,O
half,1392,1396,O
CDK4,1404,1408,O
complexed,1414,1423,O
p18,1429,1432,O
terminally,1436,1446,O
differentiated,1447,1461,O
C2C12,1462,1467,B-Cell
cells,1468,1473,I-Cell
adult,1488,1493,O
mouse,1494,1499,O
muscle,1500,1506,B-Tissue
tissue,1507,1513,I-Tissue
Finally,1515,1522,O
kinase,1524,1530,O
activity,1531,1539,O
CDK2,1543,1547,O
CDK4,1552,1556,O
decreases,1557,1566,O
C2C12,1570,1575,B-Cell
cells,1576,1581,I-Cell
differentiate,1582,1595,O
CDK6,1609,1613,O
kinase,1614,1620,O
activity,1621,1629,O
low,1633,1636,O
proliferating,1645,1658,O
myoblasts,1659,1668,B-Cell
differentiated,1673,1687,O
myotubes,1688,1696,B-Tissue
results,1702,1709,O
indicate,1710,1718,O
p18,1724,1727,O
play,1732,1736,O
critical,1739,1747,O
role,1748,1752,O
causing,1756,1763,O
maintaining,1771,1782,O
permanent,1783,1792,O
cell,1793,1797,B-Cell
cycle,1798,1803,O
arrest,1804,1810,O
associated,1811,1821,O
mature,1827,1833,O
muscle,1834,1840,B-Tissue
formation,1841,1850,O
Functional,0,10,O
model,11,16,O
benign,20,26,O
paroxysmal,27,37,O
positional,38,48,O
vertigo,49,56,O
isolated,66,74,O
frog,75,79,O
semicircular,80,92,B-Multi-tissue_structure
canal,93,98,I-Multi-tissue_structure
Bull,100,104,O
frogs,105,110,O
posterior,111,120,B-Multi-tissue_structure
semicircular,121,133,I-Multi-tissue_structure
canals,134,140,I-Multi-tissue_structure
psc,142,145,B-Multi-tissue_structure
wee,147,150,O
simulate,159,167,O
condition,172,181,O
benign,185,191,O
paroxysmal,192,202,O
positional,203,213,O
vertigo,214,221,O
BPPV,223,227,O
psc,234,237,B-Multi-tissue_structure
isolated,242,250,O
frog,254,258,O
Ringer,259,265,O
s,266,267,O
solution,268,276,O
saccular,286,294,B-Organism_substance
otoconia,295,303,I-Organism_substance
responsible,319,330,O
material,331,339,O
stimulate,343,352,O
cupula,357,363,B-Multi-tissue_structure
otoconia,374,382,B-Organism_substance
placed,388,394,O
cupular,402,409,B-Multi-tissue_structure
surface,410,417,I-Multi-tissue_structure
mimic,421,426,O
condition,431,440,O
cupulolithiasis,444,459,O
psc,465,468,B-Multi-tissue_structure
ampullary,469,478,I-Multi-tissue_structure
nerve,479,484,I-Multi-tissue_structure
action,485,491,O
potentials,492,502,O
instantaneously,503,518,O
changed,519,526,O
according,527,536,O
direction,544,553,O
gravity,561,568,O
produced,569,577,O
otoconia,581,589,B-Organism_substance
otoconia,600,608,B-Organism_substance
dropped,614,621,O
canal,631,636,B-Multi-tissue_structure
mimic,640,645,O
condition,650,659,O
moving,663,669,O
otoconia,670,678,B-Organism_substance
canal,686,691,B-Multi-tissue_structure
action,697,703,O
potentials,704,714,O
changed,715,722,O
otoconial,741,750,B-Organism_substance
flow,751,755,O
latent,764,770,O
period,771,777,O
cupulolithiasis,784,799,O
moving,804,810,O
otoconia,811,819,B-Organism_substance
possibly,824,832,O
valid,833,838,O
mechanisms,839,849,O
BPPV,853,857,O
effectively,870,881,O
stimulate,882,891,O
cupula,896,902,B-Multi-tissue_structure
moving,913,919,O
otoconia,920,928,B-Organism_substance
latent,936,942,O
period,943,949,O
better,956,962,O
explain,963,970,O
clinical,971,979,O
features,980,988,O
BPPV,992,996,O
Considerations,1,15,O
cases,30,35,O
macromastia,39,50,O
author,52,58,O
s,59,60,O
transl,61,67,O
cases,75,80,O
macromastia,84,95,O
shown,106,111,O
appeared,123,131,O
puberty,139,146,O
menopause,165,174,O
Histopathological,176,193,O
examination,194,205,O
demonstrated,210,222,O
cases,236,241,O
cystic,244,250,O
degeneracy,251,261,O
glandular,269,278,B-Tissue
tissue,279,285,I-Tissue
hyperplazia,293,304,O
hypertrophy,309,320,O
conjunctive,328,339,B-Tissue
tissue,340,346,I-Tissue
pathogeny,352,361,O
macromastia,365,376,O
discussed,386,395,O
demonstrated,406,418,O
role,428,432,O
hypophysis,436,446,O
hormones,447,455,O
prolactine,457,467,O
growth,472,478,O
hormone,479,486,O
ovarian,495,502,B-Organ
hormones,503,511,O
estrogens,513,522,O
treatment,529,538,O
surgical,543,551,O
cases,565,570,O
Procedural,0,10,O
memory,11,17,O
stimulation,18,29,O
Alzheimer,33,42,O
s,43,44,O
disease,45,52,O
impact,54,60,O
training,66,74,O
programme,75,84,O
study,90,95,O
evaluates,96,105,O
efficacy,110,118,O
procedural,124,134,O
memory,135,141,O
stimulation,142,153,O
programme,154,163,O
mild,167,171,O
mild,176,180,O
moderate,181,189,O
Alzheimer,190,199,O
s,200,201,O
disease,202,209,O
AD,211,213,O
basic,223,228,O
instrumental,233,245,O
activities,246,256,O
daily,260,265,O
living,266,272,O
selected,283,291,O
divided,297,304,O
groups,314,320,O
comparable,322,332,O
difficulty,337,347,O
normal,353,359,O
elderly,360,367,O
subjects,368,376,O
age,378,381,O
68,382,384,O
0,385,386,O
4,391,392,O
8,393,394,O
years,395,400,O
MMSE,402,406,O
score,407,412,O
28,414,416,O
7,417,418,O
0,423,424,O
9,425,426,O
education,428,437,O
7,439,440,O
6,441,442,O
3,447,448,O
5,449,450,O
years,451,456,O
asked,463,468,O
perform,472,479,O
groups,488,494,O
daily,498,503,O
activities,504,514,O
time,523,527,O
required,528,536,O
perform,540,547,O
tasks,552,557,O
group,566,571,O
recorded,576,584,O
reference,599,608,O
mild,614,618,O
mild,623,627,O
moderate,628,636,O
AD,637,639,O
patients,640,648,O
age,650,653,O
77,654,656,O
2,657,658,O
5,663,664,O
3,665,666,O
years,667,672,O
MMSE,674,678,O
score,679,684,O
19,686,688,O
8,689,690,O
3,695,696,O
5,697,698,O
education,700,709,O
7,711,712,O
3,713,714,O
4,719,720,O
7,721,722,O
years,723,728,O
major,738,743,O
behavioural,744,755,O
disturbances,756,768,O
constituted,769,780,O
experimental,785,797,O
group,798,803,O
Patients,805,813,O
evaluated,819,828,O
20,836,838,O
daily,839,844,O
activities,845,855,O
time,864,868,O
employed,869,877,O
recorded,882,890,O
baseline,894,902,O
3,915,916,O
week,917,921,O
training,922,930,O
1,932,933,O
h,934,935,O
d,936,937,O
5,939,940,O
d,941,942,O
week,943,947,O
period,949,955,O
patients,962,970,O
trained,976,983,O
3,995,996,O
weeks,997,1002,O
half,1006,1010,O
20,1018,1020,O
daily,1021,1026,O
activities,1027,1037,O
patients,1057,1065,O
trained,1071,1078,O
remainder,1086,1095,O
procedure,1102,1111,O
adopted,1116,1123,O
order,1127,1132,O
detect,1136,1142,O
separately,1143,1153,O
improvement,1158,1169,O
trained,1174,1181,O
trained,1192,1199,O
activities,1201,1211,O
allowing,1213,1221,O
control,1225,1232,O
better,1233,1239,O
effects,1244,1251,O
intervention,1259,1271,O
assessment,1277,1287,O
functional,1295,1305,O
impact,1306,1312,O
training,1320,1328,O
directly,1333,1341,O
measured,1342,1350,O
variation,1364,1373,O
time,1377,1381,O
employed,1382,1390,O
perform,1394,1401,O
tasks,1402,1407,O
training,1425,1433,O
3,1441,1442,O
weeks,1443,1448,O
training,1452,1460,O
significant,1463,1474,O
improvement,1475,1486,O
observed,1491,1499,O
trained,1508,1515,O
activities,1516,1526,O
3,1533,1534,O
6,1535,1536,O
1,1540,1541,O
9,1542,1543,O
standard,1544,1552,O
deviations,1553,1563,O
performance,1574,1585,O
normal,1593,1599,O
elderly,1600,1607,O
controls,1608,1616,O
P,1618,1619,O
0,1622,1623,O
05,1624,1626,O
AD,1629,1631,O
patients,1632,1640,O
improved,1641,1649,O
trained,1662,1669,O
activities,1670,1680,O
3,1686,1687,O
5,1688,1689,O
2,1693,1694,O
7,1695,1696,O
standard,1697,1705,O
deviations,1706,1716,O
controls,1727,1735,O
performance,1737,1748,O
P,1750,1751,O
0,1754,1755,O
05,1756,1758,O
rehabilitation,1765,1779,O
activities,1783,1793,O
daily,1797,1802,O
living,1803,1809,O
developing,1818,1828,O
procedural,1829,1839,O
memory,1840,1846,O
strategies,1847,1857,O
effective,1865,1874,O
mild,1878,1882,O
mild,1887,1891,O
moderate,1892,1900,O
AD,1901,1903,O
patients,1904,1912,O
findings,5,13,O
concerning,14,24,O
beliefs,25,32,O
alcoholism,39,49,O
beliefs,55,62,O
alcoholics,68,78,O
hold,79,83,O
alcoholism,90,100,O
beliefs,125,132,O
hospital,138,146,O
staff,147,152,O
personnel,163,172,O
hold,173,177,O
alcoholism,184,194,O
investigated,201,213,O
methods,220,227,O
derived,228,235,O
repertory,245,254,O
grid,255,259,O
anonymous,266,275,O
facial,276,282,B-Organism_subdivision
photographs,283,294,O
elements,298,306,O
Data,308,312,O
presented,317,326,O
degree,337,343,O
association,347,358,O
characteristics,370,385,O
alcoholism,391,401,O
groups,418,424,O
Differences,426,437,O
groups,446,452,O
overall,458,465,O
changes,466,473,O
group,481,486,O
psychotherapy,487,500,O
patients,505,513,O
small,519,524,O
relative,530,538,O
contribution,539,551,O
personal,555,563,O
shared,568,574,O
aspects,575,582,O
belief,586,592,O
measured,597,605,O
found,614,619,O
agreement,629,638,O
groups,647,653,O
high,658,662,O
closely,667,674,O
similar,675,682,O
predictable,691,702,O
consistencies,708,721,O
groups,729,735,O
concluded,743,752,O
general,778,785,O
stereotype,786,796,O
alcoholism,800,810,O
consistent,812,822,O
personality,830,841,O
disorder,842,850,O
concept,851,858,O
implicitly,868,878,O
held,879,883,O
face,896,900,O
nominal,904,911,O
acceptance,912,922,O
concepts,932,940,O
self,946,950,O
constructs,951,961,O
alcoholics,965,975,O
found,981,986,O
complex,993,1000,O
small,1007,1012,O
follow,1013,1019,O
study,1023,1028,O
patients,1032,1040,O
found,1052,1057,O
relationship,1066,1078,O
poor,1082,1086,O
outcome,1087,1094,O
tightness,1100,1109,O
construing,1113,1123,O
key,1128,1131,O
constructs,1132,1142,O
psychotherapy,1149,1162,O
implications,1168,1180,O
findings,1188,1196,O
discussed,1201,1210,O
briefly,1211,1218,O
Monitoring,0,10,O
efficiency,15,25,O
interferon,29,39,O
alpha,40,45,O
therapy,46,53,O
chronic,57,64,O
myelogenous,65,76,O
leukemia,77,85,O
CML,87,90,O
patients,92,100,O
competitive,104,115,O
polymerase,116,126,O
chain,127,132,O
reaction,133,141,O
Interferon,143,153,O
alpha,154,159,O
IFN,161,164,O
alpha,165,170,O
induces,172,179,O
cytogenetic,180,191,O
responses,192,201,O
variable,205,213,O
degree,214,220,O
patients,224,232,O
CML,238,241,O
sought,246,252,O
establish,256,265,O
relationship,270,282,O
BCR,291,294,O
ABL,295,298,O
transcript,299,309,O
numbers,310,317,O
measured,318,326,O
competitive,330,341,O
step,346,350,O
reverse,351,358,O
transcription,359,372,O
polymerase,373,383,O
chain,384,389,O
reaction,390,398,O
RT,400,402,O
PCR,403,406,O
cytogenetic,412,423,O
status,424,430,O
CML,434,437,O
patients,438,446,O
treated,447,454,O
IFN,460,463,O
alpha,464,469,O
398,475,478,O
samples,479,486,O
163,492,495,O
patients,496,504,O
investigated,505,517,O
RT,521,523,O
PCR,524,527,O
positive,533,541,O
BCR,546,549,O
ABL,550,553,O
transcripts,554,565,O
order,570,575,O
standardize,579,590,O
results,591,598,O
variability,603,614,O
RNA,618,621,O
cDNA,626,630,O
quality,631,638,O
quantified,643,653,O
total,654,659,O
ABL,660,663,O
transcripts,664,675,O
sample,684,690,O
internal,694,702,O
control,703,710,O
BCR,716,719,O
ABL,720,723,O
ABL,724,727,O
ratios,728,734,O
correlated,735,745,O
cytogenetic,755,766,O
results,767,774,O
Quantitative,776,788,O
nested,789,795,O
PCR,796,799,O
allowed,800,807,O
detection,812,821,O
residual,825,833,O
BCR,834,837,O
ABL,838,841,O
transcripts,842,853,O
complete,861,869,O
cytogenetic,870,881,O
responders,882,892,O
IFN,896,899,O
alpha,900,905,O
conclude,910,918,O
competitive,924,935,O
PCR,936,939,O
internal,945,953,O
controls,954,962,O
reliable,968,976,O
method,977,983,O
monitoring,988,998,O
patients,999,1007,O
IFN,1011,1014,O
alpha,1015,1020,O
reduces,1025,1032,O
need,1037,1041,O
repeated,1046,1054,O
marrow,1055,1061,B-Multi-tissue_structure
investigations,1062,1076,O
Treatment,1,10,O
acute,14,19,O
liver,20,25,B-Organ
failure,26,33,O
children,37,45,O
main,58,62,O
causes,63,69,O
acute,73,78,O
liver,79,84,B-Organ
failure,85,92,O
ALF,94,97,O
children,102,110,O
metabolic,112,121,O
diseases,122,130,O
especially,132,142,O
infants,146,153,O
viral,156,161,O
toxin,166,171,O
drug,175,179,O
induced,180,187,O
hepatitis,188,197,O
frequent,211,219,O
cause,225,230,O
remains,231,238,O
undetermined,249,261,O
30,271,273,O
cases,282,287,O
Management,289,299,O
conducted,308,317,O
pediatric,323,332,O
hepatology,333,343,O
unit,344,348,O
intensive,352,361,O
care,362,366,O
unit,367,371,O
relation,375,383,O
pediatric,391,400,O
transplant,401,411,O
team,412,416,O
order,420,425,O
1,427,428,O
perform,433,440,O
urgent,441,447,O
etiological,448,459,O
diagnosis,460,469,O
2,471,472,O
initiate,477,485,O
specific,486,494,O
therapy,495,502,O
symptomatic,507,518,O
treatment,519,528,O
3,530,531,O
evaluate,536,544,O
severity,549,557,O
prognosis,562,571,O
liver,575,580,B-Organ
disease,581,588,O
selection,593,602,O
children,606,614,O
emergency,619,628,O
liver,629,634,B-Organ
transplantation,635,650,O
4,652,653,O
evaluate,658,666,O
contraindications,667,684,O
liver,688,693,B-Organ
transplantation,694,709,O
overall,715,722,O
survival,723,731,O
post,735,739,O
emergency,740,749,O
liver,750,755,B-Organ
transplantation,756,771,O
ALF,776,779,O
children,783,791,O
averages,792,800,O
65,801,803,O
Blind,0,5,O
separation,6,16,O
auditory,20,28,O
event,29,34,O
related,35,42,O
brain,43,48,B-Organ
responses,49,58,O
independent,64,75,O
components,76,86,O
Averaged,88,96,O
event,97,102,O
related,103,110,O
potential,111,120,O
ERP,122,125,O
data,127,131,O
recorded,132,140,O
human,150,155,O
scalp,156,161,B-Multi-tissue_structure
reveal,162,168,O
electroencephalographic,169,192,O
EEG,194,197,O
activity,199,207,O
reliably,216,224,O
time,225,229,O
locked,230,236,O
phase,241,246,O
locked,247,253,O
experimental,257,269,O
events,270,276,O
report,281,287,O
application,297,308,O
method,314,320,O
based,321,326,O
information,330,341,O
theory,342,348,O
decomposes,354,364,O
ERPs,377,381,O
recorded,382,390,O
multiple,394,402,O
scalp,403,408,B-Multi-tissue_structure
sensors,409,416,O
sum,424,427,O
components,431,441,O
fixed,447,452,O
scalp,453,458,B-Multi-tissue_structure
distributions,459,472,O
sparsely,477,485,O
activated,486,495,O
maximally,497,506,O
independent,507,518,O
time,519,523,O
courses,524,531,O
Independent,533,544,O
component,545,554,O
analysis,555,563,O
ICA,565,568,O
decomposes,570,580,O
ERP,581,584,O
data,585,589,O
number,597,603,O
components,607,617,O
equal,618,623,O
number,631,637,O
sensors,641,648,O
derived,654,661,O
components,662,672,O
distinct,678,686,O
necessarily,695,706,O
orthogonal,707,717,O
scalp,718,723,B-Multi-tissue_structure
projections,724,735,O
Unlike,737,743,O
dipole,744,750,O
fitting,751,758,O
methods,759,766,O
algorithm,772,781,O
model,791,796,O
locations,801,810,O
generators,820,830,O
head,838,842,B-Organism_subdivision
Unlike,844,850,O
methods,851,858,O
remove,864,870,O
second,871,877,O
order,878,883,O
correlations,884,896,O
principal,906,915,O
component,916,925,O
analysis,926,934,O
PCA,936,939,O
ICA,942,945,O
minimizes,951,960,O
higher,961,967,O
order,968,973,O
dependencies,974,986,O
Applied,988,995,O
detected,999,1007,O
undetected,1012,1022,O
target,1023,1029,O
ERPs,1030,1034,O
auditory,1043,1051,O
vigilance,1052,1061,O
experiment,1062,1072,O
algorithm,1078,1087,O
derived,1088,1095,O
components,1100,1110,O
decomposed,1116,1126,O
major,1139,1144,O
response,1145,1153,O
peaks,1154,1159,O
ICA,1177,1180,O
components,1181,1191,O
relatively,1197,1207,O
simple,1208,1214,O
scalp,1215,1220,B-Multi-tissue_structure
distributions,1221,1234,O
components,1251,1261,O
active,1267,1273,O
subject,1288,1295,O
detected,1296,1304,O
targets,1309,1316,O
components,1330,1340,O
target,1355,1361,O
went,1362,1366,O
undetected,1367,1377,O
cases,1395,1400,O
additional,1408,1418,O
components,1419,1429,O
accounted,1430,1439,O
steady,1448,1454,O
state,1455,1460,O
brain,1461,1466,B-Organ
response,1467,1475,O
39,1481,1483,O
Hz,1484,1486,O
background,1487,1497,O
click,1498,1503,O
train,1504,1509,O
Major,1511,1516,O
features,1517,1525,O
decomposition,1533,1546,O
proved,1547,1553,O
robust,1554,1560,O
sessions,1568,1576,O
changes,1581,1588,O
sensor,1592,1598,O
number,1599,1605,O
placement,1610,1619,O
method,1626,1632,O
ERP,1636,1639,O
analysis,1640,1648,O
compare,1664,1671,O
responses,1672,1681,O
multiple,1687,1695,O
stimuli,1696,1703,O
task,1705,1709,O
conditions,1710,1720,O
subject,1726,1733,O
states,1734,1740,O
Extra,1,6,O
anatomic,7,15,O
bypass,16,22,O
ascending,32,41,B-Multi-tissue_structure
aorta,42,47,I-Multi-tissue_structure
supraceliac,55,66,O
abdominal,67,76,B-Multi-tissue_structure
aorta,77,82,I-Multi-tissue_structure
surgical,84,92,O
option,93,99,O
applied,100,107,O
reoperation,111,122,O
aortic,127,133,B-Multi-tissue_structure
coarctation,134,145,O
interruption,149,161,O
optimal,168,175,O
approach,176,184,O
reoperation,189,200,O
following,201,210,O
repair,211,217,O
aortic,221,227,B-Multi-tissue_structure
coarctation,228,239,O
CoA,241,244,O
interruption,249,261,O
IAA,263,266,O
remains,268,275,O
controversial,276,289,O
patients,296,304,O
underwent,305,314,O
extra,315,320,O
anatomic,321,329,O
bypass,330,336,O
restenosis,341,351,O
repair,358,364,O
CoA,368,371,O
IAA,375,378,O
age,384,387,O
ranged,388,394,O
4,400,401,O
12,405,407,O
years,408,413,O
initial,419,426,O
repairs,427,434,O
CoA,443,446,O
type,452,456,O
IAA,459,462,O
type,472,476,O
B,477,478,O
IAA,479,482,O
consisted,483,492,O
grafting,500,508,O
subclavian,514,524,O
arterial,525,533,B-Multi-tissue_structure
turning,534,541,O
aortoplasty,547,558,O
subclavian,568,578,O
flap,579,583,B-Multi-tissue_structure
aortoplasty,584,595,O
underwent,609,618,O
infancy,626,633,O
Preoperative,635,647,O
right,648,653,B-Organism_subdivision
arm,654,657,I-Organism_subdivision
systolic,658,666,O
pressure,667,675,O
ranged,676,682,O
140,688,691,O
190,695,698,O
mmHg,699,703,O
ar,704,706,O
rest,707,711,O
midline,723,730,O
sternotomy,731,741,O
upper,749,754,O
laparotmy,755,764,O
incision,765,773,O
extra,778,783,O
anatomic,784,792,O
bypass,793,799,O
ascending,809,818,B-Multi-tissue_structure
aorta,819,824,I-Multi-tissue_structure
supraceliac,832,843,O
abdominal,844,853,B-Multi-tissue_structure
aorta,854,859,I-Multi-tissue_structure
employed,864,872,O
12,881,883,O
18,887,889,O
mm,890,892,O
tube,893,897,O
graft,898,903,O
patients,909,917,O
survived,918,926,O
surgeries,927,936,O
hypertension,948,960,O
markedly,961,969,O
improved,970,978,O
experience,984,994,O
confirms,995,1003,O
safety,1004,1010,O
effectiveness,1015,1028,O
option,1037,1043,O
selected,1047,1055,O
young,1056,1061,O
patients,1062,1070,O
stenosis,1079,1087,O
following,1091,1100,O
repair,1101,1107,O
CoA,1111,1114,O
IAA,1118,1121,O
Effect,0,6,O
mutation,12,20,O
anticodon,28,37,O
human,41,46,O
mitochondrial,47,60,B-Cellular_component
tRNAPro,61,68,O
post,76,80,O
transcriptional,81,96,O
modification,97,109,O
pattern,110,117,O
gene,132,136,O
sequences,137,146,O
22,154,156,O
tRNAs,157,162,O
encoded,163,170,O
human,178,183,O
mitochondrial,184,197,B-Cellular_component
genome,198,204,I-Cellular_component
known,209,214,O
little,216,222,O
information,223,234,O
exists,235,241,O
sequences,254,263,O
RNA,271,274,O
level,275,280,O
crucial,297,304,O
limitation,305,315,O
searching,321,330,O
molecular,337,346,O
understanding,347,360,O
growing,368,375,O
number,376,382,O
maternally,386,396,O
inherited,397,406,O
human,407,412,O
diseases,413,421,O
correlated,422,432,O
point,438,443,O
mutations,444,453,O
tRNA,457,461,O
genes,462,467,O
describe,477,485,O
sequence,490,498,O
human,502,507,O
mt,508,510,O
tRNAPropurified,511,526,O
placenta,532,540,B-Organ
shows,545,550,O
absence,551,558,O
editing,562,569,O
events,570,576,O
tRNA,585,589,O
highlights,594,604,O
presence,609,617,O
post,627,631,O
transcriptional,632,647,O
modifications,648,661,O
include,669,676,O
T54,677,680,O
found,688,693,O
far,697,700,O
animal,707,713,O
mt,714,716,O
tRNA,717,721,O
m1G37,727,732,O
modification,736,748,O
known,749,754,O
fundamental,763,774,O
functional,775,785,O
properties,786,796,O
number,802,808,O
canonical,812,821,O
tRNAs,822,827,O
Occurrence,829,839,O
m1G37,843,848,O
investigated,861,873,O
analysis,880,888,O
substrate,896,905,O
properties,906,916,O
vitro,923,928,O
transcripts,929,940,O
human,944,949,O
mt,950,952,O
tRNAProtowards,953,967,O
pure,968,972,O
Escherichia,973,984,O
coli,985,989,O
methylguanosine,990,1005,O
transferase,1006,1017,O
enzyme,1024,1030,O
properly,1031,1039,O
methylates,1040,1050,O
G37,1051,1054,O
mt,1058,1060,O
tRNA,1061,1065,O
sensitive,1073,1082,O
presence,1090,1098,O
second,1104,1110,O
G,1111,1112,O
position,1116,1124,O
36,1125,1127,O
neighboring,1129,1140,O
target,1145,1151,O
nucleotide,1152,1162,O
methylation,1167,1178,O
mutation,1186,1194,O
nt,1198,1200,O
36,1201,1203,O
shown,1208,1213,O
correlated,1220,1230,O
myopathy,1236,1244,O
potential,1250,1259,O
consequences,1260,1272,O
non,1276,1279,O
modification,1280,1292,O
modification,1302,1314,O
mt,1318,1320,O
tRNA,1321,1325,O
nucleotides,1326,1337,O
expression,1341,1351,O
particular,1359,1369,O
myopathy,1370,1378,O
mitochondrial,1386,1399,B-Cellular_component
diseases,1400,1408,O
general,1412,1419,O
discussed,1424,1433,O
Clozapine,0,9,O
induced,10,17,O
agranulocytosis,18,33,O
thrombopenia,38,50,O
patient,56,63,O
dopaminergic,69,81,O
psychosis,82,91,O
patients,96,104,O
Parkinson,110,119,O
disease,121,128,O
dopaminergic,133,145,O
psychosis,146,155,O
clozapine,157,166,O
treatment,167,176,O
recommended,180,191,O
drug,199,203,O
free,207,211,O
extrapyramidal,217,231,O
effects,237,244,O
worsen,258,264,O
motor,265,270,O
symptoms,271,279,O
underlying,287,297,O
disease,298,305,O
use,311,314,O
clozapine,318,327,O
limited,341,348,O
hematotoxic,360,371,O
effects,377,384,O
treatment,390,399,O
clozapine,403,412,O
induced,413,420,O
agranulocytosis,421,436,O
granulocyte,438,449,O
colony,450,456,O
stimulating,457,468,O
factors,469,476,O
G,478,479,O
CSF,480,483,O
recommended,489,500,O
report,505,511,O
case,516,520,O
72,526,528,O
years,529,534,O
old,535,538,O
male,539,543,O
patient,544,551,O
clozapine,557,566,O
induced,567,574,O
agranulocytosis,575,590,O
thrombopenia,595,607,O
Neutropenia,609,620,O
successfully,625,637,O
treated,638,645,O
G,651,652,O
CSF,653,656,O
thrombopenia,662,674,O
persisted,675,684,O
resolved,689,697,O
spontaneously,698,711,O
14,718,720,O
days,721,725,O
Bone,727,731,B-Multi-tissue_structure
marrow,732,738,I-Multi-tissue_structure
toxicity,739,747,O
clozapine,751,760,O
restricted,768,778,O
white,782,787,B-Cell
cell,788,792,I-Cell
maturation,793,803,O
impair,818,824,O
thrombocytopoesis,825,842,O
Acylase,0,7,O
catalyzed,10,19,O
deacetylation,20,33,O
N,37,38,O
acetyl,39,45,O
L,46,47,O
cysteine,48,56,O
S,61,62,O
alkyl,63,68,O
N,69,70,O
acetyl,71,77,O
L,78,79,O
cysteines,80,89,O
aminoacylase,95,107,O
catalyzes,113,122,O
hydrolysis,127,137,O
N,141,142,O
acetyl,143,149,O
L,150,151,O
cysteine,152,160,O
NAC,162,165,O
identified,171,181,O
acylase,185,192,O
purification,201,213,O
column,217,223,O
chromatography,224,238,O
electrophoretic,243,258,O
analysis,259,267,O
Rat,269,272,O
kidney,273,279,B-Organism_substance
cytosol,280,287,I-Organism_substance
fractionated,292,304,O
ammonium,308,316,O
sulfate,317,324,O
precipitation,325,338,O
proteins,348,356,O
separated,362,371,O
ion,375,378,O
exchange,379,387,O
column,388,394,O
chromatography,395,409,O
gel,411,414,O
filtration,415,425,O
column,426,432,O
chromatography,433,447,O
hydrophobic,453,464,O
interaction,465,476,O
column,477,483,O
chromatography,484,498,O
Acylase,500,507,O
activity,508,516,O
NAC,522,525,O
N,530,531,O
acetyl,532,538,O
L,539,540,O
methionine,541,551,O
NAM,553,556,O
known,561,566,O
substrate,567,576,O
acylase,581,588,O
substrates,595,605,O
coeluted,606,614,O
chromatographic,626,641,O
steps,642,647,O
Sodium,649,655,O
dodecyl,656,663,O
sulfate,664,671,O
polyacrylamide,672,686,O
gel,687,690,O
electrophoresis,691,706,O
showed,707,713,O
protein,723,730,O
purified,735,743,O
near,747,751,O
homogeneity,752,763,O
subunit,774,781,O
Mr,782,784,O
43,788,790,O
000,791,794,O
identical,805,814,O
Mr,824,826,O
acylase,830,837,O
porcine,845,852,O
kidney,853,859,B-Organ
bovine,864,870,O
liver,871,876,B-Organ
n,878,879,O
Butylmalonic,880,892,O
acid,893,897,O
slow,904,908,O
binding,909,916,O
inhibitor,917,926,O
acylase,930,937,O
inhibited,944,953,O
deacetylation,958,971,O
NAC,975,978,O
Ki,986,988,O
192,992,995,O
27,1000,1002,O
microM,1003,1009,O
results,1017,1024,O
acylase,1035,1042,O
catalyzes,1045,1054,O
deacetylation,1059,1072,O
NAC,1076,1079,O
acylase,1085,1092,O
catalyzed,1095,1104,O
deacetylation,1105,1118,O
range,1124,1129,O
S,1133,1134,O
alkyl,1135,1140,O
N,1141,1142,O
acetyl,1143,1149,O
L,1150,1151,O
cysteines,1152,1161,O
carbon,1169,1175,O
oxygen,1180,1186,O
analogues,1187,1196,O
selenium,1206,1214,O
analogue,1215,1223,O
NAM,1227,1230,O
studied,1240,1247,O
porcine,1253,1260,O
kidney,1261,1267,B-Organ
acylase,1268,1275,O
specific,1283,1291,O
activity,1292,1300,O
acylase,1308,1315,O
catalyzed,1318,1327,O
deacetylation,1328,1341,O
substrates,1351,1361,O
related,1366,1373,O
calculated,1383,1393,O
molar,1394,1399,O
volumes,1400,1407,O
log,1412,1415,O
P,1416,1417,O
values,1418,1424,O
S,1430,1431,O
alkyl,1432,1437,O
N,1438,1439,O
acetyl,1440,1446,O
L,1447,1448,O
cysteines,1449,1458,O
short,1464,1469,O
C0,1471,1473,O
C3,1474,1476,O
unbranched,1482,1492,O
S,1493,1494,O
alkyl,1495,1500,O
substituents,1501,1513,O
good,1519,1523,O
acylase,1524,1531,O
substrates,1534,1544,O
S,1558,1559,O
alkyl,1560,1565,O
N,1566,1567,O
acetyl,1568,1574,O
L,1575,1576,O
cysteines,1577,1586,O
long,1592,1596,O
C3,1599,1601,O
branched,1607,1615,O
S,1616,1617,O
alkyl,1618,1623,O
substituents,1624,1636,O
poLr,1642,1646,O
acylase,1647,1654,O
substrates,1657,1667,O
carbon,1673,1679,O
oxygen,1684,1690,O
analogues,1691,1700,O
S,1704,1705,O
methyl,1706,1712,O
N,1713,1714,O
acetyl,1715,1721,O
L,1722,1723,O
cysteine,1724,1732,O
carbon,1741,1747,O
analogue,1748,1756,O
S,1760,1761,O
ethyl,1762,1767,O
N,1768,1769,O
acetyl,1770,1776,O
L,1777,1778,O
cysteine,1779,1787,O
poor,1793,1797,O
acylase,1798,1805,O
substrates,1808,1818,O
selenium,1832,1840,O
analogue,1841,1849,O
NAM,1853,1856,O
good,1863,1867,O
acylase,1868,1875,O
substrate,1878,1887,O
Hemispheric,0,11,O
control,12,19,O
motor,23,28,O
function,29,37,O
brain,47,52,B-Organ
echo,53,57,O
planar,58,64,O
fMRI,65,69,O
study,70,75,O
aim,81,84,O
study,93,98,O
explore,106,113,O
recruitment,122,133,O
ipsilateral,141,152,B-Multi-tissue_structure
motor,153,158,I-Multi-tissue_structure
cortex,159,165,I-Multi-tissue_structure
non,173,176,O
dominant,177,185,O
motor,186,191,O
movement,192,200,O
reflects,201,209,O
left,210,214,B-Multi-tissue_structure
hemispheric,215,226,I-Multi-tissue_structure
control,227,234,O
motor,238,243,O
function,244,252,O
simply,256,262,O
greater,267,274,O
complexity,275,285,O
unfamiliarity,289,302,O
motor,310,315,O
task,316,320,O
BOLD,322,326,O
fMRI,327,331,O
performed,336,345,O
normal,349,355,O
right,356,361,O
handers,362,369,O
motor,381,386,O
tasks,387,392,O
1,395,396,O
sequential,398,408,O
finger,409,415,B-Organism_subdivision
movements,416,425,O
SM,427,429,O
task,430,434,O
right,445,450,O
left,454,458,O
hand,459,463,B-Organism_subdivision
2,470,471,O
random,473,479,O
finger,480,486,B-Organism_subdivision
movements,487,496,O
RM,498,500,O
task,501,505,O
right,516,521,O
hand,522,526,B-Organism_subdivision
subjects,535,543,O
activation,545,555,O
predominantly,560,573,O
contralateral,581,594,O
motor,595,600,O
areas,601,606,O
primary,608,615,O
sensorimotor,616,628,O
lateral,630,637,O
premotor,638,646,O
parietal,648,656,O
supplementary,661,674,O
motor,675,680,O
regions,681,688,O
ipsilateral,694,705,B-Multi-tissue_structure
cerebellum,706,716,I-Multi-tissue_structure
ipsilateral,728,739,B-Multi-tissue_structure
motor,740,745,I-Multi-tissue_structure
areas,746,751,I-Multi-tissue_structure
activated,762,771,O
single,773,779,O
subject,780,787,O
analysis,788,796,O
revealed,797,805,O
areas,812,817,O
extensive,829,838,O
seen,849,853,O
subjects,862,870,O
non,882,885,O
dominant,886,894,O
hand,895,899,B-Organism_subdivision
SM,900,902,O
task,903,907,O
dominant,912,920,O
hand,921,925,B-Organism_subdivision
RM,926,928,O
task,929,933,O
familiar,955,963,O
dominant,964,972,O
hand,973,977,B-Organism_subdivision
SM,978,980,O
task,981,985,O
Similarly,987,996,O
group,998,1003,O
analysis,1004,1012,O
revealed,1018,1026,O
ipsilateral,1027,1038,O
activation,1039,1049,O
primary,1057,1064,O
sensorimotor,1065,1077,O
lateral,1082,1089,B-Multi-tissue_structure
premotor,1090,1098,I-Multi-tissue_structure
areas,1099,1104,I-Multi-tissue_structure
non,1126,1129,O
dominant,1130,1138,O
SM,1139,1141,O
task,1142,1146,O
dominant,1155,1163,O
hand,1164,1168,B-Organism_subdivision
RM,1169,1171,O
task,1172,1176,O
Non,1178,1181,O
dominant,1182,1190,O
hand,1191,1195,B-Organism_subdivision
movements,1196,1205,O
automatic,1238,1247,O
appear,1250,1256,O
require,1260,1267,O
cortical,1273,1281,B-Multi-tissue_structure
activity,1282,1290,O
similar,1291,1298,O
complex,1302,1309,O
tasks,1310,1315,O
dominant,1325,1333,O
hand,1334,1338,B-Organism_subdivision
result,1344,1350,O
greater,1354,1361,O
recruitment,1362,1373,O
ipsilateral,1377,1388,B-Multi-tissue_structure
cortical,1389,1397,I-Multi-tissue_structure
motor,1398,1403,I-Multi-tissue_structure
areas,1404,1409,I-Multi-tissue_structure
striatum,1414,1422,B-Multi-tissue_structure
study,1428,1433,O
illustrates,1439,1450,O
potentially,1455,1466,O
meaningful,1467,1477,O
subtleties,1478,1488,O
seen,1489,1493,O
individual,1497,1507,O
maps,1508,1512,O
obscured,1520,1528,O
group,1534,1539,O
averaging,1540,1549,O
approaches,1550,1560,O
Selective,0,9,O
inhibition,10,20,O
renal,28,33,B-Organ
dopamine,34,42,O
subtype,43,50,O
D1A,51,54,O
receptor,55,63,O
induces,64,71,O
antinatriuresis,72,87,O
conscious,91,100,O
rats,101,105,O
dopamine,112,120,O
D1,121,123,O
like,124,128,O
D1A,130,133,O
D1B,138,141,O
D2,147,149,O
like,150,154,O
D2,156,158,O
D3,160,162,O
D4,168,170,O
receptor,172,180,O
subfamilies,181,192,O
present,197,204,O
kidney,212,218,B-Organ
Blockade,220,228,O
intrarenal,236,246,O
D1,247,249,O
like,250,254,O
receptor,255,263,O
family,264,270,O
associated,274,284,O
natriuresis,290,301,O
diuresis,306,314,O
D1A,328,331,O
D1B,336,339,O
receptor,340,348,O
subtypes,349,357,O
distinguishable,366,381,O
currently,385,394,O
available,395,404,O
dopaminergic,405,417,O
agents,418,424,O
functional,432,442,O
role,443,447,O
remains,448,455,O
undefined,456,465,O
present,474,481,O
study,482,487,O
effect,493,499,O
selective,503,512,O
inhibition,513,523,O
renal,531,536,B-Organ
D1A,537,540,O
receptor,541,549,O
phosphorothioated,555,572,O
antisense,573,582,O
oligodeoxynucleotide,583,603,O
ODN,608,611,O
investigated,617,629,O
conscious,633,642,O
uninephrectomized,643,660,O
rats,661,665,O
renal,673,678,B-Immaterial_anatomical_entity
interstitial,679,691,I-Immaterial_anatomical_entity
administration,692,706,O
Texas,710,715,O
red,716,719,O
labeled,720,727,O
D1A,728,731,O
receptor,732,740,O
ODN,744,747,O
intense,749,756,O
fluorescent,757,768,O
signal,769,775,O
localized,780,789,O
renal,797,802,B-Tissue
tubular,803,810,I-Tissue
epithelium,811,821,I-Tissue
vasculature,826,837,B-Multi-tissue_structure
rats,842,846,O
normal,850,856,O
salt,857,861,O
intake,862,868,O
ODN,873,876,O
injected,877,885,O
interstitially,886,900,O
kidney,910,916,B-Organ
reduced,917,924,O
daily,925,930,O
urinary,931,938,B-Organism_substance
sodium,939,945,O
excretion,946,955,O
1,957,958,O
4,959,960,O
0,963,964,O
04,965,967,O
versus,968,974,O
0,975,976,O
8,977,978,O
0,981,982,O
2,983,984,O
mEq,985,988,O
d,989,990,O
n,992,993,O
5,994,995,O
P,997,998,O
0,999,1000,O
05,1001,1003,O
urine,1009,1014,B-Organism_substance
output,1015,1021,O
16,1023,1025,O
9,1026,1027,O
3,1030,1031,O
8,1032,1033,O
versus,1034,1040,O
12,1041,1043,O
5,1044,1045,O
3,1048,1049,O
6,1050,1051,O
mL,1052,1054,O
d,1055,1056,O
n,1058,1059,O
5,1060,1061,O
P,1063,1064,O
0,1065,1066,O
05,1067,1069,O
rats,1075,1079,O
high,1083,1087,O
sodium,1088,1094,O
intake,1095,1101,O
continuous,1103,1113,O
renal,1114,1119,B-Immaterial_anatomical_entity
interstitial,1120,1132,I-Immaterial_anatomical_entity
administration,1133,1147,O
D1A,1151,1154,O
receptor,1155,1163,O
ODN,1167,1170,O
transiently,1171,1182,O
decreased,1183,1192,O
daily,1193,1198,O
urinary,1199,1206,B-Organism_substance
sodium,1207,1213,O
excretion,1214,1223,O
5,1225,1226,O
4,1227,1228,O
0,1231,1232,O
5,1233,1234,O
versus,1235,1241,O
4,1242,1243,O
2,1244,1245,O
0,1248,1249,O
3,1250,1251,O
mEq,1252,1255,O
d,1256,1257,O
n,1259,1260,O
7,1261,1262,O
P,1264,1265,O
0,1266,1267,O
01,1268,1270,O
urine,1276,1281,B-Organism_substance
output,1282,1288,O
27,1290,1292,O
6,1293,1294,O
4,1297,1298,O
5,1299,1300,O
versus,1301,1307,O
18,1308,1310,O
1,1311,1312,O
1,1315,1316,O
8,1317,1318,O
mL,1319,1321,O
d,1322,1323,O
n,1325,1326,O
7,1327,1328,O
P,1330,1331,O
0,1332,1333,O
01,1334,1336,O
vehicle,1347,1354,O
sense,1359,1364,O
oligodeoxynucleotide,1365,1385,O
significant,1390,1401,O
effects,1402,1409,O
Systolic,1411,1419,O
blood,1420,1425,B-Organism_substance
pressure,1426,1434,O
remained,1435,1443,O
unchanged,1444,1453,O
renal,1459,1464,B-Organ
D1A,1465,1468,O
receptor,1469,1477,O
protein,1478,1485,O
significantly,1490,1503,O
decreased,1504,1513,O
35,1517,1519,O
46,1525,1527,O
end,1536,1539,O
study,1547,1552,O
ODN,1559,1562,O
treated,1563,1570,O
rats,1571,1575,O
normal,1579,1585,O
high,1590,1594,O
salt,1595,1599,O
intake,1600,1606,O
respectively,1608,1620,O
D1B,1634,1637,O
receptor,1638,1646,O
beta,1651,1655,O
actin,1656,1661,O
affected,1671,1679,O
results,1687,1694,O
provide,1695,1702,O
direct,1713,1719,O
evidence,1720,1728,O
renal,1738,1743,B-Organ
D1A,1744,1747,O
receptor,1748,1756,O
subtype,1757,1764,O
plays,1765,1770,O
important,1774,1783,O
role,1784,1788,O
control,1796,1803,O
sodium,1807,1813,O
excretion,1814,1823,O
Epidemiology,1,13,O
respiratory,17,28,B-Anatomical_system
allergy,29,36,O
children,40,48,O
Epidemiology,51,63,O
paediatric,67,77,O
respiratory,78,89,B-Anatomical_system
allergic,90,98,O
disorders,99,108,O
allows,109,115,O
approach,120,128,O
causal,132,138,O
preventive,143,153,O
risk,154,158,O
factors,159,166,O
studying,170,178,O
groups,179,185,O
sub,189,192,O
groups,193,199,O
children,203,211,O
different,215,224,O
locations,225,234,O
different,245,254,O
conditions,255,265,O
complicated,285,296,O
lack,304,308,O
consensus,312,321,O
disease,325,332,O
definitions,333,344,O
renders,352,359,O
comparisons,360,371,O
studies,380,387,O
difficult,388,397,O
Atopy,399,404,O
usually,408,415,O
defined,416,423,O
presence,431,439,O
positive,443,451,O
skin,452,456,B-Organ
tests,457,462,O
wheal,464,469,O
size,470,474,O
mean,489,493,O
diameter,494,502,O
3,510,511,O
mm,512,514,O
presence,524,532,O
specific,536,544,O
IgE,545,548,O
presence,560,568,O
increased,572,581,O
total,582,587,O
IgE,588,591,O
100,600,603,O
UI,604,606,O
mL,607,609,O
Infantile,612,621,O
asthma,622,628,O
defined,641,648,O
complicated,650,661,O
high,669,673,O
prevalence,674,684,O
bronchiolitis,688,701,O
questions,712,721,O
wheezing,730,738,O
wheezy,742,748,O
bronchitis,749,759,O
Prevalence,761,771,O
high,775,779,O
early,787,792,O
wheezers,793,801,O
populations,807,818,O
defined,827,834,O
medium,842,848,O
term,849,853,O
evolution,854,863,O
transient,865,874,O
wheezers,875,883,O
persistent,888,898,O
wheezers,899,907,O
Risk,909,913,O
factors,914,921,O
conditions,936,946,O
different,951,960,O
Childhood,962,971,O
asthma,972,978,O
defined,986,993,O
diagnosis,1001,1010,O
asthma,1014,1020,O
specific,1022,1030,O
fairly,1035,1041,O
non,1042,1045,O
sensitive,1046,1055,O
asthmatic,1061,1070,O
symptoms,1071,1079,O
wheezing,1081,1089,O
waking,1091,1097,O
attack,1104,1110,O
shortness,1114,1123,O
breath,1127,1133,O
sensitive,1136,1145,O
specific,1159,1167,O
combination,1180,1191,O
symptoms,1195,1203,O
airway,1208,1214,B-Multi-tissue_structure
hyperresponsiveness,1215,1234,O
ISAAC,1240,1245,O
study,1246,1251,O
standardised,1256,1268,O
questionnaire,1271,1284,O
assess,1288,1294,O
prevalence,1299,1309,O
asthma,1313,1319,O
preliminary,1325,1336,O
results,1337,1344,O
wide,1365,1369,O
variations,1370,1380,O
world,1392,1397,O
prevalence,1403,1413,O
low,1417,1420,O
Africa,1424,1430,O
Asia,1435,1439,O
intermediate,1441,1453,O
Europe,1457,1463,O
high,1469,1473,O
Anglo,1477,1482,O
Saxon,1483,1488,O
countries,1489,1498,O
prevalence,1504,1514,O
asthma,1518,1524,O
gradually,1529,1538,O
increased,1539,1548,O
past,1558,1562,O
20,1563,1565,O
years,1566,1571,O
developed,1575,1584,O
countries,1585,1594,O
Asthma,1596,1602,O
atopy,1607,1612,O
closely,1617,1624,O
associated,1625,1635,O
children,1639,1647,O
Risk,1649,1653,O
factors,1654,1661,O
genetic,1666,1673,O
associated,1675,1685,O
sex,1691,1694,O
environmental,1699,1712,O
factors,1713,1720,O
allergic,1735,1743,O
sensitisation,1744,1757,O
associated,1761,1771,O
degree,1781,1787,O
exposure,1791,1799,O
allergens,1803,1812,O
Westernization,1814,1828,O
way,1832,1835,O
life,1839,1843,O
associated,1847,1857,O
increased,1863,1872,O
prevalence,1873,1883,O
atopy,1887,1892,O
allergic,1894,1902,O
rhinitis,1903,1911,O
asthma,1916,1922,O
Atopy,1924,1929,O
inversely,1936,1945,O
correlated,1946,1956,O
certain,1960,1967,O
infections,1968,1978,O
Passive,1980,1987,O
smoking,1988,1995,O
clearly,1999,2006,O
associated,2007,2017,O
early,2023,2028,O
wheezing,2029,2037,O
atmospheric,2048,2059,O
pollution,2060,2069,O
aggravate,2070,2079,O
childhood,2080,2089,O
asthma,2090,2096,O
inducing,2111,2119,O
role,2120,2124,O
pollution,2128,2137,O
asthma,2141,2147,O
controversial,2157,2170,O
Novel,0,5,O
mechanism,6,15,O
impairment,24,34,O
cell,38,42,B-Cell
proliferation,43,56,O
HIV,60,63,O
1,64,65,O
infection,66,75,O
synthesis,81,90,O
ribonucleotides,94,109,O
essential,113,122,O
cell,126,130,B-Cell
proliferation,131,144,O
Defects,146,153,O
relevant,161,169,O
metabolic,170,179,O
pathways,180,188,O
demonstrated,199,211,O
stimulated,215,225,O
T,226,227,B-Cell
cells,228,233,I-Cell
AIDS,239,243,O
patients,244,252,O
associated,261,271,O
lymphocyte,277,287,B-Cell
necrotic,288,296,O
death,297,302,O
Margarita,310,319,O
Bofill,320,326,O
colleagues,331,341,O
discuss,342,349,O
possibility,354,365,O
impaired,374,382,O
ribonucleotide,383,397,O
metabolism,398,408,O
common,418,424,O
rapidly,432,439,O
dividing,440,448,O
cells,449,454,B-Cell
contribute,464,474,O
recognized,484,494,O
symptoms,495,503,O
HIV,507,510,O
1,511,512,O
infection,513,522,O
pancreatic,2,12,B-Cell
beta,13,17,I-Cell
cell,19,23,I-Cell
specific,24,32,O
enhancer,33,41,O
human,49,54,O
PDX,55,58,O
1,59,60,O
gene,61,65,O
regulated,69,78,O
hepatocyte,82,92,O
nuclear,93,100,O
factor,101,107,O
3beta,108,113,O
HNF,115,118,O
3beta,119,124,O
HNF,128,131,O
1alpha,132,138,O
SPs,144,147,O
transcription,148,161,O
factors,162,169,O
PDX,175,178,O
1,179,180,O
transcription,181,194,O
factor,195,201,O
plays,202,207,O
key,210,213,O
role,214,218,O
pancreas,222,230,B-Organ
development,231,242,O
expressed,253,262,O
cells,270,275,B-Cell
early,283,288,O
stages,289,295,O
adult,304,309,O
mainly,316,322,O
restricted,323,333,O
beta,341,345,B-Cell
cell,346,350,I-Cell
characterize,355,367,O
regulatory,372,382,O
elements,383,391,O
potential,396,405,O
transcription,406,419,O
factors,420,427,O
necessary,428,437,O
human,442,447,O
PDX,448,451,O
1,452,453,O
gene,454,458,O
expression,459,469,O
beta,473,477,B-Cell
cells,478,483,I-Cell
constructed,488,499,O
series,502,508,O
5,512,513,O
3,519,520,O
deletion,522,530,O
fragments,531,540,O
5,548,549,O
flanking,551,559,O
region,560,566,O
gene,574,578,O
fused,580,585,O
luciferase,593,603,O
reporter,604,612,O
gene,613,617,O
report,627,633,O
identify,638,646,O
transient,650,659,O
transfections,660,673,O
beta,677,681,B-Cell
non,687,690,B-Cell
beta,691,695,I-Cell
cells,696,701,I-Cell
novel,704,709,O
beta,710,714,B-Cell
cell,715,719,I-Cell
specific,720,728,O
distal,729,735,O
enhancer,736,744,O
element,745,752,O
located,753,760,O
3,770,771,O
7,772,773,O
3,779,780,O
45,781,783,O
kilobases,784,793,O
DNase,795,800,O
footprinting,803,815,O
analysis,816,824,O
revealed,825,833,O
protected,838,847,O
regions,848,855,O
binding,861,868,O
transcription,873,886,O
factors,887,894,O
SP1,895,898,O
SP3,903,906,O
hepatocyte,921,931,O
nuclear,932,939,O
factor,940,946,O
3beta,947,952,O
HNF,954,957,O
3beta,958,963,O
HNF,969,972,O
1alpha,973,979,O
Cotransfection,981,995,O
experiments,996,1007,O
suggest,1008,1015,O
HNF,1021,1024,O
3beta,1025,1030,O
HNF,1032,1035,O
1alpha,1036,1042,O
SP1,1048,1051,O
positive,1056,1064,O
regulators,1065,1075,O
described,1090,1099,O
human,1100,1105,O
PDX,1106,1109,O
1,1110,1111,O
enhancer,1112,1120,O
element,1121,1128,O
Furthermore,1130,1141,O
mutations,1143,1152,O
motif,1165,1170,O
abolished,1171,1180,O
binding,1185,1192,O
corresponding,1200,1213,O
factor,1214,1220,O
s,1221,1222,O
dramatically,1228,1240,O
impaired,1241,1249,O
enhancer,1254,1262,O
activity,1263,1271,O
suggesting,1283,1293,O
cooperativity,1294,1307,O
factors,1322,1329,O
decline,3,10,O
French,18,24,O
demographic,25,36,O
situation,37,46,O
context,54,61,O
Europe,67,73,O
demographic,82,93,O
decline,94,101,O
author,108,114,O
analyzes,115,123,O
decline,128,135,O
French,139,145,O
fertility,146,155,O
occurred,166,174,O
past,184,188,O
years,193,198,O
data,205,209,O
official,215,223,O
sources,224,231,O
comparisons,239,250,O
fertility,265,274,O
trends,275,281,O
European,291,299,O
countries,300,309,O
patterns,4,12,O
internal,16,24,O
migration,25,34,O
Maharashtra,38,49,O
analysis,55,63,O
1971,67,71,O
census,72,78,O
data,79,83,O
Patterns,85,93,O
internal,97,105,O
migration,106,115,O
state,123,128,O
Maharashtra,132,143,O
India,145,150,O
period,160,166,O
1961,167,171,O
1971,172,176,O
analyzed,181,189,O
1971,196,200,O
census,201,207,O
data,208,212,O
nature,219,225,O
volume,227,233,O
direction,239,248,O
migration,252,261,O
examined,266,274,O
Migrants,277,285,O
characterized,290,303,O
according,304,313,O
factors,317,324,O
including,325,334,O
age,335,338,O
sex,340,343,O
marital,345,352,O
status,353,359,O
occupation,361,371,O
areas,377,382,O
origin,386,392,O
destination,397,408,O
Deletion,0,8,O
guanine,12,19,O
nucleotide,20,30,O
binding,31,38,O
protein,39,46,O
alpha,47,52,O
z,53,54,O
subunit,55,62,O
mice,66,70,O
induces,71,78,O
gene,81,85,O
dose,86,90,O
dependent,91,100,O
tolerance,101,110,O
morphine,114,122,O
mechanism,128,137,O
underlying,138,148,O
development,153,164,O
tolerance,168,177,O
morphine,181,189,O
incompletely,199,211,O
understood,212,222,O
Morphine,224,232,O
binds,233,238,O
opioid,242,248,O
receptors,249,258,O
turn,269,273,O
activates,274,283,O
downstream,284,294,O
second,295,301,O
messenger,302,311,O
cascades,312,320,O
heterotrimeric,329,343,O
guanine,344,351,O
nucleotide,352,362,O
binding,363,370,O
proteins,371,379,O
G,381,382,O
proteins,383,391,O
paper,402,407,O
G,422,423,O
z,424,425,O
member,430,436,O
inhibitory,444,454,O
G,455,456,O
protein,457,464,O
family,465,471,O
plays,473,478,O
important,482,491,O
role,492,496,O
mediating,500,509,O
analgesic,514,523,O
lethality,528,537,O
effects,538,545,O
morphine,549,557,O
tolerance,564,573,O
development,574,585,O
blocked,590,597,O
signaling,598,607,O
G,620,621,O
z,622,623,O
second,625,631,O
messenger,632,641,O
cascade,642,649,O
genetic,653,660,O
ablation,661,669,O
alpha,677,682,O
subunit,683,690,O
G,698,699,O
protein,700,707,O
mice,711,715,O
Galpha,721,727,O
z,728,729,O
knockout,731,739,O
mouse,740,745,O
develops,746,754,O
significantly,755,768,O
increased,769,778,O
tolerance,779,788,O
morphine,792,800,O
depends,808,815,O
Galpha,819,825,O
z,826,827,O
gene,829,833,O
dosage,834,840,O
experiments,850,861,O
demonstrate,862,873,O
enhanced,883,891,O
morphine,892,900,O
tolerance,901,910,O
caused,918,924,O
pharmacokinetic,928,943,O
behavioural,948,959,O
learning,960,968,O
mechanisms,969,979,O
results,985,992,O
suggest,993,1000,O
G,1006,1007,O
z,1008,1009,O
signaling,1011,1020,O
pathways,1021,1029,O
involved,1034,1042,O
transducing,1046,1057,O
analgesic,1062,1071,O
lethality,1076,1085,O
effects,1086,1093,O
morphine,1097,1105,O
following,1106,1115,O
chronic,1116,1123,O
morphine,1124,1132,O
treatment,1133,1142,O
Effects,0,7,O
buffer,11,17,O
properties,18,28,O
cyclodextrin,32,44,O
glucanotransferase,45,63,O
reactions,64,73,O
cyclodextrin,78,90,O
production,91,101,O
raw,107,110,O
sago,111,115,O
Cycas,117,122,O
revoluta,123,131,O
starch,133,139,B-Organism_substance
Results,141,148,O
present,158,165,O
study,166,171,O
shown,177,182,O
ionic,192,197,O
species,198,205,O
buffers,209,216,O
pH,218,220,O
values,221,227,O
reaction,232,240,O
temperature,241,252,O
affect,257,263,O
enzyme,268,274,O
unit,275,279,O
activities,280,290,O
product,295,302,O
specificity,303,314,O
Toruzyme,318,326,O
Novo,328,332,O
Nordisk,333,340,O
S,343,344,O
Bagsvaerd,345,354,O
Denmark,356,363,O
CGTase,365,371,O
cyclodextrin,373,385,O
glucanotransferase,386,404,O
Applying,407,415,O
similar,418,425,O
reaction,426,434,O
environment,435,446,O
acetate,448,455,O
buffer,456,462,O
pH,464,466,O
6,467,468,O
0,469,470,O
temperature,472,483,O
60,485,487,O
degrees,488,495,O
C,496,497,O
CGTase,504,510,O
found,515,520,O
capable,527,534,O
producing,538,547,O
pre,548,551,O
dominantly,552,562,O
beta,563,567,O
cyclodextrin,568,580,O
raw,593,596,O
gelatinized,600,611,O
sago,612,616,O
Cycas,618,623,O
revoluta,624,632,O
starch,634,640,B-Organism_substance
Changing,642,650,O
buffer,655,661,O
acetate,667,674,O
phosphate,678,687,O
reduced,688,695,O
yield,700,705,O
beta,709,713,O
cyclodextrin,714,726,O
2,732,733,O
48,734,736,O
1,740,741,O
42,742,744,O
mg,745,747,O
ml,748,750,O
affected,760,768,O
product,773,780,O
specificity,781,792,O
production,800,810,O
alpha,819,824,O
beta,830,834,O
cyclodextrins,835,848,O
pronounced,859,869,O
decrease,875,883,O
production,891,901,O
cyclodextrins,905,918,O
phosphate,922,931,O
buffer,932,938,O
significant,943,954,O
pH,963,965,O
6,966,967,O
0,968,969,O
7,974,975,O
0,976,977,O
changing,988,996,O
buffer,1001,1007,O
Tris,1011,1015,O
HCl,1016,1019,O
pH,1021,1023,O
7,1024,1025,O
0,1026,1027,O
showed,1029,1035,O
significant,1038,1049,O
increase,1050,1058,O
beta,1062,1066,O
cyclodextrin,1067,1079,O
production,1080,1090,O
Increasing,1092,1102,O
ionic,1107,1112,O
strength,1113,1121,O
sodium,1125,1131,O
acetate,1132,1139,O
Tris,1144,1148,O
HCl,1149,1152,O
buffers,1153,1160,O
pH,1164,1166,O
6,1167,1168,O
0,1169,1170,O
7,1175,1176,O
0,1177,1178,O
equivalent,1182,1192,O
ionic,1193,1198,O
strength,1199,1207,O
phosphate,1211,1220,O
buffers,1221,1228,O
showed,1229,1235,O
significant,1239,1250,O
effects,1251,1258,O
cyclodextrin,1262,1274,O
production,1275,1285,O
Higher,1287,1293,O
yield,1294,1299,O
cyclodextrins,1303,1316,O
pH,1320,1322,O
7,1323,1324,O
0,1325,1326,O
Tris,1332,1336,O
HCl,1337,1340,O
binding,1370,1377,O
chloride,1381,1389,O
ions,1390,1394,O
calcium,1402,1409,O
binding,1410,1417,O
sites,1418,1423,O
CGTase,1431,1437,O
resulting,1439,1448,O
shift,1456,1461,O
optimum,1469,1476,O
pH,1477,1479,O
close,1480,1485,O
physiological,1489,1502,O
environment,1503,1514,O
leading,1516,1523,O
increase,1530,1538,O
activities,1546,1556,O
specificity,1561,1572,O
Rational,0,8,O
synthesis,9,18,O
multicyclic,22,33,O
bis,34,37,O
2,38,39,O
catenanes,40,49,O
Bis,51,54,O
loop,55,59,O
tetraurea,60,69,O
calix,70,75,O
4,76,77,O
arene,78,83,O
6,84,85,O
prepared,95,103,O
acylation,107,116,O
wide,124,128,O
rim,129,132,O
calix,133,138,O
4,139,140,O
arene,141,146,O
tetraamine,147,157,O
1,158,159,O
activated,169,178,O
bis,179,182,O
urethane,183,191,O
8,193,194,O
dilution,201,209,O
conditions,210,220,O
Similarly,222,231,O
bis,236,239,O
Boc,240,243,O
protected,244,253,O
tetraamine,255,265,O
2,266,267,O
converted,271,280,O
mono,290,294,O
loop,295,299,O
derivative,300,310,O
3,311,312,O
deprotection,325,337,O
acylation,342,351,O
gives,352,357,O
bisalkenyl,362,372,O
derivative,373,383,O
5,384,385,O
apolar,390,396,O
solvents,397,405,O
tetraurea,411,420,O
calix,421,426,O
4,427,428,O
arene,429,434,O
5,435,436,O
forms,437,442,O
regioselectively,443,459,O
single,462,468,O
hydrogen,469,477,O
bonded,478,484,O
homodimer,485,494,O
bis,511,514,O
2,515,516,O
catenane,517,525,O
10a,526,529,O
formed,533,539,O
49,543,545,O
metathesis,552,562,O
reaction,563,571,O
followed,572,580,O
hydrogenation,584,597,O
Bis,599,602,O
loop,603,607,O
derivative,608,618,O
6,619,620,O
forms,621,626,O
homodimers,630,640,O
steric,645,651,O
reasons,652,659,O
stoichiometric,667,681,O
mixture,682,689,O
open,699,703,O
chain,704,709,O
tetraalkenyl,710,722,O
derivative,723,733,O
7a,734,736,O
contains,737,745,O
exclusively,746,757,O
heterodimer,762,773,O
Metathesis,775,785,O
subsequent,790,800,O
hydrogenation,801,814,O
yields,819,825,O
65,826,828,O
pure,838,842,O
bis,843,846,O
2,847,848,O
catenane,849,857,O
10a,858,861,O
isolated,881,889,O
complex,899,906,O
reaction,907,915,O
mixture,916,923,O
obtained,924,932,O
homodimer,942,951,O
7a,952,954,O
7a,955,957,O
chirality,963,972,O
10a,976,979,O
D,981,982,O
2,983,984,O
symmetry,986,994,O
verified,1005,1013,O
optical,1017,1024,O
resolution,1025,1035,O
HPLC,1042,1046,O
chiral,1052,1058,O
stationary,1059,1069,O
phase,1070,1075,O
Sciatic,0,7,B-Multi-tissue_structure
nerve,8,13,I-Multi-tissue_structure
repair,14,20,O
microgrooved,24,36,O
nerve,37,42,B-Multi-tissue_structure
conduits,43,51,O
chitosan,60,68,O
gold,69,73,O
nanocomposites,74,88,O
BACKGROUND,90,100,O
better,105,111,O
direct,112,118,O
repair,123,129,O
peripheral,133,143,B-Multi-tissue_structure
nerve,144,149,I-Multi-tissue_structure
injury,156,162,O
implant,167,174,O
consisting,175,185,O
multicomponent,191,205,O
micropatterned,206,220,O
conduit,221,228,B-Multi-tissue_structure
seeded,229,235,O
NSC,241,244,B-Cell
designed,249,257,O
METHODS,259,266,O
mechanical,272,282,O
properties,283,293,O
chi,301,304,O
Au,305,307,O
nanocomposites,308,322,O
tested,328,334,O
vitro,339,344,O
effect,350,356,O
chi,360,363,O
Au,364,366,O
cell,370,374,B-Cell
behavior,375,383,O
NSC,385,388,B-Cell
glial,393,398,B-Cell
cell,399,403,I-Cell
line,404,408,I-Cell
C6,409,411,I-Cell
influence,421,430,O
micropattern,434,446,O
cell,450,454,B-Cell
alignment,455,464,O
evaluated,470,479,O
vivo,484,488,O
micropatterned,494,508,O
conduits,509,517,O
preseeded,535,544,O
NSC,545,548,B-Cell
implanted,554,563,O
bridge,567,573,O
10,576,578,O
mm,579,581,O
long,582,586,O
defect,587,593,O
sciatic,601,608,B-Multi-tissue_structure
nerve,609,614,I-Multi-tissue_structure
9,618,619,O
male,620,624,O
Sprague,625,632,O
Dawley,633,639,O
rats,640,644,O
repair,650,656,O
outcome,657,664,O
investigated,669,681,O
6,682,683,O
weeks,684,689,O
surgery,700,707,O
RESULTS,709,716,O
Based,718,723,O
dynamic,731,738,O
modulus,739,746,O
chitosan,748,756,O
50,762,764,O
ppm,765,768,O
gold,777,781,O
stronger,788,796,O
material,797,805,O
vitro,822,827,O
gold,829,833,O
25,837,839,O
50,843,845,O
ppm,846,849,O
led,850,853,O
better,857,863,O
cell,864,868,B-Cell
performance,869,880,O
NSC,885,888,B-Cell
gold,894,898,O
50,902,904,O
ppm,905,908,O
gave,909,913,O
better,914,920,O
cell,921,925,B-Cell
performance,926,937,O
C6,942,944,B-Cell
microgrooved,953,965,O
substrate,966,975,O
NSC,981,984,B-Cell
elongated,989,998,O
processes,999,1008,O
oriented,1009,1017,O
parallel,1018,1026,O
grooves,1034,1041,O
NSC,1055,1058,B-Cell
nonpatterned,1066,1078,O
surfaces,1079,1087,O
exhibit,1096,1103,O
particular,1106,1116,O
bias,1117,1121,O
alignment,1125,1134,O
vivo,1139,1143,O
number,1149,1155,O
regenerated,1159,1170,O
axons,1171,1176,O
regenerated,1182,1193,O
area,1194,1198,O
number,1208,1214,O
blood,1218,1223,B-Multi-tissue_structure
vessels,1224,1231,I-Multi-tissue_structure
significantly,1237,1250,O
higher,1251,1257,O
NSC,1265,1268,B-Cell
preseeded,1269,1278,O
conduit,1279,1286,O
CONCLUSION,1288,1298,O
Modification,1300,1312,O
chitosan,1320,1328,O
matrix,1329,1335,O
gold,1339,1343,O
nanoparticles,1344,1357,O
provides,1367,1375,O
mechanical,1380,1390,O
strength,1391,1399,O
affects,1409,1416,O
cellular,1421,1429,B-Cell
response,1430,1438,O
preliminary,1444,1455,O
vivo,1459,1463,O
data,1464,1468,O
demonstrated,1469,1481,O
biodegradable,1491,1504,O
micropatterned,1505,1519,O
conduits,1520,1528,O
preseeded,1529,1538,O
NSC,1544,1547,B-Cell
provided,1548,1556,O
combination,1559,1570,O
physical,1574,1582,O
biological,1587,1597,O
guidance,1598,1606,O
cues,1607,1611,O
regenerating,1616,1628,O
axons,1629,1634,B-Cellular_component
cellular,1642,1650,B-Cell
level,1651,1656,O
offered,1661,1668,O
better,1671,1677,O
alternative,1678,1689,O
repairing,1694,1703,O
sciatic,1704,1711,B-Multi-tissue_structure
nerve,1712,1717,I-Multi-tissue_structure
transactions,1718,1730,O
clinical,5,13,O
laboratory,18,28,O
features,29,37,O
acute,41,46,O
promyelocytic,47,60,O
leukemia,61,69,O
analysis,74,82,O
513,86,89,O
cases,90,95,O
OBJECTIVE,98,107,O
investigate,112,123,O
clinical,128,136,O
laboratory,141,151,O
features,152,160,O
acute,164,169,O
promyelocytic,170,183,O
leukemia,184,192,O
APL,194,197,O
METHODS,200,207,O
513,209,212,O
APL,213,216,O
patients,217,225,O
decades,242,249,O
retrospectively,255,270,O
analyzed,271,279,O
research,288,296,O
investigated,301,313,O
clinical,318,326,O
features,327,335,O
including,336,345,O
age,346,349,O
sex,351,354,O
abnormality,356,367,O
peripheral,371,381,O
hemogram,382,390,O
treatment,398,407,O
therapeutic,409,420,O
effect,421,427,O
follow,432,438,O
laboratory,446,456,O
data,457,461,O
morphology,470,480,O
immunology,482,492,O
cytogenetics,494,506,O
molecular,511,520,O
biology,521,528,O
MICM,530,534,O
RESULTS,537,544,O
median,550,556,O
age,557,560,O
APL,568,571,O
patients,572,580,O
33,585,587,O
years,588,593,O
old,594,597,O
ratio,606,611,O
male,615,619,O
female,624,630,O
1,635,636,O
21,637,639,O
1,640,641,O
treatment,650,659,O
median,665,671,O
level,672,677,O
WBC,681,684,B-Cell
4,689,690,O
3,691,692,O
x,693,694,O
10,695,697,O
9,698,699,O
L,701,702,O
detection,711,720,O
rate,721,725,O
abnormal,729,737,O
promyelocyte,738,750,B-Cell
blood,754,759,B-Organism_substance
film,760,764,O
85,769,771,O
8,772,773,O
immunophenotypic,781,797,O
detection,798,807,O
expression,813,823,O
levels,824,830,O
CD117,834,839,O
CD34,841,845,O
HLA,847,850,O
DR,851,853,O
CD7,855,858,O
CD14,860,864,O
CD19,869,873,O
APL,877,880,O
found,886,891,O
lower,898,903,O
expression,912,922,O
levels,923,929,O
CD2,933,936,O
CD33,938,942,O
MPO,947,950,O
higher,951,957,O
subtypes,978,986,O
acute,990,995,O
myelocytic,996,1006,O
leukemia,1007,1015,O
AML,1017,1020,O
P,1028,1029,O
0,1032,1033,O
01,1034,1036,O
Specific,1039,1047,O
abnormal,1048,1056,O
chromosome,1057,1067,B-Cellular_component
t,1068,1069,O
15,1071,1073,O
17,1074,1076,O
detected,1082,1090,O
91,1094,1096,O
7,1097,1098,O
patients,1107,1115,O
75,1125,1127,O
9,1128,1129,O
standard,1135,1143,O
translocation,1144,1157,O
t,1161,1162,O
15,1164,1166,O
17,1167,1169,O
common,1187,1193,O
15,1202,1204,O
8,1205,1206,O
patients,1215,1223,O
t,1228,1229,O
15,1231,1233,O
17,1234,1236,O
additional,1243,1253,O
abnormal,1254,1262,O
chromosome,1263,1273,B-Cellular_component
7,1290,1291,O
5,1292,1293,O
patients,1302,1310,O
normal,1316,1322,O
karyotype,1323,1332,O
presence,1347,1355,O
simple,1364,1370,O
translocation,1371,1384,O
complex,1389,1396,O
translocation,1397,1410,O
seldom,1415,1421,O
seen,1422,1426,O
molecular,1433,1442,O
biological,1443,1453,O
detection,1454,1463,O
PML,1465,1468,O
RARalpha,1469,1477,O
fusion,1478,1484,O
gene,1485,1489,O
positive,1490,1498,O
rate,1499,1503,O
99,1508,1510,O
6,1511,1512,O
relatively,1520,1530,O
long,1531,1535,O
clinical,1536,1544,O
follow,1545,1551,O
found,1559,1564,O
complete,1574,1582,O
remission,1583,1592,O
CR,1594,1596,O
rate,1598,1602,O
APL,1606,1609,O
patients,1610,1618,O
84,1623,1625,O
7,1626,1627,O
incidence,1630,1639,O
DIC,1643,1646,O
13,1651,1653,O
4,1654,1655,O
year,1666,1670,O
survival,1671,1679,O
rate,1680,1684,O
30,1689,1691,O
7,1692,1693,O
median,1700,1706,O
count,1707,1712,O
WBC,1716,1719,B-Cell
CR,1723,1725,O
group,1726,1731,O
lower,1736,1741,O
non,1752,1755,O
remission,1756,1765,O
group,1766,1771,O
P,1773,1774,O
0,1777,1778,O
01,1779,1781,O
significant,1798,1809,O
differences,1810,1821,O
expressions,1825,1836,O
CD34,1840,1844,O
CD2,1849,1852,O
changes,1857,1864,O
cytogenetics,1868,1880,O
groups,1897,1903,O
P,1905,1906,O
0,1909,1910,O
05,1911,1913,O
CONCLUSIONS,1916,1927,O
Comprehensive,1929,1942,O
evaluation,1943,1953,O
MICM,1957,1961,O
important,1974,1983,O
significance,1984,1996,O
diagnosis,2004,2013,O
prognosis,2018,2027,O
judgment,2028,2036,O
APL,2041,2044,O
patients,2045,2053,O
CR,2059,2061,O
rate,2062,2066,O
patients,2076,2084,O
high,2090,2094,O
WBC,2095,2098,B-Cell
count,2099,2104,O
considerable,2109,2121,O
low,2122,2125,O
Cognitive,0,9,O
function,10,18,O
number,23,29,O
teeth,33,38,B-Organ
community,44,53,O
dwelling,54,62,O
elderly,63,70,O
population,71,81,O
dementia,90,98,O
number,113,119,O
sound,123,128,O
decayed,132,139,O
teeth,140,145,B-Organ
reported,155,163,O
associated,170,180,O
cognitive,186,195,O
function,196,204,O
elderly,208,215,O
populations,216,227,O
dementia,233,241,O
little,243,249,O
known,253,258,O
association,270,281,O
elderly,285,292,O
populations,293,304,O
dementia,313,321,O
evaluated,326,335,O
relationship,341,353,O
adjustment,360,370,O
confounding,375,386,O
factors,387,394,O
Japanese,399,407,O
populations,408,419,O
60,423,425,O
year,426,430,O
old,431,434,O
n,436,437,O
270,440,443,O
120,445,448,O
males,449,454,O
150,459,462,O
females,463,470,O
65,476,478,O
year,479,483,O
old,484,487,O
n,489,490,O
123,493,496,O
57,498,500,O
males,501,506,O
66,511,513,O
females,514,521,O
individuals,523,534,O
residing,535,543,O
Fukuoka,547,554,O
Prefecture,555,565,O
Japan,569,574,O
Dental,576,582,O
examinations,583,595,O
performed,601,610,O
subjects,618,626,O
Mini,643,647,O
mental,648,654,O
state,655,660,O
examination,661,672,O
MMSE,674,678,O
assessing,684,693,O
cognitive,694,703,O
function,704,712,O
total,724,729,O
393,733,736,O
subjects,737,745,O
mean,751,755,O
MMSE,756,760,O
score,761,766,O
27,771,773,O
9,774,775,O
1,780,781,O
9,782,783,O
391,789,792,O
subjects,793,801,O
scored,802,808,O
24,809,811,O
higher,815,821,O
mean,827,831,O
numbers,832,839,O
sound,843,848,O
decayed,853,860,O
teeth,861,866,B-Organ
12,872,874,O
0,875,876,O
6,881,882,O
3,883,884,O
0,889,890,O
5,891,892,O
1,897,898,O
2,899,900,O
respectively,902,914,O
Associations,916,928,O
found,934,939,O
numbers,952,959,O
sound,963,968,O
decayed,973,980,O
teeth,981,986,B-Organ
MMSE,991,995,O
total,999,1004,O
subjects,1005,1013,O
males,1018,1023,O
females,1036,1043,O
multiple,1048,1056,O
regression,1057,1067,O
analysis,1068,1076,O
adjusted,1077,1085,O
gender,1090,1096,O
age,1098,1101,O
level,1103,1108,O
education,1112,1121,O
marital,1123,1130,O
status,1131,1137,O
smoking,1139,1146,O
alcohol,1148,1155,O
drinking,1156,1164,O
working,1166,1173,O
status,1174,1180,O
systolic,1182,1190,O
blood,1191,1196,B-Organism_substance
pressure,1197,1205,O
blood,1210,1215,B-Organism_substance
glucose,1216,1223,O
association,1228,1239,O
found,1249,1254,O
MMSE,1263,1267,O
number,1276,1282,O
sound,1286,1291,O
teeth,1292,1297,B-Organ
logistic,1303,1311,O
regression,1312,1322,O
analysis,1323,1331,O
conclusion,1336,1346,O
associations,1348,1360,O
found,1366,1371,O
normal,1380,1386,O
range,1387,1392,O
cognitive,1393,1402,O
function,1403,1411,O
numbers,1420,1427,O
sound,1431,1436,O
decayed,1441,1448,O
teeth,1449,1454,B-Organ
adjustment,1462,1472,O
confounding,1485,1496,O
factors,1497,1504,O
elderly,1512,1519,O
Japanese,1520,1528,O
population,1529,1539,O
Comment,0,7,O
reduced,16,23,O
form,24,28,O
regression,29,39,O
models,40,46,O
health,50,56,O
effects,57,64,O
versus,65,71,O
exposures,72,81,O
replace,93,100,O
QRA,101,104,O
livestock,106,115,O
production,116,126,O
infant,131,137,O
mortality,138,147,O
example,154,161,O
Louis,167,172,O
Anthony,173,180,O
Tony,182,186,O
Cox,188,191,O
Jr,193,195,O
Risk,198,202,O
Analysis,203,211,O
2009,212,216,O
Vol,218,221,O
29,223,225,O
12,231,233,O
recent,243,249,O
paper,250,255,O
Cox,259,262,O
journal,271,278,O
uses,279,283,O
motivating,291,301,O
factor,302,308,O
benefits,313,321,O
quantitative,325,337,O
risk,338,342,O
assessment,343,353,O
content,359,366,O
entirely,370,378,O
devoted,379,386,O
critiquing,390,400,O
Sneeringer,401,411,O
s,412,413,O
article,414,421,O
American,429,437,O
Journal,438,445,O
Agricultural,449,461,O
Economics,462,471,O
Cox,473,476,O
s,477,478,O
main,483,487,O
critiques,488,497,O
Sneeringer,501,511,O
fundamentally,516,529,O
flawed,530,536,O
misrepresent,541,553,O
original,558,566,O
article,567,574,O
Cox,576,579,O
posits,580,586,O
Sneeringer,592,602,O
B,613,614,O
argues,625,631,O
B,642,643,O
incorrect,648,657,O
Sneeringer,668,678,O
fact,682,686,O
C,691,692,O
D,697,698,O
critiques,705,714,O
B,724,725,O
applicable,734,744,O
Sneeringer,748,758,O
s,759,760,O
analysis,761,769,O
Prognostic,0,10,O
significance,11,23,O
TRAIL,27,32,O
signaling,33,42,O
molecules,43,52,O
stage,56,61,B-Pathological_formation
II,62,64,I-Pathological_formation
III,69,72,I-Pathological_formation
colorectal,73,83,I-Pathological_formation
cancer,84,90,I-Pathological_formation
PURPOSE,92,99,O
previously,104,114,O
found,115,120,O
cellular,126,134,O
FLICE,135,140,O
inhibitory,141,151,O
protein,152,159,O
c,161,162,O
FLIP,163,167,O
caspase,170,177,O
8,178,179,O
tumor,185,190,O
necrosis,191,199,O
factor,200,206,O
related,207,214,O
apoptosis,215,224,O
inducing,225,233,O
ligand,234,240,O
TRAIL,242,247,O
receptor,249,257,O
2,258,259,O
DR5,261,264,O
major,270,275,O
regulators,276,286,O
cell,290,294,B-Cell
viability,295,304,O
chemotherapy,309,321,O
induced,322,329,O
apoptosis,330,339,O
colorectal,343,353,B-Pathological_formation
cancer,354,360,I-Pathological_formation
study,370,375,O
determined,380,390,O
prognostic,395,405,O
significance,406,418,O
c,422,423,O
FLIP,424,428,O
caspase,430,437,O
8,438,439,O
TRAIL,441,446,O
DR5,451,454,O
expression,455,465,O
tissues,469,476,B-Tissue
patients,482,490,O
stage,496,501,B-Pathological_formation
II,502,504,I-Pathological_formation
III,509,512,I-Pathological_formation
colorectal,513,523,I-Pathological_formation
cancer,524,530,I-Pathological_formation
EXPERIMENTAL,532,544,O
DESIGN,545,551,O
Tissue,553,559,B-Tissue
microarrays,560,571,O
constructed,577,588,O
matched,594,601,O
normal,602,608,B-Tissue
tumor,613,618,B-Tissue
tissue,619,625,I-Tissue
derived,626,633,O
patients,639,647,O
n,649,650,O
253,653,656,O
enrolled,658,666,O
phase,672,677,O
III,678,681,O
trial,682,687,O
adjuvant,691,699,O
5,700,701,O
fluorouracil,702,714,O
based,715,720,O
chemotherapy,721,733,O
versus,734,740,O
postoperative,741,754,O
observation,755,766,O
TRAIL,774,779,O
DR5,781,784,O
caspase,786,793,O
8,794,795,O
c,801,802,O
FLIP,803,807,O
expression,808,818,O
levels,819,825,O
determined,831,841,O
immunohistochemistry,845,865,O
RESULTS,867,874,O
Colorectal,876,886,B-Pathological_formation
tumors,887,893,I-Pathological_formation
displayed,894,903,O
significantly,904,917,O
higher,918,924,O
expression,925,935,O
levels,936,942,O
c,946,947,O
FLIP,948,952,O
P,954,955,O
0,958,959,O
001,960,963,O
caspase,966,973,O
8,974,975,O
P,977,978,O
0,981,982,O
01,983,985,O
DR5,992,995,O
P,997,998,O
0,1001,1002,O
001,1003,1006,O
lower,1013,1018,O
levels,1019,1025,O
TRAIL,1029,1034,O
P,1036,1037,O
0,1040,1041,O
001,1042,1045,O
compared,1047,1055,O
matched,1061,1068,O
normal,1069,1075,B-Tissue
tissue,1076,1082,I-Tissue
univariate,1087,1097,O
analysis,1098,1106,O
higher,1108,1114,O
TRAIL,1115,1120,O
expression,1121,1131,O
tumor,1139,1144,B-Pathological_formation
associated,1149,1159,O
worse,1165,1170,O
overall,1171,1178,O
survival,1179,1187,O
P,1189,1190,O
0,1193,1194,O
026,1195,1198,O
trend,1208,1213,O
decreased,1217,1226,O
relapse,1227,1234,O
free,1235,1239,O
survival,1240,1248,O
RFS,1250,1253,O
P,1255,1256,O
0,1259,1260,O
06,1261,1263,O
higher,1270,1276,O
tumor,1277,1282,B-Pathological_formation
c,1283,1284,O
FLIP,1285,1289,O
expression,1290,1300,O
associated,1305,1315,O
significantly,1323,1336,O
decreased,1337,1346,O
RFS,1347,1350,O
P,1352,1353,O
0,1356,1357,O
015,1358,1361,O
multivariate,1370,1382,O
predictive,1383,1393,O
modeling,1394,1402,O
RFS,1407,1410,O
patients,1418,1426,O
including,1431,1440,O
biomarkers,1445,1455,O
age,1457,1460,O
treatment,1462,1471,O
stage,1477,1482,O
found,1487,1492,O
model,1502,1507,O
significant,1512,1523,O
mean,1533,1537,O
tumor,1538,1543,B-Pathological_formation
c,1544,1545,O
FLIP,1546,1550,O
expression,1551,1561,O
score,1562,1567,O
disease,1572,1579,O
stage,1580,1585,O
included,1591,1599,O
P,1601,1602,O
0,1605,1606,O
001,1607,1610,O
regards,1616,1623,O
overall,1624,1631,O
survival,1632,1640,O
overall,1646,1653,O
model,1654,1659,O
predictive,1664,1674,O
TRAIL,1685,1690,O
expression,1691,1701,O
disease,1706,1713,O
stage,1714,1719,O
included,1725,1733,O
P,1735,1736,O
0,1739,1740,O
001,1741,1744,O
CONCLUSIONS,1747,1758,O
High,1760,1764,O
c,1765,1766,O
FLIP,1767,1771,O
TRAIL,1776,1781,O
expression,1782,1792,O
independent,1800,1811,O
adverse,1812,1819,O
prognostic,1820,1830,O
markers,1831,1838,O
stage,1842,1847,B-Pathological_formation
II,1848,1850,I-Pathological_formation
III,1855,1858,I-Pathological_formation
colorectal,1859,1869,I-Pathological_formation
cancer,1870,1876,I-Pathological_formation
identify,1887,1895,O
patients,1896,1904,O
risk,1913,1917,O
relapse,1921,1928,O
Influences,0,10,O
pharmacokinetics,18,34,O
oxycodone,38,47,O
multicentre,51,62,O
cross,63,68,O
sectional,69,78,O
study,79,84,O
439,88,91,O
adult,92,97,O
cancer,98,104,B-Pathological_formation
patients,105,113,O
OBJECTIVE,115,124,O
Oxycodone,126,135,O
widely,139,145,O
treatment,159,168,O
cancer,172,178,B-Pathological_formation
pain,179,183,O
little,189,195,O
known,199,204,O
pharmacokinetics,212,228,O
cancer,232,238,B-Pathological_formation
pain,239,243,O
patients,244,252,O
aim,258,261,O
study,270,275,O
explore,283,290,O
relationships,295,308,O
ordinary,317,325,O
patient,326,333,O
characteristics,334,349,O
serum,354,359,B-Organism_substance
concentrations,360,374,O
oxycodone,378,387,O
ratios,396,402,O
noroxycodone,403,415,O
oxymorphone,419,430,O
oxycodone,431,440,O
cancer,444,450,B-Pathological_formation
patients,451,459,O
METHODS,461,468,O
thirty,487,493,O
patients,499,507,O
oral,514,518,O
oxycodone,519,528,O
cancer,533,539,B-Pathological_formation
pain,540,544,O
included,550,558,O
patients,564,572,O
characteristics,574,589,O
sex,591,594,O
age,596,599,O
body,601,605,B-Organism_subdivision
mass,606,610,O
index,611,616,O
BMI,618,621,O
Karnofsky,624,633,O
performance,634,645,O
status,646,652,O
time,655,659,O
starting,666,674,O
opioids,675,682,O
oxycodone,686,695,O
total,696,701,O
daily,702,707,O
dose,708,712,O
time,716,720,O
oxycodone,731,740,O
dose,741,745,O
use,748,751,O
CYP3A4,755,761,O
inducer,762,769,O
inhibitor,770,779,O
use,782,785,O
systemic,789,797,O
steroids,798,806,O
number,810,816,O
medications,820,831,O
taken,832,837,O
24,850,852,O
h,853,854,O
glomerular,857,867,B-Multi-tissue_structure
filtration,868,878,O
rate,879,883,O
GFR,885,888,O
albumin,894,901,O
serum,902,907,B-Organism_substance
concentrations,908,922,O
influence,924,933,O
oxycodone,937,946,O
serum,947,952,B-Organism_substance
concentrations,953,967,O
metabolite,971,981,O
oxycodone,982,991,O
ratios,992,998,O
explored,1004,1012,O
multiple,1016,1024,O
regression,1025,1035,O
analyses,1036,1044,O
RESULTS,1046,1053,O
Sex,1055,1058,O
CYP3A4,1060,1066,O
inducers,1067,1075,O
inhibitors,1076,1086,O
total,1088,1093,O
daily,1094,1099,O
dose,1100,1104,O
time,1111,1115,O
oxycodone,1126,1135,O
dose,1136,1140,O
predicted,1142,1151,O
oxycodone,1152,1161,O
concentrations,1162,1176,O
CYP3A4,1178,1184,O
inducers,1185,1193,O
total,1195,1200,O
daily,1201,1206,O
dose,1207,1211,O
number,1218,1224,O
medications,1228,1239,O
taken,1240,1245,O
24,1258,1260,O
h,1261,1262,O
predicted,1264,1273,O
oxymorphone,1278,1289,O
oxycodone,1290,1299,O
ratio,1300,1305,O
Total,1307,1312,O
daily,1313,1318,O
dose,1319,1323,O
time,1326,1330,O
dose,1341,1345,O
blood,1349,1354,B-Organism_substance
sample,1355,1361,I-Organism_substance
albumin,1364,1371,O
sex,1373,1376,O
CYP3A4,1378,1384,O
inducers,1385,1393,O
inhibitors,1394,1404,O
steroids,1406,1414,O
BMI,1416,1419,O
GFR,1424,1427,O
predicted,1428,1437,O
noroxycodone,1442,1454,O
oxycodone,1455,1464,O
ratio,1465,1470,O
CONCLUSION,1472,1482,O
Women,1484,1489,O
lower,1494,1499,O
oxycodone,1500,1509,O
serum,1510,1515,B-Organism_substance
concentrations,1516,1530,O
men,1536,1539,O
CYP3A4,1541,1547,O
inducers,1548,1556,O
inhibitors,1557,1567,O
caution,1588,1595,O
predicted,1609,1618,O
significant,1629,1640,O
impact,1641,1647,O
oxycodone,1651,1660,O
pharmacokinetics,1661,1677,O
characteristics,1685,1700,O
explained,1701,1710,O
minor,1716,1721,O
parts,1722,1727,O
variability,1735,1746,O
outcomes,1754,1762,O
Phase,0,5,O
II,6,8,O
trial,9,14,O
D,20,21,O
Trp,22,25,O
6,26,27,O
LH,28,30,O
RH,31,33,O
prostatic,37,46,B-Pathological_formation
carcinoma,47,56,I-Pathological_formation
comparison,58,68,O
hormonal,80,88,O
agents,89,95,O
approaches,105,115,O
hormonal,119,127,O
treatment,128,137,O
prostate,141,149,B-Pathological_formation
carcinoma,150,159,I-Pathological_formation
discussed,164,173,O
Eighty,175,181,O
patients,186,194,O
prostatic,200,209,B-Pathological_formation
carcinoma,210,219,I-Pathological_formation
stage,232,237,O
B,238,239,O
stage,251,256,O
C,257,258,O
64,264,266,O
stage,272,277,O
D,278,279,O
disease,280,287,O
treated,294,301,O
subcutaneously,302,316,O
daily,317,322,O
3,327,328,O
months,329,335,O
LH,345,347,O
RH,348,350,O
agonist,351,358,O
D,359,360,O
Trp,361,364,O
6,365,366,O
LH,367,369,O
RH,370,372,O
Decapeptyl,374,384,O
order,389,394,O
evaluate,398,406,O
incidence,411,420,O
remissions,424,434,O
according,435,444,O
recommendations,452,467,O
oncologic,472,481,O
trials,482,488,O
findings,494,502,O
compared,508,516,O
obtained,526,534,O
hormonal,546,554,O
therapies,555,564,O
prostatic,568,577,B-Pathological_formation
carcinoma,578,587,I-Pathological_formation
according,588,597,O
statistical,605,616,O
method,617,623,O
expected,628,636,O
response,637,645,O
rate,646,650,O
adapted,655,662,O
Lee,666,669,O
Wesley,674,680,O
phase,685,690,O
II,691,693,O
trials,694,700,O
Treatment,702,711,O
D,717,718,O
Trp,719,722,O
6,723,724,O
LH,725,727,O
RH,728,730,O
greatly,731,738,O
reduced,739,746,O
serum,747,752,B-Organism_substance
LH,753,755,O
testosterone,760,772,O
levels,773,779,O
raising,788,795,O
serum,796,801,B-Organism_substance
prolactin,802,811,O
1,819,820,O
2,821,822,O
weeks,823,828,O
therapy,832,839,O
relief,851,857,O
subjective,861,871,O
symptoms,872,880,O
reversal,887,895,O
signs,903,908,O
prostatism,912,922,O
marked,936,942,O
decrease,943,951,O
bone,955,959,B-Organ
pain,960,964,O
90,969,971,O
days,972,976,O
52,977,979,O
patients,980,988,O
complete,993,1001,O
relief,1002,1008,O
prostatism,1012,1022,O
21,1027,1029,O
mild,1039,1043,O
signs,1044,1049,O
symptoms,1054,1062,O
Seventy,1064,1071,O
patients,1072,1080,O
experiencing,1086,1098,O
bone,1102,1106,B-Organ
pain,1107,1111,O
additional,1119,1129,O
mild,1143,1147,O
pain,1148,1152,O
Prostatic,1154,1163,B-Organ
size,1164,1168,O
evaluated,1170,1179,O
rectal,1183,1189,O
examination,1190,1201,O
transabdominal,1206,1220,B-Organism_subdivision
ultrasonography,1221,1236,O
reverted,1238,1246,O
normal,1250,1256,O
26,1260,1262,O
4,1263,1264,O
patients,1269,1277,O
complete,1279,1287,O
remission,1288,1297,O
reduced,1307,1314,O
50,1328,1330,O
additional,1338,1348,O
17,1349,1351,O
6,1352,1353,O
partial,1356,1363,O
remission,1364,1373,O
overall,1380,1387,O
rate,1388,1392,O
complete,1396,1404,O
plus,1405,1409,O
partial,1410,1417,O
regression,1418,1428,O
prostatic,1432,1441,B-Organ
enlargement,1442,1453,O
44,1460,1462,O
Scans,1465,1470,O
showed,1471,1477,O
major,1480,1485,O
improvement,1486,1497,O
bone,1501,1505,B-Pathological_formation
lesions,1506,1513,I-Pathological_formation
14,1517,1519,O
8,1520,1521,O
cases,1526,1531,O
response,1538,1546,O
increased,1547,1556,O
37,1560,1562,O
6,1580,1581,O
months,1582,1588,O
follow,1592,1598,O
Prostatic,1603,1612,B-Organ
acid,1613,1617,O
phosphatase,1618,1629,O
levels,1630,1636,O
decreased,1642,1651,O
50,1665,1667,O
61,1672,1674,O
patients,1683,1691,O
test,1702,1706,O
appears,1707,1714,O
valid,1728,1733,O
marker,1734,1740,O
lipid,1750,1755,O
associated,1756,1766,O
sialic,1767,1773,O
acid,1774,1778,O
LASA,1780,1784,O
increase,1791,1799,O
LASA,1803,1807,O
treatment,1815,1824,O
reduction,1831,1840,O
treatment,1847,1856,O
frequently,1861,1871,O
correlated,1875,1885,O
objective,1895,1904,O
volume,1905,1911,O
neoplasms,1919,1928,B-Pathological_formation
flare,1933,1938,O
disease,1949,1956,O
encountered,1961,1972,O
effects,1997,2004,O
impotence,2016,2025,O
Statistical,2027,2038,O
analyses,2039,2047,O
results,2051,2058,O
method,2066,2072,O
Lee,2076,2079,O
Wesley,2084,2090,O
indicated,2091,2100,O
incidence,2110,2119,O
complete,2123,2131,O
partial,2136,2143,O
regression,2144,2154,O
CR,2156,2158,O
PR,2163,2165,O
observed,2167,2175,O
D,2181,2182,O
Trp,2183,2186,O
6,2187,2188,O
LH,2189,2191,O
RH,2192,2194,O
significantly,2203,2216,O
different,2217,2226,O
recorded,2237,2245,O
previous,2249,2257,O
studies,2258,2265,O
LH,2278,2280,O
RH,2281,2283,O
analog,2284,2290,O
Buserelin,2292,2301,O
CR,2312,2314,O
PR,2319,2321,O
obtained,2322,2330,O
D,2336,2337,O
Trp,2338,2341,O
6,2342,2343,O
LH,2344,2346,O
RH,2347,2349,O
44,2351,2353,O
significantly,2361,2374,O
higher,2375,2381,O
subcapsular,2392,2403,O
orchiectomy,2404,2415,O
22,2417,2419,O
Hormonal,2423,2431,O
effects,2432,2439,O
actions,2455,2462,O
D,2466,2467,O
Trp,2468,2471,O
6,2472,2473,O
LH,2474,2476,O
RH,2477,2479,O
compared,2485,2493,O
contrasted,2498,2508,O
produced,2520,2528,O
castration,2532,2542,O
estrogens,2544,2553,O
antiandrogens,2555,2568,O
progestogens,2574,2586,O
ABSTRACT,2588,2596,O
TRUNCATED,2597,2606,O
400,2610,2613,O
WORDS,2614,2619,O
Histophysiology,1,16,O
histopathology,21,35,O
adrenals,43,51,B-Organ
experimental,55,67,O
hypokinesia,68,79,O
experiments,85,96,O
male,100,104,O
rats,105,109,O
course,117,123,O
3,127,128,O
month,129,134,O
hypokinesia,135,146,O
phasic,147,153,O
changes,154,161,O
observed,167,175,O
relative,183,191,O
adrenal,192,199,B-Organ
gland,200,205,I-Organ
weight,206,212,O
volume,221,227,O
cell,235,239,B-Cellular_component
nuclei,240,246,I-Cellular_component
glomerular,254,264,B-Multi-tissue_structure
fasicular,266,275,B-Multi-tissue_structure
zones,276,281,I-Multi-tissue_structure
medulla,290,297,B-Multi-tissue_structure
activity,306,314,O
succinic,322,330,O
dehydrogenase,331,344,O
alkaline,346,354,O
acid,359,363,O
phosphatases,364,376,O
RNA,385,388,O
catecholamine,393,406,O
content,407,414,O
changes,422,429,O
associated,434,444,O
variations,450,460,O
secretion,468,477,O
biosynthesis,482,494,O
hormones,502,510,O
cortical,518,526,B-Multi-tissue_structure
medullary,535,544,B-Multi-tissue_structure
layer,545,550,I-Multi-tissue_structure
adrenal,558,565,B-Organ
glands,566,572,I-Organ
hypokinetic,584,595,O
stress,596,602,O
development,603,614,O
Dynorphin,0,9,O
contained,13,22,O
hippocampal,30,41,B-Tissue
mossy,42,47,I-Tissue
fibers,48,54,I-Tissue
immunochemical,56,70,O
alterations,71,82,O
kainic,89,95,O
acid,96,100,O
administration,101,115,O
colchicine,120,130,O
induced,131,138,O
neurotoxicity,139,152,O
Antisera,154,162,B-Organism_substance
raised,163,169,O
synthetic,178,187,O
dynorphin,188,197,O
Leu5,202,206,O
enkephalin,207,217,O
demonstrate,218,229,O
immunostaining,230,244,O
hippocampal,248,259,B-Tissue
mossy,260,265,I-Tissue
fibers,266,272,I-Tissue
dentate,280,287,B-Cell
granule,288,295,I-Cell
cells,296,301,I-Cell
dynorphin,312,321,O
immunoreactivity,322,338,O
ir,340,342,O
appears,344,351,O
denser,358,364,O
immunocytochemical,368,386,O
preparations,387,399,O
quantitatively,407,421,O
greater,422,429,O
radioimmunoassay,433,449,O
enkephalin,455,465,O
ir,466,468,O
Immunostaining,470,484,O
dynorphin,490,499,O
antisera,500,508,O
eliminated,512,522,O
adsorption,526,536,O
1,542,543,O
100,544,547,O
microM,548,554,O
dynorphin,555,564,O
17,565,567,O
immunostaining,576,590,O
enkephalin,596,606,O
antisera,607,615,O
eliminated,619,629,O
adsorption,633,643,O
1,649,650,O
100,651,654,O
microM,655,661,O
Leu5,663,667,O
enkephalin,668,678,O
dynorphin,680,689,O
17,690,692,O
dynorphin,694,703,O
1,705,706,O
13,707,709,O
alpha,715,720,O
neo,721,724,O
endorphin,725,734,O
Intrahippocampal,736,752,B-Multi-tissue_structure
colchicine,753,763,O
injections,764,774,O
selectively,782,793,O
destroy,794,801,O
dentate,802,809,O
granule,810,817,O
cells,818,823,O
significantly,825,838,O
decrease,839,847,O
dynorphin,852,861,O
ir,862,864,O
enkephalin,869,879,O
ir,880,882,O
levels,883,889,O
rat,893,896,O
hippocampus,897,908,B-Multi-tissue_structure
Intraventricularly,910,928,B-Multi-tissue_structure
administered,929,941,O
kainic,942,948,O
acid,949,953,O
selectively,961,972,O
destroys,973,981,O
CA3,982,985,B-Cell
4,986,987,I-Cell
pyramidal,988,997,I-Cell
cells,998,1003,I-Cell
results,1005,1012,O
increase,1019,1027,O
enkephalin,1031,1041,O
immunostaining,1042,1056,O
mossy,1060,1065,B-Tissue
fibers,1066,1072,I-Tissue
significant,1079,1090,O
increase,1091,1099,O
enkephalin,1103,1113,O
ir,1114,1116,O
radioimmunoassay,1120,1136,O
hippocampus,1146,1157,B-Multi-tissue_structure
enkephalin,1163,1173,B-Cell
ir,1174,1176,I-Cell
cells,1177,1182,I-Cell
fibers,1187,1193,B-Tissue
entorhinal,1197,1207,B-Multi-tissue_structure
perirhinal,1208,1218,B-Multi-tissue_structure
cortex,1219,1225,I-Multi-tissue_structure
innervate,1233,1242,O
rat,1243,1246,O
hippocampus,1247,1258,B-Multi-tissue_structure
dentate,1263,1270,B-Multi-tissue_structure
gyrus,1271,1276,I-Multi-tissue_structure
contain,1285,1292,O
dynorphin,1293,1302,O
ir,1303,1305,O
Differential,0,12,O
reactivity,13,23,O
functional,31,41,O
sulfhydryl,42,52,O
groups,53,59,O
cysteine,63,71,O
32,72,74,O
cysteine,79,87,O
35,88,90,O
present,91,98,O
reduced,106,113,O
form,114,118,O
thioredoxin,122,133,O
Escherichia,139,150,O
coli,151,155,O
sulfhydryl,173,183,O
groups,184,190,O
Cys,196,199,O
32,200,202,O
Cys,207,210,O
35,211,213,O
active,221,227,O
center,228,234,O
native,238,244,O
Escherichia,245,256,O
coli,257,261,O
thioredoxin,262,273,O
SH,275,277,O
2,278,279,O
alkylated,284,293,O
excess,297,303,O
iodoacetic,304,314,O
acid,315,319,O
pH,323,325,O
values,326,332,O
8,339,340,O
0,341,342,O
groups,349,355,O
reacted,356,363,O
protein,371,378,O
denatured,379,388,O
4,394,395,O
5,396,397,O
M,398,399,O
guanidine,400,409,O
hydrochloride,410,423,O
second,429,435,O
order,436,441,O
rate,442,446,O
alkylation,450,460,O
thioredoxin,464,475,O
SH,477,479,O
2,480,481,O
1,487,488,O
eq,489,491,O
iodoacetic,495,505,O
acid,506,510,O
pH,515,517,O
dependent,518,527,O
showed,532,538,O
independent,539,550,O
initial,551,558,O
reactions,559,568,O
thiolate,576,584,O
ion,585,588,O
pK,596,598,O
value,599,604,O
6,608,609,O
7,610,611,O
second,618,624,O
pK,632,634,O
value,635,640,O
close,641,646,O
9,650,651,O
0,652,653,O
pH,664,666,O
dependence,667,677,O
observed,682,690,O
alkylation,695,705,O
iodoacetamide,711,724,O
apparent,733,741,O
rate,742,746,O
constant,747,755,O
107,757,760,O
M,761,762,O
1,763,764,O
S,765,766,O
1,767,768,O
pH,772,774,O
7,775,776,O
2,777,778,O
20,790,792,O
fold,793,797,O
higher,798,804,O
corresponding,814,827,O
rate,828,832,O
iodoacetate,838,849,O
sulfhydryl,855,865,O
group,866,871,O
pK,879,881,O
value,882,887,O
6,891,892,O
7,893,894,O
shown,899,904,O
belong,908,914,O
Cys,918,921,O
32,922,924,O
labeling,928,936,O
thioredoxin,937,948,O
14C,955,958,O
iodoacetic,959,969,O
acid,970,974,O
followed,975,983,O
complete,987,995,O
alkylation,996,1006,O
3H,1013,1015,O
iodoacetate,1016,1027,O
amino,1032,1037,O
acid,1038,1042,O
sequence,1043,1051,O
analysis,1052,1060,O
peptides,1064,1072,O
active,1082,1088,O
center,1089,1095,O
abnormally,1101,1111,O
low,1112,1115,O
pK,1116,1118,O
value,1119,1124,O
Cys,1128,1131,O
32,1132,1134,O
suggested,1138,1147,O
arise,1151,1156,O
electrostatic,1160,1173,O
influence,1174,1183,O
positive,1191,1199,O
charge,1200,1206,O
amino,1214,1219,O
group,1220,1225,O
Lys,1229,1232,O
36,1233,1235,O
mechanism,1239,1248,O
action,1252,1258,O
thioredoxin,1263,1274,O
SH,1276,1278,O
2,1279,1280,O
protein,1286,1293,O
disulfide,1294,1303,O
reductase,1304,1313,O
formulated,1323,1333,O
based,1343,1348,O
initial,1355,1362,O
nucleophilic,1363,1375,O
attack,1376,1382,O
thiolate,1390,1398,O
Cys,1402,1405,O
32,1406,1408,O
formation,1418,1427,O
unstable,1434,1442,O
transient,1443,1452,O
mixed,1453,1458,O
disulfide,1459,1468,O
involving,1469,1478,O
Cys,1479,1482,O
32,1483,1485,O
sulfurs,1501,1508,O
substrate,1516,1525,O
followed,1535,1543,O
conformational,1549,1563,O
change,1564,1570,O
nucleophilic,1577,1589,O
attack,1590,1596,O
Cys,1600,1603,O
35,1604,1606,O
14,1619,1621,O
membered,1622,1630,O
disulfide,1631,1640,O
ring,1641,1645,O
thioredoxin,1649,1660,O
S2,1661,1663,O
dithiol,1672,1679,O
substrate,1687,1696,O
Identification,0,14,O
NAB1,18,22,O
repressor,26,35,O
NGFI,39,43,O
Krox20,51,57,O
mediated,58,66,O
transcription,67,80,O
NGFI,82,86,O
called,95,101,O
Egr1,102,106,O
Zif268,108,114,O
Krox24,119,125,O
closely,135,142,O
related,143,150,O
proteins,151,159,O
Krox20,160,166,O
NGFI,168,172,O
C,173,174,O
Egr3,180,184,O
zinc,189,193,O
finger,194,200,O
transcription,201,214,O
factors,215,222,O
encoded,223,230,O
immediate,234,243,O
early,244,249,O
genes,250,255,O
induced,266,273,O
wide,279,283,O
variety,284,291,O
extracellular,295,308,B-Immaterial_anatomical_entity
stimuli,309,316,O
NGFI,318,322,O
implicated,334,344,O
cell,348,352,B-Cell
proliferation,353,366,O
macrophage,368,378,B-Cell
differentiation,379,394,O
synaptic,396,404,B-Cellular_component
activation,405,415,O
long,421,425,O
term,426,430,O
potentiation,431,443,O
Krox20,453,459,O
critical,463,471,O
proper,476,482,O
hindbrain,483,492,O
segmentation,493,505,O
peripheral,510,520,B-Multi-tissue_structure
nerve,521,526,I-Multi-tissue_structure
myelination,527,538,O
previous,543,551,O
work,552,556,O
structure,560,569,O
function,570,578,O
analysis,579,587,O
NGFI,591,595,O
revealed,598,606,O
34,609,611,O
aa,612,614,O
inhibitory,615,625,O
domain,626,632,O
hypothesized,642,654,O
target,665,671,O
cellular,677,685,B-Cell
factor,686,692,O
represses,698,707,O
NGFI,708,712,O
transcriptional,715,730,O
activity,731,739,O
yeast,751,756,O
hybrid,761,767,O
system,768,774,O
isolated,784,792,O
cDNA,795,799,O
clone,800,805,O
encodes,812,819,O
protein,822,829,O
interacts,835,844,O
inhibitory,855,865,O
domain,866,872,O
inhibits,877,885,O
ability,890,897,O
NGFI,901,905,O
activate,911,919,O
transcription,920,933,O
NGFI,940,944,O
binding,947,954,O
protein,955,962,O
NAB1,964,968,O
570,975,978,O
aa,979,981,O
nuclear,982,989,B-Cellular_component
protein,990,997,O
bears,1003,1008,O
obvious,1012,1019,O
sequence,1020,1028,O
homology,1029,1037,O
known,1041,1046,O
proteins,1047,1055,O
NAB1,1057,1061,O
represses,1067,1076,O
Krox20,1077,1083,O
activity,1084,1092,O
influence,1110,1119,O
Egr3,1120,1124,O
NGFI,1128,1132,O
G,1133,1134,O
providing,1141,1150,O
mechanism,1153,1162,O
differential,1171,1183,O
regulation,1184,1194,O
family,1203,1209,O
immediate,1213,1222,O
early,1223,1228,O
transcription,1229,1242,O
factors,1243,1250,O
Comparison,0,10,O
image,14,19,O
CAS,21,24,O
200,25,28,O
flow,34,38,O
cytometry,39,48,O
determined,49,59,O
DNA,60,63,O
content,64,71,O
paraffin,75,83,O
embedded,84,92,O
Hodgkin,93,100,B-Tissue
s,101,102,I-Tissue
disease,103,110,I-Tissue
tissue,111,117,I-Tissue
assess,122,128,O
reliability,133,144,O
DNA,148,151,O
estimation,152,162,O
image,169,174,O
cytometry,175,184,O
deparaffinized,186,200,O
lymph,201,206,B-Multi-tissue_structure
nodes,207,212,I-Multi-tissue_structure
70,218,220,O
patients,221,229,O
Hodgkin,235,242,O
s,243,244,O
disease,245,252,O
examined,258,266,O
results,275,282,O
obtained,283,291,O
compared,297,305,O
flow,322,326,O
cytometry,327,336,O
Image,338,343,O
analysis,344,352,O
discriminating,361,375,O
cell,396,400,B-Cell
types,401,406,O
found,411,416,O
Hodgkin,420,427,O
s,428,429,O
disease,430,437,O
revealed,439,447,O
separate,451,459,O
aneuploid,460,469,O
peak,470,474,O
Selecting,476,485,O
morphologically,489,504,O
defined,505,512,O
nuclear,513,520,B-Cellular_component
types,521,526,O
DNA,527,530,O
aneuploidy,531,541,O
detected,546,554,O
20,558,560,O
cases,569,574,O
14,576,578,O
70,579,581,O
aneuploid,588,597,O
populations,598,609,O
limited,615,622,O
population,630,640,O
nuclei,644,650,B-Cellular_component
defined,651,658,O
Reed,662,666,O
Sternberg,667,676,O
RS,678,680,O
like,682,686,O
medium,690,696,O
sized,697,702,O
lymphocytes,703,714,B-Cell
Benign,716,722,B-Pathological_formation
lymph,723,728,I-Pathological_formation
nodes,729,734,I-Pathological_formation
DNA,735,738,O
aneuploidy,739,749,O
found,758,763,O
controls,778,786,O
Comparison,788,798,O
DNA,802,805,O
histograms,806,816,O
obtained,817,825,O
image,829,834,O
flow,839,843,O
cytometry,844,853,O
showed,854,860,O
aneuploid,861,870,O
peaks,871,876,O
image,883,888,O
cytometry,889,898,O
4,902,903,O
30,907,909,O
diploid,910,917,O
10,922,924,O
40,928,930,O
aneuploid,931,940,O
flow,941,945,O
histograms,946,956,O
conclusion,961,971,O
image,973,978,O
analysis,979,987,O
CAS,998,1001,O
200,1002,1005,O
system,1006,1012,O
compared,1016,1024,O
flow,1028,1032,O
cytometry,1033,1042,O
time,1051,1055,O
consuming,1056,1065,O
sensitive,1075,1084,O
assess,1088,1094,O
ploidy,1095,1101,O
status,1102,1108,O
provide,1126,1133,O
extra,1134,1139,O
information,1140,1151,O
selected,1160,1168,O
cases,1169,1174,O
Evidence,1176,1184,O
obtained,1188,1196,O
DNA,1202,1205,O
aneuploidy,1206,1216,O
Hodgkin,1220,1227,O
s,1228,1229,O
disease,1230,1237,O
preferentially,1241,1255,O
expressed,1256,1265,O
cells,1269,1274,B-Cell
RS,1284,1286,O
H,1287,1288,O
like,1289,1293,O
medium,1298,1304,O
sized,1305,1310,O
lymphocyte,1311,1321,B-Cell
morphology,1322,1332,O
Imaging,0,7,O
techniques,8,18,O
assessment,27,37,O
body,41,45,B-Organism_subdivision
composition,46,57,O
imaging,65,72,O
methods,73,80,O
ultrasound,82,92,O
imaging,93,100,O
UI,102,104,O
computer,107,115,O
assisted,116,124,O
axial,125,130,O
tomography,131,141,O
CAT,143,146,O
magnetic,152,160,O
resonance,161,170,O
imaging,171,178,O
MRI,180,183,O
widely,190,196,O
medicine,205,213,O
application,221,232,O
assessment,240,250,O
body,254,258,B-Organism_subdivision
composition,259,270,O
nutrition,274,283,O
research,284,292,O
explored,308,316,O
developed,321,330,O
Ultrasound,332,342,O
imaging,343,350,O
yields,351,357,O
poor,358,362,O
image,363,368,O
quality,369,376,O
cheap,396,401,O
safe,406,410,O
deserves,412,420,O
exploration,429,440,O
CAT,447,450,O
MRI,455,458,O
produce,463,470,O
images,471,477,O
good,483,487,O
discrimination,488,502,O
bone,509,513,B-Organ
muscle,515,521,B-Organ
adipose,526,533,B-Tissue
tissue,534,540,I-Tissue
Movement,542,550,O
artifacts,551,560,O
tend,561,565,O
MRI,588,591,O
CAT,600,603,O
longer,615,621,O
imaging,622,629,O
time,630,634,O
hand,649,653,O
X,659,660,O
ray,661,664,O
exposure,665,673,O
CAT,677,680,O
likely,684,690,O
limit,694,699,O
use,704,707,O
human,711,716,O
nutrition,717,726,O
research,727,735,O
Repeated,737,745,O
measurements,746,758,O
tissue,762,768,B-Tissue
volumes,769,776,O
CAT,780,783,O
MRI,788,791,O
similar,797,804,O
CV,805,807,O
CAT,817,820,O
MRI,825,828,O
intra,830,835,O
abdominal,836,845,B-Tissue
adipose,846,853,I-Tissue
tissue,854,860,I-Tissue
presents,861,869,O
greater,870,877,O
problems,878,886,O
measurement,890,901,O
subcutaneous,907,919,B-Tissue
adipose,920,927,I-Tissue
tissue,928,934,I-Tissue
Validation,936,946,O
studies,947,954,O
77,960,962,O
kg,963,965,O
pigs,966,970,O
MRI,974,977,O
13,985,987,O
slices,988,994,O
predicted,996,1005,O
total,1006,1011,O
body,1012,1016,B-Organism_subdivision
lipid,1017,1022,O
residual,1028,1036,O
standard,1037,1045,O
deviation,1046,1055,O
1,1059,1060,O
9,1061,1062,O
validating,1068,1078,O
methods,1092,1099,O
account,1101,1108,O
extent,1131,1137,O
information,1151,1162,O
augment,1177,1184,O
given,1190,1195,O
simple,1204,1210,O
measures,1211,1219,O
like,1220,1224,O
age,1225,1228,O
weight,1233,1239,O
Defective,0,9,O
biliary,10,17,O
copper,18,24,O
excretion,25,34,O
Wilson,38,44,O
s,45,46,O
disease,47,54,O
role,60,64,O
caeruloplasmin,68,82,O
Previous,84,92,O
studies,93,100,O
failed,106,112,O
explain,116,123,O
link,128,132,O
copper,141,147,O
accumulation,148,160,O
abnormal,165,173,O
caeruloplasmin,174,188,O
expression,189,199,O
Wilson,203,209,O
s,210,211,O
disease,212,219,O
Furthermore,221,232,O
despite,234,241,O
isolation,246,255,O
candidate,261,270,O
gene,271,275,O
Wilson,280,286,O
s,287,288,O
disease,289,296,O
predicts,304,312,O
defective,315,324,O
copper,325,331,O
transport,332,341,O
protein,342,349,O
localization,355,367,O
putative,376,384,O
protein,385,392,O
relationship,401,413,O
pathway,421,428,O
involved,429,437,O
copper,441,447,O
excretion,448,457,O
caeruloplasmin,465,479,O
remain,480,486,O
unknown,487,494,O
present,503,510,O
evidence,511,519,O
caeruloplasmin,525,539,O
major,545,550,O
plasma,551,557,B-Organism_substance
copper,558,564,O
carrying,565,573,O
protein,574,581,O
present,586,593,O
liver,601,606,B-Organ
Wilson,610,616,O
s,617,618,O
disease,619,626,O
reduced,642,649,O
circulating,650,661,O
levels,662,668,O
protein,676,683,O
result,684,690,O
post,698,702,O
translational,703,716,O
defect,717,723,O
secretory,731,740,O
pathway,741,748,O
identified,763,773,O
novel,776,781,O
form,782,786,O
caeruloplasmin,790,804,O
molecular,806,815,O
weight,816,822,O
125,823,826,O
kD,827,829,O
propose,840,847,O
act,852,855,O
carrier,863,870,O
excretory,875,884,O
copper,885,891,O
bile,897,901,B-Organism_substance
normally,915,923,O
present,924,931,O
liver,940,945,B-Organ
bile,950,954,B-Organism_substance
largely,965,972,O
absent,973,979,O
serum,985,990,B-Organism_substance
undetectable,996,1008,O
bile,1012,1016,B-Organism_substance
Wilson,1022,1028,O
s,1029,1030,O
disease,1031,1038,O
patients,1039,1047,O
presence,1053,1061,O
form,1070,1074,O
caeruloplasmin,1078,1092,O
Wilson,1096,1102,O
s,1103,1104,O
disease,1105,1112,O
liver,1113,1118,B-Organ
suggests,1119,1127,O
related,1135,1142,O
post,1143,1147,O
translational,1148,1161,O
defect,1162,1168,O
responsible,1181,1192,O
absence,1201,1208,O
bile,1214,1218,B-Organism_substance
Wilson,1222,1228,O
s,1229,1230,O
disease,1231,1238,O
study,1245,1250,O
provides,1256,1264,O
plausible,1275,1284,O
explanation,1285,1296,O
link,1302,1306,O
defective,1319,1328,O
copper,1329,1335,O
excretion,1336,1345,O
reduced,1354,1361,O
plasma,1362,1368,B-Organism_substance
caeruloplasmin,1369,1383,O
characterize,1391,1403,O
Wilson,1404,1410,O
s,1411,1412,O
disease,1413,1420,O
Conservative,0,12,O
treatment,13,22,O
endometriosis,26,39,O
effects,45,52,O
limited,56,63,O
surgery,64,71,O
hormonal,76,84,O
pseudopregnancy,85,100,O
study,107,112,O
compares,113,121,O
effects,126,133,O
limited,137,144,O
surgery,145,152,O
hormonal,156,164,O
pseudopregnancy,165,180,O
combination,187,198,O
fertility,218,227,O
need,236,240,O
subsequent,245,255,O
surgery,256,263,O
respect,269,276,O
extent,284,290,O
disease,298,305,O
time,313,317,O
initial,321,328,O
diagnosis,329,338,O
patients,342,350,O
endometriosis,356,369,O
externa,370,377,O
61,386,388,O
patients,389,397,O
desired,402,409,O
enhance,413,420,O
preserve,424,432,O
reproductive,433,445,O
capacity,446,454,O
20,456,458,O
patients,459,467,O
pregnant,475,483,O
pregnancy,491,500,O
rate,501,505,O
33,509,511,O
pregnancy,518,527,O
rate,528,532,O
categories,540,550,O
patients,567,575,O
treated,576,583,O
pseudopregnancy,589,604,O
conservative,606,618,O
surgery,619,626,O
combined,632,640,O
pseudopregnancy,641,656,O
surgery,661,668,O
found,674,679,O
direct,689,695,O
relationship,696,708,O
initial,716,723,O
extent,724,730,O
disease,734,741,O
patients,751,759,O
conservative,761,773,O
surgery,774,781,O
best,807,811,O
results,812,819,O
achievement,827,838,O
pregnancy,842,851,O
little,872,878,O
difference,879,889,O
pseudopregnancy,898,913,O
conservative,924,936,O
surgery,937,944,O
regard,948,954,O
need,962,966,O
subsequent,971,981,O
surgery,982,989,O
initial,996,1003,O
therapy,1004,1011,O
significantly,1043,1056,O
greater,1057,1064,O
chance,1065,1071,O
need,1080,1084,O
subsequent,1089,1099,O
surgery,1100,1107,O
patients,1111,1119,O
receiving,1120,1129,O
combination,1132,1143,O
forms,1155,1160,O
therapy,1164,1171,O
need,1177,1181,O
subsequent,1186,1196,O
surgery,1197,1204,O
initial,1211,1218,O
therapy,1219,1226,O
80,1230,1232,O
patients,1233,1241,O
increased,1242,1251,O
direct,1255,1261,O
relationship,1262,1274,O
initial,1282,1289,O
extent,1290,1296,O
disease,1300,1307,O
present,1308,1315,O
despite,1317,1324,O
form,1329,1333,O
therapy,1337,1344,O
patients,1368,1376,O
endometriosis,1382,1395,O
desire,1409,1415,O
preserve,1419,1427,O
fertility,1428,1437,O
presented,1442,1451,O
relief,1456,1462,O
symptoms,1472,1480,O
underwent,1482,1491,O
initial,1492,1499,O
radical,1501,1508,O
therapy,1510,1517,O
patients,1529,1537,O
underwent,1538,1547,O
complete,1548,1556,O
operation,1557,1566,O
including,1568,1577,O
removal,1578,1585,O
uterus,1589,1595,B-Organ
tubes,1597,1602,B-Multi-tissue_structure
ovaries,1607,1614,B-Organ
required,1625,1633,O
subsequent,1634,1644,O
reoperation,1645,1656,O
13,1665,1667,O
remaining,1668,1677,O
patients,1678,1686,O
underwent,1692,1701,O
incomplete,1702,1712,O
surgical,1713,1721,O
removal,1722,1729,O
leaving,1731,1738,O
ovaries,1751,1758,B-Organ
situ,1762,1766,O
11,1768,1770,O
required,1771,1779,O
subsequent,1780,1790,O
reoperation,1791,1802,O
recurrent,1807,1816,O
pelvic,1817,1823,O
endometriosis,1824,1837,O
Lack,0,4,O
developmental,8,21,O
reproductive,26,38,O
toxicity,39,47,O
2,51,52,O
3,53,54,O
3,55,56,O
4,58,59,O
4,61,62,O
pentachlorobiphenyl,64,83,O
PCB,85,88,O
105,89,92,O
ring,97,101,O
necked,102,108,O
pheasants,109,118,O
Mono,120,124,O
ortho,125,130,O
PCBs,131,135,O
global,140,146,O
contaminants,147,159,O
wildlife,163,171,O
potential,181,190,O
produce,194,201,O
toxicity,202,210,O
aryl,217,221,O
hydrocarbon,222,233,O
receptor,234,242,O
AhR,244,247,O
mediated,249,257,O
mechanism,258,267,O
determine,272,281,O
potency,286,293,O
2,297,298,O
3,299,300,O
3,301,302,O
4,304,305,O
4,307,308,O
pentachlorobiphenyl,310,329,O
PCB,331,334,O
105,335,338,O
producing,344,353,O
reproductive,354,366,O
developmental,371,384,O
toxicity,385,393,O
adult,395,400,O
ring,401,405,O
necked,406,412,O
pheasant,413,421,O
hens,422,426,O
Phasianus,428,437,O
colchicus,438,447,O
orally,454,460,O
dosed,461,466,O
0,472,473,O
0,475,476,O
06,477,479,O
0,481,482,O
6,483,484,O
6,489,490,O
mg,491,493,O
PCB,494,497,O
105,498,501,O
kg,502,504,O
hen,505,508,O
week,509,513,O
10,518,520,O
weeks,521,526,O
achieve,530,537,O
cumulative,538,548,O
doses,549,554,O
0,558,559,O
0,561,562,O
6,563,564,O
6,566,567,O
60,572,574,O
mg,575,577,O
PCB,578,581,O
105,582,585,O
kg,586,588,O
hen,589,592,O
hens,605,609,O
bred,615,619,O
untreated,625,634,O
roosters,635,643,O
week,653,657,O
8,662,663,O
weeks,664,669,O
week,681,685,O
6,686,687,O
egg,695,698,B-Developing_anatomical_structure
laying,699,705,O
period,706,712,O
cumulative,718,728,O
egg,729,732,B-Developing_anatomical_structure
production,733,743,O
6,751,752,O
mg,753,755,O
PCB,756,759,O
105,760,763,O
kg,764,766,O
hen,767,770,O
group,771,776,O
greater,781,788,O
controls,794,802,O
fertilized,804,814,O
egg,815,818,B-Developing_anatomical_structure
production,819,829,O
significantly,838,851,O
different,852,861,O
treatment,870,879,O
groups,880,886,O
Embryo,888,894,B-Developing_anatomical_structure
mortality,895,904,O
chick,909,914,O
mortality,915,924,O
significantly,934,947,O
different,948,957,O
treatment,966,975,O
groups,976,982,O
Total,984,989,O
body,990,994,B-Organism_subdivision
heart,999,1004,B-Organ
weights,1005,1012,O
chicks,1020,1026,O
1,1027,1028,O
day,1029,1032,O
posthatch,1033,1042,O
dph,1044,1047,O
different,1058,1067,O
groups,1076,1082,O
liver,1093,1098,B-Organ
weights,1099,1106,O
chicks,1110,1116,O
60,1126,1128,O
mg,1129,1131,O
kg,1132,1134,O
treatment,1135,1144,O
group,1145,1150,O
greater,1156,1163,O
controls,1169,1177,O
1,1181,1182,O
dph,1183,1186,O
chick,1198,1203,O
hatch,1207,1212,O
hen,1223,1226,O
reared,1231,1237,O
21,1241,1243,O
dph,1244,1247,O
birds,1264,1269,O
total,1275,1280,O
body,1281,1285,B-Organism_subdivision
liver,1287,1292,B-Organ
heart,1298,1303,B-Organ
weights,1304,1311,O
different,1321,1330,O
groups,1339,1345,O
dose,1361,1365,O
related,1366,1373,O
malformations,1374,1387,O
beak,1395,1399,B-Organism_subdivision
limbs,1403,1408,B-Organism_subdivision
signs,1417,1422,O
subcutaneous,1426,1438,B-Pathological_formation
edema,1439,1444,I-Pathological_formation
ascites,1446,1453,B-Organism_substance
pericardial,1458,1469,B-Pathological_formation
edema,1470,1475,I-Pathological_formation
chicks,1479,1485,O
1,1489,1490,O
21,1494,1496,O
dph,1497,1500,O
Hepatic,1502,1509,O
microsomal,1510,1520,O
monooxygenase,1521,1534,O
activities,1535,1545,O
ethoxyresorufin,1547,1562,O
O,1563,1564,O
dealkylase,1565,1575,O
EROD,1577,1581,O
benzyloxyresorufin,1584,1602,O
O,1603,1604,O
dealkylase,1605,1615,O
BROD,1617,1621,O
methyloxyresorufin,1628,1646,O
O,1647,1648,O
dealkylase,1649,1659,O
MROD,1661,1665,O
significantly,1673,1686,O
elevated,1687,1695,O
chicks,1699,1705,O
1,1709,1710,O
dph,1711,1714,O
hens,1720,1724,O
given,1725,1730,O
cumulative,1733,1743,O
PCB,1744,1747,O
105,1748,1751,O
dose,1752,1756,O
6,1760,1761,O
mg,1762,1764,O
kg,1765,1767,O
chicks,1775,1781,O
21,1785,1787,O
dph,1788,1791,O
hens,1797,1801,O
given,1802,1807,O
cumulative,1810,1820,O
PCB,1821,1824,O
dose,1825,1829,O
60,1833,1835,O
mg,1836,1838,O
kg,1839,1841,O
results,1849,1856,O
indicate,1857,1865,O
cumulative,1873,1883,O
PCB,1884,1887,O
105,1888,1891,O
dose,1892,1896,O
60,1903,1905,O
mg,1906,1908,O
kg,1909,1911,O
hen,1912,1915,O
decrease,1925,1933,O
production,1938,1948,O
fertilized,1952,1962,O
eggs,1963,1967,B-Developing_anatomical_structure
increase,1971,1979,O
embryo,1980,1986,B-Developing_anatomical_structure
chick,1990,1995,O
mortality,1996,2005,O
ring,2009,2013,O
necked,2014,2020,O
pheasants,2021,2030,O
increase,2041,2049,O
chick,2050,2055,O
hepatic,2056,2063,B-Organ
monooxygenase,2064,2077,O
activity,2078,2086,O
Detection,0,9,O
total,13,18,O
assist,19,25,O
sucking,30,37,O
points,38,44,O
based,45,50,O
pulsatility,58,69,O
continuous,75,85,O
flow,86,90,O
artificial,91,101,O
heart,102,107,O
vivo,112,116,O
evaluation,117,127,O
novel,133,138,O
control,139,146,O
strategy,147,155,O
continuous,162,172,O
flow,173,177,O
artificial,178,188,O
heart,189,194,O
detecting,198,207,O
total,212,217,O
assist,218,224,O
sucking,229,236,O
points,237,243,O
based,244,249,O
pump,253,257,O
pulsatility,258,269,O
evaluated,274,283,O
acute,287,292,O
animal,293,299,O
experiments,300,311,O
beagle,318,324,O
dogs,325,329,O
mixed,338,343,O
flow,344,348,O
pump,349,353,O
pump,359,363,O
installed,368,377,O
left,383,387,B-Multi-tissue_structure
ventricular,388,399,I-Multi-tissue_structure
LV,401,403,B-Multi-tissue_structure
bypass,405,411,O
left,422,426,O
thoracotomy,427,438,O
change,443,449,O
LV,450,452,B-Multi-tissue_structure
contractility,453,466,O
left,472,476,O
coronary,477,485,B-Multi-tissue_structure
arteries,486,494,I-Multi-tissue_structure
occluded,500,508,O
30,513,515,O
min,516,519,O
followed,521,529,O
120,535,538,O
min,539,542,O
reperfusion,543,554,O
change,559,565,O
LV,566,568,B-Multi-tissue_structure
end,569,572,O
diastolic,573,582,O
pressure,583,591,O
LVEDP,593,598,O
dextran,601,608,O
solution,609,617,O
rapidly,622,629,O
infused,630,637,O
estimate,642,650,O
pump,655,659,O
pulsatility,660,671,O
specific,684,692,O
sensor,693,699,O
calculated,704,714,O
index,719,724,O
current,728,735,O
amplitude,736,745,O
ICA,747,750,O
obtained,763,771,O
amplitude,781,790,O
motor,798,803,O
current,804,811,O
waveform,812,820,O
divided,821,828,O
simultaneous,836,848,O
mean,849,853,O
value,854,859,O
investigate,864,875,O
basic,880,885,O
characteristics,886,901,O
ICA,909,912,O
pump,918,922,O
speed,923,928,O
changed,933,940,O
temporarily,941,952,O
2,958,959,O
300,960,963,O
rpm,964,967,O
5,971,972,O
000,973,976,O
rpm,977,980,O
92,985,987,O
measurements,996,1008,O
ICA,1014,1017,O
plotted,1018,1025,O
pump,1038,1042,O
speed,1043,1048,O
peak,1055,1059,O
point,1060,1065,O
t,1067,1068,O
point,1069,1074,O
corresponded,1081,1093,O
highly,1094,1100,O
turning,1110,1117,O
point,1118,1123,O
partial,1129,1136,O
total,1140,1145,O
assistance,1146,1156,O
ICA,1162,1165,O
trough,1177,1183,O
s,1185,1186,O
point,1187,1192,O
corresponded,1199,1211,O
beginning,1221,1230,O
severe,1234,1240,O
sucking,1241,1248,O
cases,1257,1262,O
preload,1269,1276,O
significantly,1277,1290,O
influenced,1291,1301,O
pump,1302,1306,O
flow,1307,1311,O
rate,1312,1316,O
t,1324,1325,O
point,1326,1331,O
preload,1343,1350,O
LVEDP,1352,1357,O
afterload,1360,1369,O
SAoP,1371,1375,O
contractility,1382,1395,O
max,1397,1400,O
LV,1401,1403,B-Multi-tissue_structure
dP,1404,1406,O
dt,1407,1409,O
simulate,1428,1436,O
Starling,1437,1445,O
s,1446,1447,O
law,1448,1451,O
natural,1459,1466,O
heart,1467,1472,B-Organ
concluded,1477,1486,O
continuous,1494,1504,O
flow,1505,1509,O
artificial,1510,1520,O
heart,1521,1526,O
controlled,1541,1551,O
detecting,1555,1564,O
t,1569,1570,O
point,1571,1576,O
s,1581,1582,O
point,1583,1588,O
Immunostaining,0,14,O
confocal,19,27,O
analysis,28,36,O
DNA,37,40,O
labelling,41,50,O
staining,55,63,O
5,69,70,O
bromo,71,76,O
2,77,78,O
deoxyuridine,80,92,O
BrdU,94,98,O
labelling,99,108,O
detection,113,122,O
kit,123,126,O
Boehringer,130,140,O
Mannheim,141,149,O
Germany,151,158,O
performed,164,173,O
according,174,183,O
manufacturer,191,203,O
s,204,205,O
instructions,206,218,O
nucleoli,224,232,B-Cellular_component
detected,238,246,O
anti,255,259,O
nucleolin,260,269,O
antibody,270,278,O
clone,280,285,O
3G4B2,286,291,O
Upstate,293,300,O
biotechnology,301,314,O
Lake,316,320,O
Placid,321,327,O
NY,329,331,O
cells,336,341,B-Cell
fixed,342,347,O
2,351,352,O
formalin,354,362,O
10,367,369,O
min,370,373,O
followed,374,382,O
permeabilization,386,402,O
ice,408,411,O
cold,412,416,O
methanol,417,425,O
30,430,432,O
min,433,436,O
secondary,442,451,O
antibody,452,460,O
BrdU,475,479,O
nucleoli,484,492,B-Cellular_component
staining,493,501,O
rhodamine,508,517,O
tetra,519,524,O
methyl,525,531,O
conjugated,533,543,O
goat,544,548,O
anti,549,553,O
mouse,554,559,O
antibody,560,568,O
T,570,571,O
2762,572,576,O
Molecular,583,592,O
Probe,593,598,O
Eugene,600,606,O
cells,617,622,B-Cell
examined,628,636,O
Zeiss,642,647,O
LSM,648,651,O
510,652,655,O
laser,656,661,O
scanning,662,670,O
microscope,671,681,O
equipped,682,690,O
Plan,698,702,O
Apochromate,703,714,O
63x,715,718,O
1,719,720,O
4,721,722,O
oil,723,726,O
immersion,727,736,O
objective,737,746,O
488,760,763,O
nm,764,766,O
laser,767,772,O
line,773,777,O
excitation,782,792,O
EGFP,796,800,O
detected,802,810,O
505,814,817,O
nm,818,820,O
lambdaEGFP,823,833,O
530,836,839,O
nm,840,842,O
543,852,855,O
nm,856,858,O
laser,859,864,O
line,865,869,O
rhodamine,874,883,O
tetra,885,890,O
methyl,891,897,O
detected,900,908,O
lambdaRhodamine,912,927,O
560,930,933,O
nm,934,936,O
ECFP,939,943,O
fusion,944,950,O
protein,951,958,O
excited,963,970,O
458,978,981,O
nm,982,984,O
laser,985,990,O
line,991,995,O
detected,997,1005,O
480,1009,1012,O
nm,1013,1015,O
lambdaECFP,1018,1028,O
520,1031,1034,O
nm,1035,1037,O
EYFP,1040,1044,O
fusion,1045,1051,O
protein,1052,1059,O
excited,1064,1071,O
514,1079,1082,O
nm,1083,1085,O
laser,1086,1091,O
line,1092,1096,O
lambdaEGFP,1098,1108,O
560,1111,1114,O
nm,1115,1117,O
HcRed,1123,1128,O
fusion,1129,1135,O
protein,1136,1143,O
excited,1148,1155,O
543,1163,1166,O
nm,1167,1169,O
laser,1170,1175,O
line,1176,1180,O
detected,1185,1193,O
585,1198,1201,O
650,1205,1208,O
nm,1209,1211,O
images,1217,1223,O
1,1234,1235,O
mum,1236,1239,O
thick,1240,1245,O
slices,1246,1252,B-Cell
cells,1260,1265,B-Cell
images,1271,1277,O
exported,1283,1291,O
Adobe,1297,1302,O
Photoshop,1303,1312,O
Adobe,1314,1319,O
Systems,1320,1327,O
Inc,1328,1331,O
San,1334,1337,O
Jose,1338,1342,O
Conclusions,0,11,O
careful,23,30,O
consideration,31,44,O
biological,52,62,O
underpinnings,63,76,O
truly,82,87,O
beneficial,88,98,O
response,99,107,O
exposure,115,123,O
considered,127,137,O
general,146,153,O
population,154,164,O
addition,178,186,O
folic,190,195,O
acid,196,200,O
cereals,204,211,O
toxic,218,223,O
hazardous,227,236,O
pollutant,237,246,O
found,252,257,O
truly,266,271,O
beneficial,272,282,O
effects,283,290,O
low,294,297,O
dose,298,302,O
agent,314,319,O
tested,330,336,O
clinically,337,347,O
U,364,365,O
S,366,367,O
Food,369,373,O
Drug,378,382,O
Administration,383,397,O
FDA,399,402,O
approval,404,412,O
process,413,420,O
regulated,429,438,O
pharmaceutical,444,458,O
benefit,479,486,O
use,496,499,O
Certainly,501,510,O
general,516,523,O
population,524,534,O
exposed,549,556,O
chemotherapeutic,560,576,O
agents,577,583,O
benefit,589,596,O
cancer,597,603,B-Pathological_formation
patients,604,612,O
pharmaceuticals,618,633,O
understood,641,651,O
trade,667,672,O
offs,673,677,O
benefits,686,694,O
risks,699,704,O
example,710,717,O
aspirin,728,735,O
generally,741,750,O
tolerated,756,765,O
pain,766,770,O
reliever,771,779,O
increasingly,787,799,O
advocated,800,809,O
preventative,815,827,O
tool,828,832,O
heart,837,842,B-Organ
attacks,843,850,O
colorectal,855,865,B-Pathological_formation
cancer,866,872,I-Pathological_formation
Vainio,874,880,O
Miller,885,891,O
2003,892,896,O
Werner,898,904,O
et,905,907,O
al,908,910,O
2004,912,916,O
linked,930,936,O
increased,940,949,O
risk,950,954,O
gastrointestinal,958,974,B-Organism_subdivision
bleeding,975,983,O
cerebral,985,993,B-Organ
hemorrhage,994,1004,O
Werner,1006,1012,O
et,1013,1015,O
al,1016,1018,O
2004,1020,1024,O
asthma,1031,1037,O
attacks,1038,1045,O
Jenkins,1047,1054,O
et,1055,1057,O
al,1058,1060,O
2004,1062,1066,O
addition,1072,1080,O
aspirin,1082,1089,O
recommended,1097,1108,O
children,1113,1121,O
teenagers,1125,1134,O
recovering,1151,1161,O
chicken,1167,1174,O
pox,1175,1178,O
flulike,1182,1189,O
symptoms,1190,1198,O
cause,1214,1219,O
debilitating,1220,1232,O
lethal,1247,1253,O
Reyes,1254,1259,O
syndrome,1260,1268,O
U,1270,1271,O
S,1272,1273,O
FDA,1275,1278,O
2003,1279,1283,O
Individual,1286,1296,O
risks,1297,1302,O
pharmaceutical,1306,1320,O
agents,1321,1327,O
controlled,1335,1345,O
proper,1351,1357,O
usage,1358,1363,O
increased,1374,1383,O
exposure,1384,1392,O
environmental,1396,1409,O
toxins,1410,1416,O
presents,1417,1425,O
additional,1426,1436,O
involuntary,1437,1448,O
risks,1449,1454,O
general,1463,1470,O
population,1471,1481,O
condition,1500,1509,O
exposure,1511,1519,O
inadequately,1523,1535,O
controlled,1536,1546,O
mechanism,1564,1573,O
correct,1577,1584,O
individual,1589,1599,O
circumstances,1600,1613,O
e,1615,1616,O
g,1617,1618,O
medical,1621,1628,O
condition,1629,1638,O
age,1642,1645,O
result,1656,1662,O
harm,1666,1670,O
hormetic,1681,1689,O
effects,1690,1697,O
occur,1702,1707,O
instances,1716,1725,O
rare,1740,1744,O
exposures,1750,1759,O
toxic,1763,1768,O
mutagenic,1770,1779,O
teratogenic,1781,1792,O
carcinogenic,1798,1810,O
chemicals,1811,1820,O
low,1830,1833,O
exposure,1834,1842,O
levels,1843,1849,O
risk,1860,1864,O
free,1865,1869,O
provide,1874,1881,O
health,1882,1888,O
benefits,1889,1897,O
general,1906,1913,O
public,1914,1920,O
Portraying,1922,1932,O
chemicals,1933,1942,O
numerous,1948,1956,O
adverse,1957,1964,O
effects,1965,1972,O
having,1976,1982,O
benefits,1983,1991,O
ignoring,1998,2006,O
hazards,2013,2020,O
irresponsible,2024,2037,O
provide,2051,2058,O
objective,2068,2077,O
disclosure,2078,2088,O
1950s,2097,2102,O
doctors,2103,2110,O
prescribed,2111,2121,O
DES,2122,2125,O
pregnant,2129,2137,O
women,2138,2143,O
prevent,2147,2154,O
miscarriage,2155,2166,O
premature,2171,2180,O
births,2181,2187,O
produce,2195,2202,O
bigger,2204,2210,O
stronger,2215,2223,O
babies,2224,2230,O
DES,2244,2247,O
shown,2257,2262,O
cause,2266,2271,O
damage,2272,2278,O
reproductive,2282,2294,O
tissues,2295,2302,B-Tissue
animals,2306,2313,O
Dinusson,2315,2323,O
et,2324,2326,O
al,2327,2329,O
1948,2331,2335,O
Dunn,2337,2341,O
Green,2346,2351,O
1963,2352,2356,O
Takasugi,2358,2366,O
Bern,2371,2375,O
1964,2376,2380,O
Human,2383,2388,O
use,2389,2392,O
DES,2396,2399,O
banned,2404,2410,O
United,2418,2424,O
States,2425,2431,O
1971,2435,2439,O
discovery,2450,2459,O
high,2463,2467,O
rates,2468,2473,O
rare,2477,2481,O
clear,2483,2488,O
cell,2489,2493,O
adenocarcinomas,2494,2509,B-Pathological_formation
vagina,2517,2523,B-Multi-tissue_structure
cervix,2528,2534,B-Multi-tissue_structure
DES,2538,2541,O
exposed,2542,2549,O
daughters,2550,2559,O
Herbst,2561,2567,O
1981,2568,2572,O
later,2579,2584,O
studies,2585,2592,O
showed,2593,2599,O
elevated,2600,2608,O
breast,2609,2615,B-Pathological_formation
cancer,2616,2622,I-Pathological_formation
risk,2623,2627,O
women,2631,2636,O
took,2641,2645,O
DES,2646,2649,O
pregnancy,2657,2666,O
Titus,2668,2673,O
Ernstoff,2674,2682,O
et,2683,2685,O
al,2686,2688,O
2001,2690,2694,O
Certainly,2697,2706,O
health,2708,2714,O
policy,2715,2721,O
decisions,2722,2731,O
based,2742,2747,O
scientific,2751,2761,O
evidence,2762,2770,O
speculation,2782,2793,O
health,2797,2803,O
benefits,2804,2812,O
order,2816,2821,O
general,2830,2837,O
population,2838,2848,O
avoid,2852,2857,O
repeating,2858,2867,O
mistakes,2872,2880,O
past,2888,2892,O
similar,2893,2900,O
DES,2916,2919,O
tragedy,2920,2927,O
claims,2933,2939,O
projections,2944,2955,O
health,2959,2965,O
benefits,2966,2974,O
exposures,2980,2989,O
environmental,2993,3006,O
toxicants,3007,3016,O
carcinogens,3021,3032,O
based,3037,3042,O
untested,3046,3054,O
assumptions,3055,3066,O
disregard,3071,3080,O
numerous,3081,3089,O
established,3095,3106,O
scientific,3107,3117,O
principles,3118,3128,O
underpin,3134,3142,O
public,3145,3151,O
health,3152,3158,O
protective,3159,3169,O
approach,3170,3178,O
regulating,3182,3192,O
exposure,3193,3201,O
toxic,3205,3210,O
substances,3211,3221,O
hormesis,3226,3234,O
decision,3252,3260,O
making,3261,3267,O
process,3268,3275,O
allow,3279,3284,O
higher,3285,3291,O
exposures,3292,3301,O
toxic,3305,3310,O
carcinogenic,3315,3327,O
agents,3328,3334,O
substantially,3347,3360,O
increase,3361,3369,O
health,3370,3376,O
risks,3377,3382,O
segments,3406,3414,O
general,3422,3429,O
population,3430,3440,O
Measured,0,8,O
analytes,9,17,O
biologic,26,34,O
sample,35,41,O
matrices,42,50,O
Competing,0,9,O
interests,10,19,O
declared,25,33,O
article,40,47,O
ongoing,67,74,O
educational,76,87,O
review,88,94,O
series,95,101,O
medical,105,112,O
statistics,113,123,O
critical,127,135,O
care,136,140,O
Previous,142,150,O
articles,151,159,O
covered,165,172,O
presenting,174,184,O
summarising,189,200,O
data,201,205,O
3,208,209,O
samples,216,223,O
populations,228,239,O
4,242,243,O
Future,246,252,O
topics,253,259,O
covered,266,273,O
include,274,281,O
power,282,287,O
calculations,288,300,O
comparison,302,312,O
means,316,321,O
comparison,323,333,O
proportions,337,348,O
analysis,354,362,O
survival,366,374,O
data,375,379,O
medical,413,420,O
statistics,421,431,O
topic,432,437,O
like,448,452,O
explained,453,462,O
contact,463,470,O
editorial,477,486,O
ccforum,487,494,O
com,495,498,O
Results,0,7,O
set,12,15,O
E,19,20,O
coli,22,26,O
expression,27,37,O
vectors,38,45,O
encode,47,53,O
hexa,67,71,O
histidine,72,81,O
tag,82,85,O
commonly,104,112,O
solubility,118,128,O
tags,129,133,O
GST,135,138,O
MBP,140,143,O
NusA,145,149,O
N,167,168,O
terminal,169,177,O
hexa,178,182,O
histidine,183,192,O
sequence,193,201,O
result,207,213,O
fold,221,225,O
tag,235,238,O
facilitates,239,250,O
purification,251,263,O
immobilised,267,278,O
metal,279,284,O
affinity,285,293,O
chromatography,294,308,O
whilst,310,316,O
fusion,321,327,O
domains,328,335,O
act,336,339,O
primarily,340,349,O
solubility,353,363,O
aids,364,368,O
expression,376,386,O
addition,391,399,O
providing,403,412,O
optional,416,424,O
purification,425,437,O
step,438,442,O
incorporated,457,469,O
TEV,472,475,O
recognition,476,487,O
sequence,488,496,O
following,497,506,O
solubility,511,521,O
tag,522,525,O
domain,526,532,O
allows,540,546,O
highly,551,557,O
specific,558,566,O
cleavage,567,575,O
TEV,583,586,O
protease,587,595,O
fusion,604,610,O
protein,611,618,O
yield,622,627,O
native,628,634,O
protein,635,642,O
vectors,650,657,O
designed,667,675,O
ligation,680,688,O
independent,689,700,O
cloning,701,708,O
possess,718,725,O
high,728,732,O
level,733,738,O
expressing,739,749,O
T7,750,752,O
promoter,753,761,O
suitable,772,780,O
auto,785,789,O
induction,790,799,O
validate,804,812,O
vector,817,823,O
system,824,830,O
cloned,840,846,O
different,852,861,O
genes,862,867,O
gene,881,885,O
vectors,900,907,O
small,917,922,O
scale,923,928,O
expression,929,939,O
purification,944,956,O
techniques,957,967,O
demonstrate,972,983,O
vectors,993,1000,O
capable,1005,1012,O
high,1016,1020,O
levels,1021,1027,O
expression,1031,1041,O
efficient,1051,1060,O
screening,1061,1070,O
new,1074,1077,O
proteins,1078,1086,O
readily,1094,1101,O
achieved,1102,1110,O
laboratory,1118,1128,O
level,1129,1134,O
Inflammation,0,12,O
modulating,13,23,O
effect,24,30,O
antithrombin,34,46,O
endothelium,54,65,B-Tissue
Ligation,67,75,O
heparan,79,86,O
sulfate,87,94,O
proteoglycans,95,108,O
HSPGs,110,115,O
endothelium,120,131,B-Tissue
antithrombin,137,149,O
induces,155,162,O
cellular,163,171,B-Cell
signalling,172,182,O
events,183,189,O
alter,195,200,O
cell,205,209,B-Cell
s,210,211,O
biochemical,212,223,O
functional,228,238,O
responses,239,248,O
inflammatory,252,264,O
stimuli,265,272,O
e,274,275,O
g,276,277,O
bacterial,279,288,O
lipopolysaccharide,289,307,O
LPS,309,312,O
Changes,316,323,O
include,324,331,O
reduced,332,339,O
release,340,347,O
inflammatory,351,363,O
procoagulatory,368,382,O
mediators,383,392,O
e,394,395,O
g,396,397,O
interleukin,399,410,O
IL,412,414,O
1,416,417,O
IL,419,421,O
6,422,423,O
tumour,425,431,O
necrosis,432,440,O
factor,441,447,O
alpha,448,453,O
TNF,454,457,O
tissue,461,467,O
factor,468,474,O
TF,476,478,O
adenosine,481,490,O
diphosphate,491,502,O
ADP,504,507,O
cellular,513,521,B-Cell
adhesion,522,530,O
molecules,531,540,O
shown,546,551,O
increased,565,574,O
release,575,582,O
anticoagulatory,586,601,O
prostacyclin,602,614,O
prostaglandin,616,629,O
PG,631,633,O
CD39,640,644,O
ATPDase,645,652,O
neuronal,657,665,B-Tissue
tissue,666,672,I-Tissue
protective,674,684,O
mechanisms,685,695,O
mediated,703,711,O
release,720,727,O
calcitonin,731,741,O
gene,742,746,O
related,747,754,O
peptide,755,762,O
nitric,767,773,O
oxide,774,779,O
potential,789,798,O
affect,802,808,O
prostacyclin,809,821,O
release,822,829,O
55,831,833,O
Background,0,10,O
Hallucinations,11,25,O
occur,30,35,O
sensory,43,50,O
modalities,51,61,O
Formed,63,69,O
musical,70,77,O
hallucinations,78,92,O
e,96,97,O
Perception,99,109,O
vocal,120,125,O
instrumental,129,141,O
melodies,142,150,O
reported,152,160,O
English,164,171,O
literature,172,182,O
date,186,190,O
typically,196,205,O
associated,211,221,O
marked,227,233,O
hearing,234,241,O
loss,242,246,O
advanced,248,256,O
age,257,260,O
female,262,268,O
sex,269,272,O
71,274,276,O
lack,280,284,O
response,288,296,O
treatment,300,309,O
associated,314,324,O
psychopathology,325,340,O
1,342,343,O
concluded,358,367,O
hearing,373,380,O
loss,381,385,O
necessary,399,408,O
sufficient,413,423,O
condition,424,433,O
occurrence,442,452,O
musical,456,463,O
hallucinations,464,478,O
1,480,481,O
Tumor,484,489,B-Pathological_formation
like,490,494,O
Astrocytoma,495,506,B-Pathological_formation
Temporal,508,516,B-Multi-tissue_structure
lobe,517,521,I-Multi-tissue_structure
epilepsy,522,530,O
raised,532,538,O
intra,539,544,O
cranial,545,552,B-Organism_subdivision
tension,553,560,O
drug,562,566,O
induced,567,574,O
tricyclics,576,586,O
Propronolol,588,599,O
etc,600,603,O
meningitis,608,618,O
psychotic,623,632,O
illness,633,640,O
shown,646,651,O
cause,655,660,O
palinacousis,661,673,O
musical,678,685,O
hallucinations,686,700,O
2,702,703,O
3,704,705,O
Musical,708,715,O
hallucinations,716,730,O
pseudo,735,741,O
hallucinations,742,756,O
originate,762,771,O
memory,775,781,O
representations,782,797,O
undergo,811,818,O
transition,821,831,O
true,835,839,O
hallucination,840,853,O
musical,858,865,O
hallucination,866,879,O
spatial,880,887,O
projection,888,898,O
definite,907,915,O
perceived,936,945,O
like,946,950,O
tinnitus,955,963,O
patient,967,974,O
s,975,976,O
head,981,985,B-Organism_subdivision
quality,991,998,O
usually,1002,1009,O
intense,1015,1022,O
distinct,1027,1035,O
loud,1047,1051,O
vary,1058,1062,O
elementary,1068,1078,O
sounds,1079,1085,O
instrumental,1089,1101,O
music,1102,1107,O
vocal,1109,1114,O
music,1115,1120,O
bird,1122,1126,O
songs,1127,1132,O
bells,1134,1139,O
pieces,1141,1147,O
melodies,1151,1159,O
sentences,1163,1172,O
religious,1174,1183,O
music,1184,1189,O
etc,1190,1193,O
report,1199,1205,O
unusual,1209,1216,O
presentation,1217,1229,O
elderly,1236,1243,O
lady,1244,1248,O
experienced,1257,1268,O
musical,1269,1276,O
hallucinations,1277,1291,O
whilst,1292,1298,O
treated,1305,1312,O
Electro,1318,1325,O
Convulsive,1326,1336,O
Therapy,1337,1344,O
reported,1373,1381,O
earlier,1382,1389,O
good,1414,1418,O
association,1419,1430,O
initiation,1443,1453,O
Electro,1457,1464,O
convulsive,1465,1475,O
therapy,1476,1483,O
musical,1488,1495,O
hallucination,1496,1509,O
patient,1517,1524,O
Correlation,0,11,O
sperm,20,25,B-Cell
morphology,26,36,O
seminal,41,48,B-Organism_substance
plasma,49,55,I-Organism_substance
TBARS,67,72,O
b,74,75,O
levels,77,83,O
groups,92,98,O
Conclusion,0,10,O
survey,15,21,O
indicated,22,31,O
study,42,47,O
area,48,52,O
plenty,57,63,O
medicinal,67,76,O
plants,77,83,O
treat,87,92,O
wide,95,99,O
spectrum,100,108,O
human,112,117,O
ailments,118,126,O
Earlier,128,135,O
studies,136,143,O
traditional,147,158,O
medicinal,159,168,O
plants,169,175,O
revealed,181,189,O
economically,199,211,O
backward,212,220,O
local,221,226,O
tribal,231,237,O
people,238,244,O
Tamil,248,253,O
Nadu,254,258,O
prefer,259,265,O
folk,266,270,O
medicine,271,279,O
low,287,290,O
cost,291,295,O
social,332,338,O
life,339,343,O
culture,348,355,O
40,357,359,O
45,360,362,O
evident,371,378,O
interviews,388,398,O
conducted,399,408,O
different,412,421,O
villages,422,430,O
knowledge,432,441,O
medicinal,445,454,O
plants,455,461,O
limited,465,472,O
traditional,476,487,O
healers,488,495,O
herbalists,497,507,O
elderly,512,519,O
persons,520,527,O
living,536,542,O
rural,546,551,O
areas,552,557,O
study,564,569,O
points,575,581,O
certain,591,598,O
species,599,606,O
medicinal,610,619,O
plants,620,626,O
exploited,637,646,O
local,654,659,O
residents,660,669,O
unaware,678,685,O
importance,693,703,O
medicinal,707,716,O
plants,717,723,O
ecosystem,731,740,O
study,747,752,O
concluded,753,762,O
accessibility,784,797,O
Western,801,808,O
medicine,809,817,O
simple,822,828,O
complicated,833,844,O
diseases,845,853,O
available,857,866,O
people,873,879,O
studied,887,894,O
parts,895,900,O
Kancheepuram,904,916,O
district,917,925,O
continue,935,943,O
depend,947,953,O
medicinal,957,966,O
plants,967,973,O
treatment,992,1001,O
simple,1010,1016,O
diseases,1017,1025,O
cold,1035,1039,O
cough,1041,1046,O
fever,1048,1053,O
headache,1055,1063,O
poison,1065,1071,O
bites,1072,1077,O
skin,1079,1083,B-Organ
diseases,1084,1092,O
tooth,1097,1102,B-Organ
infections,1103,1113,O
knowledged,1120,1130,O
healers,1131,1138,O
good,1144,1148,O
interactions,1149,1161,O
patients,1167,1175,O
improve,1191,1198,O
quality,1203,1210,O
healthcare,1214,1224,O
delivery,1225,1233,O
present,1239,1246,O
day,1247,1250,O
traditional,1251,1262,O
healers,1263,1270,O
old,1280,1283,O
lack,1292,1296,O
interest,1300,1308,O
younger,1319,1326,O
generation,1327,1337,O
tendency,1355,1363,O
migrate,1367,1374,O
cities,1378,1384,O
lucrative,1389,1398,O
jobs,1399,1403,O
possibility,1416,1427,O
losing,1431,1437,O
wealth,1443,1449,O
knowledge,1453,1462,O
near,1470,1474,O
future,1475,1481,O
necessary,1499,1508,O
acquire,1512,1519,O
preserve,1524,1532,O
traditional,1538,1549,O
system,1550,1556,O
medicine,1560,1568,O
proper,1572,1578,O
documentation,1579,1592,O
identification,1597,1611,O
specimens,1615,1624,O
Figures,0,7,O
Tables,12,18,O
Figure,19,25,O
1,26,27,O
Modular,28,35,O
crosstalking,36,48,O
synthetic,52,61,O
gene,62,66,O
networks,67,75,O
promoter,79,87,O
binding,93,100,O
sites,101,106,O
lambda,111,117,O
cI,118,120,O
dimers,121,127,O
OR1,129,132,O
OR2,137,140,O
lac,154,157,O
repressor,158,167,O
Olac,169,173,O
controls,175,183,O
production,188,198,O
lac,206,209,O
repressor,210,219,O
encoded,221,228,O
lacI,232,236,O
module,241,247,O
1,248,249,O
lambda,254,260,O
cI,261,263,O
encoded,265,272,O
cI,276,278,O
module,283,289,O
2,290,291,O
lac,297,300,O
repressor,301,310,O
lambda,315,321,O
cI,322,324,O
dimers,325,331,O
represented,336,347,O
blue,351,355,O
ellipsoids,356,366,O
red,371,374,O
circles,375,382,O
respectively,384,396,O
modules,411,418,O
pairs,441,446,O
lambda,450,456,O
cI,457,459,O
dimers,460,466,O
bound,467,472,O
different,476,485,O
operators,486,495,O
loop,500,504,O
DNA,505,508,O
octamerize,513,523,O
forming,525,532,O
tetramer,535,543,O
dimers,547,553,O
Comparison,0,10,O
Predicted,18,27,O
Irr,28,31,O
Regulon,32,39,O
ICE,44,47,O
Motifs,48,54,O
Published,64,73,O
Expression,74,84,O
Microarray,85,95,O
Data,96,100,O
Iron,105,109,O
Irr,115,118,O
Affected,119,127,O
Genes,128,133,O
Bradyrhizobium,137,151,O
japonicum,152,161,O
Mass,0,4,O
casualty,5,13,O
estimation,14,24,O
geographic,30,40,O
basis,41,46,O
Defense,51,58,O
Threat,59,65,O
Reduction,66,75,O
Agency,76,82,O
DTRA,84,88,O
expended,94,102,O
considerable,103,115,O
effort,116,122,O
develop,126,133,O
models,134,140,O
calculating,145,156,O
mass,157,161,O
casualties,162,172,O
nuclear,180,187,O
detonation,188,198,O
order,203,208,O
specifically,212,224,O
evaluate,225,233,O
urban,234,239,O
medical,240,247,O
systems,248,255,O
vulnerability,256,269,O
employing,277,286,O
PC,291,293,O
based,294,299,O
Consequence,300,311,O
Assessment,312,322,O
Tool,323,327,O
Set,328,331,O
CATS,333,337,O
v6,339,341,O
ESRI,348,352,O
s,353,354,O
ArcGIS9,355,362,O
14,364,366,O
CATS,369,373,O
JACE,374,378,O
Joint,380,385,O
Assessment,386,396,O
Catastrophic,400,412,O
Events,413,419,O
v5,421,423,O
ESRI,429,433,O
s,434,435,O
ArcView,436,443,O
3,444,445,O
3,446,447,O
Hazard,449,455,O
Prediction,456,466,O
Assessment,471,481,O
Capability,482,492,O
HPAC,494,498,O
V4,500,502,O
04SP3,503,508,O
15,510,512,O
custom,526,532,O
GIS,533,536,O
database,541,549,O
software,550,558,O
applications,559,571,O
HPAC,573,577,O
excellent,583,592,O
Chemical,593,601,O
Biological,602,612,O
Nuclear,617,624,O
CBN,626,629,O
modeling,631,639,O
output,650,656,O
provide,663,670,O
flexibility,676,687,O
Additionally,689,701,O
results,703,710,O
exported,718,726,O
CATS,730,734,O
analysis,747,755,O
display,760,767,O
programs,779,787,O
access,792,798,O
current,803,810,O
weather,811,818,O
data,819,823,O
classified,834,844,O
unclassified,849,861,O
weather,862,869,O
servers,870,877,O
Examples,879,887,O
uses,891,895,O
CATS,899,903,O
HPAC,904,908,O
hurricane,913,922,O
tidal,924,929,O
surge,930,935,O
earthquake,940,950,O
damage,951,957,O
prediction,959,969,O
results,977,984,O
nuclear,990,997,O
biological,999,1009,O
chemical,1014,1022,O
releases,1023,1031,O
assessment,1033,1043,O
persons,1047,1054,O
infrastructure,1059,1073,O
affected,1074,1082,O
risk,1090,1094,O
e,1096,1097,O
g,1098,1099,O
hospitals,1107,1116,O
pharmacies,1121,1131,O
CBN,1144,1147,O
plume,1148,1153,O
commission,1174,1184,O
mobilization,1191,1203,O
surviving,1207,1216,O
nearby,1221,1227,O
infrastructure,1228,1242,O
outside,1243,1250,O
plume,1255,1260,O
needed,1275,1281,O
address,1285,1292,O
healthcare,1293,1303,O
emergency,1314,1323,O
response,1324,1332,O
needs,1333,1338,O
community,1346,1355,O
models,1363,1369,O
continue,1385,1393,O
developed,1401,1410,O
view,1418,1422,O
better,1426,1432,O
estimating,1433,1443,O
impact,1448,1454,O
WMD,1458,1461,O
weapons,1462,1469,O
offensive,1476,1485,O
setting,1486,1493,O
recent,1504,1510,O
DTRA,1511,1515,O
enhancements,1516,1528,O
modifications,1537,1550,O
facilitated,1556,1567,O
use,1574,1577,O
helping,1581,1588,O
estimate,1589,1597,O
potential,1598,1607,O
casualties,1608,1618,O
WMD,1626,1629,O
terrorist,1630,1639,O
incident,1640,1648,O
area,1654,1658,O
intense,1662,1669,O
interest,1670,1678,O
somewhat,1684,1692,O
vacuum,1698,1704,O
public,1708,1714,O
health,1715,1721,O
planning,1722,1730,O
utility,1745,1752,O
approach,1761,1769,O
estimating,1773,1783,O
medical,1784,1791,O
care,1792,1796,O
vulnerabilities,1797,1812,O
attack,1824,1830,O
calculation,1844,1855,O
distribution,1863,1875,O
surviving,1879,1888,O
medical,1889,1896,O
care,1897,1901,O
resources,1902,1911,O
work,1924,1928,O
occurred,1941,1949,O
estimating,1953,1963,O
impact,1968,1974,O
chemical,1978,1986,O
weapons,1987,1994,O
dual,2007,2011,O
use,2012,2015,O
chemical,2019,2027,O
spill,2028,2033,O
management,2034,2044,O
transportation,2050,2064,O
industrial,2069,2079,O
accidents,2080,2089,O
nuclear,2098,2105,O
power,2106,2111,O
plant,2112,2117,O
accident,2118,2126,O
management,2127,2137,O
research,2149,2157,O
development,2162,2173,O
gone,2178,2182,O
estimating,2188,2198,O
impact,2203,2209,O
civilian,2217,2225,O
population,2226,2236,O
nuclear,2242,2249,O
weapon,2250,2256,O
detonation,2257,2267,O
terrorist,2275,2284,O
incident,2285,2293,O
large,2299,2304,O
urban,2305,2310,O
area,2311,2315,O
models,2321,2327,O
calculate,2336,2345,O
factors,2351,2358,O
impact,2366,2372,O
blast,2376,2381,O
thermal,2383,2390,O
effects,2391,2398,O
fallout,2403,2410,O
results,2416,2423,O
available,2438,2447,O
detail,2455,2461,O
level,2462,2467,O
needed,2468,2474,O
civil,2479,2484,O
defense,2485,2492,O
purposes,2493,2501,O
casualty,2503,2511,O
management,2512,2522,O
planning,2528,2536,O
use,2541,2544,O
scarce,2548,2554,O
health,2555,2561,O
resources,2562,2571,O
response,2575,2583,O
nuclear,2589,2596,O
weapon,2597,2603,O
detonation,2604,2614,O
Furthermore,2616,2627,O
models,2633,2639,O
readily,2647,2654,O
facilitate,2655,2665,O
calculation,2670,2681,O
injuries,2685,2693,O
multiple,2699,2707,O
effects,2708,2715,O
burns,2724,2729,O
blast,2734,2739,O
fallout,2745,2752,O
prompt,2756,2762,O
radiation,2763,2772,O
complexity,2778,2788,O
urban,2796,2801,O
dimensional,2808,2819,O
landscape,2820,2829,O
local,2838,2843,O
impact,2844,2850,O
thermal,2854,2861,O
blast,2863,2868,O
radiation,2873,2882,O
poorly,2891,2897,O
understood,2898,2908,O
Additionally,2910,2922,O
given,2924,2929,O
traditional,2936,2947,O
world,2948,2953,O
wide,2954,2958,O
focus,2959,2964,O
increased,2974,2983,O
sensitivity,2984,2995,O
providing,2999,3008,O
information,3009,3020,O
U,3028,3029,O
S,3030,3031,O
use,3038,3041,O
terrorists,3045,3055,O
models,3061,3067,O
provide,3075,3082,O
detailed,3083,3091,O
current,3095,3102,O
data,3103,3107,O
exists,3113,3119,O
United,3128,3134,O
States,3135,3141,O
help,3153,3157,O
provide,3158,3165,O
better,3166,3172,O
casualty,3173,3181,O
estimates,3182,3191,O
response,3196,3204,O
models,3210,3216,O
customized,3224,3234,O
locally,3235,3242,O
data,3247,3251,O
updated,3252,3259,O
user,3267,3271,O
sufficient,3276,3286,O
expertise,3287,3296,O
significant,3324,3335,O
duplication,3336,3347,O
effort,3351,3357,O
overlapping,3365,3376,O
jurisdictions,3377,3390,O
lack,3399,3403,O
data,3407,3411,O
sharing,3412,3419,O
security,3427,3435,O
considerations,3446,3460,O
CATS,3462,3466,O
HPAC,3471,3475,O
useful,3485,3491,O
creating,3496,3504,O
realistic,3505,3514,O
scenarios,3515,3524,O
training,3529,3537,O
planning,3542,3550,O
disaster,3560,3568,O
strikes,3569,3576,O
enabling,3583,3591,O
responders,3592,3602,O
drill,3606,3611,O
exercise,3616,3624,O
know,3633,3637,O
roughly,3638,3645,O
expect,3654,3660,O
react,3672,3677,O
Contingency,3679,3690,O
plans,3691,3696,O
created,3704,3711,O
comprehensive,3718,3731,O
national,3732,3740,O
detailed,3750,3758,O
population,3759,3769,O
infrastructure,3774,3788,O
data,3789,3793,O
disaster,3802,3810,O
strike,3811,3817,O
affected,3823,3831,O
population,3832,3842,O
impact,3851,3857,O
critical,3861,3869,O
facilities,3870,3880,O
quickly,3888,3895,O
assessed,3896,3904,O
efforts,3915,3922,O
frequently,3923,3933,O
need,3934,3938,O
expended,3945,3953,O
ensure,3957,3963,O
regional,3964,3972,O
local,3977,3982,O
databases,3983,3992,O
current,3997,4004,O
useful,4009,4015,O
Case,0,4,O
Presentation,5,17,O
patient,22,29,O
80,36,38,O
year,39,43,O
old,44,47,O
male,48,52,O
diabetes,58,66,O
mellitus,67,75,O
hypertension,80,92,O
age,101,104,O
74,105,107,O
March,109,114,O
2001,115,119,O
received,125,133,O
living,136,142,O
non,143,146,O
related,147,154,O
donor,155,160,O
kidney,161,167,B-Organ
transplant,168,178,O
time,188,192,O
discharged,200,210,O
double,218,224,O
immunosuppressive,225,242,O
therapy,243,250,O
consisting,251,261,O
prednisone,265,275,O
20,276,278,O
mg,279,281,O
day,282,285,O
mophetil,290,298,O
mycophenolate,299,312,O
1,313,314,O
5,315,316,O
gr,317,319,O
day,320,323,O
calcineurin,328,339,O
inhibitor,340,349,O
administered,354,366,O
prednisone,372,382,O
dose,383,387,O
decreased,400,409,O
5,413,414,O
mg,415,417,O
day,418,421,O
mophetil,426,434,O
mycophenolate,435,448,O
doses,449,454,O
sustained,455,464,O
November,469,477,O
2001,478,482,O
developed,486,495,O
cutaneous,496,505,O
purple,506,512,O
elevated,513,521,O
lesions,522,529,B-Pathological_formation
lower,537,542,B-Organism_subdivision
limbs,543,548,I-Organism_subdivision
diagnosed,559,568,O
KS,572,574,B-Pathological_formation
skin,578,582,B-Organ
biopsy,583,589,O
received,594,602,O
19,603,605,O
administrations,606,621,O
vincristine,625,636,O
1,638,639,O
mg,640,642,O
bleomycin,648,657,O
15,659,661,O
mg,662,664,O
weekly,666,672,O
resulted,678,686,O
flattening,690,700,O
fading,705,711,O
lesions,719,726,B-Pathological_formation
Treatment,728,737,O
discontinued,742,754,O
months,763,769,O
KS,775,777,B-Pathological_formation
recurred,778,786,O
pain,793,797,O
edema,802,807,B-Pathological_formation
legs,816,820,B-Organism_subdivision
July,825,829,O
2002,830,834,O
100,851,854,O
involvement,856,867,O
lower,875,880,B-Organ
limbs,881,886,I-Organ
skin,887,891,I-Organ
KS,897,899,B-Pathological_formation
visceral,907,915,O
involvement,916,927,O
received,931,939,O
50,940,942,O
mg,943,945,O
liposomal,949,958,O
adriamycin,959,969,O
addition,974,982,O
prescribed,996,1006,O
valganciclovir,1007,1021,O
450,1022,1025,O
mg,1026,1028,O
BID,1029,1032,O
corrected,1034,1043,O
creatinine,1048,1058,O
clearance,1059,1068,O
7,1071,1072,O
additional,1084,1094,O
administrations,1095,1110,O
liposomal,1114,1123,O
adriamycin,1124,1134,O
December,1142,1150,O
2002,1151,1155,O
showed,1160,1166,O
40,1167,1169,O
response,1171,1179,O
early,1191,1196,O
relapse,1197,1204,O
January,1209,1216,O
2003,1217,1221,O
patient,1226,1233,O
developed,1234,1243,O
disseminated,1244,1256,O
herpes,1257,1263,O
zoster,1264,1270,O
treated,1282,1289,O
IV,1295,1297,O
acyclovir,1298,1307,O
2003,1316,1320,O
KS,1321,1323,B-Pathological_formation
progression,1324,1335,O
observed,1340,1348,O
received,1353,1361,O
radiotherapy,1362,1374,O
benefit,1383,1390,O
Figure,1391,1397,O
1,1398,1399,O
August,1404,1410,O
2003,1411,1415,O
started,1419,1426,O
oral,1427,1431,O
etoposide,1432,1441,O
50,1445,1447,O
mg,1448,1450,O
QD,1451,1453,O
weeks,1462,1467,O
followed,1468,1476,O
weeks,1484,1489,O
2004,1504,1508,O
achieving,1509,1518,O
slow,1526,1530,O
50,1531,1533,O
response,1535,1543,O
Tolerance,1545,1554,O
good,1559,1563,O
serum,1568,1573,B-Organism_substance
creatinine,1574,1584,O
remain,1585,1591,O
stable,1592,1598,O
1,1609,1610,O
4,1611,1612,O
mg,1613,1615,O
dl,1616,1618,O
Mophetil,1620,1628,O
mycophenolate,1629,1642,O
dose,1643,1647,O
reduced,1652,1659,O
1,1663,1664,O
g,1665,1666,O
day,1667,1670,O
prednisone,1675,1685,O
2,1689,1690,O
5,1691,1692,O
mg,1693,1695,O
day,1696,1699,O
Figure,1701,1707,O
1,1708,1709,O
Kaposi,1710,1716,B-Pathological_formation
s,1717,1718,I-Pathological_formation
sarcoma,1719,1726,I-Pathological_formation
progressions,1727,1739,O
chemotherapy,1746,1758,O
withdrawal,1759,1769,O
lower,1776,1781,B-Organism_subdivision
limbs,1782,1787,I-Organism_subdivision
completely,1793,1803,O
covered,1804,1811,O
Kaposi,1817,1823,B-Pathological_formation
s,1824,1825,I-Pathological_formation
Sarcoma,1826,1833,I-Pathological_formation
June,1835,1839,O
2003,1840,1844,O
2004,1854,1858,O
patient,1863,1870,O
requested,1871,1880,O
second,1883,1889,O
opinion,1890,1897,O
prescribed,1906,1916,O
Imatinib,1917,1925,O
200,1926,1929,O
mg,1930,1932,O
qd,1933,1935,O
weeks,1944,1949,O
followed,1950,1958,O
400,1962,1965,O
mg,1966,1968,O
qd,1969,1971,O
weeks,1984,1989,O
Imatinib,1993,2001,O
health,2007,2013,O
deteriorated,2014,2026,O
rapidly,2027,2034,O
developed,2039,2048,O
anasarca,2049,2057,B-Pathological_formation
worsening,2059,2068,O
KS,2072,2074,O
serum,2080,2085,B-Organism_substance
creatinine,2086,2096,O
increased,2097,2106,O
1,2112,2113,O
4,2114,2115,O
mg,2116,2118,O
dl,2119,2121,O
2,2125,2126,O
3,2127,2128,O
mg,2129,2131,O
dl,2132,2134,O
developed,2142,2151,O
grade,2152,2157,O
4,2158,2159,O
granulocytopenia,2160,2176,O
Figure,2178,2184,O
2,2185,2186,O
patient,2193,2200,O
hospitalized,2205,2217,O
fever,2223,2228,O
started,2237,2244,O
IV,2248,2250,O
antibiotics,2251,2262,O
daily,2267,2272,O
G,2273,2274,O
CSF,2275,2278,O
days,2288,2292,O
WBC,2309,2312,B-Cell
count,2313,2318,O
normalized,2319,2329,O
weeks,2335,2340,O
later,2341,2346,O
creatinine,2351,2361,O
level,2362,2367,O
returned,2368,2376,O
1,2380,2381,O
5,2382,2383,O
mg,2384,2386,O
dl,2387,2389,O
February,2394,2402,O
2005,2403,2407,O
started,2415,2422,O
30,2426,2428,O
mg,2429,2431,O
paclitaxel,2435,2445,O
IV,2446,2448,O
weeks,2461,2466,O
courses,2480,2487,O
clinical,2496,2504,O
benefit,2505,2512,O
developed,2516,2525,O
skin,2528,2532,B-Organ
rash,2533,2537,O
prompted,2543,2551,O
discontinuation,2552,2567,O
Figure,2569,2575,O
2,2576,2577,O
Patient,2578,2585,O
developed,2586,2595,O
anasarca,2596,2604,B-Pathological_formation
rapid,2610,2615,O
progression,2616,2627,O
Kaposi,2631,2637,B-Pathological_formation
s,2638,2639,I-Pathological_formation
Sarcoma,2640,2647,I-Pathological_formation
weeks,2659,2664,O
taking,2668,2674,O
Imatinib,2675,2683,O
June,2685,2689,O
2004,2690,2694,O
April,2700,2705,O
2005,2706,2710,O
started,2719,2726,O
Sirolimus,2730,2739,O
2,2740,2741,O
mg,2742,2744,O
day,2747,2750,O
8,2762,2763,O
weeks,2764,2769,O
escalated,2770,2779,O
4,2783,2784,O
mg,2785,2787,O
day,2790,2793,O
weeks,2801,2806,O
later,2807,2812,O
mophetil,2813,2821,O
mycophenolate,2822,2835,O
prednisone,2840,2850,O
discontinued,2856,2868,O
Sustained,2870,2879,O
significant,2884,2895,O
KS,2896,2898,B-Pathological_formation
regression,2899,2909,O
evident,2914,2921,O
16,2928,2930,O
weeks,2931,2936,O
developed,2945,2954,O
basal,2957,2962,B-Pathological_formation
cell,2963,2967,I-Pathological_formation
carcinoma,2968,2977,I-Pathological_formation
pneumonia,2982,2991,O
required,2997,3005,O
hospital,3006,3014,O
admission,3015,3024,O
Sirolimus,3026,3035,O
dose,3036,3040,O
lowered,3045,3052,O
2,3056,3057,O
mg,3058,3060,O
day,3063,3066,O
clinical,3083,3091,O
course,3092,3098,O
satisfactory,3108,3120,O
continuous,3126,3136,O
progressive,3141,3152,O
regression,3153,3163,O
KS,3167,3169,B-Pathological_formation
lesions,3170,3177,I-Pathological_formation
Figure,3179,3185,O
3,3186,3187,O
serum,3194,3199,B-Organism_substance
creatinine,3200,3210,O
remained,3215,3223,O
1,3230,3231,O
6,3232,3233,O
mg,3234,3236,O
dl,3237,3239,O
developed,3255,3264,O
new,3265,3268,O
infectious,3269,3279,O
episodes,3280,3288,O
Figure,3290,3296,O
3,3297,3298,O
Extensive,3299,3308,O
regression,3309,3319,O
Kaposi,3323,3329,B-Pathological_formation
Sarcoma,3330,3337,I-Pathological_formation
immune,3344,3350,O
suppression,3351,3362,O
changed,3367,3374,O
Sirolimus,3378,3387,O
14,3390,3392,O
months,3393,3399,O
later,3400,3405,O
hyperpigmented,3420,3434,O
areas,3435,3440,O
knee,3444,3448,B-Organism_subdivision
levels,3449,3455,O
skin,3457,3461,B-Organ
looks,3462,3467,O
thin,3468,3472,O
delicate,3477,3485,O
easily,3490,3496,O
bruised,3497,3504,O
July,3506,3510,O
2006,3511,3515,O
Hypothetical,0,12,O
distribution,13,25,O
patterns,26,34,O
meadow,42,48,O
brown,49,54,O
Maniola,55,62,O
jurtina,63,70,O
Europe,74,80,O
glacial,97,104,O
maximum,105,112,O
dark,114,118,O
hatched,119,126,O
areas,127,132,O
Postglacial,135,146,O
expansions,147,157,O
indicated,162,171,O
solid,175,180,O
arrows,181,187,O
postulated,193,203,O
actual,204,210,O
hybrid,211,217,O
zone,218,222,O
shown,226,231,O
hatched,239,246,O
area,247,251,O
Question,253,261,O
marks,262,267,O
indicate,268,276,O
lack,277,281,O
information,285,296,O
concerning,297,307,O
ancient,308,315,O
distribution,316,328,O
patterns,329,337,O
South,345,350,O
present,355,362,O
distribution,363,375,O
hybrid,379,385,O
populations,386,397,O
North,405,410,O
Redrawn,412,419,O
Schmitt,425,432,O
et,433,435,O
al,437,439,O
36,442,444,O
based,447,452,O
Thomson,456,463,O
37,465,467,O
Schmitt,473,480,O
et,481,483,O
al,484,486,O
36,489,491,O
Supporting,0,10,O
Information,11,22,O
Alternate,23,32,O
Language,33,41,O
Article,42,49,O
S1,50,52,O
Translation,53,64,O
manuscript,72,82,O
French,88,94,O
EL,98,100,O
201,102,105,O
KB,106,108,O
DOC,109,112,O
Click,115,120,O
additional,130,140,O
data,141,145,O
file,146,150,O
Extrapyramidal,0,14,O
symptoms,15,23,O
based,24,29,O
Extrapyramidal,33,47,O
Symptoms,48,56,O
Rating,57,63,O
Scale,64,69,O
Etiology,0,8,O
Anorectal,9,18,B-Organism_subdivision
malformations,19,32,O
ARM,34,37,O
represent,39,48,O
spectrum,51,59,O
abnormalities,63,76,O
ranging,77,84,O
mild,90,94,O
anal,95,99,B-Immaterial_anatomical_entity
anomalies,100,109,O
complex,113,120,O
cloacal,121,128,O
malformations,129,142,O
etiology,148,156,O
malformations,165,178,O
remains,179,186,O
unclear,187,194,O
likely,202,208,O
multifactorial,209,223,O
reasons,243,250,O
believe,254,261,O
genetic,273,280,O
componenet,281,291,O
early,296,301,O
1950s,309,314,O
recognized,323,333,O
increased,352,361,O
risk,362,366,O
sibling,373,380,O
patient,386,393,O
ARM,399,402,O
born,409,413,O
malformation,421,433,O
1,446,447,O
100,451,454,O
compared,456,464,O
incidence,474,483,O
1,493,494,O
5000,498,502,O
general,510,517,O
population,518,528,O
time,541,545,O
reports,562,569,O
families,573,581,O
2,587,588,O
affected,597,605,O
members,606,613,O
associations,618,630,O
ARMs,634,638,O
multisystem,644,655,O
syndromes,656,665,O
particular,670,680,O
mutations,682,691,O
specific,695,703,O
genes,704,709,O
encoding,710,718,O
transcription,719,732,O
factors,733,740,O
described,751,760,O
patients,764,772,O
having,773,779,O
Townes,780,786,O
Broks,787,792,O
syndrome,793,801,O
Currarino,803,812,O
s,813,814,O
syndrome,815,823,O
Pallister,829,838,O
Hall,839,843,O
syndrome,844,852,O
autosomal,873,882,O
dominant,883,891,O
modes,892,897,O
inheritance,901,912,O
addition,917,925,O
found,939,944,O
increased,971,980,O
incidence,981,990,O
ARM,994,997,O
patient,1001,1008,O
trisomy,1014,1021,O
21,1022,1024,O
s,1031,1032,O
syndrome,1033,1041,O
95,1053,1055,O
patients,1060,1068,O
trisomy,1074,1081,O
21,1082,1084,O
ARM,1089,1092,O
imperforate,1098,1109,O
anus,1110,1114,B-Immaterial_anatomical_entity
fistula,1123,1130,B-Pathological_formation
compared,1132,1140,O
5,1151,1152,O
patients,1161,1169,O
ARM,1175,1178,O
Based,1180,1185,O
evidence,1194,1202,O
likely,1210,1216,O
mutation,1226,1234,O
variety,1240,1247,O
different,1251,1260,O
genes,1261,1266,O
result,1271,1277,O
ARM,1281,1284,O
etiology,1298,1306,O
ARM,1310,1313,O
multigenic,1317,1327,O
13,1329,1331,O
Images,0,6,O
Fig,7,10,O
1,12,13,O
Fig,14,17,O
2,19,20,O
Fig,21,24,O
3,26,27,O
Images,0,6,O
Figure,7,13,O
1,14,15,O
Results,0,7,O
observation,12,23,O
AP,29,31,O
3,32,33,O
found,37,42,O
cytosolic,51,60,B-Organism_substance
membrane,65,73,B-Organism_substance
subcellular,74,85,I-Organism_substance
fractions,86,95,I-Organism_substance
membrane,106,114,B-Cellular_component
associated,115,125,O
AP,126,128,O
3,129,130,O
extracted,138,147,O
salts,153,158,O
Dell,160,164,O
Angelica,165,173,O
et,174,176,O
al,177,179,O
1997a,182,187,O
consistent,192,202,O
role,212,216,O
membrane,222,230,B-Cellular_component
coat,231,235,O
recruited,248,257,O
cytosolic,265,274,B-Organism_substance
pool,275,279,I-Organism_substance
addition,284,292,O
punctate,298,306,O
staining,307,315,O
AP,319,321,O
3,322,323,O
immunofluorescence,327,345,O
microscopy,346,356,O
redistribution,362,376,O
cytosol,384,391,B-Organism_substance
BFA,395,398,O
reversibility,408,421,O
BFA,429,432,O
effect,433,439,O
Dell,441,445,O
Angelica,446,454,O
et,455,457,O
al,458,460,O
1997a,463,468,O
Simpson,470,477,O
et,478,480,O
al,481,483,O
1997,486,490,O
indicate,497,505,O
AP,511,513,O
3,514,515,O
cycle,520,525,O
cytosol,538,545,B-Organism_substance
membranes,550,559,B-Cellular_component
sensitivity,565,576,O
AP,580,582,O
3,583,584,O
BFA,588,591,O
cells,595,600,B-Cell
suggests,601,609,O
membrane,619,627,B-Cellular_component
association,628,639,O
regulated,647,656,O
ARF1,660,664,O
BFA,672,675,O
inhibits,676,684,O
ARF1,685,689,O
guanine,690,697,O
nucleotide,698,708,O
exchange,709,717,O
shown,732,737,O
prevent,741,748,O
ARF1,749,753,O
membrane,754,762,B-Cellular_component
binding,763,770,O
vitro,774,779,O
Donaldson,781,790,O
et,791,793,O
al,794,796,O
1992,799,803,O
Helms,805,810,O
Rothman,815,822,O
1992,824,828,O
Randazzo,830,838,O
et,839,841,O
al,842,844,O
1993,847,851,O
Immunocytochemistry,0,19,O
C2C12,20,25,B-Cell
cells,26,31,I-Cell
grown,32,37,O
8,41,42,O
chamber,43,50,O
slides,51,57,O
Nunc,59,63,O
fixed,70,75,O
4,79,80,O
PFA,82,85,O
PBS,86,89,O
10,94,96,O
min,97,100,O
permeabilized,105,118,O
0,122,123,O
1,124,125,O
Triton,127,133,O
X,134,135,O
100,136,139,O
20,144,146,O
min,147,150,O
cases,160,165,O
fixed,177,182,O
permeabilized,187,200,O
methanol,204,212,O
20degreesC,217,227,O
2,232,233,O
min,234,237,O
fixed,243,248,O
permeabilized,253,266,O
cells,267,272,B-Cell
blocked,278,285,O
PBS,289,292,O
containing,293,303,O
3,304,305,O
BSA,307,310,O
Jackson,312,319,O
ImmunoResearch,320,334,O
Laboratories,335,347,O
incubated,353,362,O
overnight,363,372,O
4degreesC,376,385,O
primary,391,398,O
antibodies,399,409,O
blocking,413,421,O
solution,422,430,O
Immunoreactivity,432,448,O
detected,453,461,O
Alexa,474,479,O
conjugated,480,490,O
secondary,491,500,O
antibody,501,509,O
Molecular,511,520,O
Probes,521,527,O
combination,534,545,O
biotin,549,555,O
conjugated,556,566,O
secondary,567,576,O
antibody,577,585,O
Vector,587,593,O
Laboratories,594,606,O
Alexa,612,617,O
conjugated,618,628,O
streptavidin,629,641,O
Molecular,643,652,O
Probes,653,659,O
Cytology,0,8,O
Histology,13,22,O
semithin,27,35,O
sections,36,44,O
embryoid,46,54,B-Developing_anatomical_structure
bodies,55,61,I-Developing_anatomical_structure
washed,67,73,O
twice,74,79,O
PBS,83,86,O
fixed,88,93,O
4,97,98,O
paraformaldehyde,100,116,O
4degreesC,120,129,O
overnight,130,139,O
dehydration,151,162,O
ethanol,166,173,O
embedded,179,187,O
JB,191,193,O
4,194,195,O
resin,196,201,O
Polysciences,203,215,O
Inc,217,220,O
1,224,225,O
4,226,227,O
mum,228,231,O
sections,232,240,O
cut,246,249,O
glass,257,262,O
knife,263,268,O
cytology,274,282,O
sections,288,296,O
stained,302,309,O
toluidine,315,324,O
blue,325,329,O
cell,334,338,B-Cell
mixing,339,345,O
experiments,346,357,O
embryoid,363,371,B-Developing_anatomical_structure
bodies,372,378,I-Developing_anatomical_structure
prefixed,384,392,O
stained,397,404,O
beta,409,413,O
galactosidase,414,427,O
sections,436,444,O
counterstained,450,464,O
neutral,470,477,O
red,478,481,O
Teratocarcinomas,483,499,O
fixed,505,510,O
Bouin,514,519,O
fixative,520,528,O
embedded,530,538,O
Paraplast,542,551,O
sections,561,569,O
stained,575,582,O
hematoxylin,588,599,O
eosin,604,609,O
Microphotography,611,627,O
ZEISS,639,644,O
Axiomat,645,652,O
microscope,653,663,O
Films,665,670,O
scanned,676,683,O
figures,688,695,O
prepared,701,709,O
Photoshop,715,724,O
5,725,726,O
5,727,728,O
software,729,737,O
Stimulation,0,11,O
Inhibition,12,22,O
iDC,26,29,B-Cell
Functions,30,39,O
Activated,43,52,O
NK,53,55,B-Cell
Cells,56,61,I-Cell
previous,67,75,O
studies,76,83,O
shown,89,94,O
resting,105,112,O
activated,117,126,O
NK,127,129,B-Cell
cells,130,135,I-Cell
partially,136,145,O
kill,146,150,O
autologous,151,161,O
DCs,162,165,B-Cell
measured,170,178,O
3,182,183,O
4,184,185,O
h,186,187,O
chromium,188,196,O
release,197,204,O
assays,205,211,O
high,218,222,O
NK,223,225,B-Cell
DC,226,228,B-Cell
ratios,229,235,O
11,237,239,O
12,241,243,O
long,262,266,O
term,267,271,O
cultures,272,280,O
24,282,284,O
48,285,287,O
h,288,289,O
NK,295,297,B-Cell
cells,298,303,I-Cell
stimulated,304,314,O
iDCs,319,323,B-Cell
lysing,336,342,O
Based,349,354,O
conflicting,364,375,O
results,376,383,O
examined,388,396,O
detail,405,411,O
apparent,416,424,O
stimulation,425,436,O
iDCs,440,444,B-Cell
contact,451,458,O
NK,464,466,B-Cell
cells,467,472,I-Cell
reasoned,477,485,O
activated,491,500,O
NK,501,503,B-Cell
cells,504,509,I-Cell
useful,524,530,O
experiments,541,552,O
encounter,568,577,O
vivo,581,585,O
NK,594,596,B-Cell
cells,597,602,I-Cell
normally,608,616,O
traffic,617,624,O
blood,632,637,B-Organism_substance
4,639,640,O
iDCs,646,650,B-Cell
reside,657,663,O
tissues,671,678,B-Tissue
1,680,681,O
3,683,684,O
occur,699,704,O
cells,715,720,B-Cell
activated,725,734,O
ii,737,739,O
activated,741,750,O
NK,751,753,B-Cell
cells,754,759,I-Cell
mediate,760,767,O
potent,773,779,O
lysis,780,785,O
iDCs,789,793,B-Cell
11,795,797,O
13,798,800,O
allowing,811,819,O
rigorous,831,839,O
examination,840,851,O
potential,857,866,O
cytotoxic,867,876,O
effect,877,883,O
iii,890,893,O
number,899,905,O
NK,909,911,B-Cell
cells,912,917,I-Cell
obtained,918,926,O
short,933,938,O
term,939,943,O
vitro,947,952,O
culture,953,960,O
far,970,973,O
greater,974,981,O
providing,982,991,O
cells,997,1002,B-Cell
analysis,1007,1015,O
9,1017,1018,O
DC,1025,1027,B-Cell
maturation,1028,1038,O
induced,1039,1046,O
resting,1050,1057,O
NK,1058,1060,B-Cell
cells,1061,1066,I-Cell
observed,1070,1078,O
dependent,1083,1092,O
endogenous,1096,1106,O
TNF,1107,1110,O
alpha,1111,1116,O
production,1117,1127,O
Furthermore,1129,1140,O
TNF,1142,1145,O
alpha,1146,1151,O
proinflammatory,1162,1177,O
cytokines,1178,1187,O
important,1192,1201,O
amplifiers,1202,1212,O
immune,1216,1222,O
responses,1223,1232,O
14,1234,1236,O
TNF,1258,1261,O
alpha,1262,1267,O
production,1268,1278,O
readout,1284,1291,O
DC,1296,1298,B-Cell
stimulation,1299,1310,O
culture,1318,1325,O
system,1326,1332,O
Culturing,1334,1343,O
activated,1344,1353,O
NK,1354,1356,B-Cell
cells,1357,1362,I-Cell
DCs,1368,1371,B-Cell
low,1375,1378,O
NK,1379,1381,B-Cell
DC,1382,1384,B-Cell
ratios,1385,1391,O
1,1393,1394,O
5,1395,1396,O
led,1398,1401,O
increases,1405,1414,O
TNF,1418,1421,O
alpha,1422,1427,O
production,1428,1438,O
augmented,1451,1460,O
dramatically,1461,1473,O
addition,1481,1489,O
suboptimal,1493,1503,O
doses,1504,1509,O
10,1511,1513,O
ng,1514,1516,O
ml,1517,1519,O
LPS,1524,1527,O
Fig,1529,1532,O
2,1534,1535,O
increased,1544,1553,O
TNF,1554,1557,O
alpha,1558,1563,O
production,1564,1574,O
dependent,1579,1588,O
cell,1592,1596,B-Cell
cell,1600,1604,B-Cell
contact,1605,1612,O
cell,1634,1638,B-Cell
types,1639,1644,O
separated,1650,1659,O
trans,1663,1668,O
wells,1669,1674,O
stimulation,1679,1690,O
observed,1695,1703,O
Fig,1705,1708,O
2,1710,1711,O
B,1712,1713,O
separate,1719,1727,O
experiments,1728,1739,O
observed,1743,1751,O
NK,1757,1759,B-Cell
stimulatory,1760,1771,O
effect,1772,1778,O
TNF,1782,1785,O
alpha,1786,1791,O
production,1792,1802,O
NK,1806,1808,B-Cell
DC,1809,1811,B-Cell
ratios,1812,1818,O
low,1822,1825,O
1,1829,1830,O
20,1831,1833,O
1,1838,1839,O
40,1840,1842,O
data,1844,1848,O
shown,1853,1858,O
Raising,1861,1868,O
NK,1873,1875,B-Cell
DC,1876,1878,B-Cell
ratio,1879,1884,O
5,1888,1889,O
1,1890,1891,O
changes,1892,1899,O
interaction,1904,1915,O
potent,1928,1934,O
DC,1935,1937,B-Cell
stimulation,1938,1949,O
complete,1961,1969,O
inhibition,1970,1980,O
presence,1988,1996,O
absence,2000,2007,O
LPS,2011,2014,O
Fig,2016,2019,O
2,2021,2022,O
C,2023,2024,O
identical,2030,2039,O
pattern,2040,2047,O
seen,2051,2055,O
IL,2060,2062,O
12,2063,2065,O
p40,2066,2069,O
production,2070,2080,O
Fig,2082,2085,O
2,2087,2088,O
D,2089,2090,O
IL,2096,2098,O
10,2099,2101,O
production,2102,2112,O
cultures,2120,2128,O
detected,2133,2141,O
conditions,2159,2169,O
tested,2170,2176,O
data,2178,2182,O
shown,2187,2192,O
massive,2199,2206,O
production,2207,2217,O
TNF,2221,2224,O
alpha,2225,2230,O
cultures,2238,2246,O
lowest,2254,2260,O
ratios,2261,2267,O
mediated,2272,2280,O
primarily,2281,2290,O
DCs,2294,2297,B-Cell
culture,2305,2312,O
low,2324,2327,O
number,2328,2334,O
NK,2338,2340,B-Cell
cells,2341,2346,I-Cell
2,2348,2349,O
x,2350,2351,O
104,2352,2355,O
cells,2356,2361,B-Cell
experiments,2386,2397,O
addition,2402,2410,O
efforts,2412,2419,O
stimulate,2423,2432,O
NK,2433,2435,B-Cell
cells,2436,2441,I-Cell
directly,2442,2450,O
optimal,2456,2463,O
doses,2464,2469,O
anti,2473,2477,O
CD16,2478,2482,O
rIL,2484,2487,O
2,2488,2489,O
rIL,2491,2494,O
12,2495,2497,O
PMA,2503,2506,O
ionomycin,2507,2516,O
combination,2529,2540,O
induced,2541,2548,O
moderate,2554,2562,O
500,2565,2568,O
pg,2569,2571,O
ml,2572,2574,O
TNF,2576,2579,O
alpha,2580,2585,O
production,2586,2596,O
NK,2604,2606,B-Cell
cells,2607,2612,I-Cell
present,2630,2637,O
2,2641,2642,O
x,2643,2644,O
105,2645,2648,O
cells,2649,2654,B-Cell
data,2665,2669,O
shown,2674,2679,O
Figure,2682,2688,O
2,2689,2690,O
Activated,2692,2701,O
cultured,2702,2710,O
NK,2711,2713,B-Cell
cell,2714,2718,I-Cell
mediated,2719,2727,O
amplification,2728,2741,O
inhibition,2742,2752,O
DC,2756,2758,B-Cell
cytokine,2759,2767,O
production,2768,2778,O
Results,2780,2787,O
presented,2792,2801,O
log,2805,2808,O
scales,2809,2815,O
Cultured,2817,2825,O
iDCs,2826,2830,B-Cell
incubated,2836,2845,O
cultured,2860,2868,O
purified,2869,2877,O
NK,2878,2880,B-Cell
cells,2881,2886,I-Cell
24,2891,2893,O
h,2894,2895,O
B,2903,2904,O
48,2909,2911,O
h,2912,2913,O
C,2915,2916,O
E,2917,2918,O
presence,2927,2935,O
absence,2939,2946,O
indicated,2954,2963,O
concentrations,2964,2978,O
LPS,2982,2985,O
culture,2993,3000,O
supernatants,3005,3017,O
removed,3023,3030,O
analyzed,3035,3043,O
ELISA,3047,3052,O
TNF,3057,3060,O
alpha,3061,3066,O
IL,3070,3072,O
12,3073,3075,O
p40,3076,3079,O
TNF,3085,3088,O
alpha,3089,3094,O
production,3095,3105,O
measured,3110,3118,O
supernatants,3126,3138,O
cultures,3144,3152,O
DCs,3157,3160,B-Cell
gray,3168,3172,O
bars,3173,3177,O
NK,3180,3182,B-Cell
DC,3183,3185,B-Cell
1,3187,3188,O
5,3189,3190,O
black,3193,3198,O
bars,3199,3203,O
LPS,3206,3209,O
concentrations,3210,3224,O
0,3236,3237,O
10,3239,3241,O
1,3247,3248,O
000,3249,3252,O
ng,3253,3255,O
ml,3256,3258,O
DCs,3260,3263,B-Cell
B,3278,3279,O
Contact,3281,3288,O
dependent,3289,3298,O
stimulation,3299,3310,O
iDC,3314,3317,B-Cell
TNF,3318,3321,O
alpha,3322,3327,O
production,3328,3338,O
NK,3342,3344,B-Cell
cells,3345,3350,I-Cell
tested,3355,3361,O
following,3372,3381,O
conditions,3382,3392,O
DCs,3394,3397,B-Cell
gray,3405,3409,O
bars,3410,3414,O
NK,3417,3419,B-Cell
DC,3420,3422,B-Cell
1,3424,3425,O
5,3426,3427,O
black,3430,3435,O
bars,3436,3440,O
NK,3443,3445,B-Cell
DC,3446,3448,B-Cell
1,3450,3451,O
5,3452,3453,O
trans,3455,3460,O
wells,3461,3466,O
striped,3468,3475,O
bars,3476,3480,O
LPS,3483,3486,O
concentrations,3487,3501,O
10,3513,3515,O
ng,3516,3518,O
ml,3519,3521,O
donor,3523,3528,O
1,3529,3530,O
20,3536,3538,O
ng,3539,3541,O
ml,3542,3544,O
donor,3546,3551,O
2,3552,3553,O
C,3557,3558,O
D,3563,3564,O
Effect,3566,3572,O
increasing,3576,3586,O
NK,3591,3593,B-Cell
DC,3594,3596,B-Cell
ratio,3597,3602,O
DCs,3604,3607,B-Cell
NK,3615,3617,B-Cell
DC,3618,3620,B-Cell
1,3621,3622,O
5,3623,3624,O
1,3626,3627,O
1,3628,3629,O
5,3631,3632,O
1,3633,3634,O
C,3640,3641,O
TNF,3643,3646,O
alpha,3647,3652,O
D,3658,3659,O
IL,3661,3663,O
12,3664,3666,O
p40,3667,3670,O
production,3671,3681,O
LPS,3683,3686,O
concentrations,3687,3701,O
0,3713,3714,O
ng,3715,3717,O
ml,3718,3720,O
20,3726,3728,O
ng,3729,3731,O
ml,3732,3734,O
50,3740,3742,O
ng,3743,3745,O
ml,3746,3748,O
1,3758,3759,O
000,3760,3763,O
ng,3764,3766,O
ml,3767,3769,O
LPS,3770,3773,O
DCs,3779,3782,B-Cell
E,3797,3798,O
effect,3804,3810,O
neutralizing,3814,3826,O
IFN,3827,3830,O
gamma,3831,3836,O
production,3837,3847,O
tested,3852,3858,O
following,3869,3878,O
conditions,3879,3889,O
DCs,3891,3894,B-Cell
gray,3902,3906,O
bars,3907,3911,O
NK,3914,3916,B-Cell
DC,3917,3919,B-Cell
1,3921,3922,O
5,3923,3924,O
black,3927,3932,O
bars,3933,3937,O
NK,3940,3942,B-Cell
DC,3943,3945,B-Cell
1,3947,3948,O
5,3949,3950,O
10,3956,3958,O
mug,3959,3962,O
ml,3963,3965,O
blocking,3969,3977,O
anti,3978,3982,O
IFN,3983,3986,O
gamma,3987,3992,O
mAb,3993,3996,O
stippled,3998,4006,O
bars,4007,4011,O
LPS,4014,4017,O
concentrations,4018,4032,O
0,4044,4045,O
ng,4046,4048,O
ml,4049,4051,O
LPS,4056,4059,O
20,4065,4067,O
ng,4068,4070,O
ml,4071,4073,O
LPS,4075,4078,O
20,4079,4081,O
Blocking,4084,4092,O
reagents,4093,4101,O
CD80,4106,4110,O
CD86,4112,4116,O
CD154,4118,4123,O
CD95,4125,4129,O
CD11a,4131,4136,O
CD50,4138,4142,O
IL,4147,4149,O
12,4150,4152,O
effect,4161,4167,O
NK,4175,4177,B-Cell
cell,4178,4182,I-Cell
induced,4183,4190,O
TNF,4191,4194,O
alpha,4195,4200,O
IL,4204,4206,O
12,4207,4209,O
p40,4210,4213,O
production,4214,4224,O
neutralizing,4236,4248,O
antibody,4249,4257,O
IFN,4262,4265,O
gamma,4266,4271,O
affecting,4282,4291,O
TNF,4292,4295,O
alpha,4296,4301,O
production,4302,4312,O
partially,4313,4322,O
blocked,4323,4330,O
20,4333,4335,O
IL,4338,4340,O
12,4341,4343,O
p40,4344,4347,O
production,4348,4358,O
induced,4359,4366,O
NK,4374,4376,B-Cell
cells,4377,4382,I-Cell
Fig,4384,4387,O
2,4389,4390,O
E,4391,4392,O
partial,4400,4407,O
inhibition,4408,4418,O
consistent,4422,4432,O
numerous,4438,4446,O
previous,4447,4455,O
reports,4456,4463,O
demonstrating,4464,4477,O
central,4480,4487,O
role,4488,4492,O
IL,4500,4502,O
12,4503,4505,O
IFN,4506,4509,O
gamma,4510,4515,O
positive,4516,4524,O
feedback,4525,4533,O
loop,4534,4538,O
active,4539,4545,O
NK,4554,4556,B-Cell
cells,4557,4562,I-Cell
IL,4567,4569,B-Cell
12,4570,4572,I-Cell
producing,4573,4582,I-Cell
cells,4583,4588,I-Cell
15,4590,4592,O
17,4593,4595,O
Clearly,4598,4605,O
described,4626,4635,O
cytokine,4636,4644,O
cross,4645,4650,O
talk,4651,4655,O
mechanism,4656,4665,O
secondary,4669,4678,O
contact,4686,4693,O
dependent,4694,4703,O
activation,4704,4714,O
DCs,4718,4721,B-Cell
NK,4725,4727,B-Cell
cells,4728,4733,I-Cell
described,4734,4743,O
Taken,4750,4755,O
results,4771,4778,O
indicate,4779,4787,O
novel,4793,4798,O
mechanisms,4799,4809,O
control,4810,4817,O
cognate,4818,4825,O
interactions,4826,4838,O
NK,4847,4849,B-Cell
cells,4850,4855,I-Cell
DCs,4860,4863,B-Cell
NK,4873,4875,B-Cell
DC,4876,4878,B-Cell
contact,4879,4886,O
potential,4895,4904,O
serve,4908,4913,O
important,4920,4929,O
control,4930,4937,O
switch,4938,4944,O
amplifying,4954,4964,O
attenuating,4969,4980,O
innate,4981,4987,O
immune,4988,4994,O
responses,4995,5004,O
vivo,5008,5012,O
tested,5022,5028,O
directly,5029,5037,O
NK,5046,5048,B-Cell
cell,5049,5053,I-Cell
killing,5054,5061,O
active,5066,5072,O
system,5080,5086,O
short,5098,5103,O
term,5104,5108,O
4,5110,5111,O
h,5112,5113,O
chromium,5115,5123,O
release,5124,5131,O
assays,5132,5138,O
data,5140,5144,O
shown,5149,5154,O
flow,5162,5166,O
cytometric,5167,5177,O
assay,5178,5183,O
allowed,5190,5197,O
follow,5204,5210,O
survival,5215,5223,O
autologous,5231,5241,O
iDCs,5242,5246,B-Cell
presence,5254,5262,O
NK,5266,5268,B-Cell
cells,5269,5274,I-Cell
longer,5280,5286,O
periods,5287,5294,O
Fig,5296,5299,O
3,5301,5302,O
results,5309,5316,O
demonstrate,5317,5328,O
NK,5334,5336,B-Cell
cells,5337,5342,I-Cell
kill,5343,5347,O
autologous,5348,5358,O
iDCs,5359,5363,B-Cell
Fig,5365,5368,O
3,5370,5371,O
NK,5382,5384,B-Cell
DC,5385,5387,B-Cell
ratios,5388,5394,O
tested,5395,5401,O
4,5408,5409,O
h,5410,5411,O
level,5420,5425,O
killing,5429,5436,O
similar,5440,5447,O
lysis,5455,5460,O
K562,5464,5468,B-Cell
cells,5469,5474,I-Cell
time,5489,5493,O
Fig,5495,5498,O
3,5500,5501,O
B,5502,5503,O
24,5512,5514,O
h,5515,5516,O
presence,5531,5539,O
NK,5543,5545,B-Cell
cells,5546,5551,I-Cell
led,5552,5555,O
completely,5559,5569,O
divergent,5570,5579,O
effects,5580,5587,O
DCs,5595,5598,B-Cell
5,5607,5608,O
1,5609,5610,O
NK,5612,5614,B-Cell
DC,5615,5617,B-Cell
ratio,5619,5624,O
NK,5626,5628,B-Cell
cell,5629,5633,I-Cell
mediated,5634,5642,O
destruction,5643,5654,O
iDCs,5662,5666,B-Cell
dominant,5675,5683,O
feature,5684,5691,O
low,5708,5711,O
ratio,5712,5717,O
1,5719,5720,O
5,5721,5722,O
NK,5733,5735,B-Cell
cells,5736,5741,I-Cell
promoted,5742,5750,O
iDCs,5751,5755,B-Cell
survival,5756,5764,O
compared,5765,5773,O
iDCs,5779,5783,B-Cell
period,5804,5810,O
Fig,5812,5815,O
3,5817,5818,O
equal,5827,5832,O
ratio,5833,5838,O
NK,5842,5844,B-Cell
DC,5845,5847,B-Cell
1,5849,5850,O
1,5851,5852,O
fell,5854,5858,O
extremes,5877,5885,O
NK,5891,5893,B-Cell
cell,5894,5898,I-Cell
mediated,5899,5907,O
lysis,5908,5913,O
K562,5921,5925,B-Cell
targets,5926,5933,O
increased,5934,5943,O
ratios,5951,5957,O
tested,5958,5964,O
24,5975,5977,O
h,5978,5979,O
incubation,5980,5990,O
striking,5998,6006,O
differences,6007,6018,O
death,6027,6032,O
survival,6037,6045,O
DCs,6049,6052,B-Cell
encountering,6058,6070,O
NK,6071,6073,B-Cell
cells,6074,6079,I-Cell
correlate,6080,6089,O
precisely,6090,6099,O
previous,6109,6117,O
results,6118,6125,O
TNF,6129,6132,O
alpha,6133,6138,O
IL,6143,6145,O
12,6146,6148,O
p40,6149,6152,O
production,6153,6163,O
increasing,6170,6180,O
numbers,6181,6188,O
NK,6192,6194,B-Cell
cells,6195,6200,I-Cell
culture,6208,6215,O
shifts,6216,6222,O
NK,6227,6229,B-Cell
effect,6230,6236,O
potent,6242,6248,O
stimulation,6249,6260,O
complete,6264,6272,O
inhibition,6273,6283,O
Fig,6285,6288,O
2,6290,6291,O
Figure,6294,6300,O
3,6301,6302,O
Activated,6304,6313,O
cultured,6314,6322,O
NK,6323,6325,B-Cell
cell,6326,6330,I-Cell
mediated,6331,6339,O
death,6340,6345,O
survival,6346,6354,O
DCs,6358,6361,B-Cell
NK,6366,6368,B-Cell
DC,6369,6371,B-Cell
conjugate,6372,6381,O
formation,6382,6391,O
NK,6393,6395,B-Cell
cell,6396,6400,I-Cell
mediated,6401,6409,O
killing,6410,6417,O
survival,6418,6426,O
CFDA,6430,6434,O
SE,6435,6437,O
loaded,6438,6444,O
iDCs,6445,6449,B-Cell
K562,6458,6462,B-Cell
cells,6463,6468,I-Cell
B,6470,6471,O
measured,6477,6485,O
flow,6489,6493,O
cytometry,6494,6503,O
4,6509,6510,O
h,6511,6512,O
24,6520,6522,O
h,6523,6524,O
indicated,6536,6545,O
NK,6546,6548,B-Cell
DC,6549,6551,B-Cell
ratios,6552,6558,O
described,6562,6571,O
Materials,6575,6584,O
Methods,6589,6596,O
Results,6598,6605,O
presented,6610,6619,O
percentage,6623,6633,O
specific,6637,6645,O
lysis,6646,6651,O
SEM,6656,6659,O
n,6661,6662,O
3,6665,6666,O
independent,6667,6678,O
experiments,6679,6690,O
NK,6693,6695,B-Cell
DC,6696,6698,B-Cell
C,6700,6701,O
E,6702,6703,O
NK,6708,6710,B-Cell
K562,6711,6715,B-Cell
F,6717,6718,O
H,6719,6720,O
conjugate,6722,6731,O
formation,6732,6741,O
measured,6746,6754,O
flow,6758,6762,O
cytometry,6763,6772,O
following,6781,6790,O
ratios,6791,6797,O
NK,6799,6801,B-Cell
DC,6802,6804,B-Cell
NK,6808,6810,B-Cell
K562,6811,6815,B-Cell
1,6818,6819,O
5,6820,6821,O
C,6823,6824,O
F,6829,6830,O
1,6833,6834,O
1,6835,6836,O
D,6838,6839,O
G,6844,6845,O
5,6852,6853,O
1,6854,6855,O
E,6857,6858,O
H,6863,6864,O
Snarf,6867,6872,O
1,6873,6874,O
FL3,6876,6879,O
labeled,6881,6888,O
iDCs,6889,6893,B-Cell
K562,6897,6901,B-Cell
cells,6902,6907,I-Cell
incubated,6913,6922,O
30,6924,6926,O
min,6927,6930,O
CFDA,6937,6941,O
SE,6942,6944,O
FL1,6946,6949,O
labeled,6951,6958,O
NK,6959,6961,B-Cell
cells,6962,6967,I-Cell
different,6975,6984,O
ratios,6985,6991,O
percentage,6997,7007,O
conjugates,7011,7021,O
formed,7022,7028,O
right,7034,7039,O
quadrant,7040,7048,O
calculated,7054,7064,O
determining,7068,7079,O
percentage,7084,7094,O
FL3,7098,7101,O
Snarf,7104,7109,O
1,7110,7111,O
events,7113,7119,O
positive,7136,7144,O
FL1,7149,7152,O
CFDA,7154,7158,O
SE,7159,7161,O
results,7168,7175,O
representative,7180,7194,O
experiments,7203,7214,O
performed,7215,7224,O
activated,7230,7239,O
NK,7240,7242,B-Cell
cells,7243,7248,I-Cell
Resting,7250,7257,O
NK,7258,7260,B-Cell
cells,7261,7266,I-Cell
readily,7272,7279,O
formed,7280,7286,O
conjugates,7287,7297,O
autologous,7303,7313,O
iDCs,7314,7318,B-Cell
data,7320,7324,O
shown,7329,7334,O
NK,7337,7339,B-Cell
cells,7340,7345,I-Cell
efficiently,7355,7366,O
kill,7367,7371,O
potently,7376,7384,O
stimulate,7385,7394,O
DCs,7395,7398,B-Cell
model,7406,7411,O
system,7412,7418,O
opposing,7437,7445,O
effects,7446,7453,O
appear,7454,7460,O
dependent,7461,7470,O
cell,7474,7478,B-Cell
cell,7482,7486,B-Cell
contact,7487,7494,O
quantify,7499,7507,O
apparent,7514,7522,O
cognate,7523,7530,O
interactions,7531,7543,O
measured,7547,7555,O
formation,7560,7569,O
NK,7573,7575,B-Cell
DC,7576,7578,B-Cell
conjugates,7579,7589,O
compared,7594,7602,O
conjugates,7611,7621,O
formed,7622,7628,O
NK,7632,7634,B-Cell
cells,7635,7640,I-Cell
tumor,7645,7650,B-Pathological_formation
targets,7651,7658,O
analysis,7664,7672,O
revealed,7673,7681,O
NK,7687,7689,B-Cell
cells,7690,7695,I-Cell
bound,7696,7701,O
DC,7702,7704,B-Cell
Fig,7706,7709,O
3,7711,7712,O
C,7713,7714,O
E,7715,7716,O
efficiency,7726,7736,O
equal,7744,7749,O
NK,7761,7763,B-Cell
cell,7764,7768,I-Cell
binding,7769,7776,O
classical,7784,7793,O
NK,7794,7796,B-Cell
target,7797,7803,O
K562,7805,7809,B-Cell
Fig,7811,7814,O
3,7816,7817,O
F,7818,7819,O
H,7820,7821,O
Binding,7824,7831,O
detectable,7836,7846,O
lowest,7859,7865,O
NK,7866,7868,B-Cell
DC,7869,7871,B-Cell
ratio,7872,7877,O
tested,7878,7884,O
1,7886,7887,O
5,7888,7889,O
indicating,7891,7901,O
NK,7907,7909,B-Cell
DC,7910,7912,B-Cell
conjugates,7913,7923,O
formed,7928,7934,O
experiments,7948,7959,O
measuring,7960,7969,O
cytokine,7970,7978,O
production,7979,7989,O
cell,7994,7998,B-Cell
killing,7999,8006,O
initial,8012,8019,O
experiments,8020,8031,O
resting,8038,8045,O
NK,8046,8048,B-Cell
cells,8049,8054,I-Cell
Fig,8056,8059,O
1,8061,8062,O
demonstrated,8064,8076,O
contact,8079,8086,O
dependent,8087,8096,O
NK,8097,8099,B-Cell
effect,8100,8106,O
driving,8107,8114,O
iDCs,8115,8119,B-Cell
mature,8123,8129,O
tested,8145,8151,O
effects,8157,8164,O
activated,8165,8174,O
NK,8175,8177,B-Cell
cells,8178,8183,I-Cell
mediated,8184,8192,O
DC,8196,8198,B-Cell
maturation,8199,8209,O
Fig,8211,8214,O
4,8216,8217,O
Similar,8220,8227,O
previous,8235,8243,O
results,8244,8251,O
activated,8257,8266,O
NK,8267,8269,B-Cell
cells,8270,8275,I-Cell
Figs,8277,8281,O
2,8283,8284,O
3,8289,8290,O
addition,8293,8301,O
NK,8305,8307,B-Cell
cells,8308,8313,I-Cell
culture,8321,8328,O
leads,8329,8334,O
opposing,8338,8346,O
effects,8347,8354,O
iDC,8362,8365,B-Cell
population,8366,8376,O
depending,8377,8386,O
NK,8394,8396,B-Cell
DC,8397,8399,B-Cell
ratio,8400,8405,O
Compared,8407,8415,O
untreated,8425,8434,O
DCs,8435,8438,B-Cell
Fig,8440,8443,O
4,8445,8446,O
C,8449,8450,O
low,8453,8456,O
NK,8457,8459,B-Cell
DC,8460,8462,B-Cell
ratios,8463,8469,O
1,8471,8472,O
5,8473,8474,O
1,8478,8479,O
1,8480,8481,O
consistently,8483,8495,O
augmented,8496,8505,O
expression,8506,8516,O
maturation,8524,8534,O
markers,8535,8542,O
CD86,8544,8548,O
Fig,8550,8553,O
4,8555,8556,O
D,8557,8558,O
CD83,8563,8567,O
HLA,8573,8576,O
DR,8577,8579,O
data,8581,8585,O
shown,8590,8595,O
5,8603,8604,O
1,8605,8606,O
ratio,8607,8612,O
NK,8614,8616,B-Cell
DC,8617,8619,B-Cell
DCs,8633,8636,B-Cell
nonviable,8641,8650,O
Fig,8652,8655,O
4,8657,8658,O
J,8659,8660,O
L,8661,8662,O
Addition,8665,8673,O
suboptimal,8677,8687,O
doses,8688,8693,O
LPS,8697,8700,O
Fig,8702,8705,O
4,8707,8708,O
C,8709,8710,O
F,8712,8713,O
L,8722,8723,O
augmented,8725,8734,O
NK,8739,8741,B-Cell
induced,8742,8749,O
maturation,8750,8760,O
NK,8764,8766,B-Cell
DC,8767,8769,B-Cell
ratios,8770,8776,O
1,8780,8781,O
5,8782,8783,O
1,8788,8789,O
1,8790,8791,O
effect,8804,8810,O
5,8818,8819,O
1,8820,8821,O
ratio,8822,8827,O
DC,8836,8838,B-Cell
maturation,8839,8849,O
dependent,8854,8863,O
NK,8867,8869,B-Cell
cell,8870,8874,I-Cell
contact,8875,8882,O
endogenously,8887,8899,O
produced,8900,8908,O
TNF,8909,8912,O
alpha,8913,8918,O
occur,8939,8944,O
cell,8958,8962,B-Cell
types,8963,8968,O
separated,8974,8983,O
trans,8987,8992,O
wells,8993,8998,O
addition,9011,9019,O
neutralizing,9025,9037,O
antibody,9038,9046,O
TNF,9051,9054,O
alpha,9055,9060,O
Fig,9062,9065,O
5,9067,9068,O
addition,9081,9089,O
blocking,9093,9101,O
reagents,9102,9110,O
CD80,9115,9119,O
CD86,9121,9125,O
CD154,9127,9132,O
CD95,9134,9138,O
CD11a,9140,9145,O
CD50,9147,9151,O
IL,9153,9155,O
12,9156,9158,O
IFN,9160,9163,O
gamma,9164,9169,O
IFN,9171,9174,O
alpha,9175,9180,O
IFN,9185,9188,O
beta,9189,9193,O
effect,9201,9207,O
NK,9215,9217,B-Cell
induced,9218,9225,O
maturation,9226,9236,O
data,9238,9242,O
shown,9247,9252,O
Figure,9255,9261,O
4,9262,9263,O
Activated,9265,9274,O
cultured,9275,9283,O
NK,9284,9286,B-Cell
cell,9287,9291,I-Cell
mediated,9292,9300,O
maturation,9301,9311,O
death,9312,9317,O
DCs,9321,9324,B-Cell
Cultured,9326,9334,O
iDCs,9335,9339,B-Cell
incubated,9345,9354,O
48,9359,9361,O
h,9362,9363,O
C,9374,9375,O
NK,9386,9388,B-Cell
cells,9389,9394,I-Cell
following,9402,9411,O
ratios,9412,9418,O
NK,9420,9422,B-Cell
DC,9423,9425,B-Cell
1,9428,9429,O
5,9430,9431,O
D,9433,9434,O
F,9435,9436,O
1,9439,9440,O
1,9441,9442,O
G,9444,9445,O
5,9454,9455,O
1,9456,9457,O
J,9459,9460,O
L,9461,9462,O
Forward,9465,9472,O
versus,9473,9479,O
scatter,9485,9492,O
plots,9493,9498,O
D,9503,9504,O
G,9506,9507,O
J,9513,9514,O
gating,9525,9531,O
DC,9539,9541,B-Cell
subset,9542,9548,O
demonstrate,9553,9564,O
disappearance,9569,9582,O
5,9590,9591,O
1,9592,9593,O
NK,9595,9597,B-Cell
DC,9598,9600,B-Cell
ratio,9602,9607,O
J,9609,9610,O
Propidium,9613,9622,O
iodide,9623,9629,O
staining,9630,9638,O
NK,9646,9648,B-Cell
DC,9649,9651,B-Cell
5,9653,9654,O
1,9655,9656,O
cultures,9658,9666,O
confirmed,9667,9676,O
complete,9688,9696,O
absence,9697,9704,O
viable,9708,9714,O
DCs,9715,9718,B-Cell
data,9720,9724,O
shown,9729,9734,O
Staining,9737,9745,O
CD86,9750,9754,O
expression,9755,9765,O
performed,9770,9779,O
described,9783,9792,O
Fig,9796,9799,O
1,9801,9802,O
histograms,9811,9821,O
shown,9826,9831,O
DCs,9836,9839,B-Cell
cultured,9840,9848,O
presence,9856,9864,O
C,9866,9867,O
F,9869,9870,O
L,9879,9880,O
absence,9885,9892,O
B,9894,9895,O
E,9897,9898,O
H,9900,9901,O
K,9907,9908,O
1,9913,9914,O
ng,9915,9917,O
ml,9918,9920,O
LPS,9924,9927,O
Results,9929,9936,O
representative,9941,9955,O
experiments,9963,9974,O
performed,9975,9984,O
Figure,9986,9992,O
5,9993,9994,O
Activated,9996,10005,O
cultured,10006,10014,O
NK,10015,10017,B-Cell
cell,10018,10022,I-Cell
induced,10023,10030,O
DC,10031,10033,B-Cell
maturation,10034,10044,O
dependent,10048,10057,O
cell,10061,10065,B-Cell
cell,10069,10073,B-Cell
contact,10074,10081,O
endogenous,10086,10096,O
TNF,10097,10100,O
alpha,10101,10106,O
production,10107,10117,O
Cultured,10119,10127,O
iDCs,10128,10132,B-Cell
incubated,10138,10147,O
D,10158,10159,O
G,10165,10166,O
activated,10174,10183,O
NK,10184,10186,B-Cell
cells,10187,10192,I-Cell
NK,10199,10201,B-Cell
DC,10202,10204,B-Cell
ratio,10205,10210,O
1,10214,10215,O
5,10216,10217,O
B,10219,10220,O
E,10222,10223,O
H,10229,10230,O
activated,10238,10247,O
NK,10248,10250,B-Cell
cells,10251,10256,I-Cell
NK,10258,10260,B-Cell
DC,10261,10263,B-Cell
1,10265,10266,O
5,10267,10268,O
separated,10270,10279,O
trans,10283,10288,O
wells,10289,10294,O
C,10296,10297,O
F,10302,10303,O
activated,10314,10323,O
NK,10324,10326,B-Cell
cells,10327,10332,I-Cell
10,10337,10339,O
mug,10340,10343,O
ml,10344,10346,O
neutralizing,10352,10364,O
antibody,10365,10373,O
TNF,10378,10381,O
alpha,10382,10387,O
LPS,10393,10396,O
concentrations,10397,10411,O
0,10423,10424,O
ng,10425,10427,O
ml,10428,10430,O
C,10434,10435,O
10,10438,10440,O
ng,10441,10443,O
ml,10444,10446,O
D,10448,10449,O
F,10450,10451,O
50,10457,10459,O
ng,10460,10462,O
ml,10463,10465,O
G,10467,10468,O
CD86,10473,10477,O
staining,10478,10486,O
DC,10494,10496,B-Cell
subset,10497,10503,O
performed,10508,10517,O
Figs,10524,10528,O
1,10530,10531,O
4,10536,10537,O
Results,10539,10546,O
representative,10551,10565,O
experiments,10574,10585,O
performed,10586,10595,O
Acknowledgements,0,16,O
like,26,30,O
thank,34,39,O
colleague,44,53,O
Dr,54,56,O
Nikolaos,58,66,O
Papathanasiou,67,80,O
assistance,89,99,O
performing,103,113,O
statistical,118,129,O
analysis,130,138,O
Anion,0,5,O
cation,9,15,O
selectivity,16,27,O
ratio,28,33,O
determined,34,44,O
relative,54,62,O
rates,63,68,O
reaction,72,80,O
MTSES,84,89,O
MTSET,95,100,O
water,111,116,O
exposed,117,124,O
residues,125,133,O
M6,141,143,O
segment,144,151,O
anion,157,162,O
selectivity,163,174,O
ratio,175,180,O
calculated,184,194,O
described,198,207,O
Table,211,216,O
II,217,219,O
column,221,227,O
5,228,229,O
Note,231,235,O
marked,240,246,O
increase,247,255,O
anion,259,264,O
selectivity,265,276,O
residues,284,292,O
T351C,293,298,O
Q353C,303,308,O
ratio,312,317,O
1,321,322,O
indicates,323,332,O
selectivity,336,347,O
anions,356,362,O
cations,367,374,O
larger,380,386,O
ratio,391,396,O
greater,401,408,O
anion,413,418,O
selectivity,419,430,O
Authors,0,7,O
contributions,9,22,O
authors,27,34,O
contributed,35,46,O
development,54,65,O
methodology,73,84,O
CY,86,88,O
NZ,93,95,O
led,96,99,O
method,100,106,O
conceptualization,107,124,O
prepared,129,137,O
original,142,150,O
draft,151,156,O
revised,168,175,O
JR,179,181,O
CY,183,185,O
VD,190,192,O
performed,193,202,O
implementations,208,223,O
authors,229,236,O
read,237,241,O
approved,246,254,O
final,259,264,O
manuscript,265,275,O
Background,0,10,O
Potato,11,17,O
late,18,22,O
blight,23,29,O
disease,33,40,O
caused,41,47,O
oomycete,55,63,O
pathogen,64,72,O
Phytophthora,73,85,O
infestans,86,95,O
world,111,116,O
s,117,118,O
devastating,124,135,O
crop,136,140,O
diseases,141,149,O
World,151,156,O
wide,157,161,O
losses,162,168,O
late,176,180,O
blight,181,187,O
exceed,188,194,O
billion,203,210,O
dollars,211,218,O
annually,219,227,O
1,229,230,O
potato,245,251,O
cultivars,252,261,O
currently,262,271,O
grown,272,277,O
United,285,291,O
States,292,298,O
highly,303,309,O
susceptible,310,321,O
late,325,329,O
blight,330,336,O
control,341,348,O
disease,357,364,O
relies,365,371,O
exclusively,379,390,O
fungicide,394,403,O
applications,404,416,O
effective,427,436,O
environmentally,441,456,O
sound,457,462,O
way,463,466,O
controlling,471,482,O
late,483,487,O
blight,488,494,O
incorporate,501,512,O
natural,513,520,O
resistance,521,531,O
potato,537,543,O
cultivars,544,553,O
pedigrees,559,568,O
potato,577,583,O
cultivars,584,593,O
currently,594,603,O
different,612,621,O
countries,622,631,O
include,632,639,O
late,640,644,O
blight,645,651,O
resistant,652,661,O
germplasm,662,671,O
derived,672,679,O
Solanum,685,692,O
demissum,693,701,O
Solanum,703,710,O
andigena,711,719,O
wild,731,735,O
species,736,743,O
resistance,766,776,O
derived,777,784,O
wild,796,800,O
species,801,808,O
controlled,812,822,O
single,826,832,O
dominant,833,841,O
resistance,842,852,O
genes,853,858,O
R,860,861,O
genes,862,867,O
R,876,877,O
genes,878,883,O
effective,893,902,O
preventing,906,916,O
development,921,932,O
late,936,940,O
blight,941,947,O
invading,955,963,O
P,964,965,O
infestans,967,976,O
race,977,981,O
contains,982,990,O
corresponding,995,1008,O
avirulence,1009,1019,O
genes,1020,1025,O
R,1032,1033,O
gene,1034,1038,O
mediated,1039,1047,O
resistance,1048,1058,O
short,1068,1073,O
lived,1074,1079,O
rapidly,1087,1094,O
overcome,1095,1103,O
new,1107,1110,O
races,1111,1116,O
late,1124,1128,O
blight,1129,1135,O
pathogen,1136,1144,O
Solanum,1146,1153,O
bulbocastanum,1154,1167,O
2n,1169,1171,O
2x,1174,1176,O
24,1179,1181,O
diploid,1188,1195,O
species,1196,1203,O
adapted,1213,1220,O
environment,1233,1244,O
late,1252,1256,O
blight,1257,1263,O
pathogen,1264,1272,O
wild,1279,1283,O
species,1284,1291,O
characterized,1296,1309,O
possessing,1313,1323,O
durable,1324,1331,O
resistance,1332,1342,O
P,1351,1352,O
infestans,1354,1363,O
high,1376,1380,O
disease,1381,1388,O
pressure,1389,1397,O
2,1399,1400,O
3,1401,1402,O
resistance,1409,1419,O
genes,1420,1425,O
RB,1427,1429,O
Rpi,1431,1434,O
blb1,1435,1439,O
Rpi,1445,1448,O
blb2,1449,1453,O
cloned,1465,1471,O
S,1477,1478,O
bulbocastanum,1480,1493,O
4,1495,1496,O
6,1497,1498,O
genes,1506,1511,O
confer,1512,1518,O
broad,1519,1524,O
spectrum,1525,1533,O
resistance,1534,1544,O
wide,1555,1559,O
range,1560,1565,O
known,1569,1574,O
P,1575,1576,O
infestans,1578,1587,O
races,1588,1593,O
Transgenic,1595,1605,O
potato,1606,1612,O
lines,1613,1618,O
containing,1619,1629,O
single,1632,1638,O
RB,1639,1641,O
gene,1642,1646,O
showed,1647,1653,O
high,1656,1660,O
level,1661,1666,O
resistance,1667,1677,O
Toluca,1685,1691,O
Valley,1692,1698,O
Mexico,1700,1706,O
potato,1718,1724,O
fields,1725,1731,O
naturally,1736,1745,O
intensively,1746,1757,O
infested,1758,1766,O
diversified,1781,1792,O
P,1793,1794,O
infestans,1796,1805,O
populations,1806,1817,O
7,1819,1820,O
interestingly,1828,1841,O
transgenic,1843,1853,O
RB,1854,1856,O
plants,1857,1863,O
total,1877,1882,O
immunity,1883,1891,O
late,1895,1899,O
blight,1900,1906,O
instead,1912,1919,O
showed,1920,1926,O
marked,1929,1935,O
delay,1936,1941,O
onset,1950,1955,O
symptoms,1959,1967,O
development,1972,1983,O
lesions,1987,1994,B-Pathological_formation
rate,2001,2005,O
limiting,2006,2014,O
resistance,2015,2025,O
selection,2039,2048,O
pressure,2049,2057,O
P,2065,2066,O
infestans,2068,2077,O
populations,2078,2089,O
protect,2094,2101,O
durability,2106,2116,O
resistance,2125,2135,O
gene,2136,2140,O
RB,2146,2148,O
gene,2149,2153,O
provides,2164,2172,O
excellent,2176,2185,O
model,2186,2191,O
study,2195,2200,O
mechanism,2205,2214,O
broad,2218,2223,O
spectrum,2224,2232,O
rate,2237,2241,O
limiting,2242,2250,O
disease,2251,2258,O
resistances,2259,2270,O
understanding,2275,2288,O
underlying,2296,2306,O
mechanism,2307,2316,O
type,2325,2329,O
resistance,2333,2343,O
important,2347,2356,O
developing,2361,2371,O
strategies,2372,2382,O
breed,2386,2391,O
durable,2392,2399,O
sustainable,2404,2415,O
disease,2416,2423,O
resistance,2424,2434,O
genes,2444,2449,O
implicated,2460,2470,O
regulation,2478,2488,O
R,2492,2493,O
gene,2494,2498,O
function,2499,2507,O
genes,2518,2523,O
Rar1,2525,2529,O
Sgt1,2534,2538,O
extensively,2558,2569,O
studied,2570,2577,O
genes,2578,2583,O
Rar1,2589,2593,O
required,2595,2603,O
Mla12,2608,2613,O
resistance,2614,2624,O
gene,2626,2630,O
identified,2641,2651,O
essential,2660,2669,O
role,2670,2674,O
function,2682,2690,O
subset,2696,2702,O
Mla,2706,2709,O
genes,2710,2715,O
confer,2721,2727,O
resistance,2728,2738,O
barley,2742,2748,O
powdery,2749,2756,O
mildew,2757,2763,O
8,2765,2766,O
RAR1,2773,2777,O
protein,2778,2785,O
contains,2786,2794,O
highly,2799,2805,O
similar,2806,2813,O
distinct,2818,2826,O
cysteine,2827,2835,O
histidine,2841,2850,O
rich,2851,2855,O
CHORD,2857,2862,O
Zn2,2864,2867,O
binding,2869,2876,O
domains,2877,2884,O
proposed,2893,2901,O
play,2905,2909,O
role,2912,2916,O
stabilizing,2920,2931,O
R,2932,2933,O
proteins,2934,2942,O
confirmation,2948,2960,O
implicated,2969,2979,O
receiving,2983,2992,O
pathogen,2993,3001,O
signals,3002,3009,O
9,3011,3012,O
Sgt1,3019,3023,O
gene,3024,3028,O
suppressor,3030,3040,O
G2,3048,3050,O
allele,3051,3057,O
skp1,3061,3065,O
essential,3073,3082,O
gene,3083,3087,O
multiple,3093,3101,O
functions,3102,3111,O
yeast,3115,3120,O
SGT1,3122,3126,O
protein,3127,3134,O
initially,3139,3148,O
identified,3149,3159,O
RAR1,3165,3169,O
interacting,3170,3181,O
partner,3182,3189,O
yeast,3195,3200,O
hybrid,3205,3211,O
screen,3212,3218,O
10,3220,3222,O
SGT1,3225,3229,O
play,3234,3238,O
role,3241,3245,O
R,3249,3250,O
protein,3251,3258,O
accumulation,3259,3271,O
11,3273,3275,O
Rar1,3278,3282,O
Sgt1,3287,3291,O
genes,3292,3297,O
required,3302,3310,O
R,3322,3323,O
gene,3324,3328,O
mediated,3329,3337,O
resistance,3338,3348,O
viral,3357,3362,O
bacterial,3364,3373,O
oomycete,3375,3383,O
fungal,3387,3393,O
pathogens,3394,3403,O
12,3405,3407,O
previously,3431,3441,O
studied,3442,3449,O
R,3450,3451,O
genes,3452,3457,O
showed,3458,3464,O
race,3467,3471,O
non,3472,3475,O
specific,3476,3484,O
rate,3489,3493,O
limiting,3494,3502,O
resistance,3503,3513,O
phenotype,3514,3523,O
RB,3531,3533,O
gene,3534,3538,O
addition,3543,3551,O
role,3557,3561,O
Rar1,3566,3570,O
Sgt1,3575,3579,O
genes,3580,3585,O
universal,3594,3603,O
genes,3614,3619,O
essential,3628,3637,O
resistance,3642,3652,O
involving,3653,3662,O
R,3668,3669,O
genes,3670,3675,O
12,3677,3679,O
13,3680,3682,O
broad,3701,3706,O
spectrum,3707,3715,O
resistance,3716,3726,O
genes,3727,3732,O
RB,3733,3735,O
Rpi,3740,3743,O
blb2,3744,3748,O
race,3758,3762,O
specific,3763,3771,O
late,3772,3776,O
blight,3777,3783,O
resistance,3784,3794,O
genes,3795,3800,O
cloned,3816,3822,O
14,3824,3826,O
16,3827,3829,O
Numerous,3832,3840,O
late,3841,3845,O
blight,3846,3852,O
resistance,3853,3863,O
genes,3864,3869,O
recently,3875,3883,O
mapped,3889,3895,O
potato,3907,3913,O
species,3914,3921,O
populations,3925,3936,O
17,3938,3940,O
25,3941,3943,O
information,3974,3985,O
available,3986,3995,O
resistance,4006,4016,O
pathways,4017,4025,O
mediated,4026,4034,O
genes,4051,4056,O
initial,4064,4071,O
effort,4072,4078,O
understand,4082,4092,O
RB,4097,4099,O
mediated,4100,4108,O
late,4109,4113,O
blight,4114,4120,O
resistance,4121,4131,O
pathway,4132,4139,O
silenced,4144,4152,O
Rar1,4157,4161,O
Sgt1,4166,4170,O
genes,4171,4176,O
RNAi,4186,4190,O
based,4191,4196,O
approach,4197,4205,O
potato,4211,4217,O
line,4218,4222,O
containing,4223,4233,O
RB,4238,4240,O
gene,4241,4245,O
demonstrated,4250,4262,O
SGT1,4268,4272,O
RAR1,4282,4286,O
essential,4291,4300,O
RB,4309,4311,O
mediated,4312,4320,O
broad,4321,4326,O
spectrum,4327,4335,O
resistance,4336,4346,O
potato,4350,4356,O
late,4357,4361,O
blight,4362,4368,O
Ovariectomy,0,11,O
Based,12,17,O
uterine,25,32,B-Organ
weight,33,39,O
determined,44,54,O
seven,55,60,O
unsuccessful,61,73,O
OVXs,74,78,O
rats,84,88,O
concerned,89,98,O
removed,104,111,O
analyses,125,133,O
left,141,145,O
rats,151,155,O
control,163,170,O
group,171,176,O
OVX,190,193,O
group,194,199,O
seven,201,206,O
OVX,214,217,O
late,222,226,O
ZOL,227,230,O
group,231,236,O
OVX,255,258,O
early,263,268,O
ZOL,269,272,O
group,273,278,O
animal,289,295,O
determined,300,310,O
percentage,315,325,O
change,326,332,O
structural,336,346,O
parameters,347,357,O
compared,358,366,O
values,374,380,O
week,384,388,O
0,389,390,O
Figure,392,398,O
1,399,400,O
shows,401,406,O
average,411,418,O
percentage,419,429,O
change,430,436,O
upper,441,446,O
standard,447,455,O
deviation,456,465,O
groups,474,480,O
BV,485,487,O
TV,488,490,O
Conn,492,496,O
D,497,498,O
SMI,500,503,O
Tb,505,507,O
N,508,509,O
Tb,511,513,O
Th,514,516,O
Tb,522,524,O
Sp,525,527,O
OVX,533,536,O
group,537,542,O
treatment,551,560,O
showed,561,567,O
large,568,573,O
changes,574,581,O
structural,585,595,O
parameters,596,606,O
indicating,608,618,O
development,623,634,O
OVX,638,641,O
induced,642,649,O
bone,650,654,B-Tissue
loss,655,659,O
Figs,661,665,O
1,667,668,O
2,673,674,O
Paired,677,683,O
Student,684,691,O
s,692,693,O
t,694,695,O
test,696,700,O
indicated,701,710,O
significant,711,722,O
changes,723,730,O
2,738,739,O
weeks,740,745,O
OVX,752,755,O
structural,764,774,O
parameters,775,785,O
BV,787,789,O
TV,790,792,O
Conn,794,798,O
D,799,800,O
Tb,806,808,O
N,809,810,O
decreased,811,820,O
experiment,832,842,O
SMI,847,850,O
Tb,855,857,O
Sp,858,860,O
increased,861,870,O
Tb,877,879,O
Th,880,882,O
Tb,887,889,O
N,890,891,O
decreased,892,901,O
2,909,910,O
weeks,911,916,O
indicating,918,928,O
thinning,939,947,O
complete,952,960,O
resorption,961,971,O
trabeculae,975,985,O
started,986,993,O
directly,994,1002,O
OVX,1009,1012,O
initial,1018,1025,O
rapid,1026,1031,O
loss,1032,1036,O
bone,1040,1044,B-Tissue
connectivity,1049,1061,O
largely,1066,1073,O
accompanied,1074,1085,O
trabecular,1089,1099,B-Organ
thinning,1100,1108,O
secondary,1116,1125,O
slower,1127,1133,O
loss,1134,1138,O
bone,1142,1146,B-Tissue
concomitant,1151,1162,O
decrease,1170,1178,O
Tb,1182,1184,O
N,1185,1186,O
BV,1194,1196,O
TV,1197,1199,O
Conn,1201,1205,O
D,1206,1207,O
SMI,1209,1212,O
Tb,1214,1216,O
N,1217,1218,O
Tb,1224,1226,O
Sp,1227,1229,O
showed,1230,1236,O
continuous,1237,1247,O
changes,1248,1255,O
direction,1268,1277,O
experiment,1293,1303,O
Tb,1305,1307,O
Th,1308,1310,O
initially,1311,1320,O
decreased,1321,1330,O
significantly,1331,1344,O
4,1351,1352,O
weeks,1353,1358,O
OVX,1365,1368,O
increased,1378,1387,O
16,1406,1408,O
weeks,1409,1414,O
Tb,1415,1417,O
Th,1418,1420,O
significantly,1425,1438,O
higher,1439,1445,O
control,1458,1465,O
group,1466,1471,O
Fig,1474,1477,O
1,1479,1480,O
Average,1481,1488,O
percentage,1489,1499,O
change,1500,1506,O
structural,1510,1520,O
parameters,1521,1531,O
metaphyseal,1539,1550,O
proximal,1551,1559,O
tibia,1560,1565,B-Organ
upper,1570,1575,O
standard,1576,1584,O
deviation,1585,1594,O
groups,1603,1609,O
time,1617,1621,O
points,1622,1628,O
Brackets,1630,1638,O
indicate,1639,1647,O
P,1648,1649,O
0,1652,1653,O
05,1654,1656,O
week,1660,1664,O
16,1665,1667,O
Fig,1668,1671,O
2,1673,1674,O
slice,1680,1685,O
unprocessed,1692,1703,O
CT,1704,1706,O
scan,1707,1711,O
rat,1724,1727,O
OVX,1735,1738,O
group,1739,1744,O
taken,1745,1750,O
weeks,1754,1759,O
0,1760,1761,O
2,1767,1768,O
b,1770,1771,O
4,1774,1775,O
c,1777,1778,O
8,1781,1782,O
d,1784,1785,O
12,1788,1790,O
e,1792,1793,O
16,1800,1802,O
f,1804,1805,O
Images,1808,1814,O
typical,1820,1827,O
trabecular,1828,1838,B-Tissue
bone,1839,1843,I-Tissue
loss,1844,1848,O
OVX,1856,1859,O
metaphysis,1867,1877,O
Green,1879,1884,O
line,1885,1889,O
shows,1890,1895,O
analyzed,1900,1908,O
metaphyseal,1909,1920,O
bone,1921,1925,B-Tissue
absolute,1930,1938,O
average,1939,1946,O
values,1947,1953,O
standard,1958,1966,O
deviations,1967,1977,O
structural,1986,1996,O
parameters,1997,2007,O
measurements,2015,2027,O
shown,2032,2037,O
Table,2041,2046,O
1,2047,2048,O
starting,2057,2065,O
point,2066,2071,O
differences,2078,2089,O
values,2097,2103,O
groups,2116,2122,O
present,2128,2135,O
fact,2157,2161,O
animals,2172,2179,O
relatively,2200,2210,O
low,2211,2214,O
BV,2215,2217,O
TV,2218,2220,O
removed,2227,2234,O
study,2244,2249,O
respond,2271,2278,O
OVX,2286,2289,O
compared,2309,2317,O
relative,2322,2330,O
changes,2331,2338,O
animal,2347,2353,O
results,2359,2366,O
likely,2377,2383,O
affected,2388,2396,O
difference,2404,2414,O
absolute,2418,2426,O
values,2427,2433,O
Table,2436,2441,O
1,2442,2443,O
Mean,2444,2448,O
values,2449,2455,O
standard,2460,2468,O
deviation,2469,2478,O
structural,2486,2496,O
parameters,2497,2507,O
groups,2515,2521,O
start,2529,2534,O
experiment,2542,2552,O
Group,2553,2558,O
BV,2559,2561,O
TV,2562,2564,O
1,2566,2567,O
Conn,2569,2573,O
D,2574,2575,O
1,2577,2578,O
mm,2579,2581,O
SMI,2583,2586,O
1,2588,2589,O
Tb,2591,2593,O
N,2594,2595,O
1,2597,2598,O
mm,2599,2601,O
Tb,2603,2605,O
Th,2606,2608,O
mum,2610,2613,O
Tb,2615,2617,O
Sp,2618,2620,O
mum,2622,2625,O
Control,2627,2634,O
0,2635,2636,O
17,2637,2639,O
0,2641,2642,O
056,2643,2646,O
41,2648,2650,O
47,2652,2654,O
1,2656,2657,O
52,2658,2660,O
0,2662,2663,O
53,2664,2666,O
1,2668,2669,O
89,2670,2672,O
1,2674,2675,O
38,2676,2678,O
105,2680,2683,O
49,2685,2687,O
613,2689,2692,O
368,2694,2697,O
OVX,2699,2702,O
0,2703,2704,O
26,2705,2707,O
0,2709,2710,O
055,2711,2714,O
141,2716,2719,O
76,2721,2723,O
1,2725,2726,O
22,2727,2729,O
0,2731,2732,O
39,2733,2735,O
3,2737,2738,O
77,2739,2741,O
1,2743,2744,O
66,2745,2747,O
84,2749,2751,O
10,2753,2755,O
335,2757,2760,O
174,2762,2765,O
OVX,2767,2770,O
late,2773,2777,O
ZOL,2778,2781,O
0,2782,2783,O
23,2784,2786,O
0,2788,2789,O
062,2790,2793,O
86,2795,2797,O
66,2799,2801,O
1,2803,2804,O
23,2805,2807,O
0,2809,2810,O
34,2811,2813,O
2,2815,2816,O
77,2817,2819,O
1,2821,2822,O
55,2823,2825,O
89,2827,2829,O
13,2831,2833,O
482,2835,2838,O
227,2840,2843,O
OVX,2845,2848,O
early,2851,2856,O
ZOL,2857,2860,O
0,2861,2862,O
17,2863,2865,O
0,2867,2868,O
056,2869,2872,O
38,2874,2876,O
21,2878,2880,O
1,2882,2883,O
70,2884,2886,O
0,2888,2889,O
39,2890,2892,O
1,2894,2895,O
86,2896,2898,O
0,2900,2901,O
80,2902,2904,O
95,2906,2908,O
7,2910,2911,O
647,2913,2916,O
207,2918,2921,O
Click,0,5,O
file,15,19,O
Aim,0,3,O
study,9,14,O
reports,15,22,O
results,27,34,O
large,40,45,O
prospective,46,57,O
single,58,64,O
blinded,65,72,O
clinical,73,81,O
trial,82,87,O
3,91,92,O
SSRI,93,97,O
paroxetine,99,109,O
fluoxetine,111,121,O
escitalopram,126,138,O
PE,143,145,O
validated,154,163,O
questionnaire,164,177,O
Summary,0,7,O
studies,11,18,O
reporting,19,28,O
comorbidities,29,42,O
diabetes,48,56,O
Click,0,5,O
additional,15,25,O
data,26,30,O
file,31,35,O
Images,0,6,O
Figure,7,13,O
1,14,15,O
Figure,16,22,O
5,23,24,O
Figure,25,31,O
6,32,33,O
Characteristics,0,15,O
cases,19,24,O
childhood,30,39,O
leukaemia,40,49,O
n,51,52,O
162,53,56,O
matched,62,69,O
controls,70,78,O
n,80,81,O
2125,82,86,O
registered,93,103,O
3,111,112,O
months,113,119,O
birth,123,128,O
Appendix,0,8,O
Table,9,14,O
Detection,15,24,O
Nipah,28,33,O
virus,34,39,O
antibody,40,48,O
bat,55,58,O
serum,59,64,B-Organism_substance
samples,65,72,I-Organism_substance
collected,73,82,O
10,88,90,O
provinces,91,100,O
China,104,109,O
2004,111,115,O
2007,116,120,O
Body,6,10,O
gamma,11,16,O
Irradiation,17,28,O
evaluate,32,40,O
differential,41,53,O
sensitivity,54,65,O
irradiation,69,80,O
mice,82,86,O
exposed,92,99,O
gamma,103,108,O
irradiation,109,120,O
4,122,123,O
10,124,126,O
Gy,127,129,O
single,131,137,O
dose,138,142,O
closely,148,155,O
monitored,156,165,O
experimentation,181,196,O
period,197,203,O
Animals,205,212,O
killed,218,224,O
appearance,238,248,O
signs,252,257,O
poor,261,265,O
health,266,272,O
Recipients,274,284,O
bone,288,292,B-Multi-tissue_structure
marrow,293,299,I-Multi-tissue_structure
transplants,300,311,O
pre,317,320,O
irradiated,321,331,O
total,339,344,O
dose,345,349,O
10,353,355,O
2,356,357,O
Gy,358,360,O
doses,366,371,O
5,375,376,O
1,377,378,O
Gy,379,381,O
3,383,384,O
h,385,386,O
apart,387,392,O
vivo,402,406,O
DNA,407,410,O
damage,411,417,O
experiments,418,429,O
mice,431,435,O
irradiated,441,451,O
single,459,465,O
dose,466,470,O
5Gy,474,477,O
killed,482,488,O
1,495,496,O
3,498,499,O
6,503,504,O
hours,505,510,O
irradiations,516,528,O
carried,534,541,O
Cesium,551,557,O
Mark1,558,563,O
irradiator,564,574,O
Shepherd,576,584,O
Associates,585,595,O
Background,0,10,O
Sealant,0,7,O
application,8,19,O
criteria,20,28,O
molar,33,38,B-Organ
fissures,39,47,O
Power,0,5,O
Y,7,8,O
axis,9,13,O
function,20,28,O
main,32,36,O
effects,37,44,O
x,46,47,O
axis,48,52,O
pure,61,65,O
main,66,70,O
effects,71,78,O
model,79,84,O
x,86,87,O
axis,88,92,O
a1,95,97,O
0,100,101,O
interaction,103,114,O
effects,115,122,O
a2,123,125,O
a3,128,130,O
0,133,134,O
zero,143,147,O
Figure,150,156,O
1,157,158,O
shows,159,164,O
pattern,170,177,O
solid,179,184,O
red,185,188,O
line,189,193,O
single,199,205,O
locus,206,211,O
broken,213,219,O
blue,220,224,O
line,225,229,O
approaches,231,241,O
virtually,247,256,O
power,266,271,O
Peptide,0,7,O
BSA,8,11,O
conjugates,12,22,O
diagnostic,26,36,O
antigens,37,45,O
analyse,49,56,O
potential,61,70,O
peptides,78,86,O
behave,90,96,O
antigen,100,107,O
mimics,108,114,O
ability,122,129,O
react,133,138,O
IgM,144,147,O
antibodies,148,158,O
individuals,164,175,O
infected,176,184,O
EBV,190,193,O
assessed,198,206,O
previous,215,223,O
study,224,229,O
demonstrated,234,246,O
sensitivity,256,267,O
detection,271,280,O
greatly,285,292,O
improved,293,301,O
peptides,311,319,O
coupled,325,332,O
carrier,338,345,O
molecule,346,354,O
BSA,363,366,O
prior,367,372,O
immobilisation,376,390,O
solid,398,403,O
surface,404,411,O
Casey,413,418,O
et,419,421,O
al,422,424,O
2006,427,431,O
strategy,439,447,O
adopted,452,459,O
test,463,467,O
peptides,468,476,O
Eb1,477,480,O
4,481,482,O
H1,487,489,O
set,493,496,O
40,500,502,O
clinical,503,511,O
samples,512,519,O
classified,530,540,O
EBV,544,547,O
seropositive,548,560,O
n,562,563,O
16,566,568,O
seronegative,571,583,O
n,585,586,O
16,589,591,O
potentially,596,607,O
cross,608,613,O
reactive,614,622,O
sera,623,627,B-Organism_substance
n,629,630,O
8,633,634,O
assessed,641,649,O
reactivity,654,664,O
Eb1,670,673,O
4,674,675,O
H1,680,682,O
peptides,683,691,O
individually,692,704,O
cut,710,713,O
level,718,723,O
defined,728,735,O
mean,743,747,O
optical,748,755,O
density,756,763,O
seronegative,771,783,O
samples,784,791,O
plus,792,796,O
3,797,798,O
standard,799,807,O
deviations,808,818,O
shown,819,824,O
line,830,834,O
graphs,842,848,O
Fig,852,855,O
5,857,858,O
Readings,860,868,O
level,880,885,O
defined,891,898,O
positive,902,910,O
level,926,931,O
negative,932,940,O
set,951,954,O
samples,958,965,O
analysed,971,979,O
BSA,983,986,O
values,1003,1009,O
subtracted,1015,1025,O
peptide,1035,1042,O
BSA,1043,1046,O
conjugate,1047,1056,O
readings,1057,1065,O
corrected,1074,1083,O
absorbance,1084,1094,O
readings,1095,1103,O
plotted,1109,1116,O
individually,1117,1129,O
new,1138,1141,O
peptides,1142,1150,O
Eb1,1151,1154,O
4,1155,1156,O
H1,1161,1163,O
Fig,1167,1170,O
5,1172,1173,O
clear,1187,1192,O
difference,1193,1203,O
detection,1211,1220,O
seropositive,1224,1236,O
antibodies,1237,1247,O
peptides,1259,1267,O
Fig,1269,1272,O
5A,1274,1276,O
E,1277,1278,O
compared,1280,1288,O
analysis,1298,1306,O
BSA,1310,1313,O
Fig,1321,1324,O
5F,1326,1328,O
majority,1340,1348,O
absorbance,1352,1362,O
readings,1363,1371,O
cut,1382,1385,O
level,1390,1395,O
compared,1400,1408,O
ability,1413,1420,O
panel,1428,1433,O
peptide,1437,1444,O
mimotopes,1445,1454,O
recognised,1461,1471,O
antibodies,1475,1485,O
set,1498,1501,O
seropositive,1505,1517,O
samples,1518,1525,O
Fig,1529,1532,O
6A,1534,1536,O
sensitivity,1545,1556,O
detection,1560,1569,O
shown,1573,1578,O
Fig,1582,1585,O
6B,1587,1589,O
included,1599,1607,O
F1,1608,1610,O
Gp125,1615,1620,O
mimotopes,1621,1630,O
specific,1631,1639,O
mAbs,1648,1652,O
previous,1660,1668,O
study,1669,1674,O
Casey,1676,1681,O
et,1682,1684,O
al,1685,1687,O
2006,1690,1694,O
peptides,1704,1712,O
identified,1713,1723,O
polyclonal,1729,1739,O
sera,1740,1744,B-Organism_substance
Eb1,1745,1748,O
Gp125,1750,1755,O
F1,1760,1762,O
highest,1771,1778,O
sensitivity,1779,1790,O
94,1792,1794,O
Slightly,1798,1806,O
lower,1807,1812,O
sensitivity,1813,1824,O
observed,1829,1837,O
Eb2,1842,1845,O
3,1847,1848,O
4,1853,1854,O
88,1856,1858,O
H1,1865,1867,O
peptide,1868,1875,O
lowest,1884,1890,O
sensitivity,1891,1902,O
81,1904,1906,O
summarised,1912,1922,O
Fig,1926,1929,O
6B,1931,1933,O
sensitivity,1939,1950,O
F1,1954,1956,O
Gp125,1961,1966,O
similar,1971,1978,O
produced,1987,1995,O
mimotopes,2003,2012,O
selected,2013,2021,O
previous,2029,2037,O
study,2038,2043,O
95,2045,2047,O
F1,2053,2055,O
92,2060,2062,O
Gp125,2068,2073,O
Fig,2075,2078,O
5,2080,2081,O
Evaluation,2082,2092,O
peptides,2096,2104,O
Eb1,2105,2108,O
4,2109,2110,O
H1,2115,2117,O
coupled,2118,2125,O
BSA,2129,2132,O
EBV,2136,2139,O
diagnostic,2140,2150,O
reagents,2151,2159,O
Human,2161,2166,O
serum,2167,2172,B-Organism_substance
n,2174,2175,O
40,2178,2180,O
previously,2182,2192,O
analysed,2193,2201,O
diagnostic,2210,2220,O
test,2221,2225,O
VCA,2230,2233,O
IgM,2234,2237,O
allowed,2242,2249,O
react,2253,2258,O
peptides,2268,2276,O
bound,2285,2290,O
IgM,2291,2294,O
antibodies,2295,2305,O
detected,2311,2319,O
anti,2326,2330,O
human,2331,2336,O
IgM,2337,2340,O
HRP,2341,2344,O
absorbance,2350,2360,O
readings,2361,2369,O
1,2374,2375,O
positive,2377,2385,O
2,2388,2389,O
negative,2391,2399,O
putative,2405,2413,O
cross,2414,2419,O
reactive,2420,2428,O
sera,2429,2433,B-Organism_substance
3,2438,2439,O
Parvo,2441,2446,O
4,2449,2450,O
HSV,2452,2455,O
5,2458,2459,O
CMV,2461,2464,O
6,2470,2471,O
RF,2473,2475,O
plotted,2481,2488,O
Eb1,2497,2500,O
B,2503,2504,O
Eb2,2506,2509,O
C,2512,2513,O
Eb3,2515,2518,O
D,2521,2522,O
Eb4,2524,2527,O
E,2530,2531,O
H1,2533,2535,O
F,2541,2542,O
BSA,2544,2547,O
respectively,2549,2561,O
cut,2567,2570,O
value,2575,2580,O
defined,2584,2591,O
mean,2599,2603,O
negative,2611,2619,O
population,2620,2630,O
3SD,2632,2635,O
indicated,2636,2645,O
solid,2651,2656,O
horizontal,2657,2667,O
line,2668,2672,O
false,2694,2699,O
positives,2700,2709,O
specificity,2715,2726,O
mimotope,2736,2744,O
100,2749,2752,O
Fig,2755,2758,O
6,2760,2761,O
Comparison,2762,2772,O
reactivities,2780,2792,O
panel,2800,2805,O
mimotopes,2809,2818,O
Eb1,2819,2822,O
4,2823,2824,O
H1,2826,2828,O
F1,2830,2832,O
Gp125,2837,2842,O
conjugated,2843,2853,O
BSA,2857,2860,O
EBV,2866,2869,O
IgM,2870,2873,O
positive,2874,2882,O
sera,2883,2887,B-Organism_substance
n,2889,2890,O
16,2893,2895,O
absorbance,2897,2907,O
values,2908,2914,O
plotted,2919,2926,O
cut,2935,2938,O
levels,2943,2949,O
depicted,2954,2962,O
horizontal,2968,2978,O
line,2979,2983,O
B,2993,2994,O
Summary,2996,3003,O
false,3011,3016,O
negative,3017,3025,O
results,3026,3033,O
5,3043,3044,O
16,3045,3047,O
serum,3048,3053,B-Organism_substance
samples,3054,3061,I-Organism_substance
seropositive,3062,3074,O
IgM,3079,3082,O
EBV,3083,3086,O
overall,3095,3102,O
sensitivity,3103,3114,O
mimotope,3124,3132,O
diagnosis,3137,3146,O
EBV,3150,3153,O
IgM,3154,3157,O
antibodies,3158,3168,O
considered,3178,3188,O
seropositive,3195,3207,O
EBV,3208,3211,O
samples,3212,3219,B-Organism_substance
contained,3220,3229,O
antibodies,3230,3240,O
recognise,3254,3263,O
panel,3268,3273,O
peptides,3277,3285,O
e,3289,3290,O
false,3292,3297,O
negative,3298,3306,O
readings,3307,3315,O
listed,3317,3323,O
Fig,3327,3330,O
6B,3332,3334,O
antibodies,3340,3350,O
serum,3354,3359,B-Organism_substance
1,3360,3361,O
s1,3363,3365,O
unreactive,3372,3382,O
peptides,3399,3407,O
identified,3408,3418,O
study,3427,3432,O
s2,3434,3436,O
reactive,3445,3453,O
Eb3,3459,3462,O
Eb4,3464,3467,O
H1,3472,3474,O
s3,3479,3481,O
unreactive,3486,3496,O
H1,3502,3504,O
Gp125,3506,3511,O
F1,3516,3518,O
selected,3529,3537,O
previous,3545,3553,O
study,3554,3559,O
recognised,3565,3575,O
s1,3579,3581,O
2,3583,3584,O
3,3589,3590,O
different,3605,3614,O
serum,3615,3620,B-Organism_substance
samples,3621,3628,I-Organism_substance
s4,3630,3632,O
5,3637,3638,O
recognise,3648,3657,O
F1,3658,3660,O
Gp125,3664,3669,O
respectively,3671,3683,O
demonstrates,3690,3702,O
individual,3708,3718,O
peptides,3719,3727,O
recognised,3736,3746,O
EBV,3754,3757,O
antibodies,3758,3768,O
confirms,3773,3781,O
different,3787,3796,O
peptides,3797,3805,O
required,3810,3818,O
represent,3822,3831,O
different,3832,3841,O
epitopes,3842,3850,O
combination,3865,3876,O
Eb1,3880,3883,O
peptide,3884,3891,O
F1,3892,3894,O
Gp125,3899,3904,O
peptides,3905,3913,O
recognised,3923,3933,O
antibodies,3937,3947,O
present,3948,3955,O
set,3968,3971,O
EBV,3975,3978,O
clinical,3979,3987,O
samples,3988,3995,O
resulting,3996,4005,O
100,4009,4012,O
sensitivity,4014,4025,O
samples,4035,4042,O
defined,4043,4050,O
EBV,4054,4057,O
seronegative,4058,4070,O
readings,4086,4094,O
cut,4105,4108,O
level,4113,4118,O
false,4136,4141,O
positives,4142,4151,O
resulting,4153,4162,O
100,4166,4169,O
specificity,4171,4182,O
addition,4187,4195,O
absorbance,4211,4221,O
readings,4222,4230,O
cut,4241,4244,O
levels,4249,4255,O
potentially,4264,4275,O
cross,4276,4281,O
reactive,4282,4290,O
serum,4291,4296,B-Organism_substance
samples,4297,4304,I-Organism_substance
inferring,4306,4315,O
peptides,4325,4333,O
identified,4334,4344,O
study,4353,4358,O
high,4364,4368,O
specificity,4369,4380,O
EBV,4385,4388,O
antibodies,4389,4399,O
Additional,0,10,O
File,11,15,O
2,16,17,O
Model,23,28,O
Code,29,33,O
model,40,45,O
code,46,50,O
plus,51,55,O
instructions,56,68,O
running,73,80,O
Berkeley,84,92,O
Madonna,93,100,O
TM,101,103,O
Secchi,0,6,O
depth,7,12,O
Baltic,20,26,O
Proper,27,33,O
June,35,39,O
August,40,46,O
1957,48,52,O
1998,53,57,O
Number,59,65,O
data,69,73,O
3,75,76,O
452,77,80,O
Nucleotide,0,10,O
features,11,19,O
free,23,27,O
standing,28,36,O
homing,37,43,O
endonucleases,44,57,O
Gene,58,62,O
control,63,70,O
elements,71,79,O
identified,85,95,O
members,108,115,O
type,124,128,O
intervening,132,143,O
homing,144,150,O
endonuclease,151,163,O
genes,164,169,O
described,170,179,O
study,188,193,O
15,198,200,O
16,208,210,O
5,212,213,O
untranslated,215,227,O
regions,228,235,O
endonucleases,243,256,O
identified,260,270,O
RNA,271,274,O
hairpin,275,282,O
structures,283,293,O
upstream,294,302,O
initiation,306,316,O
codons,317,323,O
Figures,325,332,O
1,333,334,O
4A,339,341,O
translational,358,371,O
regulatory,372,382,O
hairpin,383,390,O
structure,391,400,O
known,401,406,O
phage,420,425,O
genes,426,431,O
including,433,442,O
homing,443,449,O
endonucleases,450,463,O
22,465,467,O
47,468,470,O
49,471,473,O
hairpins,480,488,O
found,492,497,O
fractured,505,514,O
gene,515,519,O
loci,520,524,O
different,530,539,O
protein,540,547,O
host,548,552,O
types,553,558,O
including,560,569,O
gp41,570,574,O
IMPDH,576,581,O
DnaE,583,587,O
NrdJ,589,593,O
NrdA,598,602,O
hairpins,617,625,O
include,631,638,O
conserved,641,650,O
sequence,651,659,O
Aeh1,663,667,O
phage,668,673,O
late,674,678,O
promoter,679,687,O
element,688,695,O
TATAAATA,697,705,O
recently,718,726,O
shown,727,732,O
inhibit,736,743,O
translation,748,759,O
gene,765,769,O
fracturing,770,780,O
endonuclease,781,793,O
gene,794,798,O
sequestering,803,815,O
ribosome,820,828,B-Cellular_component
binding,829,836,O
site,837,841,O
22,843,845,O
23,846,848,O
Analysis,851,859,O
endonuclease,867,879,O
5,880,881,O
untranslated,883,895,O
regions,896,903,O
revealed,904,912,O
conserved,917,926,O
motifs,927,933,O
Figures,935,942,O
4A,943,945,O
Supplementary,950,963,O
Figure,964,970,O
S4,971,973,O
usually,982,989,O
complement,990,1000,O
stem,1019,1023,O
conserved,1031,1040,O
hairpin,1041,1048,O
structures,1049,1059,O
Figure,1062,1068,O
4,1069,1070,O
Nucleotide,1072,1082,O
features,1083,1091,O
endonuclease,1095,1107,O
genes,1108,1113,O
RNA,1119,1122,O
hairpin,1123,1130,O
structures,1131,1141,O
5,1149,1150,O
untranslated,1152,1164,O
region,1165,1171,O
endonuclease,1175,1187,O
ORFs,1188,1192,O
gp41,1200,1204,O
1,1205,1206,O
representing,1208,1220,O
similar,1230,1237,O
sequences,1238,1247,O
gp41,1251,1255,O
1,1256,1257,O
7,1258,1259,O
nrdA,1262,1266,O
5,1267,1268,O
DnaE,1273,1277,O
1,1278,1279,O
gene,1280,1284,O
loci,1285,1289,O
Initiator,1291,1300,O
codons,1301,1307,O
marked,1312,1318,O
arrows,1322,1328,O
conserved,1330,1339,O
putative,1340,1348,O
T4,1349,1351,O
late,1352,1356,O
promoter,1357,1365,O
elements,1366,1374,O
boxed,1379,1384,O
conserved,1390,1399,O
sequence,1400,1408,O
motifs,1409,1415,O
Supplementary,1417,1430,O
Figure,1431,1437,O
S4,1438,1440,O
highlighted,1446,1457,O
grey,1461,1465,O
expected,1471,1479,O
values,1480,1486,O
motifs,1491,1497,O
1,1498,1499,O
2,1504,1505,O
1,1510,1511,O
7,1512,1513,O
10,1514,1516,O
9,1521,1522,O
9,1523,1524,O
3,1525,1526,O
respectively,1528,1540,O
RNA,1542,1545,O
structures,1546,1556,O
calculated,1562,1572,O
Vienna,1583,1589,O
package,1590,1597,O
http,1599,1603,O
rna,1606,1609,O
tbi,1610,1613,O
univie,1614,1620,O
ac,1621,1623,O
cgi,1627,1630,O
bin,1631,1634,O
RNAfold,1635,1642,O
cgi,1643,1646,O
sequence,1653,1661,O
motifs,1662,1668,O
identified,1674,1684,O
MEME,1695,1699,O
program,1700,1707,O
B,1710,1711,O
Overlapping,1713,1724,O
protein,1725,1732,O
coding,1733,1739,O
regions,1740,1747,O
endonuclease,1751,1763,O
3,1764,1765,O
termini,1767,1774,O
5,1783,1784,O
termini,1786,1793,O
downstream,1803,1813,O
genes,1814,1819,O
Additionally,1821,1833,O
15,1835,1837,O
loci,1838,1842,O
included,1843,1851,O
overlapping,1855,1866,O
region,1867,1873,O
6,1877,1878,O
69,1879,1881,O
bp,1882,1884,O
coding,1897,1903,O
regions,1904,1911,O
probable,1919,1927,O
endonuclease,1928,1940,O
C,1941,1942,O
termini,1943,1950,O
downstream,1959,1969,O
N,1970,1971,O
termini,1972,1979,O
split,1987,1992,O
intein,1993,1999,O
Figures,2006,2013,O
1,2014,2015,O
4B,2020,2022,O
overlap,2030,2037,O
present,2041,2048,O
types,2057,2062,O
endonucleases,2066,2079,O
independent,2088,2099,O
presence,2107,2115,O
split,2121,2126,O
intein,2127,2133,O
fractured,2146,2155,O
gene,2156,2160,O
occurring,2167,2176,O
putative,2184,2192,O
sbcD,2193,2197,O
DNA,2198,2201,O
repair,2202,2208,O
gene,2209,2213,O
found,2222,2227,O
Aeh1,2247,2251,O
fractured,2252,2261,O
nrdA,2262,2266,O
found,2267,2272,O
Gibb,2276,2280,O
Edgell,2285,2291,O
22,2293,2295,O
Efficacy,0,8,O
MMF,12,15,O
current,19,26,O
immunosuppressive,27,44,O
regimens,45,53,O
kidney,60,66,B-Organ
transplantation,67,82,O
Current,83,90,O
established,91,102,O
immunosuppressive,103,120,O
strategies,121,131,O
kidney,135,141,B-Organ
transplantation,142,157,O
include,164,171,O
induction,175,184,O
agent,185,190,O
monoclonal,192,202,O
polyclonal,206,216,O
anti,217,221,O
T,222,223,B-Cell
cell,224,228,I-Cell
antibodies,229,239,O
based,241,246,O
immunologic,254,265,O
risk,266,270,O
recipient,278,287,O
followed,289,297,O
maintenance,303,314,O
regimen,315,322,O
combining,323,332,O
CNI,335,338,O
anti,346,350,O
proliferative,351,364,O
agent,365,370,O
corticosteroids,388,403,O
2,404,405,O
4,406,407,O
MMF,411,414,O
MPA,429,432,O
formulation,433,444,O
approved,445,453,O
clinical,457,465,O
kidney,466,472,B-Organ
transplantation,473,488,O
extensive,495,504,O
clinical,505,513,O
data,514,518,O
available,523,532,O
drug,543,547,O
comparison,551,561,O
EC,565,567,O
MPS,568,571,O
Sex,0,3,O
age,8,11,O
distributions,12,25,O
confirmed,29,38,O
cases,39,44,O
480,48,51,O
confirmed,52,61,O
cases,62,67,O
56,69,71,O
269,74,77,O
480,78,81,O
male,88,92,O
patients,93,101,O
44,106,108,O
211,111,114,O
480,115,118,O
female,125,131,O
respectively,133,145,O
percentage,151,161,O
male,165,169,O
cases,170,175,O
higher,180,186,O
females,200,207,O
groups,215,221,O
group,237,242,O
aged,243,247,O
31,248,250,O
40,251,253,O
chi2,255,259,O
42,262,264,O
4,265,266,O
P,268,269,O
0,272,273,O
001,274,277,O
278,280,283,O
57,285,287,O
9,288,289,O
cases,292,297,O
group,310,315,O
aged,316,320,O
21,321,323,O
50,324,326,O
followed,328,336,O
102,340,343,O
21,345,347,O
3,348,349,O
79,353,355,O
16,357,359,O
5,360,361,O
21,368,370,O
4,372,373,O
4,374,375,O
cases,378,383,O
group,391,396,O
aged,397,401,O
51,402,404,O
70,405,407,O
0,409,410,O
20,411,413,O
71,422,424,O
respectively,426,438,O
youngest,444,452,O
oldest,457,463,O
cases,464,469,O
1,475,476,O
5,477,478,O
81,483,485,O
years,486,491,O
old,492,495,O
respectively,497,509,O
Table,511,516,O
2,517,518,O
Table,521,526,O
2,527,528,O
Age,529,532,O
occupational,537,549,O
distributions,550,563,O
activities,568,578,O
1,580,581,O
3,582,583,O
weeks,584,589,O
prior,590,595,O
symptom,599,606,O
appearance,607,617,O
confirmed,622,631,O
cases,632,637,O
Cases,638,643,O
Male,649,653,O
Female,655,661,O
Age,666,669,O
Years,671,676,O
0,678,679,O
10,680,682,O
46,683,685,O
9,687,688,O
6,689,690,O
76,693,695,O
24,696,698,O
11,700,702,O
20,703,705,O
33,706,708,O
6,710,711,O
9,712,713,O
79,716,718,O
21,719,721,O
21,723,725,O
30,726,728,O
78,729,731,O
16,733,735,O
3,736,737,O
51,740,742,O
49,743,745,O
31,747,749,O
40,750,752,O
99,753,755,O
20,757,759,O
6,760,761,O
46,764,766,O
54,767,769,O
41,771,773,O
50,774,776,O
101,777,780,O
21,782,784,O
0,785,786,O
56,789,791,O
44,792,794,O
51,796,798,O
60,799,801,O
47,802,804,O
9,806,807,O
8,808,809,O
55,812,814,O
45,815,817,O
61,819,821,O
70,822,824,O
55,825,827,O
11,829,831,O
5,832,833,O
53,836,838,O
47,839,841,O
71,846,848,O
21,849,851,O
4,853,854,O
4,855,856,O
52,859,861,O
48,862,864,O
Occupation,866,876,O
Children,877,885,O
preschool,889,898,O
age,899,902,O
20,903,905,O
4,907,908,O
2,909,910,O
75,913,915,O
25,916,918,O
Pupils,920,926,O
50,927,929,O
10,931,933,O
4,934,935,O
78,938,940,O
22,941,943,O
Farmers,945,952,O
408,953,956,O
85,958,960,O
0,961,962,O
52,965,967,O
48,968,970,O
2,979,980,O
0,982,983,O
4,984,985,O
50,988,990,O
50,991,993,O
Activities,995,1005,O
Farm,1006,1010,O
work,1011,1015,O
325,1016,1019,O
67,1021,1023,O
7,1024,1025,O
53,1028,1030,O
47,1031,1033,O
Play,1035,1039,O
grassland,1043,1052,O
65,1053,1055,O
13,1057,1059,O
5,1060,1061,O
75,1064,1066,O
25,1067,1069,O
Recreation,1071,1081,O
20,1082,1084,O
4,1086,1087,O
2,1088,1089,O
65,1092,1094,O
35,1095,1097,O
Housework,1099,1108,O
25,1109,1111,O
5,1113,1114,O
2,1115,1116,O
8,1119,1120,O
92,1121,1123,O
Unknown,1125,1132,O
45,1133,1135,O
9,1137,1138,O
4,1139,1140,O
71,1143,1145,O
29,1146,1148,O
Discussion,0,10,O
Netherton,19,28,O
syndrome,29,37,O
exhibits,38,46,O
allergic,47,55,O
phenotype,56,65,O
reasonable,73,83,O
speculate,87,96,O
SPINK5,102,108,O
mutated,119,126,O
Netherton,130,139,O
syndrome,140,148,O
act,154,157,O
candidate,163,172,O
gene,173,177,O
asthma,182,188,O
allergic,199,207,O
diseases,208,216,O
9,218,219,O
extensive,225,234,O
search,235,241,O
single,246,252,O
nucleotide,253,263,O
polymorphisms,264,277,O
SPINK5,285,291,O
led,292,295,O
identification,303,317,O
number,323,329,O
SNPs,333,337,O
including,339,348,O
nonsynonymous,353,366,O
SNPs,367,371,O
coding,375,381,O
region,382,388,O
perturb,400,407,O
immune,412,418,O
function,419,427,O
Subsequent,429,439,O
genotyping,440,450,O
nonsynonymous,460,473,O
SNPs,474,478,O
A1103 G,480,486,O
G1156A,488,494,O
G1258A,499,505,O
independent,513,524,O
panels,525,531,O
British,535,542,O
families,543,551,O
showed,552,558,O
significant,561,572,O
association,573,584,O
SNP,593,596,O
G1258A,597,603,O
Glu420Lys,605,614,O
atopy,620,625,O
atopic,627,633,O
dermatitis,634,644,O
elevated,646,654,O
serum,655,660,B-Organism_substance
IgE,661,664,O
levels,665,671,O
asthma,676,682,O
10,684,686,O
association,694,705,O
confirmed,710,719,O
large,725,730,O
German,731,737,O
population,738,748,O
Japanese,757,765,O
populations,766,777,O
16,779,781,O
18,782,784,O
Kato,787,791,O
et,792,794,O
al,795,797,O
analyzed,798,806,O
SNPs,813,817,O
exon,821,825,O
13,826,828,O
14,833,835,O
SPINK5,843,849,O
including,850,859,O
G1258A,860,866,O
Glu420Lys,868,877,O
found,884,889,O
positive,892,900,O
association,901,912,O
seven,916,921,O
SNPs,922,926,O
atopic,932,938,O
dermatitis,939,949,O
Japanese,955,963,O
study,964,969,O
sample,970,976,O
case,985,989,O
control,990,997,O
study,998,1003,O
design,1004,1010,O
16,1012,1014,O
Nishio,1017,1023,O
et,1024,1026,O
al,1027,1029,O
surveyed,1030,1038,O
previously,1051,1061,O
reported,1062,1070,O
nonsynonymous,1071,1084,O
SPINK5,1085,1091,O
SNPs,1092,1096,O
Japanese,1100,1108,O
atopic,1109,1115,O
families,1116,1124,O
identified,1125,1135,O
asthmatic,1144,1153,O
children,1154,1162,O
subjects,1166,1174,O
atopic,1180,1186,O
dermatitis,1187,1197,O
found,1202,1207,O
SPINK5,1213,1219,O
associated,1224,1234,O
development,1240,1251,O
atopic,1255,1261,O
dermatitis,1262,1272,O
asthma,1281,1287,O
17,1289,1291,O
Kabesch,1294,1301,O
M,1302,1303,O
et,1304,1306,O
al,1307,1309,O
analyzed,1311,1319,O
G1258A,1320,1326,O
Glu420Lys,1328,1337,O
German,1344,1350,O
population,1351,1361,O
school,1365,1371,O
children,1372,1380,O
found,1386,1391,O
association,1396,1407,O
asthma,1413,1419,O
concomitant,1433,1444,O
occurrence,1445,1455,O
asthma,1459,1465,O
atopic,1470,1476,O
dermatitis,1477,1487,O
18,1489,1491,O
subsequent,1507,1517,O
studies,1518,1525,O
failed,1526,1532,O
replicate,1536,1545,O
original,1550,1558,O
SPINK5,1559,1565,O
findings,1566,1574,O
allergic,1579,1587,O
diseases,1588,1596,O
19,1598,1600,O
20,1601,1603,O
Folster,1606,1613,O
Holst,1614,1619,O
et,1620,1622,O
al,1623,1625,O
genotyped,1626,1635,O
nonsynonymous,1641,1654,O
SNPs,1655,1659,O
Asp106Asn,1661,1670,O
Asn368Ser,1672,1681,O
Asp386Asn,1683,1692,O
Glu420Lys,1698,1707,O
detected,1714,1722,O
association,1726,1737,O
SPINK5,1746,1752,O
atopic,1757,1763,O
dermatitis,1764,1774,O
populations,1778,1789,O
Northern,1793,1801,O
German,1802,1808,O
origin,1809,1815,O
20,1817,1819,O
Jongepier,1822,1831,O
H,1832,1833,O
et,1834,1836,O
al,1837,1839,O
failed,1841,1847,O
detect,1851,1857,O
association,1862,1873,O
SPINK5,1882,1888,O
asthma,1893,1899,O
atopic,1901,1907,O
phenotypes,1908,1918,O
atopic,1923,1929,O
dermatitis,1930,1940,O
Dutch,1946,1951,O
population,1952,1962,O
19,1964,1966,O
discordant,1975,1985,O
findings,1986,1994,O
probably,1995,2003,O
reflect,2004,2011,O
different,2012,2021,O
genetic,2022,2029,O
environmental,2034,2047,O
backgrounds,2048,2059,O
populations,2071,2082,O
determine,2087,2096,O
nonsynonymous,2105,2118,O
SNPs,2119,2123,O
SPINK5,2131,2137,O
involved,2142,2150,O
pathogenesis,2158,2170,O
asthma,2174,2180,O
Chinese,2188,2195,O
Han,2196,2199,O
population,2200,2210,O
performed,2215,2224,O
case,2227,2231,O
control,2232,2239,O
study,2240,2245,O
genotyping,2249,2259,O
nonsynonymous,2265,2278,O
SNPs,2279,2283,O
SPINK5,2291,2297,O
detect,2310,2316,O
significant,2321,2332,O
association,2333,2344,O
nonsynonymous,2359,2372,O
SNPs,2373,2377,O
asthma,2382,2388,O
Chinese,2396,2403,O
samples,2404,2411,O
sample,2422,2428,O
size,2429,2433,O
expected,2438,2446,O
power,2449,2454,O
80,2467,2469,O
detecting,2474,2483,O
effect,2487,2493,O
1,2502,2503,O
3,2504,2505,O
SNPs,2524,2528,O
failure,2545,2552,O
detect,2556,2562,O
association,2566,2577,O
4,2588,2589,O
SNPs,2590,2594,O
sample,2614,2620,O
size,2621,2625,O
results,2633,2640,O
suggest,2641,2648,O
polymorphisms,2658,2671,O
coding,2679,2685,O
region,2686,2692,O
SPINK5,2700,2706,O
unlikely,2711,2719,O
contribute,2723,2733,O
asthma,2737,2743,O
risk,2744,2748,O
Chinese,2756,2763,O
Han,2764,2767,O
population,2768,2778,O
patients,2801,2809,O
ascertained,2815,2826,O
asthma,2831,2837,O
exclude,2852,2859,O
role,2862,2866,O
coding,2874,2880,O
SNPs,2881,2885,O
SPINK5,2893,2899,O
atopic,2903,2909,O
dermatitis,2910,2920,O
population,2928,2938,O
variations,2944,2954,O
regulatory,2962,2972,O
sequences,2973,2982,O
genes,2986,2991,O
determine,2996,3005,O
risks,3006,3011,O
common,3015,3021,O
diseases,3022,3030,O
causing,3034,3041,O
different,3042,3051,O
levels,3052,3058,O
expression,3062,3072,O
identification,3089,3103,O
functional,3108,3118,O
evaluation,3119,3129,O
polymorphisms,3133,3146,O
promoter,3150,3158,O
region,3159,3165,O
great,3173,3178,O
value,3179,3184,O
understanding,3188,3201,O
genetic,3206,3213,O
susceptibility,3214,3228,O
asthma,3232,3238,O
order,3243,3248,O
determine,3252,3261,O
role,3266,3270,O
SPINK5,3278,3284,O
promoter,3285,3293,O
polymorphism,3294,3306,O
pathogenesis,3314,3326,O
asthma,3330,3336,O
genotyped,3341,3350,O
promoter,3353,3361,O
polymorphism,3362,3374,O
206 G,3377,3381,O
422,3388,3391,O
asthma,3392,3398,O
patients,3399,3407,O
410,3412,3415,O
controls,3416,3424,O
found,3430,3435,O
marginal,3438,3446,O
association,3447,3458,O
frequency,3464,3473,O
allele,3477,3483,O
G,3484,3485,O
significantly,3490,3503,O
higher,3504,3510,O
asthmatic,3514,3523,O
patients,3524,3532,O
controls,3546,3554,O
p,3556,3557,O
0,3560,3561,O
022,3562,3565,O
confirm,3571,3578,O
association,3583,3594,O
additional,3596,3606,O
267,3607,3610,O
asthma,3611,3617,O
patients,3618,3626,O
301,3631,3634,O
controls,3635,3643,O
newly,3644,3649,O
recruited,3650,3659,O
hospital,3674,3682,O
genotyped,3688,3697,O
206 G,3708,3712,O
polymorphism,3715,3727,O
remained,3728,3736,O
significantly,3737,3750,O
associated,3751,3761,O
asthma,3767,3773,O
P,3775,3776,O
0,3779,3780,O
001,3781,3784,O
Bonferroni,3798,3808,O
correction,3809,3819,O
adjusted,3820,3828,O
P,3829,3830,O
0,3833,3834,O
01,3835,3837,O
knowledge,3847,3856,O
report,3876,3882,O
association,3889,3900,O
206 G,3905,3909,O
polymorphism,3912,3924,O
asthma,3930,3936,O
examined,3949,3957,O
potential,3962,3971,O
functional,3972,3982,O
role,3983,3987,O
promoter,3996,4004,O
polymorphism,4005,4017,O
found,4023,4028,O
G,4038,4039,O
substitution,4045,4057,O
206,4062,4065,O
generated,4066,4075,O
GATA,4078,4082,O
3,4083,4084,O
transcription,4085,4098,O
factor,4099,4105,O
binding,4106,4113,O
site,4114,4118,O
Major,4120,4125,O
transcription,4126,4139,O
factors,4140,4147,O
controlling,4148,4159,O
Th1,4160,4163,O
Th2,4168,4171,O
development,4172,4183,O
T,4193,4194,O
box,4195,4198,O
transcription,4199,4212,O
factor,4213,4219,O
GATA3,4224,4229,O
possibly,4235,4243,O
involved,4244,4252,O
asthma,4256,4262,O
atopic,4267,4273,O
diseases,4274,4282,O
GATA,4284,4288,O
3,4289,4290,O
transcription,4294,4307,O
factor,4308,4314,O
specifically,4315,4327,O
expressed,4328,4337,O
T,4341,4342,B-Cell
helper,4343,4349,I-Cell
2,4350,4351,I-Cell
Th2,4353,4356,I-Cell
cells,4358,4363,I-Cell
plays,4365,4370,O
critical,4373,4381,O
role,4382,4386,O
differentiation,4394,4409,O
Th2,4413,4416,B-Cell
cells,4417,4422,I-Cell
uncommitted,4428,4439,O
CD4,4440,4443,B-Cell
lymphocytes,4445,4456,I-Cell
addition,4461,4469,O
GATA,4471,4475,O
3,4476,4477,O
essential,4481,4490,O
expression,4499,4509,O
cytokines,4517,4526,O
IL,4527,4529,O
4,4530,4531,O
IL,4533,4535,O
5,4536,4537,O
IL,4542,4544,O
13,4545,4547,O
mediate,4553,4560,O
allergic,4561,4569,O
inflammation,4570,4582,O
23,4584,4586,O
luciferase,4593,4603,O
reporter,4604,4612,O
assay,4613,4618,O
confirmed,4619,4628,O
SNP,4634,4637,O
206 G,4639,4643,O
associated,4649,4659,O
transcriptional,4669,4684,O
activity,4685,4693,O
SPINK5,4697,4703,O
G,4709,4710,O
allele,4711,4717,O
associated,4722,4732,O
decreased,4738,4747,O
transcriptional,4748,4763,O
activity,4764,4772,O
SPINK5,4780,4786,O
mechanism,4792,4801,O
206 G,4816,4820,O
SNP,4823,4826,O
affects,4827,4834,O
SPINK5,4835,4841,O
expression,4842,4852,O
explained,4860,4869,O
potential,4877,4886,O
differential,4887,4899,O
transcription,4900,4913,O
factor,4914,4920,O
binding,4921,4928,O
GATA,4932,4936,O
binding,4937,4944,O
factor,4945,4951,O
206 G,4960,4964,O
located,4970,4977,O
core,4985,4989,O
sequence,4990,4998,O
GATA,5002,5006,O
binding,5007,5014,O
factor,5015,5021,O
binding,5022,5029,O
site,5030,5034,O
Electrophoretic,5036,5051,O
mobility,5052,5060,O
shift,5061,5066,O
assay,5067,5072,O
confirmed,5073,5082,O
G,5097,5098,O
substitution,5099,5111,O
206,5116,5119,O
significantly,5120,5133,O
reduced,5134,5141,O
binding,5146,5153,O
efficiency,5154,5164,O
nuclear,5168,5175,B-Cellular_component
proteins,5176,5184,O
element,5193,5200,O
data,5206,5210,O
suggest,5211,5218,O
loss,5224,5228,O
GATA,5232,5236,O
transcription,5237,5250,O
factor,5251,5257,O
regulation,5258,5268,O
206 G,5279,5283,O
decrease,5288,5296,O
SPINK5,5301,5307,O
expression,5308,5318,O
potentially,5331,5342,O
perturb,5343,5350,O
immunosuppressive,5355,5372,O
function,5373,5381,O
LEKTI,5385,5390,O
Statistical,0,11,O
Analysis,12,20,O
Mitochondrial,21,34,B-Cellular_component
DNA,35,38,O
haplogroup,39,49,O
frequencies,50,61,O
calculated,67,77,O
counting,81,89,O
observed,99,107,O
genotypes,108,117,O
Pearson,123,130,O
chi,131,134,O
square,135,141,O
test,142,146,O
chi,155,158,O
square,159,165,O
test,166,170,O
linear,175,181,O
linear,185,191,O
association,192,203,O
analyze,217,224,O
significances,229,242,O
prevalence,255,265,O
haplogroups,269,280,O
different,285,294,O
age,295,298,O
groups,299,305,O
SPSS,307,311,O
software,312,320,O
version,322,329,O
10,330,332,O
0,333,334,O
Duplicated,0,10,O
HGT,11,14,O
candidates,15,25,O
K,29,30,O
thermotolerans,32,46,O
conserved,64,73,O
synteny,74,81,O
block,82,87,O
surrounding,88,99,O
KLTH0C07700 g,100,112,O
KLTH0C07722 g,117,129,O
tandem,130,136,O
genes,137,142,O
legend,149,155,O
Figure,159,165,O
3A,166,168,O
B,171,172,O
conserved,186,195,O
synteny,196,203,O
block,204,209,O
surrounding,210,221,O
KLTH0F12276 g,222,234,O
gene,235,239,O
legend,246,252,O
Figure,256,262,O
3A,263,265,O
C,268,269,O
Sequence,271,279,O
alignment,280,289,O
proteins,293,301,O
K,307,308,O
thermotolerans,310,324,O
K,329,330,O
waltii,332,338,O
D,341,342,O
Phylogenetic,344,356,O
tree,357,361,O
reconstructed,362,375,O
sequence,381,389,O
alignment,390,399,O
100,403,406,O
sites,407,412,O
K,416,417,O
thermotolerans,419,433,O
protein,434,441,O
family,442,448,O
members,449,456,O
K,458,459,O
waltii,461,467,O
gene,468,472,O
bacterial,474,483,O
green,485,490,O
amoebal,496,503,O
blue,505,509,O
proteins,511,519,O
Bootstrap,521,530,O
values,531,537,O
indicated,542,551,O
nodes,564,569,O
branch,574,580,O
length,581,587,O
scale,588,593,O
shown,597,602,O
left,613,617,O
Quantitative,0,12,O
reverse,13,20,O
transcription,21,34,O
PCR,35,38,O
Reverse,39,46,O
transcription,47,60,O
performed,65,74,O
0,81,82,O
2,83,84,O
mug,85,88,O
total,92,97,O
RNA,98,101,O
muscle,107,113,B-Tissue
10,117,119,O
week,120,124,O
old,125,128,O
19,133,135,O
month,136,141,O
old,142,145,O
C57Bl6,146,152,O
mice,153,157,O
animals,164,171,O
group,176,181,O
Core,186,190,O
kit,191,194,O
RT,196,198,O
RTCK,199,203,O
03,204,206,O
Eurogentec,208,218,O
according,220,229,O
manufacturer,233,245,O
s,246,247,O
instruction,248,259,O
mix,266,269,O
random,273,279,O
primers,280,287,O
9,289,290,O
mers,291,295,O
oligodT,301,308,O
qPCR,310,314,O
performed,319,328,O
SDS7900HT,332,341,O
Applied,343,350,O
Biosystem,351,360,O
Mesagreen,368,377,O
qPCR,378,382,O
kit,383,386,O
SYBR,391,395,O
Eurogentec,397,407,O
following,417,426,O
primers,427,434,O
PPARbeta,437,445,O
5,447,448,O
AGATGGTGGCAGAGCTATGACC,450,472,O
3,473,474,O
5,477,478,O
TCCTCCTGTGGCTGTTCC,480,498,O
3,499,500,O
Catalase,503,511,O
5,513,514,O
GGATCCTGACATGGTCTGGG,516,536,O
3,537,538,O
5,541,542,O
TGGAGAGACTCGGGACGAAG,544,564,O
3,565,566,O
PDK4,569,573,O
5,575,576,O
GCATTTCTACTCGGATGCTCAATG,578,602,O
3,603,604,O
5,607,608,O
CCAATGTGGCTTGGGTTTCC,610,630,O
3,631,632,O
36B4,635,639,O
5,641,642,O
TCCAGGCTTTGGGCATCA,644,662,O
3,663,664,O
5,667,668,O
CTTTATCAGCTGCACATCACTCAGA,670,695,O
3,696,697,O
Data,700,704,O
normalised,714,724,O
36B4,731,735,O
housekeeping,739,751,O
gene,752,756,O
Chicken,0,7,O
CCN3,8,12,O
expression,13,23,O
embryonic,27,36,B-Tissue
extraembryonic,41,55,B-Tissue
tissues,56,63,I-Tissue
Expression,64,74,O
CCN3,78,82,O
axial,86,91,O
structure,92,101,O
visible,110,117,O
presegmentation,125,140,O
stage,141,146,O
reaches,151,158,O
highest,166,173,O
level,174,179,O
beginning,187,196,O
somitogenesis,200,213,O
HH,215,217,O
stage,218,223,O
7,224,225,O
Fig,227,230,O
1a,232,234,O
Strong,237,243,O
similarity,244,254,O
CCN3,263,267,O
Sonic,272,277,O
Hedgehog,278,286,O
observed,291,299,O
expression,308,318,O
pattern,319,326,O
axial,330,335,O
structure,336,345,O
notochord,347,356,O
floor,361,366,O
plate,367,372,O
left,388,392,O
right,393,398,O
asymmetrical,399,411,O
pattern,412,419,O
node,427,431,O
area,432,436,O
conserved,445,454,O
Fig,456,459,O
1b,461,463,O
Sonic,475,480,O
Hedgehog,481,489,O
expression,490,500,O
slightly,504,512,O
broader,513,520,O
CCN3,534,538,O
CCN3,546,550,O
stimulates,551,561,O
Notch,562,567,O
signaling,568,577,O
Sakamoto,579,587,O
et,588,590,O
al,591,593,O
2002,595,599,O
investigated,605,617,O
expression,622,632,O
Notch,636,641,O
signal,642,648,O
genes,649,654,O
Serrate1,668,676,O
ligand,680,686,O
Notch,690,695,O
unique,699,705,O
expression,718,728,O
apparently,732,742,O
right,745,750,O
deviated,751,759,O
pattern,760,767,O
node,775,779,O
area,780,784,O
Fig,786,789,O
1c,791,793,O
Notch,804,809,O
ligand,810,816,O
Delta1,818,824,O
shows,825,830,O
right,833,838,O
deviated,839,847,O
pattern,848,855,O
caudal,869,875,O
area,876,880,O
node,888,892,O
extending,893,902,O
primitive,910,919,O
streak,920,926,O
data,928,932,O
shown,937,942,O
expression,949,959,O
CCN3,963,967,O
axial,971,976,O
structure,977,986,O
followed,991,999,O
presomitic,1007,1017,O
mesoderm,1018,1026,O
diminished,1042,1052,O
Sakamoto,1054,1062,O
et,1063,1065,O
al,1066,1068,O
2002,1070,1074,O
Fig,1078,1081,O
1,1083,1084,O
Expression,1085,1095,O
mRNA,1099,1103,O
early,1107,1112,O
stage,1113,1118,O
chicken,1119,1126,O
embryo,1127,1133,B-Developing_anatomical_structure
CCN3,1135,1139,O
Sonic,1145,1150,O
Hedgehog,1151,1159,O
b,1161,1162,O
Serrate1,1168,1176,O
c,1178,1179,O
beginning,1188,1197,O
stage,1198,1203,O
somitogenesis,1207,1220,O
Hamburger,1222,1231,O
Hamilton,1236,1244,O
HH,1246,1248,O
Stage,1250,1255,O
7,1256,1257,O
Arrowheads,1260,1270,O
indicate,1271,1279,O
Hensen,1280,1286,O
s,1287,1288,O
node,1289,1293,O
Demonstrates,1295,1307,O
schematic,1312,1321,O
view,1322,1326,O
tissue,1330,1336,B-Tissue
organization,1337,1349,O
stage,1358,1363,O
d,1365,1366,O
Expression,1369,1379,O
CCN3,1383,1387,O
mRNA,1388,1392,O
blood,1396,1401,B-Organism_substance
islands,1402,1409,I-Organism_substance
chicken,1413,1420,O
extraembryonic,1421,1435,B-Tissue
tissue,1436,1442,I-Tissue
HH,1444,1446,O
stage,1447,1452,O
10,1453,1455,O
e,1458,1459,O
Ventral,1462,1469,B-Multi-tissue_structure
endothelial,1482,1493,B-Cell
precursor,1494,1503,I-Cell
cells,1504,1509,I-Cell
blood,1513,1518,B-Organism_substance
islands,1519,1526,I-Organism_substance
positive,1530,1538,O
CCN3,1543,1547,O
expression,1548,1558,O
Coloration,1560,1570,O
stopped,1575,1582,O
background,1594,1604,O
staining,1605,1613,O
started,1614,1621,O
sense,1625,1630,O
probes,1631,1637,O
negative,1639,1647,O
control,1648,1655,O
accumulating,1666,1678,O
evidence,1679,1687,O
CCN3,1691,1695,O
commitment,1696,1706,O
hematopoiesis,1710,1723,O
investigated,1741,1753,O
CCN3,1758,1762,O
expression,1763,1773,O
extraembryonic,1777,1791,B-Tissue
tissues,1792,1799,I-Tissue
Blood,1801,1806,B-Organism_substance
islands,1807,1814,I-Organism_substance
formed,1819,1825,O
yolk,1833,1837,B-Tissue
sac,1838,1841,I-Tissue
mesodermal,1842,1852,I-Tissue
area,1853,1857,O
visceral,1875,1883,B-Tissue
endodermal,1884,1894,I-Tissue
ectodermal,1899,1909,B-Tissue
layers,1910,1916,I-Tissue
supply,1924,1930,O
red,1935,1938,B-Cell
blood,1939,1944,I-Cell
cells,1945,1950,I-Cell
primary,1958,1965,O
stage,1966,1971,O
cells,1977,1982,B-Cell
blood,1986,1991,B-Organism_substance
islands,1992,1999,I-Organism_substance
called,2004,2010,O
hemangioblasts,2011,2025,B-Cell
differentiate,2042,2055,O
endothelial,2065,2076,B-Cell
cells,2077,2082,I-Cell
extraembryonic,2086,2100,B-Developing_anatomical_structure
blood,2101,2106,I-Developing_anatomical_structure
vessel,2107,2113,I-Developing_anatomical_structure
structure,2114,2123,I-Developing_anatomical_structure
chicken,2128,2135,O
embryo,2136,2142,B-Developing_anatomical_structure
differentiating,2144,2159,O
endothelial,2160,2171,B-Cell
cells,2172,2177,I-Cell
ventral,2185,2192,B-Multi-tissue_structure
blood,2201,2206,B-Organism_substance
islands,2207,2214,I-Organism_substance
express,2215,2222,O
CCN3,2223,2227,O
initial,2237,2244,O
stage,2245,2250,O
Fig,2252,2255,O
1e,2257,2259,O
Erythroblasts,2262,2275,B-Cell
center,2283,2289,O
blood,2293,2298,B-Organism_substance
islands,2299,2306,I-Organism_substance
spherical,2308,2317,O
cells,2318,2323,B-Cell
Fig,2327,2330,O
1e,2332,2334,O
weakly,2336,2342,O
express,2343,2350,O
CCN3,2351,2355,O
expression,2366,2376,O
mildly,2380,2386,O
enhanced,2387,2395,O
later,2399,2404,O
stage,2405,2410,O
data,2412,2416,O
shown,2421,2426,O
Assessment,0,10,O
forms,22,27,O
bevavioural,31,42,O
addictions,43,53,O
approach,62,70,O
comprehensive,79,92,O
standardized,97,109,O
assessment,110,120,O
different,124,133,O
forms,134,139,O
behavioural,143,154,O
addictions,155,165,O
e,167,168,O
g,169,170,O
pathological,173,185,O
gambling,186,194,O
workaholism,196,207,O
compulsive,209,219,O
buying,220,226,O
German,235,241,O
self,242,246,O
assessment,247,257,O
questionnaire,258,271,O
Fragebogen,273,283,O
zur,284,287,O
Differenzierten,288,303,O
Anamnese,304,312,O
exzessiver,313,323,O
Verhaltensweisen,324,340,O
FDAV,343,347,O
Questionnaire,349,362,O
Differentiated,366,380,O
Assessment,381,391,O
Excessive,395,404,O
Behaviours,405,415,O
96,418,420,O
FDAV,427,431,O
based,435,440,O
criteria,448,456,O
substance,460,469,O
related,470,477,O
addictions,478,488,O
pathological,490,502,O
gambling,503,511,O
impulse,516,523,O
control,524,531,O
disorders,532,541,O
ICD,549,552,O
10,553,555,O
3,557,558,O
DSM,568,571,O
IV,572,574,O
TR,575,577,O
2,579,580,O
FDAV,587,591,O
modified,597,605,O
version,606,613,O
Fragebogen,622,632,O
zur,633,636,O
Differenzierten,637,652,O
Drogenanamnese,653,667,O
FDDA,670,674,O
Questionnaire,676,689,O
Differentiated,693,707,O
Assessment,708,718,O
Addiction,722,731,O
QDAA,733,737,O
97,740,742,O
seven,749,754,O
modules,755,762,O
obtain,763,769,O
sociodemographic,771,787,O
information,788,799,O
e,802,803,O
g,804,805,O
age,808,811,O
profession,813,823,O
marital,825,832,O
status,833,839,O
history,843,850,O
excessive,854,863,O
behaviour,864,873,O
e,876,877,O
g,878,879,O
diagnostic,882,892,O
criteria,893,901,O
addictions,906,916,O
impulse,921,928,O
control,929,936,O
disorder,937,945,O
individual,947,957,O
patterns,958,966,O
behaviour,970,979,O
craving,981,988,O
symptoms,989,997,O
critical,1001,1009,O
life,1010,1014,O
events,1015,1021,O
stress,1024,1030,O
caused,1031,1037,O
traumatic,1041,1050,O
events,1051,1057,O
legal,1061,1066,O
situation,1067,1076,O
medical,1080,1087,O
history,1088,1095,O
physical,1099,1107,O
psychological,1112,1125,O
complaints,1126,1136,O
emotional,1144,1153,O
state,1154,1159,O
triggering,1162,1172,O
psychological,1173,1186,O
conditions,1187,1197,O
consequences,1202,1214,O
addictive,1222,1231,O
behaviour,1232,1241,O
respectively,1243,1255,O
module,1264,1270,O
administered,1278,1290,O
separately,1291,1301,O
according,1302,1311,O
suspected,1319,1328,O
behavioural,1329,1340,O
addiction,1341,1350,O
making,1360,1366,O
FDAV,1371,1375,O
economical,1379,1389,O
tool,1390,1394,O
assessing,1398,1407,O
behavioural,1408,1419,O
addictions,1420,1430,O
FDAV,1436,1440,O
suitable,1444,1452,O
diagnostics,1457,1468,O
evaluation,1470,1480,O
therapy,1484,1491,O
follow,1496,1502,O
clinical,1509,1517,O
practice,1518,1526,O
research,1531,1539,O
Currently,1541,1550,O
FDAV,1556,1560,O
validated,1570,1579,O
clinical,1583,1591,O
non,1596,1599,O
clinical,1600,1608,O
samples,1609,1616,O
Click,0,5,O
file,15,19,O
Method,0,6,O
Results,0,7,O
fractures,13,22,O
united,23,29,O
Individual,31,41,O
movement,42,50,O
dorsiflexion,54,66,O
palmar,68,74,B-Organism_subdivision
flexion,75,82,O
supination,84,94,O
pronation,96,105,O
radial,110,116,B-Organ
ulnar,117,122,B-Organ
deviation,123,132,O
significantly,142,155,O
better,156,162,O
dorsiflexed,170,181,O
immobilized,182,193,O
group,194,199,O
compared,203,211,O
palmar,221,227,B-Organism_subdivision
flexed,228,234,O
immobilized,235,246,O
group,247,252,O
Grip,254,258,O
strength,259,267,O
recovery,268,276,O
subjective,282,292,O
assessment,293,303,O
better,308,314,O
dorsiflexed,322,333,O
group,334,339,O
77,341,343,O
compared,349,357,O
palmar,365,371,B-Organism_subdivision
flexed,372,378,O
group,379,384,O
23,386,388,O
Radiological,392,404,O
parameters,405,415,O
markedly,421,429,O
better,430,436,O
dorsiflexed,444,455,O
group,456,461,O
Ninety,463,469,O
cent,478,482,O
patients,486,494,O
dorsiflexed,502,513,O
group,514,519,O
excellent,524,533,O
good,537,541,O
results,542,549,O
compared,553,561,O
66,565,567,O
palmar,576,582,B-Organism_subdivision
flexed,583,589,O
group,590,595,O
3,0,1,O
2,2,3,O
Cell,5,9,B-Cell
line,10,14,I-Cell
culture,19,26,O
DU145,27,32,B-Cell
prostate,34,42,I-Cell
cancer,43,49,I-Cell
cell,51,55,I-Cell
line,56,60,I-Cell
assay,78,83,O
DU145,85,90,B-Cell
grown,95,100,O
DMEM,104,108,O
F,109,110,O
12,111,113,O
medium,114,120,O
Gibco,122,127,O
BRL,128,131,O
Life,132,136,O
Technologies,137,149,O
San,151,154,O
Diego,155,160,O
USA,167,170,O
supplemented,172,184,O
10,190,192,O
fetal,194,199,B-Developing_anatomical_structure
calf,200,204,O
serum,205,210,B-Organism_substance
kept,215,219,O
humidified,225,235,O
37,236,238,O
degreesC,239,247,O
5,249,250,O
CO2,252,255,O
incubator,256,265,O
Target,0,6,O
volumes,7,14,O
coverage,16,24,O
mean,29,33,O
PTV1,34,38,O
PTV2,43,47,O
volumes,48,55,O
452,61,64,O
cm3,65,68,O
range,70,75,O
276,76,79,O
1074,80,84,O
cm3,85,88,O
300,94,97,O
cm3,98,101,O
range,103,108,O
137,109,112,O
567,113,116,O
cm3,117,120,O
respectively,122,134,O
mean,138,142,O
98,147,149,O
range,152,157,O
92,158,160,O
100,161,164,O
PTV1,174,178,O
received,179,187,O
100,188,191,O
prescribed,200,210,O
dose,211,215,O
planning,223,231,O
methods,232,239,O
mean,243,247,O
95,251,253,O
5,254,255,O
95,261,263,O
7,264,265,O
PTV2,274,278,O
received,279,287,O
100,288,291,O
prescribed,300,310,O
dose,311,315,O
TOMO,321,325,O
IMRT,330,334,O
plans,335,340,O
respectively,341,353,O
mean,357,361,O
94,365,367,O
92,373,375,O
PTV2,384,388,O
received,389,397,O
100,398,401,O
prescribed,410,420,O
dose,421,425,O
IB,431,433,O
3D,438,440,O
treatment,441,450,O
plans,451,456,O
respectively,458,470,O
mean,476,480,O
IB,481,483,O
3D,488,490,O
plans,491,496,O
PTV2,497,501,O
coverage,502,510,O
significantly,515,528,O
inferior,529,537,O
IMRT,547,551,O
TOMO,556,560,O
plans,561,566,O
p,568,569,O
0,572,573,O
02,574,576,O
comparisons,586,597,O
mean,604,608,O
Inhomogeneity,609,622,O
Coefficient,623,634,O
IC,636,638,O
significantly,644,657,O
lower,658,663,O
better,665,671,O
TOMO,682,686,O
plans,687,692,O
compared,694,702,O
plans,716,721,O
PTV1,731,735,O
PTV2,740,744,O
p,746,747,O
0,750,751,O
0003,752,756,O
comparisons,765,776,O
figure,779,785,O
3,786,787,O
mean,794,798,O
IC,799,801,O
IMRT,809,813,O
plans,814,819,O
significantly,824,837,O
higher,838,844,O
worse,846,851,O
mean,862,866,O
IC,867,869,O
3D,877,879,O
plans,880,885,O
PTV,896,899,O
1,900,901,O
p,903,904,O
0,907,908,O
02,909,911,O
higher,917,923,O
worse,925,930,O
mean,941,945,O
IC,946,948,O
IB,956,958,O
plans,959,964,O
PTV2,975,979,O
p,981,982,O
0,985,986,O
03,987,989,O
figure,992,998,O
3,999,1000,O
significant,1006,1017,O
difference,1018,1028,O
found,1033,1038,O
means,1051,1056,O
IC,1064,1066,O
3D,1074,1076,O
IB,1081,1083,O
plans,1084,1089,O
Figure,1091,1097,O
3,1098,1099,O
mean,1104,1108,O
Inhomogeneity,1109,1122,O
Coefficient,1123,1134,O
IC,1136,1138,O
achieved,1140,1148,O
different,1156,1165,O
planning,1166,1174,O
methods,1175,1182,O
mean,1188,1192,O
Inhomogeneity,1200,1213,O
Coefficient,1214,1225,O
measure,1231,1238,O
dose,1242,1246,O
inhomogeneity,1247,1260,O
target,1268,1274,O
volumes,1275,1282,O
closer,1288,1294,O
IC,1299,1301,O
zero,1305,1309,O
homogenous,1320,1330,O
dose,1335,1339,O
RESEARCH,0,8,O
DESIGN,9,15,O
METHODS,20,27,O
study,37,42,O
20,44,46,O
individuals,47,58,O
mean,60,64,O
age,65,68,O
39,69,71,O
5,72,73,O
11,78,80,O
1,81,82,O
years,83,88,O
long,95,99,O
standing,100,108,O
type,109,113,O
1,114,115,O
diabetes,116,124,O
21,126,128,O
3,129,130,O
10,135,137,O
7,138,139,O
years,140,145,O
enrolled,152,160,O
prospective,169,180,O
open,181,185,O
label,186,191,O
crossover,192,201,O
trial,202,207,O
achieving,215,224,O
optimal,225,232,O
blood,233,238,B-Organism_substance
glucose,239,246,O
control,247,254,O
16,256,258,O
subjects,259,267,O
randomized,273,283,O
exenatide,287,296,O
daclizumab,313,323,O
Endogenous,325,335,O
insulin,336,343,O
production,344,354,O
determined,359,369,O
repeatedly,373,383,O
measuring,384,393,O
serum,394,399,B-Organism_substance
C,400,401,O
peptide,402,409,O
Subjects,0,8,O
Methods,13,20,O
ABPM,21,25,O
conducted,30,39,O
60,44,46,O
selected,47,55,O
patients,56,64,O
visited,73,80,O
Sunlin,81,87,O
Hospital,88,96,O
January,105,112,O
2008,113,117,O
August,122,128,O
2008,129,133,O
Patients,135,143,O
classified,149,159,O
3,165,166,O
groups,167,173,O
obese,178,183,O
group,184,189,O
body,196,200,B-Organism_subdivision
mass,201,205,O
index,206,211,O
BMI,213,216,O
95th,228,232,O
percentile,233,243,O
overweight,248,258,O
group,259,264,O
BMI,271,274,O
85th,285,289,O
percentile,290,300,O
95th,319,323,O
percentile,324,334,O
normal,342,348,O
group,349,354,O
BMI,361,364,O
85th,379,383,O
percentile,384,394,O
Overall,396,403,O
mean,404,408,O
BP,409,411,O
day,413,416,O
night,421,426,O
BP,427,429,O
BP,434,436,O
load,437,441,O
measured,447,455,O
ABPM,459,463,O
Surgery,0,7,O
Trabeculectomy,8,22,O
considered,33,43,O
patients,51,59,O
target,71,77,O
IOP,78,81,O
achieved,90,98,O
glaucoma,104,112,O
medications,113,124,O
expected,136,144,O
rate,145,149,O
visual,153,159,O
loss,160,164,O
affect,171,177,O
patient,182,189,O
lifetime,203,211,O
procedure,221,230,O
opening,235,242,O
trabecular,258,268,B-Organ
meshwork,269,277,O
aqueous,287,294,O
humor,295,300,B-Organism_substance
drain,305,310,O
sclera,320,326,B-Multi-tissue_structure
patients,333,341,O
discontinue,346,357,O
glaucoma,358,366,O
medications,367,378,O
surgery,385,392,O
Approximately,394,407,O
trabeculectomy,425,439,O
patients,440,448,O
develop,449,456,O
cataract,457,465,O
years,478,483,O
trabeculectomy,488,502,O
fails,503,508,O
type,518,522,O
surgery,526,533,O
places,534,540,O
drainage,543,551,O
tube,552,556,O
Molteno,558,565,O
tube,566,570,O
eye,579,582,B-Organ
cornea,596,602,B-Multi-tissue_structure
iris,607,611,B-Multi-tissue_structure
exits,619,624,O
junction,632,640,O
cornea,648,654,B-Multi-tissue_structure
sclera,659,665,B-Multi-tissue_structure
Cyclodestructive,667,683,O
procedures,684,694,O
lower,702,707,O
IOP,708,711,O
destroying,715,725,O
ciliary,730,737,B-Multi-tissue_structure
body,738,742,I-Multi-tissue_structure
typically,748,757,O
reserved,758,766,O
eyes,771,775,B-Organ
refractory,787,797,O
forms,811,816,O
therapy,820,827,O
procedures,835,845,O
include,846,853,O
cyclocryotherapy,854,870,O
cylcodiathermy,872,886,O
laser,891,896,O
cyclophotocoagulation,897,918,O
91,920,922,O
93,923,925,O
Follow,0,6,O
Patients,10,18,O
followed,24,32,O
outpatient,43,53,O
clinic,54,60,O
1,64,65,O
4,67,68,O
7,74,75,O
months,76,82,O
ablation,93,101,O
procedure,102,111,O
6,122,123,O
months,124,130,O
Routine,143,150,O
24,151,153,O
48,157,159,O
h,160,161,O
Holter,162,168,O
monitoring,169,179,O
performed,184,193,O
appointment,206,217,O
12,225,227,O
lead,228,232,O
electrocardiogram,233,250,O
obtained,255,263,O
visit,272,277,O
Patients,279,287,O
asked,293,298,O
report,302,308,O
emergency,316,325,O
room,326,330,O
arrhythmia,338,348,O
unit,349,353,O
ECG,361,364,O
symptom,372,379,O
suggestive,380,390,O
recurrence,394,404,O
occurred,405,413,O
scheduled,422,431,O
visits,432,438,O
ablation,450,458,O
procedure,459,468,O
patients,474,482,O
received,483,491,O
anti,492,496,O
arrhythmic,497,507,O
treatment,508,517,O
1,531,532,O
month,533,538,O
protect,542,549,O
early,558,563,O
recurrences,564,575,O
continued,580,589,O
oral,590,594,O
anticoagulation,595,610,O
minimum,617,624,O
2,628,629,O
months,630,636,O
maintain,640,648,O
international,652,665,O
normalized,666,676,O
ratio,677,682,O
2,691,692,O
0,693,694,O
3,699,700,O
0,701,702,O
Additionally,704,716,O
magnetic,718,726,O
resonance,727,736,O
angiography,737,748,O
repeated,753,761,O
3,765,766,O
6,767,768,O
months,769,775,O
procedure,786,795,O
evaluate,799,807,O
presence,812,820,O
PV,824,826,O
stenosis,827,835,O
Arrhythmia,837,847,O
recurrence,848,858,O
defined,863,870,O
documented,876,886,O
AF,887,889,O
atrial,893,899,B-Multi-tissue_structure
flutter,900,907,O
episode,908,915,O
30,920,922,O
s,923,924,O
Arrhythmic,926,936,O
episodes,937,945,O
3,963,964,O
months,965,971,O
CPVA,982,986,O
healing,988,995,O
period,996,1002,O
considered,1013,1023,O
evaluation,1031,1041,O
final,1045,1050,O
success,1051,1058,O
rates,1059,1064,O
described,1088,1097,O
transient,1101,1110,O
recurrences,1111,1122,O
related,1123,1130,O
atrial,1134,1140,B-Multi-tissue_structure
inflammatory,1141,1153,O
processes,1154,1163,O
following,1164,1173,O
RF,1174,1176,O
lesions,1177,1184,O
26,1185,1187,O
endpoint,1192,1200,O
study,1208,1213,O
freedom,1218,1225,O
arrhythmia,1231,1241,O
recurrence,1242,1252,O
single,1261,1267,O
CPVA,1268,1272,O
procedure,1273,1282,O
anti,1292,1296,O
arrhythmic,1297,1307,O
medication,1308,1318,O
minimum,1322,1329,O
follow,1330,1336,O
3,1343,1344,O
months,1345,1351,O
required,1356,1364,O
Electrostatic,0,13,O
interaction,14,25,O
energies,26,34,O
SNARE,47,52,O
complex,53,60,O
fusing,65,71,O
membranes,72,81,B-Cellular_component
Schematic,87,96,O
diagram,97,104,O
definitions,109,120,O
intermolecular,124,138,O
interaction,139,150,O
energies,151,159,O
presented,160,169,O
B,174,175,O
C,182,183,O
C,202,203,O
SNARE,215,220,O
core,221,225,O
complex,226,233,O
considered,237,247,O
Interaction,249,260,O
free,261,265,O
energies,266,274,O
calculated,279,289,O
B,295,296,O
series,300,306,O
SNARE,310,315,O
membrane,316,324,B-Cellular_component
distances,325,334,O
C,340,341,O
different,343,352,O
membrane,353,361,B-Cellular_component
lipid,362,367,O
compositions,368,380,O
Arrow,382,387,O
B,392,393,O
indicates,395,404,O
physiologically,414,429,O
relevant,430,438,O
distance,439,447,O
closest,457,464,O
points,465,471,O
SNARE,480,485,O
membranes,490,499,B-Cellular_component
3,504,505,O
thickness,513,522,O
layer,528,533,O
water,537,542,O
19,544,546,O
D,552,553,O
F,564,565,O
TMDs,568,572,O
VAMP,576,580,O
syntaxin,585,593,O
present,598,605,O
embedded,610,618,O
membranes,622,631,B-Cellular_component
Furthermore,633,644,O
C,650,651,O
terminus,652,660,O
SNARE,668,673,O
motif,674,679,O
partially,683,692,O
unraveled,693,702,O
individual,708,718,O
alpha,719,724,O
helices,725,732,O
molecular,736,745,O
dynamics,746,754,O
simulations,755,766,O
represent,770,779,O
trans,780,785,O
SNARE,786,791,O
complex,792,799,O
Interaction,801,812,O
free,813,817,O
energies,818,826,O
calculated,836,846,O
E,852,853,O
series,857,863,O
SNARE,867,872,O
motif,873,878,O
C,879,880,O
terminus,881,889,O
separation,890,900,O
distances,901,910,O
F,916,917,O
different,919,928,O
lipid,929,934,O
compositions,935,947,O
membranes,955,964,B-Cellular_component
Conclusions,966,977,O
drawn,978,983,O
groups,994,1000,O
studies,1004,1011,O
essentially,1016,1027,O
V,1038,1039,O
circles,1041,1048,O
Interaction,1051,1062,O
energies,1063,1071,O
SNARE,1084,1089,O
complex,1090,1097,O
v,1106,1107,B-Cellular_component
membrane,1108,1116,I-Cellular_component
T,1118,1119,O
squares,1121,1128,O
Interaction,1131,1142,O
energies,1143,1151,O
SNARE,1160,1165,O
t,1174,1175,B-Cellular_component
membrane,1176,1184,I-Cellular_component
VT,1186,1188,O
triangles,1190,1199,O
Interaction,1202,1213,O
energies,1214,1222,O
v,1235,1236,B-Cellular_component
t,1246,1247,B-Cellular_component
membranes,1248,1257,I-Cellular_component
SNARE,1265,1270,O
complex,1271,1278,O
extracted,1284,1293,O
Demographic,0,11,O
data,12,16,O
subjects,20,28,O
1,0,1,O
Background,3,13,O
United,18,24,O
Republic,25,33,O
Tanzania,37,45,O
countries,65,74,O
sub,78,81,O
Saharan,82,89,O
Africa,90,96,O
facing,97,103,O
human,106,111,O
resources,112,121,O
crisis,122,128,O
health,136,142,O
sector,143,149,O
small,158,163,O
inequitably,168,179,O
distributed,180,191,O
health,192,198,O
workforce,199,208,O
1,210,211,O
shoulders,218,227,O
disproportionately,230,248,O
high,249,253,O
burden,254,260,O
disease,264,271,O
2,272,273,O
poor,289,293,O
countries,294,303,O
world,311,316,O
face,317,321,O
severe,324,330,O
human,331,336,O
resource,337,345,O
crisis,346,352,O
health,362,368,O
sectors,369,376,O
3,378,379,O
4,380,381,O
problem,388,395,O
acute,404,409,O
Sub,413,416,O
Saharan,417,424,O
Africa,425,431,O
estimated,445,454,O
workforce,455,464,O
750,468,471,O
000,472,475,O
health,476,482,O
workers,483,490,O
region,498,504,O
serves,505,511,O
682,512,515,O
million,516,523,O
people,524,530,O
2,532,533,O
comparison,539,549,O
ratio,555,560,O
10,564,566,O
15,570,572,O
times,573,578,O
higher,579,585,O
developed,589,598,O
countries,599,608,O
estimated,625,634,O
workforce,635,644,O
doctors,648,655,O
nurses,657,663,O
allied,668,674,O
health,675,681,O
workers,682,689,O
Sub,693,696,O
Saharan,697,704,O
Africa,705,711,O
constitutes,712,723,O
1,724,725,O
3,726,727,O
world,736,741,O
s,742,743,O
health,744,750,O
workforce,751,760,O
Africa,768,774,O
suffers,775,782,O
25,788,790,O
world,799,804,O
s,805,806,O
burden,807,813,O
disease,817,824,O
2,826,827,O
minimum,832,839,O
level,840,845,O
health,851,857,O
workforce,858,867,O
2,871,872,O
5,873,874,O
health,875,881,O
workers,882,889,O
1000,894,898,O
people,899,905,O
required,909,917,O
achieve,921,928,O
Millennium,933,943,O
Development,944,955,O
Goals,956,961,O
5,963,964,O
Africa,967,973,O
far,977,980,O
level,991,996,O
health,1004,1010,O
workforce,1011,1020,O
density,1021,1028,O
averages,1039,1047,O
0,1048,1049,O
8,1050,1051,O
worker,1052,1058,O
1000,1063,1067,O
people,1068,1074,O
world,1086,1091,O
median,1092,1098,O
density,1099,1106,O
health,1110,1116,O
personnel,1117,1126,O
5,1130,1131,O
1000,1136,1140,O
people,1141,1147,O
5,1149,1150,O
positive,1164,1172,O
correlation,1173,1184,O
health,1193,1199,O
worker,1200,1206,O
density,1207,1214,O
health,1227,1233,O
indices,1234,1241,O
notably,1248,1255,O
infant,1256,1262,O
mortality,1263,1272,O
rate,1273,1277,O
maternal,1279,1287,O
mortality,1288,1297,O
rates,1298,1303,O
disease,1317,1324,O
specific,1325,1333,O
mortality,1334,1343,O
morbidity,1348,1357,O
rates,1358,1363,O
6,1365,1366,O
7,1367,1368,O
increase,1374,1382,O
number,1390,1396,O
health,1400,1406,O
workers,1407,1414,O
capita,1419,1425,O
associated,1429,1439,O
notable,1447,1454,O
decline,1455,1462,O
rates,1470,1475,O
mentioned,1476,1485,O
consequence,1498,1509,O
argued,1523,1529,O
health,1535,1541,O
worker,1542,1548,O
shortages,1549,1558,O
impeded,1564,1571,O
implementation,1576,1590,O
development,1594,1605,O
goals,1606,1611,O
poor,1620,1624,O
countries,1625,1634,O
8,1636,1637,O
CASE,0,4,O
time,25,29,O
case,32,36,O
CDLS,40,44,O
Iran,50,54,O
15,58,60,O
week,61,65,O
old,66,69,O
male,70,74,O
infant,75,81,O
refereed,90,98,O
case,104,108,O
multiple,112,120,O
congenital,121,131,O
anomalies,132,141,O
Clinical,143,151,O
investigation,152,165,O
showed,166,172,O
child,182,187,O
case,194,198,O
CDLS,202,206,O
Applying,0,8,O
A1C,9,12,O
cut,13,16,O
offs,17,21,O
AusDiab,29,36,O
population,37,47,O
4,49,50,O
6,51,52,O
undiagnosed,54,65,O
diabetes,66,74,O
Applying,76,84,O
cut,94,97,O
offs,98,102,O
total,106,111,O
75,112,114,O
9,115,116,O
AusDiab,125,132,O
population,133,143,O
diabetes,148,156,O
ruled,157,162,O
ruled,169,174,O
Fig,180,183,O
1B,185,187,O
remaining,200,209,O
24,210,212,O
1,213,214,O
impaired,220,228,O
A1C,229,232,O
impaired,250,258,O
A1C,259,262,O
69,264,266,O
3,267,268,O
abnormal,274,282,O
glucose,283,290,O
status,291,297,O
diabetes,303,311,O
A1C,313,316,O
5,320,321,O
5,322,323,O
provided,325,333,O
moderate,334,342,O
sensitivity,343,354,O
83,356,358,O
5,359,360,O
high,367,371,O
NPV,372,375,O
99,377,379,O
0,380,381,O
diabetes,391,399,O
prevalence,400,410,O
lower,415,420,O
AusDiab,428,435,O
MP,448,450,O
population,451,461,O
A1C,463,466,O
7,470,471,O
0,472,473,O
gave,475,479,O
100,480,483,O
specificity,485,496,O
100,501,504,O
PPV,506,509,O
dropping,514,522,O
cut,527,530,O
6,538,539,O
5,540,541,O
specificity,544,555,O
remained,556,564,O
99,565,567,O
9,568,569,O
PPV,577,580,O
near,581,585,O
100,586,589,O
Calcium,0,7,O
intake,8,14,O
effects,19,26,O
QUS,30,33,O
T,34,35,O
score,36,41,O
Figure,42,48,O
5,49,50,O
shows,51,56,O
amounts,61,68,O
dietary,72,79,O
calcium,80,87,O
intake,88,94,O
according,95,104,O
menopausal,108,118,O
status,119,125,O
Calcium,127,134,O
consumption,135,146,O
groups,155,161,O
like,163,167,O
study,180,185,O
population,186,196,O
inadequate,213,223,O
Fewer,225,230,O
premenopausal,249,262,O
postmenopausal,267,281,O
women,282,287,O
received,288,296,O
800,307,310,O
mg,311,313,O
calcium,314,321,O
daily,322,327,O
fewer,333,338,O
16,344,346,O
premenopausal,351,364,O
women,365,370,O
50,378,380,O
59,381,383,O
age,384,387,O
decade,388,394,O
n,396,397,O
38,400,402,O
consumed,404,412,O
800,423,426,O
mg,427,429,O
calcium,430,437,O
daily,438,443,O
Figure,445,451,O
5,452,453,O
Daily,454,459,O
calcium,460,467,O
intake,468,474,O
premenopausal,478,491,O
postmenopausal,496,510,O
women,511,516,O
figure,523,529,O
depicts,530,537,O
daily,542,547,O
amounts,548,555,O
dietary,559,566,O
calcium,567,574,O
intake,575,581,O
percent,587,594,O
according,596,605,O
menopausal,609,619,O
status,620,626,O
800,633,636,O
mg,637,639,O
daily,640,645,O
cut,649,652,O
point,657,662,O
QUS,664,667,O
T,668,669,O
score,670,675,O
calculated,686,696,O
according,697,706,O
daily,710,715,O
calcium,716,723,O
intake,724,730,O
premenopausal,738,751,O
postmenopausal,756,770,O
activity,771,779,O
groups,780,786,O
800,793,796,O
mg,797,799,O
daily,800,805,O
calcium,806,813,O
cutoff,817,823,O
point,824,829,O
shown,834,839,O
Tables,843,849,O
3,850,851,O
4,856,857,O
Figure,862,868,O
6,869,870,O
premenopausal,872,885,O
women,886,891,O
systematically,901,915,O
active,916,922,O
consumed,927,935,O
800,946,949,O
mg,950,952,O
calcium,953,960,O
daily,961,966,O
significantly,971,984,O
higher,985,991,O
QUS,992,995,O
T,996,997,O
scores,998,1004,O
compared,1005,1013,O
activity,1029,1037,O
groups,1038,1044,O
p,1046,1047,O
0,1050,1051,O
05,1052,1054,O
systematically,1063,1077,O
active,1078,1084,O
premenopausal,1085,1098,O
women,1099,1104,O
received,1109,1117,O
800,1128,1131,O
mg,1132,1134,O
calcium,1135,1142,O
day,1147,1150,O
difference,1157,1167,O
separately,1172,1182,O
significant,1183,1194,O
verses,1195,1201,O
sedentary,1202,1211,O
p,1213,1214,O
0,1217,1218,O
028,1219,1222,O
moderately,1228,1238,O
active,1239,1245,O
p,1247,1248,O
0,1251,1252,O
04,1253,1255,O
women,1257,1262,O
contrast,1267,1275,O
postmenopausal,1277,1291,O
women,1292,1297,O
showed,1298,1304,O
difference,1308,1318,O
QUS,1322,1325,O
T,1326,1327,O
scores,1328,1334,O
regardless,1335,1345,O
daily,1363,1368,O
calcium,1369,1376,O
intake,1377,1383,O
Figure,1385,1391,O
6,1392,1393,O
Synergy,1394,1401,O
physical,1410,1418,O
activity,1419,1427,O
dietary,1432,1439,O
calcium,1440,1447,O
intake,1448,1454,O
women,1458,1463,O
consuming,1464,1473,O
calcium,1474,1481,O
amounts,1482,1489,O
greater,1490,1497,O
800,1503,1506,O
mg,1507,1509,O
day,1510,1513,O
graphic,1520,1527,O
depicts,1528,1535,O
mean,1536,1540,O
QUS,1541,1544,O
T,1545,1546,O
score,1547,1552,O
values,1553,1559,O
calculated,1560,1570,O
according,1571,1580,O
daily,1584,1589,O
calcium,1590,1597,O
intake,1598,1604,O
premenopausal,1612,1625,O
postmenopausal,1630,1644,O
activity,1645,1653,O
groups,1654,1660,O
800,1667,1670,O
mg,1671,1673,O
daily,1674,1679,O
cut,1683,1686,O
point,1691,1696,O
statistical,1702,1713,O
significant,1714,1725,O
values,1726,1732,O
text,1737,1741,O
CONCLUSIONS,0,11,O
lack,16,20,O
association,24,35,O
depression,44,54,O
glycemic,59,67,O
control,68,75,O
use,94,97,O
binary,103,109,O
measure,110,117,O
depression,121,131,O
Findings,133,141,O
clarify,150,157,O
significant,162,173,O
association,174,185,O
distress,194,202,O
A1C,207,210,O
Discussion,0,10,O
study,29,34,O
employ,38,44,O
large,52,57,O
number,58,64,O
replicated,68,78,O
samples,79,86,O
order,90,95,O
assess,99,105,O
bacterial,110,119,O
communities,120,131,O
healthy,135,142,O
diseased,147,155,O
corals,156,162,O
culture,178,185,O
independent,186,197,O
assessment,198,208,O
bacterial,212,221,O
communities,222,233,O
Acroporid,237,246,O
WS,247,249,O
corals,250,256,O
GBR,264,267,O
Despite,269,276,O
potential,281,290,O
capturing,298,307,O
rare,308,312,O
low,321,324,O
abundance,325,334,O
bacterial,335,344,O
ribotypes,345,354,O
DGGE,360,364,O
analysis,365,373,O
study,387,392,O
indicated,393,402,O
similar,403,410,O
results,411,418,O
captured,422,430,O
bacterial,431,440,O
ribotypes,441,450,O
tentative,455,464,O
bacterial,465,474,O
species,475,482,O
replacement,483,494,O
unhealthy,498,507,O
corals,508,514,O
replicated,531,541,O
studies,542,549,O
non,562,565,O
culture,566,573,O
based,574,579,O
techniques,580,590,O
e,592,593,O
g,594,595,O
3,598,599,O
54,603,605,O
69,609,611,O
Figure,614,620,O
4,621,622,O
results,629,636,O
research,647,655,O
reinforce,656,665,O
statistically,672,685,O
relevant,686,694,O
data,695,699,O
corals,706,712,O
harbour,713,720,O
bacterial,721,730,O
communities,731,742,O
different,743,752,O
water,760,765,O
column,766,772,O
7,774,775,O
9,779,780,O
42,784,786,O
corroborate,789,800,O
findings,801,809,O
corals,815,821,O
associate,822,831,O
certain,842,849,O
specific,850,858,O
bacterial,859,868,O
groups,869,875,O
coral,892,897,O
associated,898,908,O
bacterial,909,918,O
communities,919,930,O
host,936,940,O
species,942,949,O
specific,950,958,O
2,960,961,O
data,968,972,O
presented,973,982,O
highlight,988,997,O
cluster,1000,1007,O
bacterial,1011,1020,O
ribotypes,1021,1030,O
frequently,1031,1041,O
associated,1042,1052,O
corals,1058,1064,O
distribution,1074,1086,O
bacterial,1096,1105,O
ribotypes,1106,1115,O
healthy,1119,1126,O
diseased,1131,1139,O
corals,1140,1146,O
allows,1154,1160,O
targeted,1173,1181,O
research,1182,1190,O
tentative,1198,1207,O
link,1208,1212,O
common,1227,1233,O
coral,1234,1239,O
associates,1240,1250,O
coral,1255,1260,O
health,1261,1267,O
study,1274,1279,O
indicates,1280,1289,O
coral,1295,1300,O
bacterial,1301,1310,O
community,1311,1320,O
assessments,1321,1332,O
require,1333,1340,O
number,1343,1349,O
replicates,1353,1363,O
coral,1368,1373,O
species,1374,1381,O
site,1386,1390,O
accurately,1394,1404,O
describe,1405,1413,O
diversity,1418,1427,O
present,1428,1435,O
population,1447,1457,O
order,1465,1470,O
draw,1474,1478,O
inferences,1479,1489,O
health,1493,1499,O
related,1500,1507,O
changes,1508,1515,O
community,1523,1532,O
composition,1533,1544,O
addition,1549,1557,O
comparisons,1563,1574,O
healthy,1578,1585,O
diseased,1590,1598,O
Acropora,1599,1607,O
hyacinthus,1608,1618,O
samples,1619,1626,O
showed,1627,1633,O
bacterial,1639,1648,O
communities,1649,1660,O
change,1665,1671,O
dramatically,1672,1684,O
diseased,1688,1696,O
individuals,1697,1708,O
DGGE,1714,1718,O
profiles,1719,1727,O
observed,1728,1736,O
corals,1741,1747,O
displaying,1748,1758,O
signs,1759,1764,O
White,1768,1773,O
Syndrome,1774,1782,O
comprised,1783,1792,O
range,1795,1800,O
bacterial,1804,1813,O
ribotypes,1814,1823,O
generally,1828,1837,O
found,1838,1843,O
healthy,1847,1854,O
corals,1855,1861,O
including,1863,1872,O
close,1873,1878,O
relatives,1879,1888,O
bacteria,1892,1900,O
previously,1901,1911,O
found,1912,1917,O
Black,1921,1926,O
Band,1927,1931,O
Diseased,1932,1940,O
corals,1941,1947,O
community,1961,1970,O
profiles,1971,1979,O
samples,1991,1998,O
taken,1999,2004,O
diseased,2010,2018,O
coral,2019,2024,O
colonies,2025,2033,O
inconsistent,2039,2051,O
indicative,2060,2070,O
single,2076,2082,O
bacterial,2083,2092,O
causative,2093,2102,O
agent,2103,2108,O
eukaryotic,4,14,O
parasite,15,23,O
Trypanosoma,24,35,O
brucei,36,42,O
able,46,50,O
import,54,60,O
inositol,61,69,O
environment,79,90,O
synthesize,94,104,O
de,108,110,O
novo,111,115,O
according,126,135,O
current,143,150,O
model,151,156,O
inositol,158,166,O
imported,167,175,O
environment,185,196,O
utilized,200,208,O
primarily,209,218,O
bulk,222,226,O
phosphatidylinositol,227,247,O
red,249,252,O
yellow,257,263,O
phospholipid,264,276,O
production,278,288,O
phosphatidylinositol,295,315,O
synthase,316,324,O
PIS,326,329,O
localized,331,340,O
Golgi,348,353,B-Cellular_component
complex,354,361,I-Cellular_component
Inositol,363,371,O
synthesized,372,383,O
de,384,386,O
novo,387,391,O
primarily,395,404,O
generate,413,421,O
phosphatidylinositol,422,442,O
production,460,470,O
glycosylphosphatidylinositols,474,503,O
GPIs,505,509,O
de,516,518,O
novo,519,523,O
synthesized,524,535,O
inositol,536,544,O
believed,548,556,O
utilized,563,571,O
GPI,583,586,O
production,587,597,O
IMPase,610,616,O
dephosphorylates,622,638,O
inositol,639,647,O
3,648,649,O
phosphate,650,659,O
inositol,663,671,O
localized,675,684,O
ER,692,694,O
GPI,702,705,O
synthesis,706,715,O
occurs,716,722,O
Mutants,724,731,O
lacking,732,739,O
TbINO1,740,746,O
inviable,751,759,O
diminished,771,781,O
GPI,782,785,O
production,786,796,O
Large,0,5,O
nodular,6,13,B-Pathological_formation
hepatic,14,21,I-Pathological_formation
flexure,22,29,I-Pathological_formation
lesions,30,37,I-Pathological_formation
seen,41,45,O
Colonoscopy,49,60,O
Water,0,5,O
emerging,6,14,O
yoke,24,28,O
adapter,29,36,O
nitrous,44,51,O
oxide,52,57,O
hose,58,62,O
pedigree,4,12,O
Korean,18,24,O
family,25,31,O
macular,37,44,B-Tissue
dystrophy,45,54,O
demonstrating,55,68,O
characteristics,73,88,O
autosomal,95,104,O
dominant,105,113,O
inheritance,114,125,O
trait,126,131,O
Histological,0,12,O
analysis,13,21,O
cross,24,29,O
section,30,37,O
distal,45,51,B-Multi-tissue_structure
colon,52,57,I-Multi-tissue_structure
2,59,60,O
cm,61,63,O
fixed,69,74,O
10,78,80,O
paraformaldehyde,82,98,O
solution,99,107,O
cut,128,131,O
small,137,142,O
fragments,143,152,O
dehydrated,154,164,O
ethanol,176,183,O
series,184,190,O
70,192,194,O
100,196,199,O
cleared,203,210,O
xylol,214,219,O
embedded,224,232,O
paraffin,236,244,O
fragments,250,259,B-Multi-tissue_structure
sliced,265,271,O
5,277,278,O
mum,279,282,O
thick,283,288,O
sections,289,297,O
stained,302,309,O
hematoxylin,315,326,O
eosin,327,332,O
Histological,334,346,O
evaluation,347,357,O
pathologist,372,383,O
blinded,392,399,O
experimental,407,419,O
groups,420,426,O
based,439,444,O
intensity,452,461,O
mononuclear,465,476,O
polymorphonuclear,481,498,O
infiltrates,499,510,O
lamina,518,524,B-Tissue
propria,525,532,I-Tissue
crypt,534,539,B-Immaterial_anatomical_entity
dilation,540,548,O
cellular,550,558,B-Cell
destruction,559,570,O
mucosal,575,582,B-Multi-tissue_structure
ulceration,583,593,O
Histopathological,595,612,O
changes,613,620,O
graded,626,632,O
according,633,642,O
degree,650,656,O
inflammation,660,672,O
following,683,692,O
scale,693,698,O
absent,700,706,O
0,708,709,O
light,712,717,O
1,719,720,O
moderate,723,731,O
2,733,734,O
intense,740,747,O
3,749,750,O
numbers,761,768,O
represented,769,780,O
inflammation,785,797,O
score,798,803,O
Results,810,817,O
expressed,823,832,O
mean,836,840,O
values,841,847,O
standard,858,866,O
error,867,872,O
mean,880,884,O
SEM,886,889,O
experimental,900,912,O
group,913,918,O
Pteris,0,6,O
vittata,7,14,O
Intervention,0,12,O
Patients,13,21,O
initial,23,30,O
introduction,31,43,O
Wrist,51,56,B-Organism_subdivision
Extension,57,66,O
Dynasplint,67,77,O
WED,79,82,O
system,84,90,O
Dynasplint,93,103,O
Systems,104,111,O
Inc,113,116,O
Severna,119,126,O
Park,127,131,O
MD,133,135,O
USA,137,140,O
included,142,150,O
customized,151,161,O
fitting,162,169,O
wrist,171,176,B-Organism_subdivision
length,177,183,O
width,185,190,O
girth,196,201,O
force,214,219,O
counter,224,231,O
force,232,237,O
straps,238,244,O
properly,254,262,O
aligned,263,270,O
training,276,284,O
donning,288,295,O
doffing,300,307,O
device,315,321,O
figure,328,334,O
1,335,336,O
Verbal,339,345,O
written,350,357,O
instructions,358,370,O
provided,376,384,O
duration,400,408,O
treatment,412,421,O
safety,426,432,O
general,434,441,O
wear,442,446,O
care,451,455,O
tension,461,468,O
setting,469,476,O
goals,477,482,O
based,483,488,O
patient,492,499,O
tolerance,500,509,O
Figure,511,517,O
1,518,519,O
Wrist,520,525,B-Organism_subdivision
Extension,526,535,O
Dynasplint,536,546,O
patient,553,560,O
initially,561,570,O
wore,571,575,O
WED,580,583,O
4,588,589,O
6,590,591,O
continuous,592,602,O
hours,603,608,O
initial,615,622,O
tension,623,630,O
setting,631,638,O
2,643,644,O
0,646,647,O
1,648,649,O
foot,650,654,O
pounds,655,661,O
torque,665,671,O
duration,679,687,O
acclimatization,696,711,O
system,719,725,O
patients,732,740,O
instructed,746,756,O
wear,760,764,O
WED,769,772,O
system,773,779,O
night,783,788,O
sleeping,795,803,O
6,808,809,O
8,810,811,O
hours,812,817,O
continuous,821,831,O
wear,832,836,O
patient,849,856,O
comfortable,861,872,O
wearing,873,880,O
unit,885,889,O
week,898,902,O
tension,906,913,O
level,914,919,O
2,921,922,O
instructed,934,944,O
increase,948,956,O
tension,961,968,O
level,969,974,O
3,979,980,O
0,982,983,O
3,984,985,O
ft,986,988,O
lbs,989,992,O
continual,1004,1013,O
increases,1014,1023,O
weeks,1034,1039,O
prolonged,1044,1053,O
soreness,1054,1062,O
followed,1063,1071,O
session,1074,1081,O
soreness,1083,1091,O
15,1106,1108,O
minutes,1109,1116,O
patient,1122,1129,O
instructed,1134,1144,O
decrease,1148,1156,O
tension,1161,1168,O
half,1173,1177,O
setting,1180,1187,O
days,1196,1200,O
comfortable,1217,1228,O
wearing,1229,1236,O
6,1244,1245,O
8,1246,1247,O
hours,1248,1253,O
new,1261,1264,O
tension,1265,1272,O
setting,1273,1280,O
majority,1286,1294,O
patients,1302,1310,O
reached,1311,1318,O
level,1319,1324,O
5,1326,1327,O
0,1329,1330,O
8,1331,1332,O
foot,1333,1337,O
pounds,1338,1344,O
torque,1348,1354,O
end,1363,1366,O
months,1374,1380,O
range,1386,1391,O
motion,1395,1401,O
measurements,1402,1414,O
recorded,1420,1428,O
prescribing,1436,1447,O
clinician,1448,1457,O
Animals,0,7,O
STOP,8,12,O
mice,18,22,O
WT,33,35,O
littermates,36,47,O
generated,53,62,O
mixed,68,73,O
BALBc,74,79,O
129,80,83,O
SvPas,84,89,O
pure,99,103,O
129,104,107,O
SvPas,108,113,O
background,114,124,O
previously,128,138,O
reported,139,147,O
Andrieux,151,159,O
et,160,162,O
al,163,165,O
4,168,169,O
animals,176,183,O
study,196,201,O
underwent,202,211,O
immunohistochemistry,212,232,O
detection,241,250,O
STOP,254,258,O
protein,259,266,O
resulting,268,277,O
staining,284,292,O
STOP,296,300,O
mice,306,310,O
genotyping,316,326,O
PCR,330,333,O
described,337,346,O
Andrieux,350,358,O
et,359,361,O
al,362,364,O
4,367,368,O
mice,375,379,O
kept,385,389,O
standard,396,404,O
housing,405,412,O
conditions,413,423,O
12,431,433,O
hour,434,438,O
12,439,441,O
hour,442,446,O
dark,447,451,O
light,452,457,O
cycle,458,463,O
experiments,469,480,O
carried,486,493,O
accordance,501,511,O
European,521,529,O
Communities,530,541,O
Council,542,549,O
Directive,550,559,O
24,563,565,O
November,566,574,O
1986,575,579,O
86,581,583,O
609,584,587,O
EEC,588,591,O
French,602,608,O
Department,609,619,O
Agriculture,623,634,O
License,636,643,O
Ndegrees,644,652,O
67,653,655,O
95,656,658,O
protocol,665,673,O
approved,678,686,O
ethical,694,701,O
Animal,702,708,O
Research,709,717,O
Committee,718,727,O
Louis,731,736,O
Pasteur,737,744,O
University,745,755,O
CREMEAS,757,764,O
AL,766,768,O
01,769,771,O
19,772,774,O
10,775,777,O
07,778,780,O
experiment,794,804,O
searched,809,817,O
differences,822,833,O
glomerular,837,847,B-Multi-tissue_structure
ultrastructure,848,862,O
peripheral,867,877,O
neurogenesis,878,890,O
WT,899,901,O
STOP,906,910,O
mice,916,920,O
group,930,935,O
24,939,941,O
mice,942,946,O
3,948,949,O
6,954,955,O
month,957,962,O
old,963,966,O
ultrastructural,981,996,O
study,997,1002,O
OBs,1010,1013,O
second,1017,1023,O
group,1024,1029,O
13,1033,1035,O
animals,1036,1043,O
analyse,1056,1063,O
proliferation,1064,1077,O
apoptosis,1082,1091,O
OE,1099,1101,B-Tissue
VNE,1106,1109,B-Tissue
paraffin,1113,1121,B-Tissue
sections,1122,1130,I-Tissue
3,1134,1135,O
month,1136,1141,O
old,1142,1145,O
mice,1146,1150,O
second,1157,1163,O
experiment,1164,1174,O
analysed,1178,1186,O
WT,1191,1193,O
STOP,1198,1202,O
mice,1208,1212,O
effect,1218,1224,O
OE,1228,1230,B-Tissue
regeneration,1231,1243,O
glomeruli,1247,1256,B-Multi-tissue_structure
structure,1257,1266,O
ultrastructure,1271,1285,O
peripheral,1293,1303,O
neurogenesis,1304,1316,O
age,1324,1327,O
times,1328,1333,O
3,1335,1336,O
10,1341,1343,O
months,1344,1350,O
Effect,0,6,O
deletion,14,22,O
IRE1alpha,26,35,O
liver,43,48,B-Organ
stained,57,64,O
sections,65,73,B-Tissue
liver,81,86,B-Tissue
tissue,87,93,I-Tissue
scale,95,100,O
bar,101,104,O
50,106,108,O
mum,109,112,O
B,116,117,O
Comparison,119,129,O
serum,137,142,B-Organism_substance
AST,143,146,O
ALT,151,154,O
levels,155,161,O
IRE1alpha,174,183,O
CKO,184,187,O
mice,188,192,O
control,201,208,O
mice,209,213,O
Data,215,219,O
expressed,224,233,O
mean,237,241,O
S,246,247,O
E,248,249,O
M,250,251,O
n,253,254,O
5,257,258,O
C,262,263,O
Quantitative,265,277,O
PCR,278,281,O
analysis,282,290,O
lipid,294,299,O
synthesis,300,309,O
genes,310,315,O
liver,323,328,B-Organ
mice,332,336,O
fed,337,340,O
normal,341,347,O
high,351,355,O
fructose,356,364,O
feed,365,369,O
Columns,371,378,O
indicate,379,387,O
mean,388,392,O
error,397,402,O
bars,403,407,O
denote,408,414,O
S,415,416,O
E,417,418,O
M,419,420,O
n,422,423,O
3,426,427,O
data,438,442,O
obtained,448,456,O
20,462,464,O
weeks,465,470,O
old,471,474,O
male,475,479,O
mice,480,484,O
2,0,1,O
Methods,3,10,O
Summary,0,7,O
instrument,11,21,O
characteristics,22,37,O
Histology,0,9,O
lung,17,21,B-Organ
left,26,30,O
lung,31,35,B-Organ
fixed,40,45,O
gentle,49,55,O
infusion,56,64,O
fixative,68,76,O
4,78,79,O
paraformaldehyde,81,97,O
tracheal,111,119,B-Multi-tissue_structure
cannula,120,127,O
24,129,131,O
excision,140,148,O
lung,154,158,B-Organ
immersed,163,171,O
fresh,177,182,O
fixative,183,191,O
2,196,197,O
h,198,199,O
lung,205,209,B-Multi-tissue_structure
lobe,210,214,I-Multi-tissue_structure
embedded,219,227,O
paraffin,231,239,O
cut,244,247,O
3,253,254,O
mum,255,258,O
transverse,259,269,O
sections,270,278,O
followed,280,288,O
immunohistochemical,292,311,O
chemical,316,324,O
staining,325,333,O
Photomicrographs,335,351,O
captured,357,365,O
KS400,372,377,O
image,378,383,O
analyze,384,391,O
platform,392,400,O
Zeiss,402,407,O
Oberkochen,409,419,O
Germany,421,428,O
analyzed,434,442,O
quantitatively,443,457,O
Data,0,4,O
collection,5,15,O
CrystalClear,17,29,O
Rigaku,31,37,O
MSC,38,41,O
2005,43,47,O
cell,52,56,B-Cell
refinement,57,67,O
CrystalClear,69,81,O
data,83,87,O
reduction,88,97,O
CrystalClear,99,111,O
program,113,120,O
s,121,122,O
solve,132,137,O
structure,138,147,O
SHELXS97,149,157,O
Sheldrick,159,168,O
2008,170,174,O
program,179,186,O
s,187,188,O
refine,198,204,O
structure,205,214,O
SHELXL97,216,224,O
Sheldrick,226,235,O
2008,237,241,O
molecular,246,255,O
graphics,256,264,O
ORTEPII,266,273,O
Johnson,275,282,O
1976,284,288,O
software,293,301,O
prepare,310,317,O
material,318,326,O
publication,331,342,O
SHELXL97,344,352,O
Experimental,0,12,O
molecular,4,13,O
structure,14,23,O
showing,32,39,O
displacement,40,52,O
ellipsoids,53,63,O
30,71,73,O
probability,75,86,O
level,87,92,O
non,97,100,O
H,101,102,O
atoms,103,108,O
Discussion,0,10,O
results,15,22,O
indicate,23,31,O
beneficial,32,42,O
effects,43,50,O
motivational,54,66,O
incentives,67,77,O
cognitive,81,90,O
performance,91,102,O
alleviating,107,118,O
effects,119,126,O
cognitive,130,139,O
decline,140,147,O
beneficial,155,165,O
effects,166,173,O
evident,179,186,O
healthy,190,197,O
young,198,203,O
older,208,213,O
adults,214,220,O
patients,228,236,O
Parkinson,242,251,O
s,252,253,O
disease,254,261,O
Young,263,268,O
adults,269,275,O
showed,276,282,O
improved,283,291,O
antisaccade,292,303,O
preparation,304,315,O
reward,323,329,O
stake,337,342,O
older,344,349,O
adults,350,356,O
PD,361,363,O
patients,364,372,O
utilize,379,386,O
reward,387,393,O
prospect,394,402,O
improve,406,413,O
impaired,420,428,O
antisaccade,429,440,O
preparation,441,452,O
Elderly,454,461,O
participants,462,474,O
PD,479,481,O
patients,482,490,O
better,505,511,O
prepared,512,520,O
means,524,529,O
commonly,533,541,O
preparatory,547,558,O
aids,559,563,O
e,567,568,O
preparation,576,587,O
time,588,592,O
advance,597,604,O
information,605,616,O
upcoming,624,632,O
response,633,641,O
means,655,660,O
motivational,664,676,O
incentives,677,687,O
beneficial,695,705,O
effects,706,713,O
motivational,717,729,O
incentives,730,740,O
cognitive,744,753,O
action,754,760,O
preparation,761,772,O
healthy,776,783,O
pathological,788,800,O
aging,801,806,O
support,815,822,O
views,823,828,O
question,834,842,O
notion,847,853,O
monotonic,857,866,O
deterioration,867,880,O
cognitive,884,893,O
function,894,902,O
age,908,911,O
Allen,913,918,O
et,919,921,O
al,922,924,O
2001,927,931,O
indicate,939,947,O
age,953,956,O
related,957,964,O
declines,965,973,O
modulated,981,990,O
emotion,994,1001,O
cognition,1002,1011,O
interactions,1012,1024,O
line,1029,1033,O
predominant,1043,1054,O
view,1055,1059,O
cognitive,1065,1074,O
control,1075,1082,O
deteriorates,1083,1095,O
aging,1099,1104,O
Parkinson,1109,1118,O
s,1119,1120,O
disease,1121,1128,O
line,1137,1141,O
previous,1147,1155,O
findings,1156,1164,O
age,1168,1171,O
related,1172,1179,O
changes,1180,1187,O
antisaccade,1191,1202,O
control,1203,1210,O
specifically,1211,1223,O
Eenshuistra,1225,1236,O
et,1237,1239,O
al,1240,1242,O
2004,1245,1249,O
Chan,1251,1255,O
et,1256,1258,O
al,1259,1261,O
2005,1264,1268,O
Amador,1270,1276,O
et,1277,1279,O
al,1280,1282,O
2006,1285,1289,O
Abel,1291,1295,O
Douglas,1300,1307,O
2007,1309,1313,O
current,1320,1327,O
results,1328,1335,O
showed,1336,1342,O
decline,1343,1350,O
antisaccade,1354,1365,O
preparation,1366,1377,O
PD,1381,1383,O
patients,1384,1392,O
severe,1398,1404,O
motor,1405,1410,O
symptoms,1411,1419,O
compared,1423,1431,O
healthy,1435,1442,O
seniors,1443,1450,O
Mild,1452,1456,O
symptom,1457,1464,O
patients,1465,1473,O
healthy,1478,1485,O
elderly,1486,1493,O
differ,1502,1508,O
antisaccade,1512,1523,O
preparation,1524,1535,O
Healthy,1537,1544,O
seniors,1545,1552,O
showed,1553,1559,O
declining,1560,1569,O
antisaccade,1570,1581,O
preparation,1582,1593,O
compared,1597,1605,O
young,1609,1614,O
adults,1615,1621,O
Decline,1623,1630,O
evident,1635,1642,O
oculomotor,1654,1664,B-Multi-tissue_structure
parameters,1665,1675,O
pronounced,1685,1695,O
antisaccade,1699,1710,O
onset,1711,1716,O
latencies,1717,1726,O
line,1731,1735,O
notion,1745,1751,O
general,1760,1767,O
elderly,1769,1776,O
tend,1777,1781,O
prefer,1785,1791,O
accuracy,1792,1800,O
speed,1806,1811,O
elderly,1813,1820,O
showed,1821,1827,O
decreased,1831,1840,O
antisaccade,1841,1852,O
accuracy,1853,1861,O
compared,1865,1873,O
young,1877,1882,O
adults,1883,1889,O
compared,1894,1902,O
young,1910,1915,O
group,1916,1921,O
elderly,1923,1930,O
PD,1935,1937,O
patients,1938,1946,O
exhibited,1947,1956,O
slightly,1957,1965,O
significantly,1975,1988,O
premature,1994,2003,O
eye,2004,2007,B-Organ
movements,2008,2017,O
Premature,2019,2028,O
eye,2029,2032,B-Organ
movements,2033,2042,O
significantly,2052,2065,O
increased,2066,2075,O
elderly,2079,2086,O
PD,2091,2093,O
patients,2094,2102,O
slightly,2112,2120,O
young,2128,2133,O
specific,2145,2153,O
information,2154,2165,O
upcoming,2173,2181,O
movement,2182,2190,O
available,2195,2204,O
advance,2208,2215,O
Presumably,2217,2227,O
increase,2234,2242,O
premature,2246,2255,O
eye,2256,2259,B-Organ
movements,2260,2269,O
reflects,2270,2278,O
difficulties,2279,2291,O
inhibition,2301,2311,O
externally,2315,2325,O
guided,2326,2332,O
movement,2333,2341,O
suppression,2353,2364,O
strongly,2368,2376,O
activated,2377,2386,O
prepotent,2387,2396,O
action,2397,2403,O
plans,2404,2409,O
hand,2422,2426,O
choice,2432,2438,O
medicated,2443,2452,O
PD,2453,2455,O
patients,2456,2464,O
represents,2465,2475,O
limitation,2478,2488,O
current,2496,2503,O
study,2504,2509,O
exclude,2523,2530,O
differential,2531,2543,O
effects,2544,2551,O
medication,2555,2565,O
behavior,2569,2577,O
hand,2592,2596,O
PD,2598,2600,O
patients,2601,2609,O
generally,2610,2619,O
medication,2625,2635,O
daily,2645,2650,O
routine,2651,2658,O
results,2674,2681,O
generalized,2689,2700,O
clinical,2704,2712,O
practice,2713,2721,O
Exploratory,2723,2734,O
analysis,2735,2743,O
PD,2755,2757,O
patient,2758,2765,O
group,2766,2771,O
revealed,2772,2780,O
patients,2786,2794,O
severe,2805,2811,O
motoric,2812,2819,O
symptoms,2820,2828,O
indexed,2833,2840,O
motoric,2850,2857,O
subscore,2858,2866,O
UPDRS,2874,2879,O
displayed,2881,2890,O
signs,2896,2901,O
antisaccade,2905,2916,O
decline,2917,2924,O
longer,2934,2940,O
antisaccade,2941,2952,O
latencies,2953,2962,O
lower,2967,2972,O
accuracy,2973,2981,O
compared,2982,2990,O
mildly,2994,3000,O
affected,3001,3009,O
patients,3010,3018,O
initiated,3024,3033,O
saccades,3034,3042,O
equally,3043,3050,O
fast,3051,3055,O
healthy,3059,3066,O
adults,3067,3073,O
suggests,3080,3088,O
dopaminergic,3094,3106,O
medication,3107,3117,O
sufficient,3126,3136,O
raise,3140,3145,O
patient,3150,3157,O
s,3158,3159,O
antisaccadic,3160,3172,O
preparation,3173,3184,O
level,3195,3200,O
healthy,3208,3215,O
older,3216,3221,O
adults,3222,3228,O
intriguing,3234,3244,O
observation,3245,3256,O
despite,3266,3273,O
different,3278,3287,O
extents,3288,3295,O
observed,3299,3307,O
antisaccade,3308,3319,O
performance,3320,3331,O
decline,3332,3339,O
elderly,3343,3350,O
PD,3355,3357,O
patients,3358,3366,O
reward,3368,3374,O
prospect,3375,3383,O
led,3384,3387,O
beneficial,3391,3401,O
effects,3402,3409,O
antisaccade,3413,3424,O
latency,3425,3432,O
accuracy,3437,3445,O
young,3449,3454,O
elderly,3456,3463,O
PD,3469,3471,O
patients,3472,3480,O
alike,3481,3486,O
Young,3488,3493,O
elderly,3495,3502,O
PD,3507,3509,O
patients,3510,3518,O
benefited,3519,3528,O
reward,3534,3540,O
prospect,3541,3549,O
extent,3562,3568,O
confirming,3570,3580,O
expectancy,3590,3600,O
reward,3604,3610,O
powerful,3616,3624,O
mediator,3625,3633,O
cognitive,3637,3646,O
control,3647,3654,O
cognitive,3664,3673,O
control,3674,3681,O
suffers,3682,3689,O
decline,3695,3702,O
expectation,3708,3719,O
rewarding,3723,3732,O
incentives,3733,3743,O
support,3758,3765,O
older,3766,3771,O
adults,3772,3778,O
PD,3784,3786,O
patients,3787,3795,O
ability,3797,3804,O
anticipate,3808,3818,O
prepare,3820,3827,O
initiate,3832,3840,O
goal,3841,3845,O
directed,3846,3854,O
behavior,3855,3863,O
findings,3871,3879,O
imply,3880,3885,O
despite,3891,3898,O
general,3901,3908,O
decline,3909,3916,O
action,3924,3930,O
preparation,3931,3942,O
system,3943,3949,O
indexed,3953,3960,O
increased,3964,3973,O
antisaccade,3974,3985,O
latency,3986,3993,O
action,3995,4001,O
preparation,4002,4013,O
processes,4014,4023,O
remain,4024,4030,O
susceptible,4031,4042,O
prospect,4050,4058,O
future,4062,4068,O
reward,4069,4075,O
argued,4094,4100,O
neural,4110,4116,B-Multi-tissue_structure
representations,4117,4132,O
upcoming,4136,4144,O
rewards,4145,4152,O
influence,4153,4162,O
neural,4163,4169,B-Anatomical_system
systems,4170,4177,I-Anatomical_system
concerned,4178,4187,O
action,4193,4199,O
preparation,4200,4211,O
oculomotor,4216,4226,B-Multi-tissue_structure
control,4227,4234,O
current,4249,4256,O
behavioral,4257,4267,O
results,4268,4275,O
exclude,4283,4290,O
confirm,4294,4301,O
neural,4302,4308,B-Multi-tissue_structure
links,4309,4314,O
reward,4323,4329,O
anticipation,4330,4342,O
action,4347,4353,O
preparation,4354,4365,O
systems,4366,4373,O
brain,4381,4386,B-Organ
suggest,4393,4400,O
intact,4401,4407,O
cross,4408,4413,O
talk,4414,4418,O
subcortical,4425,4436,B-Multi-tissue_structure
circuits,4437,4445,O
allow,4451,4456,O
goal,4457,4461,O
directed,4462,4470,O
action,4471,4477,O
modified,4484,4492,O
motivational,4496,4508,O
factors,4509,4516,O
motivational,4522,4534,O
neural,4535,4541,B-Multi-tissue_structure
reward,4542,4548,O
anticipation,4549,4561,O
signal,4562,4568,O
presumably,4569,4579,O
activates,4580,4589,O
reward,4594,4600,O
network,4601,4608,O
including,4609,4618,O
amygdala,4623,4631,O
orbitofrontal,4633,4646,B-Multi-tissue_structure
cortex,4647,4653,I-Multi-tissue_structure
ventral,4664,4671,B-Multi-tissue_structure
dorsal,4676,4682,B-Multi-tissue_structure
striatum,4683,4691,I-Multi-tissue_structure
nucleus,4693,4700,B-Multi-tissue_structure
accumbens,4701,4710,I-Multi-tissue_structure
putamen,4712,4719,B-Multi-tissue_structure
caudate,4725,4732,B-Multi-tissue_structure
leading,4735,4742,O
release,4749,4756,O
caudate,4760,4767,O
SNr,4768,4771,O
inhibition,4772,4782,O
executive,4790,4799,O
oculomotor,4800,4810,B-Multi-tissue_structure
structure,4811,4820,I-Multi-tissue_structure
superior,4821,4829,I-Multi-tissue_structure
colliculus,4830,4840,I-Multi-tissue_structure
transiently,4847,4858,O
decreased,4859,4868,O
inhibitory,4869,4879,O
force,4880,4885,O
superior,4889,4897,B-Multi-tissue_structure
colliculus,4898,4908,I-Multi-tissue_structure
improve,4913,4920,O
goal,4921,4925,O
directed,4926,4934,O
oculomotor,4935,4945,B-Multi-tissue_structure
control,4946,4953,O
reward,4960,4966,O
anticipation,4967,4979,O
compensate,4986,4996,O
age,5005,5008,O
disease,5014,5021,O
related,5022,5029,O
dopaminergic,5030,5042,O
loss,5043,5047,O
SNc,5055,5058,O
projections,5059,5070,O
caudate,5078,5085,O
SNr,5086,5089,O
play,5103,5107,O
compensatory,5110,5122,O
role,5123,5127,O
boosting,5132,5140,O
efficiency,5146,5156,O
interactions,5160,5172,O
motivational,5181,5193,O
impaired,5198,5206,O
cognitive,5207,5216,O
control,5217,5224,O
processes,5225,5234,O
reward,5248,5254,O
related,5255,5262,O
modulation,5263,5273,O
oculomotor,5281,5291,B-Multi-tissue_structure
control,5292,5299,I-Multi-tissue_structure
system,5300,5306,I-Multi-tissue_structure
apply,5320,5325,O
basal,5333,5338,B-Multi-tissue_structure
ganglia,5339,5346,I-Multi-tissue_structure
oculomotor,5359,5369,B-Multi-tissue_structure
network,5370,5377,I-Multi-tissue_structure
speculative,5388,5399,O
extend,5410,5416,O
cortical,5424,5432,B-Multi-tissue_structure
eyefields,5433,5442,I-Multi-tissue_structure
frontal,5444,5451,B-Multi-tissue_structure
supplementary,5453,5466,B-Multi-tissue_structure
parietal,5472,5480,B-Multi-tissue_structure
eyefields,5481,5490,I-Multi-tissue_structure
parts,5499,5504,O
visual,5512,5518,B-Multi-tissue_structure
cortex,5519,5525,I-Multi-tissue_structure
Human,5527,5532,O
research,5533,5541,O
shows,5542,5547,O
preparatory,5558,5569,O
activation,5570,5580,O
frontal,5588,5595,B-Multi-tissue_structure
eyefields,5596,5605,I-Multi-tissue_structure
leads,5606,5611,O
faster,5617,5623,O
antisaccade,5624,5635,O
latency,5636,5643,O
Connolly,5645,5653,O
et,5654,5656,O
al,5657,5659,O
2002,5662,5666,O
2005,5668,5672,O
compensatory,5679,5691,O
effect,5692,5698,O
antisaccade,5706,5717,O
latency,5718,5725,O
theoretically,5744,5757,O
stem,5758,5762,O
propagation,5770,5781,O
reward,5785,5791,O
anticipation,5792,5804,O
signal,5805,5811,O
caudate,5819,5826,B-Multi-tissue_structure
frontal,5834,5841,B-Multi-tissue_structure
eyefields,5842,5851,I-Multi-tissue_structure
Complex,5853,5860,O
structural,5861,5871,O
connections,5872,5883,O
enable,5884,5890,O
striatum,5895,5903,B-Multi-tissue_structure
exert,5907,5912,O
controlling,5915,5926,O
influence,5927,5936,O
cerebral,5946,5954,B-Multi-tissue_structure
cortex,5955,5961,I-Multi-tissue_structure
series,5968,5974,O
reentrant,5978,5987,B-Multi-tissue_structure
corticobasal,5988,6000,I-Multi-tissue_structure
ganglia,6001,6008,I-Multi-tissue_structure
circuits,6009,6017,O
reward,6024,6030,O
anticipation,6031,6043,O
increase,6048,6056,O
level,6061,6066,O
preparation,6070,6081,O
intact,6089,6095,O
cortical,6096,6104,B-Multi-tissue_structure
eyefields,6105,6114,I-Multi-tissue_structure
compensate,6127,6137,O
age,6142,6145,O
disease,6151,6158,O
related,6159,6166,O
subcortical,6167,6178,B-Multi-tissue_structure
decrements,6179,6189,O
oculomotor,6197,6207,B-Multi-tissue_structure
network,6208,6215,I-Multi-tissue_structure
Taken,6217,6222,O
plausible,6242,6251,O
motivational,6257,6269,O
reward,6270,6276,O
processes,6277,6286,O
caudate,6294,6301,B-Multi-tissue_structure
enhance,6302,6309,O
preparatory,6310,6321,O
activation,6322,6332,O
subcortical,6336,6347,B-Multi-tissue_structure
cortical,6362,6370,B-Multi-tissue_structure
nodes,6371,6376,I-Multi-tissue_structure
oculomotor,6384,6394,B-Multi-tissue_structure
network,6395,6402,I-Multi-tissue_structure
neurotransmission,6412,6429,O
mechanisms,6430,6440,O
underlie,6445,6453,O
remedial,6458,6466,O
effect,6467,6473,O
positive,6477,6485,O
incentives,6486,6496,O
declining,6500,6509,O
antisaccadic,6510,6522,O
control,6523,6530,O
Given,6532,6537,O
convergence,6542,6553,O
dopamine,6557,6565,O
glutamate,6570,6579,O
inputs,6580,6586,O
spiny,6594,6599,B-Cell
projection,6600,6610,I-Cell
neurons,6611,6618,I-Cell
striatum,6626,6634,B-Multi-tissue_structure
Burns,6636,6641,O
et,6642,6644,O
al,6645,6647,O
1994,6650,6654,O
interaction,6660,6671,O
dopamine,6680,6688,O
glutamate,6693,6702,O
underlie,6709,6717,O
striatal,6718,6726,B-Multi-tissue_structure
processes,6727,6736,O
reward,6740,6746,O
anticipation,6747,6759,O
action,6764,6770,O
preparation,6771,6782,O
fully,6806,6811,O
excluded,6812,6820,O
alterations,6826,6837,O
neurotransmitter,6847,6863,O
systems,6864,6871,O
effect,6889,6895,O
declining,6899,6908,O
oculomotor,6909,6919,B-Multi-tissue_structure
control,6920,6927,O
remediating,6935,6946,O
incentive,6947,6956,O
effects,6957,6964,O
Non,6966,6969,O
dopaminergic,6970,6982,O
changes,6983,6990,O
noradrenergic,6999,7012,O
serotonergic,7014,7026,O
cholinergic,7032,7043,O
deafferentation,7044,7059,O
cortex,7067,7073,B-Multi-tissue_structure
occur,7079,7084,O
PD,7088,7090,O
inflict,7099,7106,O
cognitive,7107,7116,O
deficits,7117,7125,O
Agid,7127,7131,O
et,7132,7134,O
al,7135,7137,O
1987,7140,7144,O
Evidence,7147,7155,O
non,7161,7164,O
human,7165,7170,O
primates,7171,7179,O
suggests,7180,7188,O
basal,7194,7199,B-Multi-tissue_structure
ganglia,7200,7207,I-Multi-tissue_structure
dopamine,7208,7216,O
acts,7217,7221,O
speed,7225,7230,B-Multi-tissue_structure
motor,7231,7236,I-Multi-tissue_structure
responding,7237,7247,O
response,7251,7259,O
rewarding,7263,7272,O
cues,7273,7277,O
Niv,7279,7282,O
2007,7284,7288,O
Niv,7290,7293,O
et,7294,7296,O
al,7297,7299,O
2007,7302,7306,O
types,7329,7334,O
DA,7338,7340,O
receptors,7341,7350,O
mainly,7352,7358,O
D1,7359,7361,O
D2,7366,7368,O
receptors,7369,7378,O
expressed,7383,7392,O
caudate,7396,7403,B-Cell
projection,7404,7414,I-Cell
neurons,7415,7422,I-Cell
Nakamura,7424,7432,O
Hikosaka,7437,7445,O
2006,7447,7451,O
Tendencies,7454,7464,O
speed,7468,7473,O
responses,7474,7483,O
obtain,7487,7493,O
large,7494,7499,O
rewards,7500,7507,O
found,7518,7523,O
dependent,7530,7539,O
striatal,7543,7551,B-Multi-tissue_structure
D1,7552,7554,O
receptors,7555,7564,O
Dalley,7566,7572,O
et,7573,7575,O
al,7576,7578,O
2005,7581,7585,O
Berridge,7587,7595,O
2007,7597,7601,O
contrast,7607,7615,O
D1,7624,7626,O
modulated,7627,7636,O
speeding,7637,7645,O
reward,7649,7655,O
motor,7656,7661,O
tasks,7662,7667,O
evidence,7669,7677,O
saccade,7683,7690,O
tasks,7691,7696,O
non,7700,7703,O
human,7704,7709,O
primates,7710,7718,O
suggests,7719,7727,O
D2,7728,7730,O
receptor,7731,7739,O
modulation,7740,7750,O
reward,7754,7760,O
dependent,7761,7770,O
improvements,7771,7783,O
performance,7787,7798,O
Nakamura,7800,7808,O
Hikosaka,7813,7821,O
2006,7823,7827,O
Injections,7830,7840,O
D1,7846,7848,O
antagonist,7849,7859,O
D2,7866,7868,O
antagonist,7869,7879,O
region,7889,7895,O
caudate,7903,7910,B-Multi-tissue_structure
saccade,7917,7924,O
related,7925,7932,O
neurons,7933,7940,B-Cell
clustered,7945,7954,O
monkey,7965,7971,O
performed,7972,7981,O
reward,7984,7990,O
biased,7991,7997,O
saccade,7998,8005,O
task,8006,8010,O
showed,8011,8017,O
D1,8023,8025,O
antagonists,8026,8037,O
attenuate,8038,8047,O
reward,8052,8058,O
modulation,8059,8069,O
saccade,8073,8080,O
behavior,8081,8089,O
D2,8098,8100,O
antagonists,8101,8112,O
region,8127,8133,O
enhanced,8134,8142,O
reward,8147,8153,O
dependent,8154,8163,O
changes,8164,8171,O
Future,8173,8179,O
studies,8180,8187,O
Parkinson,8191,8200,O
patients,8201,8209,O
versus,8213,8219,O
medication,8224,8234,O
provide,8242,8249,O
information,8255,8266,O
role,8274,8278,O
dopaminergic,8282,8294,O
mechanisms,8295,8305,O
remedial,8313,8321,O
effects,8322,8329,O
antisaccadic,8333,8345,O
performance,8346,8357,O
recent,8361,8367,O
study,8368,8373,O
reward,8377,8383,O
learning,8384,8392,O
Parkinson,8396,8405,O
patients,8406,8414,O
dopaminergic,8422,8434,O
medication,8435,8445,O
showed,8446,8452,O
patients,8458,8466,O
adapted,8467,8474,O
behavior,8481,8489,O
maximize,8493,8501,O
expected,8502,8510,O
reward,8511,8517,O
value,8518,8523,O
dependent,8524,8533,O
medication,8543,8553,O
status,8554,8560,O
Moustafa,8562,8570,O
et,8571,8573,O
al,8574,8576,O
2008,8579,8583,O
Whilst,8586,8592,O
dopaminergic,8597,8609,O
medication,8610,8620,O
patients,8622,8630,O
slowed,8631,8637,O
responses,8644,8653,O
avoid,8657,8662,O
low,8663,8666,O
expected,8667,8675,O
values,8676,8682,O
succeeded,8688,8697,O
speeding,8711,8719,O
responses,8720,8729,O
reward,8737,8743,O
stake,8751,8756,O
opposite,8762,8770,O
pattern,8771,8778,O
emerged,8779,8786,O
patients,8801,8809,O
medication,8818,8828,O
patients,8830,8838,O
showed,8839,8845,O
better,8846,8852,O
response,8853,8861,O
speeding,8862,8870,O
worse,8876,8881,O
response,8882,8890,O
slowing,8891,8898,O
maximize,8903,8911,O
expected,8912,8920,O
value,8921,8926,O
current,8932,8939,O
behavioral,8940,8950,O
findings,8951,8959,O
line,8967,8971,O
neuroimaging,8977,8989,O
research,8990,8998,O
showing,8999,9006,O
intact,9007,9013,O
neural,9014,9020,B-Multi-tissue_structure
representations,9021,9036,O
future,9040,9046,O
reward,9047,9053,O
aging,9061,9066,O
striatum,9067,9075,B-Multi-tissue_structure
Samanez,9077,9084,O
Larkin,9085,9091,O
et,9092,9094,O
al,9095,9097,O
2007,9100,9104,O
observation,9111,9122,O
older,9136,9141,O
adults,9142,9148,O
PD,9153,9155,O
patients,9156,9164,O
use,9169,9172,O
intact,9178,9184,O
neural,9185,9191,B-Multi-tissue_structure
representation,9192,9206,O
reward,9210,9216,O
anticipation,9217,9229,O
positive,9233,9241,O
motivational,9242,9254,O
incentive,9255,9264,O
optimize,9269,9277,O
preparatory,9284,9295,O
processes,9296,9305,O
necessarily,9314,9325,O
generalized,9329,9340,O
cognitive,9344,9353,O
contexts,9354,9362,O
negative,9368,9376,O
motivational,9377,9389,O
incentives,9390,9400,O
Samanez,9402,9409,O
Larkin,9410,9416,O
et,9417,9419,O
al,9420,9422,O
2010,9424,9428,O
recently,9430,9438,O
showed,9439,9445,O
older,9451,9456,O
adults,9457,9463,O
able,9473,9477,O
optimally,9481,9490,O
use,9491,9494,O
intact,9501,9507,O
neural,9508,9514,B-Multi-tissue_structure
reward,9515,9521,O
anticipation,9522,9534,O
system,9535,9541,O
risky,9545,9550,O
financial,9551,9560,O
decision,9561,9569,O
making,9570,9576,O
Elderly,9578,9585,O
suboptimal,9596,9606,O
choices,9607,9614,O
choose,9633,9639,O
risky,9640,9645,O
assets,9646,9652,O
authors,9658,9665,O
deemed,9666,9672,O
likely,9676,9682,O
decrements,9694,9704,O
value,9708,9713,O
based,9714,9719,O
decision,9720,9728,O
making,9729,9735,O
explained,9740,9749,O
fact,9757,9761,O
value,9767,9772,O
based,9773,9778,O
decision,9779,9787,O
making,9788,9794,O
requires,9795,9803,O
weighting,9808,9817,O
behavioral,9821,9831,O
alternatives,9832,9844,O
lead,9855,9859,O
gain,9870,9874,O
loss,9878,9882,O
anticipation,9891,9903,O
rewards,9907,9914,O
older,9915,9920,O
adults,9921,9927,O
similar,9933,9940,O
neural,9941,9947,B-Multi-tissue_structure
responses,9948,9957,O
young,9961,9966,O
adults,9967,9973,O
reduced,9988,9995,O
neural,9996,10002,B-Multi-tissue_structure
activation,10003,10013,O
anticipation,10025,10037,O
losses,10041,10047,O
Samanez,10049,10056,O
Larkin,10057,10063,O
et,10064,10066,O
al,10067,10069,O
2007,10072,10076,O
observation,10109,10120,O
older,10126,10131,O
adults,10132,10138,O
tend,10139,10143,O
shift,10147,10152,O
attention,10159,10168,O
away,10169,10173,O
negative,10179,10187,O
stimuli,10188,10195,O
attend,10200,10206,O
positive,10210,10218,O
information,10219,10230,O
instead,10231,10238,O
Mather,10240,10246,O
Carstensen,10251,10261,O
2003,10263,10267,O
2005,10269,10273,O
led,10285,10288,O
underestimation,10296,10311,O
loss,10315,10319,O
risky,10342,10347,O
suboptimal,10352,10362,O
decisions,10363,10372,O
respect,10382,10389,O
limitation,10395,10405,O
current,10413,10420,O
task,10421,10425,O
built,10437,10442,O
solely,10443,10449,O
reward,10453,10459,O
prospect,10460,10468,O
prospect,10484,10492,O
loss,10496,10500,O
question,10516,10524,O
anticipation,10536,10548,O
loss,10552,10556,O
influences,10557,10567,O
action,10568,10574,O
preparation,10575,10586,O
tested,10595,10601,O
impact,10607,10613,O
negative,10617,10625,O
incentives,10626,10636,O
intriguing,10649,10659,O
question,10660,10668,O
future,10673,10679,O
research,10680,10688,O
decreased,10704,10713,O
activation,10714,10724,O
neural,10732,10738,B-Multi-tissue_structure
loss,10739,10743,O
anticipation,10744,10756,O
system,10757,10763,O
Samanez,10765,10772,O
Larkin,10773,10779,O
et,10780,10782,O
al,10783,10785,O
2007,10788,10792,O
observed,10812,10820,O
differential,10821,10833,O
attentional,10834,10845,O
bias,10846,10850,O
negative,10855,10863,O
positive,10868,10876,O
information,10877,10888,O
Mather,10890,10896,O
Carstensen,10901,10911,O
2003,10913,10917,O
likely,10929,10935,O
negative,10941,10949,O
motivational,10950,10962,O
incentives,10963,10973,O
e,10977,10978,O
prospect,10985,10993,O
loss,10997,11001,O
different,11016,11025,O
impact,11026,11032,O
action,11036,11042,O
preparation,11043,11054,O
older,11058,11063,O
adults,11064,11070,O
young,11083,11088,O
Future,11090,11096,O
approaches,11097,11107,O
effect,11115,11121,O
loss,11125,11129,O
anticipation,11130,11142,O
declining,11146,11155,O
antisaccade,11156,11167,O
control,11168,11175,O
ideally,11180,11187,O
contain,11188,11195,O
sequence,11198,11206,O
experiments,11210,11221,O
starting,11223,11231,O
separate,11239,11247,O
punishment,11249,11259,O
approach,11266,11274,O
moving,11282,11288,O
combined,11292,11300,O
reward,11301,11307,O
punishment,11308,11318,O
designs,11319,11326,O
necessary,11342,11351,O
previous,11355,11363,O
evidence,11364,11372,O
healthy,11379,11386,O
young,11387,11392,O
adults,11393,11399,O
suggests,11401,11409,O
reward,11419,11425,O
effect,11426,11432,O
oculomotor,11436,11446,B-Multi-tissue_structure
control,11447,11454,O
disappears,11455,11465,O
presence,11473,11481,O
punishment,11485,11495,O
trials,11496,11502,O
authors,11508,11515,O
deemed,11516,11522,O
likely,11526,11532,O
participants,11542,11554,O
increased,11555,11564,O
caution,11565,11572,O
incentive,11580,11589,O
reward,11591,11597,O
punishment,11602,11612,O
trials,11614,11620,O
Blaukopf,11622,11630,O
DiGirolamo,11635,11645,O
2006,11647,11651,O
age,11665,11668,O
related,11669,11676,O
changes,11677,11684,O
neural,11688,11694,B-Multi-tissue_structure
reward,11695,11701,O
anticipation,11702,11714,O
mainly,11720,11726,O
studied,11732,11739,O
isolation,11743,11752,O
Recently,11754,11762,O
interaction,11776,11787,O
neural,11791,11797,B-Multi-tissue_structure
reward,11798,11804,O
processing,11805,11815,O
cognitive,11827,11836,O
functions,11837,11846,O
underlying,11857,11867,O
neural,11868,11874,B-Anatomical_system
systems,11875,11882,I-Anatomical_system
action,11896,11902,B-Anatomical_system
control,11903,11910,I-Anatomical_system
system,11911,11917,I-Anatomical_system
gained,11923,11929,O
increasing,11930,11940,O
interest,11941,11949,O
Haber,11951,11956,O
Knutson,11961,11968,O
2010,11970,11974,O
Initial,11977,11984,O
evidence,11985,11993,O
suggests,11994,12002,O
coordinated,12003,12014,O
activity,12015,12023,O
distant,12032,12039,O
brain,12040,12045,B-Organ
regions,12046,12053,O
responsible,12054,12065,O
reward,12070,12076,O
processing,12077,12087,O
Cohen,12089,12094,O
et,12095,12097,O
al,12098,12100,O
2009,12103,12107,O
current,12114,12121,O
results,12122,12129,O
encourage,12130,12139,O
neural,12148,12154,B-Multi-tissue_structure
network,12155,12162,I-Multi-tissue_structure
investigations,12163,12177,O
role,12185,12189,O
coordinated,12193,12204,O
brain,12205,12210,B-Organ
network,12211,12218,O
activity,12219,12227,O
motivated,12231,12240,O
behavior,12241,12249,O
Behavioral,12251,12261,O
benefits,12262,12270,O
motivation,12276,12286,O
associated,12296,12306,O
changes,12312,12319,O
functional,12323,12333,O
brain,12334,12339,B-Organ
connectivity,12340,12352,O
larger,12358,12364,O
scale,12365,12370,O
e,12372,12373,O
g,12374,12375,O
frontostriatal,12386,12400,B-Multi-tissue_structure
reward,12401,12407,O
action,12412,12418,O
preparation,12419,12430,O
structures,12431,12441,O
important,12451,12460,O
factor,12461,12467,O
emerges,12473,12480,O
present,12490,12497,O
previous,12502,12510,O
results,12511,12518,O
importance,12527,12537,O
training,12545,12553,O
motivational,12561,12573,O
aspects,12574,12581,O
instructions,12589,12601,O
need,12607,12611,O
kept,12618,12622,O
working,12626,12633,O
memory,12634,12640,O
performing,12646,12656,O
cognitive,12659,12668,O
task,12669,12673,O
Samanez,12675,12682,O
Larkin,12683,12689,O
et,12690,12692,O
al,12693,12695,O
2007,12698,12702,O
found,12704,12709,O
intact,12710,12716,O
neural,12717,12723,B-Multi-tissue_structure
reward,12724,12730,O
anticipation,12731,12743,O
processes,12744,12753,O
specifically,12754,12766,O
absence,12774,12781,O
learning,12785,12793,O
learning,12805,12813,O
process,12814,12821,O
reward,12825,12831,O
cue,12832,12835,O
reward,12836,12842,O
associations,12843,12855,O
completed,12860,12869,O
important,12894,12903,O
researchers,12908,12919,O
experiments,12926,12937,O
motivation,12943,12953,O
based,12954,12959,O
instructions,12960,12972,O
mind,12984,12988,O
compared,12995,13003,O
young,13007,13012,O
adults,13013,13019,O
elderly,13021,13028,O
PD,13033,13035,O
patients,13036,13044,O
generally,13049,13058,O
hampered,13059,13067,O
stimulus,13071,13079,O
response,13080,13088,O
learning,13089,13097,O
Shohamy,13099,13106,O
et,13107,13109,O
al,13110,13112,O
2004,13115,13119,O
Marschner,13121,13130,O
et,13131,13133,O
al,13134,13136,O
2005,13139,13143,O
Reward,13146,13152,O
instruction,13153,13164,O
cues,13165,13169,O
current,13196,13203,O
study,13204,13209,O
require,13210,13217,O
participants,13218,13230,O
form,13234,13238,O
reward,13239,13245,O
cue,13246,13249,O
reward,13250,13256,O
associations,13257,13269,O
Impairments,13271,13282,O
learning,13290,13298,O
associations,13302,13314,O
cue,13327,13330,O
signaling,13331,13340,O
reward,13341,13347,O
actual,13356,13362,O
reward,13363,13369,O
conceal,13376,13383,O
intact,13384,13390,O
reward,13391,13397,O
anticipation,13398,13410,O
processes,13411,13420,O
formation,13431,13440,O
associations,13444,13456,O
weakened,13460,13468,O
appear,13479,13485,O
failure,13491,13498,O
capitalize,13502,13512,O
neural,13520,13526,B-Multi-tissue_structure
reward,13527,13533,O
anticipation,13534,13546,O
system,13547,13553,O
represents,13566,13576,O
indirect,13580,13588,O
effect,13589,13595,O
non,13599,13602,O
available,13603,13612,O
reward,13613,13619,O
associations,13620,13632,O
working,13636,13643,O
memory,13644,13650,O
preparing,13656,13665,O
response,13670,13678,O
circumvent,13697,13707,O
effect,13712,13718,O
potential,13722,13731,O
learning,13732,13740,O
impairments,13741,13752,O
reward,13756,13762,O
anticipation,13763,13775,O
processes,13776,13785,O
training,13793,13801,O
abstract,13805,13813,O
reward,13814,13820,O
cues,13821,13825,O
current,13837,13844,O
Samanez,13852,13859,O
Larkin,13860,13866,O
s,13867,13868,O
study,13869,13874,O
explicit,13888,13896,O
concrete,13901,13909,O
rewards,13910,13917,O
learning,13928,13936,O
reward,13940,13946,O
cues,13947,13951,O
accomplished,13955,13967,O
intact,13972,13978,O
reward,13979,13985,O
anticipation,13986,13998,O
processes,13999,14008,O
evident,14022,14029,O
sum,14034,14037,O
results,14043,14050,O
confirmed,14051,14060,O
preparation,14070,14081,O
goal,14085,14089,O
directed,14090,14098,O
actions,14099,14106,O
declined,14107,14115,O
PD,14119,14121,O
patients,14122,14130,O
compared,14131,14139,O
healthy,14143,14150,O
seniors,14151,14158,O
healthy,14167,14174,O
seniors,14175,14182,O
compared,14183,14191,O
young,14195,14200,O
adults,14201,14207,O
deterioration,14224,14237,O
dopaminergic,14241,14253,O
striatal,14254,14262,B-Multi-tissue_structure
circuitry,14263,14272,O
antisaccade,14274,14285,O
performance,14286,14297,O
subject,14301,14308,O
decline,14312,14319,O
healthy,14323,14330,O
seniors,14331,14338,O
individuals,14357,14368,O
Parkinson,14374,14383,O
s,14384,14385,O
disease,14386,14393,O
prospect,14399,14407,O
future,14411,14417,O
reward,14418,14424,O
provided,14433,14441,O
motivational,14444,14456,O
incentive,14457,14466,O
optimizing,14471,14481,O
oculomotor,14482,14492,B-Multi-tissue_structure
preparation,14493,14504,O
groups,14512,14518,O
alike,14519,14524,O
results,14532,14539,O
suggest,14540,14547,O
reward,14553,14559,O
processing,14560,14570,O
networks,14571,14579,O
oculomotor,14584,14594,B-Multi-tissue_structure
control,14595,14602,I-Multi-tissue_structure
networks,14603,14611,I-Multi-tissue_structure
brain,14619,14624,B-Organ
connected,14629,14638,O
way,14649,14652,O
presumably,14654,14664,O
dorsal,14674,14680,B-Multi-tissue_structure
striatum,14681,14689,I-Multi-tissue_structure
common,14695,14701,O
nexus,14702,14707,O
reward,14714,14720,O
anticipation,14721,14733,O
facilitate,14738,14748,O
oculomotor,14749,14759,B-Multi-tissue_structure
control,14760,14767,O
alleviate,14772,14781,O
deficiencies,14786,14798,O
experienced,14799,14810,O
healthy,14814,14821,O
seniors,14822,14829,O
PD,14834,14836,O
patients,14837,14845,O
Future,14847,14853,O
investigations,14854,14868,O
examine,14876,14883,O
observed,14896,14904,O
effects,14905,14912,O
specific,14917,14925,O
current,14934,14941,O
task,14942,14946,O
generalize,14950,14960,O
tasks,14970,14975,O
age,14986,14989,O
PD,14995,14997,O
related,14998,15005,O
cognitive,15006,15015,O
decrements,15016,15026,O
e,15028,15029,O
g,15030,15031,O
task,15037,15041,O
switching,15042,15051,O
related,15067,15074,O
dopaminergic,15078,15090,O
denervation,15091,15102,O
caudate,15110,15117,B-Multi-tissue_structure
e,15119,15120,O
g,15121,15122,O
impaired,15125,15133,O
verbal,15134,15140,O
episodic,15141,15149,O
memory,15150,15156,O
attention,15158,15167,O
response,15173,15181,O
inhibition,15182,15192,O
Rinne,15194,15199,O
et,15200,15202,O
al,15203,15205,O
2000,15208,15212,O
Bruck,15214,15219,O
et,15220,15222,O
al,15223,15225,O
2005,15228,15232,O
Future,15235,15241,O
studies,15242,15249,O
network,15253,15260,O
processes,15261,15270,O
help,15275,15279,O
localize,15283,15291,O
neural,15296,15302,B-Multi-tissue_structure
link,15303,15307,O
reward,15316,15322,O
prospect,15323,15331,O
action,15336,15342,O
preparation,15343,15354,O
enables,15360,15367,O
alleviating,15368,15379,O
effects,15380,15387,O
motivational,15391,15403,O
incentives,15404,15414,O
cognitive,15418,15427,O
decline,15428,15435,O
Crystal,0,7,O
data,8,12,O
C24H21ClN4O2S,13,26,O
M,27,28,O
r,29,30,O
464,33,36,O
96,37,39,O
Triclinic,40,49,O
8,56,57,O
6798,58,62,O
18,64,66,O
b,70,71,O
11,74,76,O
078,77,80,O
2,82,83,O
c,87,88,O
11,91,93,O
372,94,97,O
2,99,100,O
alpha,104,109,O
78,112,114,O
984,115,118,O
7,120,121,O
degrees,122,129,O
beta,130,134,O
81,137,139,O
867,140,143,O
10,145,147,O
degrees,148,155,O
gamma,156,161,O
81,164,166,O
718,167,170,O
11,172,174,O
degrees,175,182,O
V,183,184,O
1054,187,191,O
8,192,193,O
4,195,196,O
A3,198,200,O
Z,201,202,O
2,205,206,O
Cu,207,209,O
Kalpha,210,216,O
radiation,217,226,O
mu,227,229,O
2,232,233,O
78,234,236,O
mm,237,239,O
1,240,241,O
T,242,243,O
113,246,249,O
K,250,251,O
0,252,253,O
28,254,256,O
x,257,258,O
0,259,260,O
24,261,263,O
x,264,265,O
0,266,267,O
20,268,270,O
mm,271,273,O
Characteristics,0,15,O
fistula,19,26,B-Pathological_formation
lesions,27,34,I-Pathological_formation
Selective,0,9,O
SMA,10,13,O
angiography,14,25,O
performed,30,39,O
5,40,41,O
h,42,43,O
onset,49,54,O
therapy,63,70,O
SMA,76,79,O
completely,84,94,O
occluded,95,103,O
embolus,110,117,B-Organism_substance
proximal,125,133,O
portion,134,141,O
bolus,161,166,B-Organism_substance
infusion,167,175,O
urokinase,179,188,O
600,190,193,O
000,194,197,O
IU,198,200,O
SMA,211,214,O
peripheral,216,226,B-Organism_substance
blood,227,232,I-Organism_substance
flow,233,237,O
improved,242,250,O
thrombus,265,273,B-Organism_substance
decreased,274,283,O
size,287,291,O
remained,297,305,O
b,307,308,O
Asterisks,311,320,O
indicate,321,329,O
thrombus,330,338,B-Organism_substance
Measurement,0,11,O
IgA1,15,19,O
content,20,27,O
IgA1,28,32,O
content,33,40,O
supernatant,48,59,B-Organism_substance
culture,70,77,O
measured,87,95,O
duplicate,99,108,O
enzyme,115,121,O
linked,122,128,O
immunosorbent,129,142,O
assay,143,148,O
ELISA,150,155,O
incubations,162,173,O
performed,179,188,O
room,192,196,O
temperature,197,208,O
capture,220,227,O
antibody,228,236,O
coating,237,244,O
Briefly,246,253,O
96,255,257,O
immunoplates,263,275,O
Thermo,277,283,O
Fisher,284,290,O
Scientific,291,301,O
Waltham,303,310,O
MA,312,314,O
USA,316,319,O
coated,326,332,O
5,338,339,O
microg,340,346,O
mL,347,349,O
F,353,354,O
ab,355,357,O
2,359,360,O
fragment,361,369,O
goat,370,374,O
anti,375,379,O
human,380,385,O
IgA,386,389,O
antibody,390,398,O
Jackson,400,407,O
ImmunoResearch,408,422,O
Laboratories,423,435,O
West,437,441,O
Grove,442,447,O
PA,449,451,O
USA,453,456,O
phosphate,462,471,O
buffered,472,480,O
saline,481,487,O
PBS,489,492,O
4degreesC,497,506,O
overnight,507,516,O
washes,530,536,O
PBS,542,545,O
containing,546,556,O
0,557,558,O
05,559,561,O
Tween,563,568,O
20,569,571,O
PBST,573,577,O
plates,580,586,O
blocked,592,599,O
adding,603,609,O
PBS,610,613,O
containing,614,624,O
1,625,626,O
bovine,628,634,O
serum,635,640,B-Organism_substance
albumin,641,648,O
BSA,650,653,O
wells,662,667,O
90,672,674,O
min,675,678,O
50,686,688,O
microL,689,695,O
supernatant,699,710,B-Organism_substance
sample,711,717,I-Organism_substance
standard,721,729,O
human,730,735,O
IgA1,736,740,O
CALBIOCHEM,742,752,O
La,754,756,O
Jolla,757,762,O
USA,768,771,O
added,777,782,O
reaction,790,798,O
wells,799,804,O
incubated,814,823,O
90,828,830,O
min,831,834,O
washes,848,854,O
0,856,857,O
75,858,860,O
microg,861,867,O
mL,868,870,O
alkaline,871,879,O
phosphatase,880,891,O
conjugated,892,902,O
goat,903,907,O
anti,908,912,O
human,913,918,O
IgA,919,922,O
Southern,924,932,O
Biotechnology,933,946,O
Associates,947,957,O
Birmingham,959,969,O
AL,971,973,O
USA,975,978,O
1,983,984,O
BSA,986,989,O
PBS,990,993,O
added,998,1003,O
reaction,1011,1019,O
wells,1020,1025,O
incubated,1035,1044,O
90,1049,1051,O
min,1052,1055,O
Plates,1057,1063,O
washed,1069,1075,O
times,1082,1087,O
developed,1092,1101,O
substrate,1109,1118,O
solution,1119,1127,O
1,1131,1132,O
mg,1133,1135,O
mL,1136,1138,O
p,1139,1140,O
nitrophenyl,1141,1152,O
phosphate,1153,1162,O
disodium,1163,1171,O
salt,1172,1176,O
SIGMA,1178,1183,O
St,1185,1187,O
Louis,1189,1194,O
MO,1196,1198,O
USA,1200,1203,O
0,1208,1209,O
1,1210,1211,O
M,1212,1213,O
glycine,1214,1221,O
buffer,1222,1228,O
containing,1229,1239,O
1,1240,1241,O
mM,1242,1244,O
MgCl2,1245,1250,O
1,1252,1253,O
mM,1254,1256,O
ZnCl2,1257,1262,O
pH,1264,1266,O
10,1267,1269,O
4,1270,1271,O
optical,1277,1284,O
density,1285,1292,O
405,1296,1299,O
nm,1300,1302,O
determined,1307,1317,O
microplate,1323,1333,O
reader,1334,1340,O
Benchmark,1342,1351,O
PlusTM,1352,1358,O
Bio,1359,1362,O
Rad,1363,1366,O
Laboratories,1367,1379,O
Hercules,1381,1389,O
USA,1395,1398,O
IgA1,1401,1405,O
concentration,1406,1419,O
unknown,1423,1430,O
duplicate,1431,1440,O
samples,1441,1448,O
determined,1453,1463,O
interpolation,1467,1480,O
respective,1488,1498,O
optical,1499,1506,O
density,1507,1514,O
appropriate,1524,1535,O
standard,1536,1544,O
curve,1545,1550,O
IgG,1552,1555,O
IgM,1560,1563,O
contents,1564,1572,O
supernatant,1580,1591,B-Organism_substance
measured,1597,1605,O
sandwich,1612,1620,O
ELISA,1621,1626,O
IMMUNOtek,1628,1637,O
R,1638,1639,O
ZeptoMetrix,1642,1653,O
Corporation,1654,1665,O
Buffalo,1667,1674,O
NY,1676,1678,O
USA,1680,1683,O
according,1685,1694,O
manufacturer,1702,1714,O
s,1715,1716,O
instructions,1717,1729,O
thickness,4,13,O
inner,21,26,B-Multi-tissue_structure
retina,27,33,I-Multi-tissue_structure
established,38,49,O
distance,57,65,O
retinal,74,81,B-Tissue
nerve,82,87,I-Tissue
fiber,88,93,I-Tissue
layer,94,99,I-Tissue
inner,104,109,B-Tissue
nuclear,110,117,I-Tissue
layer,118,123,I-Tissue
measured,132,140,O
1,151,152,O
000,153,156,O
mum,157,160,O
caliper,161,168,O
available,169,178,O
OCT,186,189,O
SLO,190,193,O
Spectralis,194,204,O
age,210,213,O
matched,214,221,O
normal,222,228,O
eyes,229,233,B-Organ
controls,247,255,O
Observe,257,264,O
decrease,269,277,O
nasal,285,290,B-Organism_subdivision
temporal,295,303,O
inner,304,309,B-Multi-tissue_structure
retinal,310,317,I-Multi-tissue_structure
thickness,318,327,O
right,335,340,O
eye,341,344,B-Organ
comparison,348,358,O
left,366,370,O
normal,375,381,O
control,382,389,O
eyes,390,394,B-Organ
Real,0,4,O
time,5,9,O
RT,10,12,O
PCR,13,16,O
RNA,17,20,O
extraction,21,31,O
real,36,40,O
time,41,45,O
RT,46,48,O
PCR,49,52,O
performed,58,67,O
described,74,83,O
previously,84,94,O
22,96,98,O
sequences,105,114,O
ABCG2,118,123,O
primers,124,131,O
5,136,137,O
GGCTTTCTACCTGCACGAAAACCAGTTGAG,139,169,O
3,170,171,O
forward,174,181,O
5,187,188,O
ATGGCGTTGAGACCAG,190,206,O
3,207,208,O
reverse,211,218,O
sequences,225,234,O
GAPDH,238,243,O
primers,244,251,O
5,256,257,O
AAGGACTCATGACCACAGTCCAT,259,282,O
3,283,284,O
forward,287,294,O
5,300,301,O
CCATCACGCCACAGTTTCC,303,322,O
3,323,324,O
reverse,327,334,O
relative,341,349,O
ABCG2,350,355,O
RNA,356,359,O
level,360,365,O
2DeltaCT,367,375,O
treated,377,384,O
inhibitors,390,400,O
expressed,405,414,O
percentage,418,428,O
control,436,443,O
presence,452,460,O
0,464,465,O
1,466,467,O
DMSO,469,473,O
DeltaCT,481,488,O
threshold,490,499,O
cycle,500,505,O
CTABCG2,510,517,O
CTGAPDH,518,525,O
Introduction,0,12,O
Adipose,13,20,B-Tissue
tissue,21,27,I-Tissue
viewed,34,40,O
simply,44,50,O
storage,53,60,O
release,65,72,O
depot,73,78,O
lipids,83,89,O
considered,98,108,O
endocrine,112,121,B-Tissue
tissue,122,128,I-Tissue
1,130,131,O
2,132,133,O
secretes,140,148,O
substances,157,167,O
adipokines,169,179,O
including,182,191,O
tumor,192,197,O
necrosis,198,206,O
factor,207,213,O
alpha,214,219,O
TNF,221,224,O
alpha,225,230,O
interleukin,233,244,O
IL,246,248,O
6,250,251,O
leptin,253,259,O
adiponectin,261,272,O
resistin,274,282,O
visfatin,284,292,O
omenetin,298,306,O
3,308,309,O
4,310,311,O
adipokines,326,336,O
attention,343,352,O
paid,362,366,O
adiponectin,370,381,O
s,382,383,O
relationship,384,396,O
insulin,402,409,O
sensitivity,410,421,O
glucose,426,433,O
lipid,438,443,O
metabolism,444,454,O
past,462,466,O
10,467,469,O
years,470,475,O
addition,480,488,O
adiponectin,490,501,O
known,505,510,O
exhibit,514,521,O
potent,522,528,O
anti,529,533,O
inflammatory,534,546,O
5,548,549,O
atheroprotective,552,568,O
6,570,571,O
antidiabetic,578,590,O
7,592,593,O
effects,595,602,O
Recent,604,610,O
findings,611,619,O
suggest,620,627,O
adiponectin,633,644,O
involved,652,660,O
pathogenesis,668,680,O
rheumatoid,684,694,O
arthritis,695,704,O
RA,706,708,O
Levels,711,717,O
adiponectin,721,732,O
synovial,736,744,B-Organism_substance
fluid,745,750,I-Organism_substance
sera,755,759,B-Organism_substance
elevated,765,773,O
patients,777,785,O
RA,791,793,O
8,795,796,O
9,797,798,O
Adiponectin,801,812,O
induces,818,825,O
production,830,840,O
proinflammatory,844,859,O
cytokines,860,869,O
IL,871,873,O
6,874,875,O
matrix,877,883,O
metalloproteinase,884,901,O
MMP,903,906,O
1,908,909,O
IL,915,917,O
8,918,919,O
RA,925,927,O
synovial,928,936,B-Cell
fibroblasts,937,948,I-Cell
vitro,952,957,O
10,959,961,O
11,962,964,O
suggested,980,989,O
adiponectin,995,1006,O
exert,1016,1021,O
significant,1022,1033,O
proinflammatory,1034,1049,O
matrix,1054,1060,O
degrading,1061,1070,O
effects,1071,1078,O
role,1093,1097,O
adiponectin,1101,1112,O
pathogenesis,1120,1132,O
RA,1136,1138,O
controversial,1148,1161,O
conflicting,1173,1184,O
reports,1185,1192,O
function,1203,1211,O
10,1213,1215,O
12,1216,1218,O
15,1219,1221,O
particular,1227,1237,O
adiponectin,1239,1250,O
play,1260,1264,O
anti,1268,1272,O
inflammatory,1273,1285,O
role,1286,1290,O
significantly,1302,1315,O
inhibited,1316,1325,O
IL,1326,1328,O
1beta,1329,1334,O
stimulated,1335,1345,O
synovial,1346,1354,B-Cell
cell,1355,1359,I-Cell
proliferation,1360,1373,O
collagen,1377,1385,O
induced,1386,1393,O
arthritic,1394,1403,O
mice,1404,1408,O
despite,1410,1417,O
increased,1418,1427,O
IL,1428,1430,O
6,1431,1432,O
expression,1433,1443,O
16,1445,1447,O
contrast,1453,1461,O
high,1463,1467,O
grade,1468,1473,O
inflammation,1474,1486,O
RA,1490,1492,O
patients,1493,1501,O
negatively,1506,1516,O
correlated,1517,1527,O
circulating,1533,1544,O
adiponectin,1545,1556,O
concentrations,1557,1571,O
17,1573,1575,O
suggested,1593,1602,O
circulating,1608,1619,O
adiponectin,1620,1631,O
involved,1639,1647,O
cardiovascular,1651,1665,B-Multi-tissue_structure
disease,1666,1673,O
RA,1677,1679,O
patients,1680,1688,O
contradiction,1704,1717,O
partly,1722,1728,O
explained,1729,1738,O
induction,1746,1755,O
tolerance,1759,1768,O
inflammatory,1772,1784,O
stimuli,1785,1792,O
adiponectin,1796,1807,O
18,1809,1811,O
pro,1818,1821,O
anti,1826,1830,O
inflammatory,1831,1843,O
effects,1844,1851,O
adiponectin,1855,1866,O
pathogenesis,1874,1886,O
RA,1890,1892,O
remain,1893,1899,O
unknown,1900,1907,O
regard,1914,1920,O
adiponectin,1924,1935,O
s,1936,1937,O
proinflammatory,1938,1953,O
effects,1954,1961,O
wondered,1966,1974,O
adiponectin,1983,1994,O
stimulate,2001,2010,O
production,2015,2025,O
vascular,2029,2037,O
endothelial,2038,2049,O
growth,2050,2056,O
factor,2057,2063,O
VEGF,2065,2069,O
MMPs,2075,2079,O
proinflammatory,2091,2106,O
mediators,2107,2116,O
like,2117,2121,O
IL,2122,2124,O
1beta,2125,2130,O
TNF,2135,2138,O
alpha,2139,2144,O
study,2157,2162,O
investigated,2167,2179,O
stimulatory,2184,2195,O
effect,2196,2202,O
adiponectin,2206,2217,O
production,2225,2235,O
IL,2239,2241,O
6,2242,2243,O
IL,2245,2247,O
8,2248,2249,O
prostaglandin,2251,2264,O
E2,2265,2267,O
PGE2,2269,2273,O
VEGF,2276,2280,O
MMPs,2286,2290,O
addition,2295,2303,O
correlation,2309,2320,O
adiponectin,2329,2340,O
VEGF,2345,2349,O
MMPs,2353,2357,O
investigated,2362,2374,O
measuring,2378,2387,O
levels,2392,2398,O
proteins,2414,2422,O
joint,2430,2435,B-Organism_substance
fluid,2436,2441,I-Organism_substance
patients,2445,2453,O
RA,2459,2461,O
osteoarthritis,2465,2479,O
OA,2481,2483,O
Refinement,0,10,O
H,15,16,O
atoms,17,22,O
positioned,28,38,O
geometrically,39,52,O
O,54,55,O
H,56,57,O
0,60,61,O
82,62,64,O
C,66,67,O
H,68,69,O
0,72,73,O
93,74,76,O
included,89,97,O
refinement,105,115,O
riding,123,129,O
model,130,135,O
approximation,136,149,O
Uiso,156,160,O
H,161,162,O
xUeq,166,170,O
C,171,172,O
O,174,175,O
x,184,185,O
1,188,189,O
2,190,191,O
H,200,201,O
atoms,202,207,O
Reagents,0,8,O
antibodies,13,23,O
Maxisorp,24,32,O
strips,33,39,O
NunC,41,45,O
Roskilde,47,55,O
Denmark,57,64,O
GST,67,70,O
PNMA2,71,76,O
recombinant,77,88,O
protein,89,96,O
Abnova,98,104,O
Taipei,106,112,O
Taiwan,114,120,O
3,123,124,O
3,125,126,O
5,128,129,O
5,130,131,O
tetramethylbenzidine,132,152,O
TMB,154,157,O
substrate,161,170,O
Dako,172,176,O
Glostrup,178,186,O
Denmark,188,195,O
Peroxidase,198,208,O
dakocytomation,214,228,O
peroxidase,229,239,O
block,240,245,O
Dako,247,251,O
Dakocytomation,254,268,O
envision,269,277,O
R,278,279,O
system,281,287,O
labeled,288,295,O
polymer,296,303,O
HRP,304,307,O
anti,308,312,O
rabbit,313,319,O
kit,320,323,O
3,328,329,O
3,330,331,O
diaminobenzidine,333,349,O
Dako,351,355,O
Mayer,358,363,O
s,364,365,O
hematoxylin,366,377,O
Histolab,379,387,O
Product,388,395,O
AB,396,398,O
Gothenburg,400,410,O
Sweden,412,418,O
Graded,421,427,O
alcohol,428,435,O
Kemetyl,437,444,O
Vestby,446,452,O
Norway,454,460,O
Xylen,463,468,O
Solveco,470,477,O
Rosersberg,479,489,O
Sweden,491,497,O
Pertex,500,506,O
R,507,508,O
Histolab,511,519,O
Gothenburg,521,531,O
Sweden,533,539,O
Tris,542,546,O
Glycine,547,554,O
blotting,555,563,O
buffer,564,570,O
Amresco,572,579,O
Solon,581,586,O
OH,588,590,O
Western,593,600,O
blotting,601,609,O
WB,611,613,O
reagent,615,622,O
Lumi,627,631,O
Light,632,637,O
WB,638,640,O
substrate,641,650,O
Roche,652,657,O
Basel,659,664,O
Switzerland,666,677,O
EasyTag,680,687,O
Methionine,688,698,O
L,699,700,O
35S,701,704,O
NEG709A005MC,706,718,O
PerkinElmer,720,731,O
Waltham,733,740,O
MA,742,744,O
length,752,758,O
cDNA,759,763,O
clone,764,769,O
human,774,779,O
PNMA2,780,785,O
ID6580976,787,796,O
BioScience,798,808,O
Geneservice,809,820,O
Cambridge,822,831,O
UK,833,835,O
TnT,838,841,O
R,842,843,O
SP6,845,848,O
Quick,849,854,O
Coupled,855,862,O
Transcription,863,876,O
Translation,877,888,O
System,889,895,O
Promega,897,904,O
Madison,906,913,O
WI,915,917,O
Protein,920,927,O
G,928,929,O
Sepharose,930,939,O
beads,940,945,O
GE,947,949,O
Healthcare,950,960,O
Little,962,968,O
Chalfont,969,977,O
Buckinghamshire,979,994,O
UK,996,998,O
Peroxidase,1001,1011,O
HRP,1013,1016,O
conjugated,1018,1028,O
rabbit,1029,1035,O
anti,1036,1040,O
human,1041,1046,O
IgG,1047,1050,O
anti,1052,1056,O
IgG,1057,1060,O
Dako,1063,1067,O
rabbit,1070,1076,O
polyclonal,1077,1087,O
antibody,1088,1096,O
anti,1097,1101,O
PNMA2,1102,1107,O
Atlas,1109,1114,O
Antibodies,1115,1125,O
Stockholm,1127,1136,O
Sweden,1138,1144,O
monoclonal,1147,1157,O
mouse,1158,1163,O
anti,1164,1168,O
GST,1169,1172,O
sc,1174,1176,O
138,1177,1180,O
polyclonal,1182,1192,O
goat,1193,1197,O
anti,1198,1202,O
human,1203,1208,O
Ma2,1209,1212,O
sc,1214,1216,O
68099,1217,1222,O
HRP,1224,1227,O
donkey,1228,1234,O
anti,1235,1239,O
goat,1240,1244,O
sc,1246,1248,O
2020,1249,1253,O
Santa,1256,1261,O
Cruz,1262,1266,O
Biotechnology,1267,1280,O
Santa,1282,1287,O
Cruz,1288,1292,O
HRP,1299,1302,O
goat,1303,1307,O
anti,1308,1312,O
rabbit,1313,1319,O
P0448,1321,1326,O
Dako,1329,1333,O
Ravo,1339,1343,O
PNS,1344,1347,O
Blot,1348,1352,O
Ravo,1355,1359,O
Diagnostika,1360,1371,O
GmbH,1372,1376,O
Freiburg,1378,1386,O
Germany,1388,1395,O
Statistical,0,11,O
analysis,12,20,O
statistical,25,36,O
analyses,37,45,O
performed,51,60,O
SPSS13,67,73,O
0,74,75,O
software,76,84,O
differences,90,101,O
groups,110,116,O
compared,122,130,O
Student,137,144,O
s,145,146,O
t,147,148,O
test,149,153,O
data,159,163,O
expressed,169,178,O
mean,182,186,O
SD,191,193,O
Statistical,195,206,O
difference,207,217,O
accepted,222,230,O
P,234,235,O
0,236,237,O
05,238,240,O
importance,4,14,O
identifying,18,29,O
genes,30,35,O
involved,36,44,O
spinal,48,54,B-Organism_subdivision
curvature,55,64,O
Spinal,65,71,B-Organism_subdivision
curvature,72,81,O
prevalent,87,96,O
costly,101,107,O
deformity,108,117,O
humans,124,130,O
teleosts,135,143,O
estimated,149,158,O
annual,159,165,O
cost,166,170,O
treating,174,182,O
children,183,191,O
hospitalized,192,204,O
idiopathic,210,220,O
scoliosis,221,230,O
United,243,249,O
States,250,256,O
3,272,273,O
billion,274,281,O
cost,288,292,O
estimate,293,301,O
consider,311,319,O
Scheuermann,320,331,O
kyphosis,332,340,O
adults,345,351,O
idiopathic,357,367,O
type,368,372,O
spinal,373,379,B-Organism_subdivision
curvature,380,389,O
suffer,394,400,O
chronic,406,413,O
pain,419,423,O
contributing,425,437,O
estimated,445,454,O
849,456,459,O
billion,460,467,O
cost,468,472,O
treatment,476,485,O
lost,490,494,O
wages,495,500,O
associated,501,511,O
musculoskeletal,517,532,B-Anatomical_system
disease,533,540,O
24,542,544,O
teleosts,553,561,O
spinal,563,569,B-Organism_subdivision
column,570,576,I-Organism_subdivision
deformities,577,588,O
reduce,589,595,O
total,596,601,O
production,602,612,O
aquaculture,620,631,O
industry,632,640,O
substantially,641,654,O
12,656,658,O
contrast,664,672,O
humans,676,682,O
teleost,684,691,O
curve,692,697,O
phenotypes,698,708,O
characterized,723,736,O
heritable,747,756,O
curves,757,763,O
acknowledged,768,780,O
account,784,791,O
cases,801,806,O
cultured,813,821,O
stocks,822,828,O
cases,844,849,O
congenital,859,869,O
defects,870,877,O
idiopathic,885,895,O
type,896,900,O
known,914,919,O
Despite,921,928,O
prevalence,933,943,O
impact,948,954,O
type,963,967,O
deformity,971,980,O
genetic,986,993,O
architecture,994,1006,O
specific,1011,1019,O
genes,1020,1025,O
involved,1026,1034,O
unknown,1039,1046,O
current,1052,1059,O
view,1060,1064,O
human,1073,1078,O
idiopathic,1079,1089,O
type,1090,1094,O
scoliosis,1095,1104,O
complex,1110,1117,O
genetic,1118,1125,O
disorder,1126,1134,O
multiple,1140,1148,O
genes,1149,1154,O
segregating,1155,1166,O
population,1174,1184,O
exhibiting,1185,1195,O
complex,1196,1203,O
genotype,1204,1212,O
environment,1216,1227,O
interactions,1228,1240,O
25,1242,1244,O
30,1245,1247,O
aquaculture,1253,1264,O
stocks,1265,1271,O
inheritance,1273,1284,O
spinal,1289,1295,B-Organism_subdivision
curvature,1296,1305,O
described,1315,1324,O
Mendelian,1328,1337,O
recessive,1338,1347,O
dominant,1351,1359,O
polygenic,1372,1381,O
depending,1383,1392,O
phenotype,1409,1418,O
characterized,1422,1435,O
stock,1445,1450,O
considered,1454,1464,O
reviewed,1466,1474,O
13,1479,1481,O
16,1485,1487,O
guppy,1495,1500,O
curveback,1501,1510,O
phenotype,1511,1520,O
extensively,1530,1541,O
characterized,1542,1555,O
lineage,1568,1575,O
applied,1583,1590,O
model,1596,1601,O
understanding,1606,1619,O
biological,1624,1634,O
context,1635,1642,O
heritable,1646,1655,O
spinal,1656,1662,B-Organism_subdivision
curvature,1663,1672,O
1,1674,1675,O
7,1676,1677,O
9,1678,1679,O
Future,1682,1688,O
studies,1689,1696,O
use,1701,1704,O
approaches,1705,1715,O
map,1719,1722,O
QTL,1723,1726,O
affecting,1727,1736,O
shape,1737,1742,O
based,1743,1748,O
digital,1752,1759,O
photos,1760,1766,O
31,1768,1770,O
32,1771,1773,O
qualitative,1792,1803,O
scale,1804,1809,O
present,1822,1829,O
study,1830,1835,O
identification,1841,1855,O
QTL,1859,1862,O
study,1871,1876,O
step,1888,1892,O
understanding,1896,1909,O
genetics,1914,1922,O
type,1931,1935,O
deformity,1939,1948,O
lead,1958,1962,O
identification,1970,1984,O
biological,1988,1998,O
pathways,1999,2007,O
associated,2008,2018,O
spinal,2024,2030,B-Organism_subdivision
integrity,2031,2040,O
Intact,0,6,O
mass,7,11,O
analysis,12,20,O
mixed,26,31,O
population,32,42,O
proteins,46,54,O
mixture,58,65,O
membrane,73,81,B-Cellular_component
protein,82,89,O
KCNJ12,90,96,O
soluble,102,109,O
TEV,110,113,O
protease,114,122,O
cleave,131,137,O
fusion,142,148,O
tag,149,152,O
membrane,162,170,B-Cellular_component
protein,171,178,O
HVCN1,179,184,O
occurred,192,200,O
contaminant,206,217,O
earlier,226,233,O
analysis,234,242,O
LC,255,257,O
column,258,264,O
asymmetric,4,14,O
unit,15,19,O
title,27,32,O
compound,33,41,O
atomic,51,57,O
labelling,58,67,O
scheme,68,74,O
Displacement,75,87,O
drawn,92,97,O
50,105,107,O
probability,109,120,O
level,121,126,O
H,128,129,O
atoms,130,135,O
represented,140,151,O
small,155,160,O
spheres,161,168,O
arbitrary,172,181,O
radii,182,187,O
Hydrogen,189,197,O
bonds,198,203,O
shown,208,213,O
dashed,217,223,O
lines,224,229,O
Modified,0,8,O
radiology,9,18,O
guided,19,25,O
percutaneous,26,38,O
gastrostomy,39,50,O
technique,51,60,O
21 G,65,68,O
fine,69,73,O
needle,74,80,O
punctured,81,90,O
localized,91,100,O
collection,101,111,O
air,115,118,O
visible,130,137,O
collapsed,141,150,O
stomach,151,158,B-Organ
fluoroscopy,165,176,O
guided,177,183,O
gastrostomy,184,195,O
Needle,197,203,O
tip,204,207,O
gradually,216,225,O
withdrawn,226,235,O
injecting,242,251,O
small,252,257,O
amounts,258,265,O
water,269,274,O
soluble,275,282,O
contrast,283,291,O
medium,292,298,O
Location,300,308,O
stomach,312,319,B-Organ
confirmed,323,332,O
visualization,336,349,O
opacified,353,362,O
gastric,363,370,B-Organ
rugae,371,376,O
B,378,379,O
Stomach,381,388,B-Organ
inflated,393,401,O
approximately,407,420,O
600,421,424,O
800,425,428,O
mL,429,431,O
room,435,439,O
air,440,443,O
21 G,452,455,O
fine,456,460,O
needle,461,467,O
C,469,470,O
100,472,475,O
cm,476,478,O
stainless,479,488,O
steel,489,494,O
guide,495,500,O
wire,501,505,O
inserted,509,517,O
needle,526,532,O
gastro,538,544,B-Organ
percutaneous,545,557,O
tract,558,563,O
gradually,567,576,O
dilated,577,584,O
D,586,587,O
Insertion,589,598,O
14,602,604,O
Fr,605,607,O
pigtail,608,615,O
gastrostomy,616,627,O
catheter,628,636,O
injection,641,650,O
small,654,659,O
water,670,675,O
soluble,676,683,O
contrast,684,692,O
medium,693,699,O
pigtail,704,711,O
catheter,712,720,O
confirmed,721,730,O
gastrostomy,736,747,O
catheter,748,756,O
correctly,760,769,O
placed,770,776,O
stomach,784,791,B-Organ
Loss,0,4,O
body,8,12,B-Organism_subdivision
weight,13,19,O
challenge,26,35,O
infection,36,45,O
WNV,51,54,O
Mice,56,60,O
n,62,63,O
8,66,67,O
vaccinated,74,84,O
intranasally,85,97,B-Immaterial_anatomical_entity
Flu,103,106,O
DIII,110,114,O
Flu,122,125,O
GFP,129,132,O
o,134,135,O
subcutaneous,147,159,O
route,160,165,O
respectively,176,188,O
daily,195,200,O
weights,201,208,O
animal,217,223,O
calculated,229,239,O
compared,240,248,O
respective,258,268,O
weight,269,275,O
day,283,286,O
challenge,290,299,O
data,305,309,O
shown,314,319,O
average,327,334,O
percentage,335,345,O
initial,349,356,O
weight,357,363,O
group,373,378,O
Error,380,385,O
bars,386,390,O
represent,391,400,O
standard,405,413,O
error,414,419,O
samples,428,435,O
available,436,445,O
time,454,458,O
point,459,464,O
Subsequently,466,478,O
mice,484,488,O
challenged,494,504,O
subcutaneously,505,519,O
106,525,528,O
TCID50,529,535,O
WNV,536,539,O
NY99,540,544,O
weighed,549,556,O
daily,557,562,O
mean,568,572,O
body,573,577,B-Organism_subdivision
weight,578,584,O
expressed,588,597,O
percentage,605,615,O
body,623,627,B-Organism_subdivision
weight,628,634,O
challenge,642,651,O
infection,652,661,O
survival,671,679,O
rates,680,685,O
mice,689,693,O
challenge,700,709,O
infection,710,719,O
WNV,725,728,O
NY99,729,733,O
depicted,738,746,O
Kaplan,750,756,O
Meier,757,762,O
survival,763,771,O
curves,772,778,O
B,780,781,O
difference,788,798,O
survival,802,810,O
rate,811,815,O
Flu,824,827,O
DIII,831,835,O
Flu,840,843,O
GFP,847,850,O
vaccinated,851,861,O
mice,862,866,O
statistically,871,884,O
significant,885,896,O
determined,900,910,O
logrank,918,925,O
test,926,930,O
symbols,936,943,O
respective,952,962,O
groups,963,969,O
panel,989,994,O
Representative,0,14,O
time,15,19,O
histories,20,29,O
estimated,37,46,O
SatO2,47,52,O
levels,53,59,O
normal,63,69,O
cortex,70,76,B-Multi-tissue_structure
black,78,83,O
tumor,89,94,B-Pathological_formation
grey,96,100,O
patients,115,123,O
Etymology,0,9,O
Professor,11,20,O
Stephen,21,28,O
Lane,29,33,O
Wood,34,38,O
worked,39,45,O
extensively,46,57,O
collections,61,72,O
Scolytinae,76,86,O
preserved,87,96,O
Indian,100,106,O
museums,107,114,O
described,120,129,O
number,132,138,O
new,142,145,O
Scolytinae,146,156,O
species,157,164,O
India,170,175,O
paper,185,190,O
describe,194,202,O
new,212,215,O
bark,216,220,O
beetle,221,227,O
species,228,235,O
India,241,246,O
kept,247,251,O
Natural,259,266,O
History,267,274,O
Museum,275,281,O
Vienna,285,291,O
NHMW,293,297,O
dedicate,303,311,O
species,317,324,O
late,332,336,O
Professor,337,346,O
Stephen,347,354,O
Lane,355,359,O
Wood,360,364,O
Statistics,0,10,O
survival,15,23,O
mice,27,31,O
analyzed,36,44,O
Kaplan,51,57,O
Meier,58,63,O
survival,64,72,O
analysis,73,81,O
data,93,97,O
analyzed,103,111,O
way,119,122,O
ANOVA,123,128,O
followed,130,138,O
Student,146,153,O
Newman,154,160,O
Keuls,161,166,O
test,167,171,O
pairwise,180,188,O
comparisons,189,200,O
Prior,202,207,O
ANOVA,211,216,O
Levene,218,224,O
s,225,226,O
Test,227,231,O
Equality,236,244,O
Variances,248,257,O
performed,262,271,O
statistical,277,288,O
analyses,289,297,O
performed,303,312,O
MedCalc,319,326,O
software,327,335,O
version,337,344,O
11,345,347,O
2,348,349,O
1,350,351,O
0,352,353,O
Acknowledgements,0,16,O
authors,21,28,O
gratefully,29,39,O
acknowledge,40,51,O
support,56,63,O
DRUID,67,72,O
study,73,78,O
participants,79,91,O
study,93,98,O
staff,99,104,O
members,106,113,O
Indigenous,121,131,O
Steering,132,140,O
Group,141,146,O
partner,152,159,O
organisations,160,173,O
DRUID,179,184,O
Study,185,190,O
funded,195,201,O
National,209,217,O
Health,218,224,O
Medical,229,236,O
Research,237,245,O
Council,246,253,O
NHMRC,255,260,O
Project,261,268,O
Grant,269,274,O
236207,276,282,O
additional,290,300,O
support,301,308,O
Australian,318,328,O
Government,329,339,O
Department,340,350,O
Employment,354,364,O
Workplace,369,378,O
Relations,379,388,O
Clive,394,399,O
Vera,404,408,O
Ramaciotti,409,419,O
Foundation,420,430,O
Vincent,436,443,O
Fairfax,444,451,O
Family,452,458,O
Foundation,459,469,O
International,475,488,O
Diabetes,489,497,O
Institute,498,507,O
AusDiab,509,516,O
Partnership,517,528,O
Bayer,535,540,O
HealthCare,541,551,O
DRUID,557,562,O
Study,563,568,O
kind,578,582,O
project,583,590,O
Cooperative,598,609,O
Research,610,618,O
Centre,619,625,O
Aboriginal,630,640,O
Health,641,647,O
LMB,649,652,O
NHMRC,659,664,O
Scholarship,665,676,O
2003,677,681,O
5,682,683,O
supported,691,700,O
NHMRC,704,709,O
Training,710,718,O
Fellowship,719,729,O
605837,732,738,O
NHMRC,741,746,O
320860,748,754,O
Centre,763,769,O
Clinical,773,781,O
Research,782,790,O
Excellence,791,801,O
Clinical,805,813,O
Science,814,821,O
Diabetes,825,833,O
University,835,845,O
Melbourne,849,858,O
JC,860,862,O
supported,867,876,O
NHMRC,882,887,O
Career,888,894,O
Development,895,906,O
Award,907,912,O
283310,915,921,O
NHMRC,929,934,O
Research,935,943,O
Fellowship,944,954,O
545200,957,963,O
AH,966,968,O
supported,972,981,O
NHMRC,985,990,O
Fellowship,991,1001,O
520316,1004,1010,O
Thank,1013,1018,O
Dr,1026,1028,O
Jaquelyne,1029,1038,O
Hughes,1039,1045,O
comments,1050,1058,O
manuscript,1066,1076,O
Funding,1078,1085,O
sources,1086,1093,O
played,1094,1100,O
role,1104,1108,O
study,1116,1121,O
design,1122,1128,O
collection,1137,1147,O
analysis,1149,1157,O
interpretation,1162,1176,O
data,1184,1188,O
writing,1197,1204,O
manuscript,1212,1222,O
decision,1234,1242,O
submit,1246,1252,O
manuscript,1257,1267,O
publication,1272,1283,O
Concurrent,0,10,O
disease,11,18,O
33,22,24,O
cows,25,29,O
LDA,35,38,O
Parkin,0,6,O
regulates,7,16,O
proteasomal,21,32,B-Cellular_component
degradation,33,44,O
PARIS,48,53,O
PGC,58,61,O
1alpha,62,68,O
dependent,69,78,O
mitochondrial,79,92,B-Cellular_component
biogenesis,93,103,O
Normal,109,115,O
physiological,116,129,O
conditions,130,140,O
maintain,146,154,O
mitochondrial,155,168,B-Cellular_component
homeostasis,169,180,O
PINK1,182,187,O
recruits,188,196,O
parkin,197,203,O
mitochondria,211,223,B-Cellular_component
proteins,241,249,O
interact,250,258,O
eliminate,262,271,O
abnormal,272,280,O
mitochondria,281,293,B-Cellular_component
mitophagy,302,311,O
Alterations,313,324,O
mitochondrial,328,341,B-Cellular_component
membrane,342,350,I-Cellular_component
potential,351,360,O
DeltaPsim,362,371,O
key,375,378,O
indicator,379,388,O
mitochondrial,392,405,B-Cellular_component
physiology,406,416,O
cell,421,425,B-Cell
viability,426,435,O
initiate,437,445,O
PINK1,450,455,O
parkin,456,462,O
cascade,463,470,O
events,474,480,O
lead,486,490,O
mitophagy,494,503,O
Furthermore,505,516,O
parkin,518,524,O
ubiquitylates,525,538,O
promotes,551,559,O
proteasomal,560,571,B-Cellular_component
degradation,572,583,O
PARIS,587,592,O
PARIS,602,607,O
represses,608,617,O
expression,622,632,O
PGC,636,639,O
1alpha,640,646,O
degradation,648,659,O
PARIS,663,668,O
parkin,672,678,O
allows,679,685,O
PGC,686,689,O
1alpha,690,696,O
dependent,697,706,O
gene,707,711,O
expression,712,722,O
enables,727,734,O
mitochondrial,735,748,B-Cellular_component
biogenesis,749,759,O
Parkin,761,767,O
integral,783,791,O
regulator,792,801,O
mitochondrial,805,818,B-Cellular_component
homeostasis,819,830,O
controlling,832,843,O
degradation,849,860,O
biogenesis,865,875,O
B,878,879,O
Loss,881,885,O
parkin,889,895,O
function,896,904,O
result,910,916,O
familial,920,928,O
mutations,929,938,O
case,947,951,O
AR,955,957,O
PD,958,960,O
aging,965,970,O
environmental,972,985,O
cellular,989,997,B-Cell
stress,998,1004,O
case,1013,1017,O
sporadic,1021,1029,O
PD,1030,1032,O
leads,1034,1039,O
accumulation,1047,1059,O
abnormal,1063,1071,O
mitochondria,1072,1084,B-Cellular_component
owing,1086,1091,O
faulty,1095,1101,O
mitophagy,1102,1111,O
addition,1116,1124,O
PARIS,1126,1131,O
accumulates,1132,1143,O
represses,1148,1157,O
PGC,1158,1161,O
1alpha,1162,1168,O
preventing,1170,1180,O
mitochondrial,1181,1194,B-Cellular_component
biogenesis,1195,1205,O
Loss,1207,1211,O
parkin,1215,1221,O
function,1222,1230,O
tip,1240,1243,O
balance,1248,1255,O
mitochondrial,1264,1277,B-Cellular_component
biogenesis,1278,1288,O
degradation,1293,1304,O
leads,1325,1330,O
general,1336,1343,O
breakdown,1344,1353,O
mitochondrial,1357,1370,B-Cellular_component
homeostasis,1371,1382,O
ultimately,1392,1402,O
lead,1403,1407,O
PD,1411,1413,O
4,0,1,O
2,2,3,O
Histological,5,17,O
Findings,18,26,O
Microscopy,27,37,O
revealed,38,46,O
features,47,55,O
diffusely,61,70,O
growing,71,78,O
discohesive,79,90,B-Pathological_formation
carcinoma,91,100,I-Pathological_formation
exclusively,102,113,O
growing,114,121,O
alveolar,129,137,B-Multi-tissue_structure
interstitium,138,150,I-Multi-tissue_structure
expanding,157,166,O
leaving,177,184,O
original,189,197,O
alveolar,198,206,B-Multi-tissue_structure
architecture,207,219,O
intact,220,226,O
Figure,228,234,O
2,235,236,O
local,249,254,O
ulceration,255,265,O
pleura,273,279,B-Multi-tissue_structure
ulcer,300,305,B-Pathological_formation
tumor,311,316,B-Pathological_formation
formed,317,323,O
thick,326,331,O
cake,332,336,O
discohesive,340,351,B-Cell
tumor,352,357,I-Cell
cells,358,363,I-Cell
lining,364,370,O
pleural,375,382,B-Multi-tissue_structure
membrane,383,391,I-Multi-tissue_structure
Figure,393,399,O
2,400,401,O
c,402,403,O
focal,417,422,O
microscopic,424,435,O
invasion,436,444,O
fatty,454,459,B-Tissue
tissue,460,466,I-Tissue
parietal,474,482,B-Multi-tissue_structure
pleura,483,489,I-Multi-tissue_structure
tumor,495,500,B-Pathological_formation
consisted,501,510,O
atypical,514,522,O
moderately,524,534,O
polymorphous,535,547,O
irregularly,553,564,O
shaped,565,571,O
tumor,572,577,B-Cell
cells,578,583,I-Cell
marked,589,595,O
discohesiveness,596,611,O
featured,618,626,O
scant,627,632,O
eosinophilic,633,645,B-Organism_substance
cytoplasm,646,655,I-Organism_substance
irregularly,660,671,O
contoured,672,681,O
hyperchromatic,686,700,O
nuclei,701,707,B-Cellular_component
containing,715,725,O
prominent,738,747,O
nucleoli,748,756,B-Cellular_component
Figure,758,764,O
2,765,766,O
b,767,768,O
mitoses,788,795,O
apoptoses,800,809,O
present,810,817,O
necrosis,823,831,O
observed,840,848,O
squamous,853,861,B-Cell
glandular,865,874,B-Cell
differentiation,875,890,O
observed,895,903,O
mucin,909,914,O
stains,915,921,O
PAS,923,926,O
D,927,928,O
alcian,933,939,O
blue,940,944,O
negative,951,959,O
tumor,972,977,B-Pathological_formation
multiple,990,998,O
small,999,1004,O
blood,1005,1010,B-Organism_substance
filled,1011,1017,O
clefts,1018,1024,O
blood,1029,1034,B-Organism_substance
lakes,1035,1040,O
Angioinvasion,1042,1055,O
medium,1059,1065,O
sized,1066,1071,O
vessels,1072,1079,B-Multi-tissue_structure
including,1081,1090,O
artery,1094,1100,B-Multi-tissue_structure
demonstrated,1106,1118,O
Figure,1120,1126,O
2,1127,1128,O
d,1129,1130,O
note,1137,1141,O
broadened,1147,1156,O
alveolar,1157,1165,B-Multi-tissue_structure
septa,1166,1171,I-Multi-tissue_structure
lined,1177,1182,O
markedly,1186,1194,O
atypical,1195,1203,O
epithelial,1204,1214,B-Cell
cells,1215,1220,I-Cell
atypical,1231,1239,O
interstitial,1249,1261,B-Pathological_formation
carcinoma,1262,1271,I-Pathological_formation
Figures,1273,1280,O
2,1281,1282,O
2,1290,1291,O
b,1292,1293,O
atypia,1301,1307,O
lining,1315,1321,B-Cell
cells,1322,1327,I-Cell
extended,1328,1336,O
tumor,1348,1353,B-Pathological_formation
showing,1361,1368,O
sharp,1371,1376,O
demarcation,1377,1388,O
normal,1394,1400,O
type,1401,1405,B-Cell
pneumocytes,1408,1419,I-Cell
Figure,1421,1427,O
2,1428,1429,O
feature,1437,1444,O
characteristic,1445,1459,O
nonmucinous,1463,1474,B-Pathological_formation
adenocarcinoma,1475,1489,I-Pathological_formation
situ,1493,1497,O
lepidic,1503,1510,O
growth,1511,1517,O
pattern,1518,1525,O
bronchioloalveolar,1534,1552,B-Pathological_formation
carcinoma,1553,1562,I-Pathological_formation
BAC,1564,1567,B-Pathological_formation
3,1570,1571,O
Paederus,0,8,O
dermatitis,9,19,O
involving,20,29,O
neck,34,38,B-Organism_subdivision
Introduction,0,12,O
weaning,24,31,O
period,32,38,O
transition,43,53,O
solid,57,62,O
foods,63,68,O
year,82,86,O
life,90,94,O
infants,96,103,O
critical,111,119,O
step,120,124,O
eating,134,140,O
behavior,141,149,O
need,154,158,O
meet,162,166,O
high,167,171,O
nutrient,172,180,O
requirements,181,193,O
1,195,196,O
2,198,199,O
exposed,211,218,O
new,222,225,O
foods,226,231,O
food,236,240,O
combinations,241,253,O
ensure,268,274,O
smooth,277,283,O
transition,284,294,O
family,302,308,O
diet,309,313,O
later,314,319,O
life,323,327,O
stage,337,342,O
homemade,351,359,O
commercially,363,375,O
prepared,376,384,O
foods,385,390,O
fed,398,401,O
worth,409,414,O
noting,415,421,O
prosperous,430,440,O
countries,441,450,O
modern,455,461,O
diet,462,466,O
differs,467,474,O
considerably,475,487,O
previous,501,509,O
generations,510,521,O
dominated,527,536,O
products,540,548,O
processed,564,573,O
stored,575,581,O
transported,587,598,O
great,604,609,O
distances,610,619,O
Traditional,621,632,O
cold,634,638,O
pressed,639,646,O
vegetable,647,656,B-Organism_substance
oils,657,661,I-Organism_substance
highest,669,676,O
nutritional,677,688,O
quality,689,696,O
e,698,699,O
g,700,701,O
extra,703,708,O
virgin,709,715,O
olive,716,721,O
oil,722,725,B-Organism_substance
constitute,741,751,O
important,755,764,O
modern,777,783,O
diet,784,788,O
3,790,791,O
4,793,794,O
Poland,800,806,O
infants,813,820,O
receive,828,835,O
traditional,840,851,O
homemade,852,860,O
foods,861,866,O
fruits,876,882,B-Organism_subdivision
come,883,887,O
purchased,893,902,O
jars,903,907,O
Commercial,909,919,O
baby,920,924,O
foods,925,930,O
regarded,935,943,O
parents,952,959,O
medical,964,971,O
professionals,972,985,O
appropriate,997,1008,O
reasons,1021,1028,O
undergo,1035,1042,O
intense,1043,1050,O
screening,1051,1060,O
contaminants,1065,1077,O
comparison,1081,1091,O
foods,1095,1100,O
sold,1101,1105,O
general,1114,1121,O
population,1122,1132,O
contain,1134,1141,O
additives,1145,1154,O
certain,1158,1165,O
types,1166,1171,O
thought,1181,1188,O
designed,1195,1203,O
help,1207,1211,O
infants,1212,1219,O
meet,1220,1224,O
nutrient,1225,1233,O
requirements,1234,1246,O
5,1248,1249,O
process,1256,1263,O
peeling,1267,1274,O
identified,1289,1299,O
effective,1312,1321,O
simple,1327,1333,O
procedure,1335,1344,O
reducing,1348,1356,O
residues,1357,1365,O
e,1367,1368,O
g,1369,1370,O
pesticides,1372,1382,O
fruits,1387,1393,B-Organism_subdivision
vegetables,1398,1408,B-Organism_subdivision
6,1410,1411,O
contrary,1424,1432,O
homemade,1436,1444,O
food,1445,1449,O
contain,1466,1473,O
furan,1474,1479,O
highest,1485,1492,O
average,1493,1500,O
content,1501,1508,O
chemical,1517,1525,O
found,1530,1535,O
ready,1539,1544,O
eat,1548,1551,O
baby,1552,1556,O
foods,1557,1562,O
pasta,1568,1573,O
meals,1574,1579,O
followed,1581,1589,O
vegetable,1593,1602,B-Organism_subdivision
meals,1603,1608,O
meals,1613,1618,O
meat,1624,1628,B-Organism_subdivision
7,1630,1631,O
Furan,1634,1639,O
considered,1643,1653,O
potentially,1660,1671,O
hazardous,1672,1681,O
chemical,1682,1690,O
classified,1698,1708,O
possible,1714,1722,O
carcinogen,1723,1733,O
problem,1739,1746,O
chemical,1755,1763,O
homemade,1767,1775,O
food,1776,1780,O
arise,1790,1795,O
meals,1799,1804,O
potatoes,1810,1818,O
stored,1823,1829,O
hardly,1839,1845,O
heated,1849,1855,O
7,1857,1858,O
growing,1872,1879,O
body,1880,1884,B-Organism_subdivision
evidence,1888,1896,O
flavor,1902,1908,O
experiences,1909,1920,O
dietary,1925,1932,O
patterns,1933,1941,O
childhood,1945,1954,O
influence,1955,1964,O
patterns,1971,1979,O
later,1980,1985,O
life,1989,1993,O
1,1995,1996,O
8,1998,1999,O
9,2001,2002,O
likely,2016,2022,O
early,2023,2028,O
life,2032,2036,O
culture,2042,2049,O
specific,2050,2058,O
flavor,2059,2065,O
preferences,2066,2077,O
initiated,2082,2091,O
10,2093,2095,O
11,2097,2099,O
Consequently,2102,2114,O
exposure,2116,2124,O
flavors,2128,2135,O
smells,2140,2146,O
transitory,2150,2160,O
foods,2161,2166,O
serve,2171,2176,O
heighten,2180,2188,O
preferences,2189,2200,O
known,2206,2211,O
tastes,2212,2218,O
family,2227,2233,O
diet,2234,2238,O
later,2239,2244,O
adulthood,2248,2257,O
adopting,2269,2277,O
elements,2278,2286,O
childhood,2290,2299,O
dinner,2300,2306,O
patterns,2307,2315,O
recognized,2320,2330,O
important,2340,2349,O
social,2362,2368,O
reproduction,2369,2381,O
family,2385,2391,O
identities,2392,2402,O
generations,2410,2421,O
12,2423,2425,O
Processing,2428,2438,O
industries,2439,2449,O
successful,2460,2470,O
manufacturing,2474,2487,O
marketing,2492,2501,O
jarred,2502,2508,O
baby,2509,2513,O
foods,2514,2519,O
commercial,2525,2535,O
scale,2536,2541,O
Available,2543,2552,O
products,2553,2561,O
contain,2562,2569,O
different,2570,2579,O
ingredients,2580,2591,O
depend,2596,2602,O
manufacturer,2610,2622,O
country,2624,2631,O
traditional,2633,2644,O
cuisine,2645,2652,O
income,2654,2660,O
rate,2661,2665,O
lastly,2671,2677,O
personal,2679,2687,O
beliefs,2688,2695,O
values,2700,2706,O
parents,2710,2717,O
9,2719,2720,O
11,2722,2724,O
Jarred,2727,2733,O
foods,2734,2739,O
vegetables,2745,2755,B-Organism_subdivision
meats,2757,2762,B-Organism_subdivision
desserts,2768,2776,O
contain,2781,2788,O
added,2789,2794,O
fat,2795,2798,O
variety,2806,2813,O
sources,2817,2824,O
vegetable,2826,2835,B-Organism_substance
oils,2836,2840,I-Organism_substance
cow,2842,2845,O
milk,2846,2850,B-Organism_substance
butter,2851,2857,O
cream,2862,2867,O
Manufacturer,2869,2881,O
advertising,2882,2893,O
makes,2894,2899,O
majority,2904,2912,O
consumers,2916,2925,O
feel,2926,2930,O
safe,2931,2935,O
causing,2937,2944,O
believe,2953,2960,O
best,2985,2989,O
possible,2990,2998,O
buying,3002,3008,O
given,3009,3014,O
products,3015,3023,O
11,3025,3027,O
noteworthy,3032,3042,O
fact,3043,3047,O
types,3061,3066,O
baby,3070,3074,O
foods,3075,3080,O
produced,3081,3089,O
international,3093,3106,O
manufacturers,3107,3120,O
essence,3129,3136,O
mixtures,3147,3155,O
different,3161,3170,O
names,3171,3176,O
procedure,3183,3192,O
aims,3193,3197,O
exploit,3201,3208,O
specifics,3213,3222,O
local,3226,3231,O
markets,3232,3239,O
delivering,3248,3258,O
new,3263,3266,O
real,3268,3272,O
value,3273,3278,O
11,3280,3282,O
book,3292,3296,O
Eat,3305,3308,O
Stay,3318,3322,O
Mediterranean,3332,3345,O
Way,3346,3349,O
Keys,3353,3357,O
13,3359,3361,O
term,3378,3382,O
good,3384,3388,O
Mediterranean,3389,3402,O
diet,3403,3407,O
describe,3412,3420,O
eating,3425,3431,O
patterns,3432,3440,O
populations,3444,3455,O
dwelling,3456,3464,O
southern,3468,3476,O
Europe,3477,3483,O
olive,3495,3500,O
tree,3501,3505,O
Olea,3507,3511,O
europaea,3512,3520,O
emblematic,3528,3538,O
species,3539,3546,O
4,3548,3549,O
14,3551,3553,O
variation,3565,3574,O
exact,3587,3592,O
diet,3593,3597,O
different,3601,3610,O
parts,3611,3616,O
Mediterranean,3624,3637,O
region,3638,3644,O
generalized,3655,3666,O
distinctive,3671,3682,O
dietary,3683,3690,O
patterns,3691,3699,O
exist,3703,3708,O
including,3710,3719,O
olive,3720,3725,O
oil,3726,3729,B-Organism_substance
main,3737,3741,O
source,3742,3748,O
visible,3752,3759,O
fat,3760,3763,O
employed,3765,3773,O
cooking,3782,3789,O
dressing,3799,3807,O
moderate,3809,3817,O
fish,3818,3822,O
poultry,3827,3834,O
low,3839,3842,O
red,3843,3846,B-Organism_subdivision
meat,3847,3851,I-Organism_subdivision
consumption,3852,3863,O
high,3865,3869,O
intake,3870,3876,O
vegetables,3880,3890,B-Organism_subdivision
fruits,3892,3898,B-Organism_subdivision
legumes,3900,3907,O
nuts,3909,3913,B-Organism_subdivision
grain,3925,3930,O
cereals,3931,3938,O
4,3940,3941,O
14,3943,3945,O
16,3946,3948,O
dietary,3956,3963,B-Organism_substance
fats,3964,3968,I-Organism_substance
added,3973,3978,O
accordance,3983,3993,O
traditional,4003,4014,O
Mediterranean,4015,4028,O
diet,4029,4033,O
olive,4035,4040,O
oil,4041,4044,B-Organism_substance
choice,4052,4058,O
children,4063,4071,O
17,4073,4075,O
repeatedly,4090,4100,O
observed,4101,4109,O
individuals,4115,4126,O
applying,4127,4135,O
Mediterranean,4140,4153,O
diet,4154,4158,O
reduced,4164,4171,O
risks,4172,4177,O
type,4181,4185,O
2,4186,4187,O
diabetes,4188,4196,O
diseases,4207,4215,O
associated,4216,4226,O
metabolic,4236,4245,O
syndrome,4246,4254,O
autoimmunological,4256,4273,O
diseases,4274,4282,O
certain,4288,4295,O
forms,4296,4301,O
cancer,4305,4311,B-Pathological_formation
18,4313,4315,O
considerable,4328,4340,O
evidence,4341,4349,O
exists,4350,4356,O
Mediterranean,4366,4379,O
diet,4380,4384,O
increases,4385,4394,O
quality,4395,4402,O
life,4406,4410,O
course,4418,4424,O
ageing,4428,4434,O
longevity,4447,4456,O
13,4458,4460,O
19,4462,4464,O
health,4471,4477,O
benefits,4478,4486,O
olive,4490,4495,O
oil,4496,4499,B-Organism_substance
attributed,4510,4520,O
main,4528,4532,O
constituents,4533,4545,O
high,4549,4553,O
oleic,4554,4559,O
acid,4560,4564,O
monounsaturated,4566,4581,O
fatty,4582,4587,O
acid,4588,4592,O
18,4594,4596,O
1n,4597,4599,O
9,4600,4601,O
content,4603,4610,O
70,4612,4614,O
85,4615,4617,O
large,4626,4631,O
antioxidant,4642,4653,O
compounds,4654,4663,O
possess,4676,4683,O
antiviral,4684,4693,O
antibacterial,4695,4708,O
immunomodulating,4714,4730,O
effects,4731,4738,O
3,4740,4741,O
4,4743,4744,O
14,4746,4748,O
16,4750,4752,O
Polyphenols,4755,4766,O
found,4767,4772,O
virgin,4776,4782,O
olive,4783,4788,O
oil,4789,4792,B-Organism_substance
linked,4797,4803,O
flavor,4816,4822,O
remarkable,4831,4841,O
stability,4842,4851,O
3,4853,4854,O
introduction,4861,4873,O
solid,4877,4882,O
foods,4883,4888,O
infancy,4892,4899,O
primary,4914,4921,O
matters,4922,4929,O
discussed,4936,4945,O
parents,4949,4956,O
child,4968,4973,O
s,4974,4975,O
pediatrician,4976,4988,O
parents,5004,5011,O
feel,5019,5023,O
diet,5033,5037,O
child,5047,5052,O
linked,5060,5066,O
poor,5070,5074,O
health,5075,5081,O
outcomes,5082,5090,O
future,5098,5104,O
Parents,5106,5113,O
educated,5124,5132,O
interplay,5143,5152,O
environmental,5156,5169,O
genetic,5174,5181,O
influences,5182,5192,O
children,5196,5204,O
specifically,5206,5218,O
early,5230,5235,O
years,5236,5241,O
development,5245,5256,O
child,5266,5271,O
maturing,5275,5283,O
taking,5288,5294,O
control,5295,5302,O
diet,5314,5318,O
11,5320,5322,O
Nutrition,5325,5334,O
educators,5335,5344,O
increase,5352,5360,O
critical,5365,5373,O
awareness,5374,5383,O
parents,5387,5394,O
relation,5398,5406,O
child,5416,5421,O
s,5422,5423,O
solid,5424,5429,O
food,5430,5434,O
choices,5435,5442,O
important,5450,5459,O
emphasize,5463,5472,O
parents,5476,5483,O
fundamental,5488,5499,O
role,5500,5504,O
Mediterranean,5514,5527,O
diet,5528,5532,O
consumption,5537,5548,O
foods,5552,5557,O
olive,5563,5568,O
oil,5569,5572,B-Organism_substance
play,5573,5577,O
healthy,5583,5590,O
life,5591,5595,O
style,5596,5601,O
14,5603,5605,O
20,5607,5609,O
Parental,5612,5620,O
management,5621,5631,O
family,5639,5645,O
food,5646,5650,O
environment,5651,5662,O
complicated,5670,5681,O
numerous,5685,5693,O
mitigating,5694,5704,O
factors,5705,5712,O
e,5714,5715,O
g,5716,5717,O
health,5719,5725,O
literacy,5726,5734,O
time,5736,5740,O
availability,5741,5753,O
financial,5759,5768,O
resources,5769,5778,O
Considering,5780,5791,O
role,5796,5800,O
baby,5801,5805,O
food,5806,5810,O
manufacturers,5811,5824,O
play,5825,5829,O
infant,5837,5843,O
s,5844,5845,O
contextual,5846,5856,O
environment,5857,5868,O
products,5876,5884,O
manufacturers,5901,5914,O
viewed,5942,5948,O
key,5952,5955,O
players,5956,5963,O
central,5968,5975,O
agents,5976,5982,O
establishing,5986,5998,O
dietary,5999,6006,O
habits,6007,6013,O
Consequently,6015,6027,O
attempted,6032,6041,O
survey,6045,6051,O
manufacturer,6052,6064,O
claims,6065,6071,O
concerning,6072,6082,O
added,6083,6088,O
fat,6089,6092,O
jarred,6096,6102,O
infant,6103,6109,O
foods,6110,6115,O
supplied,6116,6124,O
Polish,6132,6138,O
market,6139,6145,O
2,0,1,O
1,2,3,O
3,4,5,O
Pixel,6,11,O
Classification,12,26,O
feature,31,38,O
vector,39,45,O
grid,51,55,O
consists,63,71,O
features,80,88,O
normalized,93,103,O
0,108,109,O
1,111,112,O
position,123,131,O
features,132,140,O
scaled,145,151,O
weighting,159,168,O
coefficient,169,180,O
wpos,181,185,O
taking,193,199,O
dimensional,209,220,O
vector,221,227,O
grid,236,240,O
input,248,253,O
classifier,261,271,O
ROI,277,280,O
non,285,288,O
ROI,289,292,O
background,293,303,O
ultrasonic,307,317,O
breast,318,324,B-Pathological_formation
tumor,325,330,I-Pathological_formation
images,331,337,O
distinguished,345,358,O
section,368,375,O
self,381,385,O
organizing,386,396,O
feature,397,404,O
map,405,408,O
neural,409,415,O
network,416,423,O
SOMNN,425,430,O
25,433,435,O
proposed,438,446,O
Kohonen,450,457,O
according,458,467,O
characteristics,471,486,O
nervous,494,501,B-Anatomical_system
system,502,508,I-Anatomical_system
classification,526,540,O
grids,550,555,O
detect,559,565,O
ROI,570,573,O
automatically,574,587,O
SOM,593,596,O
trained,600,607,O
unsupervised,615,627,O
learning,628,636,O
produce,640,647,O
low,650,653,O
dimensional,654,665,O
discretized,666,677,O
representation,678,692,O
input,700,705,O
space,706,711,O
training,719,727,O
samples,728,735,O
uses,744,748,O
neighborhood,751,763,O
function,764,772,O
preserve,776,784,O
topological,789,800,O
properties,801,811,O
input,819,824,O
space,825,830,O
makes,838,843,O
different,847,856,O
artificial,868,878,O
neural,879,885,O
networks,886,894,O
way,904,907,O
SOM,913,916,O
able,920,924,O
classify,928,936,O
sub,941,944,O
blocks,945,951,O
n,957,958,O
clusters,959,967,O
unsupervised,980,992,O
learning,993,1001,O
study,1010,1015,O
output,1021,1027,O
layer,1028,1033,O
number,1034,1040,O
n,1041,1042,O
set,1046,1049,O
2,1053,1054,O
ROI,1056,1059,O
non,1064,1067,O
ROI,1068,1071,O
output,1072,1078,O
feature,1088,1095,O
vector,1096,1102,O
extracted,1103,1112,O
grid,1123,1127,O
taken,1131,1136,O
input,1144,1149,O
map,1154,1157,O
sorted,1162,1168,O
sub,1169,1172,O
blocks,1173,1179,O
size,1192,1196,O
original,1204,1212,O
ultrasonic,1213,1223,O
images,1224,1230,O
initial,1236,1243,O
result,1244,1250,O
ROI,1254,1257,O
detection,1258,1267,O
represented,1275,1286,O
binary,1292,1298,O
image,1299,1304,O
shown,1308,1313,O
Fig,1317,1320,O
2d,1323,1325,O
white,1334,1339,O
areas,1340,1345,O
indicate,1346,1354,O
ROI,1359,1362,O
candidates,1363,1373,O
black,1380,1385,O
areas,1386,1391,O
non,1396,1399,O
ROIs,1400,1404,O
Materials,0,9,O
Methods,14,21,O
total,25,30,O
75,34,36,O
brain,37,42,B-Multi-tissue_structure
abscess,43,50,I-Multi-tissue_structure
pus,51,54,I-Multi-tissue_structure
specimens,55,64,I-Multi-tissue_structure
collected,70,79,O
neurosurgery,87,99,O
burr,111,115,O
hole,116,120,O
craniotomy,127,137,O
specimens,145,154,B-Multi-tissue_structure
subjected,168,177,O
Gram,181,185,O
stain,186,191,O
Ziehl,193,198,O
Neelsen,199,206,O
ZN,208,210,O
stain,212,217,O
conventional,223,235,O
microbiological,236,251,O
culture,252,259,O
cases,272,277,O
showed,284,290,O
presence,291,299,O
AFB,303,306,O
ZN,310,312,O
stain,313,318,O
growth,334,340,O
Mycobacterium,344,357,O
tuberculosis,358,370,O
considered,376,386,O
TBAs,390,394,O
TBA,401,404,O
cases,405,410,O
presented,424,433,O
vitro,454,459,O
Proton,460,466,O
Magnetic,467,475,O
Resonance,476,485,O
MR,487,489,O
Spectroscopic,491,504,O
findings,505,513,O
Challenges,0,10,O
creating,14,22,O
implementing,27,39,O
perioperative,42,55,O
glycemic,56,64,O
control,65,72,O
protocol,73,81,O
Parameters,0,10,O
derived,11,18,O
normalized,24,34,O
averaged,35,43,O
data,44,48,O
participants,56,68,O
Absolute,0,8,O
responder,9,18,O
rates,19,24,O
medical,29,36,O
management,37,47,O
recommendations,48,63,O
Conclusions,0,11,O
prospective,30,41,O
evaluation,42,52,O
parents,56,63,O
preferences,65,76,O
newly,80,85,O
diagnosed,86,95,O
juvenile,96,104,O
idiopathic,105,115,O
arthritis,116,125,O
patients,126,134,O
participating,135,148,O
BeSt,156,160,O
Kids,165,169,O
trial,170,175,O
limitations,188,199,O
small,207,212,O
amounts,213,220,O
patients,222,230,O
clearly,231,238,O
preferred,239,248,O
initial,249,256,O
combination,257,268,O
therapy,269,276,O
etanercept,282,292,O
disliked,297,305,O
taking,306,312,O
prednisone,313,323,O
actual,331,337,O
exposure,338,346,O
follow,351,357,O
questionnaire,367,380,O
repeated,389,397,O
preferences,408,419,O
remain,420,426,O
Patients,0,8,O
Study,13,18,O
Design,19,25,O
prospective,28,39,O
evaluation,40,50,O
different,58,67,O
CMR,68,71,O
parameters,72,82,O
predicting,87,97,O
LV,98,100,B-Multi-tissue_structure
segmental,101,110,O
global,115,121,O
functional,122,132,O
recovery,133,141,O
performed,146,155,O
46,159,161,O
patients,162,170,O
63,172,174,O
10,179,181,O
years,182,187,O
old,188,191,O
3,193,194,O
previous,200,208,O
CABG,209,213,O
35,215,217,O
vessel,229,235,O
disease,236,243,O
3,245,246,O
vessel,256,262,O
disease,263,270,O
LV,277,279,B-Multi-tissue_structure
systolic,280,288,O
dysfunction,289,300,O
LVEF,302,306,O
35,307,309,O
8,314,315,O
underwent,330,339,O
surgical,340,348,O
n,350,351,O
34,354,356,O
percutaneous,361,373,O
n,375,376,O
12,379,381,O
revascularisation,383,400,O
patients,408,416,O
contraindications,425,442,O
CMR,447,450,O
screened,456,464,O
following,473,482,O
inclusion,483,492,O
criteria,493,501,O
1,504,505,O
CAD,507,510,O
70,514,516,O
stenosis,518,526,O
major,542,547,O
epicardial,548,558,B-Multi-tissue_structure
vessels,559,566,I-Multi-tissue_structure
scheduled,569,578,O
revascularisation,585,602,O
procedure,603,612,O
2,615,616,O
LVEF,618,622,O
45,626,628,O
3,632,633,O
adjacent,648,656,O
segments,657,665,O
wall,671,675,B-Multi-tissue_structure
motion,676,682,O
abnormalities,683,696,O
rest,700,704,O
4,711,712,O
infarction,717,727,O
revascularisation,731,748,O
months,769,775,O
Patients,777,785,O
included,791,799,O
study,807,812,O
successful,826,836,O
complete,841,849,O
coronary,850,858,B-Multi-tissue_structure
revascularisation,859,876,O
14,885,887,O
patients,888,896,O
complete,909,917,O
study,922,927,O
3,929,930,O
decided,931,938,O
undergo,946,953,O
repeated,958,966,O
CMR,967,970,O
scan,971,975,O
lost,984,988,O
follow,996,1002,O
7,1007,1008,O
significant,1013,1024,O
periprocedural,1025,1039,O
injury,1040,1046,O
new,1048,1051,O
LGE,1052,1055,B-Pathological_formation
zones,1056,1061,O
repeated,1065,1073,O
CMR,1074,1077,O
scans,1078,1083,O
clinically,1088,1098,O
proven,1099,1105,O
periprocedural,1106,1120,O
myocardial,1121,1131,B-Multi-tissue_structure
infarction,1132,1142,O
MI,1144,1146,O
MI,1151,1153,O
scans,1167,1172,O
3,1175,1176,O
pacemakers,1181,1191,O
defibrillators,1195,1209,O
implanted,1210,1219,O
period,1227,1233,O
MR,1246,1248,O
scans,1249,1254,O
1,1260,1261,O
excluded,1266,1274,O
dilated,1286,1293,O
cardiomyopathy,1294,1308,O
secondary,1314,1323,O
CAD,1324,1327,O
patients,1341,1349,O
excluded,1355,1363,O
study,1373,1378,O
technical,1383,1392,O
reasons,1393,1400,O
image,1404,1409,O
quality,1410,1417,O
mean,1423,1427,O
interval,1428,1436,O
CMR,1445,1448,O
revascularisation,1453,1470,O
12,1475,1477,O
13,1482,1484,O
days,1485,1489,O
patients,1507,1515,O
presented,1516,1525,O
clinical,1526,1534,O
evidence,1535,1543,O
infarction,1547,1557,O
period,1570,1576,O
mean,1582,1586,O
interval,1587,1595,O
MI,1604,1606,O
CMR,1621,1624,O
3,1629,1630,O
6,1631,1632,O
years,1633,1638,O
46,1643,1645,O
patients,1646,1654,O
extent,1660,1666,O
regional,1670,1678,O
contractility,1679,1692,O
LGE,1697,1700,B-Pathological_formation
determined,1706,1716,O
repeatedly,1717,1727,O
CMR,1731,1734,O
28,1735,1737,O
4,1742,1743,O
weeks,1744,1749,O
6,1751,1752,O
months,1753,1759,O
revascularisation,1767,1784,O
study,1790,1795,O
approved,1800,1808,O
Lithuanian,1816,1826,O
Bioethics,1827,1836,O
Committee,1837,1846,O
Nr,1848,1850,O
17,1852,1854,O
informed,1861,1869,O
written,1870,1877,O
consent,1878,1885,O
obtained,1890,1898,O
patient,1909,1916,O
prior,1917,1922,O
inclusion,1926,1935,O
study,1943,1948,O
Authors,0,7,O
contributions,9,22,O
EEKN,23,27,O
responsible,32,43,O
data,48,52,O
collection,53,63,O
statistical,65,76,O
analysis,77,85,O
drafting,90,98,O
manuscript,103,113,O
SAGN,115,119,O
YW,124,126,O
involved,127,135,O
data,139,143,O
collection,144,154,O
helped,159,165,O
data,175,179,O
analysis,180,188,O
helped,193,199,O
data,203,207,O
analysis,208,216,O
EST,218,221,O
JL,226,228,O
directed,229,237,O
study,242,247,O
helped,252,258,O
revising,262,270,O
manuscript,275,285,O
RMVD,287,291,O
helped,292,298,O
data,302,306,O
analysis,307,315,O
interpretation,317,331,O
results,339,346,O
led,351,354,O
writing,355,362,O
manuscript,370,380,O
authors,386,393,O
read,394,398,O
approved,403,411,O
final,416,421,O
manuscript,422,432,O
Figures,0,7,O
Fig,8,11,O
1,13,14,O
view,18,22,O
displacement,35,47,O
ellipsoids,48,58,O
drawn,59,64,O
30,72,74,O
probability,76,87,O
level,88,93,O
Fig,95,98,O
2,100,101,O
Stereoview,103,113,O
sheet,121,126,O
formed,127,133,O
C,137,138,O
H,140,141,O
pi,144,146,O
interactions,147,159,O
Hydrogen,161,169,O
atoms,170,175,O
involved,180,188,O
motifs,196,202,O
included,211,219,O
growth,4,10,O
number,18,24,O
database,28,36,O
publications,37,49,O
year,54,58,O
bar,65,68,O
shows,69,74,O
number,79,85,O
research,89,97,O
articles,98,106,O
keyword,116,123,O
database,125,133,O
appearing,135,144,O
article,152,159,O
title,160,165,O
given,173,178,O
year,179,183,O
count,189,194,O
covers,200,206,O
articles,207,215,O
indexed,216,223,O
PubMed,227,233,O
increase,239,247,O
shows,248,253,O
exponential,257,268,O
trend,269,274,O
produce,285,292,O
nearly,293,299,O
2000,300,304,O
database,305,313,O
publications,314,326,O
year,331,335,O
2015,339,343,O
Cation,0,6,O
binding,7,14,O
yolk,18,22,B-Cell
platelet,23,31,I-Cell
phosvitin,32,41,O
addition,45,53,O
non,57,60,O
heme,61,65,O
iron,66,70,O
23,72,74,O
yolk,77,81,B-Developing_anatomical_structure
phosvitin,82,91,O
contains,97,105,O
Ca2,106,109,O
Mg2,112,115,O
Na,118,120,O
K,126,127,O
11,130,132,O
Partially,135,144,O
relaxed,145,152,O
23Na,153,157,O
Fourier,158,165,O
transform,166,175,O
NMR,176,179,O
spectra,180,187,O
revealed,188,196,O
existence,201,210,O
major,227,232,O
intracellular,233,246,B-Cellular_component
compartments,247,259,I-Cellular_component
NMR,263,266,O
visible,267,274,O
Na,275,277,O
35,280,282,O
large,287,292,O
fraction,293,301,O
Rana,309,313,O
oocyte,314,320,B-Cell
Na,321,323,O
NMR,329,332,O
invisible,333,342,O
recovered,356,365,O
yolk,373,377,B-Cell
platelets,378,387,I-Cell
35,389,391,O
meiotic,411,418,O
division,419,427,O
net,439,442,O
increase,443,451,O
NMR,455,458,O
visible,459,466,O
Na,467,469,O
completion,475,485,O
second,493,499,O
meiotic,500,507,O
division,508,516,O
following,518,527,O
fertilization,528,541,O
70,550,552,O
total,561,566,O
Na,567,569,O
NMR,579,582,O
visible,583,590,O
phosvitin,598,607,O
serves,617,623,O
site,629,633,O
energy,638,644,O
storage,645,652,O
storage,668,675,O
site,676,680,O
iron,685,689,O
ions,700,704,O
essential,705,714,O
embryonic,719,728,B-Developing_anatomical_structure
development,729,740,O
ponds,744,749,O
streams,754,761,O
contain,767,774,O
little,775,781,O
dissolved,782,791,O
salts,792,797,O
minerals,802,810,O
Predicted,0,9,O
methylation,10,21,O
level,22,27,O
C,31,32,O
gigas,34,39,O
genes,40,45,O
categorized,46,57,O
biological,61,71,O
processes,72,81,O
compared,82,90,O
measured,94,102,O
level,103,108,O
DNA,112,115,O
methylation,116,127,O
Mean,129,133,O
CpG,134,137,O
O,138,139,O
E,140,141,O
10,146,148,O
699,149,152,O
C,153,154,O
gigas,156,161,O
genes,162,167,O
categorized,168,179,O
according,180,189,O
Biological,193,203,O
Process,204,211,O
Gene,212,216,O
Ontology,217,225,O
Slim,231,235,O
terms,236,241,O
plotted,246,253,O
x,261,262,O
axis,263,267,O
modified,269,277,O
Gavery,283,289,O
Roberts,294,301,O
2010,303,307,O
DNA,310,313,O
methylation,314,325,O
empirically,330,341,O
measured,342,350,O
performing,354,364,O
MBD,365,368,O
seq,369,372,O
SOLiD,380,385,O
4,386,387,O
platform,388,396,O
Applied,398,405,O
Biosystems,406,416,O
Genes,419,424,O
identified,425,435,O
MBD,443,446,O
library,447,454,O
associated,460,470,O
respective,476,486,O
terms,490,495,O
enrichment,500,510,O
analysis,511,519,O
performed,524,533,O
based,534,539,O
entire,547,553,O
transcriptome,554,567,O
Fleury,569,575,O
et,576,578,O
al,579,581,O
2009,584,588,O
DAVID,596,601,O
Huang,603,608,O
et,609,611,O
al,612,614,O
2009a,617,622,O
b,623,624,O
Results,627,634,O
indicate,635,643,O
underrepresented,653,669,O
genes,670,675,O
library,683,690,O
involved,695,703,O
cell,707,711,B-Cell
adhesion,712,720,O
genes,725,730,O
involved,731,739,O
DNA,743,746,O
protein,751,758,O
metabolism,759,769,O
prevalent,780,789,O
MBD,797,800,O
library,801,808,O
Discussion,0,10,O
estimated,14,23,O
future,28,34,O
acceptability,35,48,O
PrEP,52,56,O
examining,58,67,O
attitudes,72,81,O
preferences,86,97,O
potential,101,110,O
user,111,115,O
groups,116,122,O
different,128,137,O
countries,138,147,O
hypothetical,156,168,O
known,173,178,O
PrEP,179,183,O
attributes,184,194,O
results,200,207,O
participants,218,230,O
generally,236,245,O
willing,246,253,O
accept,257,263,O
PrEP,264,268,O
adopt,273,278,O
soon,285,289,O
available,304,313,O
Surprisingly,315,327,O
participants,329,341,O
willing,352,359,O
PrEP,368,372,O
reminded,383,391,O
potential,395,404,O
effects,410,417,O
cost,419,423,O
condom,425,431,O
use,432,435,O
frequent,441,449,O
HIV,450,453,O
testing,454,461,O
findings,469,477,O
indicate,478,486,O
participants,487,499,O
motivation,501,511,O
overcome,515,523,O
barriers,524,532,O
considerable,550,562,O
impact,563,569,O
uptake,573,579,O
contrast,584,592,O
participants,594,606,O
mentioned,607,616,O
thought,626,633,O
taking,637,643,O
PrEP,644,648,O
feel,659,663,O
anxious,664,671,O
indicated,692,701,O
taking,707,713,O
PrEP,714,718,O
embarrassing,732,744,O
want,760,764,O
partner,771,778,O
partners,782,790,O
know,794,798,O
Participants,800,812,O
anxiety,814,821,O
explained,829,838,O
hypothetical,846,858,O
nature,859,865,O
presented,881,890,O
PrEP,891,895,O
characteristics,896,911,O
stigma,917,923,O
associated,924,934,O
HIV,940,943,O
34,945,947,O
settings,962,970,O
criminalization,976,991,O
sex,995,998,O
work,999,1003,O
injected,1005,1013,O
drug,1014,1018,O
use,1019,1022,O
homosexuality,1027,1040,O
35,1042,1044,O
participants,1052,1064,O
nonetheless,1066,1077,O
subsequently,1079,1091,O
indicated,1092,1101,O
PrEP,1107,1111,O
hope,1128,1132,O
suggests,1140,1148,O
initial,1160,1167,O
willingness,1168,1179,O
remained,1191,1199,O
largely,1200,1207,O
unscathed,1208,1217,O
Female,1219,1225,O
participants,1226,1238,O
indicated,1239,1248,O
higher,1251,1257,O
level,1258,1263,O
willingness,1267,1278,O
PrEP,1287,1291,O
male,1297,1301,O
participants,1302,1314,O
explained,1329,1338,O
women,1342,1347,O
s,1348,1349,O
difficulty,1350,1360,O
negotiating,1361,1372,O
use,1377,1380,O
condoms,1384,1391,O
awareness,1396,1405,O
partners,1428,1436,O
risk,1438,1442,O
infected,1455,1463,O
HIV,1469,1472,O
36,1474,1476,O
found,1487,1492,O
younger,1498,1505,O
participants,1506,1518,O
fewer,1534,1539,O
children,1540,1548,O
reported,1560,1568,O
adherence,1569,1578,O
past,1582,1586,O
medication,1587,1597,O
frequent,1604,1612,O
condom,1613,1619,O
usage,1620,1625,O
having,1627,1633,O
tested,1639,1645,O
HIV,1650,1653,O
past,1661,1665,O
injecting,1676,1685,O
drugs,1686,1691,O
reported,1693,1701,O
greater,1702,1709,O
willingness,1710,1721,O
PrEP,1730,1734,O
promising,1742,1751,O
findings,1752,1760,O
suggest,1761,1768,O
currently,1788,1797,O
bearing,1798,1805,O
brunt,1810,1815,O
HIV,1819,1822,O
1,1824,1825,O
higher,1833,1839,O
perceived,1840,1849,O
risk,1850,1854,O
likely,1869,1875,O
adhere,1879,1885,O
comprehensive,1891,1904,O
PrEP,1905,1909,O
program,1910,1917,O
motivated,1937,1946,O
enroll,1950,1956,O
participants,1969,1981,O
stated,1982,1988,O
interested,1999,2009,O
selling,2013,2020,O
PrEP,2021,2025,O
majority,2031,2039,O
reported,2040,2048,O
intentions,2049,2059,O
share,2063,2068,O
information,2084,2095,O
counseling,2100,2110,O
risks,2121,2126,O
sharing,2130,2137,O
PrEP,2138,2142,O
readily,2153,2160,O
available,2161,2170,O
implementation,2186,2200,O
program,2201,2208,O
Results,2210,2217,O
conjoint,2227,2235,O
analysis,2236,2244,O
reveal,2245,2251,O
trends,2252,2258,O
participants,2262,2274,O
preferences,2276,2287,O
deserve,2294,2301,O
consideration,2302,2315,O
PrEP,2317,2321,O
route,2322,2327,O
administration,2331,2345,O
important,2359,2368,O
attribute,2369,2378,O
bi,2384,2386,O
monthly,2387,2394,O
monthly,2399,2406,O
injections,2407,2417,O
preferred,2427,2436,O
alternatives,2437,2449,O
finding,2456,2463,O
encouraging,2467,2478,O
policy,2486,2492,O
perspective,2493,2504,O
modalities,2513,2523,O
available,2531,2540,O
reduce,2555,2561,O
users,2562,2567,O
likelihood,2569,2579,O
sharing,2583,2590,O
selling,2592,2599,O
forgetting,2603,2613,O
PrEP,2622,2626,O
raises,2640,2646,O
questions,2647,2656,O
participants,2667,2679,O
willingness,2681,2692,O
oral,2701,2705,O
PrEP,2706,2710,O
HIV,2712,2715,O
testing,2716,2723,O
second,2732,2738,O
important,2744,2753,O
attribute,2754,2763,O
test,2771,2775,O
months,2786,2792,O
expected,2801,2809,O
preferred,2815,2824,O
alternative,2825,2836,O
Interestingly,2838,2851,O
dispensing,2853,2863,O
sites,2864,2869,O
important,2880,2889,O
attribute,2905,2914,O
groups,2924,2930,O
particularly,2932,2944,O
Africa,2948,2954,O
indicate,2965,2973,O
concerns,2974,2982,O
social,2989,2995,O
stigma,2996,3002,O
access,3007,3013,O
37,3015,3017,O
encouraging,3035,3046,O
participants,3057,3069,O
willing,3075,3082,O
receive,3086,3093,O
PrEP,3094,3098,O
healthcare,3104,3114,O
facility,3115,3123,O
facilitate,3135,3145,O
synergies,3146,3155,O
PrEP,3164,3168,O
existing,3179,3187,O
prevention,3188,3198,O
services,3199,3207,O
Time,3209,3213,O
spent,3214,3219,O
obtaining,3220,3229,O
PrEP,3230,3234,O
frequency,3239,3248,O
pick,3252,3256,O
proxy,3280,3285,O
measure,3286,3293,O
cost,3298,3302,O
opportunity,3303,3314,O
generally,3321,3330,O
important,3336,3345,O
consistent,3347,3357,O
participants,3363,3375,O
willingness,3377,3388,O
pay,3392,3395,O
PrEP,3400,3404,O
findings,3410,3418,O
broadly,3423,3430,O
consistent,3431,3441,O
work,3451,3455,O
Guest,3459,3464,O
et,3465,3467,O
al,3468,3470,O
Galea,3476,3481,O
et,3482,3484,O
al,3485,3487,O
18,3489,3491,O
19,3495,3497,O
specific,3509,3517,O
comparisons,3518,3529,O
advisable,3538,3547,O
composition,3555,3566,O
size,3571,3575,O
samples,3583,3590,O
recruitment,3592,3603,O
methods,3604,3611,O
measures,3613,3621,O
statistical,3626,3637,O
analyses,3638,3646,O
differ,3647,3653,O
greatly,3654,3661,O
Previous,3663,3671,O
work,3672,3676,O
PrEP,3680,3684,O
implementation,3685,3699,O
suggests,3700,3708,O
delivery,3714,3722,O
programs,3723,3731,O
need,3737,3741,O
meet,3745,3749,O
number,3752,3758,O
requirements,3762,3774,O
order,3778,3783,O
effective,3790,3799,O
including,3801,3810,O
prioritization,3812,3826,O
groups,3830,3836,O
higher,3840,3846,O
risk,3847,3851,O
infection,3855,3864,O
delivery,3866,3874,O
PrEP,3878,3882,O
combination,3886,3897,O
prevention,3909,3919,O
services,3920,3928,O
including,3930,3939,O
risk,3940,3944,O
reduction,3945,3954,O
medication,3959,3969,O
adherence,3970,3979,O
counseling,3980,3990,O
condoms,3992,3999,O
provision,4000,4009,O
diagnosis,4011,4020,O
treatment,4025,4034,O
sexually,4044,4052,O
transmitted,4053,4064,O
infections,4065,4075,O
frequent,4081,4089,O
HIV,4090,4093,O
testing,4094,4101,O
monitoring,4107,4117,O
effects,4126,4133,O
adherence,4135,4144,O
risk,4149,4153,O
behaviors,4154,4163,O
8,4165,4166,O
38,4170,4172,O
39,4176,4178,O
40,4182,4184,O
41,4188,4190,O
42,4194,4196,O
results,4203,4210,O
provide,4211,4218,O
valuable,4219,4227,O
clues,4228,4233,O
help,4243,4247,O
countries,4248,4257,O
deliver,4261,4268,O
PrEP,4269,4273,O
effectively,4279,4290,O
decide,4304,4310,O
implement,4314,4323,O
focusing,4331,4339,O
efforts,4346,4353,O
aspects,4361,4368,O
need,4374,4378,O
attention,4384,4393,O
multinational,4413,4426,O
study,4427,4432,O
knowledge,4441,4450,O
integrates,4457,4467,O
different,4468,4477,O
disciplines,4478,4489,O
shed,4493,4497,O
light,4498,4503,O
question,4509,4517,O
believe,4526,4533,O
global,4540,4546,O
importance,4547,4557,O
study,4563,4568,O
complements,4569,4580,O
previous,4581,4589,O
work,4590,4594,O
PrEP,4598,4602,O
examining,4606,4615,O
potential,4616,4625,O
users,4626,4631,O
perspective,4633,4644,O
offering,4649,4657,O
insights,4658,4666,O
attitudes,4678,4687,O
preferences,4692,4703,O
note,4708,4712,O
possible,4732,4740,O
generalize,4744,4754,O
observed,4759,4767,O
PrEP,4768,4772,O
acceptability,4773,4786,O
settings,4796,4804,O
results,4813,4820,O
considered,4831,4841,O
context,4853,4860,O
study,4869,4874,O
s,4875,4876,O
limitations,4877,4888,O
Given,4890,4895,O
sensitive,4900,4909,O
nature,4910,4916,O
addressed,4924,4933,O
questions,4934,4943,O
despite,4949,4956,O
efforts,4965,4972,O
reduce,4976,4982,O
social,4983,4989,O
desirability,4990,5002,O
bias,5003,5007,O
unavoidable,5021,5032,O
risk,5033,5037,O
participants,5043,5055,O
felt,5065,5069,O
times,5073,5078,O
compelled,5079,5088,O
provide,5092,5099,O
felt,5110,5114,O
right,5124,5129,O
answer,5131,5137,O
Additionally,5139,5151,O
data,5157,5161,O
collection,5162,5172,O
took,5173,5177,O
place,5178,5183,O
urban,5187,5192,O
areas,5193,5198,O
HIV,5206,5209,O
incidence,5210,5219,O
normally,5223,5231,O
higher,5232,5238,O
current,5245,5252,O
findings,5253,5261,O
generalizable,5273,5286,O
rural,5290,5295,O
settings,5296,5304,O
Finally,5306,5313,O
examining,5315,5324,O
acceptability,5325,5338,O
users,5345,5350,O
enrolled,5351,5359,O
pilot,5363,5368,O
programs,5369,5377,O
deserving,5386,5395,O
actual,5400,5406,O
acceptability,5407,5420,O
differ,5425,5431,O
potential,5437,5446,O
willingness,5447,5458,O
PrEP,5467,5471,O
especially,5473,5483,O
relevant,5487,5495,O
attributes,5496,5506,O
product,5512,5519,O
program,5523,5530,O
modified,5535,5543,O
observed,5548,5556,O
comparable,5566,5576,O
interventions,5577,5590,O
43,5592,5594,O
Origins,0,7,O
Acquired,11,19,O
Antibiotic,20,30,O
Resistance,31,41,O
Mechanisms,42,52,O
Recently,53,61,O
D,63,64,O
Costa,65,70,O
et,71,73,O
al,74,76,O
2011,79,83,O
reported,90,98,O
metagenomic,101,112,O
analysis,113,121,O
Beringian,129,138,O
permafrost,139,149,O
30,160,162,O
000,163,166,O
years,167,172,O
old,173,176,O
showed,183,189,O
molecular,190,199,O
evidences,200,209,O
ancient,217,224,O
origins,225,232,O
antibiotic,236,246,O
resistances,247,258,O
detecting,260,269,O
beta,270,274,O
lactamases,275,285,O
genes,286,291,O
vanX,293,297,O
like,298,302,O
component,304,313,O
vancomycin,321,331,O
resistance,332,342,O
operon,343,349,O
tetM,355,359,O
coding,361,367,O
protein,374,381,O
protecting,382,392,O
ribosomal,397,406,B-Cellular_component
target,407,413,O
tetracycline,419,431,O
Sequence,433,441,O
analysis,442,450,O
revealed,451,459,O
beta,469,473,O
lactamases,474,484,O
genes,485,490,O
recovered,491,500,O
permafrost,510,520,O
demonstrated,521,533,O
amino,537,542,O
acid,543,547,O
homology,548,556,O
53,558,560,O
84,561,563,O
known,569,574,O
beta,575,579,O
lactamases,580,590,O
beta,596,600,O
lactams,601,608,O
producing,609,618,O
Streptomyces,619,631,O
tetM,637,641,O
sequences,642,651,O
revealed,652,660,O
high,663,667,O
similarity,668,678,O
genes,686,691,O
coding,692,698,O
ribosomal,707,716,B-Cellular_component
protection,717,727,O
protein,728,735,O
actinomycetes,739,752,O
vanX,758,762,O
sequence,763,771,O
showed,772,778,O
similarity,781,791,O
vanX,799,803,O
gene,804,808,O
recovered,809,818,O
pathogenic,822,832,O
vancomycin,833,843,O
resistant,844,853,O
enterococci,854,865,O
VRE,867,870,O
vanX,883,887,O
gene,888,892,O
Amycolatopsis,898,911,O
orientalis,912,922,O
environmental,929,942,O
species,943,950,O
belonging,952,961,O
actinobacteria,969,983,O
phylum,984,990,O
natural,997,1004,O
producer,1005,1013,O
vancomycin,1017,1027,O
likely,1038,1044,O
progenitor,1049,1059,O
van,1067,1070,O
genes,1071,1076,O
operons,1077,1084,O
responsible,1086,1097,O
resistance,1102,1112,O
vancomycin,1116,1126,O
integration,1132,1143,O
van,1151,1154,O
operons,1155,1162,O
transposons,1166,1177,O
conjugative,1185,1196,B-Cellular_component
plasmids,1197,1205,I-Cellular_component
enhanced,1210,1218,O
spread,1225,1231,O
Courvalin,1233,1242,O
2006,1244,1248,O
Reports,1251,1258,O
VRE,1262,1265,O
freshwater,1269,1279,O
provided,1290,1298,O
authors,1310,1317,O
Talebi,1319,1325,O
et,1326,1328,O
al,1329,1331,O
2008,1334,1338,O
Lata,1340,1344,O
et,1345,1347,O
al,1348,1350,O
2009,1353,1357,O
Luczkiewicz,1359,1370,O
et,1371,1373,O
al,1374,1376,O
2010,1379,1383,O
Interestingly,1386,1399,O
Schwartz,1401,1409,O
et,1410,1412,O
al,1413,1415,O
2003,1418,1422,O
detected,1424,1432,O
vanA,1433,1437,O
genes,1438,1443,O
biofilm,1451,1458,B-Cell
drinking,1462,1470,O
water,1471,1476,O
supplies,1477,1485,O
absence,1494,1501,O
enterococci,1505,1516,O
demonstrating,1518,1531,O
lateral,1536,1543,O
transfer,1544,1552,O
gene,1561,1565,O
Notably,1567,1574,O
progenitors,1580,1591,O
resistance,1601,1611,O
genes,1612,1617,O
soil,1622,1626,O
bacteria,1627,1635,O
likely,1646,1652,O
shuttle,1656,1663,O
responsible,1673,1684,O
introduction,1693,1705,O
genes,1715,1720,O
commensal,1730,1739,O
bacterial,1740,1749,O
community,1750,1759,O
afterward,1764,1773,O
pathogenic,1783,1793,O
species,1794,1801,O
Results,0,7,O
Supplementary,0,13,O
Material,14,22,O
Crystal,23,30,O
structure,31,40,O
contains,42,50,O
datablock,51,60,O
s,61,62,O
global,64,70,O
DOI,75,78,O
10,80,82,O
1107,83,87,O
S1600536812002796,88,105,O
hg5166sup1,106,116,O
cif,117,120,O
Structure,121,130,O
factors,131,138,O
contains,140,148,O
datablock,149,158,O
s,159,160,O
DOI,165,168,O
10,170,172,O
1107,173,177,O
S1600536812002796,178,195,O
hg5166Isup2,196,207,O
hkl,208,211,O
Additional,212,222,O
supplementary,223,236,O
materials,237,246,O
crystallographic,248,264,O
information,265,276,O
3D,278,280,O
view,281,285,O
checkCIF,287,295,O
report,296,302,O
Results,0,7,O
Images,0,6,O
Figure,7,13,O
1,14,15,O
Figure,16,22,O
2,23,24,O
Figure,25,31,O
3,32,33,O
Figure,34,40,O
4,41,42,O
Results,0,7,O
Images,0,6,O
FIGURE,7,13,O
2,14,15,O
Nf,0,2,O
GA,7,9,O
1,10,11,O
DNA,12,15,O
polymerases,16,27,O
couple,28,34,O
polymerization,35,49,O
strand,53,59,O
displacement,60,72,O
processively,73,85,O
results,90,97,O
presented,98,107,O
paper,116,121,O
clearly,122,129,O
indicate,130,138,O
Nf,144,146,O
GA,151,153,O
1,154,155,O
DNA,156,159,O
polymerases,160,171,O
account,176,183,O
genome,194,200,O
replication,201,212,O
assistance,225,235,O
unwinding,239,248,O
processivity,253,265,O
factors,266,273,O
contrast,278,286,O
replicative,295,306,O
DNA,307,310,O
polymerases,311,322,O
require,329,336,O
physical,343,351,O
association,352,363,O
processivity,367,379,O
factors,380,387,O
DNA,392,395,O
unwinding,396,405,O
proteins,406,414,O
1,416,417,O
70,418,420,O
Strand,423,429,O
displacement,430,442,O
capacity,443,451,O
shown,466,471,O
protein,482,489,O
primed,490,496,O
DNA,497,500,O
polymerases,501,512,O
bacteriophages,525,539,O
phi29,540,545,O
10,547,549,O
Cp,552,554,O
1,555,556,O
71,558,560,O
PRD1,566,570,O
72,572,574,O
73,575,577,O
contrary,587,595,O
adenovirus,597,607,O
DNA,608,611,O
polymerase,612,622,O
processive,633,643,O
couple,652,658,O
polymerization,659,673,O
strand,677,683,O
displacement,684,696,O
requiring,698,707,O
DNA,712,715,O
unwinding,716,725,O
activity,726,734,O
adenovirus,742,752,O
DBP,753,756,O
perform,760,767,O
strand,768,774,O
displacement,775,787,O
74,789,791,O
75,792,794,O
possible,812,820,O
obtain,824,830,O
GA,831,833,O
1,834,835,O
DNA,836,839,O
replication,840,851,O
exclusively,861,872,O
GA,877,879,O
1,880,881,O
TP,882,884,O
DNA,889,892,O
polymerase,893,903,O
Nf,905,907,O
DNA,908,911,O
polymerase,912,922,O
provided,933,941,O
competent,947,956,O
strand,957,963,O
displacement,964,976,O
processivity,981,993,O
features,994,1002,O
required,1004,1012,O
presence,1017,1025,O
Nf,1029,1031,O
DBP,1032,1035,O
effective,1043,1052,O
vitro,1056,1061,O
replication,1062,1073,O
Nf,1077,1079,O
TP,1080,1082,O
DNA,1083,1086,O
Results,1088,1095,O
presented,1096,1105,O
Nf,1121,1123,O
DBP,1124,1127,O
strongly,1128,1136,O
stimulates,1137,1147,O
formation,1152,1161,O
TP,1169,1171,O
dAMP,1172,1176,O
initiation,1177,1187,O
complex,1188,1195,O
decreasing,1199,1209,O
Km,1214,1216,O
dATP,1221,1225,O
facilitates,1230,1241,O
transition,1246,1256,O
initiation,1262,1272,O
elongation,1276,1286,O
occurs,1294,1300,O
phi29,1304,1309,O
76,1311,1313,O
results,1322,1329,O
point,1330,1335,O
specific,1348,1356,O
direct,1361,1367,O
contact,1368,1375,O
DBP,1384,1387,O
DNA,1392,1395,O
polymerase,1396,1406,O
promotes,1412,1420,O
conformational,1421,1435,O
changes,1436,1443,O
polymerization,1451,1465,O
active,1466,1472,O
site,1473,1477,O
effect,1487,1493,O
DBP,1497,1500,O
conferring,1504,1514,O
optimal,1519,1526,O
template,1527,1535,O
structure,1536,1545,O
direct,1549,1555,O
initiating,1556,1566,O
nucleotide,1567,1577,O
insertion,1578,1587,O
similar,1591,1598,O
role,1599,1603,O
proposed,1613,1621,O
adenovirus,1626,1636,O
DBP,1637,1640,O
DNA,1644,1647,O
unwinding,1648,1657,O
protein,1658,1665,O
77,1667,1669,O
case,1682,1686,O
phi29,1690,1695,O
Nf,1700,1702,O
DBP,1703,1706,O
protein,1713,1720,O
stimulates,1721,1731,O
rate,1736,1740,O
initiation,1744,1754,O
decreasing,1763,1773,O
Km,1778,1780,O
initiating,1789,1799,O
nucleotide,1800,1810,O
74,1812,1814,O
fact,1821,1825,O
adenovirus,1834,1844,O
DBP,1845,1848,O
mutant,1849,1855,O
defective,1856,1865,O
unwinding,1869,1878,O
stimulate,1889,1898,O
initiation,1899,1909,O
precludes,1910,1919,O
unwinding,1924,1933,O
role,1934,1938,O
responsible,1950,1961,O
activation,1974,1984,O
77,1986,1988,O
78,1989,1991,O
case,2002,2006,O
contacts,2008,2016,O
DBP,2025,2028,O
pTP,2033,2036,O
DNA,2037,2040,O
polymerase,2041,2051,O
complex,2052,2059,O
reported,2070,2078,O
77,2080,2082,O
effect,2089,2095,O
Nf,2099,2101,O
DBP,2102,2105,O
promoting,2109,2118,O
elongation,2119,2129,O
initiation,2137,2147,O
products,2148,2156,O
decrease,2175,2183,O
Km,2191,2193,O
incorporation,2207,2220,O
dNMPs,2228,2233,O
transition,2245,2255,O
stage,2256,2261,O
initiation,2267,2277,O
elongation,2281,2291,O
different,2298,2307,O
type,2308,2312,O
contact,2316,2323,O
DNA,2333,2336,O
polymerase,2337,2347,O
helps,2353,2358,O
transition,2359,2369,O
elongation,2373,2383,O
similarity,2398,2408,O
replication,2412,2423,O
rates,2424,2429,O
comparing,2435,2444,O
M13,2445,2448,O
DNA,2449,2452,O
replication,2453,2464,O
performed,2466,2475,O
absence,2483,2490,O
DBP,2494,2497,O
2400,2499,2503,O
nt,2504,2506,O
min,2507,2510,O
Nf,2518,2520,O
TP,2521,2523,O
DNA,2524,2527,O
replication,2528,2539,O
presence,2547,2555,O
DBP,2559,2562,O
2260,2564,2568,O
nt,2569,2571,O
min,2572,2575,O
suggests,2578,2586,O
DBP,2596,2599,O
stimulatory,2600,2611,O
role,2612,2616,O
restricted,2620,2630,O
phases,2644,2650,O
Nf,2654,2656,O
TP,2657,2659,O
DNA,2660,2663,O
replication,2664,2675,O
2,0,1,O
Theory,3,9,O
Scanning,10,18,O
holography,19,29,O
pupil,39,44,O
interaction,45,56,O
method,57,63,O
8,65,66,O
incoherent,77,87,O
imaging,88,95,O
complex,101,108,O
point,109,114,O
spread,115,121,O
functions,122,131,O
PSF,133,136,O
possible,141,149,O
method,155,161,O
recently,166,174,O
applied,180,187,O
recording,195,204,O
high,208,212,O
resolution,213,223,O
holographic,224,235,O
images,236,242,O
incoherent,246,256,O
objects,257,264,O
fluorescent,269,280,O
biological,281,291,O
specimens,292,301,O
6,303,304,O
7,305,306,O
single,311,317,O
sideband,318,326,O
line,330,334,O
Fresnel,335,342,O
hologram,343,351,O
obtained,355,363,O
2D,369,371,O
raster,372,378,O
scan,379,383,O
object,391,397,O
superposed,407,417,O
3D,418,420,O
diffraction,421,432,O
distributions,433,446,O
pupils,454,460,O
sketched,465,473,O
fig,477,480,O
1,482,483,O
pupil,493,498,O
distributions,499,512,O
P,513,514,O
1,515,516,O
rho,517,520,O
MathType,525,533,O
MTEF,534,538,O
5,539,540,O
5,541,542,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,631,662,O
OqFfea0dXdd9vqai,663,679,O
hGuQ8kuc9pgc9s8qqaq,680,699,O
dirpe0xb9q8qiLsFr0,700,718,O
vr0,719,722,O
3295,841,845,O
P,851,852,O
2,853,854,O
rho,855,858,O
MathType,863,871,O
MTEF,872,876,O
5,877,878,O
5,879,880,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,969,1000,O
OqFfea0dXdd9vqai,1001,1017,O
hGuQ8kuc9pgc9s8qqaq,1018,1037,O
dirpe0xb9q8qiLsFr0,1038,1056,O
vr0,1057,1060,O
3297,1179,1183,O
source,1199,1205,O
example,1211,1218,O
necessarily,1228,1239,O
laser,1243,1248,O
combined,1254,1262,O
beam,1268,1272,O
splitter,1273,1281,O
pupil,1289,1294,O
plane,1295,1300,O
objective,1308,1317,O
interfere,1329,1338,O
forming,1340,1347,O
Fresnel,1350,1357,O
pattern,1358,1365,O
depth,1373,1378,O
dependent,1379,1388,O
Fresnel,1389,1396,O
number,1397,1403,O
obtain,1408,1414,O
conventional,1419,1431,O
point,1432,1437,O
spread,1438,1444,O
function,1445,1453,O
wide,1457,1461,O
field,1462,1467,O
imaging,1468,1475,O
P1,1477,1479,O
chosen,1483,1489,O
point,1495,1500,O
source,1501,1507,O
P2,1513,1515,O
spherical,1521,1530,O
wave,1531,1535,O
appropriate,1541,1552,O
curvature,1553,1562,O
3D,1568,1570,O
specimen,1571,1579,O
placed,1583,1589,O
focal,1597,1602,O
region,1603,1609,O
objective,1617,1626,O
scattered,1632,1641,O
lights,1642,1648,O
transmitted,1650,1661,O
reflected,1663,1672,O
fluorescent,1678,1689,O
collected,1695,1704,O
non,1708,1711,O
imaging,1712,1719,O
detectors,1720,1729,O
hologram,1735,1743,O
data,1744,1748,O
obtained,1756,1764,O
heterodyne,1768,1778,O
detection,1779,1788,O
pupils,1805,1811,O
shifted,1812,1819,O
frequency,1823,1832,O
work,1850,1854,O
homodyne,1865,1873,O
method,1874,1880,O
requiring,1881,1890,O
capture,1895,1902,O
frames,1921,1927,O
different,1933,1942,O
relative,1943,1951,O
phases,1952,1958,O
pupils,1975,1981,O
9,1983,1984,O
amplitude,1991,2000,O
distribution,2001,2013,O
illuminating,2021,2033,O
beam,2034,2038,O
transverse,2045,2055,O
plane,2056,2061,O
axial,2068,2073,O
distance,2074,2082,O
z,2083,2084,O
focal,2094,2099,O
plane,2100,2105,O
objective,2113,2122,O
Fourier,2131,2138,O
transform,2139,2148,O
combined,2156,2164,O
pupil,2165,2170,O
distributions,2171,2184,O
10,2186,2188,O
Figure,2199,2205,O
1,2206,2207,O
Experimental,2208,2220,O
set,2221,2224,O
scanning,2233,2241,O
holographic,2242,2253,O
microscope,2254,2264,O
Sketch,2266,2272,O
experimental,2280,2292,O
setup,2293,2298,O
M,2300,2301,O
s,2302,2303,O
mirrors,2308,2315,O
BS,2317,2319,O
s,2320,2321,O
beam,2326,2330,O
splitters,2331,2340,O
EO,2342,2344,O
electro,2351,2358,O
optic,2359,2364,O
phase,2365,2370,O
modulator,2371,2380,O
Lens,2382,2386,O
L1,2387,2389,O
achromat,2391,2399,O
doublet,2400,2407,O
16,2408,2410,O
cm,2411,2413,O
focal,2414,2419,O
length,2420,2426,O
produces,2428,2436,O
desired,2441,2448,O
Fresnel,2449,2456,O
pattern,2457,2464,O
focal,2472,2477,O
plane,2478,2483,O
L2,2487,2489,O
achromat,2491,2499,O
doublet,2500,2507,O
16,2508,2510,O
cm,2511,2513,O
focal,2514,2519,O
length,2520,2526,O
L2,2529,2531,O
objective,2540,2549,O
form,2550,2554,O
4,2557,2558,O
f,2559,2560,O
system,2561,2567,O
projecting,2568,2578,O
reduced,2581,2588,O
image,2589,2594,O
Fresnel,2602,2609,O
pattern,2610,2617,O
specimen,2627,2635,O
L3,2637,2639,O
achromat,2641,2649,O
doublet,2650,2657,O
12,2658,2660,O
cm,2661,2663,O
focal,2664,2669,O
length,2670,2676,O
projects,2678,2686,O
images,2691,2697,O
pupils,2705,2711,O
pinhole,2719,2726,O
detector,2727,2735,O
shown,2742,2747,O
beam,2756,2760,O
expanders,2761,2770,O
illuminate,2779,2789,O
pupils,2794,2800,O
S,2803,2804,O
r,2805,2806,O
z,2810,2811,O
F,2813,2814,O
1,2815,2816,O
P,2818,2819,O
1,2820,2821,O
rho,2822,2825,O
z,2829,2830,O
P,2832,2833,O
2,2834,2835,O
rho,2836,2839,O
z,2843,2844,O
exp,2845,2848,O
iOmegat,2851,2858,O
1a,2863,2865,O
MathType,2867,2875,O
MTEF,2876,2880,O
5,2881,2882,O
5,2883,2884,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,2973,3004,O
OqFfea0dXdd9vqai,3005,3021,O
hGuQ8kuc9pgc9s8qqaq,3022,3041,O
dirpe0xb9q8qiLsFr0,3042,3060,O
vr0,3061,3064,O
5D95,3571,3575,O
P,3583,3584,O
1,3585,3586,O
2,3587,3588,O
rho,3589,3592,O
z,3596,3597,O
P,3599,3600,O
1,3601,3602,O
2,3603,3604,O
rho,3605,3608,O
exp,3612,3615,O
ipilambdazrho2,3617,3631,O
1b,3634,3636,O
MathType,3638,3646,O
MTEF,3647,3651,O
5,3652,3653,O
5,3654,3655,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,3744,3775,O
OqFfea0dXdd9vqai,3776,3792,O
hGuQ8kuc9pgc9s8qqaq,3793,3812,O
dirpe0xb9q8qiLsFr0,3813,3831,O
vr0,3832,3835,O
53A8,4238,4242,O
generalized,4252,4263,O
defocused,4264,4273,O
pupils,4274,4280,O
11,4282,4284,O
F,4287,4288,O
1,4289,4290,O
stands,4291,4297,O
inverse,4302,4309,O
Fourier,4310,4317,O
transform,4318,4327,O
Omega,4333,4338,O
frequency,4346,4355,O
shift,4356,4361,O
pupils,4376,4382,O
transverse,4388,4398,O
spatial,4399,4406,O
frequency,4407,4416,O
vector,4417,4423,O
rho,4424,4427,O
MathType,4431,4439,O
MTEF,4440,4444,O
5,4445,4446,O
5,4447,4448,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,4537,4568,O
OqFfea0dXdd9vqai,4569,4585,O
hGuQ8kuc9pgc9s8qqaq,4586,4605,O
dirpe0xb9q8qiLsFr0,4606,4624,O
vr0,4625,4628,O
2E85,4692,4696,O
r,4700,4701,O
MathType,4705,4713,O
MTEF,4714,4718,O
5,4719,4720,O
5,4721,4722,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,4811,4842,O
OqFfea0dXdd9vqai,4843,4859,O
hGuQ8kuc9pgc9s8qqaq,4860,4879,O
dirpe0xb9q8qiLsFr0,4880,4898,O
vr0,4899,4902,O
2E2B,4962,4966,O
P,4967,4968,O
lambdaf0,4969,4977,O
proportional,4981,4993,O
real,5001,5005,O
space,5006,5011,O
coordinate,5012,5022,O
r,5023,5024,O
MathType,5028,5036,O
MTEF,5037,5041,O
5,5042,5043,O
5,5044,5045,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,5134,5165,O
OqFfea0dXdd9vqai,5166,5182,O
hGuQ8kuc9pgc9s8qqaq,5183,5202,O
dirpe0xb9q8qiLsFr0,5203,5221,O
vr0,5222,5225,O
2E2B,5285,5289,O
P,5290,5291,O
pupil,5299,5304,O
plane,5305,5310,O
10,5312,5314,O
lambda,5317,5323,O
wavelength,5331,5341,O
illumination,5349,5361,O
f0,5367,5369,O
focal,5377,5382,O
length,5383,5389,O
objective,5397,5406,O
pupils,5416,5422,O
obtain,5431,5437,O
line,5444,5448,O
Fresnel,5449,5456,O
hologram,5457,5465,O
respectively,5471,5483,O
spherical,5487,5496,O
wave,5497,5501,O
filling,5502,5509,O
pupil,5514,5519,O
objective,5527,5536,O
point,5544,5549,O
center,5557,5563,O
pupil,5572,5577,O
P,5579,5580,O
1,5581,5582,O
rho,5583,5586,O
MathType,5591,5599,O
MTEF,5600,5604,O
5,5605,5606,O
5,5607,5608,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,5697,5728,O
OqFfea0dXdd9vqai,5729,5745,O
hGuQ8kuc9pgc9s8qqaq,5746,5765,O
dirpe0xb9q8qiLsFr0,5766,5784,O
vr0,5785,5788,O
3295,5907,5911,O
exp,5915,5918,O
ipilambdaz0rho2,5919,5934,O
circ,5935,5939,O
rho,5940,5943,O
rhoMAX,5944,5950,O
P,5952,5953,O
2,5954,5955,O
rho,5956,5959,O
delta,5964,5969,O
rho,5970,5973,O
2,5980,5981,O
MathType,5983,5991,O
MTEF,5992,5996,O
5,5997,5998,O
5,5999,6000,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,6089,6120,O
OqFfea0dXdd9vqai,6121,6137,O
hGuQ8kuc9pgc9s8qqaq,6138,6157,O
dirpe0xb9q8qiLsFr0,6158,6176,O
vr0,6177,6180,O
3D5F,6399,6403,O
circ,6405,6409,O
x,6410,6411,O
disc,6418,6422,O
function,6423,6431,O
unit,6435,6439,O
radius,6440,6446,O
rhoMAX,6448,6454,O
sinalpha,6457,6465,O
lambda,6466,6472,O
cutoff,6480,6486,O
frequency,6487,6496,O
objective,6504,6513,O
sinalpha,6521,6529,O
numerical,6542,6551,O
aperture,6552,6560,O
Fresnel,6566,6573,O
pattern,6574,6581,O
projected,6582,6591,O
object,6599,6605,O
interference,6613,6625,O
Fourier,6633,6640,O
transforms,6641,6651,O
pupils,6663,6669,O
spherical,6680,6689,O
wave,6690,6694,O
plane,6701,6706,O
wave,6707,6711,O
paraxial,6719,6727,O
approximation,6728,6741,O
Fresnel,6747,6754,O
number,6755,6761,O
pattern,6770,6777,O
determined,6781,6791,O
free,6799,6803,O
parameter,6804,6813,O
z0,6814,6816,O
distance,6831,6839,O
objective,6849,6858,O
s,6859,6860,O
focal,6861,6866,O
plane,6867,6872,O
point,6880,6885,O
spherical,6896,6905,O
wave,6906,6910,O
comes,6911,6916,O
focus,6922,6927,O
possible,6943,6951,O
modes,6952,6957,O
operation,6961,6970,O
depending,6972,6981,O
detector,6989,6997,O
geometry,6998,7006,O
5,7008,7009,O
spatially,7019,7028,O
integrating,7029,7040,O
detector,7041,7049,O
resulting,7055,7064,O
data,7065,7069,O
convolution,7075,7086,O
object,7094,7100,O
s,7101,7102,O
intensity,7103,7112,O
distribution,7113,7125,O
desired,7135,7142,O
complex,7143,7150,O
PSF,7151,7154,O
spherical,7166,7175,O
wave,7176,7180,O
radius,7188,7194,O
curvature,7198,7207,O
z0,7208,7210,O
z,7213,7214,O
radius,7222,7228,O
z0sinalpha,7233,7243,O
case,7253,7257,O
detection,7265,7274,O
mode,7275,7279,O
leads,7280,7285,O
hologram,7291,7299,O
dimensional,7321,7332,O
distribution,7333,7345,O
scattering,7349,7359,O
intensity,7360,7369,O
absorption,7371,7381,O
fluorescence,7387,7399,O
intensity,7400,7409,O
reconstructed,7417,7430,O
point,7439,7444,O
detector,7445,7453,O
center,7461,7467,O
conjugate,7473,7482,O
pupil,7483,7488,O
plane,7489,7494,O
resulting,7500,7509,O
data,7510,7514,O
convolution,7520,7531,O
object,7539,7545,O
s,7546,7547,O
complex,7548,7555,O
amplitude,7556,7565,O
distribution,7566,7578,O
complex,7593,7600,O
PSF,7601,7604,O
reconstruction,7610,7624,O
hologram,7633,7641,O
gives,7642,7647,O
dimensional,7658,7669,O
distribution,7670,7682,O
specimen,7690,7698,O
s,7699,7700,O
complex,7701,7708,O
amplitude,7709,7718,O
transmittance,7719,7732,O
particular,7737,7747,O
assuming,7749,7757,O
multiple,7763,7771,O
scattering,7772,7782,O
ignored,7790,7797,O
phase,7803,7808,O
reconstruction,7816,7830,O
quantitative,7836,7848,O
measure,7849,7856,O
integrated,7864,7874,O
optical,7875,7882,O
path,7883,7887,O
length,7888,7894,O
specimen,7907,7915,O
modes,7927,7932,O
operation,7936,7945,O
similar,7950,7957,O
usual,7965,7970,O
coherent,7971,7979,O
incoherent,7980,7990,O
imaging,7991,7998,O
modes,7999,8004,O
conventional,8010,8022,O
system,8023,8029,O
obtained,8041,8049,O
respectively,8060,8072,O
point,8076,8081,O
source,8082,8088,O
large,8095,8100,O
spatially,8101,8110,O
incoherent,8111,8121,O
source,8122,8128,O
scanning,8133,8141,O
holography,8142,8152,O
detector,8158,8166,O
size,8167,8171,O
plays,8172,8177,O
similar,8180,8187,O
role,8188,8192,O
source,8208,8214,O
size,8215,8219,O
conventional,8223,8235,O
imaging,8236,8243,O
simplicity,8249,8259,O
let,8261,8264,O
s,8265,8266,O
assume,8267,8273,O
object,8277,8283,O
amplitude,8292,8301,O
transmittance,8302,8315,O
T,8316,8317,O
r,8318,8319,O
MathType,8323,8331,O
MTEF,8332,8336,O
5,8337,8338,O
5,8339,8340,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,8429,8460,O
OqFfea0dXdd9vqai,8461,8477,O
hGuQ8kuc9pgc9s8qqaq,8478,8497,O
dirpe0xb9q8qiLsFr0,8498,8516,O
vr0,8517,8520,O
2E2B,8580,8584,O
z,8587,8588,O
Note,8591,8595,O
incoherent,8608,8618,O
fluorescent,8622,8633,O
object,8634,8640,O
phase,8646,8651,O
transmitted,8659,8670,O
field,8671,8676,O
random,8682,8688,O
variable,8689,8697,O
intensity,8712,8721,O
r,8724,8725,O
MathType,8729,8737,O
MTEF,8738,8742,O
5,8743,8744,O
5,8745,8746,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,8835,8866,O
OqFfea0dXdd9vqai,8867,8883,O
hGuQ8kuc9pgc9s8qqaq,8884,8903,O
dirpe0xb9q8qiLsFr0,8904,8922,O
vr0,8923,8926,O
2E2B,8986,8990,O
z,8993,8994,O
T,8999,9000,O
r,9001,9002,O
MathType,9006,9014,O
MTEF,9015,9019,O
5,9020,9021,O
5,9022,9023,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,9112,9143,O
OqFfea0dXdd9vqai,9144,9160,O
hGuQ8kuc9pgc9s8qqaq,9161,9180,O
dirpe0xb9q8qiLsFr0,9181,9199,O
vr0,9200,9203,O
2E2B,9263,9267,O
z,9270,9271,O
2,9273,9274,O
measurable,9278,9288,O
quasi,9296,9301,O
transparent,9302,9313,O
object,9314,9320,O
phase,9326,9331,O
equal,9335,9340,O
integrated,9348,9358,O
optical,9359,9366,O
thickness,9367,9376,O
object,9384,9390,O
Phi,9392,9395,O
r,9396,9397,O
MathType,9401,9409,O
MTEF,9410,9414,O
5,9415,9416,O
5,9417,9418,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,9507,9538,O
OqFfea0dXdd9vqai,9539,9555,O
hGuQ8kuc9pgc9s8qqaq,9556,9575,O
dirpe0xb9q8qiLsFr0,9576,9594,O
vr0,9595,9598,O
2E2B,9658,9662,O
2pi,9668,9671,O
lambda,9672,9678,O
integraldzn,9679,9690,O
r,9691,9692,O
MathType,9696,9704,O
MTEF,9705,9709,O
5,9710,9711,O
5,9712,9713,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,9802,9833,O
OqFfea0dXdd9vqai,9834,9850,O
hGuQ8kuc9pgc9s8qqaq,9851,9870,O
dirpe0xb9q8qiLsFr0,9871,9889,O
vr0,9890,9893,O
2E2B,9953,9957,O
z,9960,9961,O
n,9970,9971,O
r,9972,9973,O
MathType,9977,9985,O
MTEF,9986,9990,O
5,9991,9992,O
5,9993,9994,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,10083,10114,O
OqFfea0dXdd9vqai,10115,10131,O
hGuQ8kuc9pgc9s8qqaq,10132,10151,O
dirpe0xb9q8qiLsFr0,10152,10170,O
vr0,10171,10174,O
2E2B,10234,10238,O
z,10241,10242,O
3D,10251,10253,O
distribution,10254,10266,O
refractive,10270,10280,O
index,10281,10286,O
amplitude,10292,10301,O
distribution,10302,10314,O
object,10325,10331,O
written,10335,10342,O
r,10348,10349,O
MathType,10353,10361,O
MTEF,10362,10366,O
5,10367,10368,O
5,10369,10370,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,10459,10490,O
OqFfea0dXdd9vqai,10491,10507,O
hGuQ8kuc9pgc9s8qqaq,10508,10527,O
dirpe0xb9q8qiLsFr0,10528,10546,O
vr0,10547,10550,O
2E2B,10610,10614,O
t,10617,10618,O
integraldzS,10622,10633,O
r,10634,10635,O
MathType,10639,10647,O
MTEF,10648,10652,O
5,10653,10654,O
5,10655,10656,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,10745,10776,O
OqFfea0dXdd9vqai,10777,10793,O
hGuQ8kuc9pgc9s8qqaq,10794,10813,O
dirpe0xb9q8qiLsFr0,10814,10832,O
vr0,10833,10836,O
2E2B,10896,10900,O
z,10903,10904,O
T,10905,10906,O
r,10907,10908,O
MathType,10912,10920,O
MTEF,10921,10925,O
5,10926,10927,O
5,10928,10929,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,11018,11049,O
OqFfea0dXdd9vqai,11050,11066,O
hGuQ8kuc9pgc9s8qqaq,11067,11086,O
dirpe0xb9q8qiLsFr0,11087,11105,O
vr0,11106,11109,O
2E2B,11169,11173,O
r,11175,11176,O
MathType,11180,11188,O
MTEF,11189,11193,O
5,11194,11195,O
5,11196,11197,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,11286,11317,O
OqFfea0dXdd9vqai,11318,11334,O
hGuQ8kuc9pgc9s8qqaq,11335,11354,O
dirpe0xb9q8qiLsFr0,11355,11373,O
vr0,11374,11377,O
2E2B,11437,11441,O
S,11442,11443,O
t,11444,11445,O
z,11448,11449,O
3,11453,11454,O
r,11462,11463,O
MathType,11467,11475,O
MTEF,11476,11480,O
5,11481,11482,O
5,11483,11484,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,11573,11604,O
OqFfea0dXdd9vqai,11605,11621,O
hGuQ8kuc9pgc9s8qqaq,11622,11641,O
dirpe0xb9q8qiLsFr0,11642,11660,O
vr0,11661,11664,O
2E2B,11724,11728,O
S,11729,11730,O
t,11731,11732,O
instantaneous,11741,11754,O
position,11755,11763,O
2D,11771,11773,O
raster,11774,11780,O
scan,11781,11785,O
incoherent,11791,11801,O
imaging,11802,11809,O
mode,11810,11814,O
obtained,11818,11826,O
spatially,11834,11843,O
integrating,11844,11855,O
detector,11856,11864,O
leading,11866,11873,O
temporal,11879,11887,O
signal,11888,11894,O
proportional,11895,11907,O
integrated,11915,11925,O
intensity,11926,11935,O
integrald2r,11937,11948,O
r,11951,11952,O
MathType,11956,11964,O
MTEF,11965,11969,O
5,11970,11971,O
5,11972,11973,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,12062,12093,O
OqFfea0dXdd9vqai,12094,12110,O
hGuQ8kuc9pgc9s8qqaq,12111,12130,O
dirpe0xb9q8qiLsFr0,12131,12149,O
vr0,12150,12153,O
2E2B,12213,12217,O
t,12220,12221,O
2,12223,12224,O
stored,12235,12241,O
computer,12249,12257,O
data,12263,12267,O
corresponding,12268,12281,O
hologram,12290,12298,O
line,12299,12303,O
cut,12307,12310,O
signal,12320,12326,O
band,12332,12336,O
pass,12337,12341,O
filtered,12342,12350,O
extract,12354,12361,O
term,12366,12370,O
oscillating,12371,12382,O
Omega,12386,12391,O
lines,12397,12402,O
rearranged,12412,12422,O
2D,12428,12430,O
format,12431,12437,O
resulting,12443,12452,O
hologram,12453,12461,O
amplitude,12462,12471,O
found,12475,12480,O
HI,12487,12489,O
r,12490,12491,O
MathType,12495,12503,O
MTEF,12504,12508,O
5,12509,12510,O
5,12511,12512,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,12601,12632,O
OqFfea0dXdd9vqai,12633,12649,O
hGuQ8kuc9pgc9s8qqaq,12650,12669,O
dirpe0xb9q8qiLsFr0,12670,12688,O
vr0,12689,12692,O
2E2B,12752,12756,O
integraldzI,12761,12772,O
r,12773,12774,O
MathType,12778,12786,O
MTEF,12787,12791,O
5,12792,12793,O
5,12794,12795,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,12884,12915,O
OqFfea0dXdd9vqai,12916,12932,O
hGuQ8kuc9pgc9s8qqaq,12933,12952,O
dirpe0xb9q8qiLsFr0,12953,12971,O
vr0,12972,12975,O
2E2B,13035,13039,O
z,13042,13043,O
p1,13050,13052,O
r,13053,13054,O
MathType,13058,13066,O
MTEF,13067,13071,O
5,13072,13073,O
5,13074,13075,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,13164,13195,O
OqFfea0dXdd9vqai,13196,13212,O
hGuQ8kuc9pgc9s8qqaq,13213,13232,O
dirpe0xb9q8qiLsFr0,13233,13251,O
vr0,13252,13255,O
2E2B,13315,13319,O
z,13322,13323,O
p,13324,13325,O
2,13326,13327,O
r,13328,13329,O
MathType,13333,13341,O
MTEF,13342,13346,O
5,13347,13348,O
5,13349,13350,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,13439,13470,O
OqFfea0dXdd9vqai,13471,13487,O
hGuQ8kuc9pgc9s8qqaq,13488,13507,O
dirpe0xb9q8qiLsFr0,13508,13526,O
vr0,13527,13530,O
2E2B,13590,13594,O
z,13597,13598,O
4,13603,13604,O
symbolizes,13616,13626,O
convolution,13629,13640,O
integral,13641,13649,O
r,13653,13654,O
MathType,13658,13666,O
MTEF,13667,13671,O
5,13672,13673,O
5,13674,13675,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,13764,13795,O
OqFfea0dXdd9vqai,13796,13812,O
hGuQ8kuc9pgc9s8qqaq,13813,13832,O
dirpe0xb9q8qiLsFr0,13833,13851,O
vr0,13852,13855,O
2E2B,13915,13919,O
z,13922,13923,O
T,13928,13929,O
r,13930,13931,O
MathType,13935,13943,O
MTEF,13944,13948,O
5,13949,13950,O
5,13951,13952,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,14041,14072,O
OqFfea0dXdd9vqai,14073,14089,O
hGuQ8kuc9pgc9s8qqaq,14090,14109,O
dirpe0xb9q8qiLsFr0,14110,14128,O
vr0,14129,14132,O
2E2B,14192,14196,O
z,14199,14200,O
2,14202,14203,O
p1,14209,14211,O
2,14212,14213,O
r,14214,14215,O
MathType,14219,14227,O
MTEF,14228,14232,O
5,14233,14234,O
5,14235,14236,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,14325,14356,O
OqFfea0dXdd9vqai,14357,14373,O
hGuQ8kuc9pgc9s8qqaq,14374,14393,O
dirpe0xb9q8qiLsFr0,14394,14412,O
vr0,14413,14416,O
2E2B,14476,14480,O
z,14483,14484,O
inverse,14494,14501,O
Fourier,14502,14509,O
transforms,14510,14520,O
defocused,14528,14537,O
pupil,14538,14543,O
distributions,14544,14557,O
eq,14559,14561,O
1b,14562,14564,O
superscript,14571,14582,O
stands,14585,14591,O
complex,14596,14603,O
conjugate,14604,14613,O
hologram,14619,14627,O
convolution,14640,14651,O
object,14659,14665,O
intensity,14666,14675,O
spherical,14683,14692,O
wave,14693,14697,O
e,14701,14702,O
line,14710,14714,O
single,14715,14721,O
sideband,14722,14730,O
Gabor,14731,14736,O
hologram,14737,14745,O
Fourier,14750,14757,O
space,14758,14763,O
hologram,14769,14777,O
written,14785,14792,O
H,14796,14797,O
rho,14800,14803,O
integraldzI,14808,14819,O
rho,14821,14824,O
z,14828,14829,O
P,14831,14832,O
1,14833,14834,O
rho,14835,14838,O
z,14842,14843,O
P,14847,14848,O
2,14849,14850,O
rho,14851,14854,O
z,14858,14859,O
5,14864,14865,O
MathType,14867,14875,O
MTEF,14876,14880,O
5,14881,14882,O
5,14883,14884,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,14973,15004,O
OqFfea0dXdd9vqai,15005,15021,O
hGuQ8kuc9pgc9s8qqaq,15022,15041,O
dirpe0xb9q8qiLsFr0,15042,15060,O
vr0,15061,15064,O
58FF,15551,15555,O
symbolizes,15567,15577,O
correlation,15580,15591,O
integral,15592,15600,O
pupils,15611,15617,O
eq,15621,15623,O
2,15624,15625,O
find,15630,15634,O
paraxial,15643,15651,O
approximation,15652,15665,O
H,15667,15668,O
rho,15671,15674,O
integraldzI,15679,15690,O
rho,15692,15695,O
z,15699,15700,O
exp,15701,15704,O
ipilambda,15706,15715,O
z0,15716,15718,O
z,15719,15720,O
rho2,15721,15725,O
circ,15726,15730,O
rho,15731,15734,O
rhoMAX,15735,15741,O
6,15745,15746,O
MathType,15748,15756,O
MTEF,15757,15761,O
5,15762,15763,O
5,15764,15765,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,15854,15885,O
OqFfea0dXdd9vqai,15886,15902,O
hGuQ8kuc9pgc9s8qqaq,15903,15922,O
dirpe0xb9q8qiLsFr0,15923,15941,O
vr0,15942,15945,O
b8aWjab,16217,16224,O
67E3,16516,16520,O
Fourier,16535,16542,O
transform,16543,16552,O
Fresnel,16560,16567,O
hologram,16568,16576,O
object,16584,16590,O
s,16591,16592,O
intensity,16593,16602,O
distribution,16603,16615,O
coherent,16621,16629,O
imaging,16630,16637,O
mode,16638,16642,O
obtained,16646,16654,O
pinhole,16666,16673,O
point,16679,16684,O
detector,16685,16693,O
center,16701,16707,O
conjugate,16713,16722,O
plane,16723,16728,O
pupil,16736,16741,O
objective,16749,16758,O
leads,16765,16770,O
hologram,16778,16786,O
amplitude,16787,16796,O
HC,16797,16799,O
r,16800,16801,O
MathType,16805,16813,O
MTEF,16814,16818,O
5,16819,16820,O
5,16821,16822,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,16911,16942,O
OqFfea0dXdd9vqai,16943,16959,O
hGuQ8kuc9pgc9s8qqaq,16960,16979,O
dirpe0xb9q8qiLsFr0,16980,16998,O
vr0,16999,17002,O
2E2B,17062,17066,O
integraldz,17071,17081,O
T,17082,17083,O
r,17084,17085,O
MathType,17089,17097,O
MTEF,17098,17102,O
5,17103,17104,O
5,17105,17106,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,17195,17226,O
OqFfea0dXdd9vqai,17227,17243,O
hGuQ8kuc9pgc9s8qqaq,17244,17263,O
dirpe0xb9q8qiLsFr0,17264,17282,O
vr0,17283,17286,O
2E2B,17346,17350,O
z,17353,17354,O
p1,17360,17362,O
r,17363,17364,O
MathType,17368,17376,O
MTEF,17377,17381,O
5,17382,17383,O
5,17384,17385,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,17474,17505,O
OqFfea0dXdd9vqai,17506,17522,O
hGuQ8kuc9pgc9s8qqaq,17523,17542,O
dirpe0xb9q8qiLsFr0,17543,17561,O
vr0,17562,17565,O
2E2B,17625,17629,O
z,17632,17633,O
T,17636,17637,O
r,17638,17639,O
MathType,17643,17651,O
MTEF,17652,17656,O
5,17657,17658,O
5,17659,17660,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,17749,17780,O
OqFfea0dXdd9vqai,17781,17797,O
hGuQ8kuc9pgc9s8qqaq,17798,17817,O
dirpe0xb9q8qiLsFr0,17818,17836,O
vr0,17837,17840,O
2E2B,17900,17904,O
z,17907,17908,O
p2,17914,17916,O
r,17917,17918,O
MathType,17922,17930,O
MTEF,17931,17935,O
5,17936,17937,O
5,17938,17939,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,18028,18059,O
OqFfea0dXdd9vqai,18060,18076,O
hGuQ8kuc9pgc9s8qqaq,18077,18096,O
dirpe0xb9q8qiLsFr0,18097,18115,O
vr0,18116,18119,O
2E2B,18179,18183,O
z,18186,18187,O
7,18193,18194,O
symbolizes,18213,18223,O
convolution,18226,18237,O
product,18238,18245,O
superscript,18255,18266,O
stands,18269,18275,O
complex,18280,18287,O
conjugate,18288,18297,O
Fourier,18302,18309,O
space,18310,18315,O
H,18317,18318,O
C,18319,18320,O
rho,18321,18324,O
integraldzT,18329,18340,O
rho,18342,18345,O
z,18349,18350,O
P,18351,18352,O
1,18353,18354,O
rho,18355,18358,O
z,18362,18363,O
T,18367,18368,O
rho,18370,18373,O
z,18377,18378,O
P,18379,18380,O
2,18381,18382,O
rho,18383,18386,O
z,18390,18391,O
8,18395,18396,O
MathType,18398,18406,O
MTEF,18407,18411,O
5,18412,18413,O
5,18414,18415,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,18504,18535,O
OqFfea0dXdd9vqai,18536,18552,O
hGuQ8kuc9pgc9s8qqaq,18553,18572,O
dirpe0xb9q8qiLsFr0,18573,18591,O
vr0,18592,18595,O
5E5B,19115,19119,O
pupils,19130,19136,O
eq,19140,19142,O
2,19143,19144,O
find,19149,19153,O
H,19154,19155,O
C,19156,19157,O
rho,19158,19161,O
integraldzT,19166,19177,O
0,19180,19181,O
z,19182,19183,O
T,19184,19185,O
rho,19187,19190,O
z,19194,19195,O
exp,19196,19199,O
ipilambda,19201,19210,O
z0,19211,19213,O
z,19214,19215,O
rho2,19216,19220,O
circ,19221,19225,O
rho,19226,19229,O
rhoMAX,19230,19236,O
9,19240,19241,O
MathType,19243,19251,O
MTEF,19252,19256,O
5,19257,19258,O
5,19259,19260,O
wiFfYdH8Gipec8Eeeu0xXdbba9frFj0,19349,19380,O
OqFfea0dXdd9vqai,19381,19397,O
hGuQ8kuc9pgc9s8qqaq,19398,19417,O
dirpe0xb9q8qiLsFr0,19418,19436,O
vr0,19437,19440,O
f8aYjabc,19944,19952,O
caViab,19953,19959,O
6F41,20072,20076,O
Aside,20078,20083,O
inconsequential,20092,20107,O
complex,20108,20115,O
constant,20116,20124,O
term,20136,20140,O
integral,20151,20159,O
eq,20162,20164,O
9,20165,20166,O
Fourier,20174,20181,O
transform,20182,20191,O
Fresnel,20199,20206,O
hologram,20207,20215,O
object,20223,20229,O
s,20230,20231,O
complex,20232,20239,O
amplitude,20240,20249,O
distribution,20250,20262,O
reconstruction,20274,20288,O
hologram,20296,20304,O
recorded,20305,20313,O
coherent,20321,20329,O
mode,20330,20334,O
carries,20335,20342,O
quantitative,20345,20357,O
measure,20358,20365,O
object,20373,20379,O
s,20380,20381,O
phase,20382,20387,O
distribution,20388,20400,O
Results,0,7,O
include,16,23,O
data,24,28,O
obtained,29,37,O
active,43,49,O
oscillatory,51,62,O
brain,63,68,B-Multi-tissue_structure
slices,69,75,I-Multi-tissue_structure
recordings,92,102,O
cortical,110,118,B-Multi-tissue_structure
slow,119,123,O
oscillations,124,136,O
anesthetized,140,152,O
animals,153,160,O
recordings,166,176,O
included,177,185,O
study,194,199,O
obtained,205,213,O
visual,223,229,B-Multi-tissue_structure
cortex,230,236,I-Multi-tissue_structure
ferret,244,250,O
vitro,255,260,O
cat,263,266,O
vivo,271,275,O
barrel,286,292,B-Multi-tissue_structure
cortex,293,299,I-Multi-tissue_structure
rat,307,310,O
vivo,315,319,O
neurons,334,341,B-Cell
recorded,342,350,O
ferret,356,362,O
cortical,363,371,B-Multi-tissue_structure
slices,372,378,I-Multi-tissue_structure
included,383,391,O
study,400,405,O
22,407,409,O
regular,410,417,O
spiking,418,425,O
RS,427,429,O
5,432,433,O
chattering,434,444,O
CH,446,448,O
2,454,455,O
intrinsic,456,465,O
bursting,466,474,O
IB,476,478,O
27,482,484,O
neurons,485,492,B-Cell
cat,498,501,O
visual,502,508,B-Multi-tissue_structure
cortex,509,515,I-Multi-tissue_structure
vivo,519,523,O
14,525,527,O
RS,528,530,O
5,532,533,O
CH,534,536,O
2,538,539,O
IB,540,542,O
3,544,545,O
fast,546,550,O
spiking,551,558,O
FS,560,562,O
plus,565,569,O
3,570,571,O
non,572,575,O
classified,576,586,O
14,592,594,O
neurons,595,602,B-Cell
rat,608,611,O
barrel,612,618,B-Multi-tissue_structure
cortex,619,625,I-Multi-tissue_structure
vivo,629,633,O
12,635,637,O
RS,638,640,O
1,642,643,O
CH,644,646,O
1,648,649,O
IB,650,652,O
Synaptic,655,663,B-Cellular_component
potentials,664,674,O
evoked,680,686,O
electric,690,698,O
shocks,699,705,O
intracortical,707,720,O
thalamocortical,724,739,O
connections,740,751,O
means,759,764,O
sensory,768,775,O
visual,777,783,O
whisker,787,794,O
stimulation,796,807,O
main,813,817,O
results,818,825,O
1,831,832,O
Synaptic,834,842,B-Cellular_component
potentials,843,853,O
paired,864,870,O
pulsed,871,877,O
facilitation,878,890,O
synaptic,895,903,B-Cellular_component
augmentation,904,916,O
active,920,926,O
silent,935,941,O
cortical,942,950,B-Multi-tissue_structure
networks,951,959,O
2,964,965,O
Synaptic,967,975,B-Cellular_component
potentials,976,986,O
occurring,987,996,O
activated,1010,1019,O
states,1020,1026,O
cortex,1034,1040,B-Multi-tissue_structure
increased,1041,1050,O
amplitude,1057,1066,O
respect,1072,1079,O
occurring,1089,1098,O
states,1111,1117,O
Ca2,0,3,O
Dependence,5,15,O
Slob57,19,25,O
Modulation,26,36,O
Voltage,44,51,O
Dependence,52,62,O
Activation,66,76,O
dSlo,80,84,O
Ca2,85,88,O
plays,90,95,O
fundamental,98,109,O
role,110,114,O
regulating,118,128,O
dSlo,133,137,O
response,138,146,O
membrane,150,158,B-Cellular_component
depolarization,159,173,O
known,192,197,O
Ca2,198,201,O
binding,203,210,O
sites,211,216,O
Xia,218,221,O
et,222,224,O
al,225,227,O
2002,230,234,O
Bao,236,239,O
et,240,242,O
al,243,245,O
2002,248,252,O
Zeng,254,258,O
et,259,261,O
al,262,264,O
2005b,267,272,O
known,275,280,O
calcium,288,295,O
bowl,296,300,O
Schreiber,302,311,O
Salkoff,316,323,O
1997,325,329,O
contributes,332,343,O
high,351,355,O
affinity,356,364,O
Ca2,365,368,O
sensitivity,370,381,O
channel,389,396,O
Schreiber,398,407,O
Salkoff,412,419,O
1997,421,425,O
Schreiber,427,436,O
et,437,439,O
al,440,442,O
1999,445,449,O
Braun,451,456,O
Sy,461,463,O
2001,465,469,O
Bao,471,474,O
et,475,477,O
al,478,480,O
2002,483,487,O
Niu,489,492,O
Magleby,497,504,O
2002,506,510,O
Xia,512,515,O
et,516,518,O
al,519,521,O
2002,524,528,O
Bao,530,533,O
et,534,536,O
al,537,539,O
2004,542,546,O
Zeng,548,552,O
et,553,555,O
al,556,558,O
2005b,561,566,O
mutated,579,586,O
dSlo,587,591,O
channel,592,599,O
substitution,605,617,O
Asp966,621,627,O
Asp970,628,634,O
Asn966,638,644,O
Asn970,645,651,O
calcium,663,670,O
bowl,671,675,O
greatly,683,690,O
reduces,691,698,O
channel,703,710,O
s,711,712,O
calcium,713,720,O
sensitivity,721,732,O
Bian,734,738,O
et,739,741,O
al,742,744,O
2001,747,751,O
determine,757,766,O
Ca2,775,778,O
participates,780,792,O
Slob57,796,802,O
modulation,803,813,O
dSlo,817,821,O
mutated,828,835,O
channel,836,843,O
dSloD5N5,845,853,O
binds,861,866,O
length,875,881,O
truncated,886,895,O
Slobs,896,901,O
Fig,903,906,O
1,908,909,O
B,910,911,O
lanes,913,918,O
4,919,920,O
6,921,922,O
350,934,937,O
ms,938,940,O
test,941,945,O
pulse,946,951,O
Fig,953,956,O
7,958,959,O
E,960,961,O
Slob57,964,970,O
causes,971,977,O
dSloD5N5,978,986,O
inactivation,987,999,O
Fig,1001,1004,O
7,1006,1007,O
B,1008,1009,O
consistent,1012,1022,O
previous,1032,1040,O
finding,1041,1048,O
inactivation,1058,1070,O
caused,1071,1077,O
Slob57,1081,1087,O
Ca2,1091,1094,O
independent,1096,1107,O
Zeng,1109,1113,O
et,1114,1116,O
al,1117,1119,O
2005a,1122,1127,O
deletion,1136,1144,O
amino,1152,1157,O
terminal,1158,1166,O
residues,1167,1175,O
2,1176,1177,O
6,1178,1179,O
Slob57,1183,1189,O
inactivation,1195,1207,O
dSloD5N5,1211,1219,O
eliminated,1223,1233,O
Fig,1235,1238,O
7,1240,1241,O
C,1242,1243,O
truncation,1258,1268,O
Slob57,1272,1278,O
Arg16,1282,1287,O
eliminates,1293,1303,O
inactivation,1308,1320,O
Fig,1322,1325,O
7,1327,1328,O
D,1329,1330,O
observed,1341,1349,O
wild,1355,1359,O
type,1360,1364,O
dSlo,1365,1369,O
Fig,1371,1374,O
2,1376,1377,O
C,1379,1380,O
D,1385,1386,O
Figure,1389,1395,O
7,1396,1397,O
Slob57,1399,1405,O
causes,1406,1412,O
inactivation,1413,1425,O
dSloD5N5,1429,1437,O
Fig,1447,1450,O
2,1452,1453,O
mutated,1471,1478,O
channel,1479,1486,O
dSloD5N5,1487,1495,O
instead,1505,1512,O
wild,1516,1520,O
type,1521,1525,O
dSlo,1526,1530,O
dSloD5N5,1536,1544,O
B,1553,1554,O
dSloD5N5,1556,1564,O
Slob57,1579,1585,O
C,1588,1589,O
dSloD5N5,1591,1599,O
Slob57DeltaN5,1614,1627,O
D,1630,1631,O
dSloD5N5,1633,1641,O
Slob57DeltaN15,1656,1670,O
E,1673,1674,O
pulse,1676,1681,O
protocol,1682,1690,O
100,1707,1710,O
ms,1711,1713,O
test,1714,1718,O
pulse,1719,1724,O
inactivation,1742,1754,O
occurs,1755,1761,O
measure,1766,1773,O
voltage,1778,1785,O
dependence,1786,1796,O
activation,1800,1810,O
dSloD5N5,1814,1822,O
presence,1830,1838,O
110,1842,1845,O
muM,1846,1849,O
free,1850,1854,O
Ca2,1855,1858,O
high,1872,1876,O
concentrations,1877,1891,O
free,1895,1899,O
Ca2,1900,1903,O
tail,1909,1913,O
current,1914,1921,O
saturation,1922,1932,O
achieved,1936,1944,O
mutant,1954,1960,O
channel,1961,1968,O
Fig,1970,1973,O
8,1975,1976,O
shown,1982,1987,O
Fig,1991,1994,O
8,1996,1997,O
Slob57,1999,2005,O
rightward,2015,2024,O
shift,2025,2030,O
conductance,2035,2046,O
voltage,2047,2054,O
relationship,2055,2067,O
dSloD5N5,2071,2079,O
dSloD5N5,2089,2097,O
respond,2108,2115,O
increment,2122,2131,O
free,2135,2139,O
Ca2,2140,2143,O
high,2148,2152,O
concentration,2153,2166,O
Bian,2168,2172,O
et,2173,2175,O
al,2176,2178,O
2001,2181,2185,O
increased,2196,2205,O
concentration,2210,2223,O
free,2227,2231,O
Ca2,2232,2235,O
300,2240,2243,O
muM,2244,2247,O
shown,2252,2257,O
Fig,2261,2264,O
8,2266,2267,O
conductance,2273,2284,O
voltage,2285,2292,O
relationship,2293,2305,O
dSloD5N5,2309,2317,O
shifts,2318,2324,O
depolarized,2333,2344,O
voltages,2345,2353,O
concentration,2363,2376,O
free,2380,2384,O
Ca2,2385,2388,O
increased,2393,2402,O
110,2408,2411,O
300,2415,2418,O
muM,2419,2422,O
V1,2438,2440,O
2,2441,2442,O
modulated,2450,2459,O
Slob57,2463,2469,O
Figure,2471,2477,O
8,2478,2479,O
Conductance,2481,2492,O
voltage,2493,2500,O
relationships,2501,2514,O
dSloD5N5,2519,2527,O
protocol,2534,2542,O
Fig,2546,2549,O
6,2551,2552,O
mutated,2570,2577,O
channel,2578,2585,O
dSloD5N5,2586,2594,O
presence,2611,2619,O
circles,2621,2628,O
absence,2633,2640,O
squares,2642,2649,O
Slob57,2654,2660,O
concentration,2670,2683,O
free,2687,2691,O
Ca2,2692,2695,O
110,2708,2711,O
muM,2712,2715,O
filled,2717,2723,O
symbols,2724,2731,O
300,2736,2739,O
muM,2740,2743,O
open,2745,2749,O
symbols,2750,2757,O
measured,2768,2776,O
voltage,2781,2788,O
dependence,2789,2799,O
activation,2803,2813,O
wild,2817,2821,O
type,2822,2826,O
dSlo,2827,2831,O
presence,2840,2848,O
absence,2852,2859,O
Slob57,2863,2869,O
free,2874,2878,O
Ca2,2879,2882,O
concentrations,2884,2898,O
ranging,2899,2906,O
20,2912,2914,O
300,2918,2921,O
muM,2922,2925,O
shown,2930,2935,O
Fig,2939,2942,O
9,2944,2945,O
previous,2961,2969,O
investigators,2970,2983,O
absence,2993,3000,O
Slob57,3004,3010,O
voltage,3016,3023,O
conductance,3024,3035,O
relationship,3036,3048,O
dSlo,3052,3056,O
shifts,3057,3063,O
depolarized,3072,3083,O
voltages,3084,3092,O
free,3100,3104,O
Ca2,3105,3108,O
concentration,3110,3123,O
increased,3127,3136,O
range,3145,3150,O
V1,3156,3158,O
2,3159,3160,O
decreases,3161,3170,O
85,3176,3178,O
22,3183,3185,O
mV,3186,3188,O
change,3192,3198,O
107,3202,3205,O
mV,3206,3208,O
concentration,3219,3232,O
free,3236,3240,O
Ca2,3241,3244,O
increased,3249,3258,O
20,3264,3266,O
300,3270,3273,O
muM,3274,3277,O
contrast,3282,3290,O
dSlo,3297,3301,O
coexpressed,3305,3316,O
Slob57,3322,3328,O
increment,3335,3344,O
free,3348,3352,O
Ca2,3353,3356,O
concentration,3358,3371,O
shifts,3372,3378,O
V1,3383,3385,O
2,3386,3387,O
lesser,3398,3404,O
extent,3405,3411,O
Fig,3413,3416,O
9,3418,3419,O
B,3420,3421,O
Fig,3426,3429,O
10,3431,3433,O
Note,3438,3442,O
effect,3457,3463,O
Slob57,3467,3473,O
V1,3481,3483,O
2,3484,3485,O
apparent,3494,3502,O
higher,3506,3512,O
free,3513,3517,O
Ca2,3518,3521,O
concentrations,3523,3537,O
Fig,3539,3542,O
10,3544,3546,O
illustrate,3554,3564,O
better,3570,3576,O
plotted,3581,3588,O
V1,3593,3595,O
2,3596,3597,O
change,3598,3604,O
evoked,3605,3611,O
Slob57,3615,3621,O
DeltaV1,3623,3630,O
2,3631,3632,O
function,3639,3647,O
free,3655,3659,O
Ca2,3660,3663,O
concentration,3665,3678,O
Fig,3680,3683,O
10,3685,3687,O
B,3688,3689,O
demonstrate,3694,3705,O
magnitude,3715,3724,O
modulatory,3732,3742,O
shift,3743,3748,O
V1,3752,3754,O
2,3755,3756,O
evoked,3757,3763,O
Slob57,3767,3773,O
calcium,3784,3791,O
dependent,3792,3801,O
Figure,3803,3809,O
9,3810,3811,O
Effect,3813,3819,O
calcium,3823,3830,O
dSlo,3834,3838,O
voltage,3839,3846,O
dependence,3847,3857,O
activation,3861,3871,O
absence,3879,3886,O
presence,3890,3898,O
Slob57,3902,3908,O
Fig,3918,3921,O
6,3923,3924,O
measurements,3942,3954,O
dSlo,3958,3962,O
expressed,3963,3972,O
Slob57,4000,4006,O
B,4008,4009,O
performed,4016,4025,O
presence,4033,4041,O
different,4045,4054,O
concentrations,4055,4069,O
free,4073,4077,O
Ca2,4078,4081,O
20,4084,4086,O
muM,4087,4090,O
diamonds,4092,4100,O
40,4103,4105,O
muM,4106,4109,O
inverted,4111,4119,O
triangles,4120,4129,O
80,4132,4134,O
muM,4135,4138,O
triangles,4140,4149,O
110,4152,4155,O
muM,4156,4159,O
squares,4161,4168,O
300,4175,4178,O
muM,4179,4182,O
circles,4184,4191,O
Figure,4194,4200,O
10,4201,4203,O
Interaction,4205,4216,O
Slob57,4225,4231,O
calcium,4236,4243,O
V1,4249,4251,O
2,4252,4253,O
conductance,4265,4276,O
voltage,4277,4284,O
relationship,4285,4297,O
dSlo,4302,4306,O
expressed,4307,4316,O
O,4324,4325,O
Slob57,4344,4350,O
taken,4356,4361,O
Fig,4367,4370,O
9,4372,4373,O
difference,4383,4393,O
V1,4397,4399,O
2,4400,4401,O
DeltaV1,4403,4410,O
2,4411,4412,O
evoked,4414,4420,O
Slob57,4424,4430,O
B,4432,4433,O
plotted,4439,4446,O
function,4452,4460,O
concentration,4468,4481,O
free,4485,4489,O
Ca2,4490,4493,O
Authors,0,7,O
contributions,9,22,O
OK,23,25,O
MG,30,32,O
analyzed,33,41,O
interpreted,46,57,O
patient,62,69,O
data,70,74,O
hospitalization,89,104,O
SP,106,108,O
PK,113,115,O
performed,116,125,O
coronary,130,138,B-Multi-tissue_structure
angiography,139,150,O
major,165,170,O
contributors,171,183,O
writing,187,194,O
manuscript,199,209,O
authors,215,222,O
read,223,227,O
approved,232,240,O
final,245,250,O
manuscript,251,261,O
Authors,0,7,O
contributions,9,22,O
CM,23,25,O
JRH,27,30,O
HJP,32,35,O
JH,41,43,O
carried,44,51,O
animal,52,58,O
studies,59,66,O
CM,68,70,O
performed,71,80,O
statistical,85,96,O
analysis,97,105,O
JLK,107,110,O
conceived,111,120,O
study,128,133,O
participated,135,147,O
design,155,161,O
coordination,166,178,O
drafted,184,191,O
edited,196,202,O
manuscript,207,217,O
authors,223,230,O
read,231,235,O
approved,240,248,O
final,253,258,O
manuscript,259,269,O
Disk,0,4,O
preparation,5,16,O
phase,17,22,O
o,23,24,O
Adoption,25,33,O
stage,43,48,O
sampling,49,57,O
scheme,58,64,O
o,66,67,O
Careful,68,75,O
planning,76,84,O
choice,89,95,O
representative,99,113,O
sampling,114,122,O
groups,123,129,O
sites,134,139,O
according,140,149,O
adopted,157,164,O
network,165,172,O
sampling,173,181,O
technique,182,191,O
determining,197,208,O
certain,209,216,O
criteria,217,225,O
control,234,241,O
sites,242,247,O
major,254,259,O
sampling,260,268,O
groups,269,275,O
exist,276,281,O
e,285,286,O
surface,288,295,O
water,296,301,O
points,302,308,O
valleys,310,317,O
wells,323,328,O
impact,331,337,O
sites,338,343,O
contamination,350,363,O
expected,367,375,O
polygons,385,393,O
outlets,399,406,O
e,408,409,O
g,410,411,O
treated,413,420,O
water,421,426,O
discharges,427,437,O
site,438,442,O
maximise,447,455,O
understanding,456,469,O
quality,474,481,O
urban,485,490,O
water,491,496,O
sources,497,504,O
risk,525,529,O
missing,533,540,O
correct,545,552,O
representative,553,567,O
sampling,568,576,O
groups,577,583,O
sites,588,593,O
o,595,596,O
Attention,597,606,O
paid,607,611,O
ensure,615,621,O
inclusion,622,631,O
sampling,639,647,O
frame,648,653,O
groups,661,667,O
locations,672,681,O
sites,683,688,O
roads,690,695,O
venues,697,703,O
screening,720,729,O
browsing,731,739,O
delineation,745,756,O
satellite,764,773,O
digital,774,781,O
map,782,785,O
Khamis,793,799,O
Mushait,800,807,O
Governorate,808,819,O
zone,820,824,O
local,834,839,O
pre,840,843,O
knowledge,844,853,O
preferred,858,867,O
regard,873,879,O
accessibility,883,896,O
safety,898,904,O
permission,910,920,O
o,922,923,O
Approximation,924,937,O
number,945,951,O
target,959,965,O
study,966,971,O
population,972,982,O
group,991,996,O
sampling,1001,1009,O
location,1010,1018,O
o,1020,1021,O
Determination,1022,1035,O
proportional,1043,1055,O
allocation,1056,1066,O
samples,1070,1077,O
different,1086,1095,O
groups,1096,1102,O
locations,1107,1116,O
o,1118,1119,O
Training,1120,1128,O
interviewers,1132,1144,O
sample,1145,1151,O
collectors,1152,1162,O
follow,1166,1172,O
use,1180,1183,O
sampling,1188,1196,O
strategy,1197,1205,O
procedures,1210,1220,O
o,1222,1223,O
Implementation,1224,1238,O
ways,1242,1246,O
boost,1250,1255,O
participation,1256,1269,O
rates,1270,1275,O
screening,1283,1292,O
core,1297,1301,O
interviews,1302,1312,O
sample,1317,1323,O
collection,1324,1334,O
o,1336,1337,O
Planning,1338,1346,O
logistic,1350,1358,O
needs,1359,1364,O
timing,1368,1374,O
gathering,1376,1385,O
handling,1387,1395,O
samples,1396,1403,O
laboratory,1409,1419,O
o,1421,1422,O
Producing,1423,1432,O
sampling,1433,1441,O
cards,1442,1447,O
completed,1454,1463,O
record,1467,1473,O
observations,1474,1486,O
scene,1490,1495,O
sample,1497,1503,O
ID,1504,1506,O
data,1511,1515,O
information,1516,1527,O
date,1529,1533,O
time,1535,1539,O
temperature,1541,1552,O
group,1554,1559,O
locality,1561,1569,O
problems,1571,1579,O
area,1587,1591,O
sketch,1593,1599,O
map,1600,1603,O
o,1606,1607,O
Selection,1608,1617,O
appropriate,1624,1635,O
major,1636,1641,O
sampling,1642,1650,O
method,1651,1657,O
52,1659,1661,O
e,1666,1667,O
simple,1669,1675,O
random,1676,1682,O
sample,1683,1689,O
network,1691,1698,O
sampling,1699,1707,O
o,1710,1711,O
Planning,1712,1720,O
pilot,1724,1729,O
visits,1730,1736,O
samples,1740,1747,O
group,1756,1761,O
field,1769,1774,O
review,1778,1784,O
strategy,1785,1793,O
Results,0,7,O
established,15,26,O
adult,27,32,O
rat,33,36,O
NSC,37,40,B-Cell
culture,41,48,O
FGF,50,53,O
2,54,55,O
promotes,56,64,O
self,65,69,O
renewal,70,77,O
increasing,81,91,O
proliferation,92,105,O
inhibiting,110,120,O
spontaneous,121,132,O
differentiation,133,148,O
adult,152,157,O
NSCs,158,162,B-Cell
accompanied,164,175,O
activation,181,191,O
MAPK,195,199,O
PLC,204,207,O
pathways,208,216,O
molecular,226,235,O
genetic,236,243,O
approach,244,252,O
demonstrate,257,268,O
activation,274,284,O
FGF,288,291,O
receptor,292,300,O
1,301,302,O
FGFR1,304,309,O
largely,312,319,O
key,332,335,O
cytoplasmic,336,347,B-Organism_substance
amino,348,353,O
acid,354,358,O
residues,359,367,O
linked,377,383,O
MAPK,387,391,O
PLC,396,399,O
activation,400,410,O
suffices,412,420,O
promote,424,431,O
adult,432,437,O
NSC,438,441,B-Cell
self,442,446,O
renewal,447,454,O
canonical,460,469,O
MAPK,470,474,O
Erk1,476,480,O
2,481,482,O
activation,483,493,O
required,503,511,O
sufficient,516,526,O
NSC,535,538,B-Cell
expansion,539,548,O
anti,553,557,O
differentiation,558,573,O
effects,574,581,O
FGF,585,588,O
2,589,590,O
contrast,595,603,O
PLC,605,608,O
activation,609,619,O
integral,623,631,O
maintenance,639,650,O
adult,654,659,O
NSC,660,663,B-Cell
characteristics,664,679,O
including,681,690,O
capacity,700,708,O
neuronal,713,721,B-Cell
oligodendroglial,726,742,B-Cell
differentiation,743,758,O
Stochastic,0,10,O
models,11,17,O
Stochasticity,18,31,O
inevitably,32,42,O
emerges,43,50,O
molecular,56,65,O
components,66,76,O
present,81,88,O
low,92,95,O
cellular,96,104,B-Cell
concentrations,105,119,O
McAdams,121,128,O
Arkin,131,136,O
1997,138,142,O
Kierzek,144,151,O
et,152,154,O
al,155,157,O
2001,160,164,O
physical,172,180,O
phenomenon,181,191,O
generates,192,201,O
noise,202,207,O
synthetic,211,220,O
natural,225,232,O
circuits,233,241,O
Paulsson,243,251,O
2004,253,257,O
Mettetal,259,267,O
et,268,270,O
al,271,273,O
2006,276,280,O
consequences,291,303,O
phenotype,313,322,O
starting,327,335,O
explored,342,350,O
Suel,352,356,O
et,357,359,O
al,360,362,O
2006,365,369,O
example,376,383,O
noise,385,390,O
constitutes,391,402,O
driving,407,414,O
force,415,420,O
differentiation,428,443,O
isogenetic,447,457,O
colonies,458,466,O
Colman,468,474,O
Lerner,475,481,O
et,482,484,O
al,485,487,O
2005,490,494,O
Biological,497,507,O
theoretical,512,523,O
studies,524,531,O
aided,537,542,O
delineate,546,555,O
regulatory,560,570,O
mechanism,571,580,O
cell,594,598,B-Cell
handles,599,606,O
noise,607,612,O
efficiently,613,624,O
effectively,629,640,O
carry,644,649,O
biological,658,668,O
functions,669,678,O
Gardner,680,687,O
Collins,690,697,O
2000,699,703,O
Orrell,705,711,O
Bolouri,714,721,O
2004,723,727,O
Raser,729,734,O
O,737,738,O
Shea,739,743,O
2005,745,749,O
theoretical,759,770,O
point,771,776,O
view,780,784,O
stochastic,786,796,O
models,797,803,O
challenging,817,828,O
realistic,847,856,O
ones,857,861,O
precise,874,881,O
counting,882,890,O
individual,907,917,O
chemical,918,926,O
reactions,927,936,O
populations,942,953,O
chemical,963,971,O
species,972,979,O
change,980,986,O
milestone,992,1001,O
simulate,1005,1013,O
stochastic,1014,1024,O
processes,1025,1034,O
Gillespie,1042,1051,O
algorithm,1052,1061,O
Gillespie,1063,1072,O
1992,1074,1078,O
analytical,1098,1108,O
computational,1113,1126,O
complexity,1127,1137,O
present,1143,1150,O
models,1151,1157,O
surpass,1165,1172,O
handful,1175,1182,O
chemical,1186,1194,O
species,1195,1202,O
immediate,1208,1217,O
problems,1218,1226,O
solved,1235,1241,O
model,1245,1250,O
systems,1251,1258,O
dozens,1272,1278,O
genetic,1282,1289,O
components,1290,1300,O
systematic,1306,1316,O
determination,1317,1330,O
kinetic,1334,1341,O
constants,1342,1351,O
efficient,1360,1369,O
computation,1370,1381,O
thousands,1385,1394,O
chemical,1398,1406,O
stochastic,1407,1417,O
equations,1418,1427,O
Kuwahara,1429,1437,O
et,1438,1440,O
al,1441,1443,O
2006,1446,1450,O
Sanchez,1452,1459,O
Kondev,1462,1468,O
2008,1470,1474,O
Model,0,5,O
estrogen,13,21,O
induces,22,29,O
DNA,30,33,O
damage,34,40,O
Estrogen,42,50,O
enters,51,57,O
cell,62,66,B-Cell
bound,74,79,O
ER,87,89,O
dimeric,95,102,O
ER,103,105,O
estrogen,106,114,O
complex,115,122,O
enters,123,129,O
nucleus,134,141,B-Cellular_component
induces,146,153,O
AID,154,157,O
expression,158,168,O
leads,175,180,O
increase,187,195,O
mutations,199,208,O
translocations,213,227,O
potentially,233,244,O
cancer,245,251,B-Pathological_formation
Results,0,7,O
total,16,21,O
population,22,32,O
N,34,35,O
95,36,38,O
median,41,47,O
OS,48,50,O
significantly,55,68,O
longer,69,75,O
patients,79,87,O
baseline,93,101,O
19,105,107,O
9,108,109,O
values,110,116,O
median,133,139,O
values,159,165,O
12,176,178,O
2,179,180,O
months,181,187,O
95,189,191,O
confidence,193,203,O
interval,204,212,O
CI,214,216,O
8,219,220,O
6,221,222,O
16,223,225,O
6,226,227,O
vs,230,232,O
5,233,234,O
0,235,236,O
months,237,243,O
95,245,247,O
CI,249,251,O
3,253,254,O
9,255,256,O
5,257,258,O
7,259,260,O
P,264,265,O
0,266,267,O
0001,268,272,O
reached,285,292,O
significance,293,305,O
Gem,313,316,O
arm,319,322,O
median,324,330,O
OS,331,333,O
12,335,337,O
5,338,339,O
months,340,346,O
95,348,350,O
CI,352,354,O
8,356,357,O
6,358,359,O
16,360,362,O
6,363,364,O
vs,367,369,O
4,370,371,O
9,372,373,O
months,374,380,O
95,382,384,O
CI,386,388,O
3,390,391,O
6,392,393,O
5,394,395,O
6,396,397,O
P,401,402,O
0,403,404,O
0001,405,409,O
Patients,412,420,O
dBP,430,433,O
90,434,436,O
mmHg,437,441,O
significantly,446,459,O
longer,460,466,O
OS,467,469,O
predictive,516,526,O
significance,527,539,O
19,546,548,O
9,549,550,O
Percentage,0,10,O
reported,11,19,O
purchasing,20,30,O
intentions,31,41,O
comparing,43,52,O
ITN,53,56,O
owning,57,63,O
non,67,70,O
owning,71,77,O
households,78,88,O
School,0,6,O
environment,7,18,O
majority,26,34,O
schools,42,49,O
soft,52,56,O
drink,57,62,O
vending,63,70,O
machine,71,78,O
91,80,82,O
n,85,86,O
446,89,92,O
vending,103,110,O
machine,111,118,O
containing,119,129,O
sweets,130,136,O
candy,141,146,O
bars,147,151,O
81,153,155,O
n,158,159,O
413,162,165,O
present,170,177,O
Table,179,184,O
2,185,186,O
78,192,194,O
n,197,198,O
393,201,204,O
schools,213,220,O
supermarket,232,243,O
gas,245,248,O
station,249,256,O
fast,262,266,O
food,267,271,O
restaurant,272,282,O
neighbourhood,290,303,O
1,312,313,O
km,314,316,O
school,324,330,O
68,336,338,O
n,341,342,O
345,345,348,O
schools,357,364,O
facilities,375,385,O
school,403,409,O
property,410,418,O
students,429,437,O
physically,445,455,O
active,456,462,O
example,468,475,O
soccer,478,484,O
field,485,490,O
basketball,496,506,O
field,507,512,O
Table,514,519,O
2,520,521,O
school,526,532,O
environment,533,544,O
Total,545,550,O
School,551,557,O
level,558,563,O
Vocational,564,574,O
education,575,584,O
schools,585,592,O
Mixed,593,598,O
schools,599,606,O
Higher,607,613,O
education,614,623,O
schools,624,631,O
Vocational,632,642,O
education,643,652,O
schools,653,660,O
versus,661,667,O
higher,668,674,O
education,675,684,O
schools,685,692,O
Mixed,694,699,O
schools,700,707,O
versus,708,714,O
higher,715,721,O
education,722,731,O
schools,732,739,O
n,741,742,O
515,745,748,O
n,749,750,O
216,753,756,O
n,757,758,O
232,761,764,O
n,765,766,O
67,769,771,O
n,775,776,O
n,781,782,O
n,787,788,O
n,793,794,O
95,800,802,O
CI,803,805,O
95,811,813,O
CI,814,816,O
Soft,818,822,O
drink,823,828,O
vending,829,836,O
machine,837,844,O
present,845,852,O
school,856,862,O
91,863,865,O
4,866,867,O
466,869,872,O
90,874,876,O
2,877,878,O
194,880,883,O
91,885,887,O
3,888,889,O
209,891,894,O
95,896,898,O
5,899,900,O
63,902,904,O
1,906,907,O
0,908,909,O
0,911,912,O
9,913,914,O
1,915,916,O
1,917,918,O
1,920,921,O
0,922,923,O
0,925,926,O
9,927,928,O
1,929,930,O
0,931,932,O
Percentage,934,944,O
soft,948,952,O
drink,953,958,O
vending,959,966,O
machines,967,975,O
present,976,983,O
school,987,993,O
contain,999,1006,O
light,1007,1012,O
soft,1013,1017,O
drinks,1018,1024,O
79,1025,1027,O
8,1028,1029,O
372,1031,1034,O
75,1036,1038,O
4,1039,1040,O
147,1042,1045,O
82,1047,1049,O
2,1050,1051,O
171,1053,1056,O
85,1058,1060,O
7,1061,1062,O
54,1064,1066,O
0,1068,1069,O
9,1070,1071,O
0,1073,1074,O
8,1075,1076,O
1,1077,1078,O
0,1079,1080,O
1,1082,1083,O
0,1084,1085,O
0,1087,1088,O
9,1089,1090,O
1,1091,1092,O
1,1093,1094,O
Soft,1096,1100,O
drink,1101,1106,O
vending,1107,1114,O
machines,1115,1123,O
contain,1124,1131,O
unhealthy,1137,1146,O
drinks,1147,1153,O
healthy,1159,1166,O
drinks,1167,1173,O
57,1174,1176,O
9,1177,1178,O
268,1180,1183,O
61,1185,1187,O
9,1188,1189,O
120,1191,1194,O
58,1196,1198,O
5,1199,1200,O
121,1202,1205,O
43,1207,1209,O
6,1210,1211,O
27,1213,1215,O
1,1217,1218,O
4,1219,1220,O
1,1222,1223,O
0,1224,1225,O
1,1226,1227,O
9,1228,1229,O
1,1231,1232,O
4,1233,1234,O
1,1236,1237,O
0,1238,1239,O
1,1240,1241,O
9,1242,1243,O
Vending,1246,1253,O
machine,1254,1261,O
present,1262,1269,O
school,1273,1279,O
contains,1285,1293,O
sweets,1294,1300,O
candy,1301,1306,O
bars,1307,1311,O
80,1312,1314,O
7,1315,1316,O
413,1318,1321,O
75,1323,1325,O
6,1326,1327,O
161,1329,1332,O
84,1334,1336,O
9,1337,1338,O
197,1340,1343,O
82,1345,1347,O
1,1348,1349,O
55,1351,1353,O
1,1355,1356,O
1,1357,1358,O
0,1360,1361,O
9,1362,1363,O
1,1364,1365,O
2,1366,1367,O
1,1369,1370,O
1,1371,1372,O
1,1374,1375,O
0,1376,1377,O
1,1378,1379,O
2,1380,1381,O
Sweets,1383,1389,O
candy,1390,1395,O
bars,1396,1400,O
vending,1401,1408,O
machines,1409,1417,O
contain,1418,1425,O
unhealthy,1431,1440,O
healthy,1446,1453,O
foods,1454,1459,O
63,1460,1462,O
7,1463,1464,O
260,1466,1469,O
70,1471,1473,O
6,1474,1475,O
113,1477,1480,O
64,1482,1484,O
4,1485,1486,O
125,1488,1491,O
40,1493,1495,O
7,1496,1497,O
22,1499,1501,O
1,1503,1504,O
7,1505,1506,O
1,1508,1509,O
2,1510,1511,O
2,1512,1513,O
4,1514,1515,O
1,1518,1519,O
6,1520,1521,O
1,1523,1524,O
1,1525,1526,O
2,1527,1528,O
3,1529,1530,O
supermarket,1544,1555,O
gas,1557,1560,O
station,1561,1568,O
fast,1573,1577,O
food,1578,1582,O
restaurant,1583,1593,O
neighbourhood,1601,1614,O
school,1622,1628,O
78,1629,1631,O
3,1632,1633,O
393,1635,1638,O
76,1640,1642,O
7,1643,1644,O
161,1646,1649,O
79,1651,1653,O
7,1654,1655,O
181,1657,1660,O
78,1662,1664,O
5,1665,1666,O
51,1668,1670,O
1,1672,1673,O
1,1674,1675,O
0,1677,1678,O
9,1679,1680,O
1,1681,1682,O
2,1683,1684,O
1,1686,1687,O
1,1688,1689,O
0,1691,1692,O
9,1693,1694,O
1,1695,1696,O
2,1697,1698,O
students,1704,1712,O
allowed,1717,1724,O
leave,1728,1733,O
school,1738,1744,O
property,1745,1753,O
school,1761,1767,O
hours,1768,1773,O
57,1774,1776,O
4,1777,1778,O
295,1780,1783,O
42,1785,1787,O
6,1788,1789,O
92,1791,1793,O
65,1795,1797,O
8,1798,1799,O
152,1801,1804,O
76,1806,1808,O
1,1809,1810,O
51,1812,1814,O
0,1816,1817,O
6,1818,1819,O
0,1821,1822,O
5,1823,1824,O
0,1825,1826,O
8,1827,1828,O
0,1831,1832,O
9,1833,1834,O
0,1836,1837,O
8,1838,1839,O
1,1840,1841,O
0,1842,1843,O
facilities,1855,1865,O
school,1884,1890,O
property,1891,1899,O
students,1910,1918,O
physically,1926,1936,O
active,1937,1943,O
68,1944,1946,O
1,1947,1948,O
345,1950,1953,O
63,1955,1957,O
1,1958,1959,O
135,1961,1964,O
70,1966,1968,O
3,1969,1970,O
161,1972,1975,O
76,1977,1979,O
6,1980,1981,O
49,1983,1985,O
0,1987,1988,O
8,1989,1990,O
0,1992,1993,O
7,1994,1995,O
1,1996,1997,O
0,1998,1999,O
0,2001,2002,O
9,2003,2004,O
0,2006,2007,O
8,2008,2009,O
1,2010,2011,O
1,2012,2013,O
Associations,2017,2029,O
adjusted,2034,2042,O
school,2047,2053,O
size,2054,2058,O
p,2061,2062,O
0,2065,2066,O
05,2067,2069,O
vocational,2074,2084,O
education,2085,2094,O
schools,2095,2102,O
differ,2111,2117,O
higher,2127,2133,O
education,2134,2143,O
schools,2144,2151,O
regard,2157,2163,O
presence,2171,2179,O
vending,2183,2190,O
machines,2191,2199,O
canteen,2206,2213,O
vending,2223,2230,O
machines,2231,2239,O
canteen,2248,2255,O
contained,2256,2265,O
favourable,2273,2283,O
selection,2284,2293,O
foods,2297,2302,O
drinks,2307,2313,O
vocational,2319,2329,O
education,2330,2339,O
schools,2340,2347,O
indicated,2348,2357,O
vending,2378,2385,O
machines,2386,2394,O
canteen,2403,2410,O
contained,2411,2420,O
unhealthy,2426,2435,O
foods,2436,2441,O
drinks,2446,2452,O
healthy,2458,2465,O
foods,2466,2471,O
drinks,2476,2482,O
Vocational,2484,2494,O
education,2495,2504,O
schools,2505,2512,O
fewer,2517,2522,O
facilities,2523,2533,O
school,2552,2558,O
property,2559,2567,O
physical,2574,2582,O
higher,2592,2598,O
education,2599,2608,O
schools,2609,2616,O
associations,2623,2635,O
attenuated,2641,2651,O
adjustment,2658,2668,O
school,2673,2679,O
size,2680,2684,O
example,2690,2697,O
association,2703,2714,O
school,2723,2729,O
level,2730,2735,O
content,2740,2747,O
soft,2755,2759,O
drink,2760,2765,O
vending,2766,2773,O
machines,2774,2782,O
1,2792,2793,O
42,2794,2796,O
95,2798,2800,O
CI,2801,2803,O
1,2805,2806,O
05,2807,2809,O
1,2810,2811,O
93,2812,2814,O
crude,2822,2827,O
analysis,2828,2836,O
1,2846,2847,O
35,2848,2850,O
95,2852,2854,O
CI,2855,2857,O
0,2859,2860,O
99,2861,2863,O
1,2864,2865,O
85,2866,2868,O
adjusted,2876,2884,O
analysis,2885,2893,O
Background,0,10,O
past,20,24,O
decades,25,32,O
extensive,34,43,O
comparative,44,55,O
mapping,56,63,O
research,64,72,O
performed,82,91,O
plant,99,104,O
family,105,111,O
Solanaceae,112,122,O
recent,128,134,O
identification,135,149,O
large,155,160,O
set,161,164,O
single,168,174,O
copy,175,179,O
conserved,180,189,O
orthologous,190,201,O
COSII,203,208,O
markers,210,217,O
greatly,222,229,O
accelerated,230,241,O
comparative,242,253,O
mapping,254,261,O
studies,262,269,O
major,276,281,O
solanaceous,282,293,O
species,294,301,O
including,302,311,O
tomato,312,318,O
potato,320,326,O
eggplant,328,336,O
pepper,338,344,O
diploid,349,356,O
Nicotiana,357,366,O
species,367,374,O
tetraploid,387,397,O
tobacco,398,405,O
large,412,417,O
comparative,428,439,O
data,440,444,O
available,449,458,O
species,469,476,O
provides,477,485,O
opportunity,490,501,O
describe,505,513,O
overall,518,525,O
patterns,526,534,O
chromosomal,538,549,B-Cellular_component
evolution,550,559,O
important,568,577,O
plant,578,583,O
family,584,590,O
results,596,603,O
investigation,612,625,O
described,630,639,O
Introduction,0,12,O
Tea,13,16,O
Camellia,18,26,O
sinensis,27,35,O
L,36,37,O
widely,59,65,O
consumed,66,74,O
beverages,75,84,O
world,92,97,O
Epigallocatechin,103,119,O
3,120,121,O
O,122,123,O
gallate,124,131,O
EGCG,133,137,O
major,153,158,O
green,159,164,O
tea,165,168,O
catechin,169,177,O
present,178,185,O
leaves,193,199,B-Organ
believed,204,212,O
compound,220,228,O
responsible,234,245,O
health,254,260,O
benefits,261,269,O
attributed,270,280,O
tea,284,287,O
EGCG,289,293,O
reported,298,306,O
antioxidative,315,328,O
1,330,331,O
2,335,336,O
antimutagenic,339,352,O
3,354,355,O
anti,358,362,O
inflammatory,363,375,O
4,377,378,O
anticarcinogenic,385,401,O
activities,402,412,O
5,414,415,O
EGCG,431,435,O
concentrations,436,450,O
required,451,459,O
elicit,463,469,O
anticancer,474,484,B-Pathological_formation
activity,485,493,O
shown,504,509,O
1,526,527,O
microM,528,534,O
blood,540,545,B-Organism_substance
level,546,551,O
EGCG,555,559,O
consuming,566,575,O
equivalent,580,590,O
2,594,595,O
3,596,597,O
cups,598,602,O
green,606,611,O
tea,612,615,O
0,620,621,O
1,622,623,O
0,624,625,O
6,626,627,O
microM,628,634,O
equivalent,646,656,O
7,660,661,O
9,662,663,O
cups,664,668,O
lower,679,684,O
1,690,691,O
microM,692,698,O
6,700,701,O
7,705,706,O
cohort,714,720,O
study,721,726,O
daily,728,733,O
consumption,734,745,O
cups,753,757,O
green,761,766,O
tea,767,770,O
required,775,783,O
cancer,792,798,B-Pathological_formation
preventive,799,809,O
effect,810,816,O
8,818,819,O
adverse,832,839,O
effects,840,847,O
green,851,856,O
tea,857,860,O
mainly,862,868,O
hepatitis,869,878,O
consumption,883,894,O
high,898,902,O
doses,903,908,O
green,912,917,O
tea,918,921,O
reported,932,940,O
9,942,943,O
important,963,972,O
enhance,976,983,O
pharmacologic,988,1001,O
effect,1002,1008,O
EGCG,1012,1016,O
obtain,1020,1026,O
health,1031,1037,O
benefit,1038,1045,O
reasonable,1049,1059,O
concentration,1060,1073,O
daily,1077,1082,O
life,1083,1087,O
reported,1097,1105,O
cell,1115,1119,B-Cellular_component
surface,1120,1127,I-Cellular_component
binding,1128,1135,O
EGCG,1139,1143,O
derivatives,1152,1163,O
involved,1167,1175,O
biological,1185,1195,O
activities,1196,1206,O
10,1208,1210,O
15,1213,1215,O
identified,1226,1236,O
67,1241,1243,O
kDa,1244,1247,O
laminin,1248,1255,O
receptor,1256,1264,O
67LR,1266,1270,O
cell,1277,1281,B-Cellular_component
surface,1282,1289,I-Cellular_component
receptor,1290,1298,O
EGCG,1303,1307,O
mediates,1313,1321,O
anticancer,1326,1336,O
activity,1337,1345,O
EGCG,1349,1353,O
16,1355,1357,O
67LR,1360,1364,O
shown,1374,1379,O
overexpressed,1386,1399,O
cell,1407,1411,B-Cellular_component
surface,1412,1419,I-Cellular_component
tumor,1431,1436,B-Cell
cells,1437,1442,I-Cell
17,1444,1446,O
postulated,1456,1466,O
67LR,1472,1476,O
plays,1477,1482,O
significant,1485,1496,O
role,1497,1501,O
tumor,1509,1514,B-Pathological_formation
progression,1515,1526,O
speculated,1531,1541,O
studies,1547,1554,O
conducted,1555,1564,O
define,1568,1574,O
function,1579,1587,O
67LR,1591,1595,O
provide,1602,1609,O
new,1612,1615,O
approach,1616,1624,O
cancer,1628,1634,B-Pathological_formation
prevention,1635,1645,O
expression,1655,1665,O
67,1669,1671,O
LR,1672,1674,O
confers,1675,1682,O
EGCG,1683,1687,O
responsiveness,1688,1702,O
tumor,1706,1711,B-Cell
cells,1712,1717,I-Cell
vivo,1721,1725,O
18,1727,1729,O
Vitamin,1732,1739,O
known,1748,1753,O
retinol,1757,1764,O
participates,1766,1778,O
physiological,1782,1795,O
activities,1796,1806,O
related,1807,1814,O
immune,1822,1828,O
system,1829,1835,O
maintenance,1837,1848,O
epithelial,1852,1862,B-Tissue
mucosa,1867,1873,B-Tissue
tissues,1874,1881,I-Tissue
growth,1883,1889,O
reproduction,1891,1903,O
bone,1909,1913,B-Organ
development,1914,1925,O
comes,1930,1935,O
animal,1941,1947,O
sources,1948,1955,O
eggs,1965,1969,B-Organism_substance
meat,1971,1975,B-Organism_subdivision
milk,1977,1981,B-Organism_substance
cheese,1983,1989,O
cream,1991,1996,O
liver,1998,2003,B-Organ
kidney,2005,2011,B-Organ
cod,2013,2016,O
halibut,2021,2028,O
fish,2029,2033,O
oil,2034,2037,B-Organism_substance
vitro,2042,2047,O
animal,2055,2061,O
models,2062,2068,O
demonstrated,2082,2094,O
vitamin,2100,2107,O
involved,2113,2121,O
regulation,2129,2139,O
promotion,2144,2153,O
growth,2157,2163,O
differentiation,2168,2183,O
cells,2192,2197,B-Cell
19,2199,2201,O
visual,2208,2214,O
function,2215,2223,O
vitamin,2227,2234,O
depends,2237,2244,O
natural,2252,2259,O
synthetic,2264,2273,O
derivatives,2274,2285,O
retinoids,2287,2296,O
20,2298,2300,O
trans,2307,2312,O
retinoic,2313,2321,O
acid,2322,2326,O
ATRA,2328,2332,O
active,2339,2345,O
derivative,2346,2356,O
vitamin,2360,2367,O
documented,2385,2395,O
growth,2401,2407,O
differentiation,2412,2427,O
factor,2428,2434,O
tissues,2443,2450,B-Tissue
cells,2455,2460,B-Cell
proved,2466,2472,O
effective,2482,2491,O
treatment,2492,2501,O
diseases,2510,2518,O
including,2519,2528,O
cancers,2529,2536,B-Pathological_formation
21,2538,2540,O
22,2544,2546,O
Retinoids,2549,2558,O
exert,2559,2564,O
physiological,2571,2584,O
activities,2585,2595,O
retinoid,2604,2612,O
receptor,2613,2621,O
nuclear,2622,2629,B-Cellular_component
proteins,2630,2638,O
belong,2644,2650,O
superfamily,2658,2669,O
steroid,2673,2680,O
thyroid,2681,2688,O
hormone,2689,2696,O
receptors,2697,2706,O
classes,2731,2738,O
retinoic,2740,2748,O
acid,2749,2753,O
receptors,2754,2763,O
RARs,2765,2769,O
retinoic,2779,2787,O
X,2788,2789,O
receptors,2790,2799,O
RXRs,2801,2805,O
subtypes,2832,2840,O
alpha,2842,2847,O
beta,2849,2853,O
gamma,2859,2864,O
23,2866,2868,O
24,2872,2874,O
natural,2881,2888,O
ligands,2889,2896,O
RARs,2905,2909,O
ATRA,2914,2918,O
stereoisomers,2927,2940,O
9,2941,2942,O
cis,2943,2946,O
RA,2947,2949,O
13,2954,2956,O
cis,2957,2960,O
RA,2961,2963,O
RXRs,2973,2977,O
activated,2982,2991,O
9,2995,2996,O
cis,2997,3000,O
RA,3001,3003,O
ATRA,3010,3014,O
acts,3015,3019,O
RAR,3028,3031,O
transcriptionally,3035,3052,O
activate,3053,3061,O
target,3062,3068,O
genes,3069,3074,O
cytochrome,3084,3094,O
P450,3095,3099,O
CRABI,3104,3109,O
24,3111,3113,O
study,3121,3126,O
designed,3131,3139,O
identify,3143,3151,O
food,3154,3158,O
component,3159,3168,O
effectively,3183,3194,O
combination,3203,3214,O
EGCG,3220,3224,O
investigate,3232,3243,O
mechanism,3248,3257,O
action,3261,3267,O
combination,3276,3287,O
vitro,3301,3306,O
vivo,3314,3318,O
systems,3319,3326,O
involving,3327,3336,O
highly,3339,3345,O
metastatic,3346,3356,O
mouse,3357,3362,O
B16,3363,3366,B-Cell
melanoma,3367,3375,I-Cell
cell,3376,3380,I-Cell
line,3381,3385,I-Cell
25,3387,3389,O
found,3395,3400,O
ATRA,3406,3410,O
enhances,3411,3419,O
antitumor,3424,3433,B-Pathological_formation
activity,3434,3442,O
EGCG,3446,3450,O
upregulating,3454,3466,O
67,3471,3473,O
LR,3474,3476,O
expression,3477,3487,O
RAR,3496,3499,O
Titration,0,9,O
Ab,13,15,O
01,16,18,O
inhibition,19,29,O
ex,33,35,O
vivo,36,40,O
response,41,49,O
rhIL21,53,59,O
Samples,60,67,O
4,73,74,O
individual,75,85,O
healthy,86,93,O
human,94,99,O
donors,100,106,O
pre,112,115,O
incubated,116,125,O
2,130,131,O
hours,132,137,O
indicated,145,154,O
concentration,155,168,O
Ab,172,174,O
01,175,177,O
control,185,192,O
IgG1TM,193,199,O
prior,200,205,O
addition,209,217,O
10,221,223,O
ng,224,226,O
mL,227,229,O
rhIL21,230,236,O
2,241,242,O
hr,243,245,O
incubation,246,256,O
effect,266,272,O
6,280,281,O
biomarkers,282,292,O
assessed,302,310,O
Figures,312,319,O
4,320,321,O
5,326,327,O
2,344,345,O
donors,346,352,O
tested,353,359,O
lowest,370,376,O
concentration,377,390,O
Ab,394,396,O
01,397,399,O
0,401,402,O
1,403,404,O
mug,405,408,O
mL,409,411,O
0,413,414,O
66,415,417,O
nM,418,420,O
resulted,422,430,O
complete,434,442,O
inhibition,443,453,O
rhIL21,461,467,O
response,468,476,O
subsequent,496,506,O
donors,507,513,O
tested,519,525,O
increasing,529,539,O
concentrations,540,554,O
Ab,558,560,O
01,561,563,O
starting,564,572,O
0,576,577,O
003,578,581,O
mug,582,585,O
mL,586,588,O
Ab,590,592,O
01,593,595,O
inhibited,596,605,O
response,610,618,O
6,626,627,O
genes,628,633,O
4,641,642,O
donors,643,649,O
IC50,651,655,O
values,656,662,O
ranged,663,669,O
0,678,679,O
003,680,683,O
0,688,689,O
015,690,693,O
mug,694,697,O
mL,698,700,O
Ab,701,703,O
01,704,706,O
Figure,707,713,O
5,714,715,O
Control,718,725,O
IgG1TM,726,732,O
significant,740,751,O
effect,752,758,O
rhIL21,762,768,O
response,769,777,O
Figure4B,779,787,O
Figure,790,796,O
4,797,798,O
Average,799,806,O
percent,807,814,O
inhibition,815,825,O
expression,833,843,O
level,844,849,O
6,853,854,O
IL21,855,859,O
responsive,860,870,O
genes,871,876,O
Percent,878,885,O
inhibition,886,896,O
values,897,903,O
calculated,909,919,O
based,920,925,O
RQ,929,931,O
relative,933,941,O
quantification,942,956,O
values,958,964,O
untreated,968,977,O
control,978,985,O
rhIL21,990,996,O
treated,997,1004,O
samples,1005,1012,O
4,1029,1030,O
donors,1031,1037,O
subsequently,1043,1055,O
mean,1060,1064,O
standard,1069,1077,O
deviation,1078,1087,O
determined,1093,1103,O
gene,1113,1117,O
shown,1118,1123,O
Percent,1128,1135,O
inhibition,1136,1146,O
presence,1150,1158,O
Ab,1162,1164,O
01,1165,1167,O
B,1169,1170,O
Percent,1172,1179,O
inhibition,1180,1190,O
presence,1194,1202,O
control,1206,1213,O
IgG1TM,1214,1220,O
Data,1222,1226,O
0,1235,1236,O
1,1237,1238,O
mug,1239,1242,O
mL,1243,1245,O
0,1248,1249,O
3,1250,1251,O
mug,1252,1255,O
mL,1256,1258,O
1,1263,1264,O
mug,1265,1268,O
mL,1269,1271,O
concentrations,1272,1286,O
generated,1292,1301,O
4,1308,1309,O
donors,1310,1316,O
Data,1318,1322,O
higher,1331,1337,O
lower,1346,1351,O
concentrations,1352,1366,O
generated,1372,1381,O
2,1388,1389,O
donors,1390,1396,O
Figure,1398,1404,O
5,1405,1406,O
Inhibition,1407,1417,O
Ab,1421,1423,O
01,1424,1426,O
indicated,1434,1443,O
concentration,1444,1457,O
shown,1461,1466,O
6,1471,1472,O
IL21,1473,1477,O
responsive,1478,1488,O
genes,1489,1494,O
IC50,1496,1500,O
values,1501,1507,O
inhibition,1511,1521,O
curves,1522,1528,O
shown,1529,1534,O
Figure,1538,1544,O
4A,1545,1547,O
calculated,1553,1563,O
curve,1570,1575,O
fit,1576,1579,O
XLfit,1581,1586,O
program,1588,1595,O
referred,1612,1620,O
biomarker,1621,1630,O
genes,1631,1636,O
Values,1638,1644,O
0,1653,1654,O
1,1655,1656,O
mug,1657,1660,O
mL,1661,1663,O
0,1665,1666,O
3,1667,1668,O
mug,1669,1672,O
mL,1673,1675,O
1,1680,1681,O
mug,1682,1685,O
mL,1686,1688,O
concentrations,1689,1703,O
generated,1709,1718,O
4,1725,1726,O
donors,1727,1733,O
Data,1735,1739,O
higher,1748,1754,O
lower,1763,1768,O
concentrations,1769,1783,O
generated,1789,1798,O
2,1805,1806,O
donors,1807,1813,O
INTRODUCTION,0,12,O
years,25,30,O
virtual,36,43,O
microscopy,44,54,O
utilized,64,72,O
medical,76,83,O
teaching,84,92,O
research,94,102,O
proficiency,104,115,O
testing,116,123,O
American,125,133,O
Board,134,139,O
Pathology,143,152,O
examinations,153,165,O
pathology,167,176,O
meetings,177,185,O
conferences,190,201,O
quality,207,214,O
assurance,215,224,O
programs,225,233,O
diagnostic,238,248,O
practice,249,257,O
widely,270,276,O
routinely,281,290,O
image,299,304,O
analysis,305,313,O
practices,320,329,O
beginning,334,343,O
use,347,350,O
internally,354,364,O
group,379,384,O
frozen,390,396,O
section,397,404,O
intraoperative,405,419,O
consultations,420,433,O
subspecialty,438,450,O
consultations,451,464,O
geographic,472,482,O
time,487,491,O
constrains,492,502,O
diagnostic,513,523,O
consultation,524,536,O
expert,541,547,O
second,548,554,O
opinion,555,562,O
established,573,584,O
practice,585,593,O
pathology,597,606,O
glass,611,616,O
slides,617,623,O
similar,625,632,O
consultation,633,645,O
virtual,650,657,O
microscopy,658,668,O
poses,669,674,O
multiple,675,683,O
controversial,684,697,O
issues,698,704,O
licensing,713,722,O
liability,724,733,O
security,735,743,O
reimbursement,745,758,O
scanning,764,772,O
quality,773,780,O
validation,789,799,O
Regulations,801,812,O
standardization,817,832,O
place,848,853,O
pathologists,859,871,O
use,876,879,O
allay,883,888,O
fears,895,900,O
virtual,923,930,O
microscopy,931,941,O
scans,942,947,O
optimal,955,962,O
quality,963,970,O
simply,985,991,O
substituted,992,1003,O
glass,1008,1013,O
slides,1014,1020,O
microscope,1027,1037,O
maintaining,1044,1055,O
practice,1066,1074,O
guidelines,1075,1085,O
second,1090,1096,O
opinion,1097,1104,O
consultation,1105,1117,O
Additionally,1119,1131,O
cost,1137,1141,O
maintenance,1146,1157,O
scanning,1161,1169,O
equipment,1170,1179,O
currently,1187,1196,O
affordable,1197,1207,O
practitioners,1216,1229,O
consultants,1234,1245,O
practice,1249,1257,O
model,1258,1263,O
offers,1269,1275,O
tertiary,1276,1284,O
consultation,1285,1297,O
gastrointestinal,1301,1317,B-Organism_subdivision
GI,1319,1321,B-Organism_subdivision
liver,1327,1332,B-Organ
pathology,1333,1342,O
presented,1346,1355,O
eliminates,1361,1371,O
cost,1376,1380,O
maintenance,1385,1396,O
scanners,1400,1408,O
consultants,1416,1427,O
clients,1432,1439,O
minimizes,1441,1450,O
need,1455,1459,O
review,1464,1470,O
glass,1474,1479,O
slides,1480,1486,O
facilitates,1488,1499,O
clinicopathological,1500,1519,O
radiological,1524,1536,O
correlation,1537,1548,O
serves,1553,1559,O
need,1564,1568,O
clients,1572,1579,O
need,1584,1588,O
timely,1589,1595,O
help,1596,1600,O
challenging,1606,1617,O
liver,1618,1623,B-Organ
GI,1628,1630,B-Organism_subdivision
cases,1631,1636,O
obtain,1644,1650,O
expert,1651,1657,O
opinion,1658,1665,O
dysplasia,1670,1679,O
Barrett,1683,1690,O
s,1691,1692,O
ulcerative,1697,1707,O
colitis,1708,1715,O
surveillance,1716,1728,O
biopsies,1729,1737,O
required,1738,1746,O
American,1754,1762,O
Gastroenterology,1763,1779,O
Association,1780,1791,O
AGA,1793,1796,O
model,1804,1809,O
practiced,1819,1828,O
3,1833,1834,O
years,1835,1840,O
applied,1845,1852,O
2000,1861,1865,O
cases,1866,1871,O
small,1875,1880,O
pathology,1881,1890,O
practices,1891,1900,O
50,1908,1910,O
United,1911,1917,O
States,1918,1924,O
single,1931,1937,O
consultant,1938,1948,O
GI,1949,1951,B-Organism_subdivision
liver,1956,1961,B-Organ
pathologist,1962,1973,O
Click,0,5,O
file,15,19,O
right,4,9,O
eye,10,13,B-Organ
50,19,21,O
year,22,26,O
old,27,30,O
patient,31,38,O
severe,44,50,O
hypertension,51,63,O
visit,77,82,O
Fundus,88,94,O
photograph,95,105,O
shows,106,111,O
serous,112,118,O
retinal,119,126,B-Multi-tissue_structure
detachment,127,137,O
optic,143,148,O
disc,149,153,O
pale,157,161,O
temporal,169,177,O
b,185,186,O
Optical,188,195,O
coherence,196,205,O
tomography,206,216,O
OCT,218,221,O
shows,223,228,O
retinal,229,236,B-Multi-tissue_structure
detachment,237,247,O
involving,248,257,O
fovea,262,267,O
cystic,272,278,O
change,279,285,O
inner,289,294,B-Multi-tissue_structure
retina,295,301,I-Multi-tissue_structure
c,304,305,O
Early,307,312,O
phase,313,318,O
images,319,325,O
fluorescein,329,340,O
angiography,341,352,O
FA,354,356,O
left,359,363,O
indocyanine,369,380,O
green,381,386,O
angiography,387,398,O
IA,400,402,O
right,405,410,O
d,414,415,O
Late,417,421,O
phase,422,427,O
images,428,434,O
FA,438,440,O
left,442,446,O
IA,452,454,O
right,456,461,O
FA,464,466,O
shows,467,472,O
window,473,479,O
defect,480,486,O
associated,487,497,O
macular,503,510,B-Tissue
cystic,511,517,O
change,518,524,O
Note,526,530,O
active,539,545,O
leakage,546,553,O
observed,557,565,O
area,573,577,O
serous,583,589,O
retinal,590,597,B-Multi-tissue_structure
detachment,598,608,O
cystoid,612,619,B-Pathological_formation
edema,620,625,I-Pathological_formation
IA,627,629,O
shows,630,635,O
decreased,636,645,O
perfusion,646,655,O
choroid,663,670,O
macula,678,684,B-Tissue
window,689,695,O
defect,696,702,O
damaged,712,719,O
RPE,720,723,O
Hypofluorescence,725,741,O
arrow,743,748,O
retinal,760,767,B-Tissue
artery,768,774,I-Tissue
observed,779,787,O
unique,799,805,O
findings,806,814,O
5,0,1,O
Conclusion,3,13,O
RLs,14,17,O
new,22,25,O
actors,26,32,O
animal,36,42,O
plant,47,52,O
defense,53,60,O
low,71,74,O
toxicity,75,83,O
biodegradability,88,104,O
promising,115,124,O
molecules,125,134,O
pathogens,154,163,O
respect,173,180,O
clues,197,202,O
available,207,216,O
success,225,232,O
RL,236,238,O
applications,239,251,O
greenhouses,255,266,O
fight,270,275,O
phytopathogens,276,290,O
better,294,300,O
understanding,301,314,O
RL,318,320,O
mode,321,325,O
action,329,335,O
especially,337,347,O
perception,354,364,O
signaling,373,382,O
pathways,383,391,O
activated,392,401,O
important,416,425,O
potentiate,429,439,O
beneficial,446,456,O
effects,457,464,O
plants,468,474,O
RLs,476,479,O
dual,487,491,O
mode,492,496,O
action,500,506,O
antimicrobial,517,530,O
stimulate,540,549,O
plant,550,555,O
defense,556,563,O
responses,564,573,O
dual,580,584,O
property,585,593,O
probably,597,605,O
important,611,620,O
efficiency,629,639,O
new,643,646,O
biopesticides,647,660,O
animals,665,672,O
use,678,681,O
RLs,685,688,O
advanced,703,711,O
stage,712,717,O
RLs,719,722,O
successfully,727,739,O
antimicrobial,748,761,O
agents,762,768,O
especially,770,780,O
skin,785,789,B-Organ
disease,790,797,O
treatment,798,807,O
Deep,809,813,O
insight,814,821,O
physiochemical,831,845,O
effects,846,853,O
RLs,857,860,O
biological,871,881,O
importance,882,892,O
reveal,899,905,O
new,906,909,O
dimensions,910,920,O
fields,928,934,O
research,938,946,O
like,947,951,O
agriculture,952,963,O
medicine,968,976,O
precisely,978,987,O
plant,991,996,O
defense,997,1004,O
disease,1006,1013,O
control,1014,1021,O
pathogenesis,1026,1038,O
understanding,1043,1056,O
bacterial,1060,1069,O
genera,1070,1076,O
producing,1077,1086,O
RLs,1087,1090,O
studied,1113,1120,O
provide,1127,1134,O
light,1135,1140,O
fascinating,1150,1161,O
aspects,1162,1169,O
Objectives,0,10,O
Evaluate,11,19,O
relationships,20,33,O
MRI,42,45,O
clinical,50,58,O
laboratory,59,69,O
radiographic,70,82,O
findings,83,91,O
rheumatoid,95,105,O
arthritis,106,115,O
RA,117,119,O
Assessment,0,10,O
instruments,11,22,O
SCID,27,31,O
P,34,35,O
administered,40,52,O
psychiatrists,56,69,O
trained,70,77,O
certified,82,91,O
use,99,102,O
instruments,110,121,O
study,130,135,O
ICG,141,144,O
self,150,154,O
report,155,161,O
instrument,162,172,O
identify,193,201,O
CG,202,204,O
total,214,219,O
score,220,225,O
25,231,233,O
demonstrated,240,252,O
high,253,257,O
internal,258,266,O
consistency,267,278,O
Cronbach,280,288,O
s,289,290,O
alpha,291,296,O
0,299,300,O
94,301,303,O
convergent,310,320,O
criterion,325,334,O
validity,335,343,O
27,345,347,O
ICG,354,357,O
total,358,363,O
score,364,369,O
showed,375,381,O
fairly,384,390,O
high,391,395,O
association,396,407,O
Beck,417,421,O
Depression,422,432,O
Inventory,433,442,O
BDI,444,447,O
32,450,452,O
total,454,459,O
score,460,465,O
r,467,468,O
0,471,472,O
67,473,475,O
P,477,478,O
0,481,482,O
001,483,486,O
Texas,493,498,O
Revised,499,506,O
Inventory,507,516,O
Grief,520,525,O
TRIG,527,531,O
33,534,536,O
score,538,543,O
r,545,546,O
0,549,550,O
87,551,553,O
P,555,556,O
0,559,560,O
001,561,564,O
Grief,575,580,O
Measurement,581,592,O
Scale,593,598,O
GMS,600,603,O
34,606,608,O
score,610,615,O
r,617,618,O
0,621,622,O
70,623,625,O
P,627,628,O
0,631,632,O
001,633,636,O
ASA,643,646,O
27,647,649,O
self,655,659,O
report,660,666,O
measure,667,674,O
developed,675,684,O
rate,688,692,O
separation,693,703,O
anxiety,704,711,O
symptoms,712,720,O
adult,724,729,O
life,730,734,O
18,741,743,O
years,744,749,O
age,753,756,O
Principal,759,768,O
components,769,779,O
analysis,780,788,O
revealed,789,797,O
coherent,800,808,O
construct,809,818,O
adult,822,827,O
separation,828,838,O
anxiety,839,846,O
high,852,856,O
internal,857,865,O
consistency,866,877,O
Cronbach,879,887,O
s,888,889,O
alpha,890,895,O
0,898,899,O
95,900,902,O
sound,908,913,O
test,914,918,O
retest,919,925,O
reliability,926,937,O
r,939,940,O
0,943,944,O
86,945,947,O
P,949,950,O
0,953,954,O
001,955,958,O
receiver,972,980,O
operation,981,990,O
characteristic,991,1005,O
ROC,1007,1010,O
analysis,1012,1020,O
semistructured,1033,1047,O
interview,1048,1057,O
yielded,1058,1065,O
high,1068,1072,O
area,1073,1077,O
curve,1088,1093,O
AUC,1095,1098,O
index,1100,1105,O
0,1109,1110,O
9,1111,1112,O
suggesting,1114,1124,O
questionnaire,1134,1147,O
adequate,1154,1162,O
alternative,1163,1174,O
measure,1175,1182,O
adult,1186,1191,O
separation,1192,1202,O
anxiety,1203,1210,O
29,1212,1214,O
WSAS,1221,1225,O
self,1231,1235,O
report,1236,1242,O
scale,1243,1248,O
functional,1252,1262,O
impairment,1263,1273,O
includes,1279,1287,O
questions,1293,1302,O
rating,1303,1309,O
interference,1310,1322,O
psychiatric,1326,1337,O
symptoms,1338,1346,O
work,1350,1354,O
home,1356,1360,O
management,1361,1371,O
social,1373,1379,O
private,1383,1390,O
leisure,1391,1398,O
activities,1399,1409,O
ability,1415,1422,O
form,1426,1430,O
maintain,1435,1443,O
close,1444,1449,O
relationships,1450,1463,O
question,1482,1490,O
rated,1494,1499,O
0,1505,1506,O
8,1510,1511,O
scale,1512,1517,O
0,1523,1524,O
indicating,1525,1535,O
impairment,1539,1549,O
8,1561,1562,O
indicating,1563,1573,O
severe,1579,1585,O
impairment,1586,1596,O
Cronbach,1602,1610,O
s,1611,1612,O
alpha,1613,1618,O
measure,1619,1626,O
internal,1630,1638,O
scale,1639,1644,O
consistency,1645,1656,O
ranged,1657,1663,O
0,1669,1670,O
70,1671,1673,O
0,1677,1678,O
94,1679,1681,O
test,1687,1691,O
retest,1692,1698,O
correlation,1699,1710,O
0,1715,1716,O
73,1717,1719,O
WSAS,1729,1733,O
interactive,1734,1745,O
voice,1746,1751,O
response,1752,1760,O
administrations,1761,1776,O
gave,1777,1781,O
correlations,1782,1794,O
0,1798,1799,O
81,1800,1802,O
0,1807,1808,O
86,1809,1811,O
clinician,1817,1826,O
interviews,1827,1837,O
30,1839,1841,O
Correlations,1844,1856,O
WSAS,1860,1864,O
severity,1870,1878,O
depression,1882,1892,O
obsessive,1897,1906,O
compulsive,1907,1917,O
disorder,1918,1926,O
symptoms,1927,1935,O
0,1941,1942,O
76,1943,1945,O
0,1950,1951,O
61,1952,1954,O
respectively,1956,1968,O
scores,1978,1984,O
sensitive,1990,1999,O
patient,2003,2010,O
differences,2011,2022,O
disorder,2026,2034,O
severity,2035,2043,O
treatment,2048,2057,O
related,2058,2065,O
change,2066,2072,O
30,2074,2076,O
MOODS,2083,2088,O
SR,2089,2091,O
instrument,2098,2108,O
developed,2109,2118,O
validated,2123,2132,O
assess,2136,2142,O
lifetime,2143,2151,O
mood,2152,2156,O
spectrum,2157,2165,O
symptoms,2166,2174,O
35,2176,2178,O
including,2181,2190,O
manic,2191,2196,O
depressive,2201,2211,O
features,2212,2220,O
rhythmicity,2222,2233,O
vegetative,2238,2248,O
functions,2249,2258,O
manic,2264,2269,O
depressive,2274,2284,O
components,2285,2295,O
subtyped,2300,2308,O
mood,2314,2318,O
energy,2320,2326,O
cognition,2331,2340,O
domains,2341,2348,O
focusing,2350,2358,O
manic,2362,2367,O
depressive,2371,2381,O
symptoms,2382,2390,O
respectively,2392,2404,O
rhythmicity,2410,2421,O
vegetative,2426,2436,O
functions,2437,2446,O
domain,2447,2453,O
include,2454,2461,O
changes,2462,2469,O
energy,2473,2479,O
physical,2481,2489,O
wellbeing,2490,2499,O
mental,2501,2507,O
physical,2512,2520,O
efficiency,2521,2531,O
related,2533,2540,O
weather,2548,2555,O
season,2560,2566,O
changes,2572,2579,O
appetite,2583,2591,O
sleep,2593,2598,O
sexual,2603,2609,O
activities,2610,2620,O
sum,2626,2629,O
scores,2637,2643,O
3,2651,2652,O
manic,2653,2658,O
domains,2659,2666,O
mood,2668,2672,O
energy,2674,2680,O
cognition,2682,2691,O
constitutes,2693,2704,O
manic,2710,2715,O
component,2716,2725,O
62,2728,2730,O
items,2731,2736,O
3,2754,2755,O
depressive,2756,2766,O
domains,2767,2774,O
depressive,2780,2790,O
component,2791,2800,O
63,2803,2805,O
items,2806,2811,O
rhythmicity,2818,2829,O
vegetative,2834,2844,O
functions,2845,2854,O
domain,2855,2861,O
includes,2862,2870,O
29,2871,2873,O
items,2874,2879,O
instrument,2885,2895,O
downloaded,2903,2913,O
http,2919,2923,O
www,2926,2929,O
spectrum,2930,2938,O
project,2939,2946,O
org,2947,2950,O
Histopathologic,1,16,O
examination,17,28,O
rectal,32,38,B-Pathological_formation
carcinoma,39,48,I-Pathological_formation
patients,54,62,O
rectal,68,74,B-Pathological_formation
carcinoma,75,84,I-Pathological_formation
histopathological,90,107,O
evaluation,108,118,O
surgical,126,134,B-Pathological_formation
specimen,135,143,I-Pathological_formation
provides,144,152,O
pivotal,153,160,O
prognostic,161,171,O
therapeutic,176,187,O
information,188,199,O
Important,201,210,O
parameters,211,221,O
tumor,226,231,B-Pathological_formation
site,232,236,O
depth,238,243,O
invasion,247,255,O
histological,257,269,O
type,270,274,O
grade,279,284,O
pattern,286,293,O
invasion,297,305,O
diffusely,307,316,O
infiltrating,317,329,O
versus,330,336,O
expanding,337,346,O
margin,347,353,O
degree,356,362,O
peritumoral,366,377,B-Cell
lymphocytic,378,389,I-Cell
infiltration,390,402,O
tumor,408,413,B-Pathological_formation
involvement,414,425,O
surgical,429,437,B-Tissue
margins,438,445,I-Tissue
lymph,450,455,B-Multi-tissue_structure
nodes,456,461,I-Multi-tissue_structure
Evaluation,463,473,O
circumferential,481,496,B-Tissue
deep,498,502,I-Tissue
lateral,504,511,I-Tissue
margin,513,519,I-Tissue
utmost,526,532,O
importance,533,543,O
labeled,558,565,O
ink,571,574,O
gross,582,587,O
specimen,588,596,B-Pathological_formation
examined,611,619,O
histologically,620,634,O
tissue,649,655,B-Tissue
blocks,656,662,O
number,668,674,O
lymph,678,683,B-Pathological_formation
node,684,688,I-Pathological_formation
metastases,689,699,I-Pathological_formation
total,708,713,O
number,714,720,O
lymph,724,729,B-Multi-tissue_structure
nodes,730,735,I-Multi-tissue_structure
examined,736,744,O
reported,755,763,O
histological,767,779,O
evaluation,780,790,O
distal,798,804,B-Multi-tissue_structure
mesorectum,805,815,I-Multi-tissue_structure
entirety,823,831,O
recommended,835,846,O
detect,850,856,O
discontinuous,857,870,O
distal,871,877,B-Pathological_formation
mesorectal,878,888,I-Pathological_formation
tumor,889,894,I-Pathological_formation
spread,895,901,O
histopathological,907,924,O
findings,925,933,O
summarized,944,954,O
TNM,965,968,O
classification,969,983,O
Antisense,0,9,O
technologies,10,22,O
future,30,36,O
fighting,37,45,O
neurodegenerative,46,63,O
diseases,64,72,O
growing,78,85,O
understanding,86,99,O
role,107,111,O
unfavorable,117,128,O
patterns,129,137,O
gene,141,145,O
expression,146,156,O
play,157,161,O
etiology,169,177,O
neurodegenerative,181,198,O
disease,199,206,O
emphasizes,207,217,O
need,222,226,O
strategies,231,241,O
selectively,245,256,O
block,257,262,O
biosynthesis,267,279,O
harmful,283,290,O
proteins,291,299,O
brain,307,312,B-Organ
Antisense,314,323,O
technologies,324,336,O
ideally,341,348,O
suited,349,355,O
purpose,364,371,O
Tailor,373,379,O
designed,380,388,O
target,392,398,O
specific,399,407,O
RNA,408,411,O
antisense,413,422,O
oligonucleotides,423,439,O
ribozymes,444,453,O
offer,454,459,O
tools,460,465,O
suppress,469,477,O
production,482,492,O
proteins,496,504,O
mediating,505,514,O
neurodegeneration,515,532,O
technical,543,552,O
limitations,553,564,O
overcome,579,587,O
antisense,593,602,O
approach,603,611,O
represents,612,622,O
novel,625,630,O
exciting,635,643,O
strategy,644,652,O
intervention,657,669,O
diseases,673,681,O
central,689,696,B-Anatomical_system
nervous,697,704,I-Anatomical_system
system,705,711,I-Anatomical_system
Spacing,0,7,O
effects,8,15,O
memory,23,29,O
faces,34,39,B-Organism_subdivision
25,41,43,O
undergraduate,44,57,O
women,58,63,O
studied,64,71,O
12,72,74,O
stimulus,75,83,O
pictures,84,92,O
female,96,102,O
faces,103,108,B-Organism_subdivision
successively,109,121,O
presented,122,131,O
spaced,135,141,O
massed,145,151,O
conditions,152,162,O
affective,172,181,O
judgments,182,191,O
pictures,200,208,O
dimension,217,226,O
like,230,234,O
dislike,238,245,O
week,251,255,O
exposure,266,274,O
study,276,281,O
period,283,289,O
subjects,291,299,O
given,305,310,O
identification,314,328,O
test,329,333,O
comprised,334,343,O
photographs,347,358,O
female,371,377,O
faces,378,383,B-Organism_subdivision
different,389,398,O
expressions,399,410,O
Analysis,412,420,O
showed,421,427,O
pictures,437,445,O
presented,446,455,O
spaced,463,469,O
condition,470,479,O
frequently,490,500,O
accurately,505,515,O
identified,516,526,O
presented,538,547,O
massed,558,564,O
condition,565,574,O
affective,584,593,O
judgment,594,602,O
unrelated,607,616,O
conditions,620,630,O
presentation,634,646,O
Abdominal,0,9,B-Organism_subdivision
approach,10,18,O
ligation,27,35,O
bleeding,39,47,O
oesophageal,48,59,B-Multi-tissue_structure
varices,60,67,I-Multi-tissue_structure
conventional,73,85,O
surgical,86,94,O
treatment,95,104,O
bleeding,108,116,O
oesophageal,117,128,B-Multi-tissue_structure
varices,129,136,I-Multi-tissue_structure
emergency,144,153,O
situation,154,163,O
based,167,172,O
Boerema,182,189,O
Crile,190,195,O
operation,196,205,O
transthoracic,209,222,B-Organism_subdivision
oesophagotomy,223,236,O
ligation,241,249,O
varices,257,264,B-Multi-tissue_structure
methods,285,292,O
treatment,296,305,O
condition,314,323,O
current,327,334,O
practice,335,343,O
discussed,348,357,O
cases,363,368,O
reported,373,381,O
transabdominal,393,407,B-Organism_subdivision
oesophagogastrotomy,408,427,O
approach,440,448,O
site,453,457,O
bleeding,461,469,O
operation,476,485,O
described,489,498,O
theoretical,507,518,O
practical,523,532,O
advantages,533,543,O
appears,547,554,O
offer,558,563,O
standard,573,581,O
approach,582,590,O
considered,595,605,O
Stimulation,0,11,O
sodium,19,25,O
pump,26,30,O
azide,34,39,O
high,44,48,O
internal,49,57,O
sodium,58,64,O
changes,66,73,O
number,81,87,O
pumping,91,98,O
sites,99,104,O
turnover,109,117,O
rate,118,122,O
1,124,125,O
effects,131,138,O
5,142,143,O
mM,144,146,O
azide,147,152,O
3H,157,159,O
ouabain,160,167,O
uptake,168,174,O
22Na,179,183,O
efflux,184,190,O
determined,196,206,O
glycoside,213,222,O
uptake,223,229,O
22Na,234,238,O
efflux,239,245,O
enhanced,251,259,O
azide,263,268,O
2,270,271,O
Azide,273,278,O
stimulated,279,289,O
Na,294,296,O
pump,297,301,O
muscles,305,312,B-Tissue
pumping,319,326,O
sites,327,332,O
inhibited,342,351,O
ouabain,355,362,O
transferred,372,383,O
glycoside,389,398,O
free,399,403,O
solution,404,412,O
stimulation,419,430,O
observed,435,443,O
detecting,451,460,O
recovery,465,473,O
initial,481,488,O
pumping,489,496,O
activity,497,505,O
3,507,508,O
resting,524,531,O
azide,540,545,O
stimulated,546,556,O
22Na,557,561,O
efflux,562,568,O
blocked,578,585,O
ouabain,589,596,O
additional,601,611,O
exposure,612,620,O
azide,624,629,O
ouabain,636,643,O
free,644,648,O
solution,649,657,O
effects,674,681,O
22Na,685,689,O
efflux,690,696,O
4,698,699,O
concluded,707,716,O
increase,726,734,O
Na,738,740,O
pumping,741,748,O
caused,749,755,O
azide,759,764,O
increase,786,794,O
number,802,808,O
pumping,812,819,O
sites,820,825,O
5,827,828,O
3H,831,833,O
ouabain,834,841,O
binding,842,849,O
measured,854,862,O
muscles,866,873,B-Tissue
different,879,888,O
intracellular,889,902,B-Immaterial_anatomical_entity
alkali,903,909,O
cation,910,916,O
concentrations,917,931,O
Variations,933,943,O
Na,948,950,O
15,958,960,O
50,967,969,O
mM,970,972,O
significantly,981,994,O
affect,995,1001,O
glycoside,1016,1025,O
bound,1026,1031,O
substantial,1035,1046,O
increase,1047,1055,O
binding,1059,1066,O
occurred,1067,1075,O
Na,1082,1084,O
reached,1087,1094,O
70,1095,1097,O
mM,1098,1100,O
6,1102,1103,O
proposed,1111,1119,O
increase,1129,1137,O
Na,1141,1143,O
extrusion,1144,1153,O
occurs,1159,1165,O
recovery,1177,1185,O
Na,1189,1191,O
loaded,1192,1198,O
muscles,1199,1206,B-Tissue
results,1214,1221,O
increased,1230,1239,O
turnover,1240,1248,O
rate,1249,1253,O
pump,1261,1265,O
increase,1286,1294,O
number,1298,1304,O
pumping,1308,1315,O
sites,1316,1321,O
Focal,0,5,O
congenital,6,16,O
alveolar,17,25,B-Multi-tissue_structure
proteinosis,26,37,O
associated,38,48,O
abnormal,54,62,O
surfactant,63,73,O
protein,74,81,O
B,82,83,O
messenger,84,93,O
RNA,94,97,O
siblings,103,111,O
presented,112,121,O
typical,127,134,O
clinical,135,143,O
features,144,152,O
congenital,156,166,O
pulmonary,167,176,B-Multi-tissue_structure
alveolar,177,185,I-Multi-tissue_structure
proteinosis,186,197,O
PAP,199,202,O
Necropsy,205,213,O
sibling,221,228,O
revealed,229,237,O
scattered,238,247,O
foci,248,252,B-Pathological_formation
diagnostic,260,270,O
histologic,271,281,O
changes,282,289,O
lung,297,301,B-Tissue
tissue,302,308,I-Tissue
contrast,313,321,O
infantile,325,334,O
adult,339,344,O
PAP,345,348,O
focal,350,355,B-Pathological_formation
distribution,356,368,O
uncommon,372,380,O
congenital,384,394,O
PAP,395,398,O
Defective,400,409,O
expression,410,420,O
granulocyte,428,439,O
macrophage,440,450,O
colony,451,457,O
stimulating,458,469,O
factor,470,476,O
receptor,477,485,O
ruled,490,495,O
surfactant,505,515,O
protein,516,523,O
B,524,525,O
SP,527,529,O
B,530,531,O
content,533,540,O
lung,548,552,B-Tissue
tissue,553,559,I-Tissue
autopsied,567,576,O
patient,577,584,O
low,589,592,O
deletion,600,608,O
SP,616,618,O
B,619,620,O
messenger,621,630,O
RNA,631,634,O
detected,639,647,O
speculate,652,661,O
PAP,671,674,O
patients,682,690,O
related,695,702,O
reduced,710,717,O
quantity,718,726,O
altered,741,748,O
quality,749,756,O
SP,760,762,O
B,763,764,O
Tonometry,0,9,O
normal,13,19,O
scarred,24,31,O
corneas,32,39,B-Multi-tissue_structure
postkeratoplasty,48,64,O
eyes,65,69,B-Organ
comparative,73,84,O
study,85,90,O
Goldmann,98,106,O
ProTon,112,118,O
Schiotz,127,134,O
tonometers,135,145,O
PURPOSE,147,154,O
Clinical,156,164,O
comparison,165,175,O
intraocular,179,190,B-Immaterial_anatomical_entity
pressure,191,199,O
IOP,201,204,O
measured,206,214,O
Goldmann,224,232,O
applanation,233,244,O
tonometer,245,254,O
GAT,256,259,O
ProTon,266,272,O
tonometer,273,282,O
PT,284,286,O
Schiotz,297,304,O
tonometer,305,314,O
ST,316,318,O
normal,324,330,O
eyes,331,335,B-Organ
eyes,337,341,B-Organ
scarred,347,354,O
corneas,355,362,B-Multi-tissue_structure
postkeratoplasty,367,383,O
eyes,384,388,B-Organ
MATERIAL,390,398,O
METHODS,403,410,O
IOP,416,419,O
readings,420,428,O
GAT,434,437,O
PT,439,441,O
ST,447,449,O
compared,455,463,O
125,467,470,O
eyes,471,475,B-Organ
normal,481,487,O
corneas,488,495,B-Multi-tissue_structure
Group,497,502,O
17,507,509,O
eyes,510,514,B-Organ
scarred,520,527,O
corneas,528,535,B-Multi-tissue_structure
Group,537,542,O
B,543,544,O
21,554,556,O
postkeratoplasty,557,573,O
eyes,574,578,B-Organ
Group,580,585,O
C,586,587,O
data,594,598,O
statistically,604,617,O
analysed,618,626,O
95,630,632,O
confidence,634,644,O
interval,645,653,O
linear,655,661,O
regression,662,672,O
analysis,673,681,O
paired,686,692,O
t,693,694,O
test,695,699,O
RESULTS,711,718,O
mean,724,728,O
differences,729,740,O
standard,751,759,O
deviation,760,769,O
SD,771,773,O
GAT,783,786,O
PT,791,793,O
readings,794,802,O
GAT,808,811,O
ST,816,818,O
readings,819,827,O
respectively,828,840,O
1,848,849,O
Group,854,859,O
0,864,865,O
23,866,868,O
SD,870,872,O
2,873,874,O
75,875,877,O
mmHg,879,883,O
0,889,890,O
24,891,893,O
SD,895,897,O
3,898,899,O
18,900,902,O
mmHg,904,908,O
respectively,909,921,O
2,924,925,O
Group,930,935,O
B,936,937,O
1,940,941,O
8,942,943,O
SD,945,947,O
12,948,950,O
67,951,953,O
mmHg,955,959,O
4,965,966,O
5,967,968,O
SD,970,972,O
9,973,974,O
95,975,977,O
mmHg,978,982,O
3,989,990,O
Group,995,1000,O
C,1001,1002,O
0,1005,1006,O
24,1007,1009,O
SD,1011,1013,O
8,1014,1015,O
72,1016,1018,O
mmHg,1020,1024,O
0,1030,1031,O
12,1032,1034,O
SD,1036,1038,O
8,1039,1040,O
7,1041,1042,O
mmHg,1044,1048,O
statistically,1064,1077,O
significant,1078,1089,O
Group,1094,1099,O
95,1106,1108,O
confidence,1110,1120,O
interval,1121,1129,O
GAT,1138,1141,O
PT,1146,1148,O
readings,1149,1157,O
5,1163,1164,O
27,1165,1167,O
mmHg,1168,1172,O
5,1176,1177,O
73,1178,1180,O
mmHg,1181,1185,O
GAT,1199,1202,O
ST,1207,1209,O
readings,1210,1218,O
6,1221,1222,O
12,1223,1225,O
mmHg,1226,1230,O
6,1234,1235,O
59,1236,1238,O
mmHg,1239,1243,O
Ninety,1245,1251,O
77,1257,1259,O
eyes,1262,1266,B-Organ
PT,1276,1278,O
84,1283,1285,O
69,1287,1289,O
eyes,1292,1296,B-Organ
ST,1302,1304,O
measurements,1305,1317,O
3,1330,1331,O
mmHg,1332,1336,O
GAT,1340,1343,O
pressure,1344,1352,O
correlation,1358,1369,O
coefficients,1370,1382,O
r,1384,1385,O
PT,1391,1393,O
ST,1398,1400,O
0,1406,1407,O
93,1408,1410,O
P,1412,1413,O
0,1416,1417,O
0000,1418,1422,O
0,1428,1429,O
88,1430,1432,O
P,1434,1435,O
0,1438,1439,O
0000,1440,1444,O
respectively,1446,1458,O
Group,1463,1468,O
B,1469,1470,O
95,1471,1473,O
confidence,1475,1485,O
interval,1486,1494,O
GAT,1503,1506,O
PT,1511,1513,O
readings,1514,1522,O
27,1528,1530,O
17,1531,1533,O
mmHg,1534,1538,O
23,1542,1544,O
51,1545,1547,O
mmHg,1548,1552,O
GAT,1566,1569,O
ST,1574,1576,O
measurement,1577,1588,O
24,1591,1593,O
37,1594,1596,O
mmHg,1597,1601,O
15,1605,1607,O
44,1608,1610,O
mmHg,1611,1615,O
correlation,1621,1632,O
coefficients,1633,1645,O
r,1647,1648,O
PT,1658,1660,O
ST,1665,1667,O
0,1673,1674,O
112,1675,1678,O
P,1680,1681,O
0,1684,1685,O
660,1686,1689,O
0,1695,1696,O
630,1697,1700,O
P,1702,1703,O
0,1706,1707,O
006,1708,1711,O
respectively,1713,1725,O
group,1730,1735,O
C,1736,1737,O
95,1743,1745,O
confidence,1747,1757,O
interval,1758,1766,O
GAT,1775,1778,O
PT,1783,1785,O
measurements,1786,1798,O
17,1804,1806,O
20,1807,1809,O
mmHg,1810,1814,O
17,1818,1820,O
67,1821,1823,O
mmHg,1824,1828,O
GAT,1842,1845,O
ST,1850,1852,O
measurements,1853,1865,O
17,1868,1870,O
51,1871,1873,O
mmHg,1874,1878,O
17,1882,1884,O
27,1885,1887,O
mmHg,1888,1892,O
correlation,1898,1909,O
coefficients,1910,1922,O
r,1924,1925,O
PT,1935,1937,O
ST,1946,1948,O
0,1954,1955,O
780,1956,1959,O
P,1961,1962,O
0,1965,1966,O
0000,1967,1971,O
0,1977,1978,O
740,1979,1982,O
P,1984,1985,O
0,1988,1989,O
0001,1990,1994,O
respectively,1996,2008,O
CONCLUSIONS,2010,2021,O
clinical,2026,2034,O
practice,2035,2043,O
PT,2044,2046,O
appears,2047,2054,O
higher,2065,2071,O
level,2072,2077,O
accuracy,2081,2089,O
ST,2095,2097,O
normal,2101,2107,O
corneas,2108,2115,B-Multi-tissue_structure
scarred,2120,2127,O
corneas,2128,2135,B-Multi-tissue_structure
post,2140,2144,O
penetrating,2145,2156,O
keratoplasty,2157,2169,O
eyes,2170,2174,B-Organ
high,2187,2191,O
SD,2192,2194,O
mean,2199,2203,O
differences,2204,2215,O
wide,2220,2224,O
confidence,2225,2235,O
interval,2236,2244,O
95,2248,2250,O
PT,2258,2260,O
ST,2265,2267,O
inaccurate,2272,2282,O
measuring,2286,2295,O
IOP,2296,2299,O
compared,2303,2311,O
GAT,2315,2318,O
eyes,2327,2331,B-Organ
H,1,2,O
pylori,4,10,O
infection,11,20,O
experience,26,36,O
quadruple,46,55,O
triple,60,66,O
therapy,67,74,O
pharmacologic,84,97,O
approach,98,106,O
pharmacological,131,146,O
treatment,147,156,O
instance,166,174,O
eradication,178,189,O
Hp,193,195,O
foresees,196,204,O
utilization,205,216,O
triple,220,226,O
therapy,227,234,O
PPI,236,239,O
antibiotics,246,257,O
study,267,272,O
compared,281,289,O
kind,295,299,O
treatment,303,312,O
quadruple,322,331,O
therapy,332,339,O
PPI,341,344,O
antibiotics,353,364,O
showed,377,383,O
taller,386,392,O
percentage,393,403,O
eradication,407,418,O
end,426,429,O
therapeutical,439,452,O
cycle,453,458,O
shorter,466,473,O
time,474,478,O
lower,483,488,O
price,489,494,O
treatment,498,507,O
Renormalization,0,15,O
group,16,21,O
analysis,22,30,O
autoregressive,34,48,O
processes,49,58,O
fractional,63,73,O
noise,74,79,O
renormalization,83,98,O
group,99,104,O
analysis,105,113,O
applied,117,124,O
autoregressive,128,142,O
processes,143,152,O
infinite,161,169,O
series,170,176,O
coefficients,180,192,O
simple,196,202,O
fixed,203,208,O
point,209,214,O
given,218,223,O
random,229,235,O
walk,236,240,O
second,248,254,O
class,255,260,O
found,264,269,O
proportional,278,290,O
high,298,302,O
order,303,308,O
coefficients,309,321,O
fractional,325,335,O
autoregressive,336,350,O
integrated,351,361,O
moving,362,368,O
average,369,376,O
ARIMA,378,383,O
processes,385,394,O
approach,400,408,O
useful,418,424,O
detect,428,434,O
nonstationarity,435,450,O
autoregressive,454,468,O
processes,469,478,O
vitro,3,8,O
cytotoxic,9,18,O
potential,19,28,O
mechanism,33,42,O
action,46,52,O
selected,56,64,O
coumarins,65,74,O
human,82,87,O
renal,88,93,B-Cell
cell,94,98,I-Cell
lines,99,104,I-Cell
study,111,116,O
determined,117,127,O
selective,132,141,O
cytotoxicity,142,154,O
coumarin,164,172,O
compounds,173,182,O
human,186,191,O
renal,192,197,B-Cell
carcinoma,198,207,I-Cell
cells,208,213,I-Cell
relative,215,223,O
non,227,230,B-Cell
carcinoma,231,240,I-Cell
proximal,241,249,I-Cell
tubular,250,257,I-Cell
cells,258,263,I-Cell
Selectivity,265,276,O
cytotoxicity,277,289,O
observed,294,302,O
following,303,312,O
exposure,313,321,O
6,325,326,O
nitro,327,332,O
7,333,334,O
hydroxycoumarin,335,350,O
6,352,353,O
2,357,358,O
7,360,361,O
OHC,362,365,O
7,371,372,O
8,373,374,O
dihydroxycoumarin,375,392,O
7,394,395,O
8,396,397,O
OHC,398,401,O
6,404,405,O
2,409,410,O
7,412,413,O
OHC,414,417,O
induced,418,425,O
cytotoxicity,426,438,O
irreversible,443,455,O
cell,464,468,B-Cell
lines,469,474,I-Cell
unlike,476,482,O
7,483,484,O
8,485,486,O
OHC,487,490,O
reversible,502,512,O
carcinoma,520,529,B-Cell
cells,530,535,I-Cell
Mobility,542,550,O
shift,551,556,O
BrdU,561,565,O
incorporation,566,579,O
assays,580,586,O
showed,587,593,O
compounds,604,613,O
intercalate,622,633,O
DNA,634,637,O
concentration,648,661,O
dependent,662,671,O
inhibitory,672,682,O
effect,683,689,O
synthesis,697,706,O
coumarins,712,721,O
studied,722,729,O
found,735,740,O
non,747,750,O
mutagenic,751,760,O
standard,771,779,O
Ames,780,784,O
test,785,789,O
results,797,804,O
suggest,811,818,O
6,824,825,O
2,829,830,O
7,832,833,O
OHC,834,837,O
7,842,843,O
8,844,845,O
OHC,846,849,O
therapeutic,863,874,O
role,875,879,O
play,883,887,O
treatment,895,904,O
renal,908,913,B-Pathological_formation
cell,914,918,I-Pathological_formation
carcinoma,919,928,I-Pathological_formation
relationship,7,19,O
population,32,42,O
structure,43,52,O
national,57,65,O
economic,66,74,O
development,75,86,O
China,90,95,O
authors,101,108,O
examine,109,116,O
relationship,121,133,O
population,142,152,O
reproduction,153,165,O
production,174,184,O
material,188,196,O
goods,197,202,O
particular,209,219,O
reference,220,229,O
effect,237,243,O
changes,247,254,O
age,262,265,O
composition,266,277,O
population,285,295,O
national,303,311,O
economy,312,319,O
national,324,332,O
income,333,339,O
analysis,345,353,O
population,361,371,O
structure,372,381,O
China,385,390,O
presented,394,403,O
consideration,410,423,O
given,424,429,O
age,433,436,O
characteristics,437,452,O
occupation,454,464,O
urban,470,475,O
rural,480,485,O
population,486,496,O
Suggestions,499,510,O
improving,515,524,O
population,529,539,O
structure,540,549,O
achieve,553,560,O
maximum,561,568,O
rates,569,574,O
economic,578,586,O
development,587,598,O
presented,603,612,O
Regional,615,623,O
differences,624,635,O
population,639,649,O
structure,650,659,O
discussed,669,678,O
evidence,3,11,O
influence,19,28,O
human,36,41,O
platelet,42,50,O
antigen,51,58,O
1,59,60,O
polymorphism,61,73,O
antiplatelet,81,93,O
effects,94,101,O
glycoprotein,105,117,O
IIb,118,121,O
IIIa,122,126,O
inhibitors,127,137,O
study,144,149,O
investigated,150,162,O
hypothesis,167,177,O
human,187,192,O
platelet,193,201,O
antigen,202,209,O
1,210,211,O
HPA,213,216,O
1,217,218,O
polymorphism,220,232,O
influence,237,246,O
antiplatelet,251,263,O
effects,264,271,O
glycoprotein,275,287,O
GP,289,291,O
IIb,292,295,O
IIIa,296,300,O
inhibitors,301,311,O
Adenosine,313,322,O
diphosphate,323,334,O
30,336,338,O
micro,339,344,O
mol,345,348,O
induced,350,357,O
fibrinogen,358,368,O
binding,369,376,O
measured,381,389,O
flow,393,397,O
cytometry,398,407,O
Abciximab,409,418,O
0,420,421,O
03,422,424,O
3,425,426,O
micro,427,432,O
g,433,434,O
ml,435,437,O
tirofiban,440,449,O
0,451,452,O
3,453,454,O
30,455,457,O
nmol,458,462,O
l,463,464,O
eptifibatide,469,481,O
0,483,484,O
01,485,487,O
1,488,489,O
micro,490,495,O
g,496,497,O
ml,498,500,O
incubated,507,516,O
15,521,523,O
min,524,527,O
samples,537,544,O
prior,545,550,O
stimulation,554,565,O
IC,567,569,O
50,570,572,O
values,574,580,O
inhibition,589,599,O
fibrinogen,603,613,O
binding,614,621,O
determined,627,637,O
experiment,648,658,O
subjects,664,672,O
genotyped,678,687,O
GALIOS,691,697,O
automated,702,711,O
fluorescence,712,724,O
correlation,725,736,O
spectroscopy,737,749,O
marked,762,768,O
variability,769,780,O
inhibitory,788,798,O
effects,799,806,O
GPIIb,820,825,O
IIIa,826,830,O
inhibitors,831,841,O
confirmed,846,855,O
significant,871,882,O
differences,883,894,O
genotypes,907,916,O
respect,922,929,O
inhibition,937,947,O
fibrinogen,951,961,O
binding,962,969,O
present,981,988,O
study,989,994,O
provide,1004,1011,O
evidence,1012,1020,O
effect,1028,1034,O
HPA,1038,1041,O
1,1042,1043,O
polymorphism,1044,1056,O
inter,1064,1069,O
individual,1070,1080,O
variability,1081,1092,O
platelet,1100,1108,B-Cell
inhibitory,1109,1119,O
effects,1120,1127,O
GPIIb,1141,1146,O
IIIa,1147,1151,O
inhibitors,1152,1162,O
approved,1163,1171,O
clinical,1176,1184,O
use,1185,1188,O
Acute,4,9,O
Dialysis,10,18,O
Quality,19,26,O
Initiative,27,37,O
IV,44,46,O
membranes,48,57,B-Multi-tissue_structure
CRRT,62,66,O
extracorporeal,72,86,B-Multi-tissue_structure
membrane,87,95,I-Multi-tissue_structure
continuous,106,116,O
renal,117,122,B-Organ
replacement,123,134,O
therapy,135,142,O
CRRT,144,148,O
treatment,158,167,O
critically,173,183,O
ill,184,187,O
patient,188,195,O
acute,201,206,O
renal,207,212,B-Organ
failure,213,220,O
ARF,222,225,O
vitally,230,237,O
important,238,247,O
reasons,260,267,O
including,269,278,O
influence,283,292,O
biocompatibility,296,312,O
filter,317,323,O
performance,324,335,O
clinical,341,349,O
relevance,350,359,O
membrane,363,371,B-Multi-tissue_structure
related,372,379,O
biocompatibility,380,396,O
markers,397,404,O
traditionally,405,418,O
chronic,427,434,O
hemodialysis,435,447,O
remains,448,455,O
unclear,456,463,O
CRRT,467,471,O
Numerous,473,481,O
approaches,482,492,O
assess,508,514,O
membrane,515,523,B-Multi-tissue_structure
filter,528,534,O
performance,535,546,O
CRRT,550,554,O
specific,563,571,O
methodology,572,583,O
accepted,587,595,O
widely,596,602,O
present,606,613,O
potential,626,635,O
benefit,636,643,O
certain,647,654,O
membranes,655,664,B-Multi-tissue_structure
CRRT,674,678,O
adsorptive,682,692,O
removal,693,700,O
inflammatory,704,716,O
mediators,717,726,O
issue,733,738,O
assessed,752,760,O
carefully,761,770,O
designed,779,787,O
clinical,788,796,O
trials,797,803,O
issues,821,827,O
subject,842,849,O
future,853,859,O
clinical,860,868,O
research,869,877,O
efforts,878,885,O
Sickle,0,6,B-Cell
cell,7,11,I-Cell
disease,12,19,O
continuous,21,31,O
arterial,32,40,B-Multi-tissue_structure
spin,41,45,O
labeling,46,54,O
perfusion,55,64,O
MR,65,67,O
imaging,68,75,O
children,79,87,O
Cerebral,89,97,B-Organ
blood,98,103,B-Organism_substance
flow,104,108,O
CBF,110,113,O
measured,119,127,O
continuous,133,143,O
arterial,144,152,B-Multi-tissue_structure
spin,153,157,O
labeling,158,166,O
perfusion,167,176,O
magnetic,177,185,O
resonance,186,195,O
MR,197,199,O
imaging,201,208,O
14,212,214,O
children,215,223,O
sickle,229,235,B-Cell
cell,236,240,I-Cell
disease,241,248,O
seven,253,258,O
control,259,266,O
subjects,267,275,O
Mean,277,281,O
CBF,282,285,O
values,286,292,O
higher,298,304,O
patients,308,316,O
P,318,319,O
005,322,325,O
control,335,342,O
subjects,343,351,O
cerebral,359,367,B-Multi-tissue_structure
artery,368,374,I-Multi-tissue_structure
territories,375,386,O
patients,394,402,O
decreased,407,416,O
CBF,417,420,O
right,424,429,B-Multi-tissue_structure
anterior,430,438,I-Multi-tissue_structure
middle,443,449,O
cerebral,450,458,B-Multi-tissue_structure
artery,459,465,I-Multi-tissue_structure
territories,466,477,O
compared,478,486,O
CBF,492,495,O
left,503,507,O
patient,517,524,O
profound,531,539,O
decrease,540,548,O
CBF,552,555,O
territories,569,580,O
right,588,593,B-Organism_subdivision
hemisphere,594,604,I-Organism_subdivision
Baseline,606,614,O
CBF,615,618,O
significantly,623,636,O
decreased,637,646,O
territories,650,661,O
seen,662,666,O
unaffected,670,680,O
conventional,684,696,O
MR,697,699,O
images,700,706,O
MR,711,713,O
angiograms,714,724,O
children,733,741,O
sickle,747,753,B-Cell
cell,754,758,I-Cell
disease,759,766,O
septic,4,10,B-Multi-tissue_structure
abscess,11,18,I-Multi-tissue_structure
wall,19,23,I-Multi-tissue_structure
cytokine,27,35,O
generating,36,46,O
organ,47,52,B-Organ
associated,53,63,O
portal,69,75,B-Multi-tissue_structure
venous,76,82,I-Multi-tissue_structure
cytokinemia,83,94,O
hepatic,96,103,B-Organ
outflow,104,111,O
fibrosis,112,120,O
sinusoidal,122,132,B-Tissue
congestion,133,143,O
inflammatory,145,157,B-Cell
cell,158,162,I-Cell
sequestration,163,176,O
hepatocellular,178,192,B-Cell
lipid,193,198,O
deposition,199,209,O
focal,215,220,O
cell,221,225,B-Cell
death,226,231,O
acute,236,241,O
septic,242,248,O
inflammatory,249,261,O
response,262,270,O
access,276,282,O
portal,290,296,O
circulation,297,308,O
created,313,320,O
rat,326,329,O
model,330,335,O
intra,345,350,O
abdominal,351,360,B-Pathological_formation
abscess,361,368,I-Pathological_formation
composed,369,377,O
sterile,383,390,O
agar,391,395,O
pellet,396,402,O
contaminated,411,423,O
102,429,432,O
Escherichia,433,444,O
coli,445,449,O
E,451,452,O
coli,454,458,O
109,464,467,O
Bacteriodes,468,479,O
fragilis,480,488,O
B,490,491,O
fragilis,493,501,O
3,510,511,O
days,512,516,O
postimplantation,517,533,O
formed,542,548,O
intra,549,554,O
abdominal,555,564,B-Pathological_formation
abscess,565,572,I-Pathological_formation
occurred,573,581,O
wall,588,592,B-Tissue
showed,593,599,O
IL,600,602,O
6,603,604,O
DNA,605,608,O
PCR,612,615,O
IL,620,622,O
6,623,624,O
mRNA,625,629,O
situ,636,640,O
hybridization,641,654,O
Portal,656,662,B-Organism_substance
venous,663,669,I-Organism_substance
blood,670,675,I-Organism_substance
draining,676,684,O
liver,694,699,B-Organ
intra,709,714,O
abdominal,715,724,B-Pathological_formation
abscess,725,732,I-Pathological_formation
increased,737,746,O
levels,747,753,O
TNF,757,760,O
alpha,761,766,O
IL,768,770,O
1beta,771,776,O
IL,782,784,O
6,785,786,O
sterile,795,802,O
septic,807,813,O
groups,814,820,O
compared,821,829,O
control,837,844,O
normal,845,851,O
animal,852,858,O
group,859,864,O
Increased,866,875,O
levels,876,882,O
cytokines,892,901,O
found,912,917,O
suprahepatic,921,933,B-Organism_substance
inferior,934,942,I-Organism_substance
vena,943,947,I-Organism_substance
caval,948,953,I-Organism_substance
blood,954,959,I-Organism_substance
correlated,970,980,O
higher,990,996,O
portal,997,1003,B-Multi-tissue_structure
vein,1004,1008,I-Multi-tissue_structure
levels,1009,1015,O
suggesting,1017,1027,O
gradient,1030,1038,O
abscess,1044,1051,B-Multi-tissue_structure
wall,1052,1056,I-Multi-tissue_structure
portal,1060,1066,B-Multi-tissue_structure
vein,1067,1071,I-Multi-tissue_structure
systemic,1081,1089,O
circulation,1090,1101,O
liver,1110,1115,B-Organ
Liver,1117,1122,B-Organ
histology,1123,1132,O
demonstrated,1133,1145,O
sinusoidal,1146,1156,B-Tissue
congestion,1157,1167,O
centering,1168,1177,O
central,1185,1192,B-Multi-tissue_structure
vein,1193,1197,I-Multi-tissue_structure
growing,1199,1206,O
worse,1207,1212,O
progression,1218,1229,O
normal,1235,1241,O
control,1245,1252,O
sterile,1257,1264,O
septic,1269,1275,O
Similarly,1277,1286,O
degree,1292,1298,O
intrahepatic,1302,1314,O
myeloperoxidase,1315,1330,O
positive,1331,1339,O
inflammatory,1340,1352,B-Cell
cell,1353,1357,I-Cell
infiltration,1358,1370,O
hepatocellular,1375,1389,B-Cell
lipid,1390,1395,O
deposition,1396,1406,O
apoptosis,1411,1420,O
increased,1426,1435,O
control,1441,1448,O
sterile,1453,1460,O
septic,1465,1471,O
Gene,1473,1477,O
expression,1478,1488,O
situ,1495,1499,O
hybridization,1500,1513,O
demonstrated,1514,1526,O
significant,1529,1540,O
increase,1541,1549,O
IL,1553,1555,O
6,1556,1557,O
fibrinogen,1562,1572,O
mRNAs,1573,1578,O
cells,1582,1587,B-Cell
surrounding,1588,1599,O
central,1604,1611,B-Multi-tissue_structure
vein,1612,1616,I-Multi-tissue_structure
sterile,1620,1627,O
septic,1632,1638,O
animals,1639,1646,O
greatest,1654,1662,O
animals,1666,1673,O
sepsis,1679,1685,O
associated,1687,1697,O
increased,1706,1715,O
deposition,1716,1726,O
collagen,1730,1738,O
central,1746,1753,B-Multi-tissue_structure
vein,1754,1758,I-Multi-tissue_structure
area,1759,1763,O
prominent,1770,1779,O
septic,1787,1793,B-Organ
liver,1794,1799,I-Organ
pericentral,1805,1816,B-Cell
vein,1817,1821,I-Cell
cells,1822,1827,I-Cell
IL,1833,1835,O
6,1836,1837,O
fibrinogen,1842,1852,O
mRNA,1853,1857,O
increases,1858,1867,O
paralleled,1868,1878,O
increases,1883,1892,O
cells,1896,1901,B-Cell
containing,1902,1912,O
IL,1913,1915,O
6,1916,1917,O
fibrinogen,1922,1932,O
mRNAs,1933,1938,O
abscess,1946,1953,B-Multi-tissue_structure
walls,1954,1959,I-Multi-tissue_structure
sterile,1963,1970,O
septic,1975,1981,O
animals,1982,1989,O
respectively,1991,2003,O
data,2009,2013,O
suggest,2014,2021,O
intra,2030,2035,O
abdominal,2036,2045,B-Pathological_formation
abscess,2046,2053,I-Pathological_formation
especially,2055,2065,O
contaminated,2071,2083,O
gram,2089,2093,O
negative,2094,2102,O
bacteria,2103,2111,O
induces,2113,2120,O
mRNA,2121,2125,O
generated,2126,2135,O
cytokine,2136,2144,O
responses,2145,2154,O
abscess,2162,2169,B-Multi-tissue_structure
wall,2170,2174,I-Multi-tissue_structure
related,2184,2191,O
increased,2195,2204,O
portal,2205,2211,B-Multi-tissue_structure
venous,2212,2218,I-Multi-tissue_structure
levels,2219,2225,O
inflammatory,2233,2245,O
cytokines,2246,2255,O
TNF,2256,2259,O
alpha,2260,2265,O
IL,2267,2269,O
1beta,2270,2275,O
IL,2281,2283,O
6,2284,2285,O
perfusing,2286,2295,O
liver,2300,2305,B-Organ
turn,2317,2321,O
induce,2323,2329,O
localized,2330,2339,O
production,2340,2350,O
IL,2354,2356,O
6,2357,2358,O
fibrinogen,2363,2373,O
mRNAs,2374,2379,O
cells,2383,2388,B-Cell
central,2396,2403,B-Multi-tissue_structure
vein,2404,2408,I-Multi-tissue_structure
area,2409,2413,O
resultant,2419,2428,O
outflow,2429,2436,O
fibrosis,2437,2445,O
increased,2450,2459,O
inflammatory,2460,2472,B-Cell
cell,2473,2477,I-Cell
sequestration,2478,2491,O
liver,2503,2508,B-Multi-tissue_structure
lobular,2509,2516,I-Multi-tissue_structure
sinuses,2517,2524,I-Multi-tissue_structure
associated,2534,2544,O
generalized,2552,2563,O
inflammatory,2564,2576,O
response,2577,2585,O
intrahepatic,2590,2602,O
portal,2603,2609,O
sinusoid,2610,2618,O
congestion,2619,2629,O
increased,2645,2654,O
hepatocellular,2655,2669,B-Cell
lipid,2670,2675,O
deposition,2676,2686,O
apoptosis,2691,2700,O
cytokine,2712,2720,O
production,2721,2731,O
abscess,2739,2746,B-Multi-tissue_structure
wall,2747,2751,I-Multi-tissue_structure
appears,2759,2766,O
major,2775,2780,O
mediator,2781,2789,O
septic,2797,2803,B-Organ
hepatic,2804,2811,I-Organ
response,2812,2820,O
Treatment,0,9,O
effects,10,17,O
nigrostriatal,21,34,B-Multi-tissue_structure
projection,35,45,O
integrity,46,55,O
partial,59,66,O
6,67,68,O
OHDA,69,73,O
lesions,74,81,B-Pathological_formation
comparison,83,93,O
L,97,98,O
DOPA,99,103,O
pramipexole,108,119,O
controversy,130,141,O
potential,147,156,O
effects,157,164,O
dopaminergic,168,180,O
replacement,181,192,O
therapies,193,202,O
partially,210,219,O
lesioned,220,228,B-Multi-tissue_structure
nigrostriatal,229,242,I-Multi-tissue_structure
dopaminergic,243,255,O
projection,256,266,O
evaluated,271,280,O
indirect,281,289,O
levodopa,291,299,O
L,301,302,O
DOPA,303,307,O
versus,309,315,O
direct,316,322,O
pramipexole,324,335,O
PRA,337,340,O
dopaminergic,342,354,O
treatment,355,364,O
effects,365,372,O
nigrostriatal,376,389,B-Pathological_formation
lesion,390,396,I-Pathological_formation
severity,397,405,O
measured,409,417,O
vesicular,423,432,O
monoamine,433,442,O
transporter,443,454,O
type,455,459,O
2,460,461,O
VMAT2,463,468,O
binding,470,477,O
Prior,479,484,O
studies,485,492,O
shown,498,503,O
striatal,509,517,B-Multi-tissue_structure
VMAT2,518,523,O
density,524,531,O
provides,532,540,O
objective,544,553,O
estimate,554,562,O
dopaminergic,566,578,O
neuronal,579,587,B-Cell
integrity,588,597,O
confounding,607,618,O
effects,619,626,O
compensatory,630,642,O
regulation,643,653,O
Partial,655,662,O
unilateral,663,673,B-Multi-tissue_structure
median,674,680,I-Multi-tissue_structure
forebrain,681,690,I-Multi-tissue_structure
bundle,691,697,I-Multi-tissue_structure
lesions,698,705,I-Multi-tissue_structure
injection,719,728,O
6,732,733,O
hydroxydopamine,734,749,O
adult,753,758,O
male,759,763,O
Sprague,764,771,O
Dawley,772,778,O
rats,779,783,O
Lesion,785,791,B-Pathological_formation
severity,792,800,O
estimated,805,814,O
rotational,821,831,O
behavior,832,840,O
injections,847,857,O
apomorphine,861,872,O
amphetamine,877,888,O
Rats,890,894,O
ranked,900,906,O
matched,911,918,O
pairs,922,927,O
rotation,931,939,O
assigned,944,952,O
receive,956,963,O
PRA,971,974,O
1,976,977,O
mg,978,980,O
kg,981,983,O
day,984,987,O
L,992,993,O
DOPA,994,998,O
benserazide,999,1010,O
100,1012,1015,O
25,1016,1018,O
mg,1019,1021,O
kg,1022,1024,O
day,1025,1028,O
ip,1030,1032,O
osmotic,1037,1044,O
pump,1045,1049,O
4,1057,1058,O
weeks,1059,1064,O
drug,1068,1072,O
treatment,1073,1082,O
vitro,1087,1092,O
autoradiography,1093,1108,O
performed,1113,1122,O
3,1130,1131,O
H,1132,1133,O
methoxytetrabenazine,1134,1154,O
measure,1158,1165,O
striatal,1166,1174,B-Multi-tissue_structure
VMAT2,1175,1180,O
binding,1181,1188,O
density,1189,1196,O
Lesion,1198,1204,B-Pathological_formation
intact,1208,1214,O
VMAT2,1215,1220,O
density,1221,1228,O
correlated,1229,1239,O
rotation,1245,1253,O
treatment,1262,1271,O
groups,1272,1278,O
treatment,1293,1302,O
effect,1303,1309,O
VMAT2,1313,1318,O
expression,1319,1329,O
partially,1337,1346,O
lesioned,1347,1355,B-Multi-tissue_structure
striatum,1356,1364,I-Multi-tissue_structure
differential,1377,1389,O
effect,1390,1396,O
indirect,1400,1408,O
versus,1409,1415,O
direct,1416,1422,O
dopamimetic,1423,1434,O
treatment,1435,1444,O
nigrostriatal,1448,1461,B-Multi-tissue_structure
integrity,1462,1471,O
Neutrophil,0,10,B-Cell
function,11,19,O
chronic,23,30,O
neutrophilic,31,43,B-Cell
leukemia,44,52,O
defective,54,63,O
respiratory,64,75,B-Anatomical_system
burst,76,81,O
response,85,93,O
phorbol,97,104,O
esters,105,111,O
Functional,113,123,O
analyses,124,132,O
performed,138,147,O
neutrophils,151,162,B-Cell
isolated,163,171,O
6,177,178,O
patients,179,187,O
institutions,197,209,O
displayed,214,223,O
features,224,232,O
chronic,236,243,O
neutrophilic,244,256,B-Cell
leukemia,257,265,O
CNL,267,270,O
neutrophils,279,290,B-Cell
demonstrated,291,303,O
consistent,306,316,O
deficiency,317,327,O
44,329,331,O
8,336,337,O
control,342,349,O
values,350,356,O
superoxide,361,371,O
anion,372,377,O
O2,379,381,O
production,384,394,O
response,398,406,O
phorbol,414,421,O
ester,422,427,O
phorbol,429,436,O
myristate,437,446,O
acetate,447,454,O
PMA,456,459,O
O2,462,464,O
production,466,476,O
response,480,488,O
chemotactic,492,503,O
peptides,504,512,O
near,517,521,O
normal,522,528,O
82,530,532,O
3,533,534,O
10,539,541,O
7,542,543,O
control,548,555,O
values,556,562,O
Bacterial,565,574,O
killing,575,582,O
normal,587,593,O
patients,605,613,O
studied,614,621,O
chemotaxis,627,637,O
diminished,642,652,O
response,656,664,O
zymosan,668,675,O
activated,676,685,O
plasma,686,692,B-Organism_substance
high,700,704,O
concentrations,705,719,O
chemotactic,723,734,O
peptides,735,743,O
patients,751,759,O
studied,760,767,O
Cytosolic,769,778,O
C,779,780,O
kinase,781,787,O
activity,788,796,O
decreased,801,810,O
patients,829,837,O
studied,838,845,O
results,853,860,O
suggest,861,868,O
deficient,876,885,O
O2,886,888,O
release,890,897,O
response,901,909,O
PMA,913,916,O
hallmark,922,930,O
neutrophils,934,945,B-Cell
CNL,949,952,O
provide,961,968,O
diagnostic,971,981,O
indicator,982,991,O
condition,1000,1009,O
situ,3,7,O
alkylation,8,18,O
cysteine,22,30,O
residues,31,39,O
hydrophobic,45,56,O
membrane,57,65,B-Cellular_component
protein,66,73,O
immobilized,74,85,O
polyvinylidene,89,103,O
difluoride,104,114,O
membranes,115,124,O
electroblotting,128,143,O
prior,144,149,O
microsequence,153,166,O
amino,171,176,O
acid,177,181,O
analysis,182,190,O
identification,196,210,O
cysteine,214,222,O
residues,223,231,O
microsequence,235,248,O
analysis,249,257,O
crucial,264,271,O
derivatize,275,285,O
sulfhydryl,290,300,O
groups,301,307,O
reaction,314,322,O
requires,323,331,O
desalting,334,343,O
step,344,348,O
represents,361,371,O
major,374,379,O
obstacle,380,388,O
especially,390,400,O
sample,408,414,O
consists,415,423,O
limited,427,434,O
amounts,435,442,O
hydrophobic,448,459,O
membrane,460,468,B-Cellular_component
protein,469,476,O
alkylation,481,491,O
procedure,492,501,O
described,505,514,O
allowing,516,524,O
efficient,525,534,O
derivatization,535,549,O
greater,551,558,O
90,564,566,O
cysteines,572,581,O
cystines,586,594,O
low,603,606,O
microgram,607,616,O
quantities,617,627,O
revealed,632,640,O
test,644,648,O
analyses,649,657,O
lysozyme,663,671,O
hydrophobic,678,689,O
membrane,690,698,B-Cellular_component
protein,699,706,O
modified,712,720,O
protein,721,728,O
recovered,732,741,O
high,745,749,O
yields,750,756,O
form,762,766,O
suitable,767,775,O
microsequence,785,798,O
analysis,799,807,O
amino,812,817,O
acid,818,822,O
analysis,823,831,O
method,837,843,O
involves,844,852,O
electrophoretic,853,868,O
desalting,869,878,O
miniaturized,882,894,O
Tricine,895,902,O
sodium,903,909,O
dodecyl,910,917,O
sulfate,918,925,O
polyacrylamide,926,940,O
gel,941,944,O
electrophoresis,945,960,O
situ,968,972,O
alkylation,973,983,O
electro,990,997,O
transfer,998,1006,O
polyvinylidene,1012,1026,O
difluoride,1027,1037,O
membranes,1038,1047,O
Precautions,1049,1060,O
NH2,1069,1072,O
terminal,1073,1081,O
blocking,1082,1090,O
sample,1098,1104,O
preparations,1105,1117,O
provided,1122,1130,O
general,1136,1143,O
applicability,1144,1157,O
method,1165,1171,O
illustrated,1175,1186,O
structural,1194,1204,O
characterization,1205,1221,O
low,1229,1232,O
abundance,1233,1242,O
membrane,1243,1251,B-Cellular_component
receptor,1252,1260,O
human,1265,1270,O
urokinase,1271,1280,O
plasminogen,1281,1292,O
activator,1293,1302,O
effect,4,10,O
p,14,15,O
chlorophenylalanine,16,35,O
pethidine,43,52,O
methadone,57,66,O
induced,67,74,O
decrease,75,83,O
locomotor,87,96,O
activity,97,105,O
rats,109,113,O
pethidine,122,131,O
HCl,132,135,O
50,137,139,O
mg,140,142,O
kg,143,145,O
s,146,147,O
c,148,149,O
methadone,155,164,O
HCl,165,168,O
8,170,171,O
mg,172,174,O
kg,175,177,O
s,178,179,O
c,180,181,O
produced,184,192,O
prominent,195,204,O
decrease,205,213,O
locomotor,217,226,O
activity,227,235,O
rats,239,243,O
Pretreatment,245,257,O
rats,261,265,O
p,271,272,O
chlorophenylalanine,273,292,O
p,294,295,O
CPA,296,299,O
320,301,304,O
mg,305,307,O
kg,308,310,O
p,313,314,O
48,317,319,O
h,320,321,O
narcotic,333,341,O
injection,342,351,O
significantly,352,365,O
antagonized,366,377,O
activity,382,390,O
decreasing,391,401,O
effects,402,409,O
narcotics,413,422,O
rats,429,433,O
pretreated,434,444,O
p,450,451,O
CPA,452,455,O
given,461,466,O
5,467,468,O
hydroxytryptophan,469,486,O
75,488,490,O
mg,491,493,O
kg,494,496,O
s,497,498,O
c,499,500,O
30,503,505,O
min,506,509,O
narcotic,517,525,O
administration,526,540,O
activity,546,554,O
decreasing,555,565,O
response,566,574,O
narcotics,578,587,O
restored,592,600,O
decrease,610,618,O
locomotor,622,631,O
activity,632,640,O
induced,641,648,O
rats,652,656,O
pethidine,667,676,O
methadone,680,689,O
probably,693,701,O
mediated,702,710,O
serotonergic,714,726,O
mechanisms,727,737,O
presence,4,12,O
nitrite,16,23,O
UVA,31,34,O
irradiation,35,46,O
protects,47,55,O
apoptosis,61,70,O
Nitrite,72,79,O
occurs,80,86,O
ubiquitously,87,99,O
biological,103,113,B-Organism_substance
fluids,114,120,I-Organism_substance
blood,129,134,B-Organism_substance
sweat,139,144,B-Organism_substance
representing,146,158,O
oxidation,162,171,O
product,172,179,O
nitric,183,189,O
oxide,190,195,O
Nitrite,197,204,O
associated,214,224,O
variety,232,239,O
adverse,243,250,O
effects,251,258,O
mutagenicity,267,279,O
carcinogenesis,281,295,O
toxicity,301,309,O
contrast,314,322,O
demonstrate,332,343,O
presence,353,361,O
nitrite,365,372,O
nitrate,382,389,O
irradiation,398,409,O
endothelial,413,424,B-Cell
cells,425,430,I-Cell
culture,434,441,O
exerts,442,448,O
potent,451,457,O
concentration,462,475,O
dependent,476,485,O
protection,486,496,O
UVA,505,508,O
induced,509,516,O
apoptotic,517,526,O
cell,527,531,B-Cell
death,532,537,O
Protection,539,549,O
half,553,557,O
maximal,558,565,O
concentration,571,584,O
3,588,589,O
mM,590,592,O
complete,598,606,O
rescue,607,613,O
observed,617,625,O
10,629,631,O
mM,632,634,O
Nitrite,636,643,O
mediated,644,652,O
protection,653,663,O
mediated,667,675,O
inhibition,680,690,O
lipid,694,699,O
peroxidation,700,712,O
similar,718,725,O
manner,726,732,O
seen,736,740,O
butylated,746,755,O
hydroxytoluene,756,770,O
known,774,779,O
inhibitor,780,789,O
lipid,793,798,O
peroxidation,799,811,O
Interestingly,813,826,O
nitrite,828,835,O
mediated,836,844,O
protection,845,855,O
completely,859,869,O
abolished,870,879,O
coincubation,883,895,O
scavenger,908,917,O
cPTIO,918,923,O
electron,931,939,O
paramagnetic,940,952,O
resonance,953,962,O
EPR,964,967,O
spectroscopy,969,981,O
Faraday,985,992,O
modulation,993,1003,O
spectroscopy,1004,1016,O
directly,1021,1029,O
prove,1030,1035,O
UVA,1036,1039,O
induced,1040,1047,O
formation,1051,1060,O
solutions,1064,1073,O
containing,1074,1084,O
nitrite,1085,1092,O
conclusion,1097,1107,O
evidence,1109,1117,O
presented,1121,1130,O
nitrite,1136,1143,O
represents,1144,1154,O
protective,1157,1167,O
agent,1168,1173,O
UVA,1182,1185,O
induced,1186,1193,O
apoptosis,1194,1203,O
photodecomposition,1211,1229,O
nitrite,1233,1240,O
subsequent,1245,1255,O
formation,1256,1265,O
Induction,0,9,O
apoptosis,13,22,O
skeletal,26,34,B-Tissue
tissues,35,42,I-Tissue
phosphate,44,53,O
mediated,54,62,O
chick,63,68,O
chondrocyte,69,80,B-Cell
apoptosis,81,90,O
calcium,94,101,O
dependent,102,111,O
earlier,119,126,O
study,127,132,O
shown,142,147,O
Pi,153,155,O
induced,156,163,O
apoptosis,164,173,O
terminally,177,187,O
differentiated,188,202,O
hypertrophic,203,215,O
chondrocytes,216,228,B-Cell
ascertain,233,242,O
Ca2,251,254,O
modulates,256,265,O
Pi,266,268,O
induced,269,276,O
cell,277,281,B-Cell
death,282,287,O
asked,292,297,O
following,302,311,O
questions,316,325,O
prevent,341,348,O
Pi,349,351,O
induced,352,359,O
apoptosis,360,369,O
removing,373,381,O
Ca2,382,385,O
culture,396,403,O
medium,404,410,O
alternatively,412,425,O
potentiate,434,444,O
cell,445,449,B-Cell
death,450,455,O
increasing,459,469,O
Ca2,474,477,O
concentration,479,492,O
Second,494,500,O
inhibit,509,516,O
chondrocyte,517,528,B-Cell
apoptosis,529,538,O
blocking,542,550,O
Pi,551,553,O
transport,554,563,O
explored,573,581,O
mechanism,586,595,O
apoptosis,599,608,O
evaluating,612,622,O
mitochondrial,623,636,B-Cellular_component
activity,637,645,O
reactive,650,658,O
oxygen,659,665,O
species,666,673,O
ROS,675,678,O
generation,680,690,O
cells,694,699,B-Cell
treated,700,707,O
ion,717,720,O
pair,721,725,O
noted,730,735,O
EDTA,741,745,O
EGTA,750,754,O
blocked,755,762,O
Pi,763,765,O
induced,766,773,O
apoptosis,774,783,O
dose,789,793,O
dependent,794,803,O
manner,804,810,O
high,818,822,O
levels,823,829,O
Ca2,833,836,O
little,848,854,O
effect,855,861,O
chondrocyte,865,876,B-Cell
viability,877,886,O
cation,892,898,O
enhanced,899,907,O
Pi,908,910,O
dependent,911,920,O
cell,921,925,B-Cell
death,926,931,O
greatly,936,943,O
increased,944,953,O
Pi,954,956,O
uptake,957,963,O
Pi,970,972,O
transport,973,982,O
blocked,987,994,O
complete,1006,1014,O
inhibition,1015,1025,O
cell,1029,1033,B-Cell
killing,1034,1041,O
process,1047,1054,O
cell,1058,1062,B-Cell
death,1063,1068,O
characterized,1073,1086,O
mitochondrial,1090,1103,B-Cellular_component
hyperpolarization,1104,1121,O
hours,1127,1132,O
following,1133,1142,O
apoptogen,1143,1152,O
treatment,1153,1162,O
significant,1176,1187,O
decrease,1188,1196,O
mitochondrial,1204,1217,B-Cellular_component
membrane,1218,1226,I-Cellular_component
potential,1227,1236,O
Coincident,1238,1248,O
changes,1258,1265,O
mitochondrial,1269,1282,B-Cellular_component
function,1283,1291,O
increase,1306,1314,O
intracellular,1318,1331,B-Immaterial_anatomical_entity
Ca2,1332,1335,O
maintained,1346,1356,O
experimental,1372,1384,O
period,1385,1391,O
raised,1395,1401,O
Ca2,1402,1405,O
signal,1407,1413,O
observed,1418,1426,O
blebs,1430,1435,O
cell,1443,1447,B-Cellular_component
membrane,1448,1456,I-Cellular_component
Finally,1458,1465,O
noted,1470,1475,O
75,1482,1484,O
minutes,1485,1492,O
treatment,1499,1508,O
ion,1518,1521,O
pair,1522,1526,O
fold,1544,1548,O
elevation,1549,1558,O
ROS,1562,1565,O
levels,1566,1572,O
increase,1579,1587,O
declined,1588,1596,O
baseline,1600,1608,O
values,1609,1615,O
hours,1628,1633,O
Based,1635,1640,O
observations,1650,1662,O
suggest,1667,1674,O
cartilage,1688,1697,B-Tissue
mineralization,1698,1712,O
elevation,1723,1732,O
local,1736,1741,O
environmental,1742,1755,O
Ca2,1756,1759,O
Pi,1765,1767,O
concentrations,1768,1782,O
modulates,1783,1792,O
oxidative,1793,1802,O
metabolism,1803,1813,O
triggers,1819,1827,O
apoptosis,1828,1837,O
terminally,1841,1851,O
differentiated,1852,1866,O
chondrocytes,1867,1879,B-Cell
Outcomes,0,8,O
cefazolin,12,21,O
versus,22,28,O
ceftriaxone,29,40,O
therapy,41,48,O
treating,52,60,O
lower,61,66,B-Multi-tissue_structure
respiratory,67,78,I-Multi-tissue_structure
tract,79,84,I-Multi-tissue_structure
infections,85,95,O
adults,99,105,O
OBJECTIVE,107,116,O
determine,121,130,O
choice,139,145,O
versus,158,164,O
generation,171,181,O
cephalosporin,182,195,O
initial,199,206,O
therapy,207,214,O
lower,219,224,B-Multi-tissue_structure
respiratory,225,236,I-Multi-tissue_structure
tract,237,242,I-Multi-tissue_structure
infections,243,253,O
hospitalized,257,269,O
adults,270,276,O
affects,277,284,O
course,289,295,O
duration,300,308,O
care,312,316,O
influence,336,345,O
antimicrobial,346,359,O
treatment,360,369,O
cost,370,374,O
DESIGN,376,382,O
Retrospective,384,397,O
analysis,398,406,O
discharge,410,419,O
abstracts,420,429,O
hospital,434,442,O
pharmacy,443,451,O
records,452,459,O
SETTING,461,468,O
acute,485,490,O
care,491,495,O
hospitals,496,505,O
PATIENTS,507,515,O
thousand,521,529,O
ninety,530,536,O
hospitalized,541,553,O
adults,554,560,O
aged,562,566,O
17,569,571,O
y,572,573,O
principal,580,589,O
diagnoses,590,599,O
lower,603,608,B-Multi-tissue_structure
respiratory,609,620,I-Multi-tissue_structure
tract,621,626,I-Multi-tissue_structure
infections,627,637,O
DRGs,639,643,O
79,644,646,O
80,647,649,O
89,651,653,O
90,654,656,O
INTERVENTIONS,659,672,O
Cefazolin,674,683,O
ceftriaxone,687,698,O
given,700,705,O
sole,709,713,O
antimicrobial,714,727,O
therapy,728,735,O
day,753,756,O
MAIN,758,762,O
OUTCOME,763,770,O
MEASURES,771,779,O
1,782,783,O
number,789,795,O
patients,799,807,O
received,812,820,O
parenteral,829,839,O
antibiotic,840,850,O
anytime,851,858,O
prior,859,864,O
hospital,868,876,O
discharge,877,886,O
2,889,890,O
number,896,902,O
days,906,910,O
patients,924,932,O
received,933,941,O
parenteral,946,956,O
antibiotic,957,967,O
hospital,981,989,O
3,996,997,O
number,1003,1009,O
days,1013,1017,O
patients,1018,1026,O
remained,1027,1035,O
hospitalized,1036,1048,O
following,1049,1058,O
start,1063,1068,O
antibiotic,1072,1082,O
therapy,1083,1090,O
RESULTS,1092,1099,O
Patients,1101,1109,O
treated,1110,1117,O
cefazolin,1123,1132,O
n,1134,1135,O
763,1138,1141,O
likely,1153,1159,O
receive,1163,1170,O
parenteral,1179,1189,O
antibiotic,1190,1200,O
hospital,1214,1222,O
30,1224,1226,O
3,1227,1228,O
vs,1229,1231,O
20,1233,1235,O
7,1236,1237,O
percent,1238,1245,O
p,1247,1248,O
0,1251,1252,O
001,1253,1256,O
received,1262,1270,O
total,1276,1281,O
days,1282,1286,O
therapy,1290,1297,O
7,1299,1300,O
2,1301,1302,O
vs,1303,1305,O
6,1307,1308,O
7,1309,1310,O
d,1311,1312,O
p,1314,1315,O
0,1318,1319,O
05,1320,1322,O
treated,1335,1342,O
ceftriaxone,1348,1359,O
n,1361,1362,O
329,1365,1368,O
time,1384,1388,O
hospital,1392,1400,O
discharge,1401,1410,O
differ,1419,1425,O
sample,1438,1444,O
9,1446,1447,O
2,1448,1449,O
d,1450,1451,O
groups,1461,1467,O
greater,1477,1484,O
receiving,1497,1506,O
cefazolin,1507,1516,O
8,1518,1519,O
6,1520,1521,O
vs,1522,1524,O
8,1526,1527,O
0,1528,1529,O
d,1530,1531,O
p,1533,1534,O
0,1537,1538,O
05,1539,1541,O
patients,1548,1556,O
lengths,1562,1569,O
stay,1573,1577,O
exceeding,1578,1587,O
24,1588,1590,O
days,1591,1595,O
excluded,1601,1609,O
groups,1620,1626,O
CONCLUSIONS,1628,1639,O
addition,1644,1652,O
acquisition,1656,1667,O
cost,1668,1672,O
differences,1674,1685,O
course,1689,1695,O
duration,1700,1708,O
care,1712,1716,O
considered,1727,1737,O
determining,1743,1754,O
cost,1764,1768,O
effective,1769,1778,O
choice,1779,1785,O
antimicrobial,1790,1803,O
therapy,1804,1811,O
upper,12,17,O
limit,18,23,O
intracranial,27,39,B-Immaterial_anatomical_entity
pressure,40,48,O
patients,52,60,O
severe,66,72,O
head,73,77,B-Organism_subdivision
injury,78,84,O
cerebral,88,96,B-Organ
perfusion,97,106,O
pressure,107,115,O
maintained,119,129,O
Authors,131,138,O
recent,142,148,O
studies,149,156,O
championed,162,172,O
importance,177,187,O
maintaining,191,202,O
cerebral,203,211,B-Organ
perfusion,212,221,O
pressure,222,230,O
CPP,232,235,O
prevent,240,247,O
secondary,248,257,O
brain,258,263,B-Organ
injury,264,270,O
following,271,280,O
traumatic,281,290,O
head,291,295,B-Organism_subdivision
injury,296,302,O
Data,304,308,O
studies,320,327,O
provided,333,341,O
little,342,348,O
information,349,360,O
outcome,371,378,O
following,379,388,O
severe,389,395,O
head,396,400,B-Organism_subdivision
injury,401,407,O
patients,411,419,O
intracranial,428,440,B-Immaterial_anatomical_entity
pressure,441,449,O
ICP,451,454,O
greater,456,463,O
40,469,471,O
mm,472,474,O
Hg,475,477,O
July,491,495,O
1997,496,500,O
authors,505,512,O
instituted,513,523,O
protocol,526,534,O
management,543,553,O
severe,557,563,O
head,564,568,B-Organism_subdivision
injury,569,575,O
patients,579,587,O
Glasgow,595,602,O
Coma,603,607,O
Scale,608,613,O
score,614,619,O
lower,620,625,O
9,631,632,O
protocol,638,646,O
focused,651,658,O
resuscitation,662,675,O
acidosis,681,689,O
maintenance,691,702,O
CPP,708,711,O
greater,712,719,O
60,725,727,O
mm,728,730,O
Hg,731,733,O
means,751,756,O
necessary,757,766,O
elevation,778,787,O
head,795,799,O
bed,807,810,O
mannitol,812,820,O
infusion,821,829,O
ventriculostomy,835,850,O
cerebrospinal,856,869,B-Organism_substance
fluid,870,875,I-Organism_substance
drainage,876,884,O
control,889,896,O
ICP,900,903,O
institution,915,926,O
protocol,935,943,O
patients,950,958,O
sustained,965,974,O
ICP,975,978,O
greater,979,986,O
40,992,994,O
mm,995,997,O
Hg,998,1000,O
2,1005,1006,O
hours,1015,1020,O
ICP,1047,1050,O
greater,1051,1058,O
75,1064,1066,O
mm,1067,1069,O
Hg,1070,1072,O
insertion,1076,1085,O
ICP,1093,1096,O
monitor,1097,1104,O
later,1109,1114,O
experienced,1115,1126,O
herniation,1127,1137,O
expired,1142,1149,O
24,1157,1159,O
hours,1160,1165,O
severe,1182,1188,O
nature,1189,1195,O
injuries,1203,1211,O
demonstrated,1212,1224,O
computerized,1228,1240,O
tomography,1241,1251,O
scans,1252,1257,O
physical,1268,1276,O
examinations,1277,1289,O
patients,1297,1305,O
aggressively,1315,1327,O
treated,1328,1335,O
protocol,1347,1355,O
authors,1361,1368,O
vigorously,1369,1379,O
attempted,1380,1389,O
maintain,1393,1401,O
CPP,1404,1407,O
greater,1408,1415,O
60,1421,1423,O
mm,1424,1426,O
Hg,1427,1429,O
intensive,1435,1444,O
fluid,1445,1450,B-Organism_substance
resuscitation,1451,1464,O
administration,1473,1487,O
pressor,1491,1498,O
agents,1499,1505,O
remaining,1518,1527,O
patients,1528,1536,O
developed,1545,1554,O
ICP,1558,1561,O
higher,1562,1568,O
40,1574,1576,O
mm,1577,1579,O
Hg,1580,1582,O
placement,1589,1598,O
ICP,1606,1609,O
monitor,1610,1617,O
patients,1623,1631,O
episodic,1639,1647,O
ICP,1648,1651,O
greater,1652,1659,O
40,1665,1667,O
mm,1668,1670,O
Hg,1671,1673,O
36,1688,1690,O
hours,1691,1696,O
patient,1708,1715,O
episodic,1723,1731,O
ICP,1732,1735,O
greater,1736,1743,O
50,1752,1754,O
mm,1755,1757,O
Hg,1758,1760,O
36,1775,1777,O
hours,1778,1783,O
fourth,1793,1799,O
patient,1800,1807,O
episodic,1815,1823,O
ICP,1824,1827,O
greater,1828,1835,O
50,1841,1843,O
mm,1844,1846,O
Hg,1847,1849,O
48,1864,1866,O
hours,1867,1872,O
discharge,1877,1886,O
patients,1897,1905,O
able,1911,1915,O
perform,1919,1926,O
normal,1927,1933,O
activities,1934,1944,O
daily,1948,1953,O
living,1954,1960,O
minimal,1966,1973,O
assistance,1974,1984,O
experience,1989,1999,O
ongoing,2000,2007,O
improvement,2008,2019,O
Data,2021,2025,O
preliminary,2036,2047,O
study,2048,2053,O
indicate,2054,2062,O
intense,2068,2075,O
aggressive,2077,2087,O
management,2088,2098,O
CPP,2102,2105,O
lead,2110,2114,O
good,2118,2122,O
neurological,2123,2135,B-Anatomical_system
outcomes,2136,2144,O
despite,2145,2152,O
extremely,2153,2162,O
high,2163,2167,O
ICP,2168,2171,O
Aggressive,2173,2183,O
CPP,2184,2187,O
therapy,2188,2195,O
performed,2206,2215,O
maintained,2220,2230,O
apparently,2243,2253,O
lethal,2254,2260,O
ICP,2261,2264,O
levels,2265,2271,O
present,2279,2286,O
study,2296,2301,O
needed,2305,2311,O
support,2315,2322,O
encouraging,2329,2340,O
results,2341,2348,O
Newly,0,5,O
recognized,6,16,O
syndrome,17,25,O
heminasal,31,40,O
aplasia,41,48,O
ocular,53,59,B-Organ
anomalies,60,69,O
wider,73,78,O
spectrum,79,87,O
heminasal,91,100,O
aplasia,101,108,O
atypical,109,117,O
clefting,118,126,O
syndrome,127,135,O
report,140,146,O
unrelated,155,164,O
Brazilian,165,174,O
patients,175,183,O
heminasal,189,198,O
aplasia,199,206,O
associated,207,217,O
diverses,223,231,O
anomalies,232,241,O
including,243,252,O
lateral,253,260,O
proboscis,261,270,O
anomalies,276,285,O
eye,293,296,B-Organ
branchial,307,316,B-Multi-tissue_structure
arch,317,321,I-Multi-tissue_structure
suggest,326,333,O
patients,345,353,O
represent,354,363,O
different,364,373,O
conditions,374,384,O
spectrum,396,404,O
heminasal,412,421,O
aplasia,422,429,O
malformation,430,442,O
Clinical,444,452,O
genetic,454,461,O
differential,467,479,O
diagnosis,480,489,O
discussed,494,503,O
Neurologic,0,10,O
diagnosis,11,20,O
treatment,25,34,O
patients,38,46,O
computed,52,60,O
tomography,61,71,O
nasal,76,81,B-Organism_subdivision
endoscopy,82,91,O
negative,92,100,O
facial,101,107,B-Organism_subdivision
pain,108,112,O
OBJECTIVE,114,123,O
determine,128,137,O
helpfulness,142,153,O
specialist,157,167,O
neurology,168,177,O
referral,178,186,O
patients,191,199,O
facial,205,211,B-Organism_subdivision
pain,212,216,O
normal,220,226,O
sinus,227,232,B-Immaterial_anatomical_entity
computed,233,241,O
tomography,242,252,O
CT,254,256,O
scan,258,262,O
normal,268,274,O
nasal,275,280,B-Organism_subdivision
endoscopy,281,290,O
findings,291,299,O
STUDY,301,306,O
DESIGN,307,313,O
Prospective,315,326,O
identification,327,341,O
patients,345,353,O
analysis,358,366,O
data,370,374,O
approved,375,383,O
Institutional,391,404,O
Review,405,411,O
Board,412,417,O
METHODS,419,426,O
data,432,436,O
104,440,443,O
consecutive,444,455,O
patients,456,464,O
presenting,465,475,O
facial,481,487,B-Organism_subdivision
pain,488,492,O
normal,496,502,O
sinus,503,508,B-Immaterial_anatomical_entity
CT,509,511,O
scan,512,516,O
normal,522,528,O
nasal,529,534,B-Organism_subdivision
endoscopy,535,544,O
findings,545,553,O
reviewed,559,567,O
patients,573,581,O
presented,582,591,O
single,597,603,O
rhinologist,604,615,O
tertiary,621,629,O
care,630,634,O
institution,635,646,O
patients,652,660,O
referred,666,674,O
specialist,679,689,O
neurologic,690,700,O
evaluation,701,711,O
potential,716,725,O
treatment,726,735,O
information,745,756,O
obtained,761,769,O
patient,777,784,O
survey,785,791,O
RESULTS,793,800,O
104,809,812,O
patients,813,821,O
81,823,825,O
women,831,836,O
23,841,843,O
men,849,852,O
average,858,865,O
age,866,869,O
46,874,876,O
years,877,882,O
range,884,889,O
22,891,893,O
85,894,896,O
clear,913,918,O
CT,919,921,O
scans,922,927,O
48,929,931,O
minimal,936,943,O
change,944,950,O
negative,964,972,O
endoscopies,973,984,O
previous,1002,1010,O
unsuccessful,1011,1023,O
sinus,1024,1029,B-Immaterial_anatomical_entity
surgery,1030,1037,O
average,1043,1050,O
follow,1051,1057,O
period,1061,1067,O
10,1072,1074,O
5,1075,1076,O
months,1077,1083,O
75,1094,1096,O
patients,1097,1105,O
seeing,1106,1112,O
neurologist,1115,1126,O
seen,1132,1136,O
multiple,1140,1148,O
occasions,1149,1158,O
percent,1165,1172,O
patients,1176,1184,O
seen,1185,1189,O
neurologist,1195,1206,O
unsuspected,1214,1225,O
intracranial,1234,1246,B-Immaterial_anatomical_entity
diagnosis,1247,1256,O
common,1267,1273,O
diagnoses,1274,1283,O
migraine,1289,1297,O
37,1299,1301,O
rebound,1305,1312,O
headache,1313,1321,O
17,1323,1325,O
chronic,1329,1336,O
daily,1337,1342,O
headache,1343,1351,O
17,1353,1355,O
obstructive,1363,1374,O
sleep,1375,1380,O
apnea,1381,1386,O
16,1388,1390,O
Overall,1394,1401,O
58,1403,1405,O
improved,1407,1415,O
medical,1419,1426,O
therapy,1427,1434,O
60,1436,1438,O
clear,1456,1461,O
CT,1462,1464,O
scan,1465,1469,O
improved,1470,1478,O
53,1484,1486,O
minimal,1502,1509,O
change,1510,1516,O
CT,1520,1522,O
scan,1523,1527,O
improved,1528,1536,O
P,1538,1539,O
749,1543,1546,O
CONCLUSIONS,1549,1560,O
Facial,1562,1568,B-Organism_subdivision
pain,1569,1573,O
remains,1574,1581,O
difficult,1584,1593,O
symptom,1594,1601,O
diagnose,1605,1613,O
treat,1618,1623,O
rhinologic,1627,1637,O
practice,1638,1646,O
Patients,1648,1656,O
undergo,1663,1670,O
surgery,1671,1678,O
help,1687,1691,O
patients,1698,1706,O
facial,1712,1718,B-Organism_subdivision
pain,1719,1723,O
normal,1727,1733,O
sinus,1734,1739,B-Immaterial_anatomical_entity
CT,1740,1742,O
scan,1743,1747,O
normal,1753,1759,O
endoscopy,1760,1769,O
findings,1770,1778,O
benefit,1779,1786,O
neurologic,1792,1802,O
consultation,1803,1815,O
intracranial,1825,1837,B-Immaterial_anatomical_entity
pathologic,1838,1848,O
conditions,1849,1859,O
excluded,1867,1875,O
diagnosis,1880,1889,O
specific,1890,1898,O
pharmacogenetic,1899,1914,O
therapy,1915,1922,O
instituted,1923,1933,O
improvement,1939,1950,O
50,1964,1966,O
TBX21,0,5,O
functional,9,19,O
variant,20,27,O
predicts,28,36,O
improvement,37,48,O
asthma,52,58,O
use,68,71,O
inhaled,75,82,O
corticosteroids,83,98,O
TBX21,100,105,O
encodes,106,113,O
transcription,122,135,O
factor,136,142,O
T,143,144,O
bet,145,148,O
T,150,151,O
box,152,155,O
expressed,156,165,O
T,169,170,B-Cell
cells,171,176,I-Cell
influences,185,195,O
naive,196,201,O
T,202,203,B-Cell
lymphocyte,204,214,I-Cell
development,215,226,O
implicated,240,250,O
asthma,254,260,O
pathogenesis,261,273,O
Specifically,275,287,O
T,293,294,O
bet,295,298,O
knockout,299,307,O
mouse,308,313,O
spontaneously,314,327,O
develops,328,336,O
airway,337,343,B-Multi-tissue_structure
hyperresponsiveness,344,363,O
changes,374,381,O
consistent,382,392,O
asthma,398,404,O
airway,414,420,B-Multi-tissue_structure
responsiveness,421,435,O
moderated,439,448,O
use,456,459,O
inhaled,463,470,O
corticosteroids,471,486,O
asthma,490,496,O
conceivable,504,515,O
genetic,521,528,O
variation,529,538,O
TBX21,542,547,O
alter,552,557,O
asthma,558,564,O
phenotypes,565,575,O
treatment,581,590,O
specific,591,599,O
fashion,600,607,O
demonstrate,617,628,O
nonsynonymous,638,651,O
variation,652,661,O
TBX21,665,670,O
coding,671,677,O
replacement,682,693,O
histidine,697,706,O
33,707,709,O
glutamine,715,724,O
associated,728,738,O
significant,744,755,O
improvement,756,767,O
PC,775,777,O
20,778,780,O
measure,785,792,O
airway,796,802,B-Multi-tissue_structure
responsiveness,803,817,O
asthmatic,822,831,O
children,832,840,O
large,846,851,O
clinical,852,860,O
trial,861,866,O
spanning,867,875,O
4,876,877,O
years,878,883,O
note,888,892,O
increase,903,911,O
occurs,912,918,O
children,931,939,O
randomized,940,950,O
inhaled,954,961,O
corticosteroids,962,977,O
dramatically,990,1002,O
enhances,1003,1011,O
overall,1016,1023,O
improvement,1024,1035,O
PC,1039,1041,O
20,1042,1044,O
associated,1046,1056,O
inhaled,1062,1069,O
corticosteroid,1070,1084,O
usage,1085,1090,O
average,1096,1103,O
PC,1104,1106,O
20,1107,1109,O
trial,1114,1119,O
end,1120,1123,O
subjects,1128,1136,O
inhaled,1140,1147,O
corticosteroids,1148,1163,O
possessing,1164,1174,O
variant,1177,1184,O
allele,1185,1191,O
normal,1203,1209,O
range,1210,1215,O
nonasthmatics,1220,1233,O
cellular,1238,1246,O
models,1247,1253,O
TBX21,1272,1277,O
variant,1278,1285,O
increases,1286,1295,O
T,1296,1297,B-Cell
helper,1298,1304,I-Cell
1,1305,1306,I-Cell
decreases,1311,1320,O
T,1321,1322,B-Cell
helper,1323,1329,I-Cell
2,1330,1331,I-Cell
cytokine,1332,1340,O
expression,1341,1351,O
comparably,1352,1362,O
wild,1368,1372,O
type,1373,1377,O
TBX21,1379,1384,O
important,1400,1409,O
determinant,1410,1421,O
pharmacogenetic,1422,1437,O
response,1438,1446,O
therapy,1454,1461,O
asthma,1465,1471,O
inhaled,1477,1484,O
corticosteroids,1485,1500,O
Sox9,0,4,O
neural,5,11,B-Tissue
crest,12,17,I-Tissue
determinant,18,29,O
gene,30,34,O
controls,35,43,O
patterning,44,54,O
closure,59,66,O
posterior,74,83,B-Multi-tissue_structure
frontal,84,91,I-Multi-tissue_structure
cranial,92,99,I-Multi-tissue_structure
suture,100,106,I-Multi-tissue_structure
Cranial,108,115,B-Multi-tissue_structure
suture,116,122,I-Multi-tissue_structure
development,123,134,O
involves,135,143,O
complex,146,153,O
interaction,154,165,O
genes,169,174,O
tissues,179,186,B-Tissue
derived,187,194,O
neural,200,206,B-Cell
crest,207,212,I-Cell
cells,213,218,I-Cell
NCC,220,223,B-Cell
paraxial,229,237,B-Multi-tissue_structure
mesoderm,238,246,I-Multi-tissue_structure
mice,251,255,O
posterior,261,270,B-Multi-tissue_structure
frontal,271,278,I-Multi-tissue_structure
PF,280,282,I-Multi-tissue_structure
suture,284,290,I-Multi-tissue_structure
closes,291,297,O
month,315,320,O
life,324,328,O
sutures,341,348,B-Multi-tissue_structure
remain,349,355,O
patent,356,362,O
life,378,382,O
animal,390,396,O
Given,398,403,O
unique,408,414,O
NCC,415,418,B-Cell
origin,419,425,O
PF,429,431,B-Multi-tissue_structure
suture,432,438,I-Multi-tissue_structure
complex,439,446,O
analogous,448,457,O
metopic,461,468,B-Multi-tissue_structure
suture,469,475,I-Multi-tissue_structure
humans,479,485,O
performed,491,500,O
quantitative,501,513,O
real,514,518,O
time,519,523,O
PCR,524,527,O
immunohistochemistry,532,552,O
study,556,561,O
expression,566,576,O
pattern,577,584,O
NCC,592,595,B-Cell
determinant,596,607,O
gene,608,612,O
Sox9,613,617,O
select,622,628,O
markers,629,636,O
extracellular,640,653,B-Cellular_component
matrix,654,660,I-Cellular_component
results,666,673,O
indicated,674,683,O
unique,686,692,O
regulated,696,705,O
expression,706,716,O
Sox9,720,724,O
regulator,728,737,O
chondrogenesis,741,755,O
initiation,764,774,O
PF,778,780,B-Multi-tissue_structure
suture,781,787,I-Multi-tissue_structure
closure,788,795,O
expression,812,822,O
specific,826,834,O
cartilage,835,844,B-Tissue
markers,845,852,O
Type,854,858,O
II,859,861,O
Collagen,862,870,O
Type,875,879,O
X,880,881,O
Collagen,882,890,O
cartilage,904,913,B-Tissue
tissue,914,920,I-Tissue
formation,921,930,O
PF,938,940,B-Multi-tissue_structure
suture,941,947,I-Multi-tissue_structure
process,954,961,O
followed,966,974,O
expression,978,988,O
bone,992,996,B-Tissue
markers,997,1004,O
Type,1006,1010,O
Collagen,1013,1021,O
Osteocalcin,1026,1037,O
suggesting,1040,1050,O
endochondral,1051,1063,O
ossification,1064,1076,O
studied,1091,1098,O
effect,1103,1109,O
haploinsufficiency,1113,1131,O
NCC,1139,1142,B-Cell
determinant,1143,1154,O
gene,1155,1159,O
Sox9,1160,1164,O
NCC,1172,1175,B-Cell
derived,1176,1183,O
PF,1184,1186,B-Multi-tissue_structure
suture,1187,1193,I-Multi-tissue_structure
complex,1194,1201,O
decrease,1205,1213,O
dosage,1217,1223,O
Sox9,1227,1231,O
haploinsufficiency,1235,1253,O
NCC,1257,1260,B-Tissue
derived,1261,1268,I-Tissue
tissues,1269,1276,I-Tissue
resulted,1277,1285,O
delayed,1289,1296,O
PF,1297,1299,B-Multi-tissue_structure
suture,1300,1306,I-Multi-tissue_structure
closure,1307,1314,O
results,1322,1329,O
demonstrate,1330,1341,O
unique,1344,1350,O
development,1351,1362,O
PF,1370,1372,B-Multi-tissue_structure
suture,1373,1379,I-Multi-tissue_structure
complex,1380,1387,O
role,1396,1400,O
Sox9,1404,1408,O
important,1415,1424,O
contributor,1425,1436,O
timely,1440,1446,O
proper,1451,1457,O
closure,1458,1465,O
PF,1473,1475,B-Multi-tissue_structure
suture,1476,1482,I-Multi-tissue_structure
endochondral,1491,1503,O
ossification,1504,1516,O
Experimental,0,12,O
investigation,13,26,O
equibiaxial,30,41,O
extension,42,51,O
breakup,56,63,O
drops,67,72,O
molten,78,84,O
phase,89,94,O
polymer,95,102,O
blend,103,108,O
experimentally,113,127,O
investigate,128,139,O
breakup,144,151,O
equibiaxially,158,171,O
elongated,172,181,O
polystyrene,182,193,O
PS,195,197,O
drop,199,203,O
poly,209,213,O
methyl,214,220,O
methacrylate,221,233,O
PMMA,236,240,O
matrix,242,248,O
relaxation,256,266,O
melt,273,277,O
elongation,278,288,O
equibiaxial,293,304,O
elongation,305,315,O
initially,321,330,O
spherical,331,340,O
PS,341,343,O
drop,344,348,O
deformed,352,360,O
ellipsoidal,369,380,O
disclike,381,389,O
shape,390,395,O
test,404,408,O
parameters,409,419,O
hotstage,429,437,O
combination,441,452,O
light,460,465,O
microscope,466,476,O
observe,481,488,O
evolution,493,502,O
drop,510,514,O
shape,515,520,O
relaxation,528,538,O
initial,547,554,O
stage,555,560,O
relaxation,564,574,O
fingers,576,583,O
holes,588,593,O
formed,598,604,O
holes,610,615,O
located,620,627,O
preferentially,628,642,O
near,643,647,O
rim,652,655,O
drop,663,667,O
number,673,679,O
size,688,692,O
holes,700,705,O
increase,706,714,O
time,720,724,O
elongated,739,748,O
PS,749,751,O
drop,752,756,O
attains,757,764,O
complex,767,774,O
shape,775,780,O
relaxation,788,798,O
fingers,804,811,O
form,812,816,O
bulbous,817,824,O
ends,825,829,O
separate,836,844,O
fingers,854,861,O
discuss,866,873,O
dynamics,878,886,O
breakup,895,902,O
process,903,910,O
taking,914,920,O
account,926,933,O
interfacial,938,949,O
energy,950,956,O
PS,965,967,O
PMMA,972,976,O
analysis,982,990,O
shows,991,996,O
large,1009,1014,O
number,1015,1021,O
small,1025,1030,O
PS,1031,1033,O
droplets,1034,1042,O
generated,1050,1059,O
sequential,1067,1077,O
breakup,1078,1085,O
elongated,1093,1102,O
PS,1103,1105,O
drop,1106,1110,O
Management,0,10,O
extremity,14,23,O
trauma,24,30,O
related,35,42,O
infections,43,53,O
occurring,54,63,O
aquatic,71,78,O
environment,79,90,O
Wounds,92,98,B-Pathological_formation
sustained,99,108,O
oceans,112,118,O
lakes,120,125,O
streams,131,138,O
exposed,143,150,O
milieu,156,162,O
bacteria,166,174,O
rarely,175,181,O
encountered,182,193,O
typical,197,204,O
land,205,209,O
based,210,215,O
injuries,216,224,O
include,232,239,O
Vibrio,240,246,O
species,247,254,O
Aeromonas,256,265,O
hydrophila,266,276,O
Pseudomonas,278,289,O
Plesiomonas,294,305,O
species,306,313,O
Erysipelothrix,315,329,O
rhusiopathiae,330,343,O
Mycobacterium,345,358,O
marinum,359,366,O
microbes,378,386,O
Failure,388,395,O
recognize,399,408,O
treat,413,418,O
common,430,436,O
pathogens,437,446,O
timely,452,458,O
manner,459,465,O
result,470,476,O
significant,480,491,O
morbidity,492,501,O
death,505,510,O
Initial,512,519,O
antibiotic,520,530,O
therapy,531,538,O
address,546,553,O
common,554,560,O
gram,561,565,O
positive,566,574,O
gram,579,583,O
negative,584,592,O
aquatic,593,600,O
bacteria,601,609,O
depending,611,620,O
environment,628,639,O
Trauma,641,647,O
occurring,648,657,O
brackish,661,669,O
salt,673,677,O
water,678,683,O
treated,694,701,O
doxycycline,707,718,O
ceftazidime,723,734,O
fluoroquinolone,741,756,O
eg,758,760,O
ciprofloxacin,762,775,O
levofloxacin,779,791,O
Freshwater,794,804,O
wounds,805,811,B-Pathological_formation
managed,822,829,O
ciprofloxacin,835,848,O
levofloxacin,850,862,O
fourth,879,885,O
generation,886,896,O
cephalosporin,897,910,O
eg,912,914,O
ceftazidime,916,927,O
Injuries,930,938,O
sustained,939,948,O
marine,954,960,O
freshwater,964,974,O
environment,975,986,O
result,991,997,O
bites,1003,1008,O
venomous,1012,1020,O
stings,1021,1027,O
aquatic,1031,1038,O
organisms,1039,1048,O
accidental,1065,1075,O
trauma,1076,1082,O
Musculoskeletal,1084,1099,B-Pathological_formation
trauma,1100,1106,I-Pathological_formation
caused,1107,1113,O
venomous,1117,1125,O
underwater,1126,1136,O
species,1137,1144,O
eg,1146,1148,O
stingrays,1150,1159,O
stinging,1161,1169,O
fish,1170,1174,O
sea,1176,1179,O
urchins,1180,1187,O
coral,1193,1198,O
requires,1200,1208,O
immediate,1209,1218,O
neutralization,1219,1233,O
heat,1241,1245,O
labile,1246,1252,O
toxin,1253,1258,O
immersion,1264,1273,O
nonscalding,1277,1288,O
water,1289,1294,O
30,1299,1301,O
90,1305,1307,O
minutes,1308,1315,O
Appropriate,1317,1328,O
management,1329,1339,O
aquatic,1343,1350,O
wounds,1351,1357,B-Pathological_formation
requires,1358,1366,O
recognition,1367,1378,O
mechanism,1386,1395,O
injury,1399,1405,O
neutralization,1407,1421,O
venom,1425,1430,O
antibiotic,1432,1442,O
administration,1443,1457,O
radiographic,1459,1471,O
assessment,1472,1482,O
surgical,1484,1492,O
debridement,1493,1504,O
irrigation,1510,1520,O
wound,1522,1527,B-Pathological_formation
cultures,1528,1536,O
structural,1542,1552,O
repair,1553,1559,O
amputation,1563,1573,O
indicated,1577,1586,O
severity,1594,1602,O
injury,1610,1616,O
Involvement,0,11,O
de,15,17,O
novo,18,22,O
ceramide,23,31,O
synthesis,32,41,O
radiocontrast,45,58,O
induced,59,66,O
renal,67,72,B-Cell
tubular,73,80,I-Cell
cell,81,85,I-Cell
injury,86,92,O
reported,97,105,O
previously,106,116,O
radiocontrast,130,143,O
media,144,149,O
cause,150,155,O
apoptosis,156,165,O
porcine,169,176,O
proximal,177,185,B-Cell
tubular,186,193,I-Cell
LLC,195,198,I-Cell
PK,199,201,I-Cell
1,202,203,I-Cell
cells,206,211,I-Cell
reduction,222,231,O
B,235,236,O
cell,237,241,O
lymphoma,242,250,O
Bcl,252,255,O
2,257,258,O
expression,259,269,O
caspase,274,281,O
3,282,283,O
activation,284,294,O
implicated,299,309,O
present,318,325,O
study,326,331,O
investigated,336,348,O
role,351,355,O
ceramide,360,368,O
radiocontrast,372,385,O
media,386,391,O
induced,392,399,O
apoptosis,400,409,O
renal,413,418,B-Cell
tubular,419,426,I-Cell
cells,427,432,I-Cell
LLC,434,437,B-Cell
PK,438,440,I-Cell
1,441,442,I-Cell
cells,444,449,I-Cell
exposed,455,462,O
radiocontrast,466,479,O
media,480,485,O
30,490,492,O
min,493,496,O
followed,498,506,O
incubation,510,520,O
24,525,527,O
h,528,529,O
normal,533,539,O
medium,540,546,O
Cell,548,552,B-Cell
viability,553,562,O
assessed,567,575,O
2,579,580,O
2,582,583,O
methoxy,584,591,O
4,592,593,O
nitrophenyl,594,605,O
3,607,608,O
4,610,611,O
nitrophenyl,612,623,O
5,625,626,O
2,628,629,O
4,630,631,O
disulfophenyl,632,645,O
2H,647,649,O
tetrazolium,650,661,O
monosodium,662,672,O
salt,673,677,O
assay,678,683,O
apoptosis,691,700,O
determined,705,715,O
terminal,719,727,O
deoxynucleotidyl,728,744,O
transferase,745,756,O
mediated,757,765,O
dUTP,766,770,O
nick,771,775,O
end,776,779,O
labeling,780,788,O
stain,789,794,O
Immunofluorescent,796,813,O
stains,814,820,O
performed,826,835,O
antibodies,842,852,O
phosphorylated,861,875,O
Akt,876,879,O
pAkt,881,885,O
cAMP,891,895,O
response,896,904,O
element,905,912,O
binding,913,920,O
protein,921,928,O
CREB,930,934,O
pCREB,937,942,O
ceramide,949,957,O
mRNA,963,967,O
expression,968,978,O
protein,983,990,O
content,991,998,O
Bcl,1002,1005,O
2,1006,1007,O
determined,1013,1023,O
reverse,1027,1034,O
transcriptase,1035,1048,O
polymerase,1049,1059,O
chain,1060,1065,O
reaction,1066,1074,O
enzyme,1079,1085,O
immunoassay,1086,1097,O
respectively,1099,1111,O
vivo,1116,1120,O
model,1121,1126,O
contrast,1130,1138,O
induced,1139,1146,O
renal,1147,1152,B-Organ
injury,1153,1159,O
induced,1164,1171,O
mice,1175,1179,O
unilateral,1185,1195,O
renal,1196,1201,B-Organ
occlusion,1202,1211,O
cell,1217,1221,B-Cell
injury,1222,1228,O
induced,1229,1236,O
nonionic,1244,1252,O
radiocontrast,1253,1266,O
medium,1267,1273,O
ioversol,1274,1282,O
reversed,1287,1295,O
inhibiting,1299,1309,O
de,1310,1312,O
novo,1313,1317,O
ceramide,1318,1326,O
synthesis,1327,1336,O
fumonisin,1342,1351,O
B,1352,1353,O
1,1354,1355,O
FB,1358,1360,O
1,1361,1362,O
L,1369,1370,O
cycloserine,1371,1382,O
suppressing,1395,1406,O
sphingomyelin,1407,1420,O
breakdown,1421,1430,O
D609,1436,1440,O
FB,1442,1444,O
1,1445,1446,O
reversed,1448,1456,O
ioversol,1457,1465,O
induced,1466,1473,O
decrease,1474,1482,O
immunoreactivities,1490,1508,O
pAkt,1512,1516,O
pCREB,1521,1526,O
reduction,1528,1537,O
Bcl,1541,1544,O
2,1545,1546,O
expression,1547,1557,O
caspase,1562,1569,O
3,1570,1571,O
activation,1572,1582,O
Like,1584,1588,O
ioversol,1589,1597,O
C2,1599,1601,O
ceramide,1602,1610,O
Akt,1619,1622,O
inhibitor,1623,1632,O
Src,1633,1636,O
homology,1637,1645,O
6,1646,1647,O
induced,1648,1655,O
apoptosis,1656,1665,O
reducing,1669,1677,O
pAkt,1678,1682,O
pCREB,1687,1692,O
like,1693,1697,O
immunoreactivities,1698,1716,O
lowering,1718,1726,O
Bcl,1727,1730,O
2,1731,1732,O
expression,1733,1743,O
enhancing,1748,1757,O
caspase,1758,1765,O
3,1766,1767,O
activity,1768,1776,O
radiocontrast,1794,1807,O
media,1808,1813,O
excluding,1815,1824,O
iodixanol,1825,1834,O
showed,1841,1847,O
nephrotoxicity,1858,1872,O
enhanced,1874,1882,O
ceramide,1883,1891,O
like,1892,1896,O
immunoreactivity,1897,1913,O
role,1919,1923,O
de,1928,1930,O
novo,1931,1935,O
ceramide,1936,1944,O
synthesis,1945,1954,O
shown,1964,1969,O
vivo,1980,1984,O
model,1985,1990,O
radiocontrast,1994,2007,O
nephropathy,2008,2019,O
demonstrated,2024,2036,O
time,2056,2060,O
enhancement,2070,2081,O
de,2085,2087,O
novo,2088,2092,O
ceramide,2093,2101,O
synthesis,2102,2111,O
contributes,2112,2123,O
radiocontrast,2127,2140,O
nephropathy,2141,2152,O
potential,2,11,O
role,12,16,O
Src,25,28,O
like,29,33,O
adapter,34,41,O
protein,42,49,O
SLAP,50,54,O
2,55,56,O
signaling,60,69,O
colony,77,83,O
stimulating,84,95,O
factor,96,102,O
1,103,104,O
receptor,105,113,O
development,119,130,O
macrophages,134,145,B-Cell
myeloid,151,158,B-Cell
progenitor,159,169,I-Cell
cells,170,175,I-Cell
primarily,179,188,O
controlled,189,199,O
growth,207,213,O
factor,214,220,O
colony,221,227,O
stimulating,228,239,O
factor,240,246,O
1,247,248,O
CSF,250,253,O
1,254,255,O
cognate,265,272,O
receptor,273,281,O
transmembrane,285,298,B-Cellular_component
tyrosine,299,307,O
kinase,308,314,O
encoded,315,322,O
c,330,331,O
Fms,332,335,O
proto,336,341,O
oncogene,342,350,O
CSF,356,359,O
1,360,361,O
receptor,362,370,O
exerts,371,377,O
biological,382,392,O
effects,393,400,O
cells,404,409,B-Cell
range,416,421,O
signaling,425,434,O
proteins,435,443,O
including,444,453,O
Erk1,454,458,O
2,459,460,O
Akt,465,468,O
investigated,483,495,O
potential,500,509,O
involvement,510,521,O
Src,529,532,O
like,533,537,O
adapter,538,545,O
protein,546,553,O
SLAP,555,559,O
2,560,561,O
signaling,566,575,O
CSF,583,586,O
1,587,588,O
receptor,589,597,O
mouse,601,606,O
bone,607,611,B-Multi-tissue_structure
marrow,612,618,I-Multi-tissue_structure
derived,619,626,O
macrophages,627,638,B-Cell
RT,640,642,O
PCR,643,646,O
analysis,647,655,O
revealed,656,664,O
constitutive,665,677,O
expression,678,688,O
SLAP,696,700,O
2,701,702,O
gene,703,707,O
bone,711,715,B-Cell
marrow,716,722,I-Cell
macrophages,723,734,I-Cell
Surprisingly,736,748,O
co,750,752,O
immunoprecipitation,753,772,O
GST,777,780,O
binding,781,788,O
experiments,789,800,O
demonstrated,801,813,O
CSF,823,826,O
1,827,828,O
receptor,829,837,O
bind,844,848,O
SLAP,852,856,O
2,857,858,O
ligand,864,870,O
independent,871,882,O
manner,883,889,O
Furthermore,891,902,O
binding,908,915,O
SLAP,919,923,O
2,924,925,O
CSF,933,936,O
1,937,938,O
receptor,939,947,O
involved,948,956,O
multiple,957,965,O
domains,966,973,O
SLAP,977,981,O
2,982,983,O
SLAP,985,989,O
2,990,991,O
bound,997,1002,O
c,1003,1004,O
Cbl,1005,1008,O
interaction,1019,1030,O
mediated,1037,1045,O
unique,1072,1078,O
C,1079,1080,O
terminal,1081,1089,O
domain,1090,1096,O
SLAP,1100,1104,O
2,1105,1106,O
Overexpression,1108,1122,O
SLAP,1126,1130,O
2,1131,1132,O
bone,1136,1140,B-Cell
marrow,1141,1147,I-Cell
macrophages,1148,1159,I-Cell
partially,1160,1169,O
suppressed,1170,1180,O
CSF,1185,1188,O
1,1189,1190,O
induced,1191,1198,O
tyrosine,1199,1207,O
phosphorylation,1208,1223,O
expression,1231,1241,O
level,1242,1247,O
approximately,1253,1266,O
80,1267,1269,O
kDa,1270,1273,O
protein,1274,1281,O
affecting,1290,1299,O
CSF,1300,1303,O
1,1304,1305,O
induced,1306,1313,O
global,1314,1320,O
tyrosine,1321,1329,O
phosphorylation,1330,1345,O
activation,1350,1360,O
Akt,1364,1367,O
Erk1,1371,1375,O
2,1376,1377,O
Significantly,1379,1392,O
CSF,1394,1397,O
1,1398,1399,O
stimulation,1400,1411,O
induced,1412,1419,O
serine,1420,1426,O
phosphorylation,1427,1442,O
SLAP,1446,1450,O
2,1451,1452,O
Pharmacologic,1454,1467,O
inhibition,1468,1478,O
specific,1482,1490,O
protein,1491,1498,O
kinases,1499,1506,O
revealed,1507,1515,O
CSF,1521,1524,O
1,1525,1526,O
induced,1527,1534,O
phosphorylation,1535,1550,O
SLAP,1554,1558,O
2,1559,1560,O
dependent,1565,1574,O
JNK,1578,1581,O
activity,1582,1590,O
Taken,1592,1597,O
results,1612,1619,O
suggest,1620,1627,O
SLAP,1633,1637,O
2,1638,1639,O
potentially,1646,1657,O
involved,1661,1669,O
signaling,1673,1682,O
CSF,1690,1693,O
1,1694,1695,O
receptor,1696,1704,O
Structure,0,9,O
genetic,17,24,O
code,25,29,O
suggested,30,39,O
hydropathy,47,57,O
correlation,58,69,O
anticodons,78,88,O
amino,93,98,O
acid,99,103,O
residues,104,112,O
correlation,118,129,O
hydropathies,138,150,O
anticodons,154,164,O
amino,169,174,O
acids,175,180,O
detected,182,190,O
authors,200,207,O
utilizing,208,217,O
scales,218,224,O
amino,228,233,O
acid,234,238,O
molecules,239,248,O
solution,252,260,O
improved,266,274,O
utilization,284,295,O
scales,299,305,O
amino,309,314,O
acid,315,319,O
residues,320,328,O
proteins,332,340,O
partitions,348,358,O
discerned,364,373,O
correlation,381,392,O
plot,393,397,O
principal,407,416,O
dinucleotides,417,430,O
anticodons,434,444,O
pDiN,446,450,O
excluding,452,461,O
wobble,466,472,O
position,473,481,O
set,492,495,O
outliers,499,507,O
correlation,515,526,O
Gly,528,531,O
CC,532,534,O
Pro,536,539,O
GG,540,542,O
Ser,544,547,O
GA,548,550,O
Ser,555,558,O
CU,559,561,O
amino,567,572,O
acids,573,578,O
consistently,583,595,O
small,596,601,O
hydro,603,608,O
apathetic,609,618,O
stabilizers,620,631,O
protein,635,642,O
N,643,644,O
ends,645,649,O
preferred,651,660,O
aperiodic,664,673,O
protein,674,681,O
conformations,682,695,O
belong,700,706,O
synthetases,710,721,O
class,722,727,O
II,728,730,O
pDiN,736,740,O
sequences,741,750,O
representative,755,769,O
homogeneous,777,788,O
sector,789,795,O
triplets,797,805,O
NRR,806,809,O
NYY,814,817,O
distinguished,820,833,O
mixed,843,848,O
sector,849,855,O
triplets,857,865,O
NRY,866,869,O
NYR,874,877,O
depict,885,891,O
70,894,896,O
correspondence,898,912,O
synthetases,920,931,O
class,932,937,O
II,938,940,O
respectively,948,960,O
triplet,966,973,O
pairs,974,979,O
proposed,980,988,O
responsible,995,1006,O
coherence,1015,1024,O
set,1032,1035,O
outliers,1039,1047,O
palindromic,1059,1070,O
kind,1071,1075,O
lateral,1087,1094,O
bases,1095,1100,O
CCC,1115,1118,O
GGG,1120,1123,O
AGA,1128,1131,O
UCU,1133,1136,O
suggests,1143,1151,O
UCU,1157,1160,O
previously,1161,1171,O
belonged,1172,1180,O
Ser,1184,1187,O
adding,1189,1195,O
indications,1205,1216,O
attribution,1226,1237,O
Arg,1241,1244,O
YCU,1248,1251,O
expansion,1266,1275,O
Arg,1283,1286,O
tRNA,1287,1291,O
synthetase,1292,1302,O
specificity,1303,1314,O
attributions,1326,1338,O
produced,1339,1347,O
correlation,1352,1363,O
sets,1364,1368,O
b,1371,1372,O
corresponds,1378,1389,O
remaining,1397,1406,O
pDiN,1407,1411,O
homogeneous,1419,1430,O
sector,1431,1437,O
containing,1439,1449,O
synthetase,1455,1465,O
classes,1466,1473,O
regression,1479,1489,O
line,1490,1494,O
overlapped,1495,1505,O
formed,1514,1520,O
remaining,1528,1537,O
attributions,1538,1550,O
class,1554,1559,O
II,1560,1562,O
c,1565,1566,O
contains,1578,1586,O
pDiN,1591,1595,O
mixed,1603,1608,O
sector,1609,1615,O
produced,1620,1628,O
steeper,1629,1636,O
slopes,1637,1643,O
especially,1645,1655,O
class,1665,1670,O
attributions,1673,1685,O
suggested,1693,1702,O
correlation,1712,1723,O
established,1728,1739,O
amino,1749,1754,O
acid,1755,1759,O
composition,1760,1771,O
protein,1779,1786,O
synthetases,1787,1798,O
progressively,1806,1819,O
enriched,1820,1828,O
set,1842,1845,O
outliers,1849,1857,O
earliest,1867,1875,O
fixed,1889,1894,O
Hypocholesterolaemic,0,20,O
antioxidant,25,36,O
effects,37,44,O
Glycyrrhiza,48,59,O
glabra,60,66,O
Linn,68,72,O
rats,77,81,O
hypocholesterolaemic,87,107,O
antioxidant,112,123,O
effects,124,131,O
Glycyrrhiza,135,146,O
glabra,147,153,O
GG,155,157,O
root,159,163,B-Organ
powder,164,170,O
examined,176,184,O
hypercholesterolaemic,188,209,O
male,210,214,O
albino,215,221,O
rats,222,226,O
4,230,231,O
week,232,236,O
administration,237,251,O
GG,255,257,O
root,258,262,B-Organ
powder,263,269,O
5,271,272,O
10,277,279,O
gm,280,282,O
diet,287,291,O
hypercholesterolaemic,296,317,O
rats,318,322,O
resulted,323,331,O
significant,335,346,O
reduction,347,356,O
plasma,360,366,B-Organism_substance
hepatic,368,375,B-Organ
total,376,381,O
lipids,382,388,O
cholesterol,390,401,O
triglycerides,403,416,O
plasma,421,427,B-Organism_substance
low,428,431,O
density,432,439,O
lipoprotein,440,451,O
VLDL,456,460,O
cholesterol,461,472,O
accompanied,473,484,O
significant,488,499,O
increases,500,509,O
HDL,513,516,O
cholesterol,517,528,O
levels,529,535,O
Furthermore,537,548,O
significant,550,561,O
increases,562,571,O
fecal,575,580,B-Organism_substance
cholesterol,581,592,O
neutral,594,601,O
sterols,602,609,O
bile,614,618,O
acid,619,623,O
excretion,624,633,O
increase,648,656,O
hepatic,660,667,B-Organ
HMG,668,671,O
CoA,672,675,O
reductase,676,685,O
activity,686,694,O
bile,699,703,O
acid,704,708,O
production,709,719,O
observed,725,733,O
animals,743,750,O
root,756,760,B-Organ
powder,761,767,O
administration,768,782,O
hypercholesterolaemic,786,807,O
rats,808,812,O
decreased,818,827,O
hepatic,828,835,B-Organ
lipid,836,841,O
peroxidation,842,854,O
concomitant,862,873,O
increase,874,882,O
superoxide,886,896,O
dismutase,897,906,O
SOD,908,911,O
catalase,917,925,O
activities,926,936,O
total,941,946,O
ascorbic,947,955,O
acid,956,960,O
content,961,968,O
hypocholesterolaemic,980,1000,O
antioxidant,1005,1016,O
effects,1017,1024,O
GG,1028,1030,O
root,1031,1035,B-Organ
appeared,1036,1044,O
mediated,1051,1059,O
accelerated,1068,1079,O
cholesterol,1080,1091,O
neutral,1093,1100,O
sterol,1101,1107,O
bile,1112,1116,O
acid,1117,1121,O
elimination,1122,1133,O
fecal,1142,1147,B-Organism_substance
matter,1148,1154,I-Organism_substance
increased,1163,1172,O
hepatic,1173,1180,B-Organ
bile,1181,1185,O
acid,1186,1190,O
production,1191,1201,O
ii,1207,1209,O
improving,1211,1220,O
activities,1225,1235,O
hepatic,1239,1246,B-Organ
SOD,1247,1250,O
catalase,1252,1260,O
increasing,1265,1275,O
ascorbic,1280,1288,O
acid,1289,1293,O
content,1294,1301,O
normo,1307,1312,O
cholesterolaemic,1313,1329,O
animals,1330,1337,O
fed,1343,1346,O
GG,1352,1354,O
root,1355,1359,B-Organ
powder,1360,1366,O
10,1370,1372,O
gm,1373,1375,O
level,1377,1382,O
registered,1384,1394,O
significant,1397,1408,O
decline,1409,1416,O
plasma,1420,1426,B-Organism_substance
lipid,1427,1432,O
profiles,1433,1441,O
increase,1449,1457,O
HDL,1461,1464,O
cholesterol,1465,1476,O
content,1477,1484,O
antioxidant,1490,1501,O
status,1502,1508,O
animals,1518,1525,O
improved,1535,1543,O
treatment,1549,1558,O
Multicentre,0,11,O
study,12,17,O
peri,21,25,O
postoperative,31,44,O
central,45,52,B-Multi-tissue_structure
venous,53,59,I-Multi-tissue_structure
oxygen,60,66,O
saturation,67,77,O
high,81,85,O
risk,86,90,O
surgical,91,99,O
patients,100,108,O
INTRODUCTION,110,122,O
Low,124,127,O
central,128,135,B-Multi-tissue_structure
venous,136,142,I-Multi-tissue_structure
oxygen,143,149,O
saturation,150,160,O
ScvO2,162,167,O
associated,178,188,O
increased,194,203,O
risk,204,208,O
postoperative,212,225,O
complications,226,239,O
high,243,247,O
risk,248,252,O
surgery,253,260,O
association,275,286,O
centre,290,296,O
specific,297,305,O
generalisable,314,327,O
known,335,340,O
aim,346,349,O
study,358,363,O
assess,371,377,O
association,382,393,O
peri,402,406,O
postoperative,412,425,O
ScvO2,426,431,O
outcome,436,443,O
high,447,451,O
risk,452,456,O
surgical,457,465,O
patients,466,474,O
multicentre,480,491,O
setting,492,499,O
METHODS,501,508,O
large,516,521,O
European,522,530,O
university,531,541,O
hospitals,542,551,O
Finland,560,567,O
Switzerland,576,587,O
participated,589,601,O
60,606,608,O
patients,609,617,O
intra,623,628,O
abdominal,629,638,B-Organism_subdivision
surgery,639,646,O
lasting,647,654,O
90,665,667,O
minutes,668,675,O
presence,681,689,O
Shoemaker,709,718,O
s,719,720,O
criteria,721,729,O
ASA,735,738,O
American,740,748,O
Society,749,756,O
Anesthesiologists,760,777,O
class,779,784,O
greater,785,792,O
2,798,799,O
ScvO2,801,806,O
determined,811,821,O
preoperatively,822,836,O
hour,848,852,O
intervals,853,862,O
operation,874,883,O
12,890,892,O
hours,893,898,O
postoperatively,899,914,O
Hospital,916,924,O
length,925,931,O
stay,935,939,O
LOS,941,944,O
mortality,946,955,O
predefined,961,971,O
postoperative,972,985,O
complications,986,999,O
recorded,1005,1013,O
RESULTS,1015,1022,O
age,1028,1031,O
patients,1039,1047,O
72,1052,1054,O
10,1059,1061,O
years,1062,1067,O
mean,1069,1073,O
standard,1078,1086,O
deviation,1087,1096,O
simplified,1103,1113,O
acute,1114,1119,O
physiology,1120,1130,O
score,1131,1136,O
SAPS,1138,1142,O
II,1143,1145,O
32,1151,1153,O
12,1158,1160,O
Hospital,1162,1170,O
LOS,1171,1174,O
10,1179,1181,O
5,1182,1183,O
8,1185,1186,O
14,1190,1192,O
days,1194,1198,O
28,1204,1206,O
day,1207,1210,O
hospital,1211,1219,O
mortality,1220,1229,O
10,1234,1236,O
0,1237,1238,O
Preoperative,1241,1253,O
ScvO2,1254,1259,O
decreased,1260,1269,O
77,1275,1277,O
10,1283,1285,O
70,1290,1292,O
11,1298,1300,O
p,1303,1304,O
0,1307,1308,O
001,1309,1312,O
immediately,1314,1325,O
surgery,1332,1339,O
remained,1344,1352,O
unchanged,1353,1362,O
12,1363,1365,O
hours,1366,1371,O
later,1372,1377,O
total,1381,1386,O
67,1390,1392,O
postoperative,1393,1406,O
complications,1407,1420,O
recorded,1426,1434,O
32,1438,1440,O
patients,1441,1449,O
multivariate,1457,1469,O
analysis,1470,1478,O
mean,1480,1484,O
ScvO2,1485,1490,O
value,1491,1496,O
odds,1498,1502,O
ratio,1503,1508,O
1,1514,1515,O
23,1516,1518,O
95,1520,1522,O
confidence,1524,1534,O
interval,1535,1543,O
CI,1545,1547,O
1,1549,1550,O
01,1551,1553,O
1,1557,1558,O
50,1559,1561,O
p,1564,1565,O
0,1568,1569,O
037,1570,1573,O
hospital,1576,1584,O
LOS,1585,1588,O
0,1593,1594,O
75,1595,1597,O
95,1599,1601,O
CI,1603,1605,O
0,1606,1607,O
59,1608,1610,O
0,1614,1615,O
94,1616,1618,O
p,1621,1622,O
0,1625,1626,O
012,1627,1630,O
SAPS,1637,1641,O
II,1642,1644,O
0,1649,1650,O
90,1651,1653,O
95,1655,1657,O
CI,1659,1661,O
0,1662,1663,O
82,1664,1666,O
0,1670,1671,O
99,1672,1674,O
p,1677,1678,O
0,1681,1682,O
029,1683,1686,O
independently,1693,1706,O
associated,1707,1717,O
postoperative,1723,1736,O
complications,1737,1750,O
optimal,1756,1763,O
value,1764,1769,O
mean,1773,1777,O
ScvO2,1778,1783,O
discriminate,1787,1799,O
patients,1808,1816,O
develop,1836,1843,O
complications,1844,1857,O
73,1862,1864,O
sensitivity,1867,1878,O
72,1879,1881,O
specificity,1884,1895,O
61,1896,1898,O
CONCLUSION,1902,1912,O
Low,1914,1917,O
ScvO2,1918,1923,O
perioperatively,1924,1939,O
related,1943,1950,O
increased,1954,1963,O
risk,1964,1968,O
postoperative,1972,1985,O
complications,1986,1999,O
high,2003,2007,O
risk,2008,2012,O
surgery,2013,2020,O
warrants,2027,2035,O
trials,2036,2042,O
goal,2048,2052,O
directed,2053,2061,O
therapy,2062,2069,O
ScvO2,2076,2081,O
target,2087,2093,O
high,2097,2101,O
risk,2102,2106,O
surgery,2107,2114,O
patients,2115,2123,O
Treatment,1,10,O
squamous,14,22,B-Pathological_formation
intraepithelial,23,38,I-Pathological_formation
lesion,39,45,I-Pathological_formation
type,49,53,O
CIN2,54,58,O
et,59,61,O
CIN3,62,66,O
laser,72,77,O
CO2,78,81,O
vaporization,82,94,O
retrospective,96,109,O
study,110,115,O
52,119,121,O
cases,122,127,O
OBJECTIVES,130,140,O
study,147,152,O
carried,157,164,O
8,177,178,O
year,179,183,O
period,184,190,O
order,194,199,O
evaluate,203,211,O
long,216,220,O
term,221,225,O
effectiveness,226,239,O
laser,243,248,O
CO2,249,252,O
vaporization,253,265,O
treatment,273,282,O
squamous,286,294,B-Pathological_formation
intraepithelial,295,310,I-Pathological_formation
lesion,311,317,I-Pathological_formation
type,321,325,O
CIN2,326,330,O
CIN3,335,339,O
MATERIALS,341,350,O
METHODS,355,362,O
retrospective,366,379,O
study,380,385,O
52,389,391,O
cases,392,397,O
cervical,401,409,B-Pathological_formation
lesions,410,417,I-Pathological_formation
type,421,425,O
CIN2,426,430,O
CIN3,435,439,O
treated,440,447,O
intention,457,466,O
laser,470,475,O
CO2,476,479,O
vaporization,480,492,O
carried,497,504,O
hospital,516,524,O
Jeanne,525,531,O
de,532,534,O
Flandre,535,542,O
CHRU,546,550,O
Lille,554,559,O
1996,565,569,O
2003,573,577,O
treatment,584,593,O
performed,598,607,O
high,616,620,O
grade,621,626,O
exo,627,630,B-Pathological_formation
cervical,631,639,I-Pathological_formation
lesions,640,647,I-Pathological_formation
small,652,657,O
size,658,662,O
2cm2,665,669,O
complete,680,688,O
colposcopic,689,700,O
examination,701,712,O
RESULTS,714,721,O
patients,733,741,O
treated,747,754,O
intention,764,773,O
laser,774,779,O
vaporization,780,792,O
Mean,799,803,O
age,804,807,O
29,812,814,O
4,815,816,O
years,817,822,O
51,827,829,O
9,830,831,O
nulliparous,838,849,O
cyto,864,868,O
colposcopic,869,880,O
control,881,888,O
17,901,903,O
persistent,904,914,O
lesions,915,922,B-Pathological_formation
32,924,926,O
7,927,928,O
35,942,944,O
patients,945,953,O
persistent,962,972,O
lesion,973,979,B-Pathological_formation
29,981,983,O
achieved,984,992,O
cure,993,997,O
absence,999,1006,O
recurrence,1010,1020,O
4,1023,1024,O
presented,1025,1034,O
recurrence,1037,1047,O
2,1052,1053,O
lost,1059,1063,O
follow,1067,1073,O
CONCLUSION,1078,1088,O
current,1094,1101,O
data,1102,1106,O
literature,1114,1124,O
concerning,1125,1135,O
treatment,1140,1149,O
laser,1153,1158,O
CO2,1159,1162,O
vaporization,1163,1175,O
authorize,1176,1185,O
application,1186,1197,O
method,1206,1212,O
certain,1217,1224,O
high,1225,1229,O
grade,1230,1235,O
exocervical,1236,1247,B-Pathological_formation
lesions,1248,1255,I-Pathological_formation
complete,1264,1272,O
colposcopic,1273,1284,O
examination,1285,1296,O
type,1303,1307,O
treatment,1311,1320,O
remains,1321,1328,O
aggressive,1334,1344,O
surgical,1352,1360,O
treatment,1361,1370,O
high,1376,1380,O
rate,1381,1385,O
residual,1389,1397,O
lesions,1398,1405,B-Pathological_formation
particular,1409,1419,O
event,1427,1432,O
CIN3,1436,1440,O
incomplete,1458,1468,O
destruction,1469,1480,O
lesion,1488,1494,B-Pathological_formation
Patients,1496,1504,O
advised,1520,1527,O
monitoring,1533,1543,O
integral,1550,1558,O
treatment,1571,1580,O
Laser,1582,1587,O
vaporization,1588,1600,O
limited,1610,1617,O
CIN1,1621,1625,O
CIN2,1630,1634,O
lesions,1635,1642,B-Pathological_formation
Segmental,0,9,O
atrial,10,16,B-Multi-tissue_structure
contraction,17,28,O
patients,32,40,O
restored,41,49,O
sinus,53,58,B-Immaterial_anatomical_entity
rhythm,59,65,O
cardioversion,72,85,O
chronic,90,97,O
atrial,98,104,B-Multi-tissue_structure
fibrillation,105,117,O
colour,121,127,O
Doppler,128,135,O
tissue,136,142,B-Tissue
imaging,143,150,O
study,151,156,O
AIMS,158,162,O
little,173,179,O
known,180,185,O
segmental,192,201,O
atrial,202,208,B-Multi-tissue_structure
function,209,217,O
patients,221,229,O
atrial,235,241,B-Multi-tissue_structure
arrhythmias,242,253,O
evaluated,258,267,O
segmental,268,277,O
atrial,278,284,B-Multi-tissue_structure
contractility,285,298,O
colour,305,311,O
Doppler,312,319,O
tissue,320,326,B-Tissue
imaging,327,334,O
CDTI,336,340,O
patients,345,353,O
chronic,359,366,O
atrial,367,373,B-Multi-tissue_structure
fibrillation,374,386,O
CAF,388,391,O
successfully,402,414,O
restored,415,423,O
maintained,428,438,O
sinus,442,447,B-Immaterial_anatomical_entity
rhythm,448,454,O
SR,456,458,O
METHODS,461,468,O
RESULTS,473,480,O
compared,485,493,O
segmental,498,507,O
atrial,508,514,B-Multi-tissue_structure
contractility,515,528,O
39,532,534,O
CAF,535,538,O
patients,539,547,O
successfully,557,569,O
cardioverted,570,582,O
maintained,587,597,O
SR,601,603,O
6,608,609,O
months,610,616,O
Follow,618,624,O
echocardiograms,628,643,O
performed,649,658,O
baseline,662,670,O
1,672,673,O
week,674,678,O
1,680,681,O
month,682,687,O
6,692,693,O
months,694,700,O
compared,705,713,O
normal,719,725,O
age,726,729,O
matched,730,737,O
cohort,738,744,O
n,746,747,O
34,750,752,O
CDTI,761,765,O
mean,767,771,O
peak,772,776,O
velocities,777,787,O
atrial,791,797,B-Multi-tissue_structure
contraction,798,809,O
measured,815,823,O
annular,829,836,O
mid,838,841,O
superior,846,854,O
segments,855,863,O
lateral,867,874,B-Multi-tissue_structure
septal,879,885,B-Multi-tissue_structure
walls,886,891,I-Multi-tissue_structure
left,899,903,B-Multi-tissue_structure
atrium,904,910,I-Multi-tissue_structure
right,915,920,B-Multi-tissue_structure
atrium,921,927,I-Multi-tissue_structure
apical,935,941,O
chamber,947,954,O
view,955,959,O
Segmental,961,970,O
velocities,971,981,O
posterior,991,1000,O
anterior,1005,1013,O
walls,1014,1019,O
left,1027,1031,B-Multi-tissue_structure
atrium,1032,1038,I-Multi-tissue_structure
measured,1044,1052,O
apical,1062,1068,O
chamber,1073,1080,O
view,1081,1085,O
Segmental,1087,1096,O
left,1097,1101,B-Multi-tissue_structure
atrial,1102,1108,I-Multi-tissue_structure
velocities,1109,1119,O
improved,1120,1128,O
time,1134,1138,O
CAF,1146,1149,O
group,1150,1155,O
majority,1166,1174,O
recovery,1182,1190,O
occurring,1191,1200,O
month,1214,1219,O
failed,1225,1231,O
normalise,1235,1244,O
6,1253,1254,O
months,1255,1261,O
comparison,1266,1276,O
right,1282,1287,B-Multi-tissue_structure
atrial,1288,1294,I-Multi-tissue_structure
velocities,1295,1305,O
AF,1313,1315,O
group,1316,1321,O
normalised,1326,1336,O
1,1340,1341,O
month,1342,1347,O
CONCLUSION,1349,1359,O
Patients,1361,1369,O
CAF,1375,1378,O
persistent,1384,1394,O
segmental,1395,1404,O
left,1405,1409,B-Multi-tissue_structure
atrial,1410,1416,I-Multi-tissue_structure
dysfunction,1417,1428,O
6,1434,1435,O
months,1436,1442,O
restoration,1449,1460,O
maintenance,1465,1476,O
SR,1480,1482,O
right,1491,1496,B-Multi-tissue_structure
atrial,1497,1503,I-Multi-tissue_structure
velocities,1504,1514,O
appear,1515,1521,O
normalise,1525,1534,O
differential,1541,1553,O
recovery,1554,1562,O
indicates,1563,1572,O
left,1578,1582,B-Multi-tissue_structure
atrial,1583,1589,I-Multi-tissue_structure
function,1590,1598,O
remains,1599,1606,O
subnormal,1607,1616,O
patients,1620,1628,O
CAF,1634,1637,O
despite,1638,1645,O
maintenance,1646,1657,O
SR,1661,1663,O
suggesting,1665,1675,O
underlying,1676,1686,O
atrial,1687,1693,B-Multi-tissue_structure
myopathy,1694,1702,O
fibrosis,1706,1714,O
consequence,1720,1731,O
CAF,1735,1738,O
Anomalous,1,10,O
origin,11,17,O
right,25,30,B-Multi-tissue_structure
coronary,31,39,I-Multi-tissue_structure
artery,40,46,I-Multi-tissue_structure
left,56,60,O
sinus,61,66,B-Immaterial_anatomical_entity
Valsalva,70,78,O
case,80,84,O
report,85,91,O
literature,96,106,O
review,107,113,O
describe,119,127,O
case,132,136,O
patient,142,149,O
evaluation,158,168,O
effort,172,178,O
angina,179,185,O
revealed,186,194,O
tight,197,202,O
stenosis,203,211,O
right,217,222,B-Multi-tissue_structure
coronary,223,231,I-Multi-tissue_structure
artery,232,238,I-Multi-tissue_structure
anomalously,239,250,O
arising,251,258,O
left,268,272,O
sinus,273,278,B-Immaterial_anatomical_entity
Valsalva,282,290,O
successfully,302,314,O
treated,315,322,O
stent,326,331,O
implantation,332,344,O
abnormal,350,358,O
origin,359,365,O
right,373,378,B-Multi-tissue_structure
coronary,379,387,I-Multi-tissue_structure
artery,388,394,I-Multi-tissue_structure
left,404,408,O
aortic,409,415,B-Immaterial_anatomical_entity
sinus,416,421,I-Immaterial_anatomical_entity
coursing,422,430,O
aorta,443,448,B-Multi-tissue_structure
pulmonary,457,466,B-Multi-tissue_structure
trunk,467,472,I-Multi-tissue_structure
rare,478,482,O
congenital,483,493,O
anomaly,494,501,O
remain,510,516,O
asymptomatic,517,529,O
cause,544,549,O
major,550,555,O
cardiac,556,563,B-Organ
events,564,570,O
absence,584,591,O
coronary,595,603,B-Multi-tissue_structure
atherosclerosis,604,619,O
discuss,624,631,O
clinical,636,644,O
importance,645,655,O
anomaly,664,671,O
review,676,682,O
literature,687,697,O
concerning,698,708,O
current,709,716,O
views,717,722,O
therapy,727,734,O
Determination,0,13,O
eprosartan,17,27,O
human,31,36,O
plasma,37,43,B-Organism_substance
urine,48,53,B-Organism_substance
LC,57,59,O
MS,60,62,O
MS,63,65,O
protein,69,76,O
precipitation,77,90,O
liquid,92,98,O
chromatography,99,113,O
tandem,114,120,O
mass,121,125,O
spectrometry,126,138,O
LC,140,142,O
MS,143,145,O
MS,146,148,O
method,150,156,O
developed,166,175,O
validated,180,189,O
determination,198,211,O
eprosartan,215,225,O
human,229,234,O
plasma,235,241,B-Organism_substance
urine,246,251,B-Organism_substance
solvent,257,264,O
system,265,271,O
served,277,283,O
protein,289,296,O
precipitation,297,310,O
reagent,311,318,O
chromatographic,324,339,O
separation,340,350,O
achieved,355,363,O
CAPCELL,369,376,O
PAK,377,380,O
C18,381,384,O
column,385,391,O
50,393,395,O
mmx2,396,400,O
0,401,402,O
mm,403,405,O
5,407,408,O
microm,409,415,O
Shiseido,417,425,O
mobile,430,436,O
phase,437,442,O
consisted,447,456,O
0,460,461,O
5,462,463,O
formic,465,471,O
acid,472,476,O
water,480,485,O
0,490,491,O
5,492,493,O
formic,495,501,O
acid,502,506,O
acetonitrile,510,522,O
72,524,526,O
28,527,529,O
Detection,532,541,O
positive,549,557,O
ion,558,561,O
electrospray,562,574,O
tandem,575,581,O
mass,582,586,O
spectrometry,587,599,O
Sciex,605,610,O
API3000,611,618,O
standard,624,632,O
curves,633,639,O
ranged,647,653,O
5,659,660,O
2000,664,668,O
ng,669,671,O
mL,672,674,O
human,678,683,O
plasma,684,690,B-Organism_substance
0,700,701,O
25,702,704,O
50,708,710,O
microg,711,717,O
mL,718,720,O
urine,724,729,B-Organism_substance
fitted,736,742,O
1,748,749,O
x,750,751,O
weighted,752,760,O
quadratic,761,770,O
regression,771,781,O
model,782,787,O
method,793,799,O
proved,800,806,O
accurate,813,821,O
specific,823,831,O
sensitive,836,845,O
successfully,859,871,O
applied,872,879,O
pharmacokinetic,885,900,O
study,901,906,O
Synthetic,1,10,O
fragments,11,20,O
NS1,28,31,O
protein,32,39,O
tick,47,51,O
borne,52,57,O
encephalitis,58,70,O
virus,71,76,O
exhibiting,77,87,O
protective,90,100,O
effect,101,107,O
Potentially,110,121,O
immunoactive,122,134,O
regions,135,142,O
NS1,150,153,O
nonstructural,154,167,O
protein,168,175,O
tick,183,187,O
borne,188,193,O
encephalitis,194,206,O
virus,207,212,O
stimulate,222,231,O
antibody,236,244,O
formation,245,254,O
vivo,258,262,O
protect,267,274,O
animals,275,282,O
disease,293,300,O
chosen,306,312,O
basis,320,325,O
theoretical,329,340,O
calculations,341,353,O
16,362,364,O
27,369,371,O
aa,372,374,O
peptides,375,383,O
containing,384,394,O
chosen,399,405,O
regions,406,413,O
synthesized,419,430,O
ability,436,443,O
free,451,455,O
peptides,456,464,O
high,478,482,O
molecular,483,492,O
mass,493,497,O
carrier,498,505,O
stimulate,510,519,O
production,524,534,O
antipeptide,538,549,O
antibodies,550,560,O
mice,564,568,O
lines,578,583,O
ensure,588,594,O
formation,599,608,O
protective,612,622,O
immunity,623,631,O
studied,636,643,O
peptides,659,667,O
shown,673,678,O
exhibit,682,689,O
immunogenic,694,705,O
activity,706,714,O
free,720,724,O
state,725,730,O
fragments,737,746,O
protect,756,763,O
mice,764,768,O
infection,778,787,O
lethal,793,799,O
dose,800,804,O
tick,808,812,O
borne,813,818,O
encephalitis,819,831,O
virus,832,837,O
found,843,848,O
Long,0,4,O
term,5,9,O
immunosuppression,10,27,O
burned,31,37,O
patients,38,46,O
assessed,47,55,O
vitro,62,67,O
neutrophil,68,78,B-Cell
oxidative,79,88,O
burst,89,94,O
Phagoburst,96,106,O
OBJECTIVE,109,118,O
assess,123,129,O
duration,134,142,O
magnitude,147,156,O
immunosuppression,160,177,O
induced,178,185,O
burns,189,194,O
measured,198,206,O
neutrophil,214,224,B-Cell
oxidative,225,234,O
burst,235,240,O
vitro,244,249,O
DESIGN,251,257,O
Prospective,259,270,O
exploratory,271,282,O
cohort,283,289,O
study,290,295,O
SETTING,297,304,O
Tertiary,306,314,O
referral,315,323,O
unit,324,328,O
University,330,340,O
Hospital,341,349,O
Linkoping,351,360,O
Sweden,362,368,O
National,370,378,O
Burn,379,383,O
Unit,384,388,O
PATIENTS,391,399,O
HEALTHY,404,411,O
VOLUNTEERS,412,422,O
CONTROLS,424,432,O
subjects,448,456,O
consecutively,457,470,O
admitted,471,479,O
Burn,487,491,O
Unit,492,496,O
mean,502,506,O
total,507,512,O
burn,513,517,O
surface,518,525,O
area,526,530,O
TBSA,532,536,O
36,543,545,O
range,547,552,O
13,553,555,O
87,556,558,O
mean,564,568,O
age,569,572,O
44,573,575,O
years,576,581,O
range,583,588,O
14,589,591,O
89,592,594,O
Patients,597,605,O
data,607,611,O
collected,617,626,O
prospectively,627,640,O
burn,648,652,O
unit,653,657,O
included,670,678,O
sequential,679,689,O
organ,690,695,B-Organ
failure,696,703,O
assessment,704,714,O
SOFA,716,720,O
score,722,727,O
INTERVENTIONS,729,742,O
MEASUREMENTS,750,762,O
RESULTS,767,774,O
assess,779,785,O
changes,790,797,O
oxidative,805,814,O
capacity,815,823,O
neutrophils,827,838,B-Cell
burn,849,853,O
blood,855,860,B-Organism_substance
samples,861,868,I-Organism_substance
Phagoburst,877,887,O
analysis,888,896,O
taken,902,907,O
admission,911,920,O
second,945,951,O
week,952,956,O
duration,965,973,O
stay,977,981,O
hospital,985,993,O
monthly,1009,1016,O
12,1023,1025,O
months,1026,1032,O
burn,1043,1047,O
Neutrophils,1049,1060,B-Cell
stimulated,1066,1076,O
vitro,1080,1085,O
Escherichia,1089,1100,O
coli,1101,1105,O
phorbol,1107,1114,O
12,1115,1117,O
phorbol,1118,1125,O
myristate,1126,1135,O
13,1136,1138,O
acetate,1139,1146,O
PMA,1148,1151,O
peptide,1158,1165,O
N,1166,1167,O
formyl,1168,1174,O
Met,1175,1178,O
Leu,1179,1182,O
Phe,1183,1186,O
fMLP,1188,1192,O
Oxidative,1195,1204,O
burst,1205,1210,O
measured,1215,1223,O
flow,1227,1231,O
cytometry,1232,1241,O
Oxidative,1243,1252,O
capacity,1253,1261,O
neutrophils,1269,1280,B-Cell
decreased,1281,1290,O
similarly,1291,1300,O
stimulants,1315,1325,O
pathological,1339,1351,O
decrease,1352,1360,O
shortly,1361,1368,O
admission,1375,1384,O
lowest,1395,1401,O
value,1402,1407,O
occurring,1408,1417,O
days,1426,1430,O
7,1431,1432,O
10,1437,1439,O
followed,1441,1449,O
gradual,1455,1462,O
recovery,1463,1471,O
ensuing,1483,1490,O
months,1491,1497,O
recovery,1504,1512,O
values,1521,1527,O
controls,1535,1543,O
seen,1549,1553,O
3,1560,1561,O
5,1562,1563,O
months,1564,1570,O
burn,1581,1585,O
multiple,1593,1601,O
regression,1602,1612,O
found,1617,1622,O
age,1633,1636,O
time,1641,1645,O
burn,1656,1660,O
significantly,1661,1674,O
p,1676,1677,O
0,1678,1679,O
05,1680,1682,O
affected,1684,1692,O
oxidative,1697,1706,O
burst,1707,1712,O
White,1714,1719,B-Cell
cell,1720,1724,I-Cell
count,1725,1730,O
WCC,1732,1735,O
C,1741,1742,O
reactive,1743,1751,O
protein,1752,1759,O
CRP,1761,1764,O
values,1766,1772,O
returned,1773,1781,O
reference,1785,1794,O
ranges,1795,1801,O
long,1802,1806,O
oxidative,1818,1827,O
burst,1828,1833,O
CONCLUSIONS,1835,1846,O
study,1853,1858,O
provides,1859,1867,O
evidence,1868,1876,O
immunosuppression,1882,1899,O
injured,1909,1916,O
burns,1920,1925,O
assessed,1930,1938,O
vitro,1949,1954,O
oxidative,1955,1964,O
burst,1965,1970,O
neutrophils,1974,1985,B-Cell
remains,1987,1994,O
long,1995,1999,O
event,2010,2015,O
burn,2023,2027,O
3,2035,2036,O
5,2037,2038,O
months,2039,2045,O
burn,2052,2056,O
Absence,2059,2066,O
correlations,2070,2082,O
TBSA,2086,2090,O
FTB,2093,2096,O
blood,2099,2104,B-Organism_substance
transfusion,2105,2116,O
opiates,2118,2125,O
provided,2126,2134,O
multiple,2140,2148,O
organ,2149,2154,B-Organ
failure,2155,2162,O
score,2163,2168,O
laboratory,2173,2183,O
infection,2184,2193,O
variables,2194,2203,O
finding,2222,2229,O
decreased,2235,2244,O
oxidative,2245,2254,O
burst,2255,2260,O
uniform,2265,2272,O
injury,2283,2289,O
suggesting,2291,2301,O
immunosuppression,2312,2329,O
primarily,2333,2342,O
general,2354,2361,O
metabolic,2362,2371,O
response,2372,2380,O
recurring,2393,2402,O
infections,2403,2413,O
Neurohypophyseal,0,16,B-Pathological_formation
granulomatous,17,30,I-Pathological_formation
germinoma,31,40,I-Pathological_formation
invading,41,49,O
right,54,59,B-Immaterial_anatomical_entity
cavernous,60,69,I-Immaterial_anatomical_entity
sinus,70,75,I-Immaterial_anatomical_entity
case,77,81,O
report,82,88,O
review,93,99,O
literature,107,117,O
encountered,122,133,O
rare,136,140,O
case,141,145,O
neurohypophyseal,149,165,B-Pathological_formation
germinoma,166,175,I-Pathological_formation
prominent,183,192,O
granulomatous,193,206,O
reaction,207,215,O
invaded,223,230,O
right,235,240,B-Immaterial_anatomical_entity
cavernous,241,250,I-Immaterial_anatomical_entity
sinus,251,256,I-Immaterial_anatomical_entity
neuroimaging,262,274,O
histopathology,279,293,O
features,294,302,O
case,311,315,O
unique,321,327,O
distinguishing,329,343,O
types,358,363,O
suprasellar,367,378,B-Pathological_formation
lesions,379,386,I-Pathological_formation
13,390,392,O
year,393,397,O
old,398,401,O
boy,402,405,O
presented,406,415,O
loss,421,425,O
appetite,429,437,O
polyuria,442,450,O
symptoms,457,465,O
present,471,478,O
1,483,484,O
year,485,489,O
headache,495,503,O
general,505,512,O
fatigue,513,520,O
blurred,525,532,O
vision,533,539,O
present,540,547,O
prior,556,561,O
2,562,563,O
months,564,570,O
admission,575,584,O
neurological,586,598,O
examination,599,610,O
indicated,611,620,O
bitemporal,621,631,O
hemianopsia,632,643,O
optic,648,653,O
atrophy,654,661,O
Endocrinological,663,679,O
exam,680,684,O
showed,685,691,O
panhypopituitarism,692,710,O
Tumor,712,717,B-Pathological_formation
markers,718,725,O
alpha,734,739,O
fetoprotein,740,751,O
human,753,758,O
growth,759,765,O
hormone,766,773,O
carcinoembryonic,775,791,O
antigen,792,799,O
placental,805,814,B-Organ
alkaline,815,823,O
phosphatase,824,835,O
negative,841,849,O
Brain,851,856,B-Organ
CT,857,859,O
revealed,860,868,O
suprasellar,871,882,B-Pathological_formation
tumor,883,888,I-Pathological_formation
calcification,894,907,O
MR,909,911,O
T,912,913,O
1,914,915,O
weighted,917,925,O
T,930,931,O
2,932,933,O
weighted,935,943,O
images,944,950,O
showed,951,957,O
tumor,962,967,B-Pathological_formation
isointense,974,984,O
normal,988,994,O
brain,995,1000,B-Organ
parenchyma,1001,1011,O
enhanced,1022,1030,O
densely,1031,1038,O
tumor,1044,1049,B-Pathological_formation
involved,1055,1063,O
right,1068,1073,B-Immaterial_anatomical_entity
cavernous,1074,1083,I-Immaterial_anatomical_entity
sinus,1084,1089,I-Immaterial_anatomical_entity
biopsy,1101,1107,O
performed,1112,1121,O
transsphenoidal,1129,1144,B-Multi-tissue_structure
approach,1145,1153,O
pathologic,1158,1168,O
examination,1169,1180,O
specimen,1188,1196,O
typical,1198,1205,O
large,1206,1211,O
tumor,1212,1217,B-Cell
cells,1218,1223,I-Cell
lymphocytic,1229,1240,B-Cell
cell,1241,1245,I-Cell
infiltration,1246,1258,O
prominent,1263,1272,O
granulomatous,1273,1286,O
reaction,1287,1295,O
observed,1301,1309,O
Neurohypophyseal,1311,1327,B-Pathological_formation
granulomatous,1328,1341,I-Pathological_formation
germinoma,1342,1351,I-Pathological_formation
diagnosed,1356,1365,O
Radiotherapy,1367,1379,O
performed,1384,1393,O
total,1401,1406,O
dose,1407,1411,O
51,1415,1417,O
Gy,1418,1420,O
tumor,1429,1434,B-Pathological_formation
shrank,1435,1441,O
remarkably,1442,1452,O
patient,1458,1465,O
returned,1466,1474,O
school,1478,1484,O
hormone,1491,1498,O
replacement,1499,1510,O
therapy,1511,1518,O
Melanoma,0,8,B-Pathological_formation
skin,9,13,B-Pathological_formation
cancer,14,20,I-Pathological_formation
screening,21,30,O
clinics,31,38,O
experiences,40,51,O
Netherlands,59,70,O
1989,75,79,O
1990,84,88,O
conducted,92,101,O
free,106,110,O
melanoma,111,119,B-Pathological_formation
skin,120,124,B-Organ
screening,125,134,O
clinics,135,142,O
Oss,146,149,O
Arnhem,154,160,O
Netherlands,168,179,O
study,185,190,O
carried,195,202,O
lines,217,222,O
recent,230,236,O
campaigns,237,246,O
supported,247,256,O
American,264,272,O
Academy,273,280,O
Dermatology,284,295,O
2564,300,304,O
persons,305,312,O
screened,313,321,O
53,323,325,O
melanoma,330,338,B-Pathological_formation
nonmelanoma,342,353,B-Pathological_formation
skin,354,358,I-Pathological_formation
cancer,359,365,I-Pathological_formation
2,367,368,O
1,369,370,O
Compliance,374,384,O
follow,390,396,O
persons,404,411,O
suspected,417,426,O
melanoma,427,435,B-Pathological_formation
skin,436,440,B-Pathological_formation
cancer,441,447,I-Pathological_formation
adequate,452,460,O
93,462,464,O
103,468,471,O
90,473,475,O
3,476,477,O
Impact,0,6,O
dexamethasone,10,23,O
induced,24,31,O
immunosuppression,32,49,O
duration,57,65,O
level,70,75,O
shedding,79,87,O
Escherichia,91,102,O
coli,103,107,O
O157,108,112,O
H7,113,115,O
calves,119,125,O
goal,131,135,O
study,144,149,O
determine,157,166,O
immunosuppression,175,192,O
plays,193,198,O
role,201,205,O
level,213,218,O
duration,223,231,O
fecal,235,240,B-Organism_substance
shedding,241,249,O
Escherichia,253,264,O
coli,265,269,O
O157,270,274,O
Immunosuppression,276,293,O
induced,298,305,O
calves,309,315,O
administering,319,332,O
dexamethasone,333,346,O
1,352,353,O
week,354,358,O
old,359,362,O
Holstein,363,371,O
bull,372,376,O
calves,377,383,O
injected,389,397,O
intramuscularly,398,413,B-Tissue
dexamethasone,419,432,O
orally,437,443,O
inoculated,444,454,O
10,460,462,O
9,463,464,O
CFU,466,469,O
mixture,475,482,O
nalidixic,492,501,O
acid,502,506,O
resistant,507,516,O
strains,517,524,O
E,528,529,O
coli,531,535,O
O157,536,540,O
H7,541,543,O
1,550,551,O
week,552,556,O
old,557,560,O
Holstein,561,569,O
bull,570,574,O
calves,575,581,O
given,592,597,O
oral,607,611,O
inoculation,612,623,O
E,627,628,O
coli,630,634,O
O157,635,639,O
H7,640,642,O
dexamethasone,656,669,O
injections,670,680,O
served,682,688,O
controls,692,700,O
calves,706,712,O
examined,718,726,O
daily,727,732,O
fecal,737,742,B-Organism_substance
samples,743,750,O
collected,756,765,O
times,772,777,O
week,780,784,O
detection,789,798,O
enumeration,803,814,O
nalidixic,822,831,O
acid,832,836,O
resistant,837,846,O
E,847,848,O
coli,850,854,O
O157,855,859,O
weeks,866,871,O
calf,887,891,O
stopped,892,899,O
shedding,900,908,O
calves,914,920,O
necropsied,926,936,O
samples,941,948,O
gastrointestinal,958,974,B-Organism_subdivision
tract,975,980,I-Organism_subdivision
taken,986,991,O
detection,1000,1009,O
nalidixic,1017,1026,O
acid,1027,1031,O
resistant,1032,1041,O
E,1042,1043,O
coli,1045,1049,O
O157,1050,1054,O
Dexamethasone,1056,1069,O
injected,1070,1078,O
calves,1079,1085,O
shed,1086,1090,O
higher,1094,1100,O
levels,1101,1107,O
P,1109,1110,O
0,1113,1114,O
04,1115,1117,O
days,1122,1126,O
4,1127,1128,O
7,1133,1134,O
postinoculation,1135,1150,O
samples,1184,1191,O
collected,1192,1201,O
necropsy,1205,1213,O
positive,1219,1227,O
E,1232,1233,O
coli,1235,1239,O
O157,1240,1244,O
Data,1246,1250,O
study,1261,1266,O
suggest,1267,1274,O
time,1295,1299,O
dependent,1300,1309,O
relationship,1310,1322,O
dexamethasone,1331,1344,O
immunosuppression,1345,1362,O
fecal,1371,1376,B-Organism_substance
concentration,1377,1390,O
E,1394,1395,O
coli,1397,1401,O
O157,1402,1406,O
transient,1416,1425,O
immunosuppression,1426,1443,O
appear,1453,1459,O
prolong,1463,1470,O
shedding,1471,1479,O
E,1483,1484,O
coli,1486,1490,O
O157,1491,1495,O
Analysis,0,8,O
processivity,12,24,O
mungbean,28,36,O
dideoxynucleotide,37,54,O
sensitive,55,64,O
DNA,65,68,O
polymerase,69,79,O
detection,84,93,O
activity,101,109,O
expression,114,124,O
enzyme,132,138,O
meristematic,146,158,B-Tissue
meiotic,163,170,B-Tissue
tissues,171,178,I-Tissue
following,183,192,O
DNA,193,196,O
damaging,197,205,O
agent,206,211,O
Analysis,213,221,O
processivity,229,241,O
mungbean,245,253,O
ddNTP,254,259,O
sensitive,260,269,O
DNA,270,273,O
polymerase,274,284,O
showed,285,291,O
incorporation,296,309,O
approximately,313,326,O
35,327,329,O
40,330,332,O
nucleotides,333,344,O
binding,349,356,O
event,357,362,O
replication,370,381,O
assays,382,388,O
involving,389,398,O
M13,399,402,O
ss,403,405,O
DNA,406,409,O
template,410,418,O
5,424,425,O
labeled,427,434,O
17,435,437,O
mer,438,441,O
primer,442,448,O
Optimal,450,457,O
processivity,458,470,O
obtained,475,483,O
100,489,492,O
150,493,496,O
mM,497,499,O
KCl,500,503,O
6,508,509,O
8,510,511,O
mM,512,514,O
Mg2,515,518,O
pH,523,525,O
7,526,527,O
5,528,529,O
enzyme,535,541,O
showed,542,548,O
preference,549,559,O
Mg2,564,567,O
Mn2,574,577,O
metal,586,591,O
activator,592,601,O
processivity,606,618,O
2,620,621,O
3,624,625,O
dideoxythymidine,627,643,O
5,644,645,O
triphosphate,647,659,O
ddTTP,661,666,O
rat,672,675,O
DNA,676,679,O
pol,680,683,O
beta,684,688,O
antibody,689,697,O
strongly,698,706,O
influenced,707,717,O
distributive,718,730,O
synthesis,731,740,O
Considerable,742,754,O
enhancement,755,766,O
processivity,770,782,O
noticed,787,794,O
1mM,798,801,O
ATP,802,805,O
2,810,811,O
4,812,813,O
mM,814,816,O
spermidine,817,827,O
higher,834,840,O
concentrations,841,855,O
spermidine,859,869,O
caused,870,876,O
distributive,877,889,O
synthesis,890,899,O
enzyme,905,911,O
found,916,921,O
active,928,934,O
meristematic,943,955,B-Tissue
meiotic,960,967,B-Tissue
tissues,968,975,I-Tissue
distinctly,980,990,O
induced,991,998,O
EMS,1002,1005,O
treatment,1006,1015,O
DNA,1017,1020,O
binding,1021,1028,O
assays,1029,1035,O
revealed,1036,1044,O
distinct,1045,1053,O
binding,1054,1061,O
ability,1062,1069,O
enzyme,1077,1083,O
template,1087,1095,O
primer,1096,1102,O
damaged,1107,1114,O
DNA,1115,1118,O
substrate,1119,1128,O
observations,1145,1157,O
illustrate,1158,1168,O
probable,1173,1181,O
involvement,1182,1193,O
enzyme,1201,1207,O
replication,1211,1222,O
repair,1227,1233,O
machinery,1234,1243,O
higher,1247,1253,O
plants,1254,1260,O
detection,4,13,O
macrosomia,17,27,O
teaching,33,41,O
hospital,42,50,O
sought,55,61,O
determine,65,74,O
detection,79,88,O
clinical,90,98,O
sonographic,102,113,O
rate,115,119,O
macrosomic,123,133,O
newborns,134,142,O
4000,153,157,O
g,158,159,O
peripartum,169,179,O
factors,180,187,O
identified,221,231,O
accurately,232,242,O
retrospectively,247,262,O
reviewed,263,271,O
deliveries,276,286,O
1,292,293,O
year,294,298,O
maternal,307,315,O
neonatal,320,328,O
charts,329,335,O
macrosomic,339,349,O
newborns,350,358,O
delivered,359,368,O
year,381,385,O
Odds,387,391,O
ratio,392,397,O
ORs,399,402,O
95,408,410,O
confidence,412,422,O
intervals,423,432,O
CIs,434,437,O
calculated,444,454,O
12,463,465,O
month,466,471,O
period,472,478,O
rate,484,488,O
macrosomia,492,502,O
10,507,509,O
421,512,515,O
4194,516,520,O
11,541,543,O
95,546,548,O
CI,550,552,O
8,553,554,O
14,558,560,O
suspected,568,577,O
clinically,578,588,O
sonographically,592,607,O
newborns,621,629,O
weighing,630,638,O
4500,639,643,O
g,644,645,O
recognized,659,669,O
birth,677,682,O
0,684,685,O
57,686,688,O
95,690,692,O
CI,694,696,O
0,697,698,O
6,702,703,O
rate,711,715,O
cesarean,719,727,O
delivery,728,736,O
significantly,741,754,O
higher,755,761,O
newborns,768,776,O
correctly,777,786,O
identified,787,797,O
macrosomic,801,811,O
58,813,815,O
versus,818,824,O
missed,831,837,O
36,839,841,O
2,847,848,O
76,849,851,O
95,853,855,O
CI,857,859,O
1,860,861,O
46,862,864,O
5,866,867,O
16,868,870,O
incidence,877,886,O
newborns,890,898,O
weighing,899,907,O
excess,911,917,O
4000,921,925,O
g,926,927,O
10,931,933,O
approximately,940,953,O
90,954,956,O
macrosomic,967,977,O
newborns,978,986,O
unsuspected,992,1003,O
birth,1011,1016,O
Heart,0,5,B-Organ
sound,6,11,O
electrocardiogram,16,33,O
recording,34,43,O
devices,44,51,O
telemedicine,56,68,O
environments,69,81,O
currently,92,101,O
worldwide,104,113,O
trend,114,119,O
bring,123,128,O
healthcare,129,139,O
services,140,148,O
close,152,157,O
possible,161,169,O
patient,177,184,O
home,201,205,O
healthcare,206,216,O
systems,217,224,O
telemedicine,229,241,O
general,259,266,O
need,267,271,O
equipment,276,285,O
capture,295,302,O
patient,303,310,O
data,311,315,O
electronically,316,330,O
automated,335,344,O
review,345,351,O
analysis,355,363,O
medical,369,376,O
practitioner,377,389,O
paper,396,401,O
presents,402,410,O
prototype,411,420,O
systems,421,428,O
developed,439,448,O
ultimate,458,466,O
aim,467,470,O
use,475,478,O
telemedicine,482,494,O
settings,495,503,O
rural,507,512,O
Africa,513,519,O
devices,527,534,O
electronically,550,564,O
capture,565,572,O
data,573,577,O
patients,581,589,O
sensors,603,610,O
quick,616,621,O
easy,625,629,O
manner,630,636,O
presented,645,654,O
cases,655,660,O
focus,664,669,O
cardiovascular,673,687,B-Anatomical_system
information,688,699,O
main,712,716,O
advantages,717,727,O
proposed,735,743,O
systems,744,751,O
data,764,768,O
captured,773,781,O
simultaneously,782,796,O
multiple,802,810,O
sensors,811,818,O
data,824,828,O
stored,836,842,O
sent,847,851,O
electronically,852,866,O
review,871,877,O
analysis,882,890,O
knowledge,896,905,O
based,906,911,O
systems,912,919,O
neural,923,929,O
network,930,937,O
type,938,942,O
models,943,949,O
future,969,975,O
semi,980,984,O
autonomous,985,995,O
screening,996,1005,O
recordings,1013,1023,O
patient,1034,1041,O
referred,1045,1053,O
specialist,1059,1069,O
introduction,3,15,O
evidence,19,27,O
based,28,33,O
practice,34,42,O
hand,47,51,B-Organism_subdivision
surgeons,52,60,O
therapists,65,75,O
Evidence,77,85,O
based,86,91,O
practice,92,100,O
methodical,106,116,O
approach,117,125,O
clinical,129,137,O
practice,138,146,O
experience,153,163,O
best,165,169,O
research,170,178,O
evidence,179,187,O
patient,193,200,O
goals,201,206,O
values,211,217,O
integrated,222,232,O
optimal,241,248,O
decisions,249,258,O
making,264,270,O
diagnosis,273,282,O
selecting,284,293,O
diagnostic,296,306,O
test,307,311,O
picking,313,320,O
intervention,324,336,O
determining,340,351,O
prognosis,352,361,O
steps,378,383,O
process,392,399,O
Hand,401,405,B-Organism_subdivision
surgeons,406,414,O
therapists,419,429,O
use,434,437,O
evidence,442,450,O
based,451,456,O
process,457,464,O
attain,468,474,O
optimal,475,482,O
management,483,493,O
individual,497,507,O
patients,508,516,O
manage,518,524,O
overall,531,538,O
practice,539,547,O
guide,549,554,O
ongoing,559,566,O
professional,567,579,O
development,580,591,O
deal,597,601,O
funding,607,614,O
policy,619,625,O
makers,626,632,O
Prolonged,0,9,O
control,10,17,O
patterned,21,30,O
biofilm,31,38,B-Cell
formation,39,48,O
bio,52,55,O
inert,56,61,O
surface,62,69,O
chemistry,70,79,O
bio,83,86,O
inert,87,92,O
surface,93,100,O
chemistry,101,110,O
developed,115,124,O
confine,134,141,O
biofilm,142,149,B-Cell
formation,150,159,O
designed,163,171,O
patterns,172,180,O
26,194,196,O
days,197,201,O
Women,0,5,O
s,6,7,O
attitudes,8,17,O
preferences,19,30,O
perceived,36,45,O
barriers,46,54,O
treatment,58,67,O
perinatal,72,81,O
depression,82,92,O
BACKGROUND,94,104,O
Perinatal,106,115,O
depression,116,126,O
associated,130,140,O
potential,146,155,O
negative,156,164,O
consequences,165,177,O
mother,186,192,O
infant,197,203,O
efforts,219,226,O
improve,230,237,O
treatment,238,247,O
access,248,254,O
efficacy,259,267,O
warranted,272,281,O
purpose,287,294,O
study,303,308,O
examine,316,323,O
pregnant,324,332,O
women,333,338,O
s,339,340,O
preferences,341,352,O
attitudes,357,366,O
treatment,373,382,O
depression,387,397,O
perceived,403,412,O
potential,413,422,O
barriers,423,431,O
accessing,435,444,O
treatment,445,454,O
METHODS,456,463,O
Data,465,469,O
collected,475,484,O
means,488,493,O
questionnaire,499,512,O
convenience,520,531,O
sample,532,538,O
509,542,545,O
predominantly,546,559,O
educated,565,573,O
high,575,579,O
income,580,586,O
married,588,595,O
women,596,601,O
northeastern,609,621,O
United,622,628,O
States,629,635,O
trimester,652,661,O
pregnancy,665,674,O
Participants,676,688,O
queried,694,701,O
treatment,708,717,O
modalities,718,728,O
likely,754,760,O
participate,761,772,O
wanted,781,787,O
help,788,792,O
depression,797,807,O
attitudes,815,824,O
psychotherapeutic,832,849,O
pharmacological,854,869,O
treatments,870,880,O
perceived,886,895,O
barriers,896,904,O
receiving,908,917,O
help,918,922,O
RESULTS,924,931,O
women,938,943,O
92,945,947,O
indicated,950,959,O
likely,971,977,O
participate,978,989,O
individual,993,1003,O
therapy,1004,1011,O
help,1015,1019,O
needed,1024,1030,O
35,1037,1039,O
percent,1040,1047,O
stated,1048,1054,O
likely,1071,1077,O
medication,1083,1093,O
recommended,1097,1108,O
14,1114,1116,O
percent,1117,1124,O
indicated,1125,1134,O
participate,1151,1162,O
group,1166,1171,O
therapy,1172,1179,O
greatest,1185,1193,O
perceived,1194,1203,O
potential,1204,1213,O
barriers,1214,1222,O
treatment,1226,1235,O
lack,1241,1245,O
time,1249,1253,O
65,1255,1257,O
stigma,1261,1267,O
43,1269,1271,O
childcare,1279,1288,O
issues,1289,1295,O
33,1297,1299,O
women,1308,1313,O
indicated,1314,1323,O
preference,1326,1336,O
receive,1340,1347,O
mental,1348,1354,O
health,1355,1361,O
care,1362,1366,O
obstetrics,1374,1384,O
clinic,1385,1391,O
obstetrics,1411,1421,O
practitioner,1422,1434,O
mental,1445,1451,O
health,1452,1458,O
practitioner,1459,1471,O
located,1472,1479,O
clinic,1487,1493,O
Factors,1495,1502,O
associated,1503,1513,O
acceptability,1519,1532,O
depression,1544,1554,O
treatments,1555,1565,O
presented,1570,1579,O
CONCLUSIONS,1581,1592,O
Understanding,1594,1607,O
prevents,1613,1621,O
women,1622,1627,O
seeking,1633,1640,O
obtaining,1644,1653,O
help,1654,1658,O
depression,1663,1673,O
determining,1678,1689,O
prefer,1700,1706,O
way,1714,1717,O
treatment,1721,1730,O
lead,1735,1739,O
improved,1743,1751,O
depression,1752,1762,O
treatment,1763,1772,O
rates,1773,1778,O
hold,1783,1787,O
promise,1788,1795,O
improving,1800,1809,O
overall,1814,1821,O
health,1822,1828,O
childbearing,1832,1844,O
women,1845,1850,O
impact,4,10,O
tracheal,14,22,B-Multi-tissue_structure
intubation,23,33,O
host,37,41,O
defenses,42,50,O
risks,55,60,O
nosocomial,65,75,O
pneumonia,76,85,O
Nosocomial,87,97,O
pneumonia,98,107,O
remains,108,115,O
common,118,124,O
complication,125,137,O
patients,141,149,O
treated,150,157,O
endotracheal,163,175,O
intubation,176,186,O
mechanical,191,201,O
ventilation,202,213,O
continues,218,227,O
significant,238,249,O
impact,250,256,O
mortality,264,273,O
rate,274,278,O
patients,288,296,O
Epidemiologic,298,311,O
studies,312,319,O
shown,325,330,O
risk,340,344,O
pneumonia,348,357,O
increases,358,367,O
duration,377,385,O
intubation,389,399,O
period,413,419,O
highest,423,430,O
risk,431,435,O
2,449,450,O
weeks,451,456,O
therapy,460,467,O
Gram,469,473,O
negative,474,482,O
bacteria,483,491,O
account,492,499,O
nosocomial,509,519,O
pneumonias,520,530,O
intubated,534,543,O
patients,544,552,O
Staphylococcus,558,572,O
aureus,573,579,O
play,589,593,O
role,596,600,O
polymicrobial,618,631,O
infection,632,641,O
seriously,655,664,O
ill,665,668,O
individuals,669,680,O
treated,695,702,O
long,708,712,O
term,713,717,O
mechanical,718,728,O
ventilation,729,740,O
Pseudomonas,742,753,O
aeruginosa,754,764,O
common,770,776,O
pathogen,777,785,O
Endotracheal,787,799,O
intubation,800,810,O
mechanical,815,825,O
ventilation,826,837,O
predispose,838,848,O
pneumonia,852,861,O
variety,868,875,O
reasons,879,886,O
Fig,892,895,O
1,897,898,O
endotracheal,905,917,B-Multi-tissue_structure
tube,918,922,I-Multi-tissue_structure
direct,932,938,O
effects,939,946,O
airway,954,960,B-Multi-tissue_structure
result,966,972,O
reduction,978,987,O
local,991,996,O
host,997,1001,O
defenses,1002,1010,O
mucosal,1018,1025,B-Multi-tissue_structure
injury,1026,1032,O
reduce,1037,1043,O
mucociliary,1044,1055,B-Tissue
function,1056,1064,O
upper,1072,1077,O
airway,1078,1084,B-Multi-tissue_structure
defenses,1085,1093,O
bypassed,1098,1106,O
effectiveness,1115,1128,O
cough,1132,1137,O
reduced,1141,1148,O
Indirectly,1150,1160,O
intubation,1162,1172,O
result,1177,1183,O
enhanced,1190,1198,O
capacity,1199,1207,O
tracheobronchial,1211,1227,B-Cell
cells,1228,1233,I-Cell
bind,1237,1241,O
gram,1242,1246,O
negative,1247,1255,O
bacteria,1256,1264,O
effect,1269,1275,O
favors,1281,1287,O
airway,1288,1294,B-Multi-tissue_structure
colonization,1295,1307,O
pneumonia,1312,1321,O
injury,1327,1333,O
airway,1341,1347,B-Multi-tissue_structure
create,1352,1358,O
binding,1359,1366,O
sites,1367,1372,O
bacteria,1377,1385,O
basement,1393,1401,B-Multi-tissue_structure
membrane,1402,1410,I-Multi-tissue_structure
bronchial,1418,1427,B-Multi-tissue_structure
tree,1428,1432,I-Multi-tissue_structure
stimulation,1441,1452,O
secretion,1460,1469,O
mucus,1473,1478,B-Organism_substance
stagnates,1491,1500,O
create,1509,1515,O
potential,1516,1525,O
sites,1526,1531,O
bacterial,1536,1545,O
adherence,1546,1555,O
endotracheal,1561,1573,B-Multi-tissue_structure
tube,1574,1578,I-Multi-tissue_structure
enhances,1584,1592,O
bacterial,1593,1602,O
entry,1603,1608,O
lung,1616,1620,B-Organ
serving,1624,1631,O
reservoir,1637,1646,O
bacteria,1651,1659,O
remain,1663,1669,O
sequestered,1670,1681,O
safe,1683,1687,O
host,1693,1697,O
defenses,1698,1706,O
Respiratory,1708,1719,O
therapy,1720,1727,O
devices,1728,1735,O
allow,1740,1745,O
bacteria,1746,1754,O
proliferate,1758,1769,O
introduce,1783,1792,O
patient,1807,1814,O
handled,1822,1829,O
properly,1830,1838,O
Finally,1840,1847,O
patients,1849,1857,O
ill,1866,1869,O
require,1880,1887,O
intubation,1888,1898,O
disease,1909,1916,O
associated,1917,1927,O
impairments,1928,1939,O
systemic,1943,1951,O
host,1952,1956,O
defense,1957,1964,O
add,1972,1975,O
impairments,1983,1994,O
caused,1995,2001,O
use,2009,2012,O
artificial,2019,2029,O
airway,2030,2036,B-Multi-tissue_structure
host,2042,2046,O
defense,2047,2054,O
impairments,2055,2066,O
occur,2072,2077,O
mechanically,2081,2093,O
ventilated,2094,2104,O
patients,2105,2113,O
lead,2118,2122,O
respiratory,2126,2137,B-Multi-tissue_structure
tract,2138,2143,I-Multi-tissue_structure
infection,2144,2153,O
form,2161,2165,O
febrile,2176,2183,O
tracheobronchitis,2184,2201,O
pneumonia,2205,2214,O
diagnosis,2220,2229,O
pneumonia,2233,2242,O
intubated,2246,2255,O
patients,2256,2264,O
difficult,2268,2277,O
controversial,2282,2295,O
clinical,2322,2330,O
criteria,2331,2339,O
microbiologic,2343,2356,O
criteria,2357,2365,O
bronchoscopically,2389,2406,O
directed,2407,2415,O
protected,2416,2425,O
specimen,2426,2434,O
brush,2435,2440,O
Therapy,2442,2449,O
pneumonia,2453,2462,O
mechanically,2466,2478,O
ventilated,2479,2489,O
patients,2490,2498,O
successful,2513,2523,O
systemic,2529,2537,O
antibiotics,2538,2549,O
need,2554,2558,O
supplemented,2565,2577,O
topical,2581,2588,O
antimicrobials,2589,2603,O
clearly,2608,2615,O
effective,2616,2625,O
prophylactic,2626,2638,O
strategy,2639,2647,O
currently,2648,2657,O
exists,2658,2664,O
understanding,2674,2687,O
pneumonia,2691,2700,O
pathogenesis,2701,2713,O
led,2718,2721,O
promising,2730,2739,O
directions,2740,2750,O
data,2760,2764,O
collected,2769,2778,O
inhaled,2780,2787,O
antibiotics,2788,2799,O
selective,2801,2810,O
digestive,2811,2820,O
decontamination,2821,2836,O
enhancement,2842,2853,O
host,2857,2861,O
defenses,2862,2870,O
cytokines,2874,2883,O
pre,2888,2891,O
formed,2892,2898,O
antibodies,2899,2909,O
emerge,2914,2920,O
useful,2924,2930,O
approaches,2931,2941,O
Mapping,0,7,O
L,15,16,O
methylmalonyl,17,30,O
CoA,31,34,O
mutase,35,41,O
gene,42,46,O
mouse,50,55,O
chromosome,56,66,B-Cellular_component
17,67,69,I-Cellular_component
humans,74,80,O
methylmalonyl,82,95,O
acidemia,96,104,O
caused,108,114,O
deficiency,120,130,O
L,134,135,O
methylmalonyl,136,149,O
CoA,150,153,O
mutase,154,160,O
MUT,162,165,O
controlled,167,177,O
gene,183,187,O
mapped,202,208,O
chromosome,212,222,B-Cellular_component
6,223,224,I-Cellular_component
mouse,230,235,O
homolog,236,243,O
gene,252,256,O
mapped,270,276,O
mouse,280,285,O
chromosome,286,296,B-Cellular_component
17,297,299,I-Cellular_component
Recombinant,301,312,O
inbred,313,319,O
congenic,324,332,O
strains,333,340,O
place,341,346,O
mouse,351,356,O
Mut,357,360,O
locus,361,366,O
1,367,368,O
06,369,371,O
cM,372,374,O
distal,375,381,O
H,385,386,O
2,387,388,O
Pgk,398,401,O
2,402,403,O
Ce,408,410,O
2,411,412,O
relative,418,426,O
order,427,432,O
syntenic,436,444,O
probes,445,451,O
flanking,452,460,O
H,461,462,O
2,463,464,O
mouse,468,473,O
chromosome,474,484,B-Cellular_component
17,485,487,I-Cellular_component
HLA,492,495,O
human,499,504,O
chromosome,505,515,B-Cellular_component
6,516,517,I-Cellular_component
shown,521,526,O
different,533,542,O
Range,0,5,O
motion,9,15,O
limitation,16,26,O
rotator,33,40,B-Organ
cuff,41,45,I-Organ
repair,46,52,O
HYPOTHESIS,54,64,O
study,71,76,O
conducted,81,90,O
identify,94,102,O
preoperative,103,115,O
factors,116,123,O
correlating,124,135,O
limited,141,148,O
motion,149,155,O
rotator,162,169,B-Organ
cuff,170,174,I-Organ
repair,175,181,O
RCR,183,186,O
evaluate,195,203,O
affect,208,214,O
loss,218,222,O
motion,226,232,O
outcome,236,243,O
hypothesized,248,260,O
patients,266,274,O
preoperative,280,292,O
ROM,293,296,O
loss,297,301,O
diabetes,303,311,O
workman,317,324,O
s,325,326,O
compensation,327,339,O
claims,340,346,O
exhibit,353,360,O
postoperative,361,374,O
ROM,375,378,O
loss,379,383,O
3,387,388,O
months,389,395,O
MATERIAL,397,405,O
METHODS,410,417,O
Preoperative,419,431,O
postoperative,436,449,O
evaluations,450,461,O
including,463,472,O
outcomes,473,481,O
assessment,482,492,O
physical,497,505,O
examination,506,517,O
parameters,518,528,O
reviewed,535,543,O
345,548,551,O
patients,552,560,O
underwent,565,574,O
RCR,575,578,O
Correlations,580,592,O
demographic,601,612,O
physical,614,622,O
examination,623,634,O
surgical,640,648,O
variables,649,658,O
postoperative,663,676,O
limitation,677,687,O
motion,691,697,O
need,702,706,O
capsular,711,719,O
release,720,727,O
determined,733,743,O
RESULTS,745,752,O
3,757,758,O
month,759,764,O
follow,765,771,O
mean,776,780,O
active,781,787,O
forward,788,795,O
elevation,796,805,O
AFE,807,810,O
active,813,819,O
external,820,828,O
rotation,829,837,O
AER,839,842,O
passive,849,856,O
internal,857,865,O
rotation,866,874,O
PIR,876,879,O
90,886,888,O
78,891,893,O
80,900,902,O
contralateral,911,924,O
Limitation,931,941,O
preoperative,945,957,O
motion,958,964,O
correlated,965,975,O
limitation,981,991,O
postoperative,995,1008,O
AFE,1009,1012,O
AER,1014,1017,O
PIR,1023,1026,O
P,1028,1029,O
001,1033,1036,O
seven,1045,1050,O
patients,1051,1059,O
considered,1060,1070,O
clinically,1071,1081,O
stiff,1082,1087,O
followed,1093,1101,O
1,1105,1106,O
year,1107,1111,O
postoperatively,1112,1127,O
patients,1135,1143,O
required,1144,1152,O
arthroscopic,1153,1165,O
capsular,1166,1174,O
release,1175,1182,O
persistent,1187,1197,O
range,1198,1203,O
motion,1207,1213,O
loss,1214,1218,O
CONCLUSION,1220,1230,O
Early,1232,1237,O
postoperative,1238,1251,O
limitation,1252,1262,O
motion,1266,1272,O
RCR,1279,1282,O
associated,1286,1296,O
restricted,1302,1312,O
preoperative,1313,1325,O
motion,1326,1332,O
factors,1340,1347,O
including,1349,1358,O
diabetes,1359,1367,O
mellitus,1368,1376,O
worker,1381,1387,O
s,1388,1389,O
compensation,1390,1402,O
claim,1403,1408,O
associated,1419,1429,O
range,1435,1440,O
motion,1444,1450,O
loss,1451,1455,O
shoulders,1462,1471,B-Organism_subdivision
early,1477,1482,O
motion,1483,1489,O
loss,1490,1494,O
recover,1495,1502,O
motion,1503,1509,O
rarely,1514,1520,O
require,1521,1528,O
capsular,1529,1537,O
release,1538,1545,O
Neural,0,6,O
network,7,14,O
analysis,15,23,O
spectroscopic,27,40,O
data,41,45,O
lycopene,49,57,O
beta,62,66,O
carotene,67,75,O
content,76,83,O
food,87,91,O
samples,92,99,O
compared,100,108,O
HPLC,112,116,O
UV,117,119,O
vis,120,123,O
study,133,138,O
neural,141,147,O
network,148,155,O
NN,157,159,O
model,161,166,O
designed,171,179,O
predict,183,190,O
lycopene,191,199,O
beta,204,208,O
carotene,209,217,O
concentrations,218,232,O
food,236,240,O
samples,241,248,O
combined,250,258,O
simple,266,272,O
fast,277,281,O
technique,282,291,O
UV,301,303,O
vis,304,307,O
spectroscopy,308,320,O
measurement,326,337,O
absorbance,345,355,O
446,359,362,O
502,367,370,O
nm,371,373,O
different,377,386,O
beta,387,391,O
carotene,392,400,O
lycopene,405,413,O
standard,414,422,O
mixtures,423,431,O
optimize,444,452,O
neural,455,461,O
network,462,469,O
based,470,475,O
multilayer,481,491,O
perceptron,492,502,O
MLP,504,507,O
learning,510,518,O
verification,523,535,O
process,536,543,O
validation,556,566,O
purposes,567,575,O
optimized,581,590,O
NN,591,593,O
applied,603,610,O
determine,614,623,O
concentration,628,641,O
compounds,650,659,O
food,663,667,O
samples,668,675,O
fresh,677,682,O
tomato,683,689,O
tomato,691,697,O
concentrate,698,709,B-Organism_substance
tomato,711,717,O
sauce,718,723,O
ketchup,725,732,O
tomato,734,740,O
juice,741,746,B-Organism_substance
watermelon,748,758,O
medlar,760,766,O
green,768,773,O
pepper,774,780,O
carrots,786,793,O
comparing,796,805,O
NN,810,812,O
results,813,820,O
known,830,835,O
values,836,842,O
compounds,852,861,O
obtained,862,870,O
analytical,874,884,O
techniques,885,895,O
UV,897,899,O
vis,900,903,O
HPLC,908,912,O
concluded,922,931,O
MLP,946,949,O
NN,950,952,O
range,972,977,O
studied,978,985,O
optimized,991,1000,O
NN,1001,1003,O
able,1007,1011,O
estimate,1015,1023,O
beta,1028,1032,O
carotene,1033,1041,O
lycopene,1046,1054,O
concentrations,1055,1069,O
food,1073,1077,O
samples,1078,1085,O
adequate,1094,1102,O
accuracy,1103,1111,O
solving,1113,1120,O
UV,1125,1127,O
vis,1128,1131,O
interference,1132,1144,O
beta,1148,1152,O
carotene,1153,1161,O
lycopene,1166,1174,O
Costs,0,5,O
hip,9,12,B-Organism_subdivision
fracture,13,21,O
Rehabilitation,23,37,O
180,41,44,O
patients,45,53,O
primary,57,64,O
health,65,71,O
care,72,76,O
Costs,78,83,O
related,84,91,O
functional,95,105,O
status,106,112,O
calculated,118,128,O
180,133,136,O
consecutive,137,148,O
hip,149,152,B-Organism_subdivision
fracture,153,161,O
patients,162,170,O
mean,172,176,O
age,177,180,O
78,181,183,O
years,184,189,O
admitted,200,208,O
home,224,228,O
rehabilitated,233,246,O
primary,250,257,O
health,258,264,O
care,265,269,O
4,278,279,O
months,280,286,O
fracture,297,305,O
75,307,309,O
percent,310,317,O
patients,325,333,O
discharged,343,353,O
home,367,371,O
9,373,374,O
percent,375,382,O
dead,388,392,O
short,402,407,O
term,408,412,O
medical,413,420,O
treatment,421,430,O
costs,431,436,O
patient,441,448,O
SEK,454,457,O
43,458,460,O
000,461,464,O
total,478,483,O
costs,484,489,O
including,490,499,O
communal,500,508,O
help,509,513,O
costs,518,523,O
living,528,534,O
accommodations,535,549,O
discharge,556,565,O
twice,571,576,O
high,580,584,O
total,590,595,O
costs,596,601,O
patient,606,613,O
long,618,622,O
term,623,627,O
medical,628,635,O
treatment,636,645,O
4,652,653,O
months,654,660,O
3,667,668,O
years,669,674,O
fracture,681,689,O
7,696,697,O
percent,698,705,O
short,713,718,O
term,719,723,O
medical,724,731,O
treatment,732,741,O
costs,742,747,O
Patients,749,757,O
cervical,765,773,B-Organism_subdivision
fracture,774,782,O
discharged,783,793,O
home,807,811,O
good,821,825,O
functional,826,836,O
status,837,843,O
consumed,844,852,O
fifth,862,867,O
resources,875,884,O
patients,890,898,O
trochanteric,906,918,B-Multi-tissue_structure
fracture,919,927,O
discharged,928,938,O
institutional,942,955,O
care,956,960,O
reduced,973,980,O
functional,981,991,O
status,992,998,O
consumed,999,1007,O
substantial,1011,1022,O
costs,1035,1040,O
saved,1048,1053,O
improved,1057,1065,O
organization,1066,1078,O
rehabilitation,1082,1096,O
discharge,1103,1112,O
hospital,1122,1130,O
cost,1142,1146,O
reduction,1147,1156,O
require,1163,1170,O
combination,1173,1184,O
technologic,1188,1199,O
social,1201,1207,O
organizational,1213,1227,O
changes,1228,1235,O
aimed,1236,1241,O
early,1245,1250,O
discharge,1251,1260,O
continued,1265,1274,O
follow,1275,1281,O
primary,1288,1295,O
health,1296,1302,O
care,1303,1307,O
randomized,2,12,O
pilot,13,18,O
study,19,24,O
Engaging,32,40,O
Moms,41,45,O
Program,46,53,O
family,58,64,O
drug,65,69,O
court,70,75,O
response,80,88,O
need,96,100,O
effective,105,114,O
drug,115,119,O
court,120,125,O
interventions,126,139,O
effectiveness,145,158,O
Engaging,166,174,O
Moms,175,179,O
Program,180,187,O
EMP,189,192,O
versus,194,200,O
Intensive,201,210,O
Case,211,215,O
Management,216,226,O
Services,227,235,O
ICMS,237,241,O
multiple,246,254,O
outcomes,255,263,O
mothers,268,275,O
enrolled,276,284,O
family,288,294,O
drug,295,299,O
court,300,305,O
investigated,310,322,O
intent,332,338,O
treat,342,347,O
study,348,353,O
mothers,355,362,O
N,364,365,O
62,368,370,O
randomly,377,385,O
assigned,386,394,O
usual,405,410,O
drug,411,415,O
court,416,421,O
care,422,426,O
Engaging,434,442,O
Moms,443,447,O
drug,448,452,O
court,453,458,O
program,459,466,O
Mothers,468,475,O
assessed,481,489,O
intake,493,499,O
3,504,505,O
6,507,508,O
12,510,512,O
18,518,520,O
months,521,527,O
following,528,537,O
intake,538,544,O
Results,546,553,O
indicated,554,563,O
18,572,574,O
months,575,581,O
post,582,586,O
drug,587,591,O
court,592,597,O
enrollment,598,608,O
77,610,612,O
mothers,617,624,O
assigned,625,633,O
EMP,637,640,O
versus,641,647,O
55,648,650,O
mothers,655,662,O
assigned,663,671,O
ICMS,675,679,O
positive,684,692,O
child,693,698,O
welfare,699,706,O
dispositions,707,719,O
statistically,732,745,O
significant,746,757,O
time,758,762,O
effects,763,770,O
intervention,780,792,O
groups,793,799,O
multiple,803,811,O
outcomes,812,820,O
including,821,830,O
substance,831,840,O
use,841,844,O
mental,846,852,O
health,853,859,O
parenting,861,870,O
practices,871,880,O
family,886,892,O
functioning,893,904,O
EMP,906,909,O
showed,910,916,O
equal,917,922,O
better,926,932,O
improvement,933,944,O
ICMS,950,954,O
outcomes,962,970,O
results,976,983,O
suggest,984,991,O
EMP,997,1000,O
family,1004,1010,O
drug,1011,1015,O
court,1016,1021,O
viable,1027,1033,O
promising,1038,1047,O
intervention,1048,1060,O
approach,1061,1069,O
reduce,1073,1079,O
maternal,1080,1088,O
addiction,1089,1098,O
child,1103,1108,O
maltreatment,1109,1121,O
Absence,0,7,O
microbiota,11,21,O
germ,23,27,O
free,28,32,O
conditions,33,43,O
accelerates,45,56,O
atherosclerosis,61,76,O
ApoE,80,84,O
deficient,85,94,O
mice,95,99,O
fed,100,103,O
standard,104,112,O
low,113,116,O
cholesterol,117,128,O
diet,129,133,O
AIM,135,138,O
aim,144,147,O
work,155,159,O
determine,167,176,O
influence,181,190,O
intestinal,194,204,B-Multi-tissue_structure
bacteria,205,213,O
development,221,232,O
atherosclerotic,236,251,B-Pathological_formation
lesions,252,259,I-Pathological_formation
apolipoprotein,266,280,O
E,281,282,O
ApoE,284,288,O
deficient,290,299,O
knockout,300,308,O
mice,309,313,O
METHODS,315,322,O
experiments,328,339,O
performed,345,354,O
ApoE,358,362,O
deficient,366,375,O
mouse,376,381,O
strain,382,388,O
C57BL,389,394,O
6,395,396,O
bred,398,402,O
germ,409,413,O
free,414,418,O
GF,420,422,O
conditions,424,434,O
generations,443,454,O
conventional,464,476,O
conditions,477,487,O
defined,493,500,O
microflora,501,511,O
CV,513,515,O
mice,522,526,O
fed,532,535,O
standard,538,546,O
low,547,550,O
cholesterol,551,562,O
diet,563,567,O
cholesterol,571,582,O
rich,583,587,O
diet,588,592,O
3,597,598,O
4,599,600,O
months,601,607,O
studied,612,619,O
development,624,635,O
advanced,639,647,O
lesions,648,655,B-Pathological_formation
thoracic,663,671,B-Multi-tissue_structure
abdominal,676,685,B-Multi-tissue_structure
aorta,686,691,I-Multi-tissue_structure
histological,695,707,O
morphometric,709,721,O
immunohistological,726,744,O
methods,745,752,O
RESULTS,754,761,O
Conventionally,763,777,O
reared,778,784,O
ApoE,785,789,O
mice,793,797,O
containing,799,809,O
pathogenic,813,823,O
intestinal,824,834,B-Multi-tissue_structure
microbiota,835,845,O
fed,851,854,O
standard,857,865,O
low,866,869,O
cholesterol,870,881,O
diet,882,886,O
contrast,890,898,O
high,904,908,O
cholesterol,909,920,O
diet,921,925,O
develop,934,941,O
atherosclerotic,942,957,B-Pathological_formation
aortic,958,964,I-Pathological_formation
plaques,965,972,I-Pathological_formation
contrast,977,985,O
ApoE,987,991,O
mice,995,999,O
reared,1000,1006,O
germfree,1013,1021,O
conditions,1022,1032,O
2,1037,1038,O
generations,1039,1050,O
fed,1055,1058,O
low,1061,1064,O
cholesterol,1065,1076,O
diet,1077,1081,O
exhibited,1082,1091,O
atherosclerotic,1092,1107,B-Pathological_formation
plaques,1108,1115,I-Pathological_formation
aorta,1123,1128,B-Multi-tissue_structure
Characteristic,1130,1144,O
lipid,1145,1150,O
deposition,1151,1161,O
foam,1167,1171,O
cells,1172,1177,B-Cell
macrophages,1182,1193,B-Cell
found,1198,1203,O
arterial,1213,1221,B-Multi-tissue_structure
walls,1222,1227,I-Multi-tissue_structure
CONCLUSION,1229,1239,O
contrast,1244,1252,O
absence,1260,1267,O
atherosclerotic,1271,1286,B-Pathological_formation
plaques,1287,1294,I-Pathological_formation
conventionally,1298,1312,O
reared,1313,1319,O
ApoE,1320,1324,O
deficient,1325,1334,O
mice,1335,1339,O
germ,1341,1345,O
free,1346,1350,O
ApoE,1351,1355,O
mice,1359,1363,O
consuming,1364,1373,O
low,1383,1386,O
cholesterol,1387,1398,O
standard,1399,1407,O
diet,1408,1412,O
developed,1413,1422,O
atherosclerotic,1423,1438,B-Pathological_formation
plaques,1439,1446,I-Pathological_formation
aorta,1454,1459,B-Multi-tissue_structure
Differences,1461,1472,O
atherosclerotic,1476,1491,B-Pathological_formation
plaques,1492,1499,I-Pathological_formation
GF,1508,1510,O
CV,1515,1517,O
ApoE,1518,1522,O
mice,1526,1530,O
apparent,1542,1550,O
mice,1556,1560,O
fed,1565,1568,O
high,1571,1575,O
cholesterol,1576,1587,O
diet,1588,1592,O
findings,1598,1606,O
document,1612,1620,O
protective,1625,1635,O
effect,1636,1642,O
microbiota,1646,1656,O
commensal,1658,1667,O
bacteria,1668,1676,O
atherosclerosis,1681,1696,O
development,1697,1708,O
generative,2,12,O
model,13,18,O
image,23,28,O
segmentation,29,41,O
based,42,47,O
label,51,56,O
fusion,57,63,O
propose,68,75,O
nonparametric,78,91,O
probabilistic,93,106,O
model,107,112,O
automatic,121,130,O
segmentation,131,143,O
medical,147,154,O
images,155,161,O
given,163,168,O
training,171,179,O
set,180,183,O
images,187,193,O
corresponding,198,211,O
label,212,217,O
maps,218,222,O
resulting,228,237,O
inference,238,247,O
algorithms,248,258,O
rely,259,263,O
pairwise,267,275,O
registrations,276,289,O
test,302,306,O
image,307,312,O
individual,317,327,O
training,328,336,O
images,337,343,O
training,349,357,O
labels,358,364,O
transferred,374,385,O
test,393,397,O
image,398,403,O
fused,408,413,O
compute,417,424,O
final,429,434,O
segmentation,435,447,O
test,455,459,O
subject,460,467,O
label,474,479,O
fusion,480,486,O
methods,487,494,O
shown,505,510,O
yield,514,519,O
accurate,520,528,O
segmentation,529,541,O
use,553,556,O
multiple,560,568,O
registrations,569,582,O
captures,583,591,O
greater,592,599,O
inter,600,605,O
subject,606,613,O
anatomical,614,624,O
variability,625,636,O
improves,641,649,O
robustness,650,660,O
occasional,669,679,O
registration,680,692,O
failures,693,701,O
best,710,714,O
knowledge,722,731,O
manuscript,738,748,O
presents,749,757,O
comprehensive,768,781,O
probabilistic,782,795,O
framework,796,805,O
rigorously,811,821,O
motivates,822,831,O
label,832,837,O
fusion,838,844,O
segmentation,850,862,O
approach,863,871,O
proposed,877,885,O
framework,886,895,O
allows,896,902,O
compare,909,916,O
different,917,926,O
label,927,932,O
fusion,933,939,O
algorithms,940,950,O
theoretically,951,964,O
practically,969,980,O
particular,985,995,O
recent,997,1003,O
label,1004,1009,O
fusion,1010,1016,O
multiatlas,1020,1030,O
segmentation,1031,1043,O
algorithms,1044,1054,O
interpreted,1059,1070,O
special,1074,1081,O
cases,1082,1087,O
framework,1095,1104,O
conduct,1109,1116,O
sets,1121,1125,O
experiments,1129,1140,O
validate,1144,1152,O
proposed,1157,1165,O
methods,1166,1173,O
set,1188,1191,O
experiments,1195,1206,O
use,1211,1214,O
39,1215,1217,O
brain,1218,1223,B-Organ
MRI,1224,1227,O
scans,1228,1233,O
manually,1239,1247,O
segmented,1248,1257,O
white,1258,1263,B-Multi-tissue_structure
matter,1264,1270,I-Multi-tissue_structure
cerebral,1272,1280,B-Multi-tissue_structure
cortex,1281,1287,I-Multi-tissue_structure
ventricles,1289,1299,B-Multi-tissue_structure
subcortical,1304,1315,B-Multi-tissue_structure
structures,1316,1326,I-Multi-tissue_structure
compare,1330,1337,O
different,1338,1347,O
label,1348,1353,O
fusion,1354,1360,O
algorithms,1361,1371,O
widely,1380,1386,O
FreeSurfer,1392,1402,O
brain,1409,1414,B-Organ
segmentation,1415,1427,O
tool,1428,1432,O
results,1438,1445,O
indicate,1446,1454,O
proposed,1464,1472,O
framework,1473,1482,O
yields,1483,1489,O
accurate,1495,1503,O
segmentation,1504,1516,O
FreeSurfer,1522,1532,O
previous,1537,1545,O
label,1546,1551,O
fusion,1552,1558,O
algorithms,1559,1569,O
second,1576,1582,O
experiment,1583,1593,O
use,1598,1601,O
brain,1602,1607,B-Organ
MRI,1608,1611,O
scans,1612,1617,O
282,1621,1624,O
subjects,1625,1633,O
demonstrate,1637,1648,O
proposed,1658,1666,O
segmentation,1667,1679,O
tool,1680,1684,O
sufficiently,1688,1700,O
sensitive,1701,1710,O
robustly,1714,1722,O
detect,1723,1729,O
hippocampal,1730,1741,B-Multi-tissue_structure
volume,1742,1748,O
changes,1749,1756,O
study,1762,1767,O
aging,1771,1776,O
Alzheimer,1781,1790,O
s,1791,1792,O
Disease,1793,1800,O
Listerine,0,9,O
past,11,15,O
present,17,24,O
future,29,35,O
test,39,43,O
thyme,47,52,O
Listerine,54,63,O
mouthrinse,67,77,O
composed,78,86,O
mixture,92,99,O
essential,103,112,O
oils,113,117,O
created,123,130,O
1879,134,138,O
originally,147,157,O
formulated,158,168,O
surgical,174,182,O
antiseptic,183,193,O
spite,198,203,O
known,211,216,O
antimicrobial,217,230,O
properties,231,241,O
thought,249,256,O
product,265,272,O
search,276,282,O
use,288,291,O
promoted,296,304,O
deterrent,310,319,O
halitosis,324,333,O
floor,343,348,O
cleaner,349,356,O
years,378,383,O
Listerine,384,393,O
emerged,398,405,O
bona,411,415,O
fide,416,420,O
therapeutic,421,432,O
agent,433,438,O
reduction,443,452,O
plaque,456,462,B-Organism_substance
induced,463,470,O
oral,471,475,B-Organism_subdivision
diseases,476,484,O
contrast,489,497,O
inconsistent,505,517,O
history,518,525,O
Listerine,529,538,O
systemic,540,548,O
antibiotics,549,560,O
discovered,561,571,O
1940,579,583,O
s,584,585,O
heralded,591,599,O
miracle,603,610,O
drugs,611,616,O
value,631,636,O
prophylactic,640,652,O
usage,653,658,O
antibiotics,662,673,O
come,678,682,O
scrutiny,689,697,O
result,703,709,O
increasing,713,723,O
resistance,724,734,O
adverse,739,746,O
reactions,747,756,O
reports,768,775,O
American,784,792,O
British,797,804,O
professional,805,817,O
societies,818,827,O
led,833,836,O
evaluation,845,855,O
relative,863,871,O
risks,872,877,O
associated,878,888,O
plaque,894,900,B-Organism_substance
induced,901,908,O
bacteremia,909,919,O
twice,925,930,O
yearly,931,937,O
visits,938,944,O
dental,948,954,O
professionals,955,968,O
compared,973,981,O
daily,985,990,O
activities,991,1001,O
new,1009,1012,O
recommendations,1013,1028,O
revelations,1033,1044,O
open,1045,1049,O
door,1054,1058,O
local,1063,1068,O
antimicrobial,1069,1082,O
approaches,1083,1093,O
reduce,1097,1103,O
challenge,1108,1117,O
plaque,1121,1127,B-Organism_substance
induced,1128,1135,O
bacteremias,1136,1147,O
issues,1155,1161,O
discussed,1170,1179,O
context,1187,1194,O
Listerine,1198,1207,O
intricate,1213,1222,O
complicated,1227,1238,O
past,1239,1243,O
connection,1253,1263,O
current,1267,1274,O
uses,1275,1279,O
oral,1283,1287,B-Organism_subdivision
health,1288,1294,O
Acute,0,5,O
ablation,6,14,O
Langerhans,18,28,B-Cell
cells,29,34,I-Cell
enhances,35,43,O
skin,44,48,B-Organ
immune,49,55,O
responses,56,65,O
Understanding,67,80,O
function,85,93,O
Langerhans,97,107,B-Cell
cells,108,113,I-Cell
LCs,115,118,B-Cell
vivo,123,127,O
complicated,137,148,O
conflicting,152,163,O
results,164,171,O
LC,177,179,B-Cell
deficient,180,189,O
mice,190,194,O
Human,196,201,O
Langerin,202,210,O
DTA,211,214,O
mice,215,219,O
constitutively,220,234,O
lack,235,239,O
LCs,240,243,B-Cell
develop,248,255,O
exaggerated,256,267,O
contact,268,275,O
hypersensitivity,276,292,O
CHS,294,297,O
responses,299,308,O
Murine,310,316,O
Langerin,317,325,O
diphtheria,326,336,O
toxin,337,342,O
receptor,343,351,O
DTR,353,356,O
mice,358,362,O
allow,363,368,O
inducible,377,386,O
elimination,387,398,O
LCs,402,405,B-Cell
Langerin,410,418,B-Cell
dermal,422,428,I-Cell
dendritic,429,438,I-Cell
cells,439,444,I-Cell
dDCs,446,450,B-Cell
administration,458,472,O
diphtheria,476,486,O
toxin,487,492,O
results,500,507,O
reduced,511,518,O
CHS,519,522,O
Langerin,529,537,B-Cell
dDCs,541,545,I-Cell
partially,551,560,O
repopulated,561,572,O
skin,577,581,B-Organ
LCs,586,589,B-Cell
absent,600,606,O
CHS,608,611,O
returns,612,619,O
normal,623,629,O
LCs,637,640,B-Cell
appear,641,647,O
suppressive,654,665,O
human,669,674,O
Langerin,675,683,O
DTA,684,687,O
mice,688,692,O
redundant,697,706,O
murine,710,716,O
Langerin,717,725,O
DTR,726,729,O
mice,730,734,O
determine,739,748,O
inducible,757,766,O
versus,767,773,O
constitutive,774,786,O
LC,787,789,B-Cell
ablation,790,798,O
explains,799,807,O
results,814,821,O
engineered,826,836,O
human,837,842,O
Langerin,843,851,O
DTR,852,855,O
mice,856,860,O
diphtheria,870,880,O
toxin,881,886,O
ablates,887,894,O
LCs,895,898,B-Cell
affecting,907,916,O
Langerin,917,925,B-Cell
dDCs,929,933,I-Cell
inducible,939,948,O
ablation,949,957,O
LCs,961,964,B-Cell
human,968,973,O
Langerin,974,982,O
DTR,983,986,O
mice,987,991,O
resulted,992,1000,O
increased,1004,1013,O
CHS,1014,1017,O
LC,1025,1027,B-Cell
mediated,1028,1036,O
suppression,1037,1048,O
require,1058,1065,O
absence,1072,1079,O
ontogeny,1087,1095,O
steady,1110,1116,O
state,1117,1122,O
consistent,1130,1140,O
model,1148,1153,O
LCs,1163,1166,B-Cell
actively,1167,1175,O
suppress,1176,1184,O
Ag,1185,1187,O
specific,1188,1196,O
CHS,1197,1200,O
responses,1201,1210,O
proenkephalin,4,17,O
derivative,20,30,O
Met,31,34,O
enkephalin,35,45,O
Arg,46,49,O
Gly,50,53,O
Leu,54,57,O
present,65,72,O
feline,80,86,O
species,87,94,O
opioid,99,105,O
octapeptide,106,117,O
Met,118,121,O
enkephalin,122,132,O
Arg,133,136,O
Gly,137,140,O
Leu,141,144,O
detected,149,157,O
brain,172,177,B-Organ
adrenal,188,195,B-Organ
gland,196,201,I-Organ
cat,209,212,O
specific,221,229,O
radioimmunoassay,230,246,O
possible,263,271,O
determine,275,284,O
Met,289,292,O
enkephalin,293,303,O
Leu,308,311,O
enkephalin,312,322,O
contents,323,331,O
Met,337,340,O
enkephalin,341,351,O
versus,352,358,O
Leu,359,362,O
enkephalin,363,373,O
concentration,374,387,O
ratio,388,393,O
area,418,422,O
brain,430,435,B-Organ
assayed,436,443,O
presence,449,457,O
authentic,461,470,O
Met,471,474,O
enkephalin,475,485,O
Leu,490,493,O
enkephalin,494,504,O
confirmed,509,518,O
high,522,526,O
performance,527,538,O
liquid,539,545,O
chromatography,546,560,O
analysis,561,569,O
data,589,593,O
indicate,602,610,O
cat,620,623,O
proenkephalin,624,637,O
partly,641,647,O
different,648,657,O
previously,668,678,O
analysed,679,687,O
mammalian,691,700,O
species,701,708,O
including,709,718,O
humans,719,725,O
rats,727,731,O
cows,736,740,O
Dissecting,0,10,O
genetic,11,18,O
networks,19,27,O
underlying,28,38,O
complex,39,46,O
phenotypes,47,57,O
theoretical,63,74,O
framework,75,84,O
Great,86,91,O
progress,92,100,O
genetic,118,125,O
dissection,126,136,O
quantitative,140,152,O
trait,153,158,O
variation,159,168,O
past,180,184,O
decades,189,196,O
studies,207,214,O
reveal,221,227,O
small,235,240,O
fraction,241,249,O
quantitative,253,265,O
trait,266,271,O
loci,272,276,O
QTLs,278,282,O
epistasis,289,298,O
remains,299,306,O
elusive,307,314,O
integrate,319,328,O
contemporary,329,341,O
knowledge,342,351,O
signal,355,361,O
transduction,362,374,O
pathways,375,383,O
principles,389,399,O
quantitative,403,415,O
population,420,430,O
genetics,431,439,O
characterize,443,455,O
genetic,456,463,O
networks,464,472,O
underlying,473,483,O
complex,484,491,O
traits,492,498,O
model,508,513,O
founded,514,521,O
way,531,534,O
functional,535,545,O
dependency,546,556,O
downstream,560,570,O
genes,571,576,O
upstream,580,588,O
regulators,589,599,O
principle,605,614,O
hierarchy,618,627,O
mutual,633,639,O
functional,640,650,O
dependency,651,661,O
related,668,675,O
genes,676,681,O
functional,683,693,O
genetic,694,701,O
units,702,707,O
FGU,709,712,O
simulated,720,729,O
real,734,738,O
data,739,743,O
suggest,744,751,O
complementary,757,770,O
epistasis,771,780,O
contributes,781,792,O
greatly,793,800,O
quantitative,804,816,O
trait,817,822,O
variation,823,832,O
obscures,838,846,O
phenotypic,851,861,O
effects,862,869,O
downstream,879,889,O
loci,891,895,O
pathways,899,907,O
mathematical,913,925,O
relationships,926,939,O
main,952,956,O
effects,957,964,O
epistatic,969,978,O
effects,979,986,O
genes,990,995,O
acting,996,1002,O
different,1006,1015,O
levels,1016,1022,O
signaling,1026,1035,O
pathways,1036,1044,O
established,1050,1061,O
quantitative,1072,1084,O
population,1089,1099,O
genetic,1100,1107,O
parameters,1108,1118,O
loss,1125,1129,O
function,1133,1141,O
co,1147,1149,O
adapted,1150,1157,O
gene,1159,1163,O
complexes,1164,1173,O
formed,1174,1180,O
multiple,1184,1192,O
alleles,1193,1200,O
differentiated,1206,1220,O
functions,1221,1230,O
effects,1232,1239,O
predicted,1245,1254,O
frequent,1261,1269,O
types,1270,1275,O
allelic,1279,1286,O
diversity,1287,1296,O
loci,1300,1304,O
contribute,1310,1320,O
genetic,1328,1335,O
variation,1336,1345,O
complex,1349,1356,O
traits,1357,1363,O
populations,1367,1378,O
Downstream,1380,1390,O
FGUs,1391,1395,O
appear,1396,1402,O
vulnerable,1414,1424,O
loss,1428,1432,O
function,1436,1444,O
upstream,1456,1464,O
regulators,1465,1475,O
vulnerability,1486,1499,O
apparently,1503,1513,O
compensated,1514,1525,O
different,1529,1538,O
FGUs,1539,1543,O
similar,1547,1554,O
functions,1555,1564,O
predictions,1572,1583,O
model,1593,1598,O
account,1603,1610,O
puzzling,1615,1623,O
results,1624,1631,O
responses,1642,1651,O
selection,1655,1664,O
genotype,1666,1674,O
environment,1678,1689,O
interaction,1690,1701,O
genetic,1711,1718,O
basis,1719,1724,O
heterosis,1728,1737,O
3,0,1,O
Methyl,4,10,O
carbamo,11,18,O
yl,19,21,O
amino,22,27,O
1H,29,31,O
isoindolium,32,43,O
chloride,44,52,O
title,58,63,O
compound,64,72,O
C,74,75,O
10,76,78,O
H,79,80,O
12,81,83,O
N,84,85,O
3,86,87,O
O,88,89,O
Cl,93,95,O
derivative,105,115,O
o,119,120,O
phthaldehyde,121,133,O
methyl,138,144,O
thio,145,149,O
urea,150,154,O
mol,160,163,O
ecules,164,170,O
form,171,175,O
dimers,176,182,O
intra,191,196,O
inter,202,207,O
molecular,208,217,O
N,218,219,O
H,220,221,O
O,224,225,O
hydrogen,226,234,O
bonds,235,240,O
dimers,246,252,O
linked,265,271,O
chains,277,283,O
C,296,297,O
H,298,299,O
Cl,302,304,O
N,313,314,O
H,315,316,O
Cl,319,321,O
hydrogen,322,330,O
bonds,331,336,O
Oscillatory,0,11,O
alpha,12,17,O
band,18,22,O
mechanisms,23,33,O
deployment,42,52,O
spatial,56,63,O
attention,64,73,O
anticipated,77,88,O
auditory,89,97,O
visual,102,108,O
target,109,115,O
locations,116,125,O
supramodal,127,137,O
sensory,141,148,O
specific,149,157,O
control,158,165,O
mechanisms,166,176,O
Oscillatory,178,189,O
alpha,190,195,O
band,196,200,O
activity,201,209,O
8,211,212,O
15,213,215,O
Hz,216,218,O
parieto,225,232,B-Multi-tissue_structure
occipital,233,242,I-Multi-tissue_structure
cortex,243,249,I-Multi-tissue_structure
humans,253,259,O
plays,260,265,O
important,269,278,O
role,279,283,O
suppression,287,298,O
processing,302,312,O
inputs,317,323,O
ignored,333,340,O
regions,341,348,O
space,352,357,O
increased,364,373,O
alpha,374,379,O
band,380,384,O
power,385,390,O
observed,391,399,O
cortex,405,411,B-Multi-tissue_structure
contralateral,412,425,O
locations,429,438,O
expected,439,447,O
contain,451,458,O
distractors,459,470,O
unclear,478,485,O
similar,494,501,O
processes,502,511,O
operate,512,519,O
deployment,527,537,O
spatial,541,548,O
attention,549,558,O
sensory,568,575,O
modalities,576,586,O
Evidence,588,596,O
lesion,602,608,B-Pathological_formation
patients,609,617,O
suggests,618,626,O
parietal,632,640,B-Organism_subdivision
regions,641,648,I-Organism_subdivision
house,649,654,O
supramodal,655,665,O
representations,666,681,O
space,685,690,O
parietal,696,704,B-Multi-tissue_structure
lobes,705,710,I-Multi-tissue_structure
prominent,715,724,O
generators,725,735,O
alpha,739,744,O
oscillations,745,757,O
raising,759,766,O
possibility,771,782,O
alpha,788,793,O
neural,799,805,B-Multi-tissue_structure
signature,806,815,O
supramodal,819,829,O
spatial,830,837,O
attention,838,847,O
Furthermore,849,860,O
spatial,867,874,O
attention,875,884,O
deployed,888,896,O
vision,904,910,O
processing,912,922,O
task,926,930,O
irrelevant,931,941,O
auditory,942,950,O
inputs,951,957,O
attended,961,969,O
locations,970,979,O
enhanced,988,996,O
pointing,998,1006,O
automatic,1010,1019,O
links,1020,1025,O
spatial,1034,1041,O
deployments,1042,1053,O
senses,1061,1067,O
asked,1078,1083,O
lateralized,1092,1103,O
alpha,1104,1109,O
band,1110,1114,O
activity,1115,1123,O
evident,1132,1139,O
purely,1145,1151,O
auditory,1152,1160,O
spatial,1161,1168,O
cueing,1169,1175,O
task,1176,1180,O
underlying,1209,1219,O
generator,1220,1229,O
configuration,1230,1243,O
purely,1252,1258,O
visuospatial,1259,1271,O
task,1272,1276,O
common,1281,1287,O
sensory,1296,1303,O
systems,1304,1311,O
provide,1324,1331,O
strong,1332,1338,O
support,1339,1346,O
supramodal,1352,1362,O
attention,1364,1373,O
theory,1374,1380,O
Alternately,1382,1393,O
alpha,1395,1400,O
band,1401,1405,O
differences,1406,1417,O
auditory,1426,1434,O
visual,1439,1445,O
tasks,1446,1451,O
support,1458,1465,O
sensory,1468,1475,O
specific,1476,1484,O
account,1485,1492,O
Lateralized,1494,1505,O
shifts,1506,1512,O
alpha,1516,1521,O
band,1522,1526,O
activity,1527,1535,O
observed,1548,1556,O
purely,1566,1572,O
auditory,1573,1581,O
spatial,1582,1589,O
task,1590,1594,O
Crucially,1596,1605,O
clear,1618,1623,O
differences,1624,1635,O
scalp,1639,1644,B-Multi-tissue_structure
topographies,1645,1657,O
alpha,1666,1671,O
activity,1672,1680,O
depending,1681,1690,O
sensory,1698,1705,O
system,1706,1712,O
spatial,1726,1733,O
attention,1734,1743,O
deployed,1748,1756,O
Findings,1758,1766,O
suggest,1767,1774,O
parietally,1780,1790,O
generated,1791,1800,O
alpha,1801,1806,O
band,1807,1811,O
mechanisms,1812,1822,O
central,1827,1834,O
attentional,1838,1849,O
deployments,1850,1861,O
modalities,1869,1879,O
invoked,1898,1905,O
sensory,1911,1918,O
specific,1919,1927,O
manner,1928,1934,O
data,1940,1944,O
support,1945,1952,O
interactivity,1957,1970,O
account,1971,1978,O
supramodal,1991,2001,O
system,2002,2008,O
interacts,2009,2018,O
sensory,2024,2031,O
specific,2032,2040,O
control,2041,2048,O
systems,2049,2056,O
deployment,2064,2074,O
spatial,2078,2085,O
attention,2086,2095,O
Absence,0,7,O
antisperm,11,20,O
antibodies,21,31,O
anejaculatory,35,48,O
men,49,52,O
Antisperm,54,63,O
antibodies,64,74,O
assessed,80,88,O
serum,96,101,B-Organism_substance
samples,102,109,I-Organism_substance
73,113,115,O
men,116,119,O
unable,120,126,O
ejaculate,130,139,O
naturally,140,149,O
sperm,161,166,B-Cell
cells,167,172,I-Cell
13,176,178,O
men,188,191,O
serum,205,210,B-Organism_substance
samples,211,218,I-Organism_substance
found,224,229,O
positive,236,244,O
sperm,248,253,B-Cell
agglutination,254,267,O
sperm,271,276,B-Cell
immobilization,277,291,O
methods,292,299,O
antibodies,304,314,O
detected,320,328,O
immunobead,335,345,O
assay,346,351,O
sperm,359,364,B-Cell
cells,365,370,I-Cell
13,385,387,O
men,388,391,O
examined,392,400,O
Biotechnological,1,17,O
biomedical,22,32,O
aspects,33,40,O
production,44,54,O
study,59,64,O
metal,68,73,O
cation,74,80,O
phospholipid,81,93,O
complexes,94,103,O
Problems,106,114,O
relating,115,123,O
technology,131,141,O
phospholipid,147,159,O
preparation,160,171,O
natural,177,184,O
materials,185,194,O
liposome,196,204,O
production,205,215,O
studies,221,228,O
mechanisms,238,248,O
interaction,252,263,O
metal,272,277,O
trace,279,284,O
elements,285,293,O
cations,295,302,O
model,307,312,O
bilayer,313,320,B-Cellular_component
lipid,321,326,I-Cellular_component
membranes,327,336,I-Cellular_component
discussed,341,350,O
proposed,356,364,O
technology,365,375,O
extraction,379,389,O
allows,390,396,O
preparation,401,412,O
phospholipids,416,429,O
utilizable,430,440,O
liposome,445,453,O
formation,454,463,O
cation,469,475,O
specificity,476,487,O
lipid,491,496,O
bilayers,497,505,O
found,509,514,O
determined,521,531,O
presence,539,547,O
anionic,551,558,O
phosphate,559,568,O
adsorption,569,579,O
sites,580,585,O
surface,595,602,O
Endoscopic,0,10,O
injection,11,20,O
therapy,21,28,O
acute,33,38,O
upper,39,44,B-Organism_subdivision
GI,45,47,I-Organism_subdivision
bleeding,48,56,O
summary,61,68,O
found,78,83,O
technique,89,98,O
useful,105,111,O
patients,115,123,O
coagulation,132,143,O
therapy,144,151,O
possible,159,167,O
effective,171,180,O
considered,199,209,O
technique,212,221,O
undergoing,231,241,O
evaluation,242,252,O
Prospective,254,265,O
randomized,266,276,O
trials,277,283,O
comparing,284,293,O
therapy,299,306,O
currently,318,327,O
available,328,337,O
therapies,338,347,O
electrocoagulation,355,373,O
laser,375,380,O
conservative,385,397,O
management,398,408,O
completed,417,426,O
firmly,430,436,O
define,437,443,O
place,448,453,O
treatment,457,466,O
strategy,467,475,O
acute,480,485,O
upper,486,491,B-Organism_subdivision
GI,492,494,I-Organism_subdivision
bleeding,495,503,O
Effects,0,7,O
hypertension,11,23,O
sympathetic,28,39,O
denervation,40,51,O
cerebral,55,63,B-Organ
blood,64,69,B-Organism_substance
flow,70,74,O
newborn,78,85,O
pigs,86,90,O
investigate,95,106,O
potential,111,120,O
role,121,125,O
sympathetic,129,140,O
nerves,141,147,B-Multi-tissue_structure
preventing,151,161,O
pronounced,162,172,O
increases,173,182,O
cerebral,186,194,B-Organ
blood,195,200,B-Organism_substance
flow,201,205,O
evaluated,210,219,O
effects,224,231,O
abrupt,235,241,O
hypertension,242,254,O
cerebral,262,270,B-Organ
circulation,271,282,O
newborn,286,293,O
pigs,294,298,O
intact,304,310,O
cerebral,311,319,B-Organ
sympathetic,320,331,O
innervation,332,343,O
cerebral,354,362,B-Organ
sympathetic,363,374,O
denervation,375,386,O
Epinephrine,388,399,O
infusion,400,408,O
induce,421,427,O
abrupt,428,434,O
increases,435,444,O
mean,448,452,O
SEM,458,461,O
arterial,463,471,B-Multi-tissue_structure
pressure,472,480,O
innervated,482,492,O
pigs,493,497,O
62,499,501,O
3,506,507,O
mm,508,510,O
Hg,514,516,O
115,520,523,O
3,528,529,O
mm,530,532,O
Hg,536,538,O
denervated,540,550,O
pigs,551,555,O
71,557,559,O
4,564,565,O
mm,566,568,O
Hg,572,574,O
132,578,581,O
4,586,587,O
mm,588,590,O
Hg,594,596,O
remained,603,611,O
increased,612,621,O
3,630,631,O
minutes,632,639,O
study,647,652,O
Abrupt,654,660,O
hypertension,661,673,O
increased,674,683,O
blood,684,689,B-Organism_substance
flow,690,694,O
brain,702,707,B-Organ
regions,708,715,O
denervated,720,730,O
pigs,731,735,O
increased,741,750,O
flow,751,755,O
cerebrum,763,771,B-Multi-tissue_structure
prolonged,776,785,O
compared,787,795,O
pigs,809,813,O
intact,819,825,O
sympathetic,826,837,O
innervation,838,849,O
Differences,851,862,O
pigs,871,875,O
innervated,883,893,O
denervated,898,908,O
groups,909,915,O
apparent,925,933,O
respect,940,947,O
blood,951,956,B-Organism_substance
flow,957,961,O
region,975,981,O
caudate,983,990,O
region,991,997,O
brain,999,1004,B-Multi-tissue_structure
stem,1005,1009,I-Multi-tissue_structure
cerebellum,1011,1021,B-Multi-tissue_structure
newborn,1027,1034,O
pigs,1035,1039,O
sympathetic,1041,1052,O
nerves,1053,1059,B-Multi-tissue_structure
attenuate,1064,1073,O
hypertension,1074,1086,O
induced,1087,1094,O
increases,1095,1104,O
blood,1108,1113,B-Organism_substance
flow,1114,1118,O
cerebrum,1126,1134,B-Multi-tissue_structure
appear,1147,1153,O
affect,1157,1163,O
flow,1164,1168,O
rest,1176,1180,O
brain,1188,1193,B-Organ
Sensitivity,0,11,O
analysis,12,20,O
influence,28,37,O
source,41,47,O
term,48,52,O
environmental,57,70,O
parameters,71,81,O
radiological,89,101,O
risk,102,106,O
coal,110,114,O
fired,115,120,O
plants,121,127,O
sensitivity,131,142,O
analysis,143,151,O
undertaken,156,166,O
determine,170,179,O
influence,184,193,O
different,197,206,O
source,207,213,O
term,214,218,O
environmental,223,236,O
parameters,237,247,O
radiological,255,267,O
risks,268,273,O
coal,281,285,O
fired,286,291,O
plant,292,297,O
CFP,299,302,O
found,312,317,O
release,327,334,O
rate,335,339,O
radionuclides,343,356,O
effective,365,374,O
release,375,382,O
height,383,389,O
significantly,395,408,O
influence,409,418,O
radiological,419,431,O
risk,432,436,O
Site,438,442,O
characteristics,443,458,O
rain,468,472,O
scavenging,473,483,O
coefficients,484,496,O
food,501,505,O
acquirement,506,517,O
habits,518,524,O
lesser,533,539,O
influence,540,549,O
parameters,560,570,O
time,580,584,O
delay,585,590,O
ingestion,598,607,O
contaminated,611,623,O
food,624,628,O
practically,635,646,O
influence,650,659,O
radiological,667,679,O
impact,680,686,O
CFP,692,695,O
contribution,701,713,O
radiation,717,726,O
risks,727,732,O
different,736,745,O
exposure,746,754,O
modes,755,760,O
e,764,765,O
inhalation,767,777,O
ingestion,779,788,O
contact,793,800,O
ground,806,812,O
surface,813,820,O
analyzed,832,840,O
specific,856,864,O
radionuclides,865,878,O
human,883,888,O
body,889,893,B-Organ
organs,894,900,I-Organ
Results,902,909,O
sensitivity,917,928,O
analysis,929,937,O
interpreted,943,954,O
terms,958,963,O
characteristics,971,986,O
fuel,994,998,O
facilities,1000,1010,O
site,1015,1019,O
CFP,1025,1028,O
concluded,1036,1045,O
proper,1054,1060,O
choice,1061,1067,O
coal,1071,1075,O
furnace,1077,1084,O
ash,1086,1089,O
filtration,1090,1100,O
stack,1105,1110,O
height,1111,1117,O
proper,1133,1139,O
siting,1140,1146,O
radiological,1152,1164,O
impact,1165,1171,O
CFP,1177,1180,O
drastically,1188,1199,O
reduced,1200,1207,O
Antishock,0,9,O
trousers,10,18,O
collective,22,32,O
review,33,39,O
Antishock,41,50,O
trousers,51,59,O
integral,75,83,O
emergency,92,101,O
medical,102,109,O
care,110,114,O
traumatic,124,133,O
life,138,142,O
threatening,143,154,O
emergencies,155,166,O
article,173,180,O
represents,181,191,O
summary,194,201,O
current,209,216,O
state,217,222,O
knowledge,226,235,O
concerning,236,246,O
use,251,254,O
device,263,269,O
brief,273,278,O
history,279,286,O
development,294,305,O
antishock,309,318,O
garments,319,327,O
discussed,331,340,O
followed,350,358,O
discussion,364,374,O
human,378,383,O
clinical,384,392,O
studies,393,400,O
results,405,412,O
clinical,416,424,O
research,425,433,O
hemodynamics,437,449,O
respiration,451,462,O
use,464,467,O
head,471,475,B-Organism_subdivision
injury,476,482,O
effects,488,495,O
vascular,499,507,B-Multi-tissue_structure
hemostasis,508,518,O
Indications,520,531,O
contraindications,533,550,O
complications,552,565,O
recommended,571,582,O
procedure,583,592,O
use,597,600,O
discussed,605,614,O
Based,616,621,O
randomized,625,635,O
prospective,636,647,O
studies,648,655,O
antishock,657,666,O
garments,667,675,O
shown,699,704,O
improve,708,715,O
patient,716,723,O
morbidity,724,733,O
mortality,737,746,O
Proper,748,754,O
use,755,758,O
antishock,762,771,O
garments,772,780,O
requires,781,789,O
understanding,793,806,O
function,821,829,O
limitations,840,851,O
Measurement,0,11,O
serum,15,20,B-Organism_substance
glycosylated,21,33,O
proteins,34,42,O
glycosylated,47,59,O
low,60,63,O
density,64,71,O
lipoprotein,72,83,O
fraction,84,92,O
diabetes,96,104,O
mellitus,105,113,O
simple,117,123,O
method,124,130,O
developed,135,144,O
estimating,149,159,O
serum,160,165,B-Organism_substance
glycosylated,166,178,O
protein,179,186,O
levels,187,193,O
gel,200,203,O
filtration,204,214,O
Bio,220,223,O
Gel,224,227,O
P6,228,230,O
determining,234,245,O
protein,250,257,O
sugar,262,267,O
content,268,275,O
void,283,287,O
volume,288,294,O
fraction,295,303,O
glycosylated,309,321,O
protein,322,329,O
levels,330,336,O
GSP,338,341,O
correlated,343,353,O
fasting,364,371,O
blood,372,377,B-Organism_substance
sugar,378,383,O
levels,384,390,O
glycosylated,395,407,O
albumin,408,415,O
level,416,421,O
G,423,424,O
ALB,425,428,O
determined,430,440,O
affinity,444,452,O
chromatography,453,467,O
Blue,473,477,O
Sepharose,478,487,O
CL6B,488,492,O
glycosylation,498,511,O
level,512,517,O
heparin,521,528,O
citrate,529,536,O
precipitable,537,549,O
fraction,550,558,O
serum,562,567,B-Organism_substance
predominantly,574,587,O
contained,588,597,O
low,598,601,O
density,602,609,O
lipoprotein,610,621,O
G,623,624,O
LDL,625,628,O
correlated,635,645,O
GSP,656,659,O
LDL,664,667,O
cholesterol,668,679,O
levels,680,686,O
Significantly,688,701,O
different,702,711,O
values,712,718,O
obtained,724,732,O
GSP,737,740,O
G,742,743,O
ALB,744,747,O
G,753,754,O
LDL,755,758,O
normals,767,774,O
diabetics,779,788,O
origin,4,10,O
yolk,14,18,B-Developing_anatomical_structure
DNA,19,22,O
Xenopus,26,33,O
laevis,34,40,O
Xenopus,42,49,O
laevis,50,56,O
serum,57,62,B-Organism_substance
plasma,67,73,B-Organism_substance
found,78,83,O
contain,87,94,O
average,98,105,O
25,109,111,O
microgram,112,121,O
DNA,122,125,O
ml,126,128,O
Isolated,130,138,O
X,139,140,O
laevis,142,148,O
oocytes,149,156,B-Cell
incubated,157,166,O
medium,170,176,O
containing,177,187,O
25,188,190,O
microgram,191,200,O
DNA,201,204,O
ml,205,207,O
labeled,208,215,O
125I,228,232,O
32P,234,237,O
14C,241,244,O
different,260,269,O
sources,270,277,O
bovine,279,285,O
E,287,288,O
coli,290,294,O
X,299,300,O
laevis,302,308,O
incorporated,311,323,O
label,328,333,O
average,340,347,O
rate,348,352,O
0,356,357,O
11,358,360,O
ng,361,363,O
mm,364,366,O
2,367,368,O
hr,369,371,O
1,372,373,O
Sucrose,375,382,O
gradient,383,391,O
fractionation,392,405,O
oocytes,409,416,B-Cell
revealed,417,425,O
40,431,433,O
75,434,436,O
acid,445,449,O
precipitable,450,462,O
label,463,468,O
incorporated,469,481,O
associated,486,496,O
yolk,506,510,B-Cell
platelets,511,520,I-Cell
Additional,522,532,O
incubations,533,544,O
oocytes,548,555,B-Cell
unlabeled,559,568,O
medium,569,575,O
demonstrated,576,588,O
DNA,598,601,O
incorporated,602,614,O
yolk,624,628,B-Cell
platelets,629,638,I-Cell
undergoing,643,653,O
turnover,654,662,O
20,669,671,O
yolk,680,684,B-Developing_anatomical_structure
associated,685,695,O
DNA,696,699,O
present,710,717,O
week,730,734,O
incubation,735,745,O
data,751,755,O
suggest,756,763,O
yolk,769,773,B-Developing_anatomical_structure
DNA,774,777,O
arises,778,784,O
adventitious,792,804,O
uptake,805,811,O
DNA,815,818,O
present,819,826,O
maternal,834,842,O
serum,843,848,B-Organism_substance
vitellogenic,852,864,O
oocytes,865,872,B-Cell
Immunoglobulins,0,15,O
associated,16,26,O
elevated,32,40,O
riboflavin,41,51,O
binding,52,59,O
plasma,63,69,B-Organism_substance
cancer,75,81,B-Pathological_formation
patients,82,90,O
Plasma,92,98,B-Organism_substance
182,104,107,O
patients,108,116,O
different,122,131,O
malignant,132,141,O
diseases,142,150,O
tested,155,161,O
riboflavin,166,176,O
binding,177,184,O
immunoglobulins,188,203,O
recently,221,229,O
identified,230,240,O
major,244,249,O
carriers,250,258,O
micronutrient,267,280,O
wide,284,288,O
range,289,294,O
binding,298,305,O
5,307,308,O
9,309,310,O
130,314,317,O
pmole,318,323,O
ml,324,326,O
plasma,327,333,O
observed,339,347,O
significant,353,364,O
elevations,365,375,O
found,381,386,O
patients,391,399,O
having,400,406,O
breast,407,413,B-Pathological_formation
cancer,414,420,I-Pathological_formation
21,422,424,O
2,425,426,O
1,431,432,O
9,433,434,O
P,436,437,O
0,448,449,O
05,450,452,O
melanoma,458,466,B-Pathological_formation
25,468,470,O
7,471,472,O
1,477,478,O
9,479,480,O
P,482,483,O
0,494,495,O
001,496,499,O
compared,501,509,O
controls,513,521,O
15,523,525,O
5,526,527,O
1,532,533,O
9,534,535,O
proteins,542,550,O
responsible,551,562,O
majority,569,577,O
higher,585,591,O
binding,592,599,O
identified,605,615,O
immunoglobulins,619,634,O
based,636,641,O
elution,651,658,O
gel,664,667,O
filtration,668,678,O
columns,679,686,O
removal,695,702,O
57,706,708,O
88,709,711,O
non,720,723,O
albumin,724,731,O
binding,732,739,O
treating,743,751,O
plasma,755,761,B-Organism_substance
Protein,767,774,O
agarose,777,784,O
binding,790,797,O
weakly,807,813,O
related,814,821,O
total,829,834,O
concentration,835,848,O
immunoglobulins,852,867,O
r,869,870,O
0,873,874,O
11,875,877,O
linear,881,887,O
regression,888,898,O
analysis,899,907,O
apparently,926,936,O
subclass,946,954,O
elevated,963,971,O
types,980,985,O
cancer,989,995,O
Elevated,997,1005,O
levels,1006,1012,O
immunoglobulins,1022,1037,O
contribute,1042,1052,O
lower,1060,1065,O
urinary,1066,1073,B-Organism_substance
levels,1074,1080,O
clearance,1085,1094,O
riboflavin,1098,1108,O
cancer,1112,1118,B-Pathological_formation
Postpartum,0,10,O
rubella,11,18,O
immunization,19,31,O
association,33,44,O
development,50,61,O
prolonged,65,74,O
arthritis,75,84,O
neurological,86,98,B-Anatomical_system
sequelae,99,107,O
chronic,113,120,O
rubella,121,128,O
viremia,129,136,O
women,142,147,O
developed,148,157,O
chronic,158,165,O
long,166,170,O
term,171,175,O
arthropathy,176,187,O
postpartum,194,204,O
immunization,205,217,O
rubella,226,233,O
individuals,239,250,O
developed,251,260,O
acute,261,266,O
polyarticular,267,280,O
arthritis,281,290,O
12,298,300,O
days,301,305,O
weeks,315,320,O
postimmunization,321,337,O
continuing,351,361,O
chronic,362,369,O
recurrent,373,382,O
arthralgia,383,393,O
arthritis,397,406,O
seven,418,423,O
years,424,429,O
vaccination,436,447,O
Acute,449,454,O
neurological,455,467,B-Anatomical_system
manifestations,468,482,O
consisting,484,494,O
carpal,498,504,O
tunnel,505,511,O
syndrome,512,520,O
multiple,524,532,O
paresthesiae,533,545,O
developed,547,556,O
postvaccination,557,572,O
women,582,587,O
developed,598,607,O
continuing,608,618,O
active,619,625,O
chronic,629,636,O
recurrent,637,646,O
episodes,647,655,O
blurred,659,666,O
vision,667,673,O
paresthesiae,675,687,O
painful,693,700,O
limb,701,705,B-Organism_subdivision
syndromes,706,715,O
recurrent,730,739,O
joint,740,745,O
symptoms,746,754,O
Chronic,756,763,O
rubella,764,771,O
viremia,772,779,O
detected,789,797,O
peripheral,801,811,B-Cell
blood,812,817,I-Cell
mononuclear,818,829,I-Cell
cell,830,834,I-Cell
MNC,836,839,B-Cell
populations,841,852,O
women,872,877,O
years,888,893,O
vaccination,900,911,O
addition,916,924,O
rubella,925,932,O
virus,933,938,O
isolated,943,951,O
breast,957,963,B-Cell
milk,964,968,I-Cell
MNCs,969,973,I-Cell
individual,981,991,O
months,1000,1006,O
postvaccination,1007,1022,O
peripheral,1032,1042,B-Cell
blood,1043,1048,I-Cell
MNCs,1049,1053,I-Cell
breast,1069,1075,B-Organism_subdivision
fed,1076,1079,O
infants,1080,1087,O
studied,1088,1095,O
12,1099,1101,O
18,1102,1104,O
months,1105,1111,O
age,1115,1118,O
Immune,1120,1126,O
responses,1127,1136,O
rubella,1140,1147,O
virus,1148,1153,O
studied,1154,1161,O
sequential,1165,1175,O
intervals,1176,1185,O
vaccination,1192,1203,O
correlated,1204,1214,O
development,1220,1231,O
rheumatologic,1235,1248,O
neurological,1253,1265,B-Anatomical_system
manifestations,1266,1280,O
Cardiac,0,7,B-Organ
gap,8,11,O
junction,12,20,O
configuration,21,34,O
uncoupling,44,54,O
treatment,55,64,O
function,70,78,O
time,82,86,O
Rabbit,88,94,O
ventricle,95,104,B-Multi-tissue_structure
fixed,116,121,O
glutaraldehyde,125,139,O
injury,148,154,O
control,156,163,O
injured,172,179,O
fixation,187,195,O
presumably,197,207,O
causing,208,215,O
electrical,216,226,O
uncoupling,227,237,O
gap,245,248,O
junctions,249,258,O
tissue,264,270,B-Tissue
processed,280,289,O
freeze,294,300,O
fracture,301,309,O
Replicas,311,319,O
control,323,330,O
gap,331,334,O
junctions,335,344,O
exhibited,345,354,O
irregular,355,364,O
packing,365,372,O
P,380,381,O
face,382,386,O
particles,387,396,O
E,401,402,O
face,403,407,O
pits,408,412,O
Average,414,421,O
center,422,428,O
center,432,438,O
spacing,439,446,O
particles,454,463,O
10,468,470,O
5,471,472,O
nm,473,475,O
Tissue,477,483,B-Tissue
fixed,484,489,O
1,490,491,O
5,492,493,O
min,494,497,O
injury,504,510,O
showed,511,517,O
clumping,518,526,O
gap,530,533,O
junctional,534,544,O
particles,545,554,O
pits,559,563,O
clumps,576,582,O
particles,588,597,O
pits,602,606,O
hexagonally,612,623,O
packed,624,630,O
center,639,645,O
center,649,655,O
spacing,656,663,O
particles,671,680,O
averaged,681,689,O
9,690,691,O
5,692,693,O
nm,694,696,O
tissue,701,707,B-Tissue
fixed,708,713,O
15,714,716,O
30,717,719,O
min,720,723,O
injury,730,736,O
clumps,742,748,O
gap,752,755,O
junctional,756,766,O
particles,767,776,O
coalesced,781,790,O
homogeneous,798,809,O
structure,810,819,O
junctions,828,837,O
packing,843,850,O
particles,858,867,O
pits,872,876,O
hexagonal,881,890,O
spacing,899,906,O
particles,914,923,O
averaged,924,932,O
9,933,934,O
5,935,936,O
nm,937,939,O
pieces,947,953,O
rabbit,957,963,O
atrium,964,970,B-Multi-tissue_structure
frozen,976,982,O
prior,991,996,O
fixation,997,1005,O
cryoprotection,1009,1023,O
try,1027,1030,O
assess,1034,1040,O
effect,1045,1051,O
glutarldehyde,1055,1068,O
fixation,1069,1077,O
gap,1081,1084,O
junction,1085,1093,O
structure,1094,1103,O
tissue,1113,1119,B-Tissue
gap,1124,1127,O
junctional,1128,1138,O
particles,1139,1148,O
irregularly,1154,1165,O
packed,1166,1172,O
spacing,1183,1190,O
averaged,1191,1199,O
10,1200,1202,O
0,1203,1204,O
nm,1205,1207,O
Absence,0,7,O
effect,11,17,O
prenatal,21,29,O
ethanol,30,37,O
adult,41,46,O
emotionality,47,59,O
ethanol,64,71,O
consumption,72,83,O
rats,87,91,O
Lower,93,98,O
peak,99,103,O
blood,104,109,B-Organism_substance
ethanol,110,117,O
concentrations,118,132,O
1,139,140,O
2,145,146,O
g,147,148,O
ethanol,152,159,O
kg,164,166,O
found,172,177,O
pregnant,181,189,O
rats,190,194,O
virgin,203,209,O
females,210,217,O
significant,222,233,O
differences,234,245,O
adult,249,254,O
emotionality,256,268,O
ethanol,273,280,O
consumption,281,292,O
found,298,303,O
rats,307,311,O
exposed,312,319,O
prenatal,323,331,O
alcohol,332,339,O
pair,347,351,O
fed,352,355,O
untreated,360,369,O
controls,370,378,O
Tropical,0,8,O
splenomegaly,9,21,O
syndrome,22,30,O
Zambia,34,40,O
observations,50,62,O
effects,67,74,O
cycloguanil,78,89,O
proguanil,94,103,O
Nineteen,105,113,O
Zambian,114,121,O
patients,122,130,O
tropical,140,148,O
splenomegaly,149,161,O
syndrome,162,170,O
sinusoidal,175,185,B-Tissue
lymphocytosis,186,199,O
liver,203,208,B-Organ
biopsy,209,215,O
studied,221,228,O
association,234,245,O
macrobulinaemia,249,264,O
tropical,274,282,O
splenomegaly,283,295,O
syndrome,296,304,O
confirmed,320,329,O
Sixteen,331,338,O
patients,339,347,O
treated,353,360,O
antimalarials,366,379,O
12,380,382,O
cycloguanil,388,399,O
pamoate,400,407,O
3,415,416,O
cycloguanil,422,433,O
proguanil,438,447,O
1,453,454,O
proguanil,460,469,O
patients,484,492,O
observed,498,506,O
periods,511,518,O
sufficient,522,532,O
length,533,539,O
drug,548,552,O
effect,553,559,O
assessed,566,574,O
11,583,585,O
good,598,602,O
response,603,611,O
terms,615,620,O
decrease,624,632,O
spleen,636,642,B-Organ
size,643,647,O
Cycloguanil,648,659,O
pamoate,660,667,O
value,678,683,O
prophylaxis,693,704,O
treatment,709,718,O
areas,722,727,O
tropical,734,742,O
splenomegaly,743,755,O
syndrome,756,764,O
endemic,768,775,O
Regulation,0,10,O
glucosyl,14,22,O
fructosyltransferase,28,48,O
synthesis,49,58,O
continuous,62,72,O
cultures,73,81,O
Streptococcus,85,98,O
mutans,99,105,O
Streptococcus,107,120,O
mutans,121,127,O
strains,128,135,O
Ingbritt,136,144,O
derivative,154,164,O
B7,165,167,O
passaged,183,191,O
monkeys,200,207,O
investigate,227,238,O
synthesis,247,256,O
extracellular,260,273,B-Immaterial_anatomical_entity
glucosyl,274,282,O
fructosyltransferases,288,309,O
regulated,313,322,O
active,333,339,O
enzyme,340,346,O
carbon,352,358,O
limited,359,366,O
continuous,367,377,O
cultures,378,386,O
fructosyltransferase,393,413,O
enzymes,415,422,O
catalysing,423,433,O
formation,438,447,O
water,451,456,O
insoluble,457,466,O
glucans,467,474,O
sucrose,480,487,O
relatively,493,503,O
inactive,504,512,O
Dextransucrase,514,528,O
EC,530,532,O
2,533,534,O
4,535,536,O
1,537,538,O
5,539,540,O
catalyses,549,558,O
soluble,559,566,O
glucan,567,573,O
synthesis,574,583,O
active,594,600,O
supernatant,608,619,O
fluid,620,625,O
cultures,631,639,O
grown,640,645,O
excess,651,657,O
glucose,658,665,O
fructose,667,675,O
sucrose,679,686,O
activity,697,705,O
detected,710,718,O
enzyme,733,739,O
incubated,744,753,O
sucrose,764,771,O
dextran,776,783,O
Little,785,791,O
dextransucrase,792,806,O
activity,807,815,O
detected,820,828,O
carbon,832,838,O
limited,839,846,O
cultures,847,855,O
concluded,863,872,O
glucosyl,878,886,O
fructosyltransferases,892,913,O
constitutive,918,930,O
enzymes,931,938,O
synthesized,956,967,O
similar,971,978,O
rates,979,984,O
growth,992,998,O
excess,1007,1013,O
substrate,1021,1030,O
products,1041,1049,O
reactions,1057,1066,O
catalyse,1078,1086,O
Ingbritt,1101,1109,O
strain,1110,1116,O
originally,1121,1131,O
isolated,1132,1140,O
carious,1148,1155,B-Pathological_formation
lesion,1156,1162,I-Pathological_formation
poor,1176,1180,O
source,1181,1187,O
glucosyltransferase,1191,1210,O
activity,1211,1219,O
Glucosyltransferases,1221,1241,O
extremely,1247,1256,O
active,1257,1263,O
cultures,1267,1275,O
recent,1281,1287,O
clinical,1288,1296,O
isolate,1297,1304,O
strain,1306,1312,O
3209,1313,1317,O
apparently,1328,1338,O
induced,1339,1346,O
growth,1354,1360,O
excess,1366,1372,O
glucose,1373,1380,O
Role,0,4,O
interleukin,8,19,O
1,20,21,O
antigen,25,32,O
specific,33,41,O
T,42,43,B-Cell
cell,44,48,I-Cell
proliferation,49,62,O
role,68,72,O
interleukin,76,87,O
1,88,89,O
IL,91,93,O
1,94,95,O
human,100,105,O
antigen,106,113,O
specific,114,122,O
T,123,124,B-Cell
cell,125,129,I-Cell
proliferation,130,143,O
examined,148,156,O
Nylon,158,163,O
wool,164,168,O
purified,169,177,O
T,178,179,B-Cell
cells,180,185,I-Cell
proliferated,186,198,O
presence,206,214,O
autologous,218,228,B-Cell
monocytes,229,238,I-Cell
Mo,240,242,B-Cell
pulsed,245,251,O
18,256,258,O
h,259,260,O
tetanus,266,273,O
toxoid,274,280,O
TT,282,284,O
antigen,286,293,O
Mo,295,297,B-Cell
TT,298,300,O
Irradiation,303,314,O
Mo,318,320,B-Cell
TT,321,323,O
ultraviolet,329,340,O
UV,342,344,O
light,346,351,O
72,353,355,O
J,356,357,O
m2,358,360,O
abolished,362,371,O
capacity,378,386,O
support,390,397,O
T,398,399,B-Cell
cell,400,404,I-Cell
proliferation,405,418,O
drastically,423,434,O
reduced,435,442,O
capacity,449,457,O
secrete,461,468,O
IL,469,471,O
1,472,473,O
stimulation,480,491,O
Staphylococcus,497,511,O
albus,512,517,O
defect,523,529,O
antigen,533,540,O
presentation,541,553,O
induced,554,561,O
UV,565,567,O
irradiation,568,579,O
Mo,583,585,B-Cell
TT,586,588,O
reversed,593,601,O
dose,607,611,O
dependent,612,621,O
manner,622,628,O
addition,636,644,O
different,652,661,O
preparations,662,674,O
containing,675,685,O
human,686,691,O
interleukin,692,703,O
1,704,705,O
IL,707,709,O
1,710,711,O
preparation,724,735,O
consisted,736,745,O
supernatants,749,761,O
Mo,765,767,B-Cell
stimulated,769,779,O
Con,785,788,O
18,795,797,O
hr,798,800,O
Con,814,817,O
activity,820,828,O
blocked,833,840,O
alpha,844,849,O
D,850,851,O
methyl,852,858,O
mannoside,859,868,O
Mo,870,872,B-Cell
Con,874,877,O
Sup,880,883,O
second,890,896,O
preparation,897,908,O
consisted,909,918,O
human,922,927,O
IL,928,930,O
1,931,932,O
partially,933,942,O
purified,943,951,O
supernatants,957,969,O
human,973,978,O
peripheral,979,989,B-Cell
blood,990,995,I-Cell
mononuclear,996,1007,I-Cell
cells,1008,1013,I-Cell
stimulated,1014,1024,O
S,1030,1031,O
albus,1033,1038,O
IL,1045,1047,O
1,1048,1049,O
copurified,1050,1060,O
human,1066,1071,O
leukocyte,1072,1081,B-Cell
pyrogen,1082,1089,O
LP,1091,1093,O
termed,1103,1109,O
IL,1110,1112,O
1,1113,1114,O
LP,1115,1117,O
IL,1124,1126,O
1,1127,1128,O
containing,1129,1139,O
preparations,1140,1152,O
enhanced,1153,1161,O
response,1166,1174,O
C57BL,1178,1183,O
6,1184,1185,O
mouse,1186,1191,O
thymocytes,1192,1202,B-Cell
phytohemagglutinin,1206,1224,O
rabbit,1228,1234,O
antibody,1235,1243,O
human,1247,1252,O
IL,1253,1255,O
1,1256,1257,O
LP,1258,1260,O
inhibited,1261,1270,O
capacity,1275,1283,O
T,1287,1288,B-Cell
cells,1289,1294,I-Cell
proliferate,1298,1309,O
response,1313,1321,O
Mo,1325,1327,B-Cell
TT,1328,1330,O
inhibited,1335,1344,O
capacity,1349,1357,O
Mo,1361,1363,B-Cell
Con,1365,1368,O
Sup,1371,1374,O
reconstitute,1378,1390,O
T,1395,1396,B-Cell
cell,1397,1401,I-Cell
response,1402,1410,O
UV,1414,1416,O
irradiated,1417,1427,O
Mo,1428,1430,B-Cell
TT,1431,1433,O
IL,1435,1437,O
1,1438,1439,O
LP,1440,1442,O
necessary,1451,1460,O
T,1465,1466,B-Cell
cells,1467,1472,I-Cell
recognize,1476,1485,O
immunogenic,1490,1501,O
moiety,1502,1508,O
presented,1509,1518,O
Mo,1522,1524,B-Cell
monolayers,1535,1545,O
UV,1549,1551,O
irradiated,1552,1562,O
Mo,1563,1565,B-Cell
TT,1566,1568,O
equivalent,1574,1584,O
monolayers,1588,1598,O
unirradiated,1602,1614,O
MO,1615,1617,B-Cell
TT,1618,1620,O
capacity,1630,1638,O
adsorb,1642,1648,O
TT,1649,1651,O
reactive,1652,1660,O
T,1661,1662,B-Cell
cells,1663,1668,I-Cell
specifically,1669,1681,O
Furthermore,1683,1694,O
addition,1700,1708,O
rabbit,1712,1718,O
antibody,1719,1727,O
IL,1731,1733,O
1,1734,1735,O
LP,1736,1738,O
interfere,1747,1756,O
capacity,1766,1774,O
UV,1778,1780,O
irradiated,1781,1791,O
Mo,1792,1794,B-Cell
TT,1795,1797,O
adsorb,1801,1807,O
TT,1808,1810,O
reactive,1811,1819,O
T,1820,1821,B-Cell
cells,1822,1827,I-Cell
results,1833,1840,O
obtained,1841,1849,O
study,1858,1863,O
indicate,1864,1872,O
IL,1878,1880,O
1,1881,1882,O
involved,1886,1894,O
optimal,1898,1905,O
antigen,1906,1913,O
driven,1914,1920,O
proliferation,1921,1934,O
human,1938,1943,O
T,1944,1945,B-Cell
lymphocytes,1946,1957,I-Cell
distribution,5,17,O
Na,24,26,O
pump,28,32,O
inhibition,33,43,O
cultured,47,55,O
neonatal,56,64,O
rat,65,68,O
myocardial,69,79,B-Cell
cells,80,85,I-Cell
influence,91,100,O
inhibition,104,114,O
Na,122,124,O
pump,126,130,O
secondary,137,146,O
stimulation,147,158,O
Na,162,164,O
exchange,171,179,O
cellular,184,192,B-Cell
distribution,198,210,O
examined,214,222,O
line,236,240,O
scintillation,241,254,O
disk,255,259,O
technique,260,269,O
cultured,274,282,O
neonatal,283,291,O
rat,292,295,O
myocardial,296,306,B-Cell
cells,307,312,I-Cell
control,320,327,O
conditions,328,338,O
La,340,342,O
displaced,346,355,O
78,356,358,O
1,359,360,O
1,365,366,O
13,367,369,O
SEM,372,375,O
total,384,389,O
cell,390,394,B-Cell
associated,395,405,O
45Ca,406,410,O
Application,412,423,O
1,427,428,O
mm,429,431,O
ouabain,432,439,O
reduction,443,452,O
K,457,458,O
o,460,461,O
0,465,466,O
5,467,468,O
mM,469,471,O
resulted,472,480,O
net,486,489,O
increase,490,498,O
10,502,504,O
6,505,506,O
1,511,512,O
3,513,514,O
13,520,522,O
8,523,524,O
2,529,530,O
respectively,533,545,O
total,550,555,O
cell,556,560,B-Cell
associated,561,571,O
added,586,591,O
45Ca,592,596,O
75,598,600,O
9,601,602,O
2,607,608,O
7,609,610,O
78,616,618,O
4,619,620,O
2,625,626,O
1,627,628,O
respectively,631,643,O
remained,644,652,O
La,653,655,O
displaceable,659,671,O
45Ca,677,681,O
binding,682,689,O
characteristics,690,705,O
isolated,709,717,O
sarcolemma,718,728,B-Cellular_component
prepared,730,738,O
cultured,748,756,O
neonatal,757,765,O
rat,766,769,O
myocardial,770,780,B-Cell
cells,781,786,I-Cell
gas,797,800,O
dissection,801,811,O
technique,812,821,O
examined,828,836,O
treated,843,850,O
ouabain,863,870,O
low,874,877,O
K,879,880,O
o,882,883,O
solutions,884,893,O
sarcolemmal,895,906,B-Cellular_component
45Ca,907,911,O
binding,912,919,O
change,928,934,O
result,941,947,O
indicates,948,957,O
functional,963,973,O
intact,975,981,O
tissue,982,988,B-Tissue
necessary,992,1001,O
observe,1005,1012,O
increase,1022,1030,O
Treatment,1032,1041,O
cells,1049,1054,B-Cell
verapamil,1060,1069,O
ouabain,1088,1095,O
exposure,1096,1104,O
failed,1105,1111,O
inhibit,1115,1122,O
ouabain,1127,1134,O
induced,1135,1142,O
increase,1143,1151,O
cell,1155,1159,B-Cell
associated,1160,1170,O
45Ca,1171,1175,O
evidence,1181,1189,O
indicates,1190,1199,O
inhibition,1205,1215,O
Na,1223,1225,O
pump,1227,1231,O
secondary,1237,1246,O
stimulation,1247,1258,O
Na,1262,1264,O
exchange,1271,1279,O
result,1281,1287,O
net,1293,1296,O
increase,1297,1305,O
11,1309,1311,O
15,1312,1314,O
cell,1319,1323,O
associated,1324,1334,O
78,1341,1343,O
remains,1354,1361,O
La,1362,1364,O
displaceable,1368,1380,O
localized,1400,1409,O
sarcolemma,1417,1427,B-Cellular_component
glycocalyx,1428,1438,B-Cellular_component
complex,1439,1446,O
Oesophageal,0,11,B-Organ
candidiasis,12,23,O
croup,28,33,O
child,39,44,O
defective,50,59,O
neutrophil,60,70,B-Cell
motility,71,79,O
Severe,81,87,O
oesophageal,88,99,B-Organ
candidiasis,100,111,O
croup,116,121,O
involvement,129,140,O
larynx,148,154,B-Multi-tissue_structure
developed,155,164,O
insidiously,165,176,O
girl,182,186,O
aged,187,191,O
20,192,194,O
months,195,201,O
delayed,218,225,O
separation,226,236,O
umbilical,244,253,O
cord,254,258,O
repeated,263,271,O
infections,272,282,O
associated,283,293,O
defect,301,307,O
neutrophil,311,321,B-Cell
motility,322,330,O
significance,336,348,O
early,356,361,O
clinical,362,370,O
features,371,379,O
fully,388,393,O
appreciated,394,405,O
diagnosis,414,423,O
considered,424,434,O
stricture,445,454,O
oesophagus,462,472,B-Organ
evident,480,487,O
treated,497,504,O
oral,510,514,O
ketoconazole,515,527,O
100,528,531,O
mg,532,534,O
daily,535,540,O
month,552,557,O
s,558,559,O
treatment,560,569,O
striking,580,588,O
radiological,589,601,O
improvement,602,613,O
apart,614,619,O
persistence,629,640,O
oesophageal,648,659,B-Organ
stricture,660,669,O
croup,675,680,O
resolved,681,689,O
completely,690,700,O
partial,720,727,O
relief,728,734,O
dysphagia,738,747,O
residual,763,771,O
stricture,772,781,O
emphasis,792,800,O
candidiasis,806,817,O
anticipated,828,839,O
treated,844,851,O
vigorously,852,862,O
children,866,874,O
defect,887,893,O
neutrophil,897,907,B-Cell
motility,908,916,O
Suppurated,1,11,O
acute,12,17,O
obstructive,18,29,O
cholangitis,30,41,O
Anatomoclinical,43,58,O
therapeutic,63,74,O
aspects,75,82,O
total,87,92,O
134,96,99,O
cases,100,105,O
discussed,110,119,O
suppurated,126,136,O
acute,137,142,O
obstructive,143,154,O
angiocholitis,155,168,O
underwent,175,184,O
surgical,185,193,O
treatment,194,203,O
period,211,217,O
10,221,223,O
years,224,229,O
representing,231,243,O
12,244,246,O
8,247,248,O
total,257,262,O
number,263,269,O
organic,273,280,O
obstructions,281,293,O
hepato,301,307,B-Multi-tissue_structure
choledocus,308,318,I-Multi-tissue_structure
standpoint,329,339,O
etiopathogenic,347,361,O
mechanisms,362,372,O
angiocholitis,377,390,O
determined,395,405,O
biliary,409,416,O
lithiasis,417,426,O
59,430,432,O
cases,433,438,O
sclerosis,443,452,O
Oddi,460,464,B-Tissue
sphincter,465,474,I-Tissue
5,478,479,O
cases,480,485,O
postoperative,490,503,O
cicatriceal,504,515,O
stenosis,516,524,O
main,532,536,O
biliary,537,544,O
pathway,545,552,O
2,556,557,O
cases,558,563,O
hepatic,568,575,B-Organ
hydatitosis,576,587,O
16,591,593,O
cases,594,599,O
Vater,604,609,O
ampuloma,610,618,O
10,622,624,O
cases,625,630,O
cancers,634,641,B-Pathological_formation
main,649,653,O
biliary,654,661,O
pathway,662,669,O
40,673,675,O
cases,676,681,O
congenital,693,703,O
cyst,704,708,B-Pathological_formation
choledocus,716,726,B-Multi-tissue_structure
case,734,738,O
high,744,748,O
frequency,749,758,O
noted,763,768,O
severe,777,783,O
forms,784,789,O
ictero,793,799,O
uremigenic,800,810,O
angiocholitis,811,824,O
representing,826,838,O
68,839,841,O
cases,842,847,O
50,852,854,O
7,855,856,O
total,865,870,O
death,879,884,O
rate,885,889,O
34,893,895,O
Medico,899,905,O
surgical,906,914,O
treatment,915,924,O
performed,935,944,O
early,948,953,O
possible,957,965,O
intensive,982,991,O
complex,993,1000,O
adapted,1006,1013,O
anatomo,1021,1028,O
clinical,1029,1037,O
forms,1038,1043,O
authors,1049,1056,O
performed,1057,1066,O
evacuation,1067,1077,O
choledocotomy,1078,1091,O
external,1097,1105,O
draining,1106,1114,O
22,1118,1120,O
cases,1121,1126,O
3,1128,1129,O
deaths,1130,1136,O
choledoco,1143,1152,O
duodenal,1153,1161,O
anastomosis,1162,1173,O
46,1177,1179,O
cases,1180,1185,O
10,1187,1189,O
deaths,1190,1196,O
choledoco,1199,1208,O
jejunostomia,1209,1221,O
3,1225,1226,O
cases,1227,1232,O
Oddi,1234,1238,O
sphincterotomia,1239,1254,O
12,1258,1260,O
cases,1261,1266,O
2,1268,1269,O
deaths,1270,1276,O
ampulectomia,1278,1290,O
5,1294,1295,O
cases,1296,1301,O
2,1303,1304,O
deaths,1305,1311,O
Peripheral,1314,1324,O
bilio,1325,1330,O
hepatodigestive,1331,1346,O
anastomoses,1347,1358,O
performed,1364,1373,O
40,1377,1379,O
cases,1380,1385,O
5,1391,1392,O
deaths,1393,1399,O
Reactive,1,9,O
states,10,16,O
psychopathic,23,35,O
personalities,36,49,O
different,53,62,O
clinical,63,71,O
groups,72,78,O
basis,88,93,O
clinical,99,107,O
follow,108,114,O
71,121,123,O
psychopaths,124,135,O
manifestations,141,155,O
reactive,159,167,O
psychosis,168,177,O
authors,183,190,O
established,191,202,O
clinico,207,214,O
typological,215,226,O
characteristics,227,242,O
groups,251,257,O
pathology,261,270,O
system,279,285,O
correlations,289,301,O
described,326,335,O
structure,340,349,O
psychopathic,357,369,O
psychogenic,374,385,O
syndromes,386,395,O
type,401,405,O
psychopathic,409,421,O
personality,422,433,O
reaction,434,442,O
form,451,455,O
psychogenic,459,470,O
responses,471,480,O
proved,485,491,O
statistically,492,505,O
close,512,517,O
interrelationship,518,535,O
Data,537,541,O
obtained,547,555,O
general,564,571,O
regularities,572,584,O
interrelations,588,602,O
reactive,606,614,O
psychoses,615,624,O
psychopathic,632,644,O
background,645,655,O
important,666,675,O
prognosis,684,693,O
prophylaxis,695,706,O
therapy,711,718,O
reactive,722,730,O
states,731,737,O
unusual,3,10,O
case,11,15,O
benign,19,25,O
mucous,26,32,B-Multi-tissue_structure
membrane,33,41,I-Multi-tissue_structure
pemphigoid,42,52,O
case,59,63,O
benign,67,73,O
mucous,74,80,B-Multi-tissue_structure
membrane,81,89,I-Multi-tissue_structure
pemphigoid,90,100,O
BMMP,102,106,O
unusual,111,118,O
blistering,127,137,O
scarring,139,147,O
lesions,148,155,B-Pathological_formation
confined,161,169,O
skin,177,181,B-Organ
15,186,188,O
years,189,194,O
mucous,202,208,B-Multi-tissue_structure
membranes,209,218,I-Multi-tissue_structure
involved,224,232,O
onset,238,243,O
disorder,252,260,O
age,268,271,O
38,275,277,O
unusual,286,293,O
Detailed,295,303,O
immunological,304,317,O
investigation,318,331,O
performed,336,345,O
patient,354,361,O
results,370,377,O
way,384,387,O
clarify,388,395,O
present,400,407,O
confusion,408,417,O
immunopathological,432,450,O
processes,451,460,O
BMMP,464,468,O
related,469,476,O
operative,486,495,O
bullous,499,506,O
pemphigoid,507,517,O
LHRH,4,8,O
pulse,9,14,O
generator,15,24,O
mediobasal,28,38,B-Multi-tissue_structure
hypothalamic,39,51,I-Multi-tissue_structure
location,52,60,O
location,66,74,O
mechanism,79,88,O
LHRH,92,96,O
pulse,97,102,O
generator,103,112,O
discussed,117,126,O
based,127,132,O
series,140,146,O
experiments,150,161,O
Suckling,163,171,O
stimulus,172,180,O
novel,186,191,O
stimulus,192,200,O
inhibits,206,214,O
LH,215,217,O
pulses,218,224,O
cooperation,237,248,O
ovarian,254,261,B-Organ
steroids,262,270,O
unlike,272,278,O
stimuli,285,292,O
stress,301,307,O
photoperiod,309,320,O
etc,321,324,O
directly,332,340,O
involved,341,349,O
suppressing,353,364,O
activity,369,377,O
LHRH,385,389,O
pulse,390,395,O
generator,396,405,O
information,411,422,O
teats,428,433,O
suckled,434,441,O
pups,445,449,O
babies,453,459,O
conveyed,463,471,O
dorsally,472,480,O
mediobasal,488,498,B-Multi-tissue_structure
hypothalamus,499,511,I-Multi-tissue_structure
MBH,513,516,O
LHRH,529,533,O
pulse,534,539,O
generator,540,549,O
located,557,564,O
Experiments,566,577,O
types,592,597,O
deafferentation,601,616,O
fetal,621,626,B-Tissue
brain,627,632,I-Tissue
tissue,633,639,I-Tissue
transplantation,640,655,O
confirmed,656,665,O
LHRH,675,679,O
pulse,680,685,O
generator,686,695,O
located,699,706,O
MBH,714,717,O
suggested,722,731,O
LHRH,737,741,O
pulse,742,747,O
generator,748,757,O
consists,758,766,O
nonLHRH,770,777,O
neurons,778,785,O
Endogenous,787,797,O
excitatory,798,808,O
amino,809,814,O
acid,815,819,O
possible,834,842,O
neurotransmitters,843,860,O
regulate,866,874,O
LHRH,875,879,O
release,880,887,O
nerve,895,900,B-Multi-tissue_structure
terminal,901,909,I-Multi-tissue_structure
Colorimetrical,0,14,O
rate,15,19,O
assay,20,25,O
urinary,30,37,B-Organism_substance
dipeptidyl,38,48,O
peptidase,49,58,O
IV,59,61,O
DPPIV,63,68,O
activity,70,78,O
new,87,90,O
substrate,91,100,O
synthesized,105,116,O
new,119,122,O
substrate,123,132,O
glycyl,133,139,O
L,140,141,O
proline,142,149,O
3,150,151,O
5,152,153,O
dibromo,154,161,O
4,162,163,O
hydroxyanilide,164,178,O
Gly,180,183,O
Pro,184,187,O
DBAP,188,192,O
dipeptidyl,199,209,O
peptidase,210,219,O
IV,220,222,O
DPPIV,224,229,O
hydrolysis,236,246,O
DPPIV,250,255,O
resulted,256,264,O
formation,272,281,O
chromophore,287,298,O
2,300,301,O
6,302,303,O
dibromophenol,304,317,O
indo,318,322,O
p,323,324,O
xylenol,325,332,O
maximal,342,349,O
absorption,350,360,O
wavelength,361,371,O
600,373,376,O
nm,377,379,O
longer,385,391,O
p,405,406,O
nitroaniline,407,419,O
415,421,424,O
nm,425,427,O
released,429,437,O
conventional,443,455,O
substrate,456,465,O
glycyl,467,473,O
L,474,475,O
proline,476,483,O
p,484,485,O
nitroanilide,486,498,O
Gly,500,503,O
Pro,504,507,O
pNA,508,511,O
established,522,533,O
rate,538,542,O
assay,543,548,O
urinary,553,560,B-Organism_substance
DPPIV,561,566,O
activity,567,575,O
Gly,582,585,O
Pro,586,589,O
DBAP,590,594,O
optimum,600,607,O
pH,608,610,O
8,623,624,O
5,625,626,O
9,631,632,O
0,633,634,O
apparent,640,648,O
Km,649,651,O
1,656,657,O
1,658,659,O
mmol,660,664,O
1,665,666,O
detectable,672,682,O
range,683,688,O
2,693,694,O
5,695,696,O
350,697,700,O
U,701,702,O
l,703,704,O
changes,709,716,O
blank,720,725,O
values,726,732,O
occurred,733,741,O
enzyme,757,763,O
reaction,764,772,O
optimum,780,787,O
pH,788,790,O
value,796,801,O
lower,816,821,O
Gly,827,830,O
Pro,831,834,O
pNA,835,838,O
CVs,840,843,O
run,855,858,O
run,871,874,O
1,880,881,O
1,882,883,O
n,886,887,O
10,890,892,O
3,898,899,O
0,900,901,O
n,904,905,O
10,908,910,O
respectively,913,925,O
tested,933,939,O
peptidases,940,950,O
DPPIV,957,962,O
hydrolyze,969,978,O
Gly,979,982,O
Pro,983,986,O
DBAP,987,991,O
protease,1003,1011,O
inhibitors,1012,1022,O
diprotin,1034,1042,O
phenylmethylsulfonyl,1049,1069,O
fluoride,1070,1078,O
PMSA,1080,1084,O
inhibit,1093,1100,O
DPPIV,1101,1106,O
activity,1107,1115,O
present,1121,1128,O
method,1129,1135,O
interfere,1144,1153,O
urinary,1159,1166,B-Organism_substance
ingredients,1167,1178,O
hemoglobin,1187,1197,O
correlation,1203,1214,O
present,1227,1234,O
y,1236,1237,O
conventional,1243,1255,O
x,1257,1258,O
methods,1260,1267,O
presented,1271,1280,O
equation,1288,1296,O
y,1297,1298,O
1,1301,1302,O
121x,1303,1307,O
0,1310,1311,O
096,1312,1315,O
r,1317,1318,O
0,1321,1322,O
993,1323,1326,O
present,1338,1345,O
method,1346,1352,O
provides,1353,1361,O
practical,1362,1371,O
advantages,1372,1382,O
conventional,1392,1404,O
method,1405,1411,O
routine,1416,1423,O
laboratory,1424,1434,O
use,1435,1438,O
Primary,0,7,O
hyperparathyroidism,8,27,O
heart,36,41,B-Organ
cardiac,43,50,B-Organ
abnormalities,51,64,O
correlated,65,75,O
clinical,79,87,O
biochemical,92,103,O
data,104,108,O
Comparing,110,119,O
patients,120,128,O
primary,134,141,O
hyperparathyroidism,142,161,O
PHP,163,166,O
normocalcemic,173,186,O
control,187,194,O
population,195,205,O
PHP,218,221,O
higher,229,235,O
incidence,236,245,O
cardiovascular,249,263,B-Multi-tissue_structure
disease,264,271,O
cardiac,276,283,B-Organ
abnormalities,284,297,O
study,304,309,O
aimed,310,315,O
correlating,319,330,O
cardiac,331,338,B-Organ
findings,339,347,O
valvular,349,357,B-Multi-tissue_structure
myocardial,362,372,B-Multi-tissue_structure
calcification,373,386,O
myocardial,388,398,B-Multi-tissue_structure
hypertrophy,399,410,O
clinical,417,425,O
data,426,430,O
age,432,435,O
sex,437,440,O
clinical,442,450,O
manifestation,451,464,O
nephrolithiasis,466,481,O
nephrocalcinosis,483,499,O
hypertension,501,513,O
skeletal,515,523,B-Anatomical_system
abnormalities,524,537,O
hypercalcemic,539,552,O
syndrome,553,561,O
biochemical,567,578,O
data,579,583,O
serum,585,590,B-Organism_substance
calcium,591,598,O
serum,600,605,B-Organism_substance
phosphate,606,615,O
serum,617,622,B-Organism_substance
iPTH,623,627,O
level,628,633,O
serum,635,640,B-Organism_substance
creatinine,641,651,O
group,656,661,O
132,665,668,O
consecutive,669,680,O
patients,681,689,O
surgically,695,705,O
verified,706,714,O
PHP,715,718,O
94,720,722,O
women,723,728,O
38,730,732,O
men,733,736,O
ages,738,742,O
15,743,745,O
86,746,748,O
mean,750,754,O
age,755,758,O
57,759,761,O
16,766,768,O
years,769,774,O
included,781,789,O
study,798,803,O
Blood,805,810,B-Organism_substance
chemistry,811,820,O
clinical,822,830,O
presentation,831,843,O
radiography,845,856,O
echocardiography,862,878,O
carried,884,891,O
patients,903,911,O
univariate,916,926,O
multivariate,931,943,O
analyses,944,952,O
parameters,960,970,O
statistical,985,996,O
correlation,997,1008,O
clinical,1017,1025,O
symptoms,1026,1034,O
biochemical,1036,1047,O
data,1048,1052,O
cardiac,1058,1065,B-Organ
calcific,1066,1074,O
alterations,1075,1086,O
Typical,1088,1095,O
skeletal,1096,1104,B-Anatomical_system
manifestations,1105,1119,O
osteolysis,1121,1131,O
subperiostal,1132,1144,O
resorption,1145,1155,O
valvular,1161,1169,B-Multi-tissue_structure
calcifications,1170,1184,O
significantly,1190,1203,O
correlated,1204,1214,O
left,1218,1222,B-Multi-tissue_structure
ventricular,1223,1234,I-Multi-tissue_structure
hypertrophy,1235,1246,O
p,1248,1249,O
0,1252,1253,O
005,1254,1257,O
Cardiac,1260,1267,B-Organ
abnormalities,1268,1281,O
calcific,1290,1298,O
myocardial,1299,1309,B-Multi-tissue_structure
deposits,1310,1318,O
mitral,1322,1328,B-Multi-tissue_structure
aortic,1333,1339,B-Multi-tissue_structure
valvular,1340,1348,I-Multi-tissue_structure
calcifications,1349,1363,O
correlate,1371,1380,O
laboratory,1386,1396,O
findings,1397,1405,O
clinical,1410,1418,O
presentation,1419,1431,O
time,1439,1443,O
diagnosis,1447,1456,O
biochemical,1471,1482,O
clinical,1486,1494,O
variable,1495,1503,O
predict,1515,1522,O
frequency,1527,1536,O
severity,1540,1548,O
valvular,1552,1560,B-Multi-tissue_structure
sclerosis,1561,1570,O
calcific,1574,1582,O
deposits,1583,1591,O
myocardium,1599,1609,B-Multi-tissue_structure
PHP,1620,1623,O
related,1624,1631,O
skeletal,1632,1640,B-Anatomical_system
abnormalities,1641,1654,O
valvular,1659,1667,B-Multi-tissue_structure
calcification,1668,1681,O
predicting,1687,1697,O
factors,1698,1705,O
left,1710,1714,B-Multi-tissue_structure
ventricular,1715,1726,I-Multi-tissue_structure
hypertrophy,1727,1738,O
reversible,1742,1752,O
cardiac,1753,1760,B-Organ
manifestation,1761,1774,O
PHP,1778,1781,O
Myocardial,1783,1793,B-Multi-tissue_structure
hypertrophy,1794,1805,O
found,1820,1825,O
classic,1831,1838,O
symptomatic,1839,1850,O
PHP,1851,1854,O
osseous,1860,1867,B-Organ
abnormalities,1868,1881,O
Image,0,5,O
directed,6,14,O
color,19,24,O
Doppler,25,32,O
studies,33,40,O
gallbladder,44,55,B-Pathological_formation
tumors,56,62,I-Pathological_formation
Thirteen,64,72,O
cases,73,78,O
primary,82,89,O
adenocarcinoma,90,104,B-Pathological_formation
gallbladder,112,123,B-Organ
GB,125,127,B-Organ
1,130,131,O
malignant,135,144,B-Pathological_formation
fibrous,145,152,I-Pathological_formation
histocytoma,153,164,I-Pathological_formation
3,166,167,O
metastatic,171,181,B-Pathological_formation
adenocarcinoma,182,196,I-Pathological_formation
5,198,199,O
adenoma,203,210,B-Pathological_formation
5,212,213,O
polypus,217,224,B-Pathological_formation
2,226,227,O
xanthogranuloma,231,246,B-Pathological_formation
6,248,249,O
chronic,253,260,O
cholecystitis,261,274,O
4,276,277,O
acute,281,286,O
cholecystitis,287,300,O
8,306,307,O
subacute,311,319,O
cholecystitis,320,333,O
studied,339,346,O
image,350,355,O
directed,356,364,O
color,369,374,O
Doppler,375,382,O
ultrasonography,383,398,O
CDUS,400,404,O
14,418,420,O
cases,421,426,O
primary,430,437,O
GB,438,440,B-Pathological_formation
cancer,441,447,I-Pathological_formation
10,449,451,O
masses,452,458,O
4,460,461,O
thickening,462,472,O
wall,473,477,B-Multi-tissue_structure
found,484,489,O
high,500,504,O
velocity,505,513,O
arterial,514,522,B-Organism_substance
blood,523,528,I-Organism_substance
flow,529,533,O
signal,534,540,O
wall,548,552,B-Multi-tissue_structure
GB,560,562,B-Organ
contrast,567,575,O
3,581,582,O
cases,583,588,O
metastatic,592,602,B-Pathological_formation
cancer,603,609,I-Pathological_formation
GB,617,619,B-Organ
blood,627,632,B-Organism_substance
flow,633,637,O
signal,638,644,O
wall,652,656,B-Multi-tissue_structure
GB,664,666,B-Organ
30,676,678,O
cases,679,684,O
benign,688,694,B-Pathological_formation
lesions,695,702,I-Pathological_formation
GB,710,712,B-Organ
12,722,724,O
cases,725,730,O
low,737,740,O
velocity,741,749,O
blood,750,755,B-Organism_substance
flow,756,760,O
signal,761,767,O
found,768,773,O
10,783,785,O
cases,786,791,O
primary,795,802,O
GB,803,805,B-Pathological_formation
malignancy,806,816,I-Pathological_formation
found,822,827,O
high,836,840,O
velocity,841,849,O
arterial,850,858,B-Organism_substance
blood,859,864,I-Organism_substance
flow,865,869,O
signals,870,877,O
tumor,885,890,B-Pathological_formation
masses,891,897,O
blood,902,907,B-Organism_substance
flow,908,912,O
signal,913,919,O
observed,924,932,O
masses,940,946,O
13,950,952,O
cases,953,958,O
3,960,961,O
metastatic,965,975,B-Pathological_formation
adenocarcinoma,976,990,I-Pathological_formation
5,992,993,O
adenoma,997,1004,B-Pathological_formation
5,1006,1007,O
polypus,1011,1018,B-Pathological_formation
abnormal,1024,1032,O
high,1033,1037,O
velocity,1038,1046,O
arterial,1047,1055,B-Organism_substance
blood,1056,1061,I-Organism_substance
flow,1062,1066,O
signal,1067,1073,O
observed,1074,1082,O
masses,1090,1096,O
GB,1104,1106,B-Organ
GB,1117,1119,B-Multi-tissue_structure
wall,1120,1124,I-Multi-tissue_structure
significant,1130,1141,O
feature,1142,1149,O
primary,1153,1160,O
GB,1161,1163,B-Pathological_formation
cancer,1164,1170,I-Pathological_formation
helps,1180,1185,O
differentiate,1189,1202,O
primary,1203,1210,O
GB,1211,1213,B-Pathological_formation
cancer,1214,1220,I-Pathological_formation
metastatic,1226,1236,B-Pathological_formation
benign,1241,1247,B-Pathological_formation
lesions,1248,1255,I-Pathological_formation
GB,1263,1265,B-Organ
Inhibition,0,10,O
calmodulin,14,24,O
dependent,25,34,O
myosin,35,41,O
light,42,47,O
chain,48,53,O
kinase,54,60,O
growth,64,70,O
hormone,71,78,O
releasing,79,88,O
factor,89,95,O
vasoactive,100,110,O
intestinal,111,121,B-Multi-tissue_structure
peptide,122,129,O
view,134,138,O
ability,146,153,O
calmodulin,157,167,O
bind,171,175,O
vasoactive,176,186,O
intestinal,187,197,B-Multi-tissue_structure
peptide,198,205,O
VIP,207,210,O
growth,216,222,O
hormone,223,230,O
releasing,231,240,O
factor,241,247,O
GRF,249,252,O
high,259,263,O
affinity,264,272,O
Stallwood,274,283,O
Brugger,285,292,O
Baggenstoss,294,305,O
Stemmer,307,314,O
Shiraga,316,323,O
Landers,325,332,O
Paul,337,341,O
1992,343,347,O
J,349,350,O
Biol,352,356,O
Chem,358,362,O
267,364,367,O
19617,369,374,O
19621,375,380,O
effects,387,394,O
neuropeptides,404,417,O
model,423,428,O
calmodulin,429,439,O
dependent,440,449,O
enzyme,450,456,O
myosin,458,464,O
light,465,470,O
chain,471,476,O
kinase,477,483,O
MLCK,485,489,O
studied,497,504,O
peptides,511,519,O
potent,525,531,O
inhibitors,532,542,O
MLCK,546,550,O
activity,551,559,O
inhibition,565,575,O
enzyme,579,585,O
activity,586,594,O
VIP,598,601,O
GRF,606,609,O
progressively,614,627,O
overcome,628,636,O
increasing,642,652,O
calmodulin,653,663,O
concentrations,664,678,O
inhibition,688,698,O
observed,699,707,O
saturating,713,723,O
calmodulin,724,734,O
concentration,735,748,O
Nanomolar,750,759,O
concentrations,760,774,O
MLCK,778,782,O
blocked,783,790,O
formation,795,804,O
calmodulin,808,818,O
125I,820,824,O
Tyr10,825,830,O
VIP,831,834,O
complexes,835,844,O
data,852,856,O
provide,857,864,O
support,865,872,O
functional,879,889,O
role,890,894,O
VIP,898,901,O
GRF,906,909,O
binding,910,917,O
calmodulin,921,931,O
Methotrexate,0,12,O
osteopathy,13,23,O
rheumatic,27,36,O
disease,37,44,O
OBJECTIVE,46,55,O
determine,60,69,O
adults,82,88,O
stress,94,100,O
fractures,101,110,O
receiving,111,120,O
low,121,124,O
weekly,125,131,O
doses,132,137,O
methotrexate,141,153,O
methotrexate,158,170,O
osteopathy,171,181,O
CASE,183,187,O
REPORTS,188,195,O
adult,201,206,O
patients,207,215,O
developed,216,225,O
features,226,234,O
consistent,235,245,O
methotrexate,251,263,O
osteopathy,264,274,O
receiving,281,290,O
low,291,294,O
weekly,295,301,O
doses,302,307,O
methotrexate,311,323,O
METHODS,325,332,O
Iliac,334,339,B-Multi-tissue_structure
crest,340,345,I-Multi-tissue_structure
biopsy,346,352,I-Multi-tissue_structure
samples,353,360,I-Multi-tissue_structure
taken,366,371,O
bone,376,380,B-Tissue
histomorphometry,381,397,O
carried,398,405,O
RESULTS,411,418,O
Symptoms,420,428,O
resolved,429,437,O
methotrexate,447,459,O
discontinued,464,476,O
Bone,478,482,B-Tissue
histology,483,492,O
showed,493,499,O
changes,500,507,O
consistent,508,518,O
osteoblast,524,534,B-Cell
inhibition,535,545,O
methotrexate,549,561,O
CONCLUSIONS,563,574,O
given,581,586,O
low,590,593,O
doses,594,599,O
prolonged,604,613,O
periods,614,621,O
methotrexate,623,635,O
adverse,645,652,O
effects,653,660,O
bone,664,668,B-Organ
particularly,670,682,O
post,686,690,O
menopausal,691,701,O
women,702,707,O
Methodologies,0,13,O
measuring,18,27,O
carcinogen,28,38,O
adducts,39,46,O
humans,50,56,O
summary,61,68,O
optimistic,96,106,O
aspirations,107,118,O
human,123,128,O
biomonitoring,129,142,O
studies,143,150,O
envisaged,151,160,O
decade,163,169,O
ago,170,173,O
realized,188,196,O
far,202,205,O
considerable,212,224,O
advances,225,233,O
examples,254,262,O
cited,263,268,O
indicate,275,283,O
feasibility,293,304,O
biomonitoring,308,321,O
clearly,331,338,O
established,339,350,O
addition,355,363,O
demonstrate,370,381,O
need,386,390,O
preliminary,395,406,O
biomarker,407,416,O
testing,417,424,O
validation,429,439,O
transitional,448,460,O
studies,461,468,O
prior,469,474,O
field,484,489,O
application,490,501,O
decade,515,521,O
research,525,533,O
carcinogen,539,549,O
adducts,550,557,O
humans,561,567,O
continued,569,578,O
improvements,579,591,O
reproducibility,599,614,O
specificity,619,630,O
assays,634,640,O
DNA,645,648,O
adducts,649,656,O
needed,665,671,O
increasing,685,695,O
use,696,699,O
hybrid,703,709,O
methodologies,710,723,O
concentrate,727,738,O
adducts,739,746,O
followed,747,755,O
specific,759,767,O
chemical,768,776,O
analyses,777,785,O
allow,791,796,O
adducts,802,809,O
monitored,816,825,O
precisely,831,840,O
course,845,851,O
basic,861,866,O
research,867,875,O
mechanisms,885,895,O
carcinogenesis,899,913,O
allow,919,924,O
measurement,929,940,O
specific,944,952,O
novel,953,958,O
markers,959,966,O
closely,982,989,O
tied,990,994,O
disease,1002,1009,O
endpoint,1010,1018,O
adducts,1024,1031,O
development,1037,1048,O
new,1052,1055,O
assays,1056,1062,O
determining,1067,1078,O
metabolic,1079,1088,O
phenotypes,1089,1099,O
genotypes,1104,1113,O
relevant,1114,1122,O
carcinogenesis,1126,1140,O
improve,1148,1155,O
estimates,1160,1169,O
susceptibility,1173,1187,O
46,1189,1191,O
48,1192,1194,O
new,1202,1205,O
approaches,1206,1216,O
sustained,1232,1241,O
improvement,1242,1253,O
current,1257,1264,O
assays,1265,1271,O
allow,1277,1282,O
molecular,1283,1292,O
approaches,1293,1303,O
continue,1307,1315,O
enrich,1319,1325,O
cancer,1326,1332,B-Pathological_formation
epidemiology,1333,1345,O
future,1353,1359,O
Lactotransferrin,0,16,O
binding,17,24,O
platelet,32,40,B-Cell
receptor,41,49,O
inhibits,50,58,O
platelet,59,67,B-Cell
aggregation,68,79,O
fluorescent,83,94,O
lactotransferrin,95,111,O
probe,112,117,O
prepared,122,130,O
coupling,134,142,O
5,143,144,O
2,148,149,O
carbhydrazino,151,164,O
methyl,165,171,O
thio,173,177,O
acetyl,178,184,O
amino,185,190,O
fluorescein,191,202,O
aldehyde,206,214,O
groups,215,221,O
produced,232,240,O
mild,246,250,O
periodic,251,259,O
acid,260,264,O
oxidation,265,274,O
glycan,282,288,O
moieties,289,297,O
lactotransferrin,301,317,O
manner,327,333,O
receptor,339,347,O
binding,348,355,O
site,356,360,O
lactotransferrin,368,384,O
remains,385,392,O
active,393,399,O
contrast,403,411,O
binding,419,426,O
site,427,431,O
lactotransferrin,439,455,O
derivatized,456,467,O
fluorescein,473,484,O
isothiocyanate,485,499,O
fluorescent,505,516,O
probe,517,522,O
allowed,523,530,O
characterize,537,549,O
flow,554,558,O
cytometry,559,568,O
binding,574,581,O
lactotransferrin,585,601,O
non,605,608,O
activated,609,618,O
human,619,624,O
platelets,625,634,B-Cell
putative,640,648,O
lactotransferrin,649,665,O
platelet,666,674,B-Cell
receptor,675,683,O
purified,688,696,O
immunological,705,718,O
physico,723,730,O
chemical,731,739,O
properties,740,750,O
found,756,761,O
similar,773,780,O
receptor,797,805,O
previously,806,816,O
isolated,817,825,O
activated,831,840,O
human,841,846,O
lymphocytes,847,858,B-Cell
Lactotransferrin,860,876,O
inhibits,877,885,O
ADP,886,889,O
induced,890,897,O
platelet,898,906,B-Cell
aggregation,907,918,O
concentrations,922,936,O
5,945,946,O
nM,947,949,O
reached,964,971,O
plasma,979,985,B-Organism_substance
leukocyte,992,1001,B-Cell
degranulation,1002,1015,O
Inhibition,1017,1027,O
platelet,1031,1039,B-Cell
aggregation,1040,1051,O
observed,1061,1069,O
N,1079,1080,O
terminal,1081,1089,O
fragment,1090,1098,O
lactotransferrin,1102,1118,O
residues,1120,1128,O
3,1129,1130,O
281,1131,1134,O
50,1136,1138,O
inhibition,1140,1150,O
2,1153,1154,O
microM,1155,1161,O
CFQWQRNMRKVRGPPVSC,1172,1190,O
synthetic,1191,1200,O
octodecapeptide,1201,1216,O
residues,1218,1226,O
20,1227,1229,O
37,1230,1232,O
50,1234,1236,O
inhibition,1238,1248,O
20,1251,1253,O
microM,1254,1260,O
corresponding,1262,1275,O
external,1294,1302,O
loops,1303,1308,O
residues,1310,1318,O
28,1319,1321,O
34,1322,1324,O
39,1329,1331,O
42,1332,1334,O
recently,1345,1353,O
located,1354,1361,O
receptor,1366,1374,O
binding,1375,1382,O
site,1383,1387,O
activity,1393,1401,O
50,1403,1405,O
inhibition,1407,1417,O
500,1420,1423,O
microM,1424,1430,O
tetrapeptide,1439,1451,O
KRDS,1452,1456,O
residues,1458,1466,O
39,1467,1469,O
42,1470,1472,O
described,1498,1507,O
25,1522,1524,O
times,1525,1530,O
16000,1535,1540,O
times,1541,1546,O
lower,1547,1552,O
activity,1562,1570,O
octodecapeptide,1578,1593,O
lactotransferrin,1605,1621,O
molecules,1622,1631,O
respectively,1633,1645,O
Finally,1647,1654,O
inhibition,1660,1670,O
demonstrated,1675,1687,O
mediated,1694,1702,O
mechanism,1708,1717,O
requires,1724,1732,O
binding,1737,1744,O
lactotransferrin,1748,1764,O
putative,1772,1780,O
receptor,1781,1789,O
platelet,1801,1809,B-Cell
glycoprotein,1810,1822,O
IIb,1823,1826,O
IIIa,1827,1831,O
know,6,10,O
people,20,26,O
like,27,31,O
Metaperception,45,59,O
person,65,71,O
s,72,73,O
perception,74,84,O
second,93,99,O
person,100,106,O
s,107,108,O
perception,109,119,O
person,131,137,O
purpose,143,150,O
article,159,166,O
examine,173,180,O
accuracy,185,193,O
metaperceptions,197,212,O
liking,216,222,O
related,226,233,O
question,234,242,O
concerns,243,251,O
heuristics,264,274,O
balance,278,285,O
reciprocity,287,298,O
agreement,304,313,O
perceivers,326,336,O
forming,342,349,O
judgments,355,364,O
authors,370,377,O
present,378,385,O
analyses,386,394,O
5,400,401,O
diverse,402,409,O
research,410,418,O
studies,419,426,O
adaptation,440,450,O
social,458,464,O
relations,465,474,O
model,475,480,O
triads,485,491,O
C,493,494,O
F,495,496,O
Bond,498,502,O
E,504,505,O
M,506,507,O
Horn,509,513,O
D,517,518,O
Kenny,522,527,O
press,532,537,O
results,544,551,O
indicate,552,560,O
people,566,572,O
know,573,577,O
people,587,593,O
like,594,598,O
small,622,627,O
amounts,628,635,O
information,639,650,O
evidence,670,678,O
use,687,690,O
heuristics,694,704,O
particularly,706,718,O
reciprocity,719,730,O
agreement,735,744,O
accuracy,746,754,O
enhanced,768,776,O
heuristics,792,802,O
Genetic,0,7,O
heterogeneity,8,21,O
evidenced,22,31,O
low,35,38,O
incidence,39,48,O
KAL,52,55,O
1,56,57,O
gene,58,62,O
mutations,63,72,O
sporadic,76,84,O
cases,85,90,O
gonadotropin,94,106,O
releasing,107,116,O
hormone,117,124,O
deficiency,125,135,O
Isolated,137,145,O
GnRH,146,150,O
deficiency,151,161,O
heritable,167,176,O
condition,177,186,O
characterized,187,200,O
functional,206,216,O
deficit,217,224,O
GnRH,228,232,O
secretion,233,242,O
Familial,244,252,O
cases,253,258,O
different,264,273,O
modes,274,279,O
inheritance,283,294,O
described,305,314,O
gene,324,328,O
responsible,329,340,O
X,349,350,O
linked,351,357,O
form,358,362,O
KAL,364,367,O
1,368,369,O
identified,380,390,O
sporadic,401,409,O
cases,410,415,O
documented,424,434,O
family,435,441,O
history,442,449,O
GnRH,453,457,O
deficiency,458,468,O
account,469,476,O
majority,485,493,O
affected,501,509,O
patients,510,518,O
reason,529,535,O
sought,540,546,O
determine,550,559,O
frequency,564,573,O
KAL,585,588,O
1,589,590,O
gene,591,595,O
mutations,596,605,O
occur,606,611,O
patients,615,623,O
sporadic,629,637,O
GnRH,638,642,O
deficiency,643,653,O
1,660,661,O
21,665,667,O
patients,668,676,O
sporadic,682,690,O
GnRH,691,695,O
deficiency,696,706,O
found,711,716,O
bear,720,724,O
defect,727,733,O
KAL,741,744,O
1,745,746,O
gene,747,751,O
deletion,755,763,O
14,767,769,O
bases,770,775,O
starting,776,784,O
codon,788,793,O
464,794,797,O
types,806,811,O
polymorphic,815,826,O
single,827,833,O
base,834,838,O
substitutions,839,852,O
apparent,861,869,O
correlation,870,881,O
GnRH,887,891,O
deficiency,892,902,O
detected,913,921,O
patients,933,941,O
3,954,955,O
different,956,965,O
patients,966,974,O
X,983,984,O
linked,985,991,O
mode,992,996,O
inheritance,1000,1011,O
3,1013,1014,O
genetic,1015,1022,O
defects,1023,1030,O
2,1032,1033,O
point,1034,1039,O
mutations,1040,1049,O
small,1056,1061,O
intragenic,1062,1072,O
deletion,1073,1081,O
detected,1088,1096,O
defects,1104,1111,O
consist,1112,1119,O
single,1125,1131,O
base,1132,1136,O
mutation,1137,1145,O
introducing,1146,1157,O
stop,1160,1164,O
codon,1165,1170,O
position,1174,1182,O
328,1183,1186,O
single,1190,1196,O
base,1197,1201,O
mutation,1202,1210,O
resulting,1211,1220,O
phenylalanine,1226,1239,O
leucine,1243,1250,O
substitution,1251,1263,O
position,1267,1275,O
517,1276,1279,O
9,1287,1288,O
base,1289,1293,O
deletion,1294,1302,O
3,1310,1311,O
exon,1313,1317,O
intron,1318,1324,O
splice,1325,1331,O
site,1332,1336,O
exon,1340,1344,O
8,1345,1346,O
respectively,1348,1360,O
identified,1366,1376,O
genetic,1377,1384,O
defects,1385,1392,O
occur,1393,1398,O
fibronectin,1410,1421,O
type,1422,1426,O
III,1427,1430,O
repeats,1431,1438,O
predicted,1446,1455,O
protein,1456,1463,O
encoded,1464,1471,O
KAL,1479,1482,O
1,1483,1484,O
gene,1485,1489,O
conclusion,1494,1504,O
study,1510,1515,O
indicates,1516,1525,O
incidence,1535,1544,O
genetic,1548,1555,O
defects,1556,1563,O
coding,1575,1581,O
region,1582,1588,O
KAL,1596,1599,O
1,1600,1601,O
gene,1602,1606,O
patients,1610,1618,O
sporadic,1624,1632,O
GnRH,1633,1637,O
deficiency,1638,1648,O
low,1652,1655,O
5,1657,1658,O
8,1659,1660,O
supporting,1669,1679,O
idea,1684,1688,O
X,1698,1699,O
linked,1700,1706,O
form,1707,1711,O
inheritance,1715,1726,O
represents,1727,1737,O
common,1748,1754,O
form,1755,1759,O
disease,1767,1774,O
effect,4,10,O
early,14,19,O
diagnosis,20,29,O
treatment,34,43,O
cystic,47,53,O
fibrosis,54,62,O
seven,66,71,O
year,72,76,O
study,77,82,O
16,86,88,O
sibling,89,96,O
pairs,97,102,O
Data,104,108,O
16,112,114,O
sibling,115,122,O
pairs,123,128,O
cystic,134,140,O
fibrosis,141,149,O
analyzed,155,163,O
test,167,171,O
hypothesis,176,186,O
early,192,197,O
treatment,198,207,O
condition,216,225,O
improves,226,234,O
prognosis,235,244,O
Younger,246,253,O
siblings,254,262,O
conditions,264,274,O
diagnosed,280,289,O
1,297,298,O
year,299,303,O
age,307,310,O
usually,312,319,O
onset,331,336,O
pulmonary,340,349,B-Organ
disease,350,357,O
Older,359,364,O
siblings,365,373,O
conditions,375,385,O
diagnosed,391,400,O
1,407,408,O
year,409,413,O
age,417,420,O
onset,435,440,O
pulmonary,444,453,B-Organ
disease,454,461,O
sibling,476,483,O
pairs,484,489,O
received,490,498,O
similar,499,506,O
treatment,507,516,O
comparison,518,528,O
7,532,533,O
years,534,539,O
age,543,546,O
showed,547,553,O
younger,563,570,O
siblings,571,579,O
significantly,584,597,O
better,598,604,O
chest,605,610,B-Organism_subdivision
roentgenogram,611,624,O
scores,625,631,O
total,633,638,O
clinical,639,647,O
scores,648,654,O
residual,656,664,O
lung,665,669,B-Organ
volumes,670,677,O
ratios,683,689,O
residual,693,701,O
volume,702,708,O
total,712,717,O
lung,718,722,B-Organ
volume,723,729,O
Younger,731,738,O
siblings,739,747,O
required,753,761,O
fewer,762,767,O
hospital,768,776,O
admissions,777,787,O
control,791,798,O
lung,805,809,B-Organ
disease,810,817,O
results,823,830,O
suggest,831,838,O
general,848,855,O
early,857,862,O
initiation,863,873,O
therapy,877,884,O
beneficial,888,898,O
patients,903,911,O
cystic,917,923,O
fibrosis,924,932,O
effects,4,11,O
oxidative,15,24,O
stress,25,31,O
vivo,38,42,O
brain,43,48,B-Organ
GSH,49,52,O
turnover,53,61,O
young,65,70,O
mature,75,81,O
mice,82,86,O
Glutathione,88,99,O
GSH,101,104,O
synthetase,106,116,O
activities,117,127,O
GSH,132,135,O
turnover,136,144,O
rates,145,150,O
examined,156,164,O
severe,172,178,O
oxidative,179,188,O
stress,189,195,O
mouse,203,208,O
brain,209,214,B-Organ
induced,218,225,O
t,229,230,O
butylhydroperoxide,231,249,O
t,251,252,O
BuOOH,253,258,O
Brain,261,266,B-Organ
GSH,267,270,O
synthetase,271,281,O
activities,282,292,O
8,296,297,O
mo,298,300,O
old,301,304,O
mice,305,309,O
cortex,317,323,B-Multi-tissue_structure
striatum,325,333,B-Multi-tissue_structure
thalamus,335,343,B-Multi-tissue_structure
hippocampus,345,356,B-Multi-tissue_structure
midbrain,358,366,B-Multi-tissue_structure
cerebellum,372,382,B-Multi-tissue_structure
found,388,393,O
increase,397,405,O
following,406,415,O
t,416,417,O
BuOOH,418,423,O
treatment,424,433,O
effect,439,445,O
GSH,449,452,O
synthesis,453,462,O
brain,466,471,B-Organ
GSH,472,475,O
turnover,476,484,O
rates,485,490,O
2,495,496,O
8,502,503,O
mo,504,506,O
old,507,510,O
mice,511,515,O
determined,521,531,O
intracerebroventricular,538,561,O
icv,563,566,O
injection,568,577,O
35S,582,585,O
cysteine,586,594,O
Rate,596,600,O
constants,601,610,O
GSH,615,618,O
turnover,619,627,O
determined,633,643,O
squares,653,660,O
iterative,661,670,O
minimization,671,683,O
specific,693,701,O
activity,702,710,O
data,711,715,O
20,721,723,O
min,724,727,O
108,731,734,O
h,735,736,O
35S,744,747,O
cysteine,748,756,O
administration,757,771,O
GSH,773,776,O
glutathione,781,792,O
disulfide,793,802,O
GSSG,804,808,O
specific,810,818,O
activities,819,829,O
determined,835,845,O
separation,852,862,O
high,866,870,O
pressure,871,879,O
liquid,880,886,O
chromatography,887,901,O
HPLC,903,907,O
half,914,918,O
life,919,923,O
GSH,927,930,O
2,938,939,O
mo,940,942,O
old,943,946,O
mouse,947,952,O
59,957,959,O
5,960,961,O
h,962,963,O
8,975,976,O
mo,977,979,O
old,980,983,O
mouse,984,989,O
79,994,996,O
1,997,998,O
h,999,1000,O
summary,1005,1012,O
defense,1014,1021,O
mechanisms,1022,1032,O
oxidative,1041,1050,O
stress,1051,1057,O
brain,1065,1070,B-Organ
differ,1071,1077,O
age,1083,1086,O
Young,1088,1093,O
mice,1094,1098,O
increase,1103,1111,O
cellular,1116,1124,B-Cell
availability,1125,1137,O
GSH,1141,1144,O
mature,1154,1160,O
mice,1161,1165,O
increase,1170,1178,O
GSH,1179,1182,O
synthetase,1183,1193,O
activity,1194,1202,O
oxidative,1210,1219,O
stress,1220,1226,O
differences,1234,1245,O
mature,1251,1257,O
mice,1258,1262,O
susceptible,1268,1279,O
brain,1283,1288,B-Organ
oxidative,1289,1298,O
damage,1299,1305,O
Multiple,0,8,O
phosphotyrosine,9,24,O
phosphatase,25,36,O
mRNAs,37,42,O
expressed,47,56,O
human,64,69,O
lung,70,74,B-Cell
fibroblast,75,85,I-Cell
cell,86,90,I-Cell
line,91,95,I-Cell
WI,96,98,I-Cell
38,99,101,I-Cell
Protein,103,110,O
tyrosine,111,119,O
phosphatases,120,132,O
important,137,146,O
components,147,157,O
signal,161,167,O
transduction,168,180,O
pathways,181,189,O
authors,195,202,O
reverse,213,220,O
transcription,221,234,O
polymerase,235,245,O
chain,246,251,O
reactions,252,261,O
accomplish,265,275,O
comprehensive,278,291,O
examination,292,303,O
RNA,311,314,O
expression,315,325,O
58,330,332,O
distinct,333,341,O
mammalian,342,351,O
protein,352,359,O
tyrosine,360,368,O
dual,373,377,O
specificity,378,389,O
phosphatase,390,401,O
PTPase,403,409,O
PTPase,415,421,O
like,422,426,O
genes,427,432,O
normal,440,446,O
human,447,452,O
diploid,453,460,B-Cell
fibroblast,461,471,I-Cell
cell,472,476,I-Cell
line,477,481,I-Cell
WI,482,484,I-Cell
38,485,487,I-Cell
Thirty,489,495,O
seven,496,501,O
PTPase,511,517,O
genes,518,523,O
express,524,531,O
easily,532,538,O
measurable,539,549,O
RNA,550,553,O
simultaneously,564,578,O
express,579,586,O
RNA,591,594,O
isoforms,611,619,O
Messages,621,629,O
additional,637,647,O
PTPase,654,660,O
genes,661,666,O
detectable,671,681,O
low,685,688,O
levels,689,695,O
14,702,704,O
known,705,710,O
PTPase,711,717,O
genes,718,723,O
express,731,738,O
measurable,739,749,O
RNA,750,753,O
conditions,764,774,O
purposes,780,788,O
comparison,792,802,O
authors,808,815,O
assessed,821,829,O
PTPases,834,841,O
expressed,842,851,O
WI,859,861,B-Cell
38,862,864,I-Cell
cell,865,869,I-Cell
line,870,874,I-Cell
highly,881,887,O
degenerate,888,898,O
primers,899,906,O
conserved,910,919,O
motifs,920,926,O
found,927,932,O
classical,940,949,O
tyrosine,950,958,O
specific,959,967,O
PTPases,968,975,O
22,995,997,O
classic,998,1005,O
tyrosine,1006,1014,O
specific,1015,1023,O
PTPases,1024,1031,O
detected,1032,1040,O
specific,1051,1059,O
primers,1060,1067,O
detected,1073,1081,O
degenerate,1094,1104,O
primers,1105,1112,O
panel,1118,1123,O
specific,1127,1135,O
PTPase,1136,1142,O
primers,1143,1150,O
useful,1166,1172,O
semiquantitatively,1177,1195,O
assessing,1196,1205,O
repertoire,1210,1220,O
PTPases,1224,1231,O
expressed,1232,1241,O
cells,1245,1250,B-Cell
Epstein,0,7,O
Barr,8,12,O
virus,13,18,O
associated,19,29,O
nonsmall,30,38,B-Pathological_formation
cell,39,43,I-Pathological_formation
lung,44,48,I-Pathological_formation
carcinoma,49,58,I-Pathological_formation
undifferentiated,60,76,O
lymphoepithelioma,78,95,I-Pathological_formation
like,96,100,I-Pathological_formation
carcinoma,102,111,I-Pathological_formation
distinct,117,125,O
entity,126,132,O
better,138,144,O
prognosis,145,154,O
BACKGROUND,156,166,O
Epstein,168,175,O
Barr,176,180,O
virus,181,186,O
EBV,188,191,O
infection,193,202,O
nonsmall,206,214,B-Pathological_formation
cell,215,219,I-Pathological_formation
lung,220,224,I-Pathological_formation
carcinoma,225,234,I-Pathological_formation
NSCLC,236,241,B-Pathological_formation
demonstrated,252,264,O
ethnic,273,279,O
groups,280,286,O
pathobiology,292,304,O
role,313,317,O
EBV,321,324,O
oncoprotein,329,340,O
expression,341,351,O
tumors,361,367,B-Pathological_formation
studied,382,389,O
extensively,390,401,O
study,411,416,O
authors,422,429,O
investigated,430,442,O
EBV,443,446,O
encoded,447,454,O
RNA,455,458,O
1,459,460,O
EBER1,462,467,O
transcripts,469,480,O
situ,487,491,O
hybridization,492,505,O
expression,514,524,O
latent,528,534,O
membrane,535,543,O
protein,544,551,O
1,552,553,O
LMP,555,558,O
1,559,560,O
bcl,566,569,O
2,570,571,O
protein,572,579,O
immunohistochemistry,583,603,O
NSCLC,607,612,B-Pathological_formation
patients,613,621,O
Taiwan,627,633,O
nasopharyngeal,641,655,B-Pathological_formation
carcinoma,656,665,I-Pathological_formation
endemic,669,676,O
METHODS,678,685,O
total,689,694,O
127,698,701,O
cases,702,707,O
NSCLC,711,716,B-Pathological_formation
43,718,720,O
cases,721,726,O
squamous,730,738,B-Pathological_formation
cell,739,743,I-Pathological_formation
carcinoma,744,753,I-Pathological_formation
SCC,755,758,B-Pathological_formation
67,761,763,O
cases,764,769,O
adenocarcinoma,773,787,B-Pathological_formation
AD,789,791,B-Pathological_formation
12,794,796,O
cases,797,802,O
large,806,811,B-Pathological_formation
cell,812,816,I-Pathological_formation
carcinoma,817,826,I-Pathological_formation
LCC,828,831,B-Pathological_formation
5,838,839,O
cases,840,845,O
lymphoepithelioma,849,866,B-Pathological_formation
like,867,871,I-Pathological_formation
carcinoma,872,881,I-Pathological_formation
LE,883,885,B-Pathological_formation
included,893,901,O
sensitive,905,914,O
polymerase,915,925,O
chain,926,931,O
reaction,932,940,O
derived,941,948,O
digoxigenin,950,961,O
labeled,962,969,O
DNA,970,973,O
probe,974,979,O
situ,987,991,O
detection,992,1001,O
EBER1,1005,1010,O
transcripts,1011,1022,O
performed,1027,1036,O
detection,1045,1054,O
EBV,1058,1061,O
Immunohistochemistry,1063,1083,O
avidin,1094,1100,O
biotin,1101,1107,O
immunoperoxidase,1108,1124,O
method,1125,1131,O
performed,1141,1150,O
evaluate,1154,1162,O
expression,1167,1177,O
bcl,1181,1184,O
2,1185,1186,O
LMP,1191,1194,O
1,1195,1196,O
RESULTS,1198,1205,O
EBER1,1207,1212,O
detected,1217,1225,O
11,1229,1231,O
127,1239,1242,O
NSCLC,1243,1248,B-Pathological_formation
cases,1249,1254,O
8,1256,1257,O
7,1258,1259,O
6,1262,1263,O
SCC,1264,1267,B-Pathological_formation
cases,1268,1273,O
5,1278,1279,O
LE,1280,1282,B-Pathological_formation
cases,1283,1288,O
5,1295,1296,O
LE,1297,1299,B-Pathological_formation
cases,1300,1305,O
EBV,1311,1314,O
positive,1315,1323,O
6,1338,1339,O
43,1347,1349,O
SCC,1350,1353,B-Pathological_formation
cases,1354,1359,O
14,1361,1363,O
0,1367,1368,O
67,1372,1374,O
AD,1375,1377,B-Pathological_formation
cases,1378,1383,O
12,1389,1391,O
LCC,1392,1395,B-Pathological_formation
cases,1396,1401,O
EBV,1407,1410,O
positive,1411,1419,O
P,1421,1422,O
0,1425,1426,O
05,1427,1429,O
LE,1441,1443,B-Pathological_formation
cases,1444,1449,O
showed,1450,1456,O
diffuse,1457,1464,O
strong,1466,1472,O
positive,1474,1482,O
staining,1483,1491,O
tumor,1495,1500,B-Cell
cells,1501,1506,I-Cell
SCC,1524,1527,B-Pathological_formation
cases,1528,1533,O
showed,1534,1540,O
diffuse,1541,1548,O
weak,1553,1557,O
staining,1558,1566,O
nontumor,1578,1586,B-Cell
epithelial,1587,1597,I-Cell
cells,1598,1603,I-Cell
EBER1,1618,1623,O
staining,1624,1632,O
11,1647,1649,O
EBER1,1650,1655,O
positive,1656,1664,O
cases,1665,1670,O
mean,1676,1680,O
age,1681,1684,O
LE,1692,1694,B-Pathological_formation
patients,1695,1703,O
10,1708,1710,O
years,1711,1716,O
younger,1717,1724,O
patients,1742,1750,O
histological,1762,1774,O
types,1775,1780,O
5,1786,1787,O
LE,1788,1790,B-Pathological_formation
patients,1791,1799,O
nonsmokers,1805,1815,O
3,1825,1826,O
6,1834,1835,O
patients,1836,1844,O
EBER1,1850,1855,O
positive,1856,1864,O
SCC,1865,1868,B-Pathological_formation
50,1870,1872,O
smokers,1880,1887,O
EBER1,1889,1894,O
expression,1895,1905,O
correlate,1914,1923,O
2,1933,1934,O
year,1935,1939,O
survival,1940,1948,O
rate,1949,1953,O
overall,1957,1964,O
cases,1965,1970,O
5,1980,1981,O
LE,1982,1984,B-Pathological_formation
patients,1985,1993,O
alive,1999,2004,O
clinical,2013,2021,O
evidence,2022,2030,O
disease,2034,2041,O
follow,2050,2056,O
Gender,2061,2067,O
lymph,2069,2074,B-Multi-tissue_structure
node,2075,2079,I-Multi-tissue_structure
distant,2083,2090,O
metastasis,2091,2101,O
clinical,2107,2115,O
stage,2116,2121,O
found,2131,2136,O
correlation,2149,2160,O
EBER1,2166,2171,O
expression,2172,2182,O
P,2184,2185,O
0,2188,2189,O
05,2190,2192,O
LE,2199,2201,B-Pathological_formation
cases,2202,2207,O
bcl,2212,2215,O
2,2216,2217,O
oncoprotein,2218,2229,O
expression,2230,2240,O
100,2242,2245,O
frequency,2254,2263,O
significantly,2268,2281,O
different,2282,2291,O
histologic,2303,2313,O
types,2314,2319,O
P,2321,2322,O
0,2325,2326,O
05,2327,2329,O
LMP,2336,2339,O
1,2340,2341,O
detection,2342,2351,O
rate,2352,2356,O
low,2361,2364,O
demonstrated,2369,2381,O
correlation,2385,2396,O
bcl,2402,2405,O
2,2406,2407,O
expression,2408,2418,O
CONCLUSIONS,2420,2431,O
study,2441,2446,O
authors,2452,2459,O
found,2460,2465,O
primary,2475,2482,O
LE,2483,2485,B-Pathological_formation
lung,2493,2497,B-Organ
associated,2501,2511,O
young,2517,2522,O
age,2523,2526,O
history,2530,2537,O
smoking,2545,2552,O
high,2554,2558,O
bcl,2559,2562,O
2,2563,2564,O
immunoreactivity,2565,2581,O
better,2587,2593,O
survival,2594,2602,O
rate,2603,2607,O
characteristics,2615,2630,O
demonstrate,2631,2642,O
EBV,2648,2651,O
associated,2652,2662,O
LE,2663,2665,B-Pathological_formation
lung,2673,2677,B-Organ
unique,2683,2689,O
entity,2690,2696,O
findings,2702,2710,O
current,2718,2725,O
study,2726,2731,O
suggest,2732,2739,O
EBV,2745,2748,O
infection,2749,2758,O
play,2763,2767,O
different,2770,2779,O
role,2780,2784,O
tumorigenesis,2792,2805,O
primary,2809,2816,O
LE,2817,2819,B-Pathological_formation
lung,2827,2831,B-Organ
EBER1,2854,2859,B-Pathological_formation
positive,2860,2868,I-Pathological_formation
NSCLCs,2869,2875,I-Pathological_formation
Antisocial,0,10,O
patients,11,19,O
comparison,23,33,O
childhood,66,75,O
conduct,76,83,O
disorder,84,92,O
purpose,98,105,O
study,114,119,O
compare,127,134,O
persons,135,142,O
antisocial,148,158,O
personality,159,170,O
disorder,171,179,O
ASP,181,184,O
meet,201,205,O
adult,210,215,O
criteria,216,224,O
ASP,229,232,O
fail,237,241,O
meet,245,249,O
criteria,254,262,O
childhood,267,276,O
conduct,277,284,O
disorder,285,293,O
Sociodemographic,295,311,O
data,312,316,O
medical,318,325,O
history,326,333,O
psychiatric,339,350,O
symptoms,351,359,O
exhibited,360,369,O
recent,379,385,O
hospital,386,394,O
admission,395,404,O
compared,410,418,O
groups,430,436,O
chart,440,445,O
review,446,452,O
groups,462,468,O
virtually,474,483,O
indistinguishable,484,501,O
patients,515,523,O
childhood,532,541,O
conduct,542,549,O
disorder,550,558,O
likely,569,575,O
smoke,579,584,O
consume,588,595,O
alcohol,596,603,O
likely,615,621,O
spent,630,635,O
time,636,640,O
training,646,654,O
school,655,661,O
boot,662,666,O
camp,667,671,O
child,677,682,O
adolescent,686,696,O
likely,708,714,O
admitted,728,736,O
recent,743,749,O
suicide,750,757,O
attempt,758,765,O
likely,781,787,O
conned,796,802,O
conclude,814,822,O
persons,828,835,O
meeting,836,843,O
adult,848,853,O
criteria,854,862,O
ASP,867,870,O
childhood,883,892,O
conduct,893,900,O
disorder,901,909,O
criteria,910,918,O
essentially,919,930,O
suffer,931,937,O
disorder,947,955,O
meet,969,973,O
ASP,979,982,O
criteria,983,991,O
severely,1005,1013,O
affected,1014,1022,O
Brainstem,0,9,B-Multi-tissue_structure
auditory,10,18,O
evoked,19,25,O
potential,26,35,O
evaluation,36,46,O
children,50,58,O
meningitis,64,74,O
Brainstem,76,85,B-Multi-tissue_structure
auditory,86,94,O
evoked,95,101,O
potential,102,111,O
BAEP,113,117,O
performed,123,132,O
101,136,139,O
children,140,148,O
meningitis,154,164,O
assess,168,174,O
incidence,179,188,O
hearing,192,199,O
impairment,200,210,O
51,223,225,O
5,226,227,O
children,230,238,O
bacterial,243,252,O
meningitis,253,263,O
5,270,271,O
9,272,273,O
viral,280,285,O
meningitis,286,296,O
43,302,304,O
42,306,308,O
6,309,310,O
aseptic,317,324,O
meningitis,325,335,O
50,348,350,O
5,351,352,O
patients,355,363,O
assessed,369,377,O
discharge,385,394,O
50,399,401,O
49,403,405,O
5,406,407,O
9,410,411,O
days,412,416,O
17,420,422,O
months,423,429,O
later,430,435,O
mean,437,441,O
4,444,445,O
months,446,452,O
BAEP,455,459,O
impairment,460,470,O
found,475,480,O
28,484,486,O
27,488,490,O
7,491,492,O
101,498,501,O
patients,502,510,O
24,512,514,O
sensorineural,519,532,O
conductive,546,556,O
type,557,561,O
hearing,565,572,O
loss,573,577,O
17,583,585,O
60,587,589,O
7,590,591,O
unilateral,598,608,O
11,613,615,O
39,617,619,O
3,620,621,O
bilateral,628,637,O
impairment,638,648,O
Hearing,650,657,O
threshold,658,667,O
elevated,672,680,O
22,684,686,O
21,688,690,O
8,691,692,O
patients,695,703,O
increased,727,736,O
latency,737,744,O
interpeak,749,758,O
latencies,759,768,O
normal,774,780,O
threshold,781,790,O
Frequency,792,801,O
BAEP,805,809,O
impairment,810,820,O
hearing,824,831,O
loss,832,836,O
associated,837,847,O
bacterial,853,862,O
meningitis,863,873,O
34,878,880,O
6,881,882,O
30,888,890,O
8,891,892,O
respectively,895,907,O
frequency,909,918,O
associated,919,929,O
aseptic,935,942,O
meningitis,943,953,O
20,958,960,O
9,961,962,O
13,968,970,O
9,971,972,O
respectively,975,987,O
child,993,998,O
viral,1004,1009,O
meningitis,1010,1020,O
coxsackie,1022,1031,O
virus,1032,1037,O
mild,1043,1047,O
BAEP,1048,1052,O
impairment,1053,1063,O
BAEP,1077,1081,O
impairment,1082,1092,O
bacterial,1100,1109,O
meningitis,1110,1120,O
group,1121,1126,O
associated,1131,1141,O
H,1147,1148,O
influenzae,1150,1160,O
Prospective,1162,1173,O
BAEP,1174,1178,O
study,1179,1184,O
performed,1189,1198,O
20,1202,1204,O
patients,1205,1213,O
randomly,1214,1222,O
0,1226,1227,O
3,1228,1229,O
18,1233,1235,O
months,1236,1242,O
assess,1246,1252,O
hearing,1253,1260,O
status,1261,1267,O
antibiotic,1274,1284,O
treatment,1285,1294,O
10,1296,1298,O
normal,1304,1310,O
10,1315,1317,O
abnormal,1323,1331,O
BAEP,1332,1336,O
initially,1346,1355,O
normal,1356,1362,O
BAEP,1363,1367,O
patients,1368,1376,O
remained,1377,1385,O
normal,1386,1392,O
10,1401,1403,O
patients,1404,1412,O
abnormal,1418,1426,O
BAEP,1427,1431,O
results,1432,1439,O
initially,1440,1449,O
returned,1456,1464,O
normal,1468,1474,O
improved,1480,1488,O
remained,1496,1504,O
unchanged,1505,1514,O
deteriorated,1524,1536,O
incidence,1542,1551,O
hearing,1555,1562,O
loss,1563,1567,O
bacterial,1574,1583,O
aseptic,1588,1595,O
meningitis,1596,1606,O
high,1610,1614,O
BAEP,1616,1620,O
useful,1624,1630,O
screen,1634,1640,O
possible,1645,1653,O
hearing,1654,1661,O
loss,1662,1666,O
children,1670,1678,O
meningitis,1684,1694,O
follow,1700,1706,O
BAEP,1710,1714,O
necessary,1718,1727,O
patients,1738,1746,O
initially,1752,1761,O
abnormal,1762,1770,O
BAEP,1771,1775,O
assessment,5,15,O
flow,19,23,O
velocity,24,32,O
carotid,36,43,B-Multi-tissue_structure
intracranial,48,60,B-Multi-tissue_structure
arteries,61,69,I-Multi-tissue_structure
different,79,88,O
age,89,92,O
groups,93,99,O
report,110,116,O
assess,120,126,O
systolic,131,139,O
maximal,140,147,O
flow,148,152,O
velocity,153,161,O
carotid,165,172,B-Multi-tissue_structure
intracranial,177,189,B-Multi-tissue_structure
arteries,190,198,I-Multi-tissue_structure
191,202,205,O
subjects,206,214,O
history,223,230,O
cerebral,234,242,B-Multi-tissue_structure
vascular,243,251,I-Multi-tissue_structure
disease,252,259,O
3,263,264,O
age,265,268,O
groups,269,275,O
20,277,279,O
40,280,282,O
years,283,288,O
1,290,291,O
group,292,297,O
41,300,302,O
60,303,305,O
years,306,311,O
2,313,314,O
group,315,320,O
60,333,335,O
years,336,341,O
3,343,344,O
group,345,350,O
subjects,357,365,O
assessed,371,379,O
Sonomed,386,393,O
Transcranial,394,406,O
Doppler,407,414,O
Spectrograph,415,427,O
according,428,437,O
generally,441,450,O
accepted,451,459,O
principles,460,470,O
purpose,476,483,O
study,491,496,O
establish,504,513,O
mean,518,522,O
value,523,528,O
maximal,532,539,O
flow,540,544,O
velocity,545,553,O
particular,562,572,O
artery,573,579,B-Multi-tissue_structure
age,589,592,O
groups,593,599,O
observe,608,615,O
changes,620,627,O
parameter,636,645,O
age,651,654,O
results,660,667,O
analyzed,673,681,O
statistical,688,699,O
methods,700,707,O
significant,714,725,O
decrease,726,734,O
blood,738,743,B-Organism_substance
flow,744,748,O
Vmax,750,754,O
found,760,765,O
investigated,773,785,O
arteries,786,794,B-Multi-tissue_structure
mean,798,802,O
decrease,803,811,O
8,815,816,O
02,817,819,O
flow,824,828,O
velocity,829,837,O
Vmax,838,842,O
found,847,852,O
comparing,859,868,O
groups,869,875,O
2,876,877,O
1,882,883,O
difference,889,899,O
15,900,902,O
99,903,905,O
comparing,907,916,O
3,917,918,O
1,923,924,O
Schematic,4,13,O
drawing,14,21,O
magnetic,29,37,O
tweezers,38,46,O
DNA,50,53,O
molecule,54,62,O
attached,66,74,O
end,82,85,O
flow,107,111,O
cell,112,116,B-Cell
end,134,137,O
magnetic,143,151,O
bead,152,156,O
molecule,163,171,O
pulled,179,185,O
twisted,190,197,O
small,204,209,O
magnets,210,217,O
placed,218,224,O
flow,235,239,O
cell,240,244,B-Cell
position,250,258,O
magnetic,266,274,O
bead,275,279,O
measured,283,291,O
inverted,301,309,O
microscope,310,320,O
placed,321,327,O
beneath,328,335,O
flow,340,344,O
cell,345,349,B-Cell
bead,355,359,O
position,360,368,O
end,382,385,O
end,389,392,O
distance,393,401,O
DNA,409,412,O
molecule,413,421,O
determined,425,435,O
video,442,447,O
microscopy,448,458,O
image,463,468,O
analysis,469,477,O
b,480,481,O
Extension,483,492,O
DNA,498,501,O
molecule,502,510,O
versus,511,517,O
number,522,528,O
turns,532,537,O
applied,538,545,O
magnets,553,560,O
stretching,573,583,O
forces,584,590,O
low,595,598,O
force,599,604,O
contraction,606,617,O
molecule,625,633,O
symmetrical,637,648,O
positive,655,663,O
negative,668,676,O
applied,677,684,O
turns,685,690,O
higher,695,701,O
force,702,707,O
molecule,713,721,O
s,722,723,O
extension,724,733,O
initially,734,743,O
remains,744,751,O
constant,752,760,O
positive,765,773,O
applied,774,781,O
turns,782,787,O
induced,793,800,O
torque,801,807,O
increases,808,817,O
linearly,818,826,O
number,836,842,O
applied,846,853,O
turns,854,859,O
depicted,864,872,O
graph,884,889,O
buckling,898,906,O
transition,907,917,O
allows,918,924,O
system,929,935,O
saturate,939,947,O
torsional,952,961,O
constraint,962,972,O
formation,985,994,O
plectonemes,998,1009,B-Cellular_component
Effect,0,6,O
Trail,10,15,O
expression,23,33,O
endogenous,37,47,O
M2,48,50,O
Effect,56,62,O
Trail,66,71,O
level,79,84,O
endogenous,88,98,O
M2,99,101,O
protein,102,109,O
expression,115,125,O
level,126,131,O
endogenous,135,145,O
M2,146,148,O
protein,149,156,O
HeLa,160,164,B-Cell
cells,165,170,I-Cell
determined,175,185,O
western,192,199,O
blot,200,204,O
4,205,206,O
h,207,208,O
following,209,218,O
Trail,219,224,O
250,226,229,O
mug,230,233,O
ml,234,236,O
treatment,238,247,O
B,250,251,O
Effect,253,259,O
Trail,263,268,O
endogenous,276,286,O
M2,287,289,O
mRNA,290,294,O
expression,300,310,O
level,311,316,O
endogenous,320,330,O
M2,331,333,O
mRNA,334,338,O
HeLa,342,346,B-Cell
cells,347,352,I-Cell
detected,357,365,O
RNase,372,377,O
protection,378,388,O
assay,389,394,O
4,395,396,O
h,397,398,O
following,399,408,O
Trail,409,414,O
250,416,419,O
mug,420,423,O
ml,424,426,O
treatment,428,437,O
C,440,441,O
Effect,443,449,O
Trail,453,458,O
synthesis,466,475,O
endogenous,479,489,O
M2,490,492,O
protein,493,500,O
HeLa,502,506,B-Cell
cells,507,512,I-Cell
treated,524,531,O
250,537,540,O
mug,541,544,O
ml,545,547,O
Trail,548,553,O
followed,554,562,O
pulse,566,571,O
labeling,572,580,O
newly,584,589,O
synthesized,590,601,O
proteins,602,610,O
35S,617,620,O
methionine,621,631,O
M2,633,635,O
protein,636,643,O
immunoprecipitated,653,671,O
separated,676,685,O
SDS,689,692,O
PAGE,693,697,O
autoradiography,702,717,O
described,721,730,O
Materials,734,743,O
Methods,748,755,O
highly,9,15,O
represented,16,27,O
gene,28,32,O
ontology,33,41,O
themes,42,48,O
neurosphere,56,67,B-Cell
vs,68,70,O
differentiated,72,86,B-Cell
cells,87,92,I-Cell
comparison,93,103,O
F,105,106,O
G,107,108,O
Planning,0,8,O
Future,17,23,O
Disaster,25,33,O
Preparedness,34,46,O
Mitigation,51,61,O
believed,74,82,O
casualties,88,98,O
natural,104,111,O
disasters,112,121,O
unavoidable,126,137,O
belief,148,154,O
false,158,163,O
8,165,166,O
measures,184,192,O
reduce,202,208,O
morbidity,209,218,O
mortality,223,232,O
following,233,242,O
large,243,248,O
potentially,253,264,O
catastrophic,265,277,O
flooding,278,286,O
events,287,293,O
19,295,297,O
Early,300,305,O
warning,306,313,O
impending,317,326,O
floods,327,333,O
natural,338,345,O
events,346,352,O
hurricanes,361,371,O
allows,372,378,O
sufficient,379,389,O
time,390,394,O
communities,399,410,O
evacuated,417,426,O
safe,430,434,O
areas,435,440,O
Florida,451,458,O
experienced,459,470,O
worst,482,487,O
hurricane,488,497,O
seasons,498,505,O
record,509,515,O
2004,519,523,O
number,529,535,O
fatalities,539,549,O
lower,554,559,O
expected,565,573,O
early,585,590,O
warning,591,598,O
evacuation,603,613,O
Early,615,620,O
warning,621,628,O
provides,634,642,O
sufficient,643,653,O
time,654,658,O
prepare,662,669,O
evacuation,675,685,O
possible,693,701,O
Hurricane,703,712,O
George,713,719,O
1998,723,727,O
caused,728,734,O
widespread,735,745,O
damage,746,752,O
fatalities,765,775,O
Dominican,783,792,O
Republic,793,801,O
residents,809,818,O
warned,828,834,O
contrast,839,847,O
Cuba,849,853,O
Puerto,858,864,O
Rico,865,869,O
experienced,870,881,O
relatively,882,892,O
limited,893,900,O
damage,901,907,O
loss,912,916,O
life,920,924,O
preparations,934,946,O
hours,964,969,O
storm,981,986,O
Disaster,988,996,O
preparedness,997,1009,O
developed,1022,1031,O
communities,1036,1047,O
regularly,1057,1066,O
exposed,1067,1074,O
flooding,1078,1086,O
disasters,1087,1096,O
Cyclone,1098,1105,O
shelters,1106,1114,O
built,1115,1120,O
Red,1128,1131,O
Cross,1132,1137,O
Orissa,1141,1147,O
India,1149,1154,O
saved,1156,1161,O
thousands,1167,1176,O
lives,1180,1185,O
1999,1189,1193,O
cyclones,1203,1211,O
struck,1212,1218,O
region,1227,1233,O
Americas,1241,1249,O
Pan,1255,1258,O
American,1259,1267,O
Health,1268,1274,O
Organization,1275,1287,O
spent,1292,1297,O
years,1303,1308,O
promoting,1309,1318,O
integrating,1323,1334,O
disaster,1335,1343,O
preparedness,1344,1356,O
building,1362,1370,O
health,1371,1377,O
facilities,1378,1388,O
ensure,1392,1398,O
medical,1404,1411,O
services,1412,1420,O
needed,1421,1427,O
treat,1431,1436,O
victims,1437,1444,O
maintain,1449,1457,O
ongoing,1458,1465,O
care,1466,1470,O
patients,1475,1483,O
chronic,1489,1496,O
conditions,1497,1507,O
disrupted,1520,1529,O
disasters,1533,1542,O
recent,1546,1552,O
global,1553,1559,O
scale,1560,1565,O
review,1566,1572,O
health,1576,1582,O
risks,1583,1588,O
flooding,1594,1602,O
highlights,1603,1613,O
flood,1622,1627,O
prone,1628,1633,O
areas,1634,1639,O
disaster,1641,1649,O
preparedness,1650,1662,O
health,1674,1680,O
system,1681,1687,O
particularly,1702,1714,O
important,1715,1724,O
20,1726,1728,O
addition,1734,1742,O
infrastructure,1746,1760,O
early,1765,1770,O
warning,1771,1778,O
systems,1779,1786,O
key,1796,1799,O
element,1800,1807,O
disaster,1811,1819,O
preparedness,1820,1832,O
education,1836,1845,O
raising,1850,1857,O
awareness,1858,1867,O
disaster,1874,1882,O
risks,1883,1888,O
response,1893,1901,O
plans,1902,1907,O
greater,1924,1931,O
awareness,1932,1941,O
risk,1952,1956,O
tsunamis,1960,1968,O
lives,1983,1988,O
saved,2005,2010,O
South,2018,2023,O
Asian,2024,2029,O
disaster,2030,2038,O
December,2042,2050,O
2004,2051,2055,O
Discussion,0,10,O
adolescent,17,27,O
boys,28,32,O
Chapaevsk,36,45,O
Russia,47,53,O
higher,55,61,O
serum,62,67,B-Organism_substance
levels,68,74,O
sum,78,81,O
dioxin,85,91,O
like,92,96,O
compounds,97,106,O
sum,111,114,O
dioxin,118,124,O
TEQs,125,129,O
positively,135,145,O
associated,146,156,O
increased,162,171,O
age,172,175,O
consumption,177,188,O
fish,192,196,O
local,198,203,O
meats,204,209,B-Organism_subdivision
chicken,221,228,O
inversely,234,243,O
weeks,249,254,O
gestation,258,267,O
age,273,276,O
association,277,288,O
found,293,298,O
despite,299,306,O
narrow,309,315,O
age,316,319,O
range,320,325,O
slightly,329,337,O
years,347,352,O
study,360,365,O
statistically,380,393,O
significant,394,405,O
distance,411,419,O
boy,424,427,O
lived,428,433,O
Khimprom,443,451,O
factory,452,459,O
time,467,471,O
blood,475,480,B-Organism_substance
draw,481,485,O
inversely,490,499,O
associated,500,510,O
serum,516,521,B-Organism_substance
levels,522,528,O
sum,532,535,O
dioxin,539,545,O
like,546,550,O
compounds,551,560,O
sum,565,568,O
dioxin,572,578,O
TEQs,579,583,O
expected,588,596,O
serum,598,603,B-Organism_substance
PCBs,604,608,O
specifically,610,622,O
PCB,623,626,O
118,627,630,O
strongly,637,645,O
associated,646,656,O
sum,667,670,O
dioxin,674,680,O
like,681,685,O
compounds,686,695,O
sum,700,703,O
dioxin,707,713,O
TEQs,714,718,O
association,733,744,O
distance,757,765,O
residence,773,782,O
Khimprom,792,800,O
plant,801,806,O
pregnancy,818,827,O
subsequent,832,842,O
serum,843,848,B-Organism_substance
dioxin,849,855,O
levels,856,862,O
potential,868,877,O
explanation,878,889,O
lack,898,902,O
association,906,917,O
include,922,929,O
misclassification,930,947,O
distance,951,959,O
mother,970,976,O
asked,981,986,O
recall,990,996,O
time,999,1003,O
period,1004,1010,O
14,1021,1023,O
years,1024,1029,O
prior,1030,1035,O
study,1043,1048,O
expect,1068,1074,O
mother,1084,1090,O
able,1100,1104,O
recall,1108,1114,O
residential,1115,1126,O
history,1127,1134,O
time,1142,1146,O
birth,1154,1159,O
son,1169,1172,O
Mother,1174,1180,O
s,1181,1182,O
self,1183,1187,O
reported,1188,1196,O
estimates,1197,1206,O
current,1210,1217,O
residential,1218,1229,O
distance,1230,1238,O
Khimprom,1244,1252,O
generally,1257,1266,O
accurate,1267,1275,O
mothers,1303,1310,O
correctly,1311,1320,O
categorized,1321,1332,O
current,1339,1346,O
residential,1347,1358,O
distance,1359,1367,O
Khimprom,1377,1385,O
plants,1386,1392,O
based,1393,1398,O
cross,1402,1407,O
referencing,1408,1419,O
GIS,1426,1429,O
mapping,1430,1437,O
explanations,1445,1457,O
include,1458,1465,O
prenatal,1471,1479,O
exposure,1480,1488,O
14,1489,1491,O
years,1500,1505,O
prior,1506,1511,O
current,1519,1526,O
serum,1527,1532,B-Organism_substance
sample,1533,1539,I-Organism_substance
strong,1550,1556,O
predictor,1559,1568,O
exposures,1576,1585,O
resulting,1586,1595,O
present,1601,1608,O
residential,1609,1620,O
location,1621,1629,O
association,1653,1664,O
case,1668,1672,O
status,1673,1679,O
cryptorchidism,1681,1695,O
hypospadias,1699,1710,O
dioxin,1717,1723,O
levels,1724,1730,O
sufficient,1748,1758,O
power,1759,1764,O
definitively,1768,1780,O
assess,1781,1787,O
relationship,1793,1805,O
Perinatal,1807,1816,O
history,1817,1824,O
e,1826,1827,O
g,1828,1829,O
weeks,1831,1836,O
breastfeeding,1840,1853,O
generally,1859,1868,O
associated,1873,1883,O
exposure,1889,1897,O
measures,1898,1906,O
population,1915,1925,O
function,1941,1949,O
older,1953,1958,O
age,1959,1962,O
children,1970,1978,O
limited,1999,2006,O
data,2007,2011,O
relationship,2019,2031,O
perinatal,2035,2044,O
factors,2045,2052,O
organochlorine,2058,2072,O
exposures,2073,2082,O
age,2091,2094,O
group,2095,2100,O
finding,2111,2118,O
interest,2125,2133,O
given,2134,2139,O
reports,2140,2147,O
differences,2153,2164,O
organochlorine,2168,2182,O
levels,2183,2189,O
breastfed,2196,2205,O
non,2210,2213,O
breastfed,2214,2223,O
generally,2228,2237,O
longer,2241,2247,O
discernable,2248,2259,O
early,2263,2268,O
school,2269,2275,O
age,2276,2279,O
24,2281,2283,O
25,2284,2286,O
furthermore,2293,2304,O
dietary,2311,2318,O
intake,2319,2325,O
age,2337,2340,O
contributes,2341,2352,O
significantly,2353,2366,O
total,2370,2375,O
dioxin,2376,2382,O
intake,2383,2389,O
26,2391,2393,O
prior,2399,2404,O
studies,2405,2412,O
substantial,2414,2425,O
emphasis,2426,2434,O
placed,2444,2450,O
pre,2454,2457,O
early,2463,2468,O
postnatal,2469,2478,O
breastfeeding,2484,2497,O
exposures,2499,2508,O
particular,2520,2530,O
vulnerability,2531,2544,O
fetal,2552,2557,B-Developing_anatomical_structure
early,2562,2567,O
infant,2568,2574,O
development,2575,2586,O
exposure,2592,2600,O
risk,2601,2605,O
factors,2606,2613,O
peri,2621,2625,O
adolescence,2626,2637,O
period,2647,2653,O
potential,2657,2666,O
developmental,2667,2680,O
vulnerability,2681,2694,O
studied,2709,2716,O
detail,2720,2726,O
identification,2743,2757,O
exposure,2761,2769,O
risk,2770,2774,O
factors,2775,2782,O
specific,2783,2791,O
period,2800,2806,O
enhance,2812,2819,O
understanding,2824,2837,O
critical,2846,2854,O
period,2855,2861,O
data,2872,2876,O
levels,2880,2886,O
PCDD,2890,2894,O
PCDFs,2895,2900,O
children,2904,2912,O
limited,2916,2923,O
results,2929,2936,O
suggest,2937,2944,O
mean,2954,2958,O
total,2959,2964,O
TEQs,2965,2969,O
Chapaevsk,2976,2985,O
adolescents,2986,2997,O
higher,3003,3009,O
values,3020,3026,O
previously,3027,3037,O
reported,3038,3046,O
non,3050,3053,O
occupationally,3054,3068,O
exposed,3069,3076,O
populations,3077,3088,O
comparable,3092,3102,O
older,3111,3116,O
ages,3117,3121,O
Figure,3123,3129,O
2,3130,3131,O
shows,3132,3137,O
comparison,3140,3150,O
mean,3158,3162,O
PCDD,3163,3167,O
PCDFs,3168,3173,O
TEQ,3174,3177,O
levels,3178,3184,O
Chapaevsk,3188,3197,O
boys,3198,3202,O
populations,3214,3225,O
TEQ,3227,3230,O
dioxin,3236,3242,O
like,3243,3247,O
PCBs,3248,3252,O
included,3261,3269,O
studies,3291,3298,O
report,3307,3313,O
mean,3325,3329,O
TEQs,3330,3334,O
pooled,3338,3344,O
blood,3345,3350,B-Organism_substance
samples,3351,3358,I-Organism_substance
10,3364,3366,O
year,3367,3371,O
old,3372,3375,O
German,3376,3382,O
boys,3383,3387,O
rural,3391,3396,O
urban,3401,3406,O
settings,3407,3415,O
8,3420,3421,O
2,3422,3423,O
pg,3424,3426,O
TEQ,3427,3430,O
g,3431,3432,O
lipid,3433,3438,O
urban,3446,3451,O
industrial,3452,3462,O
area,3463,3467,O
9,3469,3470,O
0,3471,3472,O
pg,3473,3475,O
TEQ,3476,3479,O
g,3480,3481,O
lipid,3482,3487,O
industrial,3495,3505,O
area,3506,3510,O
rural,3520,3525,O
setting,3526,3533,O
10,3539,3541,O
1,3542,3543,O
pg,3544,3546,O
TEQ,3547,3550,O
g,3551,3552,O
lipid,3553,3558,O
rural,3565,3570,O
area,3571,3575,O
27,3577,3579,O
comparison,3585,3595,O
mean,3601,3605,O
TEQ,3606,3609,O
Chapevsk,3617,3625,O
boys,3626,3630,O
19,3635,3637,O
3,3638,3639,O
pg,3640,3642,O
TEQ,3643,3646,O
g,3647,3648,O
lipid,3649,3654,O
exception,3665,3674,O
children,3678,3686,O
described,3687,3696,O
Wuthe,3700,3705,O
et,3706,3708,O
al,3709,3711,O
27,3714,3716,O
subjects,3719,3727,O
studies,3741,3748,O
Figure,3752,3758,O
2,3759,3760,O
significantly,3766,3779,O
older,3780,3785,O
Chapaevsk,3795,3804,O
boys,3805,3809,O
Despite,3811,3818,O
age,3819,3822,O
differences,3823,3834,O
mean,3840,3844,O
TEQ,3845,3848,O
Chapaevsk,3852,3861,O
boys,3862,3866,O
comparable,3871,3881,O
higher,3893,3899,O
mean,3909,3913,O
TEQ,3914,3917,O
older,3921,3926,O
populations,3927,3938,O
countries,3950,3959,O
example,3965,3972,O
higher,3984,3990,O
mean,3996,4000,O
TEQs,4001,4005,O
18,4009,4011,O
4,4012,4013,O
pg,4014,4016,O
TEQ,4017,4020,O
g,4021,4022,O
lipid,4023,4028,O
adults,4032,4038,O
40,4040,4042,O
6,4043,4044,O
years,4045,4050,O
old,4051,4054,O
average,4055,4062,O
South,4069,4074,O
Germany,4075,4082,O
27,4084,4086,O
16,4091,4093,O
4,4094,4095,O
pg,4096,4098,O
TEQ,4099,4102,O
g,4103,4104,O
lipid,4105,4110,O
20,4116,4118,O
year,4119,4123,O
old,4124,4127,O
Japanese,4128,4136,O
women,4137,4142,O
28,4144,4146,O
pooled,4151,4157,O
samples,4158,4165,B-Organism_substance
randomly,4171,4179,O
selected,4180,4188,O
males,4189,4194,O
females,4199,4206,O
18,4207,4209,O
69,4210,4212,O
years,4213,4218,O
age,4222,4225,O
Spanish,4235,4242,O
city,4243,4247,O
Mataro,4251,4257,O
29,4259,4261,O
12,4275,4277,O
5,4278,4279,O
14,4284,4286,O
7,4287,4288,O
pg,4289,4291,O
TEQ,4292,4295,O
g,4296,4297,O
lipid,4298,4303,O
respectively,4304,4316,O
mean,4322,4326,O
levels,4327,4333,O
adult,4337,4342,O
female,4343,4349,O
mean,4351,4355,O
age,4356,4359,O
41,4360,4362,O
years,4363,4368,O
non,4370,4373,O
factory,4374,4381,O
workers,4382,4389,O
Russian,4397,4404,O
city,4405,4409,O
Shelekhovo,4413,4423,O
lower,4434,4439,O
14,4443,4445,O
5,4446,4447,O
pg,4448,4450,O
TEQ,4451,4454,O
g,4455,4456,O
lipid,4457,4462,O
30,4464,4466,O
Mean,4469,4473,O
TEQs,4474,4478,O
general,4487,4494,O
population,4495,4505,O
mean,4507,4511,O
age,4512,4515,O
44,4516,4518,O
2,4519,4520,O
years,4521,4526,O
Germany,4531,4538,O
collected,4540,4549,O
1997,4553,4557,O
98,4558,4560,O
31,4562,4564,O
median,4571,4577,O
TEQs,4578,4582,O
long,4587,4591,O
term,4592,4596,O
workers,4597,4604,O
pulp,4608,4612,O
paper,4617,4622,O
mill,4623,4627,O
non,4632,4635,O
workers,4636,4643,O
U,4651,4652,O
S,4653,4654,O
1996,4659,4663,O
32,4665,4667,O
similar,4674,4681,O
levels,4685,4691,O
found,4692,4697,O
Chapaevsk,4705,4714,O
boys,4715,4719,O
mean,4725,4729,O
levels,4730,4736,O
study,4744,4749,O
Germany,4753,4760,O
20,4766,4768,O
71,4769,4771,O
pg,4772,4774,O
TEQ,4775,4778,O
g,4779,4780,O
lipid,4781,4786,O
U,4798,4799,O
S,4800,4801,O
median,4807,4813,O
levels,4814,4820,O
19,4826,4828,O
1,4829,4830,O
pg,4831,4833,O
TEQ,4834,4837,O
g,4838,4839,O
lipid,4840,4845,O
community,4850,4859,O
residents,4860,4869,O
21,4874,4876,O
2,4877,4878,O
pg,4879,4881,O
TEQ,4882,4885,O
g,4886,4887,O
lipid,4888,4893,O
low,4898,4901,O
exposure,4902,4910,O
workers,4911,4918,O
Figure,4920,4926,O
2,4927,4928,O
Mean,4929,4933,O
PCDD,4934,4938,O
PCDFs,4939,4944,O
TEQ,4945,4948,O
levels,4949,4955,O
Chapaevsk,4959,4968,O
boys,4969,4973,O
comparison,4977,4987,O
populations,4999,5010,O
TCDD,5021,5025,O
largely,5030,5037,O
detection,5048,5057,O
limits,5058,5064,O
small,5073,5078,O
pilot,5079,5084,O
sample,5085,5091,B-Organism_substance
boys,5101,5105,O
detectable,5111,5121,O
values,5122,5128,O
high,5133,5137,O
TCDD,5138,5142,O
levels,5143,5149,O
17,5151,5153,O
9,5154,5155,O
21,5160,5162,O
7,5163,5164,O
pg,5165,5167,O
g,5168,5169,O
lipid,5170,5175,O
suggesting,5178,5188,O
exposure,5194,5202,O
portion,5221,5228,O
population,5237,5247,O
substantially,5251,5264,O
higher,5265,5271,O
typical,5277,5284,O
age,5293,5296,O
group,5297,5302,O
comparison,5307,5317,O
cohort,5324,5330,O
adult,5334,5339,O
mean,5341,5345,O
age,5346,5349,O
58,5353,5355,O
years,5356,5361,O
fishermen,5363,5372,O
polluted,5380,5388,O
region,5389,5395,O
Finland,5399,5406,O
mean,5412,5416,O
TCDD,5417,5421,O
concentration,5422,5435,O
19,5440,5442,O
pg,5443,5445,O
g,5446,5447,O
lipid,5448,5453,O
33,5455,5457,O
adult,5463,5468,O
mean,5470,5474,O
age,5475,5478,O
53,5482,5484,O
years,5485,5490,O
residents,5492,5501,O
Calcasieu,5507,5516,O
Parish,5517,5523,O
Louisiana,5525,5534,O
near,5545,5549,O
chemical,5552,5560,O
industrial,5561,5571,O
complex,5572,5579,O
mean,5585,5589,O
TCDD,5590,5594,O
level,5595,5600,O
7,5605,5606,O
6,5607,5608,O
pg,5609,5611,O
g,5612,5613,O
lipid,5614,5619,O
34,5621,5623,O
dioxin,5644,5650,O
levels,5651,5657,O
children,5671,5679,O
higher,5680,5686,O
found,5698,5703,O
studies,5713,5720,O
adults,5730,5736,O
previous,5744,5752,O
studies,5753,5760,O
decades,5774,5781,O
older,5782,5787,O
expected,5811,5819,O
higher,5828,5834,O
dioxin,5835,5841,O
body,5842,5846,B-Organism_subdivision
burdens,5847,5854,O
younger,5860,5867,O
children,5868,5876,O
35,5878,5880,O
Potential,5883,5892,O
explanations,5893,5905,O
large,5914,5919,O
number,5920,5926,O
non,5930,5933,O
detectable,5934,5944,O
samples,5945,5952,B-Organism_substance
TCDD,5957,5961,O
include,5962,5969,O
small,5974,5979,O
sample,5980,5986,B-Organism_substance
volume,5987,5993,O
young,5998,6003,O
age,6004,6007,O
subjects,6015,6023,O
future,6032,6038,O
studies,6039,6046,O
population,6055,6065,O
collect,6075,6082,O
larger,6083,6089,O
volumes,6090,6097,O
serum,6101,6106,B-Organism_substance
dioxin,6111,6117,O
analysis,6118,6126,O
studies,6146,6153,O
dioxin,6157,6163,O
like,6164,6168,O
compounds,6169,6178,O
children,6188,6196,O
included,6202,6210,O
Eskenazi,6212,6220,O
coworkers,6225,6234,O
36,6236,6238,O
evaluated,6240,6249,O
relationship,6254,6266,O
serum,6275,6280,B-Organism_substance
TCDD,6281,6285,O
concentrations,6286,6300,O
age,6305,6308,O
exposure,6312,6320,O
female,6324,6330,O
residents,6331,6340,O
Seveso,6344,6350,O
Italy,6352,6357,O
Residents,6359,6368,O
near,6369,6373,O
ICMESA,6378,6384,O
chemical,6385,6393,O
plant,6394,6399,O
Seveso,6403,6409,O
exposed,6415,6422,O
highest,6438,6445,O
known,6446,6451,O
residential,6452,6463,O
levels,6464,6470,O
2,6474,6475,O
3,6476,6477,O
7,6478,6479,O
8,6480,6481,O
TCDD,6482,6486,O
result,6492,6498,O
explosion,6505,6514,O
plant,6522,6527,O
Archived,6529,6537,O
serum,6538,6543,B-Organism_substance
collected,6544,6553,O
near,6554,6558,O
time,6563,6567,O
accident,6575,6583,O
measure,6596,6603,O
exposures,6604,6613,O
Residents,6615,6624,O
closest,6625,6632,O
plant,6640,6645,O
median,6652,6658,O
2,6659,6660,O
3,6661,6662,O
7,6663,6664,O
8,6665,6666,O
TCDD,6667,6671,O
level,6672,6677,O
272,6681,6684,O
ppt,6685,6688,O
IQR,6690,6693,O
92,6694,6696,O
883,6699,6702,O
ppt,6703,6706,O
Residential,6709,6720,O
proximity,6721,6730,O
plant,6738,6743,O
younger,6748,6755,O
age,6756,6759,O
13,6767,6769,O
years,6770,6775,O
old,6776,6779,O
strongest,6790,6799,O
predictors,6800,6810,O
individual,6817,6827,O
s,6828,6829,O
serum,6830,6835,B-Organism_substance
2,6836,6837,O
3,6838,6839,O
7,6840,6841,O
8,6842,6843,O
TCDD,6844,6848,O
level,6849,6854,O
predictors,6862,6872,O
included,6873,6881,O
outdoors,6888,6896,O
time,6904,6908,O
explosion,6912,6921,O
consumption,6926,6937,O
homegrown,6941,6950,O
food,6951,6955,O
higher,6961,6967,O
levels,6968,6974,O
found,6975,6980,O
children,6984,6992,O
likely,7003,7009,O
result,7012,7018,O
increased,7022,7031,O
exposure,7032,7040,O
result,7046,7052,O
activity,7056,7064,O
patterns,7065,7073,O
greater,7080,7087,O
proportionate,7088,7101,O
consumption,7102,7113,O
food,7117,7121,O
water,7123,7128,O
air,7133,7136,O
adults,7142,7148,O
37,7150,7152,O
exposure,7168,7176,O
scenario,7177,7185,O
acute,7190,7195,O
high,7196,7200,O
exposure,7201,7209,O
event,7210,7215,O
different,7220,7229,O
chronic,7239,7246,O
low,7247,7250,O
moderate,7251,7259,O
exposure,7260,7268,O
occurring,7269,7278,O
Chapaevsk,7282,7291,O
results,7297,7304,O
Seveso,7310,7316,O
suggest,7317,7324,O
children,7330,7338,O
increased,7349,7358,O
risk,7359,7363,O
high,7368,7372,O
dioxin,7373,7379,O
exposure,7380,7388,O
environmental,7394,7407,O
contamination,7408,7421,O
study,7430,7435,O
distance,7446,7454,O
Khimprom,7464,7472,O
plants,7473,7479,O
weak,7486,7490,O
predictor,7491,7500,O
serum,7504,7509,B-Organism_substance
dioxin,7510,7516,O
like,7517,7521,O
compounds,7522,7531,O
consumption,7533,7544,O
local,7548,7553,O
foods,7554,7559,O
specifically,7561,7573,O
meat,7574,7578,B-Organism_subdivision
fish,7583,7587,O
Seveso,7600,7606,O
study,7607,7612,O
strong,7620,7626,O
predictor,7627,7636,O
sum,7640,7643,O
dioxin,7647,7653,O
like,7654,7658,O
compounds,7659,7668,O
dioxin,7673,7679,O
TEQs,7680,7684,O
finding,7691,7698,O
notable,7702,7709,O
given,7710,7715,O
concerns,7716,7724,O
environmental,7735,7748,O
dioxin,7749,7755,O
contamination,7756,7769,O
community,7777,7786,O
suggests,7791,7799,O
food,7805,7809,O
important,7847,7856,O
routes,7857,7863,O
environmental,7867,7880,O
contaminant,7881,7892,O
exposure,7893,7901,O
residents,7906,7915,O
setting,7924,7931,O
settings,7942,7950,O
contaminated,7952,7964,O
food,7965,7969,O
generally,7970,7979,O
contributes,7980,7991,O
substantially,8002,8015,O
human,8019,8024,O
organochlorine,8025,8039,O
burden,8040,8046,O
air,8052,8055,O
soil,8059,8063,O
related,8078,8085,O
residential,8089,8100,O
proximity,8101,8110,O
pollutant,8114,8123,O
sources,8124,8131,O
6,8134,8135,O
investigate,8146,8157,O
issue,8163,8168,O
detail,8177,8183,O
ongoing,8191,8198,O
study,8199,8204,O
Figures,0,7,O
Tables,12,18,O
Figure,19,25,O
1,26,27,O
Allergen,28,36,O
particle,41,49,O
dose,50,54,O
response,55,63,O
experiments,64,75,O
BALB,79,83,O
NIH,91,94,O
mice,95,99,O
Levels,100,106,O
serum,110,115,B-Organism_substance
OVA,116,119,O
specific,120,128,O
IgE,129,132,O
D,137,138,O
IgG1,141,145,O
B,147,148,O
E,150,151,O
IgG2a,157,162,O
C,164,165,O
F,167,168,O
day,173,176,O
26,177,179,O
injection,186,195,O
hind,205,209,B-Organism_subdivision
footpad,210,217,I-Organism_subdivision
100,221,224,O
open,226,230,O
columns,231,238,O
50,241,243,O
gray,245,249,O
10,254,256,O
black,258,263,O
mug,265,268,O
OVA,269,272,O
combined,273,281,O
100,287,290,O
40,292,294,O
10,296,298,O
0,302,303,O
mug,304,307,O
PSP,308,311,O
buffer,316,322,O
HBSS,324,328,O
hatched,330,337,O
BALB,344,348,O
B,356,357,O
C,359,360,O
NIH,366,369,O
D,371,372,O
E,374,375,O
F,377,378,O
mice,380,384,O
day,389,392,O
21,393,395,O
mice,400,404,O
boostered,410,419,O
OVA,434,437,O
dose,438,442,O
footpad,450,457,B-Organism_subdivision
PSP,463,466,O
control,467,474,O
PSP,477,480,O
ctr,481,484,O
group,487,492,O
given,497,502,O
100,503,506,O
mug,507,510,O
PSP,511,514,O
day,518,521,O
0,522,523,O
followed,525,533,O
HBSS,537,541,O
injection,542,551,O
day,555,558,O
21,559,561,O
diamonds,563,571,O
Values,574,580,O
arbitrary,582,591,O
units,592,597,O
AU,599,601,O
individual,607,617,O
mice,618,622,O
circles,624,631,O
median,637,643,O
values,644,650,O
columns,652,659,O
groups,665,671,O
mice,681,685,O
shown,690,695,O
Dotted,697,703,O
lines,704,709,O
indicate,710,718,O
lower,723,728,O
higher,732,738,O
detection,739,748,O
limits,749,755,O
ELISA,764,769,O
assays,770,776,O
Note,778,782,O
different,783,792,O
scales,793,799,O
strains,812,819,O
mice,823,827,O
Figure,829,835,O
2,836,837,O
adjuvant,842,850,O
effect,851,857,O
PSP,861,864,O
OVA,868,871,O
specific,872,880,O
IgE,881,884,O
IgG2a,889,894,O
responses,895,904,O
different,908,917,O
strains,918,925,O
mice,929,933,O
Levels,934,940,O
serum,944,949,B-Organism_substance
OVA,950,953,O
specific,954,962,O
IgE,963,966,O
IgG2a,975,980,O
B,982,983,O
day,988,991,O
26,992,994,O
injection,1001,1010,O
hind,1020,1024,B-Organism_subdivision
footpad,1025,1032,I-Organism_subdivision
HBSS,1036,1040,O
open,1042,1046,O
columns,1047,1054,O
10,1057,1059,O
mug,1060,1063,O
OVA,1064,1067,O
gray,1069,1073,O
40,1076,1078,O
mug,1079,1082,O
PSP,1083,1086,O
hatched,1088,1095,O
10,1100,1102,O
mug,1103,1106,O
OVA,1107,1110,O
40,1113,1115,O
mug,1116,1119,O
PSP,1120,1123,O
black,1125,1130,O
different,1135,1144,O
mouse,1145,1150,O
strains,1151,1158,O
day,1163,1166,O
21,1167,1169,O
mice,1174,1178,O
boostered,1184,1193,O
10,1199,1201,O
mug,1202,1205,O
OVA,1206,1209,O
footpad,1217,1224,B-Organism_subdivision
Vertical,1226,1234,O
straight,1235,1243,O
lines,1244,1249,O
indicate,1250,1258,O
separate,1259,1267,O
experiments,1268,1279,O
Values,1281,1287,O
arbitrary,1289,1298,O
units,1299,1304,O
AU,1306,1308,O
individual,1314,1324,O
mice,1325,1329,O
circles,1331,1338,O
median,1344,1350,O
values,1351,1357,O
columns,1359,1366,O
groups,1372,1378,O
mice,1382,1386,O
shown,1391,1396,O
Dotted,1398,1404,O
lines,1405,1410,O
indicate,1411,1419,O
lower,1424,1429,O
detection,1430,1439,O
limits,1440,1446,O
ELISA,1455,1460,O
assays,1461,1467,O
Brackets,1469,1477,O
indicate,1478,1486,O
statistically,1487,1500,O
significant,1501,1512,O
differences,1513,1524,O
groups,1533,1539,O
p,1541,1542,O
0,1545,1546,O
05,1547,1549,O
experiments,1556,1567,O
performed,1573,1582,O
twice,1583,1588,O
similar,1594,1601,O
results,1602,1609,O
mice,1622,1626,O
group,1631,1636,O
Figure,1638,1644,O
3,1645,1646,O
primary,1651,1658,O
cellular,1659,1667,B-Cell
response,1668,1676,O
draining,1684,1692,O
lymph,1693,1698,B-Multi-tissue_structure
node,1699,1703,I-Multi-tissue_structure
primary,1708,1715,O
cellular,1716,1724,B-Cell
response,1725,1733,O
draining,1741,1749,O
PLN,1750,1753,B-Multi-tissue_structure
determined,1758,1768,O
days,1774,1778,O
single,1787,1793,O
injection,1794,1803,O
HBSS,1807,1811,O
open,1813,1817,O
columns,1818,1825,O
10,1828,1830,O
mug,1831,1834,O
OVA,1835,1838,O
gray,1840,1844,O
40,1847,1849,O
mug,1850,1853,O
PSP,1854,1857,O
hatched,1859,1866,O
10,1871,1873,O
mug,1874,1877,O
OVA,1878,1881,O
40,1884,1886,O
mug,1887,1890,O
PSP,1891,1894,O
black,1896,1901,O
hind,1913,1917,O
footpads,1918,1926,O
BALB,1930,1934,O
NIH,1939,1942,O
C3H,1947,1950,O
HeN,1951,1954,O
mice,1955,1959,O
total,1965,1970,O
lymph,1971,1976,B-Cell
node,1977,1981,I-Cell
cell,1982,1986,I-Cell
numbers,1987,1994,O
IL,2003,2005,O
4,2006,2007,O
B,2009,2010,O
IFN,2013,2016,O
gamma,2017,2022,O
C,2024,2025,O
IL,2031,2033,O
10,2034,2036,O
D,2038,2039,O
secreted,2041,2049,O
PLN,2059,2062,B-Cell
cells,2063,2068,I-Cell
ex,2075,2077,O
vivo,2078,2082,O
stimulation,2083,2094,O
Con,2100,2103,O
determined,2111,2121,O
Values,2123,2129,O
individual,2134,2144,O
samples,2145,2152,B-Cell
circles,2154,2161,O
group,2167,2172,O
median,2173,2179,O
values,2180,2186,O
columns,2188,2195,O
shown,2201,2206,O
Dotted,2208,2214,O
lines,2215,2220,O
indicate,2221,2229,O
lower,2234,2239,O
detection,2240,2249,O
limits,2250,2256,O
cytokine,2265,2273,O
ELISA,2274,2279,O
assays,2280,2286,O
brackets,2292,2300,O
indicate,2301,2309,O
statistically,2310,2323,O
significant,2324,2335,O
differences,2336,2347,O
groups,2356,2362,O
p,2364,2365,O
0,2368,2369,O
05,2370,2372,O
Figures,0,7,O
Tables,12,18,O
Stages,19,25,O
life,33,37,O
cycle,38,43,O
Plasmodium,47,57,O
falciparum,58,68,O
Illustration,70,82,O
Coatney,84,91,O
GR,92,94,O
Collins,96,103,O
Warren,108,114,O
M,115,116,O
Contacos,118,126,O
PG,127,129,O
1971,131,135,O
primate,141,148,O
malarias,149,157,O
Bethesda,160,168,O
U,171,172,O
S,173,174,O
Department,176,186,O
Health,190,196,O
Education,198,207,O
Welfare,212,219,O
Images,0,6,O
FIGURE,7,13,O
2,14,15,O
FIGURE,19,25,O
2,26,27,O
B,29,30,O
FIGURE,31,37,O
3,38,39,O
Supporting,0,10,O
Information,11,22,O
Table,23,28,O
S1,29,31,O
Supplementary,32,45,O
Information,46,57,O
Genes,61,66,O
Gene,80,84,O
Sets,85,89,O
219,91,94,O
KB,95,97,O
PDF,98,101,O
Click,103,108,O
additional,118,128,O
data,129,133,O
file,134,138,O
Table,140,145,O
S2,146,148,O
UFW,149,152,O
Primers,153,160,O
Gene,165,169,O
Set,170,173,O
36,177,179,O
KB,180,182,O
PDF,183,186,O
Click,188,193,O
additional,203,213,O
data,214,218,O
file,219,223,O
Table,225,230,O
S3,231,233,O
UFW,234,237,O
Primers,238,245,O
Gene,250,254,O
Set,255,258,O
II,259,261,O
44,263,265,O
KB,266,268,O
PDF,269,272,O
Click,274,279,O
additional,289,299,O
data,300,304,O
file,305,309,O
Table,311,316,O
S4,317,319,O
UFW,320,323,O
Primers,324,331,O
Gene,336,340,O
Set,341,344,O
III,345,348,O
31,350,352,O
KB,353,355,O
PDF,356,359,O
Click,361,366,O
additional,376,386,O
data,387,391,O
file,392,396,O
Table,398,403,O
S5,404,406,O
Transposable,407,419,O
Element,420,427,O
Specific,428,436,O
Primers,437,444,O
Additional,449,459,O
Screens,460,467,O
80,469,471,O
KB,472,474,O
PDF,475,478,O
Click,480,485,O
additional,495,505,O
data,506,510,O
file,511,515,O
Table,517,522,O
S6,523,525,O
Primers,526,533,O
Intergenic,538,548,O
Regions,549,556,O
58,558,560,O
KB,561,563,O
PDF,564,567,O
Click,569,574,O
additional,584,594,O
data,595,599,O
file,600,604,O
Table,606,611,O
S7,612,614,O
P,615,616,O
Element,617,624,O
Specific,625,633,O
Primers,634,641,O
Orientation,646,657,O
Length,662,668,O
Determination,669,682,O
299,684,687,O
KB,688,690,O
PDF,691,694,O
Click,696,701,O
additional,711,721,O
data,722,726,O
file,727,731,O
Background,0,10,O
HIV,11,14,O
1,15,16,O
infectivity,17,28,O
depends,29,36,O
free,40,44,O
cholesterol,45,56,O
incorporated,57,69,O
viral,79,84,O
envelope,85,93,B-Cellular_component
analyze,104,111,O
HIV,112,115,O
infectivity,116,127,O
presence,135,143,O
drugs,147,152,O
stimulate,158,167,O
cholesterol,168,179,O
efflux,180,186,O
Additional,0,10,O
File,11,15,O
1,16,17,O
Appendix,18,26,O
1,27,28,O
Indications,30,41,O
liver,46,51,B-Organ
function,52,60,O
tests,61,66,O
obvious,75,82,O
liver,83,88,B-Organ
disease,89,96,O
consequent,102,112,O
investigations,113,127,O
Representative,0,14,O
PCR,15,18,O
LDR,19,22,O
results,23,30,O
HPTs,35,39,O
fimX,43,47,O
BP0059,49,55,O
BP0880,57,63,O
sphB2,65,70,O
ptxA,72,76,O
bhuR,82,86,O
Raw,88,91,O
capillary,92,101,O
electrophoresis,102,117,O
data,118,122,O
ligation,127,135,O
products,136,144,O
green,146,151,O
molecular,157,166,O
weight,167,173,O
standards,174,183,O
red,185,188,O
displayed,190,199,O
electrophoretic,209,224,O
gel,225,228,O
image,229,234,O
Assayed,236,243,O
locus,244,249,O
indicated,253,262,O
panel,282,287,O
strain,289,295,O
length,300,306,O
HPT,314,317,O
allele,318,324,O
noted,329,334,O
lane,346,350,O
Representative,352,366,O
LDR,367,370,O
results,371,378,O
depicted,383,391,O
complete,402,410,O
data,411,415,O
strains,425,432,O
Additional,437,447,O
files,448,453,O
8,454,455,O
9,457,458,O
10,460,462,O
11,464,466,O
12,468,470,O
13,476,478,O
BP0880,480,486,O
BP0059,488,494,O
fimX,496,500,O
sphB2,506,511,O
HPTs,512,516,O
screened,522,530,O
uniplex,534,541,O
LDR,542,545,O
reactions,546,555,O
containing,556,566,O
discriminating,576,590,O
oligonucleotide,591,606,O
targets,612,619,O
Tohama,624,630,O
sequence,633,641,O
ptxA,647,651,O
bhuR,656,660,O
HPTs,661,665,O
screened,671,679,O
multiplex,683,692,O
reactions,693,702,O
contain,708,715,O
discriminating,726,740,O
oligonucleotides,741,757,O
Letters,759,766,O
teal,770,774,O
indicate,775,783,O
molecular,784,793,O
weight,794,800,O
standards,801,810,O
labeled,814,821,O
corresponding,829,842,O
supplementary,843,856,O
figures,857,864,O
Ligation,866,874,O
products,875,883,O
arrows,885,891,O
labeled,897,904,O
notation,915,923,O
described,924,933,O
legend,941,947,O
Figure,951,957,O
1,958,959,O
open,965,969,O
arrowhead,970,979,O
indicates,980,989,O
synthesis,992,1001,O
artifact,1002,1010,O
BP0059,1018,1024,O
common,1025,1031,O
oligonucleotide,1032,1047,O
preparation,1048,1059,O
INTRODUCTION,0,12,O
Comparing,13,22,O
genomic,23,30,O
sequences,31,40,O
related,48,55,O
species,56,63,O
fruitful,69,77,O
source,78,84,O
biological,88,98,O
insight,99,106,O
Functional,108,118,O
elements,119,127,O
exons,136,141,O
tend,142,146,O
exhibit,150,157,O
significant,158,169,O
sequence,170,178,O
similarity,179,189,O
purifying,197,206,O
selection,207,216,O
regions,226,233,O
functional,247,257,O
tend,258,262,O
neutrally,269,278,O
evolving,279,287,O
conserved,302,311,O
step,323,327,O
comparing,331,340,O
genomic,341,348,O
sequences,349,358,O
align,365,370,O
map,380,383,O
letters,388,395,O
sequences,403,412,O
alignment,437,446,O
computed,450,458,O
visualization,460,473,O
frameworks,474,484,O
essential,492,501,O
enable,505,511,O
users,512,517,O
interact,521,529,O
sequence,539,547,O
conservation,552,564,O
data,565,569,O
especially,571,581,O
context,589,596,O
longer,600,606,O
DNA,607,610,O
sequences,611,620,O
genomes,630,637,O
Visualization,639,652,O
frameworks,653,663,O
easy,674,678,O
understand,682,692,O
biologist,698,707,O
provide,712,719,O
insight,720,727,O
mutations,737,746,O
particular,754,764,O
genomic,765,772,O
locus,773,778,O
undergone,783,792,O
VISTA,798,803,O
portal,804,810,O
comprehensive,816,829,O
comparative,830,841,O
genomics,842,850,O
resource,851,859,O
provides,865,873,O
biomedical,874,884,O
scientists,885,895,O
single,903,909,O
unified,910,917,O
framework,918,927,O
generate,931,939,O
download,944,952,O
multiple,953,961,O
sequence,962,970,O
alignments,971,981,O
visualize,983,992,O
results,997,1004,O
context,1012,1019,O
existing,1023,1031,O
annotations,1032,1043,O
analyze,1048,1055,O
comparative,1056,1067,O
results,1068,1075,O
search,1079,1085,O
important,1090,1099,O
sequence,1100,1108,O
signals,1109,1116,O
alignments,1120,1130,O
VISTA,1136,1141,O
suite,1142,1147,O
programs,1151,1159,O
development,1172,1183,O
continued,1188,1197,O
use,1198,1201,O
2000,1208,1212,O
1,1214,1215,O
4,1216,1217,O
originally,1227,1237,O
developed,1238,1247,O
alignment,1256,1265,O
comparative,1270,1281,O
analysis,1282,1290,O
long,1294,1298,O
genomic,1299,1306,O
sequences,1307,1316,O
later,1321,1326,O
expanded,1331,1339,O
pair,1343,1347,O
wise,1348,1352,O
multiple,1357,1365,O
alignment,1366,1375,O
vertebrate,1379,1389,O
genomes,1390,1397,O
VISTA,1399,1404,O
popularized,1409,1420,O
visualization,1425,1438,O
level,1446,1451,O
conservation,1455,1467,O
format,1475,1481,O
continuous,1487,1497,O
curve,1498,1503,O
based,1504,1509,O
conservation,1517,1529,O
sliding,1535,1542,O
window,1543,1549,O
concept,1556,1563,O
proved,1564,1570,O
extremely,1577,1586,O
successful,1587,1597,O
easy,1609,1613,O
interpretation,1614,1628,O
resulting,1636,1645,O
plots,1646,1651,O
VISTA,1653,1658,O
built,1663,1668,O
close,1679,1684,O
collaboration,1685,1698,O
computational,1707,1720,O
biological,1725,1735,O
scientists,1736,1746,O
resulting,1748,1757,O
product,1763,1770,O
robust,1779,1785,O
efficient,1787,1796,O
powerful,1801,1809,O
simple,1815,1821,O
use,1825,1828,O
person,1835,1841,O
extensive,1850,1859,O
computer,1860,1868,O
experience,1869,1879,O
illustrated,1887,1898,O
1000,1912,1916,O
citations,1917,1926,O
VISTA,1942,1947,O
associated,1948,1958,O
tools,1959,1964,O
according,1966,1975,O
http,1979,1983,O
scholar,1986,1993,O
google,1994,2000,O
com,2001,2004,O
2,2019,2020,O
years,2021,2026,O
VISTA,2031,2036,O
portal,2037,2043,O
seen,2048,2052,O
significant,2058,2069,O
improvements,2070,2082,O
addition,2087,2095,O
updating,2099,2107,O
genome,2118,2124,O
alignments,2125,2135,O
computed,2137,2145,O
recent,2152,2158,O
assemblies,2159,2169,O
vertebrate,2173,2183,O
insect,2185,2191,O
plant,2193,2198,O
microbial,2203,2212,O
genomes,2213,2220,O
added,2230,2235,O
significant,2236,2247,O
new,2248,2251,O
functionality,2252,2265,O
resources,2270,2279,O
Genome,2287,2293,O
Browser,2294,2301,O
tools,2312,2317,O
including,2319,2328,O
novel,2333,2338,O
multiple,2339,2347,O
genome,2354,2360,O
alignment,2361,2370,O
algorithm,2371,2380,O
new,2384,2387,O
server,2388,2394,O
genome,2405,2411,O
alignment,2412,2421,O
bacterial,2425,2434,O
genomes,2435,2442,O
Base,2444,2448,O
pair,2449,2453,O
level,2454,2459,O
visualization,2460,2473,O
ability,2474,2481,O
VISTA,2493,2498,O
browser,2499,2506,O
Visual,2508,2514,O
access,2515,2521,O
results,2529,2536,O
prediction,2544,2554,O
potential,2558,2567,O
deleteriousness,2568,2583,O
non,2587,2590,O
synonymous,2591,2601,O
Single,2602,2608,O
Nucleotide,2609,2619,O
Polymorphisms,2620,2633,O
SNPs,2635,2639,O
algorithm,2648,2657,O
PolyPhen,2658,2666,O
5,2668,2669,O
novel,2674,2679,O
conservation,2680,2692,O
track,2693,2698,O
Rank,2700,2704,O
VISTA,2705,2710,O
statistical,2724,2735,O
significance,2736,2748,O
conserved,2752,2761,O
regions,2762,2769,O
computed,2770,2778,O
Gumby,2786,2791,O
algorithm,2792,2801,O
6,2803,2804,O
genome,2813,2819,O
rVISTA,2820,2826,O
allows,2833,2839,O
evaluation,2844,2854,O
conserved,2864,2873,O
transcription,2874,2887,O
factor,2888,2894,O
binding,2895,2902,O
sites,2903,2908,O
TFBS,2910,2914,O
represented,2925,2936,O
group,2942,2947,O
genes,2951,2956,O
Images,0,6,O
Figure,7,13,O
5,14,15,O
Miscellaneous,0,13,O
Proteins,14,22,O
Apart,23,28,O
described,44,53,O
proteins,54,62,O
molecules,78,87,O
associated,97,107,O
pathological,117,129,B-Pathological_formation
lesions,130,137,I-Pathological_formation
AD,141,143,O
regarded,170,178,O
amateur,182,189,O
chaperones,190,200,O
Acute,202,207,O
phase,208,213,O
proteins,214,222,O
alpha1,232,238,O
antichymotrypsin,239,255,O
ACT,257,260,O
alpha2,263,269,O
macroglobulin,270,283,O
alpha2 M,285,292,O
SAP,299,302,O
associated,312,322,O
Abeta,328,333,O
deposition,334,344,O
129,346,349,O
132,350,353,O
ACT,356,359,O
serine,365,371,O
protease,372,380,O
inhibitor,381,390,O
serpin,398,404,O
family,405,411,O
AD,420,422,O
ACT,424,427,O
levels,428,434,O
upregulated,439,450,O
binding,456,463,O
ACT,467,470,O
Abeta,476,481,O
induces,482,489,O
Abeta,490,495,O
fibrillogenesis,496,511,O
133,513,516,O
135,517,520,O
Furthermore,523,534,O
ACT,541,544,O
overexpressed,548,561,O
transgenic,565,575,O
mice,576,580,O
increased,585,594,O
plaque,595,601,B-Cell
load,602,606,O
brains,614,620,B-Organ
mice,630,634,O
impaired,639,647,O
spatial,648,655,O
learning,656,664,O
observed,668,676,O
134,678,681,O
135,683,686,O
alpha2 M,689,696,O
binds,702,707,O
Abeta,708,713,O
contrast,727,735,O
ACT,739,742,O
binding,749,756,O
prevents,757,765,O
Abeta,766,771,O
fibril,772,778,B-Pathological_formation
formation,779,788,O
fibril,793,799,O
associated,800,810,O
neurotoxicity,811,824,O
136,826,829,O
137,831,834,O
alpha2 M,837,844,O
promotes,845,853,O
protease,858,866,O
mediated,867,875,O
degradation,876,887,O
alpha2 M,891,898,O
Abeta,899,904,O
complexes,905,914,O
contributes,919,930,O
clearance,934,943,O
Abeta,947,952,O
brain,962,967,B-Organ
discussed,969,978,O
paragraph,982,991,O
4,992,993,O
138,996,999,O
139,1001,1004,O
glycoprotein,1011,1023,O
SAP,1024,1027,O
belongs,1028,1035,O
pentraxin,1043,1052,O
family,1053,1059,O
common,1069,1075,O
component,1076,1085,O
known,1093,1098,O
types,1099,1104,O
amyloid,1108,1115,B-Pathological_formation
fibrils,1116,1123,I-Pathological_formation
SAP,1125,1128,O
upregulated,1132,1143,O
AD,1147,1149,O
protects,1154,1162,O
amyloid,1163,1170,B-Pathological_formation
fibrils,1171,1178,I-Pathological_formation
proteolysis,1184,1195,O
vitro,1199,1204,O
140,1206,1209,O
141,1211,1214,O
SAP,1217,1220,O
colocalizes,1230,1241,O
SPs,1247,1250,O
interacts,1255,1264,O
aggregated,1270,1280,O
Abeta,1281,1286,O
SAP,1288,1291,O
oligomers,1292,1301,O
bind,1307,1311,O
activate,1316,1324,O
C1,1325,1327,O
142,1329,1332,O
C1,1340,1342,O
SAP,1347,1350,O
bind,1355,1359,O
fibrillar,1363,1372,B-Pathological_formation
Abeta,1373,1378,O
deposits,1379,1387,O
vivo,1391,1395,O
induce,1400,1406,O
microglial,1407,1417,B-Cell
activation,1418,1428,O
cultured,1433,1441,O
human,1442,1447,O
microglial,1448,1458,B-Cell
cells,1459,1464,I-Cell
increase,1473,1481,O
cytokine,1485,1493,O
production,1494,1504,O
co,1511,1513,O
stimulation,1514,1525,O
Abeta,1529,1534,O
C1q,1540,1543,O
SAP,1548,1551,O
104,1553,1556,O
observations,1565,1577,O
strengthen,1586,1596,O
noted,1607,1612,O
suggestion,1613,1623,O
Abeta,1638,1643,O
Abeta,1662,1667,O
binding,1668,1675,O
proteins,1676,1684,O
capable,1690,1697,O
activating,1701,1711,O
complement,1716,1726,O
system,1727,1733,O
contribute,1745,1755,O
neuroinflammation,1759,1776,O
AD,1780,1782,O
addition,1787,1795,O
alpha2 M,1802,1809,O
ACT,1814,1817,O
contrast,1822,1830,O
SAP,1834,1837,O
regarded,1846,1854,O
amateur,1858,1865,O
chaperones,1866,1876,O
regulate,1886,1894,O
conformational,1895,1909,O
changes,1910,1917,O
Abeta,1921,1926,O
Tissue,1928,1934,O
type,1935,1939,O
plasminogen,1940,1951,O
activator,1952,1961,O
tPA,1963,1966,O
regulates,1968,1977,O
activation,1978,1988,O
plasminogen,1992,2003,O
plasmin,2009,2016,O
expressed,2024,2033,O
regions,2045,2052,O
brain,2060,2065,B-Organ
especially,2066,2076,O
hippocampus,2084,2095,B-Multi-tissue_structure
143,2097,2100,O
reports,2111,2118,O
suggested,2119,2128,O
important,2132,2141,O
role,2142,2146,O
tPA,2151,2154,O
AD,2158,2160,O
tPA,2169,2172,O
system,2173,2179,O
involved,2183,2191,O
Abeta,2195,2200,O
turnover,2201,2209,O
144,2211,2214,O
145,2216,2219,O
Fibrillar,2222,2231,B-Pathological_formation
forms,2232,2237,O
Abeta,2241,2246,O
stimulate,2247,2256,O
tPA,2257,2260,O
activity,2261,2269,O
vitro,2273,2278,O
AD,2291,2293,O
patients,2294,2302,O
reduction,2306,2315,O
tPA,2319,2322,O
activity,2323,2331,O
observed,2335,2343,O
affected,2351,2359,O
areas,2360,2365,O
144,2367,2370,O
146,2372,2375,O
tPA,2387,2390,O
effect,2398,2404,O
conformational,2408,2422,O
changes,2423,2430,O
Abeta,2434,2439,O
play,2450,2454,O
role,2457,2461,O
clearance,2469,2478,O
Abeta,2482,2487,O
brain,2497,2502,B-Organ
paragraph,2504,2513,O
4,2514,2515,O
actin,2522,2527,O
regulatory,2528,2538,O
protein,2539,2546,O
gelsolin,2547,2555,O
found,2559,2564,O
intracellularly,2570,2585,B-Cell
plasma,2593,2599,B-Organism_substance
147,2601,2604,O
148,2606,2609,O
Plasma,2612,2618,B-Organism_substance
gelsolin,2619,2627,O
considered,2635,2645,O
amateur,2649,2656,O
chaperone,2657,2666,O
binds,2674,2679,O
Abeta,2680,2685,O
inhibits,2699,2707,O
Abeta,2712,2717,O
fibrillization,2718,2732,O
capable,2745,2752,O
degrading,2756,2765,O
preformed,2766,2775,O
Abeta,2776,2781,O
fibrils,2782,2789,B-Pathological_formation
149,2791,2794,O
150,2796,2799,O
Furthermore,2802,2813,O
gelsolin,2815,2823,O
inhibits,2824,2832,O
Abeta,2833,2838,O
mediated,2839,2847,O
neurotoxicity,2848,2861,O
151,2863,2866,O
major,2880,2885,O
gangliosides,2886,2898,O
brain,2906,2911,B-Organ
GM1,2915,2918,O
Soluble,2920,2927,O
Abeta,2928,2933,O
binds,2934,2939,O
GM1,2940,2943,O
formed,2952,2958,O
complexes,2959,2968,O
accelerate,2969,2979,O
Abeta,2980,2985,O
fibrillogenesis,2986,3001,O
acting,3005,3011,O
seed,3017,3021,O
Abeta,3026,3031,O
152,3033,3036,O
presence,3046,3054,O
GM1,3058,3061,O
Abeta,3063,3068,O
neurotoxic,3077,3087,O
Abeta,3093,3098,O
cholesterol,3110,3121,O
rich,3122,3126,O
membranes,3127,3136,B-Cellular_component
demonstrate,3137,3148,O
accelerated,3149,3160,O
Abeta,3161,3166,O
binding,3167,3174,O
formation,3186,3195,O
GM1,3199,3202,O
clusters,3203,3211,O
153,3213,3216,O
154,3218,3221,O
GM1,3227,3230,O
major,3236,3241,O
component,3242,3251,O
lipid,3255,3260,B-Organism_substance
rafts,3261,3266,I-Organism_substance
recent,3271,3277,O
studies,3278,3285,O
suggest,3286,3293,O
Abeta,3299,3304,O
accumulation,3305,3317,O
lipid,3327,3332,B-Organism_substance
rafts,3333,3338,I-Organism_substance
early,3345,3350,O
event,3351,3356,O
AD,3360,3362,O
development,3363,3374,O
GM1,3376,3379,O
play,3386,3390,O
important,3394,3403,O
role,3404,3408,O
early,3416,3421,O
steps,3422,3427,O
AD,3431,3433,O
pathogenesis,3434,3446,O
155,3448,3451,O
156,3453,3456,O
summary,3462,3469,O
proteins,3479,3487,O
associated,3492,3502,O
Abeta,3508,3513,O
aggregates,3514,3524,O
AD,3532,3534,B-Organ
brain,3535,3540,I-Organ
contribute,3545,3555,O
aggregation,3563,3574,O
Abeta,3578,3583,O
considered,3610,3620,O
amateur,3624,3631,O
chaperones,3632,3642,O
addition,3647,3655,O
play,3668,3672,O
role,3675,3679,O
triggering,3683,3693,O
inflammation,3694,3706,O
Mineralization,0,14,O
red,16,19,O
aorta,28,33,B-Multi-tissue_structure
prevented,37,46,O
local,50,55,O
left,57,61,O
global,72,78,O
right,80,85,O
Mgp,88,91,O
expression,92,102,O
Basilar,0,7,B-Multi-tissue_structure
papilla,8,15,I-Multi-tissue_structure
basilar,20,27,B-Multi-tissue_structure
papilla,28,35,I-Multi-tissue_structure
found,39,44,O
recess,50,56,O
opens,62,67,O
saccular,77,85,B-Immaterial_anatomical_entity
space,86,91,I-Immaterial_anatomical_entity
end,99,102,O
limited,111,118,O
thin,124,128,O
contact,129,136,B-Multi-tissue_structure
membrane,137,145,I-Multi-tissue_structure
contact,164,171,B-Multi-tissue_structure
membrane,172,180,I-Multi-tissue_structure
separates,181,190,O
endolymphatic,195,208,B-Organism_substance
fluid,209,214,I-Organism_substance
papillar,222,230,B-Multi-tissue_structure
recess,231,237,O
perilymphatic,247,260,B-Organism_substance
fluid,261,266,I-Organism_substance
round,274,279,O
window,280,286,O
Lewis,288,293,O
Narins,298,304,O
1999,305,309,O
Wever,311,316,O
1985,317,321,O
recess,328,334,O
perimeter,335,344,O
roughly,348,355,O
oval,356,360,O
shape,364,369,O
bullfrog,378,386,O
Rana,388,392,O
catesbeiana,393,404,O
major,410,415,O
axis,416,420,O
approximately,424,437,O
200,438,441,O
mum,442,445,O
long,446,450,O
minor,462,467,O
axis,468,472,O
measures,473,481,O
approximately,482,495,O
150,496,499,O
mum,500,503,O
Van,505,508,O
Bergeijk,509,517,O
1957,518,522,O
leopard,532,539,O
frog,540,544,O
Rana,546,550,O
pipiens,551,558,O
pipiens,559,566,O
similar,577,584,O
size,585,589,O
personal,591,599,O
observation,600,611,O
RLMS,613,617,O
JMS,620,623,O
oval,630,634,O
perimeter,635,644,O
lumen,652,657,B-Immaterial_anatomical_entity
formed,661,667,O
limbic,673,679,B-Tissue
tissue,680,686,I-Tissue
substance,690,699,O
unique,700,706,O
inner,714,719,B-Multi-tissue_structure
ear,720,723,I-Multi-tissue_structure
similar,729,736,O
cartilage,740,749,B-Tissue
Wever,751,756,O
1985,757,761,O
sensory,768,775,B-Tissue
epithelium,776,786,I-Tissue
approximately,790,803,O
100,804,807,O
mum,808,811,O
long,812,816,O
occupies,821,829,O
curved,832,838,O
area,839,843,O
symmetrical,852,863,O
major,871,876,O
axis,877,881,O
elliptical,889,899,B-Immaterial_anatomical_entity
lumen,900,905,I-Immaterial_anatomical_entity
contains,910,918,O
approximately,919,932,O
60,933,935,O
hair,936,940,B-Cell
cells,941,946,I-Cell
measured,948,956,O
Rana,960,964,O
catesbeiana,965,976,O
stereovilli,994,1005,B-Cellular_component
protrude,1006,1014,O
lumen,1024,1029,B-Immaterial_anatomical_entity
connect,1034,1041,O
tectorial,1049,1058,B-Multi-tissue_structure
membrane,1059,1067,I-Multi-tissue_structure
Frishkopf,1069,1078,O
Flock,1083,1088,O
1974,1089,1093,O
Typically,1096,1105,O
orientation,1110,1121,O
hair,1129,1133,B-Cell
cells,1134,1139,I-Cell
defined,1144,1151,O
direction,1159,1168,O
v,1182,1183,O
shape,1184,1189,O
stereovilli,1197,1208,B-Cellular_component
bundle,1209,1215,O
points,1216,1222,O
Lewis,1224,1229,O
et,1230,1232,O
al,1233,1235,O
1985,1237,1241,O
away,1247,1251,O
sacculus,1261,1269,B-Multi-tissue_structure
Ranidae,1273,1280,O
tectorial,1286,1295,B-Multi-tissue_structure
membrane,1296,1304,I-Multi-tissue_structure
spans,1305,1310,O
lumen,1315,1320,B-Immaterial_anatomical_entity
papillar,1328,1336,B-Multi-tissue_structure
recess,1337,1343,O
occludes,1348,1356,O
half,1363,1367,O
lumen,1372,1377,B-Immaterial_anatomical_entity
consequently,1383,1395,O
takes,1396,1401,O
approximately,1405,1418,O
semi,1419,1423,O
circular,1424,1432,O
shape,1433,1438,O
viewed,1444,1450,O
saccular,1460,1468,B-Multi-tissue_structure
Frishkopf,1475,1484,O
Flock,1489,1494,O
1974,1495,1499,O
Wever,1501,1506,O
1985,1507,1511,O
membrane,1518,1526,B-Multi-tissue_structure
pores,1531,1536,O
surface,1544,1551,O
closest,1552,1559,O
epithelium,1567,1577,B-Tissue
tips,1594,1598,O
hair,1606,1610,B-Multi-tissue_structure
bundles,1611,1618,O
project,1619,1626,O
Lewis,1628,1633,O
Narins,1638,1644,O
1999,1645,1649,O
4,1651,1652,O
Haplotype,0,9,O
block,10,15,O
structure,16,25,O
replicate,35,44,O
generated,45,54,O
block,62,67,O
method,68,74,O
ALS,76,79,O
Competing,0,9,O
interests,10,19,O
authors,24,31,O
declare,32,39,O
competing,58,67,O
interests,68,77,O
Background,0,10,O
Previous,11,19,O
publications,20,32,O
indicate,33,41,O
acupuncture,47,58,O
efficient,62,71,O
treatment,80,89,O
pelvic,93,99,B-Multi-tissue_structure
girdle,100,106,I-Multi-tissue_structure
pain,107,111,O
PGP,113,116,O
pregnant,121,129,O
women,130,135,O
use,150,153,O
acupuncture,157,168,O
PGP,173,176,O
rare,180,184,O
insufficient,192,204,O
documentation,205,218,O
adverse,222,229,O
effects,230,237,O
treatment,246,255,O
specific,264,272,O
condition,273,282,O
aim,288,291,O
present,299,306,O
work,307,311,O
assess,319,325,O
adverse,326,333,O
effects,334,341,O
acupuncture,345,356,O
pregnancy,364,373,O
mother,375,381,O
delivery,383,391,O
fetus,400,405,B-Developing_anatomical_structure
neonate,406,413,O
comparison,417,427,O
women,433,438,O
received,444,452,O
stabilising,453,464,O
exercises,465,474,O
adjunct,478,485,O
standard,489,497,O
treatment,498,507,O
standard,511,519,O
treatment,520,529,O
Authors,0,7,O
contributions,9,22,O
MP,23,25,O
prepared,26,34,O
draft,45,50,O
assistance,60,70,O
JLdR,74,78,O
authors,86,93,O
reviewed,94,102,O
manuscript,107,117,O
provided,119,127,O
contributions,136,149,O
suggestions,154,165,O
authors,178,185,O
worked,186,192,O
collectively,193,205,O
develop,209,216,O
algorithms,221,231,O
methods,236,243,O
described,244,253,O
paper,262,267,O
Study,0,5,O
freeze,9,15,O
thaw,16,20,O
effects,21,28,O
CSF,33,36,O
pH,37,39,O
tissue,43,49,B-Tissue
RNA,50,53,O
integrity,54,63,O
long,72,76,O
suspected,77,86,O
basis,95,100,O
tissue,108,114,B-Tissue
banking,115,122,O
experience,123,133,O
molecular,152,161,O
degradation,162,173,O
occurs,179,185,O
banked,189,195,O
tissue,196,202,B-Tissue
repeated,213,221,O
freeze,222,228,O
thaw,229,233,O
cycles,234,240,O
occur,248,253,O
improper,261,269,O
handling,270,278,O
dissection,286,296,O
tissue,301,307,B-Tissue
retrieval,308,317,O
freezer,328,335,O
malfunctions,336,348,O
freezers,354,362,O
currently,367,376,O
protected,377,386,O
temperature,390,401,O
sensitive,402,411,O
alarms,412,418,O
automatically,424,437,O
telephone,438,447,O
maintenance,448,459,O
tissue,464,470,B-Tissue
banking,471,478,O
personnel,479,488,O
temperature,498,509,O
reaches,510,517,O
certain,520,527,O
level,528,533,O
protection,540,550,O
preferable,554,564,O
CO2,571,574,O
tanks,575,580,O
backup,585,591,O
cooling,592,599,O
optimum,604,611,O
expensive,617,626,O
approach,628,636,O
plan,641,645,O
systematically,649,663,O
investigate,664,675,O
effects,680,687,O
thawing,691,698,O
refreezing,703,713,O
RNA,717,720,O
integrity,721,730,O
deliberately,735,747,O
thawing,748,755,O
freezing,760,768,O
small,769,774,O
samples,775,782,B-Tissue
brain,786,791,B-Tissue
tissue,792,798,I-Tissue
varying,804,811,O
time,812,816,O
intervals,817,826,O
temperatures,831,843,O
Printing,0,8,O
solution,9,17,O
transfection,26,38,O
reagents,39,47,O
tested,53,59,O
data,61,65,O
shown,70,75,O
found,85,90,O
X,100,101,O
tremeGENE,102,111,O
siRNA,112,117,O
transfection,118,130,O
reagent,131,138,O
Roche,140,145,O
gave,147,151,O
good,152,156,O
transfection,157,169,O
efficiencies,170,182,O
plasmids,192,200,B-Cellular_component
siRNAs,205,211,O
chose,217,222,O
use,226,229,O
reagent,235,242,O
transfected,251,262,O
cell,263,267,B-Cell
microarray,268,278,O
experiments,279,290,O
present,298,305,O
study,306,311,O
printing,317,325,O
arrays,330,336,O
major,342,347,O
challenge,348,357,O
find,364,368,O
good,371,375,O
balance,376,383,O
high,392,396,O
transfection,397,409,O
efficiency,410,420,O
spatially,425,434,O
confined,435,443,O
spots,444,449,O
avoid,453,458,O
cross,459,464,O
contamination,465,478,O
spots,491,496,O
order,501,506,O
optimize,510,518,O
reverse,523,530,O
transfection,531,543,O
protocol,544,552,O
HEK,557,560,B-Cell
293ind,561,567,I-Cell
ICER,568,572,I-Cell
IIgamma,573,580,I-Cell
cells,581,586,I-Cell
X,603,604,O
tremeGENE,605,614,O
transfection,615,627,O
reagent,628,635,O
investigated,640,652,O
effect,657,663,O
varying,667,674,O
concentrations,679,693,O
gelatine,697,705,O
sucrose,710,717,O
printing,725,733,O
solution,734,742,O
reagents,750,758,O
reported,769,777,O
influence,781,790,O
transfection,800,812,O
efficiency,813,823,O
spot,828,832,O
integrity,833,842,O
6,844,845,O
27,846,848,O
Sucrose,851,858,O
observed,863,871,O
specifically,878,890,O
beneficial,891,901,O
obtaining,906,915,O
high,916,920,O
transfection,921,933,O
efficiency,934,944,O
storing,950,957,O
arrays,962,968,O
weeks,981,986,O
use,994,997,O
data,999,1003,O
shown,1008,1013,O
Figure,1016,1022,O
1A,1023,1025,O
B,1030,1031,O
representative,1037,1051,O
images,1052,1058,O
observed,1066,1074,O
effects,1075,1082,O
varying,1086,1093,O
concentrations,1098,1112,O
gelatine,1116,1124,O
sucrose,1129,1136,O
observed,1141,1149,O
transfection,1159,1171,O
efficiency,1172,1182,O
increased,1183,1192,O
increasing,1198,1208,O
gelatine,1209,1217,O
concentration,1218,1231,O
tested,1233,1239,O
range,1247,1252,O
0,1253,1254,O
01,1255,1257,O
0,1258,1259,O
40,1260,1262,O
increased,1278,1287,O
disturbance,1288,1299,O
spatial,1307,1314,O
definition,1315,1325,O
spots,1333,1338,O
observed,1343,1351,O
increasing,1357,1367,O
concentrations,1368,1382,O
gelatine,1386,1394,O
sucrose,1398,1405,O
tested,1407,1413,O
range,1421,1426,O
0,1427,1428,O
100,1429,1432,O
mM,1433,1435,O
combined,1440,1448,O
effect,1449,1455,O
concentrations,1463,1477,O
gelatine,1481,1489,O
sucrose,1494,1501,O
observed,1511,1519,O
low,1524,1527,O
concentrations,1528,1542,O
gelatine,1546,1554,O
allowed,1555,1562,O
use,1569,1572,O
higher,1573,1579,O
concentrations,1580,1594,O
sucrose,1598,1605,O
higher,1616,1622,O
concentrations,1623,1637,O
gelatine,1641,1649,O
cells,1657,1662,B-Cell
spread,1663,1669,O
outside,1670,1677,O
spots,1682,1687,O
Based,1689,1694,O
optimizing,1706,1716,O
experiments,1717,1728,O
found,1733,1738,O
3,1744,1745,O
microl,1746,1752,O
X,1753,1754,O
tremeGENE,1755,1764,O
solution,1765,1773,O
microgram,1778,1787,O
nucleic,1788,1795,O
acid,1796,1800,O
25,1802,1804,O
mM,1805,1807,O
sucrose,1808,1815,O
0,1820,1821,O
1,1822,1823,O
gelatine,1825,1833,O
final,1841,1846,O
printing,1847,1855,O
solution,1856,1864,O
reproducibly,1865,1877,O
gave,1878,1882,O
spatial,1883,1890,O
restricted,1891,1901,O
transfection,1902,1914,O
high,1920,1924,O
transfection,1925,1937,O
efficiency,1938,1948,O
printing,1949,1957,O
arrays,1962,1968,O
pipette,1981,1988,O
tip,1989,1992,O
hand,1999,2003,O
held,2004,2008,O
arrayer,2009,2016,O
Figure,2031,2037,O
1,2038,2039,O
Effects,2041,2048,O
sucrose,2052,2059,O
gelatine,2064,2072,O
concentrations,2073,2087,O
spot,2091,2095,O
integrity,2096,2105,O
transfection,2110,2122,O
efficiency,2123,2133,O
Array,2139,2144,O
printed,2145,2152,O
pDsRed,2158,2164,O
50,2166,2168,O
ng,2169,2171,O
microl,2172,2178,O
printing,2185,2193,O
solution,2194,2202,O
different,2208,2217,O
gelatine,2218,2226,O
sucrose,2231,2238,O
concentrations,2239,2253,O
Scanning,2255,2263,O
image,2264,2269,O
array,2283,2288,O
magnifications,2293,2307,O
specific,2311,2319,O
spots,2320,2325,O
B,2328,2329,O
Array,2331,2336,O
printed,2337,2344,O
pEGFP,2350,2355,O
50,2357,2359,O
ng,2360,2362,O
microl,2363,2369,O
printing,2376,2384,O
solution,2385,2393,O
25,2399,2401,O
mM,2402,2404,O
sucrose,2405,2412,O
different,2422,2431,O
concentrations,2432,2446,O
gelatine,2450,2458,O
Box,2465,2468,O
plot,2469,2473,O
fluorescence,2481,2493,O
intensities,2494,2505,O
spot,2514,2518,O
n,2520,2521,O
32,2524,2526,O
34,2527,2529,O
Scanning,2540,2548,O
image,2549,2554,O
showing,2555,2562,O
squares,2563,2570,O
seven,2574,2579,O
times,2580,2585,O
spots,2591,2596,O
gelatine,2610,2618,O
concentrations,2619,2633,O
left,2640,2644,O
right,2648,2653,O
0,2655,2656,O
01,2657,2659,O
0,2661,2662,O
05,2663,2665,O
0,2667,2668,O
1,2669,2670,O
0,2675,2676,O
2,2677,2678,O
gelatine,2680,2688,O
DNA,2694,2697,O
lipid,2698,2703,O
gelatine,2704,2712,O
sucrose,2713,2720,O
solutions,2721,2730,O
printed,2736,2743,O
manually,2744,2752,O
10,2760,2762,O
microl,2763,2769,O
pipette,2770,2777,O
tip,2778,2781,O
MicroCasterTM,2792,2805,O
manual,2806,2812,O
arrayer,2813,2820,O
system,2821,2827,O
B,2829,2830,O
1,2838,2839,O
5,2840,2841,O
ml,2842,2844,O
microcentrifuge,2845,2860,O
tube,2861,2865,O
plasmid,2867,2874,O
1,2876,2877,O
microg,2878,2884,O
microl,2885,2891,O
siRNA,2897,2902,O
mixed,2908,2913,O
growth,2919,2925,O
medium,2926,2932,O
fetal,2941,2946,B-Developing_anatomical_structure
calf,2947,2951,O
serum,2952,2957,B-Organism_substance
FCS,2959,2962,O
0,2965,2966,O
5,2967,2968,O
microl,2969,2975,O
1,2976,2977,O
5,2978,2979,O
M,2980,2981,O
sucrose,2982,2989,O
3,2994,2995,O
microl,2996,3002,O
X,3003,3004,O
tremeGENE,3005,3014,O
microgram,3019,3028,O
nucleic,3029,3036,O
acid,3037,3041,O
final,3047,3052,O
volume,3053,3059,O
22,3063,3065,O
5,3066,3067,O
microl,3068,3074,O
15,3082,3084,O
20,3085,3087,O
min,3088,3091,O
incubation,3095,3105,O
7,3107,3108,O
5,3109,3110,O
microl,3111,3117,O
0,3118,3119,O
4,3120,3121,O
gelatine,3123,3131,O
Type,3133,3137,O
B,3138,3139,O
G9391,3141,3146,O
Sigma,3148,3153,O
added,3159,3164,O
30,3173,3175,O
microl,3176,3182,O
printing,3183,3191,O
solution,3192,3200,O
gelatine,3206,3214,O
solution,3215,3223,O
prepared,3228,3236,O
described,3240,3249,O
Ziauddin,3253,3261,O
Sabatini,3266,3274,O
1,3276,3277,O
achieve,3283,3290,O
sufficient,3291,3301,O
level,3302,3307,O
expression,3311,3321,O
transfected,3331,3342,O
plasmids,3343,3351,O
25,3353,3355,O
50,3356,3358,O
ng,3359,3361,O
microl,3362,3368,O
pEGFP,3369,3374,O
N1,3375,3377,O
pDsRed,3381,3387,O
express,3388,3395,O
N1,3396,3398,O
50,3403,3405,O
75,3406,3408,O
ng,3409,3411,O
microl,3412,3418,O
CRE,3422,3425,O
NFkappaB,3429,3437,O
reporter,3438,3446,O
plasmids,3447,3455,B-Cellular_component
siRNA,3470,3475,O
studies,3476,3483,O
2,3485,3486,O
30,3487,3489,O
ng,3490,3492,O
microl,3493,3499,O
siRNA,3500,3505,O
final,3513,3518,O
printing,3519,3527,O
solution,3528,3536,O
Candle,0,6,O
wicks,7,12,O
Candles,13,20,O
lead,28,32,O
metal,33,38,O
core,39,43,O
contribute,44,54,O
lead,58,62,O
home,70,74,O
Nriagu,76,82,O
Kim,87,90,O
2000,91,95,O
van,97,100,O
Alphen,101,107,O
1999,108,112,O
Exposure,115,123,O
occurs,124,130,O
air,141,144,O
hand,154,158,O
mouth,162,167,O
activity,168,176,O
date,190,194,O
children,199,207,O
s,208,209,O
EBLs,210,214,O
traceable,215,224,O
candles,228,235,O
reported,246,254,O
2002,259,263,O
CPSC,269,273,O
banned,274,280,O
candlewicks,281,292,O
containing,293,303,O
0,306,307,O
06,308,310,O
lead,312,316,O
CPSC,318,322,O
2003,323,327,O
Variables,0,9,O
study,14,19,O
following,29,38,O
9,39,40,O
HRQOL,41,46,O
questions,47,56,O
2004,66,70,O
Rhode,71,76,O
Island,77,83,O
BRFSS,84,89,O
1,91,92,O
self,94,98,O
rated,99,104,O
general,105,112,O
health,113,119,O
status,120,126,O
self,132,136,O
reported,137,145,O
number,146,152,O
healthy,156,163,O
unhealthy,168,177,O
days,178,182,O
previous,190,198,O
30,199,201,O
days,202,206,O
2,211,212,O
physical,214,222,O
health,223,229,O
3,231,232,O
mental,234,240,O
health,241,247,O
4,249,250,O
physical,252,260,O
mental,264,270,O
health,271,277,O
related,278,285,O
activity,286,294,O
limitation,295,305,O
5,307,308,O
pain,310,314,O
related,315,322,O
activity,323,331,O
limitation,332,342,O
6,344,345,O
sad,347,350,O
blue,352,356,O
depressed,361,370,O
7,372,373,O
worried,375,382,O
tense,384,389,O
anxious,394,401,O
8,403,404,O
lack,406,410,O
rest,414,418,O
sleep,422,427,O
9,433,434,O
lack,436,440,O
energy,444,450,O
1,452,453,O
2,454,455,O
15,456,458,O
created,464,471,O
9,472,473,O
dichotomous,474,485,O
indicator,486,495,O
variables,496,505,O
responses,511,520,O
self,528,532,O
rated,533,538,O
general,539,546,O
health,547,553,O
status,554,560,O
question,561,569,O
dichotomized,575,587,O
poor,594,598,O
poor,601,605,O
fair,609,613,O
health,615,621,O
good,626,630,O
good,633,637,O
good,644,648,O
excellent,653,662,O
health,664,670,O
indicators,676,686,O
measured,687,695,O
days,699,703,O
dichotomized,709,721,O
cutoff,727,733,O
value,734,739,O
14,743,745,O
days,754,758,O
poor,762,766,O
health,767,773,O
previous,781,789,O
month,790,795,O
compared,796,804,O
14,818,820,O
days,821,825,O
3,827,828,O
selected,834,842,O
14,847,849,O
day,850,853,O
minimum,854,861,O
period,862,868,O
publications,889,901,O
reviewed,905,913,O
use,919,922,O
BRFSS,927,932,O
HRQOL,933,938,O
indicators,939,949,O
outcomes,951,959,O
use,961,964,O
cutoff,969,975,O
14,979,981,O
days,990,994,O
compared,995,1003,O
13,1007,1009,O
fewer,1013,1018,O
days,1019,1023,O
3,1025,1026,O
5,1027,1028,O
7,1029,1030,O
11,1031,1033,O
16,1034,1036,O
17,1037,1039,O
Adopting,1042,1050,O
precedent,1056,1065,O
ensured,1066,1073,O
comparability,1074,1087,O
addition,1092,1100,O
clinicians,1102,1112,O
clinical,1117,1125,O
researchers,1126,1137,O
use,1144,1147,O
period,1153,1159,O
marker,1165,1171,O
clinical,1176,1184,O
depression,1185,1195,O
anxiety,1200,1207,O
disorders,1208,1217,O
long,1223,1227,O
symptomatic,1228,1239,O
durations,1240,1249,O
associated,1254,1264,O
high,1270,1274,O
levels,1275,1281,O
activity,1285,1293,O
limitation,1294,1304,O
2,1306,1307,O
18,1308,1310,O
Detailed,1313,1321,O
definitions,1322,1333,O
9,1341,1342,O
indicators,1343,1353,O
available,1358,1367,O
previous,1375,1383,O
article,1384,1391,O
1,1393,1394,O
accessible,1403,1413,O
Centers,1426,1433,O
Disease,1438,1445,O
Control,1446,1453,O
Prevention,1458,1468,O
s,1469,1470,O
HRQOL,1471,1476,O
Web,1477,1480,O
site,1481,1485,O
2,1487,1488,O
chose,1494,1499,O
12,1500,1502,O
predictors,1503,1513,O
analysis,1522,1530,O
5,1532,1533,O
standard,1534,1542,O
demographic,1543,1554,O
measures,1555,1563,O
age,1565,1568,O
sex,1570,1573,O
race,1575,1579,O
Hispanic,1580,1588,O
ethnicity,1589,1598,O
annual,1600,1606,O
income,1607,1613,O
employment,1619,1629,O
status,1630,1636,O
4,1639,1640,O
health,1641,1647,O
conditions,1648,1658,O
asthma,1660,1666,O
diabetes,1668,1676,O
obesity,1678,1685,O
physical,1691,1699,O
disability,1700,1710,O
3,1717,1718,O
health,1719,1725,O
risk,1726,1730,O
behaviors,1731,1740,O
smoking,1742,1749,O
chronic,1751,1758,O
alcohol,1759,1766,O
use,1767,1770,O
leisure,1779,1786,O
time,1787,1791,O
physical,1792,1800,O
activity,1801,1809,O
predictors,1818,1828,O
paralleled,1829,1839,O
results,1844,1851,O
studies,1861,1868,O
examined,1879,1887,O
relationships,1888,1901,O
specific,1912,1920,O
HRQOL,1921,1926,O
indicator,1927,1936,O
predictors,1949,1959,O
17,1961,1963,O
19,1964,1966,O
examined,1982,1990,O
multiple,1991,1999,O
HRQOL,2000,2005,O
indicators,2006,2016,O
relation,2020,2028,O
demographics,2032,2044,O
4,2046,2047,O
20,2048,2050,O
health,2053,2059,O
risks,2060,2065,O
5,2067,2068,O
10,2069,2071,O
21,2072,2074,O
specific,2080,2088,O
health,2089,2095,O
conditions,2096,2106,O
6,2108,2109,O
9,2110,2111,O
12,2112,2114,O
22,2115,2117,O
dichotomized,2123,2135,O
predictors,2141,2151,O
analysis,2160,2168,O
ie,2170,2172,O
sex,2174,2177,O
current,2179,2186,O
smoking,2187,2194,O
alcohol,2196,2203,O
use,2204,2207,O
physical,2209,2217,O
activity,2218,2226,O
asthma,2228,2234,O
diabetes,2236,2244,O
obesity,2246,2253,O
disability,2259,2269,O
predictors,2286,2296,O
multiple,2301,2309,O
categories,2310,2320,O
ie,2322,2324,O
age,2326,2329,O
race,2331,2335,O
Hispanic,2336,2344,O
ethnicity,2345,2354,O
income,2356,2362,O
employment,2368,2378,O
status,2379,2385,O
definitions,2392,2403,O
12,2411,2413,O
predictors,2414,2424,O
available,2429,2438,O
previous,2446,2454,O
article,2455,2462,O
1,2464,2465,O
Reference,2468,2477,O
groups,2478,2484,O
chosen,2485,2491,O
IRT,2500,2503,O
model,2504,2509,O
having,2521,2527,O
lowest,2532,2538,O
risk,2539,2543,O
poor,2548,2552,O
fair,2556,2560,O
general,2561,2568,O
health,2569,2575,O
usually,2580,2587,O
lowest,2592,2598,O
risk,2599,2603,O
HRQOL,2618,2623,O
variables,2624,2633,O
Results,0,7,O
1,0,1,O
Introduction,3,15,O
Phase,16,21,O
clinical,24,32,O
trials,33,39,O
new,43,46,O
anticancer,47,57,O
agents,58,64,O
commonly,75,83,O
conducted,84,93,O
method,104,110,O
modified,114,122,O
Fibonacci,123,132,O
1,134,135,O
brief,141,146,O
3,148,149,O
patients,150,158,O
treated,163,170,O
starting,176,184,O
dose,185,189,O
typically,199,208,O
tenth,213,218,O
dose,226,230,O
lethal,239,245,O
10,249,251,O
animals,256,263,O
defined,264,271,O
preclinical,275,286,O
studies,287,294,O
3,311,312,O
patients,313,321,O
experiences,322,333,O
DLT,334,337,O
3,353,354,O
patients,355,363,O
treated,372,379,O
higher,392,398,O
dose,399,403,O
DLT,408,411,O
observed,415,423,O
additional,425,435,O
patients,436,444,O
treated,453,460,O
lower,476,481,O
dose,482,486,O
level,487,492,O
determine,496,505,O
MTD,506,509,O
according,510,519,O
predetermined,525,538,O
schema,539,545,O
MTD,551,554,O
defined,558,565,O
highest,573,580,O
dose,581,585,O
reached,586,593,O
incidence,608,617,O
DLT,621,624,O
occurs,625,631,O
33,645,647,O
subjects,656,664,O
Typically,666,675,O
intrapatient,677,689,O
dose,690,694,O
escalation,695,705,O
allowed,713,720,O
shortcomings,740,752,O
associated,753,763,O
modified,773,781,O
Fibonacci,782,791,O
design,792,798,O
long,807,811,O
recognized,817,827,O
substantial,835,846,O
number,847,853,O
patients,857,865,O
likely,870,876,O
treated,883,890,O
subtherapeutic,894,908,O
doses,909,914,O
2,916,917,O
3,919,920,O
particularly,931,943,O
true,944,948,O
drugs,953,958,O
potential,964,973,O
anticancer,974,984,O
activity,985,993,O
primary,1005,1012,O
purpose,1013,1020,O
phase,1024,1029,O
trials,1032,1038,O
determine,1045,1054,O
DLT,1055,1058,O
MTD,1063,1066,O
efficacy,1072,1080,O
drug,1088,1092,O
evident,1104,1111,O
certain,1116,1123,O
tumor,1124,1129,B-Pathological_formation
types,1130,1135,O
small,1156,1161,O
number,1162,1168,O
patients,1172,1180,O
enrolled,1181,1189,O
trial,1199,1204,O
Furthermore,1206,1217,O
modified,1223,1231,O
Fibonacci,1232,1241,O
design,1242,1248,O
account,1268,1275,O
individual,1276,1286,O
variations,1287,1297,O
therapeutic,1301,1312,O
toxicologic,1317,1328,O
responses,1329,1338,O
genomic,1346,1353,O
polymorphisms,1354,1367,O
4,1369,1370,O
5,1372,1373,O
addition,1379,1387,O
limit,1406,1411,O
3,1415,1416,O
subjects,1417,1425,O
allowed,1426,1433,O
cohort,1443,1449,O
waiting,1453,1460,O
period,1461,1467,O
weeks,1482,1487,O
commonly,1491,1499,O
required,1500,1508,O
enrollment,1516,1526,O
cohort,1539,1545,O
subjects,1549,1557,O
requirement,1571,1582,O
creates,1583,1590,O
anxiety,1591,1598,O
waiting,1602,1609,O
eligible,1614,1622,O
patients,1623,1631,O
alternative,1641,1652,O
phase,1653,1658,O
designs,1661,1668,O
proposed,1679,1687,O
limit,1694,1699,O
number,1704,1710,O
patients,1714,1722,O
accrued,1723,1730,O
dose,1739,1743,O
level,1744,1749,O
accelerate,1754,1764,O
dose,1769,1773,O
escalation,1774,1784,O
process,1785,1792,O
1,1794,1795,O
6,1797,1798,O
increase,1824,1832,O
number,1840,1846,O
clinical,1850,1858,O
trials,1859,1865,O
include,1871,1878,O
component,1881,1890,O
intrapatient,1894,1906,O
dose,1907,1911,O
escalation,1912,1922,O
formal,1935,1941,O
validation,1942,1952,O
modified,1962,1970,O
Fibonacci,1971,1980,O
approach,1981,1989,O
reported,1999,2007,O
7,2009,2010,O
9,2011,2012,O
pioneered,2023,2032,O
population,2035,2045,O
based,2046,2051,O
design,2052,2058,O
maximize,2062,2070,O
therapeutic,2071,2082,O
efficacy,2083,2091,O
provide,2096,2103,O
preliminary,2104,2115,O
efficacy,2116,2124,O
information,2125,2136,O
allow,2144,2149,O
derivation,2150,2160,O
pMTD,2166,2170,O
subsequent,2175,2185,O
phase,2186,2191,O
II,2192,2194,O
trials,2195,2201,O
Irinotecan,2203,2213,O
cisplatin,2218,2227,O
shown,2238,2243,O
promising,2252,2261,O
efficacy,2262,2270,O
patients,2274,2282,O
small,2288,2293,B-Pathological_formation
cell,2294,2298,I-Pathological_formation
lung,2299,2303,I-Pathological_formation
cancer,2304,2310,I-Pathological_formation
phase,2314,2319,O
III,2320,2323,O
trial,2324,2329,O
irinotecan,2336,2346,O
given,2351,2356,O
weekly,2362,2368,O
schedule,2369,2377,O
10,2379,2381,O
wished,2387,2393,O
perform,2397,2404,O
population,2407,2417,O
based,2418,2423,O
phase,2424,2429,O
trial,2432,2437,O
irinotecan,2441,2451,O
given,2453,2458,O
3,2465,2466,O
weeks,2467,2472,O
carboplatin,2478,2489,O
platinated,2493,2503,O
anticancer,2504,2514,O
drug,2515,2519,O
generally,2529,2538,O
better,2539,2545,O
tolerated,2546,2555,O
cisplatin,2565,2574,O
analog,2575,2581,O
2,0,1,O
2,2,3,O
Iris,5,9,B-Multi-tissue_structure
Ciliary,14,21,B-Multi-tissue_structure
Body,22,26,I-Multi-tissue_structure
Serotonin,27,36,O
present,40,47,O
mammalian,51,60,O
iris,61,65,B-Multi-tissue_structure
ciliary,66,73,I-Multi-tissue_structure
body,74,78,I-Multi-tissue_structure
complex,79,86,I-Multi-tissue_structure
ICB,88,91,B-Multi-tissue_structure
higher,96,102,O
concentration,103,116,O
non,125,128,O
mammalian,129,138,O
species,139,146,O
5,148,149,O
45,151,153,O
73,155,157,O
129,159,162,O
137,164,167,O
presence,184,192,O
serotonergic,196,208,O
nerves,209,215,B-Multi-tissue_structure
demonstrated,225,237,O
studies,241,248,O
conducted,249,258,O
ICB,266,269,B-Multi-tissue_structure
species,281,288,O
102,290,293,O
137,295,298,O
138,300,303,O
Experimental,306,318,O
evidence,319,327,O
radioligand,332,343,O
analyses,344,352,O
defined,358,365,O
presence,370,378,O
level,387,392,O
different,402,411,O
types,412,417,O
serotonin,421,430,O
receptors,431,440,O
10,442,444,O
28,446,448,O
85,450,452,O
136,454,457,O
137,459,462,O
e,467,468,O
5,470,471,O
HT1A,472,476,O
5,478,479,O
HT2A,480,484,O
2C,485,487,O
5,492,493,O
HT7,494,497,O
98,499,501,O
linked,508,514,O
stimulation,520,531,O
inositol,535,543,O
phosphates,544,554,O
5,556,557,O
HT2,558,561,O
subtype,562,569,O
linked,597,603,O
cAMP,607,611,O
activity,612,620,O
plausibility,626,638,O
existence,646,655,O
5,673,674,O
HT,675,677,O
receptor,678,686,O
type,687,691,O
ciliary,699,706,B-Multi-tissue_structure
body,707,711,I-Multi-tissue_structure
confirmed,715,724,O
intraocular,728,739,B-Immaterial_anatomical_entity
pressure,740,748,O
IOP,750,753,O
experiments,755,766,O
Topical,768,775,O
application,776,787,O
serotonin,791,800,O
reported,810,818,O
elevate,827,834,O
84,836,838,O
lower,844,849,O
88,851,853,O
IOP,855,858,O
rabbit,862,868,O
large,872,877,O
number,878,884,O
reports,888,895,O
shown,901,906,O
serotonin,912,921,O
agonists,922,930,O
antagonists,935,946,O
produce,951,958,O
increases,959,968,O
decreases,973,982,O
IOP,986,989,O
given,995,1000,O
orally,1001,1007,O
topically,1009,1018,O
eye,1026,1029,B-Organ
directly,1047,1055,O
injected,1056,1064,O
anterior,1072,1080,B-Multi-tissue_structure
chamber,1081,1088,I-Multi-tissue_structure
10,1090,1092,O
26,1094,1096,O
34,1098,1100,O
35,1102,1104,O
64,1106,1108,O
75,1110,1112,O
84,1114,1116,O
87,1118,1120,O
88,1122,1124,O
112,1126,1129,O
113,1131,1134,O
126,1136,1139,O
136,1141,1144,O
137,1146,1149,O
rationale,1154,1163,O
apparently,1173,1183,O
contradictory,1184,1197,O
results,1198,1205,O
different,1224,1233,O
sites,1234,1239,O
action,1243,1249,O
e,1253,1254,O
class,1262,1267,O
serotonin,1271,1280,O
receptor,1281,1289,O
activated,1293,1302,O
fact,1307,1311,O
rabbit,1316,1322,O
administration,1327,1341,O
5,1345,1346,O
methyl,1347,1353,O
urapidil,1354,1362,O
combined,1366,1374,O
5,1375,1376,O
HT1A,1377,1381,O
agonist,1382,1389,O
alpha1,1390,1396,O
adrenoreceptor,1397,1411,O
antagonist,1412,1422,O
8,1428,1429,O
OH,1430,1432,O
DPAT,1433,1437,O
8,1439,1440,O
hydroxydypropylaminotetralin,1441,1469,O
5HT1A,1473,1478,O
agonist,1479,1486,O
reduces,1488,1495,O
IOP,1496,1499,O
administration,1511,1525,O
5,1529,1530,O
CT,1531,1533,O
5,1535,1536,O
carboxamidotryptamine,1537,1558,O
5,1562,1563,O
HT1A,1564,1568,O
5,1573,1574,O
HT7,1575,1578,O
agonist,1579,1586,O
increases,1588,1597,O
IOP,1598,1601,O
36,1603,1605,O
84,1607,1609,O
99,1611,1613,O
Chidlow,1616,1623,O
Le,1625,1627,O
Corre,1628,1633,O
Osborne,1638,1645,O
28,1647,1649,O
recently,1656,1664,O
demonstrated,1665,1677,O
section,1687,1694,O
taken,1695,1700,O
eye,1719,1722,B-Organ
ciliary,1727,1734,B-Multi-tissue_structure
body,1735,1739,I-Multi-tissue_structure
prominent,1741,1750,O
5,1751,1752,O
HT1A,1753,1757,O
5,1762,1763,O
HT7,1764,1767,O
receptor,1768,1776,O
messenger,1777,1786,O
ribonucleic,1787,1798,O
acid,1799,1803,O
signals,1804,1811,O
obtained,1817,1825,O
signals,1833,1840,O
evident,1846,1853,O
pigmented,1866,1875,O
non,1880,1883,O
pigmented,1884,1893,O
epithelial,1894,1904,B-Cell
cell,1905,1909,I-Cell
layers,1910,1916,O
pars,1924,1928,B-Multi-tissue_structure
plicata,1929,1936,I-Multi-tissue_structure
region,1937,1943,O
ciliary,1951,1958,B-Multi-tissue_structure
processes,1959,1968,O
pars,1985,1989,B-Multi-tissue_structure
plana,1990,1995,I-Multi-tissue_structure
ciliary,2006,2013,B-Multi-tissue_structure
musculature,2014,2025,I-Multi-tissue_structure
5,2027,2028,O
HT1A,2029,2033,O
5,2038,2039,O
HT7,2040,2043,O
signals,2044,2051,O
apparent,2057,2065,O
posterior,2073,2082,O
processes,2083,2092,O
iris,2108,2112,B-Multi-tissue_structure
processes,2113,2122,O
presence,2128,2136,O
receptors,2145,2154,O
ciliary,2162,2169,B-Multi-tissue_structure
body,2170,2174,I-Multi-tissue_structure
certainly,2181,2190,O
provide,2191,2198,O
explanation,2202,2213,O
shallow,2222,2229,O
displacement,2230,2242,O
curves,2243,2249,O
observed,2250,2258,O
3H,2263,2265,O
5,2266,2267,O
HT,2268,2270,O
binding,2271,2278,O
studies,2279,2286,O
tissue,2296,2302,B-Tissue
110,2304,2307,O
ligand,2321,2327,O
label,2343,2348,O
receptors,2354,2363,O
ciliary,2377,2384,B-Tissue
epithelium,2385,2395,I-Tissue
pars,2403,2407,B-Multi-tissue_structure
plicata,2408,2415,I-Multi-tissue_structure
responsible,2419,2430,O
secretion,2439,2448,O
aqueous,2452,2459,O
humor,2460,2465,O
obvious,2470,2477,O
function,2478,2486,O
receptors,2501,2510,O
involvement,2523,2534,O
control,2542,2549,O
aqueous,2553,2560,O
production,2561,2571,O
consequently,2577,2589,O
IOP,2598,2601,O
level,2602,2607,O
identical,2629,2638,O
distribution,2639,2651,O
5,2659,2660,O
HT1A,2661,2665,O
5,2670,2671,O
HT7,2672,2675,O
messengers,2676,2686,O
ribonucleic,2687,2698,O
acid,2699,2703,O
indicate,2704,2712,O
receptors,2722,2731,O
co,2739,2741,O
localized,2742,2751,O
epithelial,2755,2765,B-Cell
cells,2766,2771,I-Cell
presence,2777,2785,O
serotonin,2793,2802,O
receptors,2803,2812,O
opposing,2818,2826,O
effects,2827,2834,O
cAMP,2838,2842,O
cell,2855,2859,B-Cell
layer,2860,2865,O
prompts,2866,2873,O
suggestion,2878,2888,O
act,2905,2908,O
antagonistically,2909,2925,O
agonism,2931,2938,O
5,2942,2943,O
HT1A,2944,2948,O
receptors,2949,2958,O
negatively,2960,2970,O
coupled,2971,2978,O
cAMP,2982,2986,O
reduces,2988,2995,O
IOP,2996,2999,O
decreasing,3003,3013,O
production,3018,3028,O
aqueous,3032,3039,O
humor,3040,3045,O
like,3047,3051,O
beta,3052,3056,O
receptor,3057,3065,O
antagonists,3066,3077,O
diminishing,3085,3096,O
content,3101,3108,O
cAMP,3112,3116,O
postjunctional,3124,3138,O
site,3139,3143,O
lowers,3145,3151,O
aqueous,3156,3163,O
humor,3164,3169,B-Organism_substance
secretion,3170,3179,O
consequent,3187,3197,O
decrease,3198,3206,O
IOP,3210,3213,O
98,3215,3217,O
contrary,3227,3235,O
administration,3241,3255,O
5,3259,3260,O
CT,3261,3263,O
induces,3264,3271,O
rise,3274,3278,O
IOP,3282,3285,O
partly,3296,3302,O
entirely,3306,3314,O
caused,3315,3321,O
increase,3328,3336,O
aqueous,3340,3347,O
humor,3348,3353,B-Organism_substance
secretion,3354,3363,O
mediated,3364,3372,O
5,3376,3377,O
HT7,3378,3381,O
receptors,3382,3391,O
84,3393,3395,O
type,3408,3412,O
serotonin,3416,3425,O
receptor,3426,3434,O
present,3435,3442,O
ICB,3450,3453,B-Multi-tissue_structure
5,3459,3460,O
HT2,3461,3464,O
type,3465,3469,O
Serotonin,3471,3480,O
stimulates,3481,3491,O
accumulation,3496,3508,O
inositol,3512,3520,O
phosphates,3521,3531,O
ICB,3539,3542,B-Multi-tissue_structure
effect,3552,3558,O
partially,3562,3571,O
counteracted,3572,3584,O
5,3592,3593,O
HT2,3594,3597,O
antagonists,3598,3609,O
ketanserin,3610,3620,O
methysergide,3622,3634,O
mianserin,3639,3648,O
98,3650,3652,O
Studies,3655,3662,O
ketanserin,3668,3678,O
demonstrated,3684,3696,O
orally,3708,3714,O
topically,3718,3727,O
applied,3728,3735,O
lowers,3740,3746,O
IOP,3747,3750,O
animals,3754,3761,O
healthy,3763,3770,O
volunteers,3771,3781,O
glaucomatous,3789,3801,O
patients,3802,3810,O
26,3812,3814,O
34,3816,3818,O
37,3820,3822,O
64,3824,3826,O
75,3828,3830,O
88,3832,3834,O
113,3836,3839,O
126,3841,3844,O
emphasized,3859,3869,O
ketanserin,3875,3885,O
possesses,3891,3900,O
affinity,3904,3912,O
alpha1,3917,3923,O
adrenoreceptors,3924,3939,O
27,3941,3943,O
36,3945,3947,O
139,3949,3952,O
reason,3968,3974,O
effects,3979,3986,O
ketanserin,3990,4000,O
IOP,4004,4007,O
entirely,4019,4027,O
caused,4028,4034,O
action,4042,4048,O
5,4052,4053,O
HT2,4054,4057,O
receptors,4058,4067,O
data,4078,4082,O
human,4088,4093,O
studies,4094,4101,O
conducted,4102,4111,O
oral,4118,4122,O
topical,4126,4133,O
administration,4134,4148,O
ketanserin,4152,4162,O
determined,4178,4188,O
variations,4193,4203,O
IOP,4207,4210,O
total,4212,4217,O
outflow,4218,4225,O
facility,4226,4234,O
pupil,4239,4244,B-Multi-tissue_structure
diameter,4245,4253,O
demonstrated,4255,4267,O
alpha1,4277,4283,O
adrenoreceptor,4284,4298,O
blocking,4299,4307,O
effect,4308,4314,O
exerted,4315,4322,O
ketanserin,4326,4336,O
represent,4344,4353,O
aspect,4364,4370,O
mechanism,4378,4387,O
action,4391,4397,O
probably,4399,4407,O
functional,4417,4427,O
sharing,4428,4435,O
receptors,4445,4454,O
64,4456,4458,O
87,4460,4462,O
Lastly,4465,4471,O
1992,4484,4488,O
Martin,4489,4495,O
co,4500,4502,O
workers,4503,4510,O
showed,4511,4517,O
occurrence,4522,4532,O
significant,4538,4549,O
correlation,4550,4561,O
content,4574,4581,O
serotonin,4585,4594,O
aqueous,4602,4609,O
humor,4610,4615,B-Organism_substance
IOP,4620,4623,O
human,4631,4636,O
eye,4637,4640,B-Organ
85,4642,4644,O
1981,4650,4654,O
Moro,4656,4660,O
collaborators,4669,4682,O
found,4683,4688,O
intravitreal,4694,4706,O
injection,4707,4716,O
5,4720,4721,O
6,4723,4724,O
dihydroxytryptamine,4725,4744,O
serotonergic,4748,4760,O
neurotoxin,4761,4771,O
causes,4773,4779,O
miosis,4780,4786,O
91,4788,4790,O
identification,4797,4811,O
5,4815,4816,O
HT7,4817,4820,O
5,4833,4834,O
HT1,4835,4838,O
receptors,4839,4848,O
rabbit,4856,4862,O
iris,4863,4867,B-Multi-tissue_structure
suggests,4869,4877,O
population,4888,4898,O
serotonergic,4902,4914,O
receptors,4915,4924,O
involved,4928,4936,O
relaxation,4944,4954,O
sphincter,4962,4971,B-Tissue
pupil,4979,4984,B-Multi-tissue_structure
fact,4989,4993,O
function,5006,5014,O
correlate,5015,5024,O
5,5028,5029,O
HT7,5030,5033,O
receptor,5034,5042,O
activation,5043,5053,O
includes,5054,5062,O
smooth,5063,5069,B-Tissue
muscle,5070,5076,I-Tissue
relaxation,5077,5087,O
observed,5088,5096,O
variety,5102,5109,O
isolated,5113,5121,O
tissue,5122,5128,B-Tissue
preparations,5129,5141,O
elevation,5152,5161,O
cAMP,5165,5169,O
concentration,5170,5183,O
detected,5193,5201,O
3,5203,5204,O
44,5206,5208,O
evidence,5219,5227,O
mediation,5236,5245,O
relaxant,5253,5261,O
response,5262,5270,O
5,5279,5280,O
HT7,5281,5284,O
receptor,5285,5293,O
provided,5297,5305,O
localization,5313,5325,O
messenger,5329,5338,O
ribonucleic,5339,5350,O
acid,5351,5355,O
transcripts,5356,5367,O
encoding,5368,5376,O
5,5381,5382,O
HT7,5383,5386,O
receptor,5387,5395,O
blood,5404,5409,B-Multi-tissue_structure
vessels,5410,5417,I-Multi-tissue_structure
67,5419,5421,O
hypothesized,5429,5441,O
mechanism,5442,5451,O
action,5455,5461,O
supported,5470,5479,O
fact,5487,5491,O
receptor,5511,5519,O
types,5520,5525,O
positively,5532,5542,O
coupled,5543,5550,O
cAMP,5554,5558,O
iris,5567,5571,B-Multi-tissue_structure
cause,5572,5577,O
relaxation,5578,5588,O
sphincter,5596,5605,B-Tissue
muscle,5606,5612,I-Tissue
1,5614,5615,O
28,5617,5619,O
Luciferase,0,10,O
Assay,11,16,O
Fig,21,24,O
1,26,27,O
10,29,31,O
ng,32,34,O
TORC1,38,43,O
5,45,46,O
ng,47,49,O
TORC2,53,58,O
15,64,66,O
ng,67,69,O
PKAalpha,73,81,O
expression,82,92,O
plasmids,93,101,B-Cellular_component
transfected,107,118,O
HEK293,124,130,B-Cell
cells,131,136,I-Cell
Fig,142,145,O
2,147,148,O
800,150,153,O
ng,154,156,O
total,160,165,O
DNA,166,169,O
consisted,170,179,O
200,183,186,O
ng,187,189,O
pMLHoxb1ARE,197,208,O
luciferase,209,219,O
reporter,220,228,O
100,233,236,O
ng,237,239,O
expression,248,258,O
plasmid,259,266,O
lacZ,270,274,O
reporter,275,283,O
co,288,290,O
transfected,291,302,O
normalize,306,315,O
transfection,316,328,O
efficiency,329,339,O
Fig,345,348,O
3A,350,352,O
amounts,358,365,O
pENTR,369,374,O
T2i,375,378,O
shRNA,379,384,O
TORC2,386,391,O
shRNA,392,397,O
given,403,408,O
panel,420,425,O
Fig,431,434,O
3B,436,438,O
25,440,442,O
000,443,446,O
cells,447,452,B-Cell
plated,467,473,O
48,477,479,O
plates,485,491,O
transfected,496,507,O
Lipofectamine,514,527,O
2000,528,532,O
following,542,551,O
vectors,552,559,O
40,561,563,O
ng,564,566,O
pML5xUAS,570,578,O
40,580,582,O
ng,583,585,O
pGAL,589,593,O
DBD,594,597,O
pGAL,601,605,O
MEIS1A,606,612,O
335,613,616,O
390,617,620,O
40,623,625,O
ng,626,628,O
pRSV,632,636,O
PBS,637,640,O
pRSV,644,648,O
PKA,649,652,O
40,654,656,O
ng,657,659,O
pENTR,663,668,O
U6,669,671,O
control,673,680,O
shRNA,681,686,O
pENTR,691,696,O
T2i,697,700,O
shRNA,701,706,O
TORC2,708,713,O
shRNA,714,719,O
100,726,729,O
ng,730,732,O
pRSV,736,740,O
beta,741,745,O
galactosidase,746,759,O
48,764,766,O
h,767,768,O
post,769,773,O
transfection,774,786,O
cell,788,792,B-Organism_substance
lysates,793,800,I-Organism_substance
prepared,806,814,O
100,821,824,O
mul,825,828,O
lysis,841,846,O
buffer,847,853,O
1,855,856,O
Triton,858,864,O
X,865,866,O
100,867,870,O
1,872,873,O
mm,874,876,O
dithiothreitol,877,891,O
92,893,895,O
8,896,897,O
mm,898,900,O
K2HPO4,901,907,O
pH,909,911,O
7,912,913,O
8,914,915,O
9,917,918,O
2,919,920,O
mm,921,923,O
KH2PO4,924,930,O
pH,932,934,O
7,935,936,O
8,937,938,O
centrifuged,944,955,O
5,960,961,O
min,962,965,O
4,969,970,O
degreesC,971,979,O
20,983,985,O
mul,986,989,O
aliquot,990,997,O
supernatant,1005,1016,B-Organism_substance
added,1021,1026,O
12,1030,1032,O
5,1033,1034,O
mul,1035,1038,O
assay,1042,1047,O
buffer,1048,1054,O
20,1056,1058,O
mm,1059,1061,O
ATP,1062,1065,O
40,1067,1069,O
mm,1070,1072,O
MgCl2,1073,1078,O
0,1080,1081,O
4,1082,1083,O
m,1084,1085,O
Tris,1086,1090,O
Cl,1091,1093,O
pH,1095,1097,O
7,1098,1099,O
8,1100,1101,O
mixture,1108,1115,O
immediately,1120,1131,O
quantified,1132,1142,O
luciferase,1147,1157,O
activity,1158,1166,O
Lumat,1175,1180,O
LB,1181,1183,O
9507,1184,1188,O
luminometer,1189,1200,O
EG,1202,1204,O
G,1205,1206,O
Berthold,1207,1215,O
dispensed,1222,1231,O
100,1232,1235,O
mul,1236,1239,O
reaction,1244,1252,O
luciferin,1256,1265,O
solution,1266,1274,O
contains,1282,1290,O
1,1291,1292,O
mm,1293,1295,O
d,1296,1297,O
luciferin,1302,1311,O
catalogue,1313,1322,O
number,1323,1329,O
11626353001,1330,1341,O
Roche,1343,1348,O
0,1354,1355,O
1,1356,1357,O
m,1358,1359,O
Tris,1360,1364,O
Cl,1365,1367,O
pH,1369,1371,O
7,1372,1373,O
8,1374,1375,O
Implications,0,12,O
Psychological,17,30,O
Models,31,37,O
Interval,41,49,O
Timing,50,56,O
models,65,71,O
previously,82,92,O
applied,93,100,O
interpret,104,113,O
data,114,118,O
obtained,119,127,O
interval,131,139,O
timing,140,146,O
experiments,147,158,O
involving,159,168,O
gaps,169,173,O
retention,175,184,O
intervals,185,194,O
switch,199,205,O
model,206,211,O
assuming,213,221,O
gap,238,241,O
time,242,246,O
fails,247,252,O
accumulate,256,266,O
opening,278,285,O
stimulus,291,299,O
controlled,300,310,O
switch,311,317,O
predicts,319,327,O
irrespective,334,346,O
gap,350,353,O
criterion,358,367,O
durations,368,377,O
subjects,379,387,O
use,395,398,O
stop,401,405,O
rule,406,410,O
14,412,414,O
15,418,420,O
30,424,426,O
31,430,432,O
contrast,438,446,O
present,452,459,O
data,460,464,O
indicate,465,473,O
rats,479,483,O
flexibly,484,492,O
change,493,499,O
behavior,506,514,O
gap,525,528,O
criterion,533,542,O
duration,543,551,O
instructional,556,569,O
ambiguity,570,579,O
model,580,585,O
proposing,586,595,O
subjects,601,609,O
perceive,610,618,O
gap,623,626,O
ambiguous,633,642,O
ITI,644,647,O
like,648,652,O
event,653,658,O
predicts,660,668,O
manipulations,674,687,O
render,693,699,O
gap,704,707,O
similar,708,715,O
ITI,723,726,O
reset,734,739,O
clock,744,749,O
manipulations,757,770,O
render,776,782,O
gap,787,790,O
dissimilar,791,801,O
ITI,811,814,O
stop,822,826,O
clock,831,836,O
37,838,840,O
experiment,858,868,O
gap,873,876,O
ITI,881,884,O
identical,890,899,O
dark,901,905,O
hypothesis,912,922,O
predicts,923,931,O
use,936,939,O
rule,952,956,O
reset,958,963,O
gap,972,975,O
criteria,980,988,O
durations,989,998,O
contrast,1003,1011,O
current,1019,1026,O
data,1027,1031,O
showing,1032,1039,O
use,1044,1047,O
different,1051,1060,O
rules,1061,1066,O
different,1071,1080,O
temporal,1081,1089,O
criteria,1090,1098,O
account,1103,1110,O
flexible,1119,1127,O
use,1128,1131,O
run,1139,1142,O
stop,1143,1147,O
reset,1148,1153,O
rules,1154,1159,O
rats,1163,1167,O
pigeons,1172,1179,O
Cabeza,1181,1187,O
de,1188,1190,O
Vaca,1191,1195,O
et,1196,1198,O
al,1199,1201,O
38,1204,1206,O
proposed,1208,1216,O
passive,1219,1226,O
memory,1227,1233,O
decay,1234,1239,O
model,1240,1245,O
assumes,1252,1259,O
subjective,1265,1275,O
time,1276,1280,O
stored,1282,1288,O
WM,1292,1294,O
decays,1296,1302,O
passively,1303,1312,O
gap,1324,1327,O
model,1334,1339,O
predicts,1340,1348,O
effect,1358,1364,O
gap,1370,1373,O
depend,1381,1387,O
solely,1388,1394,O
absolute,1398,1406,O
gap,1407,1410,O
duration,1411,1419,O
criterion,1432,1441,O
duration,1442,1450,O
found,1455,1460,O
Fig,1467,1470,O
1B,1472,1474,O
D,1475,1476,O
models,1485,1491,O
account,1500,1507,O
differential,1516,1528,O
effects,1529,1536,O
gaps,1540,1544,O
multiple,1548,1556,O
intervals,1557,1566,O
contrast,1571,1579,O
alternatives,1589,1601,O
present,1607,1614,O
resource,1615,1623,O
allocation,1624,1634,O
model,1635,1640,O
assumes,1641,1648,O
gaps,1665,1669,O
resources,1670,1679,O
allocated,1687,1696,O
diverted,1698,1706,O
away,1707,1711,O
timing,1717,1723,O
clock,1731,1736,O
unable,1740,1746,O
maintain,1750,1758,O
current,1763,1770,O
subjective,1771,1781,O
time,1782,1786,O
WM,1790,1792,O
response,1802,1810,O
delayed,1814,1821,O
16,1823,1825,O
17,1829,1831,O
27,1835,1837,O
proportion,1842,1852,O
perceived,1860,1869,O
salience,1870,1878,O
distracter,1886,1896,O
relative,1897,1905,O
times,1913,1918,O
signal,1919,1925,O
34,1927,1929,O
35,1933,1935,O
effect,1950,1956,O
gap,1962,1965,O
affected,1969,1977,O
contrast,1985,1993,O
intensity,1997,2006,O
gap,2019,2022,O
timed,2031,2036,O
signal,2037,2043,O
27,2045,2047,O
34,2051,2053,O
39,2057,2059,O
perceptual,2072,2082,O
acuity,2083,2089,O
subjects,2097,2105,O
27,2107,2109,O
Importantly,2112,2123,O
predictions,2129,2140,O
resource,2149,2157,O
allocation,2161,2171,O
model,2172,2177,O
restricted,2186,2196,O
retention,2200,2209,O
intervals,2210,2219,O
e,2223,2224,O
gaps,2227,2231,O
extend,2238,2244,O
distracters,2248,2259,O
presented,2260,2269,O
continuous,2281,2291,O
presentation,2292,2304,O
timed,2310,2315,O
signal,2316,2322,O
Previous,2324,2332,O
data,2333,2337,O
quantitatively,2343,2357,O
accounted,2358,2367,O
assuming,2375,2383,O
gap,2398,2401,O
distracter,2409,2419,O
accumulated,2424,2435,O
time,2436,2440,O
decays,2441,2447,O
rate,2453,2457,O
varies,2463,2469,O
relative,2479,2487,O
salience,2488,2496,O
distracter,2504,2514,O
timed,2522,2527,O
signal,2528,2534,O
25,2536,2538,O
26,2542,2544,O
35,2548,2550,O
found,2561,2566,O
comparison,2576,2586,O
gap,2599,2602,O
multiple,2612,2620,O
timed,2622,2627,O
signal,2628,2634,O
s,2635,2636,O
extends,2638,2645,O
temporal,2653,2661,O
domain,2662,2668,O
Simulations,2670,2681,O
indicate,2682,2690,O
differential,2705,2717,O
effect,2718,2724,O
gap,2732,2735,O
multiple,2739,2747,O
durations,2748,2757,O
gradual,2767,2774,O
hierarchical,2775,2787,O
reset,2788,2793,O
increasing,2801,2811,O
gap,2812,2815,O
duration,2816,2824,O
quantitatively,2832,2846,O
accounted,2847,2856,O
assuming,2861,2869,O
clocks,2885,2891,O
separate,2897,2905,O
resources,2906,2915,O
allocated,2919,2928,O
independently,2929,2942,O
gap,2952,2955,O
rate,2961,2965,O
proportional,2966,2978,O
ratio,2986,2991,O
g,2992,2993,O
Tk,2994,2996,O
duration,3009,3017,O
gap,3025,3028,O
criterion,3038,3047,O
duration,3048,3056,O
Fig,3058,3061,O
2A,3063,3065,O
D,3066,3067,O
Model,3068,3073,O
SUMMARY,0,7,O
prospective,18,29,O
study,30,35,O
carried,36,43,O
determine,51,60,O
outcome,65,72,O
patients,76,84,O
refuse,89,95,O
cystectomy,96,106,O
receiving,113,122,O
neoadjuvant,123,134,O
chemotherapy,135,147,O
muscle,152,158,B-Pathological_formation
invasive,159,167,I-Pathological_formation
bladder,168,175,I-Pathological_formation
cancer,176,182,I-Pathological_formation
patients,196,204,O
evaluated,210,219,O
1995,228,232,O
2001,237,241,O
declined,246,254,O
undergo,258,265,O
planned,268,275,O
cystectomy,276,286,O
achieved,300,308,O
complete,311,319,O
clinical,320,328,O
response,329,337,O
neoadjuvant,341,352,O
cisplatin,353,362,O
based,363,368,O
chemotherapy,369,381,O
Herr,383,387,O
assessed,388,396,O
patient,397,404,O
tumor,406,411,B-Pathological_formation
treatment,416,425,O
features,426,434,O
median,441,447,O
follow,448,454,O
86,462,464,O
months,465,471,O
patients,477,485,O
followed,492,500,O
5,518,519,O
years,520,525,O
patients,533,541,O
64,543,545,O
survived,548,556,O
54,563,565,O
having,575,581,O
intact,585,591,O
functioning,592,603,O
bladder,604,611,B-Organ
number,617,623,O
size,628,632,O
invasive,636,644,O
tumors,645,651,B-Pathological_formation
strongly,657,665,O
associated,666,676,O
overall,686,693,O
survival,694,702,O
significant,713,724,O
treatment,725,734,O
variable,735,743,O
predicting,744,754,O
better,755,761,O
survival,762,770,O
complete,775,783,O
resection,784,793,O
invasive,801,809,O
tumor,810,815,B-Pathological_formation
restaging,819,828,O
transurethral,829,842,O
resection,843,852,O
TUR,854,857,O
starting,866,874,O
chemotherapy,875,887,O
23,892,894,O
patients,895,903,O
36,905,907,O
subsequently,914,926,O
died,927,931,O
disease,935,942,O
19,944,946,O
30,948,950,O
relapsed,953,961,O
invasive,967,975,O
cancer,976,982,B-Pathological_formation
bladder,990,997,B-Organ
90,1004,1006,O
surviving,1015,1024,O
patients,1025,1033,O
solitary,1038,1046,O
small,1048,1053,O
low,1058,1061,O
stage,1062,1067,O
invasive,1068,1076,O
tumors,1077,1083,B-Pathological_formation
completely,1084,1094,O
resected,1095,1103,O
83,1108,1110,O
survived,1112,1120,O
relapses,1129,1137,O
bladder,1145,1152,B-Organ
1,1154,1155,O
COMMENTS,0,8,O
Recurrent,9,18,O
anterior,19,27,B-Multi-tissue_structure
vaginal,28,35,I-Multi-tissue_structure
wall,36,40,I-Multi-tissue_structure
prolapse,41,49,O
develop,54,61,O
20,75,77,O
patients,82,90,O
undergoing,91,101,O
traditional,102,113,O
anterior,114,122,O
colporrhaphy,123,135,O
light,140,145,O
high,154,158,O
recurrence,159,169,O
rate,170,174,O
surgeons,180,188,O
incorporating,199,212,O
synthetic,213,222,O
allograft,226,235,O
mesh,236,240,O
augment,244,251,O
repair,256,262,O
study,272,277,O
shortcomings,293,305,O
including,307,316,O
retrospective,317,330,O
design,331,337,O
short,339,344,O
follow,345,351,O
study,361,366,O
spanning,367,375,O
years,387,392,O
lack,399,403,O
validated,407,416,O
questionnaires,417,431,O
Authors,433,440,O
report,441,447,O
negative,450,458,O
experience,459,469,O
porcine,475,482,O
dermis,483,489,B-Multi-tissue_structure
terms,499,504,O
success,508,515,O
extrusion,520,529,O
rate,530,534,O
reported,557,565,O
better,566,572,O
outcome,573,580,O
1,581,582,O
different,604,613,O
follow,614,620,O
times,624,629,O
outcome,634,641,O
measures,642,650,O
Apart,652,657,O
biological,669,679,O
grafts,680,686,O
associated,696,706,O
allergic,712,720,O
reactions,721,730,O
disease,735,742,O
transmission,743,755,O
paucity,766,773,O
data,777,781,O
prospective,792,803,O
randomized,804,814,O
trials,815,821,O
use,829,832,O
biomaterials,842,854,O
prior,855,860,O
widespread,870,880,O
human,881,886,O
need,887,891,O
help,904,908,O
reducing,912,920,O
type,926,930,O
experiences,934,945,O
data,959,963,O
available,968,977,O
surgeons,978,986,O
thought,1007,1014,O
prior,1015,1020,O
embarking,1024,1033,O
use,1041,1044,O
biological,1053,1063,O
materials,1064,1073,O
2,1075,1076,O
Background,0,10,O
Opioid,11,17,O
analgesics,18,28,O
generally,33,42,O
combat,51,57,O
pain,62,66,O
associated,67,77,O
cancerous,83,92,B-Pathological_formation
conditions,93,103,O
agents,111,117,O
inhibit,127,134,O
respiratory,135,146,B-Anatomical_system
function,147,155,O
cause,160,165,O
constipation,166,178,O
induce,189,195,O
significant,202,213,O
effects,219,226,O
addiction,235,244,O
tolerance,249,258,O
contribute,281,291,O
reduced,297,304,O
quality,305,312,O
life,316,320,O
cancer,325,331,B-Pathological_formation
patients,332,340,O
present,355,362,O
study,363,368,O
effects,374,381,O
electro,385,392,O
acupuncture,393,404,O
treatment,405,414,O
EA,416,418,O
mechanical,423,433,O
allodynia,434,443,O
examined,449,457,O
cancer,463,469,B-Pathological_formation
pain,470,474,O
mouse,475,480,O
model,481,486,O
2,0,1,O
1,2,3,O
Biological,5,15,O
samples,16,23,O
Placental,24,33,B-Tissue
tissues,34,41,I-Tissue
trimester,57,66,O
legally,67,74,O
induced,75,82,O
abortions,83,92,O
8,94,95,O
12,96,98,O
weeks,99,104,O
gestation,108,117,O
obtained,124,132,O
Department,142,152,O
Obstetrics,156,166,O
Gynecology,171,181,O
Broussais,189,198,O
Saint,200,205,O
Vincent,206,213,O
de,214,216,O
Paul,217,221,O
Cochin,226,232,O
Hospitals,233,242,O
Second,244,250,O
trimester,251,260,O
placental,261,270,B-Tissue
tissues,271,278,I-Tissue
collected,284,293,O
time,301,305,O
termination,309,320,O
pregnancy,324,333,O
15,337,339,O
25,344,346,O
weeks,347,352,O
gestation,356,365,O
weeks,370,375,O
amenorrhea,379,389,O
trisomy,394,401,O
21,402,404,O
affected,405,413,O
pregnancies,414,425,O
Fetal,427,432,B-Developing_anatomical_structure
syndrome,438,446,O
diagnosed,451,460,O
karyotyping,464,475,O
amniotic,479,487,B-Cell
fluid,488,493,I-Cell
cells,494,499,I-Cell
indication,505,515,O
amniocentesis,519,532,O
maternal,541,549,O
age,550,553,O
Term,555,559,O
placentas,560,569,B-Organ
obtained,575,583,O
elective,590,598,O
cesarean,599,607,O
section,608,615,O
healthy,621,628,O
mothers,629,636,O
near,637,641,O
term,642,646,O
uncomplicated,652,665,O
pregnancies,666,677,O
written,684,691,O
informed,692,700,O
consent,701,708,O
pregnant,716,724,O
woman,725,730,O
following,736,745,O
samples,746,753,O
collected,759,768,O
term,772,776,O
fragment,780,788,B-Organ
placenta,796,804,B-Organ
umbilical,806,815,B-Organism_substance
cord,816,820,I-Organism_substance
fetal,821,826,I-Organism_substance
blood,827,832,I-Organism_substance
maternal,837,845,O
blood,846,851,B-Organism_substance
placenta,857,865,B-Organ
biopsy,866,872,I-Organ
sample,873,879,I-Organ
collected,884,893,O
depth,899,904,O
1,908,909,O
cm,910,912,O
distance,922,930,O
8,934,935,O
cm,936,938,O
edge,948,952,O
placenta,960,968,B-Organ
maternal,979,987,O
facing,993,999,O
upward,1000,1006,O
use,1012,1015,O
biological,1025,1035,O
samples,1036,1043,O
approved,1048,1056,O
local,1060,1065,O
ethical,1066,1073,O
committee,1074,1083,O
Villous,1085,1092,B-Cell
cytotrophoblastic,1093,1110,I-Cell
cells,1111,1116,I-Cell
isolated,1122,1130,O
sequential,1134,1144,O
enzymatic,1145,1154,O
digestion,1155,1164,O
chorionic,1168,1177,B-Multi-tissue_structure
villi,1178,1183,I-Multi-tissue_structure
trimester,1199,1208,O
second,1210,1216,O
trimester,1217,1226,O
term,1231,1235,O
placenta,1236,1244,B-Organ
purified,1249,1257,O
discontinuous,1263,1276,O
percoll,1277,1284,O
gradient,1285,1293,O
described,1298,1307,O
previously,1308,1318,O
47,1319,1321,O
49,1322,1324,O
cells,1331,1336,B-Cell
positively,1342,1352,O
stained,1353,1360,O
cytokeratin,1365,1376,O
7,1377,1378,O
95,1382,1384,O
indicating,1387,1397,O
cytotrophoblastic,1402,1419,O
origin,1420,1426,O
cells,1434,1439,B-Cell
Placental,1441,1450,B-Cell
fibroblasts,1451,1462,I-Cell
isolated,1468,1476,O
prolonged,1480,1489,O
enzymatic,1490,1499,O
digestion,1500,1509,O
trimester,1521,1530,O
chorionic,1531,1540,B-Multi-tissue_structure
villi,1541,1546,I-Multi-tissue_structure
Malassine,1553,1562,O
et,1563,1565,O
al,1566,1568,O
50,1569,1571,O
Fibroblastic,1572,1584,B-Cell
cells,1585,1590,I-Cell
1,1592,1593,O
25,1594,1596,O
x,1597,1598,O
105,1599,1602,O
cells,1603,1608,O
mL,1609,1611,O
plated,1618,1624,O
35,1628,1630,O
mm,1631,1633,O
plastic,1634,1641,O
dishes,1642,1648,O
TPP,1650,1653,O
Switzerland,1655,1666,O
cultured,1672,1680,O
48,1685,1687,O
h,1688,1689,O
culture,1699,1706,O
medium,1707,1713,O
changed,1718,1725,O
daily,1726,1731,O
cultured,1739,1747,O
fibroblasts,1748,1759,B-Cell
characterized,1765,1778,O
immunocytochemistry,1785,1804,O
found,1813,1818,O
98,1824,1826,O
cells,1835,1840,B-Cell
vimentin,1846,1854,O
positive,1855,1863,O
positive,1873,1881,O
monoclonal,1888,1898,O
antibody,1899,1907,O
specific,1916,1924,O
fibroblast,1925,1935,B-Cell
antigen,1936,1943,O
clone,1945,1950,O
ASO2,1951,1955,O
Dianova,1957,1964,O
Hamburg,1966,1973,O
Germany,1975,1982,O
Owing,1985,1990,O
limited,1998,2005,O
cells,2016,2021,B-Cell
DNA,2028,2031,O
extracted,2036,2045,O
Methods,0,7,O
developed,22,31,O
reciprocal,34,44,O
system,45,51,O
length,62,68,I-Cell
HIV,69,72,I-Cell
packaging,73,82,I-Cell
cell,83,87,I-Cell
line,88,92,I-Cell
shortened,99,108,O
HI,109,111,O
viral,112,117,O
shuttle,118,125,O
vector,126,132,O
Tat,138,141,O
deficient,142,151,O
packaging,152,161,O
construct,162,171,O
stably,175,181,O
integrated,182,192,O
VSVG,198,202,B-Cell
pseudotyped,203,214,I-Cell
cell,215,219,I-Cell
line,220,224,I-Cell
transactivated,229,243,O
shuttle,251,258,O
vector,259,265,O
expression,269,279,O
TATGFP,283,289,O
heterologous,297,309,O
promoter,310,318,O
indicates,330,339,O
positive,340,348,O
cells,349,354,B-Cell
Expression,356,366,O
HI,374,376,O
viral,377,382,O
structure,383,392,O
proteins,393,401,O
driven,405,411,O
natural,417,424,O
5,425,426,O
LTR,428,431,O
promoter,432,440,O
3,447,448,O
polyadenylation,450,465,O
signal,466,472,O
envelope,486,494,B-Cellular_component
expression,495,505,O
shuttle,517,524,O
vector,525,531,O
achieved,535,543,O
IRES,550,554,O
system,561,567,O
vectors,575,582,O
tightly,586,593,O
controllable,594,606,O
bypasses,611,619,O
problem,624,631,O
limited,635,642,O
packaging,643,652,O
capacity,653,661,O
HIV,667,670,O
1,671,672,O
virions,673,680,O
Percutaneous,0,12,O
coronary,13,21,B-Multi-tissue_structure
intervention,22,34,O
late,48,52,O
stent,53,58,O
thrombosis,59,69,O
right,73,78,B-Multi-tissue_structure
coronary,79,87,I-Multi-tissue_structure
artery,88,94,I-Multi-tissue_structure
balloon,101,108,O
angioplasty,109,120,O
performed,125,134,O
treat,138,143,O
total,144,149,O
occlusion,150,159,O
stented,167,174,O
right,175,180,B-Multi-tissue_structure
coronary,181,189,I-Multi-tissue_structure
artery,190,196,I-Multi-tissue_structure
B,198,199,O
final,201,206,O
coronary,207,215,B-Multi-tissue_structure
angiogram,216,225,O
showed,226,232,O
good,233,237,O
distal,238,244,O
flow,245,249,O
residual,258,266,O
stenosis,267,275,O
cause,4,9,O
mortality,10,19,O
RALES,23,28,O
EPHESUS,33,40,O
adapted,42,49,O
4,56,57,O
5,64,65,O
Mean,69,73,O
follow,74,80,O
period,84,90,O
24,94,96,O
months,97,103,O
RALES,107,112,O
16,117,119,O
months,120,126,O
EPHESUS,130,137,O
Pre,0,3,O
publication,4,15,O
history,16,23,O
pre,28,31,O
publication,32,43,O
history,44,51,O
paper,61,66,O
accessed,74,82,O
http,89,93,O
www,96,99,O
biomedcentral,100,113,O
com,114,117,O
1471,118,122,O
2377,123,127,O
9,128,129,O
57,130,132,O
prepub,133,139,O
Magnetic,0,8,O
resonance,9,18,O
imaging,19,26,O
axial,30,35,O
plan,36,40,O
intravenous,46,57,B-Multi-tissue_structure
contrast,58,66,O
gadolinium,67,77,O
BOPTA,78,83,O
demonstrating,84,97,O
mass,100,104,O
adherent,105,113,O
right,121,126,O
ventricular,127,138,B-Multi-tissue_structure
wall,139,143,I-Multi-tissue_structure
Additional,0,10,O
file,11,15,O
3,16,17,O
Primers,18,25,O
study,39,44,O
primers,57,64,O
generating,74,84,O
PCR,85,88,O
products,89,97,O
microinjection,102,116,O
site,121,125,O
direct,126,132,O
mutagenesis,133,144,O
listed,149,155,O
2,0,1,O
Methods,3,10,O
conducted,14,23,O
systematic,26,36,O
study,37,42,O
patients,46,54,O
hospitalized,55,67,O
August,73,79,O
2006,80,84,O
September,91,100,O
2007,101,105,O
Yerevan,113,120,O
City,121,125,O
Republican,134,144,O
Dispensaries,145,157,O
reference,167,176,O
TB,177,179,O
hospitals,180,189,O
Armenia,193,200,O
Following,202,211,O
focus,212,217,O
group,218,223,O
discussions,224,235,O
pilot,240,245,O
testing,246,253,O
refine,257,263,O
survey,268,274,O
instrument,275,285,O
patient,287,294,O
interviews,295,305,O
began,306,311,O
fall,319,323,O
2006,327,331,O
conducted,341,350,O
trained,354,361,O
students,362,370,O
public,378,384,O
health,385,391,O
program,392,399,O
American,407,415,O
University,416,426,O
Armenia,430,437,O
Students,439,447,O
received,448,456,O
training,457,465,O
study,473,478,O
designer,479,487,O
principles,496,506,O
interview,510,519,O
ethics,520,526,O
interviewing,531,543,O
processes,544,553,O
patient,560,567,O
interviews,568,578,O
conducted,584,593,O
Republican,601,611,O
Dispensary,612,622,O
Abovian,626,633,O
Marz,634,638,O
national,644,652,O
TB,653,655,O
diagnostic,656,666,O
treatment,671,680,O
facility,681,689,O
suspected,703,712,O
cases,713,718,O
country,734,741,O
referred,746,754,O
diagnostic,759,769,O
confirmation,770,782,O
past,791,795,O
years,804,809,O
strong,811,817,O
financial,818,827,O
support,828,835,O
provided,845,853,O
Armenia,857,864,O
number,870,876,O
international,880,893,O
organizations,894,907,O
German,921,927,O
Gesellschaft,928,940,O
fur,941,944,O
Technische,945,955,O
Zusammenarbeit,956,970,O
GTZ,972,975,O
Global,982,988,O
Fund,989,993,O
Fight,997,1002,O
AIDS,1003,1007,O
Tuberculosis,1009,1021,O
Malaria,1026,1033,O
Red,1043,1046,O
Cross,1047,1052,O
enabled,1064,1071,O
microscopic,1077,1088,O
culture,1093,1100,O
examinations,1101,1113,O
TB,1123,1125,O
case,1126,1130,O
performed,1137,1146,O
National,1154,1162,O
Reference,1163,1172,O
Laboratory,1173,1183,O
located,1184,1191,O
Republican,1199,1209,O
TB,1210,1212,O
Dispensary,1213,1223,O
culture,1229,1236,O
confirmed,1237,1246,O
TB,1247,1249,O
cases,1250,1255,O
admitted,1260,1268,O
patients,1275,1283,O
undergoing,1290,1300,O
initial,1305,1312,O
phase,1313,1318,O
therapy,1322,1329,O
confirmed,1343,1352,O
TB,1353,1355,O
patients,1356,1364,O
Armenia,1368,1375,O
referred,1380,1388,O
dispensaries,1405,1417,O
treatment,1422,1431,O
population,1438,1448,O
represents,1449,1459,O
known,1464,1469,O
TB,1470,1472,O
cases,1473,1478,O
country,1486,1493,O
culture,1510,1517,O
confirmed,1518,1527,O
TB,1528,1530,O
patients,1534,1542,O
present,1543,1550,O
time,1558,1562,O
interviewer,1570,1581,O
visits,1582,1588,O
eligible,1594,1602,O
inclusion,1607,1616,O
study,1624,1629,O
study,1635,1640,O
group,1641,1646,O
included,1647,1655,O
new,1661,1664,O
relapsed,1669,1677,O
patients,1678,1686,O
systematic,1693,1703,O
sample,1704,1710,O
inpatient,1718,1727,O
TB,1728,1730,O
population,1731,1741,O
interviewers,1752,1764,O
visited,1765,1772,O
hospital,1779,1787,O
room,1788,1792,O
identify,1796,1804,O
patients,1805,1813,O
willing,1814,1821,O
participate,1825,1836,O
yielded,1838,1845,O
participation,1848,1861,O
rate,1862,1866,O
approximately,1870,1883,O
80,1884,1886,O
total,1891,1896,O
240,1900,1903,O
patients,1904,1912,O
Interviewers,1915,1927,O
collected,1928,1937,O
demographic,1938,1949,O
information,1950,1961,O
asked,1966,1971,O
patient,1977,1984,O
recall,1988,1994,O
began,2011,2016,O
feel,2020,2024,O
ill,2025,2028,O
symptoms,2035,2043,O
experienced,2049,2060,O
long,2066,2070,O
symptom,2077,2084,O
onset,2085,2090,O
waited,2096,2102,O
doctor,2112,2118,O
reasons,2126,2133,O
delaying,2138,2146,O
medical,2147,2154,O
evaluation,2155,2165,O
type,2171,2175,O
facility,2179,2187,O
sought,2208,2214,O
care,2215,2219,O
initial,2225,2232,O
diagnosis,2233,2242,O
referred,2261,2269,O
evaluation,2282,2292,O
adherence,2304,2313,O
treatment,2317,2326,O
diagnosed,2332,2341,O
TB,2347,2349,O
2006,2354,2358,O
129,2360,2363,O
planned,2371,2378,O
250,2379,2382,O
surveys,2383,2390,O
completed,2396,2405,O
Data,2407,2411,O
collection,2412,2422,O
resumed,2423,2430,O
fall,2438,2442,O
2007,2446,2450,O
total,2457,2462,O
240,2466,2469,O
interviews,2470,2480,O
conducted,2486,2495,O
Summary,0,7,O
Kindt,8,13,O
et,14,16,O
al,17,19,O
1,20,21,O
published,22,31,O
report,34,40,O
entitled,41,49,O
Intestinal,51,61,B-Multi-tissue_structure
immune,62,68,O
activation,69,79,O
presumed,83,91,O
post,92,96,O
infectious,97,107,O
functional,108,118,O
syspepsia,119,128,O
August,137,143,O
issue,144,149,O
Neurogastroenterology,153,174,O
Motility,179,187,O
2009,191,195,O
comparing,200,209,O
signs,214,219,O
inflammation,223,235,O
degree,244,250,O
hyperplasia,254,265,O
enterochromaffin,273,289,B-Cell
cells,290,295,I-Cell
EC,297,299,B-Cell
duodenal,304,312,O
biopsies,313,321,O
obtained,322,330,O
patients,336,344,O
presumed,350,358,O
post,359,363,O
infectious,364,374,O
functional,375,385,O
dyspepsia,386,395,O
PI,397,399,O
FD,400,402,O
unspecified,408,419,O
onset,420,425,O
functional,426,436,O
dyspepsia,437,446,O
U,448,449,O
FD,450,452,O
showed,460,466,O
PI,472,474,O
FD,475,477,O
associated,481,491,O
persistence,497,508,O
focal,512,517,O
T,518,519,B-Cell
cell,520,524,I-Cell
aggregates,525,535,O
decrease,537,545,O
CD4,549,552,B-Cell
cells,554,559,I-Cell
increased,564,573,O
macrophage,574,584,B-Cell
counts,585,591,O
surrounding,592,603,O
crypts,608,614,B-Multi-tissue_structure
significant,628,639,O
differences,640,651,O
numbers,659,666,O
EC,670,672,B-Cell
chromogranin,676,688,B-Cell
positive,696,704,I-Cell
cells,705,710,I-Cell
mast,712,716,B-Cell
cells,717,722,I-Cell
finding,730,737,O
indicate,742,750,O
impaired,751,759,O
ability,760,767,O
immune,775,781,B-Anatomical_system
system,782,788,I-Anatomical_system
cases,798,803,O
terminate,807,816,O
inflammatory,821,833,O
response,834,842,O
acute,852,857,O
insult,858,864,O
Temporary,0,9,O
migration,10,19,O
module,20,26,O
temporary,29,38,O
migration,39,48,O
census,49,55,O
module,56,62,O
conducted,67,76,O
2002,80,84,O
2007,89,93,O
People,95,101,O
identified,111,121,O
temporary,125,134,O
migrants,135,143,O
entered,149,156,O
module,166,172,O
household,180,189,O
respondent,190,200,O
answered,201,209,O
questions,210,219,O
migration,230,239,O
Key,241,244,O
areas,245,250,O
included,251,259,O
duration,264,272,O
migration,276,285,O
destination,287,298,O
reasons,300,307,O
migration,312,321,O
return,323,329,O
pattern,330,337,O
communication,339,352,O
pattern,353,360,O
remittances,362,373,O
linked,375,381,O
moves,382,387,O
child,392,397,O
care,398,402,O
arrangements,403,415,O
MOR1 K,0,5,O
expression,6,16,O
binding,21,28,O
pattern,29,36,O
schematic,46,55,O
diagram,56,63,O
illustrates,64,75,O
exonic,80,86,O
composition,87,98,O
relative,103,111,O
positions,112,121,O
PCR,125,128,O
primers,129,136,O
designed,137,145,O
amplify,149,156,O
major,161,166,O
MOR1,167,171,O
isoform,172,179,O
newly,188,193,O
identified,194,204,O
alternative,205,216,O
MOR1 K,217,222,O
isoform,223,230,O
relative,236,244,O
positions,245,254,O
translation,258,269,O
initiation,270,280,O
start,281,286,O
stop,291,295,O
codons,296,302,O
designated,307,317,O
ATG,321,324,O
TGA,329,332,O
respectively,334,346,O
predicted,352,361,O
protein,362,369,O
structure,370,379,O
MOR1,383,387,O
MOR1 K,392,397,O
isoforms,398,406,O
schematically,410,423,O
presented,424,433,O
Translation,435,446,O
MOR1 K,454,459,O
variant,460,467,O
results,468,475,O
6TM,481,484,O
receptor,485,493,O
truncated,495,504,O
N,512,513,O
terminus,514,522,O
B,525,526,O
Real,528,532,O
time,533,537,O
PCR,538,541,O
performed,546,555,O
total,559,564,O
RNA,565,568,O
samples,569,576,O
human,586,591,O
brain,592,597,B-Organ
regions,598,605,O
known,606,611,O
express,615,622,O
MOR1,623,627,O
Primers,629,636,O
specific,637,645,O
exons,650,655,O
1,656,657,O
2,662,663,O
measure,677,684,O
MOR1,685,689,O
primers,694,701,O
specific,702,710,O
exons,715,720,O
13,721,723,O
exon,728,732,O
2,733,734,O
measure,748,755,O
MOR1 K,756,761,O
32,762,764,O
GAP3DH,767,773,O
control,788,795,O
cDNA,800,804,O
loading,805,812,O
PCR,817,820,O
efficiency,821,831,O
C,834,835,O
Confocal,837,845,O
images,846,852,O
C,856,857,O
terminally,858,868,O
MYC,869,872,O
tagged,873,879,O
MOR1,880,884,O
FLAG,888,892,O
tagged,893,899,O
MOR1 K,900,905,O
overexpressed,906,919,O
HEK293,923,929,B-Cell
cells,930,935,I-Cell
stained,940,947,O
Anti,960,964,O
MYC,965,968,O
Tag,969,972,O
Antibody,973,981,O
Alexa,983,988,O
Fluor,989,994,O
647,995,998,O
Conjugate,999,1008,O
Anti,1013,1017,O
DYKDDDDK,1018,1026,O
Tag,1027,1030,O
Antibody,1031,1039,O
Alexa,1041,1046,O
Fluor,1047,1052,O
555,1053,1056,O
conjugate,1057,1066,O
Cells,1069,1074,B-Cell
transfected,1075,1086,O
MOR1,1092,1096,O
showed,1097,1103,O
membrane,1104,1112,B-Cellular_component
expression,1113,1123,O
receptor,1127,1135,O
cell,1143,1147,B-Cell
transfected,1148,1159,O
MOR1 K,1165,1170,O
express,1171,1178,O
receptor,1179,1187,O
intracellular,1193,1206,B-Immaterial_anatomical_entity
D,1209,1210,O
Confocal,1212,1220,O
images,1221,1227,O
C,1231,1232,O
terminally,1233,1243,O
FLAG,1244,1248,O
tagged,1249,1255,O
MOR1 K,1256,1261,O
overexpressed,1262,1275,O
Be2C,1279,1283,B-Cell
cells,1284,1289,I-Cell
stained,1294,1301,O
Anti,1314,1318,O
FLAG,1319,1323,O
M2,1324,1326,O
Antibody,1327,1335,O
Alexa,1336,1341,O
Fluor,1342,1347,O
Conjugate,1348,1357,O
fluorescent,1361,1372,O
labeled,1373,1380,O
naloxone,1381,1389,O
FNAL,1391,1395,O
Cells,1398,1403,B-Cell
transfected,1404,1415,O
MOR1 K,1421,1426,O
showed,1427,1433,O
intracellular,1434,1447,B-Immaterial_anatomical_entity
retention,1448,1457,O
FNAL,1461,1465,O
co,1471,1473,O
localized,1474,1483,O
antibody,1489,1497,O
labeled,1498,1505,O
receptor,1506,1514,O
E,1517,1518,O
binding,1524,1531,O
naloxone,1535,1543,O
MOR1 K,1547,1552,O
assessed,1557,1565,O
flow,1572,1576,O
cytometry,1577,1586,O
measure,1590,1597,O
FNAL,1598,1602,O
retention,1603,1612,O
Be2C,1614,1618,B-Cell
cells,1619,1624,I-Cell
transfected,1625,1636,O
MOR1,1649,1653,O
MOR1 K,1657,1662,O
isoforms,1663,1671,O
showed,1672,1678,O
increased,1679,1688,O
retention,1689,1698,O
FNAL,1702,1706,O
concentrations,1710,1724,O
0,1728,1729,O
1,1730,1731,O
1,1736,1737,O
muM,1738,1741,O
FNAL,1743,1747,O
retention,1748,1757,O
abolished,1762,1771,O
presence,1779,1787,O
10,1791,1793,O
muM,1794,1797,O
unlabelled,1798,1808,O
naloxone,1809,1817,O
Nal,1819,1822,O
panel,1828,1833,O
E,1834,1835,O
data,1837,1841,O
presented,1846,1855,O
mean,1859,1863,O
SEM,1866,1869,O
P,1872,1873,O
0,1876,1877,O
05,1878,1880,O
different,1881,1890,O
controls,1896,1904,O
Authors,0,7,O
contributions,9,22,O
MBH,23,26,O
pathological,36,48,O
diagnosis,49,58,O
responsible,67,78,O
conception,83,93,O
final,98,103,O
approval,104,112,O
manuscript,120,130,O
MB,132,134,O
carried,135,142,O
literature,151,161,O
search,162,168,O
drafted,173,180,O
manuscript,185,195,O
IC,197,199,O
carried,200,207,O
surgical,216,224,O
procedure,225,234,O
reviewed,239,247,O
manuscript,252,262,O
RM,264,266,O
carried,267,274,O
surgical,283,291,O
procedure,292,301,O
provided,303,311,O
clinical,312,320,O
details,321,328,O
followed,330,338,O
patient,346,353,O
obtained,358,366,O
consent,371,378,O
publish,382,389,O
case,395,399,O
report,400,406,O
authors,412,419,O
read,420,424,O
approved,429,437,O
final,442,447,O
manuscript,448,458,O
Breast,0,6,B-Pathological_formation
cancer,7,13,I-Pathological_formation
incidence,18,27,O
breast,31,37,B-Pathological_formation
cancer,38,44,I-Pathological_formation
higher,51,57,O
rest,70,74,O
population,82,92,O
Tamoxifen,94,103,O
worsen,133,139,O
symptoms,140,148,O
43,150,152,O
Women,155,160,O
need,161,165,O
specific,171,179,O
management,180,190,O
treatment,195,204,O
HAE,208,211,O
Short,213,218,O
term,219,223,O
prophylaxis,224,235,O
options,243,250,O
available,255,264,O
attenuated,266,276,O
androgens,277,286,O
tranexamic,288,298,O
acid,299,303,O
C1Inh,307,312,O
concentrate,313,324,O
specific,338,346,O
problem,347,354,O
use,363,366,O
theses,370,376,O
drugs,377,382,O
short,387,392,O
course,393,399,O
female,403,409,O
patients,410,418,O
case,423,427,O
short,431,436,O
term,437,441,O
prophylaxis,442,453,O
attenuated,459,469,O
androgens,470,479,O
virilisation,484,496,O
observed,506,514,O
44,516,518,O
45,519,521,O
Acute,524,529,O
attack,530,536,O
treatment,537,546,O
specific,560,568,O
problem,569,576,O
use,585,588,O
C1inh,592,597,O
concentrate,598,609,O
tranexamic,611,621,O
acid,622,626,O
icatibant,628,637,O
ecallantide,642,653,O
female,657,663,O
patients,664,672,O
RNA,0,3,O
extraction,4,14,O
reverse,19,26,O
transcription,27,40,O
Total,41,46,O
RNA,47,50,O
extracted,56,65,O
cells,71,76,B-Cell
Trizol,90,96,O
reagent,97,104,O
Invitrogen,106,116,O
RNeasy,121,127,O
kit,128,131,O
Qiagen,133,139,O
treated,145,152,O
DNaseI,158,164,O
reagent,165,172,O
Macherey,174,182,O
Nagel,183,188,O
30,194,196,O
min,197,200,O
room,204,208,O
temperature,209,220,O
Reverse,222,229,O
transcriptions,230,244,O
performed,250,259,O
1microg,266,273,O
total,274,279,O
RNA,280,283,O
High,292,296,O
capacity,297,305,O
cDNA,306,310,O
reverse,311,318,O
transcription,319,332,O
kit,333,336,O
RNase,342,347,O
Inhibitor,348,357,O
Applied,359,366,O
Biosystems,367,377,O
Statistical,0,11,O
results,12,19,O
showing,20,27,O
significant,28,39,O
differences,40,51,O
habitats,60,68,O
Definition,0,10,O
pathogens,14,23,O
remains,27,34,O
difficult,35,44,O
determine,48,57,O
organisms,70,79,O
detected,80,88,O
DNA,96,99,O
Detection,100,109,O
Kit,110,113,O
true,118,122,O
pathogens,123,132,O
applies,144,151,O
lesser,172,178,O
degree,179,185,O
conventional,190,202,O
blood,203,208,B-Organism_substance
culture,209,216,O
analysis,217,225,O
detected,236,244,O
organisms,245,254,O
considered,260,270,O
pathogens,277,286,O
results,294,301,O
culture,305,312,O
tests,313,318,O
samples,324,331,O
suspected,339,348,O
infectious,349,359,O
sites,360,365,O
coincided,366,375,O
results,385,392,O
DNA,396,399,O
Detection,400,409,O
Kit,410,413,O
blood,417,422,B-Organism_substance
culture,423,430,O
analysis,431,439,O
culture,445,452,O
data,453,457,O
sputum,461,467,B-Organism_substance
urine,469,474,B-Organism_substance
pus,476,479,B-Organism_substance
drainage,484,492,O
fluid,493,498,B-Organism_substance
define,512,518,O
pathogens,523,532,O
decision,536,544,O
identified,562,572,O
organism,573,581,O
pathogen,588,596,O
taken,601,606,O
based,607,612,O
decision,620,628,O
tree,629,633,O
shown,634,639,O
Figure,643,649,O
1,650,651,O
organism,673,681,O
detected,686,694,O
DNA,703,706,O
Detection,707,716,O
Kit,717,720,O
blood,725,730,B-Organism_substance
culture,731,738,O
analysis,739,747,O
detected,753,761,O
organism,762,770,O
considered,775,785,O
infectious,789,799,O
pathogen,800,808,O
discrepancy,825,836,O
organism,849,857,O
detected,867,875,O
SeptiFast,879,888,O
analysis,889,897,O
detected,907,915,O
blood,919,924,B-Organism_substance
culture,925,932,O
analysis,933,941,O
organism,952,960,O
detected,970,978,O
tests,995,1000,O
samples,1013,1020,O
taken,1021,1026,O
infection,1036,1045,O
site,1046,1050,O
analyzed,1056,1064,O
second,1074,1080,O
culture,1081,1088,O
test,1089,1093,O
suspected,1101,1110,O
infectious,1111,1121,O
site,1122,1126,O
revealed,1127,1135,O
presence,1140,1148,O
organism,1161,1169,O
organism,1176,1184,O
considered,1189,1199,O
pathogen,1208,1216,O
microbial,1225,1234,O
strain,1235,1241,O
detected,1251,1259,O
sample,1271,1277,O
checked,1287,1294,O
second,1299,1305,O
culture,1306,1313,O
results,1314,1321,O
suspected,1329,1338,O
infectious,1339,1349,O
sites,1350,1355,O
result,1365,1371,O
identified,1372,1382,O
strain,1392,1398,O
identified,1407,1417,O
SeptiFast,1421,1430,O
analysis,1431,1439,O
decided,1452,1459,O
strain,1470,1476,O
pathogen,1483,1491,O
strain,1509,1515,O
detected,1531,1539,O
assays,1555,1561,O
determined,1571,1581,O
patient,1589,1596,O
involved,1597,1605,O
suffered,1606,1614,O
sepsis,1620,1626,O
Sepsis,1628,1634,O
defined,1638,1645,O
SIRS,1649,1653,O
caused,1654,1660,O
infection,1664,1673,O
definition,1679,1689,O
sepsis,1693,1699,O
based,1717,1722,O
International,1730,1743,O
Sepsis,1744,1750,O
Forum,1751,1756,O
Definition,1757,1767,O
Infection,1771,1780,O
ICU,1788,1791,O
Consensus,1792,1801,O
Conference,1802,1812,O
7,1814,1815,O
underlying,1834,1844,O
disease,1845,1852,O
acute,1856,1861,O
lymphoma,1862,1870,O
leukemia,1871,1879,O
malignant,1887,1896,B-Pathological_formation
lymphoma,1897,1905,I-Pathological_formation
ML,1907,1909,B-Pathological_formation
acute,1915,1920,O
myelogenous,1921,1932,O
leukemia,1933,1941,O
AML,1943,1946,O
definition,1953,1963,O
infection,1967,1976,O
defined,1980,1987,O
ability,1995,2002,O
detect,2006,2012,O
infectious,2013,2023,O
organisms,2024,2033,O
blood,2037,2042,B-Organism_substance
culture,2043,2050,O
analysis,2051,2059,O
patient,2068,2075,O
defined,2084,2091,O
having,2095,2101,O
sepsis,2102,2108,O
blood,2120,2125,I-Organism_substance
administered,2130,2142,O
patient,2150,2157,O
decided,2162,2169,O
strain,2179,2185,O
detected,2186,2194,O
subsequent,2198,2208,O
DNA,2209,2212,O
Detection,2213,2222,O
Kit,2223,2226,O
blood,2230,2235,B-Organism_substance
culture,2236,2243,O
analysis,2244,2252,O
pathogen,2263,2271,O
Figure,2273,2279,O
1,2280,2281,O
Flowchart,2282,2291,O
pathogen,2296,2304,O
decision,2305,2313,O
Samples,2315,2322,O
defined,2328,2335,O
negative,2339,2347,O
pathogens,2352,2361,O
pathogen,2367,2375,O
detected,2389,2397,O
method,2405,2411,O
analysis,2415,2423,O
seven,2431,2436,O
days,2437,2441,O
type,2458,2462,O
culture,2466,2473,O
test,2474,2478,O
detect,2487,2493,O
pathogen,2499,2507,O
detect,2518,2524,O
organisms,2531,2540,O
CoNS,2542,2546,O
bacteria,2547,2555,O
represented,2567,2578,O
Staphylococcus,2586,2600,O
epidermidis,2601,2612,O
S,2614,2615,O
epidermidis,2617,2628,O
Streptococcus,2634,2647,O
spp,2648,2651,O
indigenous,2657,2667,O
bacteria,2668,2676,O
cause,2687,2692,O
contamination,2693,2706,O
assays,2710,2716,O
pathogens,2720,2729,O
CoNS,2747,2751,O
Streptococcus,2755,2768,O
spp,2769,2772,O
detected,2779,2787,O
blood,2791,2796,B-Organism_substance
culture,2797,2804,O
SeptiFast,2809,2818,O
analysis,2819,2827,O
following,2833,2842,O
criteria,2843,2851,O
applied,2857,2864,O
define,2868,2874,O
strains,2889,2896,O
represented,2897,2908,O
pathogenic,2911,2921,O
infection,2922,2931,O
1,2934,2935,O
Tests,2937,2942,O
performed,2948,2957,O
twice,2967,2972,O
48,2980,2982,O
hours,2983,2988,O
CoNS,3006,3010,O
detected,3016,3024,O
blood,3028,3033,B-Organism_substance
culture,3034,3041,O
SeptiFast,3045,3054,O
analysis,3055,3063,O
2,3066,3067,O
CoNS,3069,3073,O
Streptococcus,3077,3090,O
spp,3091,3094,O
detected,3101,3109,O
different,3117,3126,O
blood,3127,3132,B-Organism_substance
culture,3133,3140,O
tests,3141,3146,O
separately,3157,3167,O
performed,3168,3177,O
twice,3178,3183,O
48,3191,3193,O
hours,3194,3199,O
3,3207,3208,O
CoNS,3210,3214,O
Streptococcus,3218,3231,O
spp,3232,3235,O
detected,3242,3250,O
twice,3251,3256,O
tests,3268,3273,O
performed,3284,3293,O
times,3300,3305,O
11,3307,3309,O
15,3310,3312,O
sample,3320,3326,O
s,3327,3328,O
results,3329,3336,O
met,3337,3340,O
criteria,3360,3368,O
sample,3379,3385,B-Organism_substance
evaluated,3390,3399,O
pathogen,3405,3413,O
distinction,3419,3430,O
pathogen,3439,3447,O
contamination,3452,3465,O
determined,3475,3485,O
CoNS,3490,3494,O
Streptococcus,3498,3511,O
spp,3512,3515,O
crossing,3526,3534,O
point,3535,3540,O
Cp,3542,3544,O
obtained,3546,3554,O
LightCycler,3565,3576,O
analysis,3577,3585,O
software,3586,3594,O
v4,3595,3597,O
05,3598,3600,O
Cp,3606,3608,O
represents,3609,3619,O
point,3624,3629,O
amplification,3637,3650,O
cycle,3651,3656,O
amplification,3667,3680,O
curve,3681,3686,O
crosses,3687,3694,O
detection,3699,3708,O
threshold,3709,3718,O
CoNS,3725,3729,O
Streptococcus,3733,3746,O
spp,3747,3750,O
detected,3757,3765,O
LightCycler,3776,3787,O
analysis,3788,3796,O
software,3797,3805,O
v4,3806,3808,O
05,3809,3811,O
Cp,3815,3817,O
20,3831,3833,O
defined,3838,3845,O
indicating,3849,3859,O
pathogen,3862,3870,O
Cp,3877,3879,O
20,3888,3890,O
defined,3895,3902,O
contamination,3906,3919,O
checking,3923,3931,O
amplification,3936,3949,O
curve,3950,3955,O
Conclusion,0,10,O
study,17,22,O
demonstrates,23,35,O
surgery,41,48,O
plus,49,53,O
chemotherapy,54,66,O
radiation,71,80,O
therapy,81,88,O
helpful,92,99,O
treating,104,112,O
patients,113,121,O
pelvic,127,133,B-Pathological_formation
Ewing,134,139,I-Pathological_formation
s,140,141,I-Pathological_formation
sarcoma,142,149,I-Pathological_formation
particularly,151,163,O
achieving,167,176,O
local,177,182,O
control,183,190,O
Fractional,0,10,O
atomic,11,17,O
coordinates,18,29,O
isotropic,34,43,O
equivalent,47,57,O
isotropic,58,67,O
displacement,68,80,O
parameters,81,91,O
A2,93,95,O
x,97,98,O
y,99,100,O
z,101,102,O
Uiso,103,107,O
Ueq,109,112,O
C1,113,115,O
0,116,117,O
3043,118,122,O
3,124,125,O
0,127,128,O
1779,129,133,O
4,135,136,O
0,138,139,O
79280,140,145,O
13,147,149,O
0,151,152,O
0445,153,157,O
6,159,160,O
C2,162,164,O
0,165,166,O
4358,167,171,O
4,173,174,O
0,176,177,O
1697,178,182,O
5,184,185,O
0,187,188,O
84058,189,194,O
17,196,198,O
0,200,201,O
0604,202,206,O
8,208,209,O
H2,211,213,O
0,214,215,O
4201,216,220,O
0,221,222,O
1476,223,227,O
0,228,229,O
8809,230,234,O
0,235,236,O
072,237,240,O
C3,242,244,O
0,245,246,O
5911,247,251,O
4,253,254,O
0,256,257,O
1953,258,262,O
6,264,265,O
0,267,268,O
8269,269,273,O
2,275,276,O
0,278,279,O
0783,280,284,O
12,286,288,O
H3,290,292,O
0,293,294,O
6811,295,299,O
0,300,301,O
1914,302,306,O
0,307,308,O
8584,309,313,O
0,314,315,O
094,316,319,O
C4,321,323,O
0,324,325,O
6130,326,330,O
4,332,333,O
0,335,336,O
2267,337,341,O
6,343,344,O
0,346,347,O
7670,348,352,O
2,354,355,O
0,357,358,O
0773,359,363,O
11,365,367,O
H4,369,371,O
0,372,373,O
7180,374,378,O
0,379,380,O
2427,381,385,O
0,386,387,O
7582,388,392,O
0,393,394,O
093,395,398,O
C5,400,402,O
0,403,404,O
4818,405,409,O
5,411,412,O
0,414,415,O
2344,416,420,O
5,422,423,O
0,425,426,O
7202,427,431,O
2,433,434,O
0,436,437,O
0746,438,442,O
10,444,446,O
H5,448,450,O
0,451,452,O
4980,453,457,O
0,458,459,O
2547,460,464,O
0,465,466,O
6798,467,471,O
0,472,473,O
090,474,477,O
C6,479,481,O
0,482,483,O
3257,484,488,O
4,490,491,O
0,493,494,O
2121,495,499,O
4,501,502,O
0,504,505,O
73293,506,511,O
15,513,515,O
0,517,518,O
0562,519,523,O
7,525,526,O
H6,528,530,O
0,531,532,O
2360,533,537,O
0,538,539,O
2200,540,544,O
0,545,546,O
7015,547,551,O
0,552,553,O
067,554,557,O
C7,559,561,O
0,562,563,O
1252,564,568,O
3,570,571,O
0,573,574,O
3838,575,579,O
4,581,582,O
0,584,585,O
90059,586,591,O
11,593,595,O
0,597,598,O
0400,599,603,O
6,605,606,O
C8,608,610,O
0,611,612,O
2051,613,617,O
4,619,620,O
0,622,623,O
5522,624,628,O
4,630,631,O
0,633,634,O
90920,635,640,O
13,642,644,O
0,646,647,O
0484,648,652,O
6,654,655,O
H8,657,659,O
0,660,661,O
2132,662,666,O
0,667,668,O
6288,669,673,O
0,674,675,O
8758,676,680,O
0,681,682,O
058,683,686,O
C9,688,690,O
0,691,692,O
2725,693,697,O
4,699,700,O
0,702,703,O
6041,704,708,O
4,710,711,O
0,713,714,O
96827,715,720,O
15,722,724,O
0,726,727,O
0558,728,732,O
7,734,735,O
C10,737,740,O
0,741,742,O
2645,743,747,O
4,749,750,O
0,752,753,O
4935,754,758,O
4,760,761,O
1,763,764,O
01861,765,770,O
14,772,774,O
0,776,777,O
0590,778,782,O
8,784,785,O
H10,787,790,O
0,791,792,O
3122,793,797,O
0,798,799,O
5293,800,804,O
1,805,806,O
0582,807,811,O
0,812,813,O
071,814,817,O
C11,819,822,O
0,823,824,O
1830,825,829,O
4,831,832,O
0,834,835,O
3278,836,840,O
4,842,843,O
1,845,846,O
00819,847,852,O
13,854,856,O
0,858,859,O
0534,860,864,O
7,866,867,O
C12,869,872,O
0,873,874,O
1118,875,879,O
3,881,882,O
0,884,885,O
2699,886,890,O
4,892,893,O
0,895,896,O
95062,897,902,O
12,904,906,O
0,908,909,O
0480,910,914,O
6,916,917,O
H12,919,922,O
0,923,924,O
0561,925,929,O
0,930,931,O
1577,932,936,O
0,937,938,O
9451,939,943,O
0,944,945,O
058,946,949,O
N1,951,953,O
0,954,955,O
0494,956,960,O
3,962,963,O
0,965,966,O
3297,967,971,O
3,973,974,O
0,976,977,O
84009,978,983,O
10,985,987,O
0,989,990,O
0441,991,995,O
5,997,998,O
H1N,1000,1003,O
0,1004,1005,O
038,1006,1009,O
4,1011,1012,O
0,1014,1015,O
418,1016,1019,O
3,1021,1022,O
0,1024,1025,O
8138,1026,1030,O
12,1032,1034,O
0,1036,1037,O
053,1038,1041,O
O1,1043,1045,O
0,1047,1048,O
0021,1049,1053,O
3,1055,1056,O
0,1058,1059,O
1298,1060,1064,O
3,1066,1067,O
0,1069,1070,O
74998,1071,1076,O
9,1078,1079,O
0,1081,1082,O
0527,1083,1087,O
5,1089,1090,O
O2,1092,1094,O
0,1095,1096,O
1112,1097,1101,O
3,1103,1104,O
0,1107,1108,O
0066,1109,1113,O
3,1115,1116,O
0,1118,1119,O
85135,1120,1125,O
10,1127,1129,O
0,1131,1132,O
0574,1133,1137,O
6,1139,1140,O
Cl1,1142,1145,O
0,1146,1147,O
37237,1148,1153,O
16,1155,1157,O
0,1159,1160,O
81541,1161,1166,O
13,1168,1170,O
0,1172,1173,O
97944,1174,1179,O
5,1181,1182,O
0,1184,1185,O
0927,1186,1190,O
4,1192,1193,O
Cl2,1195,1198,O
0,1199,1200,O
16462,1201,1206,O
15,1208,1210,O
0,1212,1213,O
18752,1214,1219,O
15,1221,1223,O
1,1225,1226,O
07089,1227,1232,O
4,1234,1235,O
0,1237,1238,O
0834,1239,1243,O
4,1245,1246,O
S1,1248,1250,O
0,1251,1252,O
10584,1253,1258,O
7,1260,1261,O
0,1263,1264,O
14095,1265,1270,O
9,1272,1273,O
0,1275,1276,O
80800,1277,1282,O
3,1284,1285,O
0,1287,1288,O
0412,1289,1293,O
3,1295,1296,O
Crystal,0,7,O
data,8,12,O
C16H20N4,13,21,O
M,22,23,O
r,24,25,O
268,28,31,O
36,32,34,O
Monoclinic,35,45,O
12,52,54,O
819,55,58,O
4,60,61,O
b,65,66,O
8,69,70,O
441,71,74,O
3,76,77,O
c,81,82,O
13,85,87,O
310,88,91,O
4,93,94,O
beta,98,102,O
95,105,107,O
462,108,111,O
5,113,114,O
degrees,115,122,O
V,123,124,O
1433,127,131,O
7,132,133,O
8,135,136,O
A3,138,140,O
Z,141,142,O
4,145,146,O
Mo,147,149,O
Kalpha,150,156,O
radiation,157,166,O
mu,167,169,O
0,172,173,O
08,174,176,O
mm,177,179,O
1,180,181,O
T,182,183,O
298,186,189,O
2,191,192,O
K,194,195,O
0,196,197,O
33,198,200,O
x,201,202,O
0,203,204,O
28,205,207,O
x,208,209,O
0,210,211,O
21,212,214,O
mm,215,217,O
Crystal,0,7,O
data,8,12,O
C15H12ClN3O2S2,13,27,O
F,28,29,O
000,30,33,O
752,37,40,O
Mr,41,43,O
365,46,49,O
85,50,52,O
Dx,53,55,O
1,58,59,O
507,60,63,O
Mg,64,66,O
m,67,68,O
3,69,70,O
Monoclinic,71,81,O
P21,83,86,O
n,87,88,O
Mo,89,91,O
Kalpha,92,98,O
radiation,99,108,O
lambda,110,116,O
0,119,120,O
71073,121,126,O
Hall,129,133,O
symbol,134,140,O
P,143,144,O
2yn,145,148,O
Cell,149,153,B-Cell
parameters,154,164,O
25,170,172,O
reflections,173,184,O
10,189,191,O
175,192,195,O
2,197,198,O
theta,202,207,O
9,210,211,O
12degrees,212,221,O
b,222,223,O
8,226,227,O
4958,228,232,O
17,234,236,O
micro,240,245,O
0,248,249,O
51,250,252,O
mm,253,255,O
1,256,257,O
c,258,259,O
19,262,264,O
318,265,268,O
4,270,271,O
T,275,276,O
293,279,282,O
K,283,284,O
beta,285,289,O
105,292,295,O
01,296,298,O
3,300,301,O
degrees,302,309,O
Block,310,315,O
yellow,317,323,O
V,324,325,O
1613,328,332,O
0,333,334,O
6,336,337,O
A3,339,341,O
0,342,343,O
25,344,346,O
x,347,348,O
0,349,350,O
15,351,353,O
x,354,355,O
0,356,357,O
15,358,360,O
mm,361,363,O
Z,364,365,O
4,368,369,O
Results,0,7,O
Discussion,12,22,O
Figure,23,29,O
4,30,31,O
shows,32,37,O
frequency,42,51,O
response,52,60,O
device,68,74,O
plating,92,99,O
cells,100,105,B-Cell
frequency,114,123,O
range,124,129,O
measured,130,138,O
4,140,141,O
600,142,145,O
Hz,146,148,O
clear,160,165,O
peaks,166,171,O
seen,179,183,O
bare,191,195,O
device,196,202,O
cells,210,215,B-Cell
adhered,220,227,O
surface,235,242,O
shift,255,260,O
resonant,273,281,O
frequency,282,291,O
height,300,306,O
peaks,316,321,O
Table,323,328,O
1,329,330,O
shows,331,336,O
results,341,348,O
trial,358,363,O
second,370,376,O
trial,377,382,O
experiment,393,403,O
repeated,408,416,O
confirm,420,427,O
initial,432,439,O
results,440,447,O
plating,454,461,O
density,462,469,O
1300,473,477,O
cells,478,483,B-Cell
mm2,484,487,O
approximately,500,513,O
140,514,517,O
cells,518,523,B-Cell
portion,531,538,O
cantilever,546,556,O
free,557,561,O
vibrate,565,572,O
dimensions,574,584,O
shown,585,590,O
Figure,594,600,O
1,601,602,O
Table,605,610,O
1,611,612,O
Cantilever,613,623,O
response,624,632,O
data,633,637,O
trials,647,653,O
Experiment,654,664,O
1,666,667,O
Experiment,668,678,O
2,680,681,O
Freq,682,686,O
1,688,689,O
kHz,691,694,O
Amp,696,699,O
1,701,702,O
deg,704,707,O
Freq,709,713,O
2,715,716,O
kHz,718,721,O
Amp,723,726,O
2,728,729,O
deg,731,734,O
Freq,736,740,O
1,742,743,O
kHz,745,748,O
Amp,750,753,O
1,755,756,O
deg,758,761,O
Freq,763,767,O
2,769,770,O
kHz,772,775,O
Amp,777,780,O
2,782,783,O
deg,785,788,O
Initial,790,797,O
313,798,801,O
0,802,803,O
086,805,808,O
375,809,812,O
5,813,814,O
055,816,819,O
313,820,823,O
9,824,825,O
091,827,830,O
376,831,834,O
5,835,836,O
071,838,841,O
cells,847,852,B-Cell
307,853,856,O
5,857,858,O
031,860,863,O
371,864,867,O
0,868,869,O
018,871,874,O
308,875,878,O
052,880,883,O
370,884,887,O
5,888,889,O
043,891,894,O
Change,895,901,O
5,902,903,O
5,904,905,O
055,907,910,O
4,911,912,O
5,913,914,O
037,916,919,O
5,920,921,O
9,922,923,O
039,925,928,O
6,929,930,O
0,931,932,O
028,934,937,O
Figure,938,944,O
4,945,946,O
Phase,947,952,O
angle,953,958,O
vs,959,961,O
frequency,963,972,O
left,975,979,O
Phase,981,986,O
angle,987,992,O
impedance,996,1005,O
linear,1011,1017,O
regression,1018,1028,O
line,1029,1033,O
right,1036,1041,O
provide,1046,1053,O
easier,1057,1063,O
comparison,1064,1074,O
phase,1076,1081,O
angles,1082,1088,O
levelled,1099,1107,O
respect,1113,1120,O
linear,1128,1134,O
regression,1135,1145,O
line,1146,1150,O
passes,1156,1162,O
set,1176,1179,O
data,1183,1187,O
addition,1193,1201,O
cells,1205,1210,B-Cell
causes,1211,1217,O
peaks,1222,1227,O
shift,1231,1236,O
lower,1240,1245,O
frequencies,1246,1257,O
decrease,1262,1270,O
amplitude,1274,1283,O
peaks,1293,1298,O
shown,1299,1304,O
detectable,1319,1329,O
resonances,1330,1340,O
despite,1341,1348,O
relatively,1353,1363,O
wide,1364,1368,O
frequency,1369,1378,O
range,1379,1384,O
measured,1385,1393,O
electrical,1399,1409,O
detection,1410,1419,O
resonances,1423,1433,O
critically,1437,1447,O
compromised,1448,1459,O
strong,1467,1473,O
damping,1474,1481,O
imposed,1482,1489,O
cell,1497,1501,B-Cell
media,1502,1507,O
making,1509,1515,O
measurements,1522,1534,O
challenging,1540,1551,O
carried,1563,1570,O
air,1578,1581,O
vacuum,1590,1596,O
resonance,1603,1612,O
peaks,1613,1618,O
larger,1629,1635,O
amplitude,1636,1645,O
18,1647,1649,O
desired,1659,1666,O
vivo,1670,1674,O
application,1675,1686,O
work,1696,1700,O
sensor,1707,1713,O
stent,1718,1723,O
healing,1724,1731,O
expected,1743,1751,O
course,1764,1770,O
normal,1774,1780,O
healing,1781,1788,O
stent,1793,1798,O
fully,1807,1812,O
populated,1813,1822,O
significantly,1830,1843,O
thicker,1844,1851,O
layer,1852,1857,O
endothelial,1861,1872,B-Cell
cells,1873,1878,I-Cell
case,1887,1891,O
restenosis,1895,1905,O
lining,1912,1918,O
thicker,1933,1940,O
hamper,1951,1957,O
movement,1962,1970,O
cantilever,1978,1988,O
cause,1993,1998,O
peaks,2003,2008,O
eventually,2012,2022,O
undetectable,2030,2042,O
Frequent,2044,2052,O
measurements,2053,2065,O
resonant,2073,2081,O
frequencies,2082,2093,O
differentiate,2099,2112,O
end,2118,2121,O
state,2122,2127,O
possibility,2137,2148,O
device,2152,2158,O
failure,2159,2166,O
noninvasive,2172,2183,O
nature,2184,2190,O
measurements,2200,2212,O
transmitted,2225,2236,O
wirelessly,2237,2247,O
external,2254,2262,O
device,2263,2269,O
attractive,2283,2293,O
low,2298,2301,O
risk,2302,2306,O
option,2307,2313,O
monitoring,2318,2328,O
healing,2329,2336,O
2,0,1,O
1,2,3,O
Genome,5,11,O
sequencing,12,22,O
assembly,24,32,O
validation,37,47,O
DNA,48,51,O
shotgun,52,59,O
libraries,60,69,O
average,75,82,O
insert,83,89,O
sizes,90,95,O
1,99,100,O
6,101,102,O
6,107,108,O
5,109,110,O
kb,111,113,O
constructed,119,130,O
pUC118,134,140,O
TaKaRa,142,148,O
fosmid,161,167,O
library,168,175,O
average,181,188,O
insert,189,195,O
size,196,200,O
37,204,206,O
kb,207,209,O
constructed,214,225,O
pCC1FOS,229,236,O
EPICENTRE,238,247,O
described,252,261,O
previously,262,272,O
18,273,275,O
19,276,278,O
total,281,286,O
50,290,292,O
400,293,296,O
clones,297,303,O
34,305,307,O
560,308,311,O
10,313,315,O
752,316,319,O
5088,324,328,O
clones,329,335,O
libraries,341,350,O
1,356,357,O
6,358,359,O
6,361,362,O
5,363,364,O
37,369,371,O
kb,372,374,O
inserts,375,382,O
respectively,384,396,O
subjected,403,412,O
sequencing,416,426,O
ends,437,441,O
inserts,449,456,O
ABI,467,470,O
3730xl,471,477,O
DNA,478,481,O
Analyzer,482,490,O
Applied,492,499,O
Biosystems,500,510,O
Base,515,519,O
Station,520,527,O
DNA,528,531,O
Fragment,532,540,O
Analyzer,541,549,O
BST,550,553,O
0100,554,558,O
MJ,560,562,O
Research,563,571,O
Inc,573,576,O
Sequence,580,588,O
reads,589,594,O
trimmed,600,607,O
threshold,613,622,O
quality,623,630,O
value,631,636,O
20,640,642,O
Phred,646,651,O
assembled,656,665,O
Phrap,669,674,O
CONSED,679,685,O
assembly,686,694,O
tools,695,700,O
20,701,703,O
21,704,706,O
alignment,711,720,O
validation,725,735,O
contigs,739,746,O
Optical,748,755,O
Mapping,756,763,O
OpGen,765,770,O
Gaps,782,786,O
contigs,795,802,O
closed,808,814,O
sequencing,818,828,O
PCR,829,832,O
products,833,841,O
bridge,849,855,O
neighboring,860,871,O
contigs,872,879,O
Finally,881,888,O
base,895,899,O
K,903,904,O
setae,906,911,O
NBRC,912,916,O
14216 T,917,923,O
genome,924,930,O
ensured,935,942,O
sequenced,949,958,O
multiple,964,972,O
clones,973,979,O
directions,994,1004,O
Phrap,1010,1015,O
quality,1016,1023,O
score,1024,1029,O
70,1032,1034,O
direction,1047,1056,O
Phrap,1062,1067,O
quality,1068,1075,O
score,1076,1081,O
40,1084,1086,O
Chromosomal,1088,1099,O
terminus,1100,1108,O
determined,1113,1123,O
attaching,1130,1139,O
adenine,1140,1147,O
thymine,1152,1159,O
homopolymers,1160,1172,O
naked,1180,1185,O
3,1186,1187,O
ends,1189,1193,O
chromosome,1201,1211,B-Cellular_component
described,1215,1224,O
previously,1225,1235,O
5,1236,1237,O
Correlation,0,11,O
matrix,12,18,O
ear,23,26,O
E,28,29,O
traits,31,37,O
2006,41,45,O
data,47,51,O
water,57,62,O
stress,63,69,O
plots,70,75,O
lower,77,82,O
left,83,87,O
watered,98,105,O
plots,106,111,O
upper,113,118,O
right,119,124,O
350,129,132,O
maize,133,138,O
inbreds,139,146,O
FUNDING,0,7,O
National,8,16,O
Institutes,17,27,O
Health,31,37,O
grants,38,44,O
National,46,54,O
Institute,55,64,O
Environmental,68,81,O
Health,82,88,O
Sciences,89,97,O
National,106,114,O
Library,115,122,O
Medicine,126,134,O
R01,136,139,O
ES014065,140,148,O
R01,153,156,O
ES014065,157,165,O
04S1,166,170,O
CTD,174,177,O
INBRE,180,185,O
program,186,193,O
National,201,209,O
Center,210,216,O
Research,221,229,O
Resources,230,239,O
P20,241,244,O
RR016463,245,253,O
Funding,256,263,O
open,268,272,O
access,273,279,O
charge,280,286,O
NIEHS,288,293,O
grant,294,299,O
R01,301,304,O
ES014065,305,313,O
Conflict,316,324,O
interest,328,336,O
statement,337,346,O
declared,353,361,O
Tarsoconjunctival,0,17,B-Multi-tissue_structure
flap,18,22,I-Multi-tissue_structure
division,29,37,O
MoClo,0,5,O
cloning,6,13,O
protocol,14,22,O
Restriction,23,34,O
ligations,35,44,O
set,50,53,O
pipetting,60,69,O
tube,77,81,O
approximately,82,95,O
40,96,98,O
fmol,99,103,O
100,106,109,O
ng,110,112,O
DNA,116,119,O
4,126,127,O
kb,128,130,O
plasmid,131,138,O
DNA,148,151,O
component,152,161,O
PCR,163,166,O
product,167,174,O
plasmid,178,185,O
10,188,190,O
U,191,192,O
required,200,208,O
restriction,209,220,O
enzyme,221,227,O
BsaI,229,233,O
BpiI,237,241,O
10,247,249,O
U,250,251,O
T4,252,254,O
DNA,255,258,O
ligase,259,265,O
high,273,277,O
concentration,278,291,O
ligase,292,298,O
20,300,302,O
U,303,304,O
microl,305,311,O
Promega,316,323,O
ligation,324,332,O
buffer,333,339,O
final,345,350,O
reaction,351,359,O
volume,360,366,O
20,370,372,O
microl,373,379,O
reaction,385,393,O
incubated,398,407,O
thermocycler,413,425,O
5,430,431,O
hours,432,437,O
37degreesC,441,451,O
5,453,454,O
min,455,458,O
50degreesC,462,472,O
10,477,479,O
min,480,483,O
80degreesC,487,497,O
reaction,503,511,O
mix,512,515,O
added,525,530,O
100,534,537,O
microl,538,544,O
chemically,545,555,O
competent,556,565,O
DH10b,566,571,B-Cell
cells,572,577,I-Cell
incubated,579,588,O
15,593,595,O
30,596,598,O
min,599,602,O
ice,606,609,O
transformed,614,625,O
heat,629,633,O
shock,634,639,O
800,641,644,O
microl,645,651,O
liquid,655,661,O
LB,662,664,O
added,674,679,O
transformation,687,701,O
cells,711,716,B-Cell
let,722,725,O
recover,729,736,O
45,737,739,O
min,740,743,O
37degreesC,747,757,O
Different,759,768,O
aliquots,769,777,O
transformation,785,799,O
plated,805,811,O
LB,815,817,O
plates,818,824,O
containing,825,835,O
appropriate,840,851,O
antibiotic,852,862,O
number,868,874,O
colonies,878,886,O
counted,891,898,O
selected,914,922,O
plates,923,929,O
containing,931,941,O
countable,942,951,O
number,952,958,O
colonies,962,970,O
section,983,990,O
plates,998,1004,O
high,1015,1019,O
number,1020,1026,O
colonies,1030,1038,O
obtained,1044,1052,O
lowest,1066,1072,O
volume,1073,1079,O
plated,1080,1086,O
number,1092,1098,O
colonies,1102,1110,O
extrapolated,1120,1132,O
entire,1141,1147,O
transformation,1148,1162,O
level,1168,1173,O
2,1174,1175,O
2,1176,1177,O
cloning,1178,1185,O
type,1191,1195,O
IIS,1196,1199,O
enzymes,1200,1207,O
required,1213,1221,O
BpiI,1223,1227,O
BsaI,1232,1236,O
protocol,1247,1255,O
described,1268,1277,O
10,1296,1298,O
U,1299,1300,O
2,1305,1306,O
5,1307,1308,O
U,1309,1310,O
enzymes,1329,1336,O
BpiI,1337,1341,O
BsaI,1346,1350,O
respectively,1352,1364,O
optimize,1369,1377,O
efficiency,1378,1388,O
restriction,1396,1407,O
ligation,1408,1416,O
final,1425,1430,O
construct,1431,1440,O
containing,1441,1451,O
11,1452,1454,O
transcription,1455,1468,O
units,1469,1474,O
cL2,1476,1479,O
13,1480,1482,O
variation,1488,1497,O
protocol,1506,1514,O
follows,1527,1534,O
reaction,1540,1548,O
mix,1549,1552,O
set,1557,1560,O
containing,1564,1574,O
20,1575,1577,O
U,1578,1579,O
ligase,1580,1586,O
5,1588,1589,O
U,1590,1591,O
BpiI,1592,1596,O
5,1601,1602,O
U,1603,1604,O
BsaI,1605,1609,O
total,1616,1621,O
reaction,1622,1630,O
volume,1631,1637,O
20,1641,1643,O
microl,1644,1650,O
mix,1656,1659,O
incubated,1664,1673,O
thermocycler,1679,1691,O
following,1701,1710,O
parameters,1711,1721,O
incubation,1723,1733,O
2,1738,1739,O
minutes,1740,1747,O
37degreesC,1751,1761,O
5,1763,1764,O
minutes,1765,1772,O
16degreesC,1776,1786,O
steps,1793,1798,O
repeated,1799,1807,O
45,1808,1810,O
times,1811,1816,O
followed,1818,1826,O
incubation,1830,1840,O
5,1845,1846,O
minutes,1847,1854,O
50degreesC,1858,1868,O
10,1873,1875,O
minutes,1876,1883,O
80degreesC,1887,1897,O
reaction,1903,1911,O
mix,1912,1915,O
transformed,1920,1931,O
E,1935,1936,O
coli,1938,1942,O
chemically,1943,1953,O
competent,1954,1963,B-Cell
cells,1964,1969,I-Cell
described,1973,1982,O
Observed,0,8,O
type,9,13,O
error,16,21,O
datasets,26,34,O
simulated,35,44,O
hypothesis,60,70,O
DNA,0,3,O
isolation,4,13,O
solutions,18,27,O
DNA,37,40,O
isolation,41,50,O
purged,55,61,O
nitrogen,67,75,O
immediately,77,88,O
prior,89,94,O
use,98,101,O
supplemented,107,119,O
50,125,127,O
muM,128,131,O
phenyl,132,138,O
tert,139,143,O
butyl,144,149,O
nitrone,150,157,O
minimise,161,169,O
oxidative,170,179,O
damage,180,186,O
DNA,190,193,O
31,194,196,O
Qiagen,199,205,O
DNAeasy,206,213,O
Kit,214,217,O
69506,220,225,O
includes,227,235,O
Proteinase,237,247,O
K,248,249,O
AW1,251,254,O
AW2,256,259,O
AE,261,263,O
Spin,268,272,O
columns,273,280,O
Dithiothreitol,281,295,O
DTT,297,300,O
Sigma,302,307,O
Ethanol,309,316,O
Ajax,318,322,O
Finechem,323,331,O
214,333,336,O
2,337,338,O
5L,339,341,O
Nitrogen,343,351,O
purging,357,364,O
buffers,368,375,O
Genes,0,5,O
related,6,13,O
signal,17,23,O
transduction,24,36,O
day,40,43,O
7,44,45,O
regulated,54,63,O
genes,64,69,O
related,70,77,O
signal,81,87,O
transduction,88,100,O
PDE1A,106,111,O
MYO10,113,118,O
APOB,120,124,O
regulated,146,155,O
genes,156,161,O
CYTL1,167,172,O
IL6,177,180,O
day,185,188,O
14,189,191,O
regulated,200,209,O
genes,210,215,O
ANGPTL4,221,228,O
EPHA3,230,235,O
RASL10B,237,244,O
etc,246,249,O
regulated,265,274,O
genes,275,280,O
CXCL12,286,292,O
CCL8,294,298,O
VLDLR,303,308,O
genes,314,319,O
regulated,323,332,O
days,341,345,O
LEP,351,354,O
RAC3,356,360,O
RASL11B,366,373,O
regulated,390,399,O
days,405,409,O
MX1,415,418,O
WISP2,423,428,O
Notably,430,437,O
regulated,452,461,O
genes,462,467,O
PDE1A,468,473,O
APOB,475,479,O
ALCAM,481,486,O
PSCD4,488,493,O
CYTL1,495,500,O
IL6,506,509,O
strongly,520,528,O
expressed,529,538,O
day,542,545,O
7,546,547,O
day,556,559,O
14,560,562,O
ANGPTL4,570,577,O
EPHA3,579,584,O
RAB12,586,591,O
CXCL12,593,599,O
CCL8,601,605,O
VLDLR,611,616,O
strongly,627,635,O
expressed,636,645,O
day,649,652,O
14,653,655,O
day,664,667,O
7,668,669,O
SUMMARY,0,7,O
innate,17,23,O
adaptive,28,36,O
immune,37,43,B-Anatomical_system
subsystems,44,54,I-Anatomical_system
necessary,59,68,O
provide,72,79,O
effective,83,92,O
immune,93,99,O
response,100,108,O
actual,123,129,O
pathogenic,130,140,O
agent,141,146,O
immunization,156,168,O
effective,179,188,O
immunizations,189,202,O
induce,208,214,O
long,215,219,O
term,220,224,O
stimulation,225,236,O
humoral,249,256,O
cell,261,265,B-Cell
mediated,266,274,O
arms,275,279,O
adaptive,287,295,O
system,296,302,O
production,310,320,O
effector,324,332,B-Cell
cells,333,338,I-Cell
current,347,354,O
infection,355,364,O
memory,369,375,B-Cell
cells,376,381,I-Cell
future,386,392,O
infections,393,403,O
pathogenic,413,423,O
agent,424,429,O
seven,440,445,O
different,446,455,O
types,456,461,O
vaccines,465,473,O
currently,478,487,O
use,491,494,O
development,501,512,O
produce,518,525,O
effective,531,540,O
immunity,541,549,O
contributed,559,570,O
greatly,571,578,O
prevention,586,596,O
infectious,600,610,O
disease,611,618,O
world,630,635,O
Encoding,0,8,O
methods,9,16,O
SOLiDzipper,20,31,O
Notes,33,38,O
quality,47,54,O
value,55,60,O
QV,64,66,O
files,67,72,O
ABI,78,81,O
SOLiD,82,87,O
system,88,94,O
ranges,95,101,O
1,108,109,O
40,113,115,O
requires,123,131,O
6,132,133,O
bit,134,137,O
space,138,143,O
remaining,149,158,O
2,159,160,O
bit,161,164,O
space,165,170,O
1,178,179,O
byte,180,184,O
storing,201,208,O
quality,217,224,O
value,225,230,O
B,240,241,O
Csfasta,243,250,O
files,251,256,O
contain,257,264,O
sequence,269,277,O
information,278,289,O
digits,298,304,O
0123,307,311,O
require,320,327,O
2,328,329,O
bit,330,333,O
space,334,339,O
Provided,341,349,O
0,356,357,O
1,360,361,O
byte,362,366,O
character,367,376,O
csfasta,380,387,O
files,388,393,O
mapped,398,404,O
binary,408,414,O
data,415,419,O
00,421,423,O
1,427,428,O
01,434,436,O
2,440,441,O
10,446,448,O
3,452,453,O
11,459,461,O
4,464,465,O
byte,466,470,O
data,471,475,O
0113,477,481,O
encoded,490,497,O
1,503,504,O
byte,505,509,O
character,510,519,O
0x17,520,524,O
00010111,525,533,O
shift,543,548,O
operation,549,558,O
C,560,561,O
Sequence,563,571,O
IDs,572,575,O
extracted,580,589,O
QV,595,597,O
csfasta,602,609,O
files,610,615,O
combined,617,625,O
compressed,631,641,O
general,652,659,O
purpose,660,667,O
compression,668,679,O
methods,680,687,O
D,689,690,O
Encoded,692,699,O
data,700,704,O
stored,709,715,O
data,719,723,O
blocks,724,730,O
fixed,734,739,O
size,740,744,O
allows,751,757,O
selective,762,771,O
decoding,772,780,O
CONCLUSION,0,10,O
Intra,11,16,O
operative,17,26,O
monitoring,27,37,O
partial,41,48,O
pressure,49,57,O
tissue,61,67,B-Tissue
oxygen,68,74,O
PtiO2,76,81,O
sensitive,94,103,O
method,104,110,O
detecting,114,123,O
decrease,128,136,O
oxygen,140,146,O
cell,151,155,B-Cell
utilization,156,167,O
decreased,176,185,O
blood,186,191,B-Organism_substance
flow,192,196,O
temporary,205,214,O
clipping,215,223,O
definitive,234,244,O
clipping,245,253,O
middle,258,264,O
cerebral,265,273,B-Multi-tissue_structure
artery,274,280,I-Multi-tissue_structure
incidental,281,291,O
unruptured,292,302,O
aneurysm,303,311,B-Pathological_formation
surgery,312,319,O
Basal,322,327,O
values,328,334,O
obtained,337,345,O
influence,358,367,O
subarachnoid,371,383,B-Organism_substance
blood,384,389,I-Organism_substance
lower,396,401,O
expected,407,415,O
uninjured,420,429,O
brain,431,436,B-Organ
fact,447,451,O
unexplained,462,473,O
kept,485,489,O
mind,493,497,O
future,501,507,O
investigation,508,521,O
field,530,535,O
values,546,552,O
predictive,567,577,O
brain,581,586,B-Organ
ischemia,587,595,O
established,609,620,O
incomplete,625,635,O
recovery,636,644,O
continuous,648,658,O
decrease,659,667,O
PtiO2,671,676,O
values,677,683,O
definitive,690,700,O
clipping,701,709,O
considered,720,730,O
indicator,734,743,O
high,747,751,O
risk,752,756,O
development,765,776,O
post,780,784,O
operative,785,794,O
brain,795,800,B-Organ
infarction,801,811,O
indication,832,842,O
verification,847,859,O
position,867,875,O
clip,883,887,O
View,0,4,O
structure,12,21,O
title,29,34,O
compound,35,43,O
axis,56,60,O
displaying,61,71,O
chains,72,78,O
alternating,79,90,O
amine,96,101,O
groups,102,108,O
Results,0,7,O
Sequence,4,12,O
alignment,13,22,O
PY,26,28,O
NLSs,29,33,O
homologous,39,49,O
regions,50,57,O
C,61,62,O
NLS,63,66,O
EWS,74,77,O
protein,78,85,O
NLS,87,90,O
Sam68,94,99,O
FUS,104,107,O
TLS,108,111,O
protein,112,119,O
M9,124,126,O
NLS,127,130,O
hnRNP,134,139,O
A1,140,142,O
hnRNP,147,152,O
M,153,154,O
classified,156,166,O
PY,170,172,O
NLS,173,176,O
yellow,184,190,O
boxes,191,196,O
Phosphorylated,198,212,O
Y656,213,217,O
EWS,225,228,O
protein,229,236,O
Y440,241,245,O
Sam68,249,254,O
indicated,259,268,O
red,273,276,O
Positions,279,288,O
identical,292,301,O
residues,302,310,O
SAM68,314,319,O
EWS,324,327,O
C,328,329,O
NLS,330,333,O
indicated,338,347,O
bold,351,355,O
residues,360,368,O
identical,374,383,O
charges,384,391,O
underlined,396,406,O
Known,408,413,O
positions,414,423,O
FUS,431,434,O
TLS,435,438,O
mutations,439,448,O
ALS,452,455,O
bold,463,467,O
b,470,471,O
Subcellular,473,484,B-Cellular_component
localization,485,497,O
YFP,501,504,O
C,510,511,O
terminally,512,522,O
tagged,523,529,O
EWS,530,533,O
YFP,534,537,O
EWS,539,542,O
Y656A,543,548,O
YFP,550,553,O
EWS,555,558,O
Y656F,559,564,O
YFP,566,569,O
EWS,575,578,O
Y656D,579,584,O
YFP,586,589,O
green,594,599,O
Nuclei,602,608,B-Cellular_component
shown,613,618,O
DAPI,622,626,O
staining,627,635,O
blue,640,644,O
Bars,647,651,O
15,653,655,O
mum,656,659,O
Conclusions,0,11,O
Myocardial,12,22,B-Multi-tissue_structure
ischaemia,23,32,O
DCMR,40,44,O
independently,48,61,O
predictive,62,72,O
cardiac,76,83,B-Organ
events,84,90,O
patients,97,105,O
previous,111,119,O
myocardial,120,130,B-Multi-tissue_structure
revascularisation,131,148,O
Importing,0,9,O
citations,10,19,O
different,23,32,O
formats,33,40,O
Google,47,53,O
Scholar,54,61,O
Subject,0,7,O
disposition,8,19,O
Data,21,25,O
110,31,34,O
enrolled,35,43,O
subjects,44,52,O
eligible,58,66,O
analysis,71,79,O
demographics,85,97,O
study,105,110,O
subjects,111,119,O
site,124,128,O
recorded,134,142,O
Table,146,151,O
1,152,153,O
population,159,169,O
studied,170,177,O
predominantly,182,195,O
HIV,200,203,O
infected,204,212,O
92,214,216,O
study,231,236,O
entry,237,242,O
criteria,243,251,O
probability,259,270,O
infection,274,283,O
considered,288,298,O
low,305,308,O
risk,314,318,O
categories,319,329,O
assigned,330,338,O
time,346,350,O
study,354,359,O
entry,360,365,O
combined,371,379,O
groups,385,391,O
analysis,396,404,O
based,406,411,O
predisposition,419,433,O
PCP,438,441,O
analysis,447,455,O
groups,456,462,O
follows,471,478,O
HIV,484,487,O
AIDS,488,492,O
ii,495,497,O
lung,499,503,B-Organ
transplant,504,514,O
subject,520,527,O
dual,535,539,O
organ,540,545,B-Organ
transplant,546,556,O
lung,558,562,B-Organ
kidney,563,569,B-Organ
included,575,583,O
category,592,600,O
iii,604,607,O
organ,619,624,B-Organ
transplants,625,636,O
allogeneic,641,651,B-Cell
hematopoietic,652,665,I-Cell
stem,666,670,I-Cell
cell,671,675,I-Cell
transplants,676,687,O
HSCT,689,693,O
iv,697,699,O
leukemia,701,709,O
hematological,717,730,O
disorders,731,740,O
autologous,746,756,O
HSCT,757,761,O
v,764,765,O
solid,773,778,B-Pathological_formation
tumors,779,785,I-Pathological_formation
vi,792,794,O
nonmalignant,802,814,O
conditions,815,825,O
Table,827,832,O
1,833,834,O
Subject,836,843,O
enrollment,844,854,O
disposition,856,867,O
demographics,873,885,O
sitea,889,894,O
Characteristic,895,909,O
Valueb,910,916,O
Site,917,921,O
1,922,923,O
Site,924,928,O
2,929,930,O
Site,931,935,O
3,936,937,O
Site,938,942,O
4,943,944,O
Enrollment,945,955,O
Unique,956,962,O
subjects,963,971,O
18,972,974,O
29,975,977,O
22,978,980,O
62,981,983,O
Subjects,984,992,O
entering,993,1001,O
primary,1007,1014,O
analysisc,1015,1024,O
18,1025,1027,O
22,1028,1030,O
22,1031,1033,O
48,1034,1036,O
Subjects,1037,1045,O
repeat,1051,1057,O
visits,1058,1064,O
0,1065,1066,O
0,1067,1068,O
0,1069,1070,O
16,1071,1073,O
samples,1081,1088,O
assayed,1089,1096,O
18,1097,1099,O
22,1100,1102,O
22,1103,1105,O
70,1106,1108,O
Gender,1109,1115,O
Male,1116,1120,O
7,1121,1122,O
10,1123,1125,O
13,1126,1128,O
29,1129,1131,O
Female,1132,1138,O
11,1139,1141,O
12,1142,1144,O
9,1145,1146,O
19,1147,1149,O
Race,1150,1154,O
Caucasian,1155,1164,O
12,1165,1167,O
4,1168,1169,O
0,1170,1171,O
48,1172,1174,O
Black,1175,1180,O
6,1181,1182,O
13,1183,1185,O
0,1186,1187,O
0,1188,1189,O
nonwhite,1197,1205,O
0,1207,1208,O
5,1209,1210,O
0,1211,1212,O
0,1213,1214,O
data,1218,1222,O
0,1223,1224,O
0,1225,1226,O
22,1227,1229,O
0,1230,1231,O
Mean,1232,1236,O
range,1238,1243,O
age,1245,1248,O
yr,1250,1252,O
57,1254,1256,O
26,1258,1260,O
78,1261,1263,O
54,1265,1267,O
21,1269,1271,O
75,1272,1274,O
52,1276,1278,O
26,1280,1282,O
74,1283,1285,O
56,1287,1289,O
23,1291,1293,O
73,1294,1296,O
Pretest,1298,1305,O
probability,1306,1317,O
PCP,1321,1324,O
Moderate,1325,1333,O
0,1334,1335,O
3,1336,1337,O
4,1338,1339,O
0,1340,1341,O
Low,1342,1345,O
18,1346,1348,O
19,1349,1351,O
18,1352,1354,O
48,1355,1357,O
Sample,1358,1364,O
type,1365,1369,O
BAL,1370,1373,O
18,1374,1376,O
20,1377,1379,O
20,1380,1382,O
43,1383,1385,O
Sputum,1386,1392,B-Organism_substance
0,1393,1394,O
1,1395,1396,O
1,1397,1398,O
0,1399,1400,O
LRT,1407,1410,O
0,1411,1412,O
1,1413,1414,O
1,1415,1416,O
5,1417,1418,O
risk,1422,1426,O
group,1427,1432,O
HIV,1433,1436,O
AIDS,1437,1441,O
0,1442,1443,O
3,1444,1445,O
6,1446,1447,O
0,1448,1449,O
Lung,1450,1454,B-Organ
transplant,1455,1465,O
8,1466,1467,O
0,1468,1469,O
1,1470,1471,O
31,1472,1474,O
transplants,1481,1492,O
1,1493,1494,O
7,1495,1496,O
3,1497,1498,O
0,1499,1500,O
Leukemia,1501,1509,O
1,1510,1511,O
1,1512,1513,O
7,1514,1515,O
0,1516,1517,O
solid,1524,1529,B-Pathological_formation
tumors,1530,1536,I-Pathological_formation
2,1537,1538,O
1,1539,1540,O
1,1541,1542,O
7,1543,1544,O
nonmalignant,1551,1563,O
conditions,1564,1574,O
6,1575,1576,O
10,1577,1579,O
4,1580,1581,O
10,1582,1584,O
testing,1591,1598,O
enrollment,1603,1613,O
sites,1614,1619,O
study,1628,1633,O
Duke,1639,1643,O
University,1644,1654,O
School,1655,1661,O
Medicine,1665,1673,O
Durham,1675,1681,O
NC,1683,1685,O
Albert,1687,1693,O
Einstein,1694,1702,O
College,1703,1710,O
Medicine,1714,1722,O
Montefiore,1727,1737,O
Medical,1738,1745,O
Center,1746,1752,O
Bronx,1754,1759,O
NY,1761,1763,O
Centre,1765,1771,O
Hospitalier,1772,1783,O
Universitaire,1784,1797,O
Vaudois,1798,1805,O
University,1810,1820,O
Lausanne,1824,1832,O
Lausanne,1834,1842,O
Switzerland,1844,1855,O
Medizinische,1861,1873,O
Universitat,1874,1885,O
Landeskrankenhaus,1890,1907,O
Natters,1908,1915,O
Innsbruck,1917,1926,O
Austria,1928,1935,O
b,1937,1938,O
indicated,1962,1971,O
values,1973,1979,O
numbers,1984,1991,O
patients,1995,2003,O
c,2005,2006,O
Subjects,2007,2015,O
excluded,2021,2029,O
analysis,2035,2043,O
withdrew,2052,2060,O
consent,2061,2068,O
inadequate,2085,2095,O
sample,2096,2102,O
left,2103,2107,O
PCR,2112,2115,O
testing,2116,2123,O
Acknowledgments,0,15,O
Funding,20,27,O
authors,32,39,O
thank,40,45,O
CRB,46,49,O
GADIE,50,55,O
Diane,57,62,O
Esquerre,63,71,O
BAC,77,80,O
clones,81,87,O
handling,88,96,O
Brian,101,106,O
Smith,107,112,O
Renee,114,119,O
Fincham,120,127,O
Kristy,132,138,O
Shewbridge,139,149,O
microsatellites,154,169,O
genotyping,170,180,O
grateful,189,197,O
Yann,201,205,O
Guiguen,206,213,O
help,218,222,O
precious,227,235,O
contribution,236,248,O
fund,252,256,O
raising,257,264,O
study,274,279,O
work,286,290,O
possible,300,308,O
financial,312,321,O
support,322,329,O
Genoscope,333,342,O
acknowledge,347,358,O
Rene,359,363,O
Guyomard,364,372,O
initial,381,388,O
contribution,389,401,O
BAC,405,408,O
library,409,416,O
procurement,417,428,O
microsatellites,434,449,O
genotyping,450,460,O
supported,465,474,O
NRI,478,481,O
Grant,482,487,O
2007,492,496,O
35616,497,502,O
17875,503,508,O
USDA,518,522,O
National,523,531,O
Institute,532,541,O
Food,545,549,O
Agriculture,554,565,O
Confocal,0,8,O
scanning,13,21,O
microscopic,22,33,O
images,34,40,O
mammoth,44,51,O
s,52,53,O
human,58,63,O
hair,64,68,B-Multi-tissue_structure
Taphonomic,70,80,O
changes,81,88,O
indicated,90,99,O
arrow,103,108,O
heads,109,114,O
straight,119,127,O
white,128,133,O
arrow,134,139,O
confocal,147,155,O
image,156,161,O
Bacterial,163,172,O
fungal,173,179,O
colonies,180,188,O
shown,193,198,O
broken,202,208,O
arrows,209,215,O
Red,217,220,O
arrow,221,226,O
indicates,227,236,O
space,237,242,O
cuticle,251,258,O
hair,263,267,B-Multi-tissue_structure
shaft,268,273,I-Multi-tissue_structure
shrinkage,281,290,O
Extensive,292,301,O
taphonomic,302,312,O
changes,313,320,O
YUK,324,327,O
evident,332,339,O
Note,341,345,O
preservation,350,362,O
cuticle,370,377,O
human,385,390,O
hair,391,395,B-Multi-tissue_structure
contrast,399,407,O
craters,415,422,O
cuticles,430,438,O
mammoth,446,453,O
s,454,455,O
hair,456,460,B-Multi-tissue_structure
Bacterial,462,471,O
biofilms,472,480,O
feature,487,494,O
human,498,503,O
hair,504,508,B-Multi-tissue_structure
mammoth,510,517,O
s,518,519,O
hair,520,524,B-Multi-tissue_structure
protected,529,538,O
bacterial,544,553,O
invasion,554,562,O
permafrost,566,576,O
Calculation,0,11,O
male,15,19,O
mating,20,26,O
success,27,34,O
order,38,43,O
compare,47,54,O
males,63,68,O
access,70,76,O
receptive,80,89,O
females,90,97,O
followed,98,106,O
predictions,111,122,O
PoA,130,133,O
model,134,139,O
calculated,144,154,O
mating,155,161,O
success,162,169,O
follows,173,180,O
mating,194,200,O
partners,201,209,O
female,212,218,O
receptive,234,243,O
period,244,250,O
conceptive,258,268,O
cycle,269,274,O
mating,276,282,O
success,283,290,O
mating,299,305,O
partner,306,313,O
calculated,318,328,O
number,336,342,O
mating,346,352,O
series,353,359,O
male,362,366,O
involved,371,379,O
divided,383,390,O
total,398,403,O
number,404,410,O
mating,414,420,O
series,421,427,O
female,432,438,O
involved,443,451,O
Overall,456,463,O
mating,464,470,O
success,471,478,O
male,487,491,O
calculated,496,506,O
sum,514,517,O
mating,525,531,O
successes,532,541,O
calculated,542,552,O
male,562,566,O
described,570,579,O
Tail,0,4,O
flick,5,10,O
test,11,15,O
CSLE,16,20,O
difference,38,48,O
compared,49,57,O
control,63,70,O
tested,83,89,O
doses,90,95,O
Figure,97,103,O
4,104,105,O
Morphine,108,116,O
showed,117,123,O
significant,126,137,O
increase,138,146,O
latency,150,157,O
time,158,162,O
45,166,168,O
60,170,172,O
75,177,179,O
min,180,183,O
Figure,185,191,O
4,192,193,O
Effect,194,200,O
CSLE,204,208,O
100,210,213,O
200,215,218,O
500,223,226,O
mg,227,229,O
kg,230,232,O
morphine,238,246,O
latency,254,261,O
response,262,270,O
mice,274,278,O
tail,286,290,B-Organism_subdivision
flick,291,296,O
test,297,301,O
Values,303,309,O
presented,314,323,O
mean,331,335,O
SEM,340,343,O
n,345,346,O
5,349,350,O
P,353,354,O
0,357,358,O
05,359,361,O
significant,363,374,O
increase,375,383,O
control,389,396,O
Details,0,7,O
treatment,11,20,O
programs,21,29,O
B,36,37,O
respect,41,48,O
visits,52,58,O
different,62,71,O
health,72,78,O
care,79,83,O
professionals,84,97,O
treatment,102,111,O
activities,112,122,O
Genes,0,5,O
associated,6,16,O
nonsegmental,22,34,O
vitiligo,35,43,O
b,3,4,O
Radiographs,5,16,O
left,24,28,O
elbow,29,34,B-Organism_subdivision
forearm,39,46,B-Organism_subdivision
5,47,48,O
months,49,55,O
surgery,66,73,O
Discussion,0,10,O
important,24,33,O
factors,34,41,O
leading,42,49,O
development,57,68,O
hypoxia,72,79,O
biological,84,94,O
processes,95,104,O
determine,110,119,O
organic,134,141,O
matter,142,148,O
available,149,158,O
degraded,165,173,O
physical,178,186,O
factors,187,194,O
creating,195,203,O
stratification,204,218,O
Stratification,220,234,O
areas,243,248,O
coastal,256,263,O
zone,264,268,O
Baltic,276,282,O
Sea,283,286,O
seasonal,297,305,O
temperature,306,317,O
changes,318,325,O
stratification,336,350,O
occasional,354,364,O
inflowing,365,374,O
saltier,375,382,O
water,383,388,O
occur,394,399,O
estuaries,408,417,O
14,419,421,O
Hypoxia,423,430,O
common,434,440,O
estuaries,444,453,O
located,454,461,O
Danish,469,475,O
Straits,476,483,O
large,495,500,O
load,501,505,O
nutrients,509,518,O
sustaining,519,529,O
algal,530,535,O
production,536,546,O
strong,555,561,O
stratification,562,576,O
caused,577,583,O
large,587,592,O
differences,593,604,O
surface,608,615,O
water,627,632,O
salinity,633,641,O
5,643,644,O
Hypoxia,646,653,O
Swedish,661,668,O
Finnish,673,680,O
archipelagos,681,693,O
influenced,698,708,O
phytoplankton,712,725,O
growth,726,732,O
stimulated,733,743,O
nutrient,747,755,O
loads,756,761,O
urban,767,772,O
agricultural,777,789,O
sources,790,797,O
restricted,811,821,O
water,822,827,O
circulation,828,839,O
Finnish,845,852,O
Archipelago,853,864,O
Sea,865,868,O
impacted,872,880,O
drifting,884,892,O
algal,893,898,O
mats,899,903,O
consume,909,916,O
oxygen,917,923,O
decomposition,937,950,O
sink,961,965,O
15,981,983,O
contrast,988,996,O
hypoxia,998,1005,O
rare,1009,1013,O
northern,1021,1029,O
Baltic,1030,1036,O
Sea,1037,1040,O
estuaries,1041,1050,O
located,1051,1058,O
Bothnian,1066,1074,O
Sea,1075,1078,O
coastal,1079,1086,O
zone,1087,1091,O
nutrient,1098,1106,O
loads,1107,1112,O
lower,1117,1122,O
Hypoxia,1124,1131,O
uncommon,1135,1143,O
eastern,1154,1161,O
shore,1162,1167,O
Estonia,1173,1180,O
Poland,1184,1190,O
enhanced,1198,1206,O
circulation,1207,1218,O
water,1222,1227,O
open,1231,1235,O
areas,1236,1241,O
coastline,1252,1261,O
Figure,1263,1269,O
1,1270,1271,O
limited,1289,1296,O
data,1297,1301,O
available,1302,1311,O
examine,1315,1322,O
far,1327,1330,O
time,1339,1343,O
hypoxia,1344,1351,O
occurred,1356,1364,O
key,1368,1371,O
question,1372,1380,O
ecosystem,1389,1398,O
affected,1399,1407,O
daily,1408,1413,O
85,1422,1424,O
million,1425,1432,O
people,1433,1439,O
hypoxia,1453,1460,O
natural,1463,1470,O
phenomenon,1471,1481,O
16,1485,1487,O
large,1493,1498,O
numbers,1499,1506,O
enclosed,1510,1518,O
areas,1519,1524,O
cases,1534,1539,O
shallow,1545,1552,O
sills,1553,1558,O
restrict,1564,1572,O
exchange,1577,1585,O
water,1596,1601,O
combination,1615,1626,O
large,1632,1637,O
irregular,1638,1647,O
changes,1648,1655,O
salinity,1659,1667,O
mean,1675,1679,O
hypoxia,1685,1692,O
present,1709,1716,O
coastal,1724,1731,O
zone,1732,1736,O
sediment,1747,1755,O
laminations,1756,1767,O
Stockholm,1773,1782,O
Archipelago,1783,1794,O
indicator,1799,1808,O
past,1812,1816,O
hypoxia,1817,1824,O
17,1826,1828,O
shown,1840,1845,O
recent,1854,1860,O
phenomenon,1861,1871,O
areas,1886,1891,O
laminated,1897,1906,O
sediments,1907,1916,O
prior,1917,1922,O
1900,1926,1930,O
17,1931,1933,O
18,1934,1936,O
long,1941,1945,O
term,1946,1950,O
millennial,1951,1961,O
trends,1962,1968,O
coastal,1972,1979,O
hypoxia,1980,1987,O
remain,1988,1994,O
unknown,1995,2002,O
hypoxia,2013,2020,O
occurred,2025,2033,O
intermittently,2034,2048,O
8000,2069,2073,O
years,2074,2079,O
offshore,2083,2091,O
deep,2092,2096,O
waters,2097,2103,O
Baltic,2111,2117,O
Sea,2118,2121,O
10,2123,2125,O
sediment,2135,2143,O
studies,2144,2151,O
necessary,2156,2165,O
similar,2167,2174,O
carried,2184,2191,O
open,2203,2207,O
Baltic,2208,2214,O
Sea,2215,2218,O
10,2220,2222,O
ascertain,2227,2236,O
far,2241,2244,O
time,2253,2257,O
hypoxia,2258,2265,O
observed,2270,2278,O
coastal,2286,2293,O
zone,2294,2298,O
Key,2300,2303,O
uncertainties,2304,2317,O
remain,2318,2324,O
including,2325,2334,O
driving,2348,2355,O
forces,2356,2362,O
hypoxia,2367,2374,O
e,2376,2377,O
g,2378,2379,O
climate,2382,2389,O
19,2390,2392,O
nutrient,2398,2406,O
loading,2407,2414,O
changed,2416,2423,O
time,2432,2436,O
Baltic,2444,2450,O
Sea,2451,2454,O
coastal,2455,2462,O
zone,2463,2467,O
vary,2481,2485,O
time,2502,2506,O
periods,2507,2514,O
hypoxia,2520,2527,O
varies,2528,2534,O
open,2542,2546,O
waters,2547,2553,O
16,2555,2557,O
important,2562,2571,O
consideration,2572,2585,O
determining,2589,2600,O
number,2605,2611,O
ecosystems,2615,2625,O
experiencing,2626,2638,O
hypoxia,2639,2646,O
size,2654,2658,O
assessment,2666,2676,O
unit,2677,2681,O
combined,2686,2694,O
numerous,2695,2703,O
monitoring,2704,2714,O
points,2715,2721,O
sites,2726,2731,O
form,2735,2739,O
coherent,2742,2750,O
coastal,2751,2758,O
unit,2759,2763,O
waters,2776,2782,O
physically,2788,2798,O
connected,2799,2808,O
means,2829,2834,O
assessment,2840,2850,O
units,2851,2856,O
considered,2857,2867,O
hypoxic,2868,2875,O
occur,2882,2887,O
geographical,2900,2912,O
region,2913,2919,O
close,2936,2941,O
proximately,2942,2953,O
waters,2985,2991,O
physically,2997,3007,O
disconnected,3008,3020,O
Baltic,3026,3032,O
Sea,3033,3036,O
archipelagos,3037,3049,O
complex,3057,3064,O
topography,3065,3075,O
basins,3086,3092,O
disjoined,3093,3102,O
shallow,3106,3113,O
sills,3114,3119,O
resulting,3120,3129,O
distinct,3138,3146,O
sites,3147,3152,O
affected,3176,3184,O
similar,3188,3195,O
mechanisms,3196,3206,O
fact,3211,3215,O
Stockholm,3221,3230,O
Finnish,3235,3242,O
archipelagos,3243,3255,O
contributed,3256,3267,O
21,3268,3270,O
total,3279,3284,O
assessment,3285,3295,O
units,3296,3301,O
relatively,3305,3315,O
large,3316,3321,O
share,3322,3327,O
compared,3328,3336,O
total,3344,3349,O
Baltic,3350,3356,O
Sea,3357,3360,O
coastal,3361,3368,O
zone,3369,3373,O
40,3380,3382,O
hypoxic,3391,3398,O
sites,3399,3404,O
coastal,3410,3417,O
stretches,3418,3427,O
Western,3435,3442,O
Gotland,3443,3450,O
Basin,3451,3456,O
Gulf,3461,3465,O
Finland,3469,3476,O
substantial,3489,3500,O
number,3501,3507,O
hypoxic,3511,3518,O
sites,3519,3524,O
archipelagos,3534,3546,O
prone,3563,3568,O
hypoxia,3572,3579,O
complex,3595,3602,O
topography,3603,3613,O
proximity,3615,3624,O
development,3628,3639,O
consequently,3645,3657,O
sensitive,3663,3672,O
enhanced,3676,3684,O
nutrient,3685,3693,O
inputs,3694,3700,O
land,3706,3710,O
Surprisingly,3712,3724,O
4,3730,3731,O
0,3732,3733,O
sites,3742,3747,O
classified,3753,3763,O
seasonally,3767,3777,O
hypoxic,3778,3785,O
according,3786,3795,O
definition,3803,3813,O
50,3820,3822,O
80,3829,3831,O
profiles,3836,3844,O
stratified,3856,3866,O
period,3867,3873,O
oxygen,3879,3885,O
concentrations,3886,3900,O
2,3911,3912,O
mg,3913,3915,O
L,3916,3917,O
1,3918,3919,O
statistically,3923,3936,O
rigorous,3937,3945,O
definition,3946,3956,O
constitutes,3965,3976,O
seasonal,3977,3985,O
hypoxia,3986,3993,O
currently,4003,4012,O
exist,4013,4018,O
fact,4026,4030,O
linked,4041,4047,O
ecological,4051,4061,O
consequences,4062,4074,O
ecologically,4088,4100,O
relevant,4101,4109,O
connected,4123,4132,O
absolute,4136,4144,O
concentrations,4145,4159,O
3,4161,4162,O
Currently,4164,4173,O
coastal,4174,4181,O
marine,4182,4188,O
ecosystems,4189,4199,O
experience,4205,4215,O
hypoxia,4216,4223,O
period,4230,4236,O
days,4240,4244,O
months,4248,4254,O
year,4261,4265,O
considered,4276,4286,O
seasonally,4293,4303,O
hypoxic,4304,4311,O
categorized,4330,4341,O
episodic,4361,4369,O
required,4382,4390,O
monitoring,4395,4405,O
units,4406,4411,O
hypoxic,4418,4425,O
stratified,4442,4452,O
period,4453,4459,O
Limfjorden,4473,4483,O
Denmark,4485,4492,O
water,4501,4506,O
oxygen,4507,4513,O
concentrations,4514,4528,O
vary,4533,4537,O
greatly,4538,4545,O
weekly,4554,4560,O
samplings,4561,4570,O
SI,4572,4574,O
Figure,4575,4581,O
S6,4582,4584,O
nearly,4596,4602,O
year,4609,4613,O
hypoxic,4614,4621,O
conditions,4622,4632,O
observed,4637,4645,O
Limfjorden,4663,4673,O
statistical,4679,4690,O
estimation,4691,4701,O
Limfjorden,4710,4720,O
episodically,4724,4736,O
hypoxic,4737,4744,O
Diaz,4746,4750,O
Rosenberg,4755,4764,O
1,4765,4766,O
classify,4774,4782,O
Limfjorden,4783,4793,O
periodically,4797,4809,O
hypoxic,4810,4817,O
found,4836,4841,O
difficult,4845,4854,O
create,4858,4864,O
statistically,4867,4880,O
robust,4881,4887,O
indicator,4888,4897,O
classify,4909,4917,O
systems,4918,4925,O
periodically,4929,4941,O
hypoxic,4942,4949,O
Periodic,4951,4959,O
hypoxia,4960,4967,O
problematic,4971,4982,O
allows,5000,5006,O
establishment,5014,5027,O
benthic,5031,5038,O
communities,5039,5050,O
20,5052,5054,O
Currently,5056,5065,O
416,5077,5080,O
areas,5081,5086,O
world,5094,5099,O
reported,5105,5113,O
coastal,5114,5121,O
hypoxia,5122,5129,O
30,5141,5143,O
previously,5144,5154,O
reported,5155,5163,O
sites,5164,5169,O
Baltic,5177,5183,O
Sea,5184,5187,O
region,5188,5194,O
includes,5202,5210,O
coastal,5216,5223,O
zone,5224,5228,O
hypoxia,5229,5236,O
deep,5241,5245,O
water,5246,5251,O
sites,5252,5257,O
Baltic,5265,5271,O
Sea,5272,5275,O
1,5277,5278,O
identified,5288,5298,O
additional,5302,5312,O
96,5313,5315,O
sites,5316,5321,O
experienced,5332,5343,O
hypoxia,5344,5351,O
increasing,5353,5363,O
global,5368,5374,O
total,5375,5380,O
nearly,5384,5390,O
500,5391,5394,O
sites,5395,5400,O
known,5413,5418,O
sites,5419,5424,O
world,5436,5441,O
20,5450,5452,O
sites,5461,5466,O
found,5471,5476,O
Baltic,5484,5490,O
Sea,5491,5494,O
region,5495,5501,O
sites,5508,5513,O
experienced,5514,5525,O
episodic,5526,5534,O
hypoxia,5535,5542,O
precursor,5555,5564,O
development,5568,5579,O
seasonal,5583,5591,O
hypoxia,5592,5599,O
20,5601,5603,O
large,5609,5614,O
number,5615,5621,O
sites,5625,5630,O
partially,5631,5640,O
reflects,5641,5649,O
fact,5654,5658,O
Baltic,5668,5674,O
Sea,5675,5678,O
data,5698,5702,O
rich,5703,5707,O
regions,5708,5715,O
world,5723,5728,O
tidal,5737,5742,O
mixing,5743,5749,O
complex,5754,5761,O
topography,5769,5779,O
creating,5780,5788,O
conditions,5789,5799,O
favorable,5800,5809,O
hypoxia,5814,5821,O
monitored,5852,5861,O
areas,5862,5867,O
hypoxic,5883,5890,O
sites,5891,5896,O
probably,5897,5905,O
exist,5906,5911,O
Baltic,5919,5925,O
Sea,5926,5929,O
coastal,5930,5937,O
zone,5938,5942,O
contrast,5947,5955,O
evidence,5970,5978,O
hypoxia,5982,5989,O
95,5993,5995,O
stations,5996,6004,O
estuarine,6008,6017,O
coastal,6022,6029,O
waters,6030,6036,O
Ireland,6044,6051,O
sufficient,6059,6069,O
tidal,6070,6075,O
mixing,6076,6082,O
21,6084,6086,O
detailed,6096,6104,O
data,6105,6109,O
existed,6110,6117,O
coastal,6128,6135,O
regions,6136,6143,O
world,6155,6160,O
likely,6168,6174,O
number,6184,6190,O
areas,6194,6199,O
increase,6206,6214,O
globally,6215,6223,O
Oxygen,6225,6231,O
important,6238,6247,O
parameter,6248,6257,O
water,6261,6266,O
quality,6267,6274,O
assessments,6275,6286,O
sufficient,6293,6303,O
oxygen,6304,6310,O
essential,6314,6323,O
aquatic,6327,6334,O
life,6335,6339,O
necessary,6347,6356,O
support,6360,6367,O
healthy,6368,6375,O
biological,6376,6386,O
communities,6387,6398,O
3,6400,6401,O
example,6407,6414,O
oxygen,6416,6422,O
concentration,6423,6436,O
supporting,6442,6452,O
element,6453,6460,O
biological,6468,6478,O
quality,6479,6486,O
elements,6487,6495,O
European,6503,6511,O
Water,6512,6517,O
Framework,6518,6527,O
Directive,6528,6537,O
21,6539,6541,O
ecological,6557,6567,O
objectives,6568,6578,O
Helsinki,6586,6594,O
Commission,6595,6605,O
s,6606,6607,O
HELCOM,6609,6615,O
eutrophication,6617,6631,O
assessment,6632,6642,O
Baltic,6650,6656,O
Sea,6657,6660,O
included,6669,6677,O
European,6685,6693,O
Marine,6694,6700,O
Strategy,6701,6709,O
Framework,6710,6719,O
Directive,6720,6729,O
effect,6736,6742,O
parameter,6743,6752,O
eutrophication,6756,6770,O
Accurate,6772,6780,O
data,6781,6785,O
concentration,6794,6807,O
dissolved,6811,6820,O
oxygen,6821,6827,O
essential,6832,6841,O
documenting,6846,6857,O
environmental,6858,6871,O
changes,6872,6879,O
water,6883,6888,O
resources,6889,6898,O
resulting,6899,6908,O
natural,6914,6921,O
phenomena,6922,6931,O
human,6936,6941,O
activities,6942,6952,O
Reports,6954,6961,O
hypoxia,6965,6972,O
globally,6973,6981,O
increasing1,6986,6997,O
22,6998,7000,O
recognition,7017,7028,O
seriousness,7036,7047,O
hypoxia,7051,7058,O
ecosystem,7062,7071,O
functioning,7072,7083,O
decades,7091,7098,O
long,7099,7103,O
monitoring,7104,7114,O
records,7115,7122,O
available,7130,7139,O
databases,7143,7152,O
large,7162,7167,O
number,7168,7174,O
newly,7178,7183,O
identified,7184,7194,O
hypoxic,7195,7202,O
areas,7203,7208,O
influences,7209,7219,O
nutrient,7220,7228,O
biogeochemical,7229,7243,O
cycles,7244,7250,O
ecosystem,7255,7264,O
services,7265,7273,O
coastal,7281,7288,O
zone,7289,7293,O
Baltic,7301,7307,O
Sea,7308,7311,O
currently,7315,7324,O
unknown,7325,7332,O
functioning,7347,7358,O
coastal,7366,7373,O
filter,7374,7380,O
certainly,7381,7390,O
plays,7391,7396,O
important,7400,7409,O
role,7410,7414,O
adjacent,7422,7430,O
marine,7431,7437,O
systems,7438,7445,O
respond,7446,7453,O
changes,7457,7464,O
nutrient,7468,7476,O
loading,7477,7484,O
Presently,7486,7495,O
40,7502,7504,O
world,7513,7518,O
s,7519,7520,O
population,7521,7531,O
lives,7532,7537,O
100,7545,7548,O
km,7549,7551,O
coastal,7559,7566,O
zone,7567,7571,O
strongly,7572,7580,O
impacting,7581,7590,O
ocean,7591,7596,O
health,7597,7603,O
24,7605,7607,O
including,7609,7618,O
increasing,7619,7629,O
occurrence,7634,7644,O
hypoxic,7648,7655,O
areas,7656,7661,O
1,7662,7663,O
2,7664,7665,O
currently,7674,7683,O
lacking,7684,7691,O
link,7699,7703,O
driving,7711,7718,O
factors,7719,7726,O
hypoxia,7730,7737,O
including,7738,7747,O
nutrient,7748,7756,O
enrichment,7757,7767,O
organic,7769,7776,O
carbon,7777,7783,O
loading,7784,7791,O
climate,7796,7803,O
change,7804,7810,O
25,7812,7814,O
determination,7822,7835,O
appropriate,7839,7850,O
nutrient,7851,7859,O
loading,7860,7867,O
targets,7868,7875,O
guidance,7880,7888,O
managers,7892,7900,O
ameliorate,7904,7914,O
devastating,7919,7930,O
impact,7931,7937,O
hypoxia,7941,7948,O
24,7950,7952,O
Pharmacokinetic,0,15,O
pharmacodynamic,16,31,O
analysis,32,40,O
mean,46,50,O
90,52,54,O
CI,56,58,O
slope,60,65,O
estimate,66,74,O
linezolid,84,93,O
concentration,94,107,O
R,108,109,O
R,110,111,O
interval,112,120,O
analysis,121,129,O
0,135,136,O
0017,137,141,O
0,144,145,O
0022,146,150,O
0,155,156,O
0011,157,161,O
ms,163,165,O
ng,166,168,O
ml,169,171,O
translates,178,188,O
mean,192,196,O
90,198,200,O
CI,202,204,O
predicted,206,215,O
decreases,216,225,O
heart,229,234,B-Organ
rate,235,239,O
approximately,243,256,O
1,257,258,O
5,259,260,O
1,262,263,O
0,264,265,O
2,269,270,O
0,271,272,O
3,278,279,O
0,280,281,O
2,283,284,O
1,285,286,O
4,290,291,O
1,292,293,O
beats,295,300,O
min,301,304,O
mean,312,316,O
Cmax,317,321,O
following,322,331,O
administration,336,350,O
600,354,357,O
1,363,364,O
200,365,368,O
mg,369,371,O
linezolid,372,381,O
doses,382,387,O
respectively,389,401,O
study,407,412,O
specific,413,421,O
mean,422,426,O
correction,427,437,O
factor,438,444,O
estimated,445,454,O
baseline,460,468,O
data,469,473,O
0,478,479,O
278,480,483,O
slightly,494,502,O
Fridericia,513,523,O
s,524,525,O
correction,526,536,O
0,538,539,O
333,540,543,O
Evaluation,546,556,O
correction,572,582,O
factors,583,590,O
showed,591,597,O
QTcF,603,607,O
appropriately,613,626,O
resolves,627,635,O
relationship,640,652,O
QT,665,667,O
interval,668,676,O
heart,685,690,B-Organ
rate,691,695,O
baseline,703,711,O
data,712,716,O
present,726,733,O
study,734,739,O
evident,749,756,O
inspection,762,772,O
Fig,776,779,O
4,781,782,O
slope,794,799,O
QTcF,812,816,O
interval,817,825,O
R,834,835,O
R,836,837,O
interval,838,846,O
closest,850,857,O
zero,861,865,O
correction,876,886,O
applied,890,897,O
Fig,899,902,O
4,904,905,O
Evaluation,907,917,O
heart,929,934,B-Organ
rate,935,939,O
correction,940,950,O
factors,951,958,O
QT,967,969,O
interval,970,978,O
versus,979,985,O
R,990,991,O
R,992,993,O
interval,994,1002,O
predicted,1008,1017,O
line,1018,1022,O
figure,1031,1037,O
represents,1038,1048,O
fit,1053,1056,O
linear,1064,1070,O
mixed,1071,1076,O
effect,1077,1083,O
model,1084,1089,O
R,1095,1096,O
R,1097,1098,O
interval,1099,1107,O
fixed,1113,1118,O
effect,1119,1125,O
subject,1130,1137,O
specific,1138,1146,O
random,1147,1153,O
effects,1154,1161,O
intercept,1166,1175,O
slope,1180,1185,O
results,1191,1198,O
concentration,1208,1221,O
QTcF,1222,1226,O
analysis,1227,1235,O
graphically,1240,1251,O
depicted,1252,1260,O
Fig,1264,1267,O
5,1269,1270,O
mean,1276,1280,O
90,1282,1284,O
CI,1286,1288,O
slope,1290,1295,O
estimate,1296,1304,O
linezolid,1314,1323,O
concentration,1324,1337,O
QTcF,1338,1342,O
analysis,1343,1351,O
0,1357,1358,O
0145,1359,1363,O
0,1366,1367,O
0768,1368,1372,O
0,1376,1377,O
0477,1378,1382,O
ms,1384,1386,O
mug,1387,1390,O
ml,1391,1393,O
geometric,1402,1411,O
mean,1412,1416,O
Cmax,1417,1421,O
following,1422,1431,O
infusion,1436,1444,O
linezolid,1448,1457,O
600,1461,1464,O
mg,1465,1467,O
14,1469,1471,O
9,1472,1473,O
mug,1474,1477,O
ml,1478,1480,O
1,1486,1487,O
200,1488,1491,O
mg,1492,1494,O
30,1496,1498,O
5,1499,1500,O
mug,1501,1504,O
ml,1505,1507,O
mean,1514,1518,O
90,1520,1522,O
CI,1524,1526,O
predicted,1528,1537,O
placebo,1538,1545,O
adjusted,1546,1554,O
changes,1555,1562,O
baseline,1572,1580,O
QTcF,1581,1585,O
0,1592,1593,O
217,1594,1597,O
1,1600,1601,O
14,1602,1604,O
0,1608,1609,O
710,1610,1613,O
0,1620,1621,O
444,1622,1625,O
2,1628,1629,O
34,1630,1632,O
1,1636,1637,O
45,1638,1640,O
ms,1642,1644,O
respectively,1646,1658,O
confirming,1665,1675,O
lack,1678,1682,O
relationship,1688,1700,O
linezolid,1709,1718,O
concentrations,1719,1733,O
QTc,1738,1741,O
interval,1742,1750,O
Fig,1752,1755,O
5,1757,1758,O
QTcF,1760,1764,O
interval,1765,1773,O
versus,1774,1780,O
plasma,1781,1787,B-Organism_substance
linezolid,1788,1797,O
concentrations,1798,1812,O
Results,0,7,O
primary,8,15,O
pancreatic,16,26,B-Pathological_formation
sarcomas,27,35,I-Pathological_formation
extremely,40,49,O
rare,50,54,O
Pancreatic,56,66,B-Pathological_formation
sarcomas,67,75,I-Pathological_formation
aggressive,85,95,O
pancreatic,107,117,B-Pathological_formation
neoplasms,118,127,I-Pathological_formation
Introduction,0,12,O
Hip,13,16,B-Organism_subdivision
fractures,17,26,O
aged,34,38,O
constitute,39,49,O
major,52,57,O
health,58,64,O
problem,65,72,O
substantial,78,89,O
morbidity,90,99,O
1,101,102,O
mortality,105,114,O
2,116,117,O
3,119,120,O
ageing,135,141,O
population,142,152,O
increases,153,162,O
increasing,167,177,O
burden,178,184,O
health,192,198,O
care,199,203,O
system,204,210,O
4,212,213,O
Fracture,216,224,O
risk,225,229,O
varies,230,236,O
markedly,237,245,O
countries,254,263,O
5,265,266,O
study,274,279,O
Kanis,283,288,O
et,289,291,O
al,292,294,O
6,297,298,O
comparing,301,310,O
10,311,313,O
year,314,318,O
probability,319,330,O
hip,334,337,B-Organism_subdivision
fracture,338,346,O
countries,352,361,O
Norway,369,375,O
lower,380,385,O
risk,386,390,O
Sweden,396,402,O
countries,410,419,O
categorized,420,431,O
high,440,444,O
risk,445,449,O
75,452,454,O
risk,463,467,O
Sweden,471,477,O
Iceland,484,491,O
Denmark,493,500,O
age,520,523,O
80,527,529,O
estimated,535,544,O
probability,545,556,O
sustaining,560,570,O
hip,573,576,B-Organism_subdivision
fracture,577,585,O
10,595,597,O
years,598,603,O
8,607,608,O
6,609,610,O
17,616,618,O
7,619,620,O
Norwegian,625,634,O
men,635,638,O
women,643,648,O
respectively,650,662,O
7,664,665,O
report,674,680,O
Norwegian,690,699,O
capital,700,707,O
Oslo,708,712,O
calculated,713,723,O
overall,727,734,O
annual,735,741,O
fracture,742,750,O
rate,751,755,O
118,759,762,O
0,763,764,O
women,768,773,O
44,778,780,O
0,781,782,O
men,786,789,O
10,794,796,O
000,797,800,O
8,802,803,O
recent,814,820,O
studies,821,828,O
reporting,833,842,O
declining,843,852,O
fracture,853,861,O
incidence,862,871,O
9,873,874,O
14,875,877,O
Norwegian,893,902,O
hip,903,906,B-Organism_subdivision
fracture,907,915,O
rates,916,921,O
remain,922,928,O
highest,933,940,O
reported,941,949,O
world,957,962,O
data,964,968,O
Oslo,974,978,O
1996,982,986,O
1997,987,991,O
indicated,992,1001,O
increasing,1005,1015,O
incidence,1016,1025,O
rates,1026,1031,O
compared,1032,1040,O
1988,1048,1052,O
1989,1053,1057,O
8,1059,1060,O
Norway,1069,1075,O
considerable,1077,1089,O
geographic,1090,1100,O
differences,1101,1112,O
reported,1123,1131,O
substantially,1138,1151,O
lower,1152,1157,O
rates,1158,1163,O
smaller,1167,1174,O
cities,1175,1181,O
rural,1186,1191,O
areas,1192,1197,O
compared,1198,1206,O
Oslo,1210,1214,O
7,1216,1217,O
15,1219,1221,O
reports,1243,1250,O
based,1251,1256,O
sporadic,1260,1268,O
studies,1269,1276,O
regions,1284,1291,O
limited,1299,1306,O
time,1307,1311,O
periods,1312,1319,O
16,1321,1323,O
17,1325,1327,O
1985,1335,1339,O
2003,1343,1347,O
Norwegian,1353,1362,O
Institute,1363,1372,O
Public,1376,1382,O
Health,1383,1389,O
commissioned,1390,1402,O
Norwegian,1408,1417,O
hospitals,1418,1427,O
representing,1429,1441,O
10,1442,1444,O
population,1453,1463,O
run,1468,1471,O
national,1474,1482,O
injury,1483,1489,O
registry,1490,1498,O
18,1500,1502,O
registry,1509,1517,O
collected,1518,1527,O
variety,1530,1537,O
data,1541,1545,O
connected,1546,1555,O
actual,1563,1569,O
injury,1570,1576,O
event,1592,1597,O
leading,1598,1605,O
injury,1613,1619,O
city,1628,1632,O
Harstad,1636,1643,O
Northern,1647,1655,O
Norway,1656,1662,O
registration,1668,1680,O
continued,1681,1690,O
running,1704,1711,O
23,1726,1728,O
years,1729,1734,O
years,1751,1756,O
National,1764,1772,O
Injury,1773,1779,O
Registry,1780,1788,O
injury,1794,1800,O
rates,1801,1806,O
Harstad,1810,1817,O
closely,1818,1825,O
resembled,1826,1835,O
rates,1840,1845,O
national,1853,1861,O
registry,1862,1870,O
18,1872,1874,O
reference,1882,1891,O
recent,1899,1905,O
reports,1906,1913,O
suggesting,1914,1924,O
stabilizing,1925,1936,O
hip,1937,1940,B-Organism_subdivision
fracture,1941,1949,O
incidence,1950,1959,O
internationally,1960,1975,O
nationally,1987,1997,O
regional,2003,2011,O
differences,2012,2023,O
Norway,2031,2037,O
hip,2056,2059,B-Organism_subdivision
fracture,2060,2068,O
data,2069,2073,O
Harstad,2081,2088,O
Injury,2089,2095,O
Registry,2096,2104,O
Describe,2110,2118,O
age,2119,2122,O
sex,2128,2131,O
specific,2132,2140,O
incidence,2141,2150,O
hip,2154,2157,B-Organism_subdivision
fractures,2158,2167,O
Harstad,2171,2178,O
Northern,2180,2188,O
Norway,2189,2195,O
comparison,2205,2215,O
rates,2221,2226,O
Norwegian,2236,2245,O
capital,2246,2253,O
Oslo,2254,2258,O
Describe,2259,2267,O
time,2268,2272,O
trends,2273,2279,O
hip,2283,2286,B-Organism_subdivision
fracture,2287,2295,O
incidence,2296,2305,O
Harstad,2309,2316,O
1994,2322,2326,O
2008,2330,2334,O
Describe,2335,2343,O
place,2344,2349,O
injury,2353,2359,O
seasonal,2364,2372,O
variations,2373,2383,O
hip,2387,2390,B-Organism_subdivision
fracture,2391,2399,O
incidence,2400,2409,O
Harstad,2413,2420,O
Compare,2421,2428,O
3,2429,2430,O
month,2431,2436,O
6,2438,2439,O
month,2440,2445,O
1,2451,2452,O
year,2453,2457,O
mortality,2458,2467,O
hip,2474,2477,B-Organism_subdivision
fracture,2478,2486,O
women,2495,2500,O
men,2505,2508,O
Harstad,2512,2519,O
Tn6087,8,14,O
target,15,21,O
site,22,26,O
S,34,35,O
oralis,37,43,O
F,44,45,O
MI,46,48,O
5,49,50,O
b,53,54,O
left,60,64,O
end,65,68,O
c,74,75,O
right,77,82,O
end,83,86,O
Tn6087,90,96,O
shown,101,106,O
bold,110,114,O
d,117,118,O
joint,124,129,O
circular,137,145,O
intermediate,146,158,O
Tn6087,162,168,O
shown,172,177,O
transposon,183,193,O
s,194,195,O
coupling,196,204,O
sequences,205,214,O
shown,219,224,O
bold,228,232,O
italics,233,240,O
seen,252,256,O
d,261,262,O
coupling,269,277,O
sequence,278,286,O
joint,294,299,O
circular,307,315,O
form,316,320,O
heteroduplex,326,338,O
Breeding,0,8,O
p53,12,15,O
mice,16,20,O
BCCIP,26,31,O
conditional,32,43,O
knockdown,44,53,O
mice,54,58,O
heterozygous,63,75,O
p53,76,79,O
knockout,80,88,O
mice,89,93,O
36,95,97,O
crossed,104,111,O
LoxPshBCCIP,117,128,O
4,132,133,O
mouse,134,139,O
EIIaCre,144,151,O
mouse,155,160,O
respectively,161,173,O
generate,177,185,O
p53,186,189,O
LoxPshBCCIP,193,204,O
p53,213,216,O
EIIaCre,220,227,O
mice,231,235,O
PCR,241,244,O
primers,245,252,O
genotype,261,269,O
p53,270,273,O
p53ex6F,279,286,O
5,288,289,O
GTATCCCGAGTATCTGGAAGACAG,291,315,O
3,316,317,O
p53neoF,320,327,O
5,329,330,O
GCCTTCTATCGCCTTCTTGACG,332,354,O
3,355,356,O
p53ex7RN,359,367,O
5,369,370,O
AAGGATAGGTCGGCGGTTCATGC,372,395,O
3,396,397,O
PCR,409,412,O
primer,413,419,O
pairs,420,425,O
described,429,438,O
earlier,439,446,O
report,455,461,O
BCCIPshRNA,476,486,O
EIIaCre,491,498,O
genotyping,499,509,O
p53,515,518,O
LoxPshBCCIP,522,533,O
mice,537,541,O
obtained,547,555,O
crossing,559,567,O
p53,568,571,O
LoxPshBCCIP,575,586,O
females,590,597,O
p53,603,606,O
LoxPshBCCIP,610,621,O
males,625,630,O
p53,636,639,O
LoxPshBCCIP,643,654,O
p53,661,664,O
LoxPshBCCIP,668,679,O
mice,683,687,O
crossed,693,700,O
p53,706,709,O
EIIaCre,713,720,O
mice,724,728,O
respectively,729,741,O
Biochemical,0,11,O
traits,12,18,O
ERK,0,3,O
signaling,4,13,O
involved,17,25,O
decreasing,29,39,O
BDNF,40,44,O
induced,45,52,O
gene,53,57,O
activity,58,66,O
Eph,71,74,O
receptors,75,84,O
Data,85,89,O
provided,90,98,O
far,102,105,O
suggest,106,113,O
ephrin,119,125,O
A5,126,128,O
counteract,135,145,O
BDNF,146,150,O
mediated,151,159,O
gene,160,164,O
expression,165,175,O
growth,180,186,B-Cellular_component
cone,187,191,I-Cellular_component
responses,192,201,O
decreasing,206,216,O
ERK,217,220,O
activity,221,229,O
nuclear,234,241,B-Cellular_component
localization,242,254,O
Figs,256,260,O
2,262,263,O
3,268,269,O
test,275,279,O
hypothesis,285,295,O
directly,301,309,O
analyzed,314,322,O
Eph,331,334,O
forward,335,342,O
signaling,343,352,O
suppress,363,371,O
BDNF,372,376,O
stimulated,377,387,O
IEG,388,391,O
induction,392,401,O
growth,406,412,B-Cellular_component
cone,413,417,I-Cellular_component
collapse,418,426,O
ERK,432,435,O
kinase,436,442,O
activity,443,451,O
experimentally,456,470,O
raised,471,477,O
ERK,489,492,O
activity,493,501,O
elevated,506,514,O
expressing,518,528,O
constitutively,529,543,O
active,544,550,O
MEK1,551,555,O
MEK1,560,564,O
ERK,570,573,O
upstream,574,582,O
activator,583,592,O
cortical,597,605,B-Cell
neurons,606,613,I-Cell
Fig,615,618,O
S3,620,622,O
Subsequently,625,637,O
neurons,639,646,B-Cell
subjected,652,661,O
ephrin,675,681,O
A5,682,684,O
mediated,685,693,O
growth,694,700,B-Cellular_component
cone,701,705,I-Cellular_component
collapse,706,714,O
assay,715,720,O
Fig,722,725,O
5,727,728,O
stimulated,733,743,O
guidance,749,757,O
cues,758,762,O
20,767,769,O
minutes,770,777,O
IEG,782,785,O
mRNA,786,790,O
levels,791,797,O
quantified,803,813,O
qRT,818,821,O
PCR,822,825,O
Fig,827,830,O
6,832,833,O
10,836,838,O
1371,839,843,O
journal,844,851,O
pone,852,856,O
0026089,857,864,O
g005,865,869,O
Figure,870,876,O
5,877,878,O
Constitutively,879,893,O
active,894,900,O
MEK1,901,905,O
blocks,906,912,O
ephrin,913,919,O
A5,920,922,O
mediated,923,931,O
growth,932,938,B-Cellular_component
cone,939,943,I-Cellular_component
collapse,944,952,O
Wild,954,958,O
type,959,963,O
neurons,964,971,B-Cell
electroporated,977,991,O
vectors,997,1004,O
expressing,1005,1015,O
GFP,1016,1019,O
control,1021,1028,O
C,1033,1034,O
E,1036,1037,O
expressing,1042,1052,O
FLAG,1055,1059,O
tagged,1060,1066,O
constitutively,1067,1081,O
active,1082,1088,O
MEK1,1089,1093,O
MEK1,1098,1102,O
B,1104,1105,O
D,1107,1108,O
F,1110,1111,O
Neurons,1114,1121,B-Cell
treated,1127,1134,O
ephrin,1140,1146,O
A5,1147,1149,O
Fc,1150,1152,O
30,1157,1159,O
min,1160,1163,O
followed,1164,1172,O
visualization,1176,1189,O
GFP,1193,1196,O
C,1201,1202,O
E,1204,1205,O
MEK,1213,1216,O
1,1217,1218,O
green,1220,1225,O
B,1229,1230,O
D,1232,1233,O
F,1235,1236,O
F,1239,1240,O
actin,1241,1246,O
betaIII,1251,1258,O
tubulin,1259,1266,O
B,1272,1273,O
Overexpression,1275,1289,O
MEK1,1296,1300,O
B,1302,1303,O
reduces,1305,1312,O
mean,1313,1317,O
neurite,1318,1325,B-Cellular_component
length,1326,1332,O
compared,1333,1341,O
control,1347,1354,O
GFP,1355,1358,O
expressing,1359,1369,O
neuron,1370,1376,B-Cell
C,1383,1384,O
F,1385,1386,O
control,1390,1397,O
growth,1398,1404,B-Cellular_component
cone,1405,1409,I-Cellular_component
ephrin,1418,1424,O
A5,1425,1427,O
application,1428,1439,O
C,1441,1442,O
typically,1444,1453,O
protrudes,1454,1463,O
multiple,1464,1472,O
filopodia,1473,1482,B-Cellular_component
arrow,1484,1489,O
MEK,1495,1498,O
1,1499,1500,O
expressing,1501,1511,O
growth,1512,1518,B-Cellular_component
cones,1519,1524,I-Cellular_component
D,1526,1527,O
indistinguishable,1534,1551,O
GFP,1559,1562,O
expressing,1563,1573,O
growth,1574,1580,B-Cellular_component
cone,1581,1585,I-Cellular_component
Note,1587,1591,O
MEK1,1600,1604,O
expressed,1609,1618,O
dot,1624,1627,O
like,1628,1632,O
pattern,1633,1640,O
growth,1648,1654,B-Cellular_component
cone,1655,1659,I-Cellular_component
arrowheads,1661,1671,O
D,1675,1676,O
F,1681,1682,O
ephrin,1690,1696,O
A5,1697,1699,O
application,1700,1711,O
control,1715,1722,O
growth,1723,1729,B-Cellular_component
cone,1730,1734,I-Cellular_component
E,1736,1737,O
collapsed,1739,1748,O
resulting,1749,1758,O
filopodia,1771,1780,B-Cellular_component
contrast,1785,1793,O
MEK1,1800,1804,O
expressing,1805,1815,O
growth,1816,1822,B-Cellular_component
cone,1823,1827,I-Cellular_component
F,1829,1830,O
partially,1841,1850,O
collapsed,1851,1860,O
filopodia,1870,1879,B-Cellular_component
structures,1880,1890,O
preserved,1896,1905,O
ephrin,1912,1918,O
A5,1919,1921,O
induction,1922,1931,O
G,1934,1935,O
Quantification,1937,1951,O
average,1955,1962,O
neurite,1963,1970,B-Cellular_component
length,1971,1977,O
H,1980,1981,O
Quantification,1986,2000,O
growth,2004,2010,B-Cellular_component
cone,2011,2015,I-Cellular_component
area,2016,2020,O
H,2022,2023,O
filopodia,2029,2038,B-Cellular_component
number,2039,2045,O
growth,2046,2052,B-Cellular_component
cone,2053,2057,I-Cellular_component
conditions,2074,2084,O
Ephrin,2086,2092,O
A5,2093,2095,O
induces,2096,2103,O
growth,2106,2112,B-Cellular_component
cone,2113,2117,I-Cellular_component
collapse,2118,2126,O
resulting,2128,2137,O
reduced,2141,2148,O
growth,2149,2155,B-Cellular_component
cone,2156,2160,I-Cellular_component
area,2161,2165,O
filopodia,2170,2179,B-Cellular_component
number,2180,2186,O
GFP,2190,2193,O
MEK1,2205,2209,O
expressing,2210,2220,O
neurons,2221,2228,B-Cell
Scale,2230,2235,O
bar,2236,2239,O
B,2244,2245,O
10,2249,2251,O
microm,2252,2258,O
C,2261,2262,O
F,2263,2264,O
2,2268,2269,O
microm,2270,2276,O
10,2278,2280,O
1371,2281,2285,O
journal,2286,2293,O
pone,2294,2298,O
0026089,2299,2306,O
g006,2307,2311,O
Figure,2312,2318,O
6,2319,2320,O
Ephrin,2321,2327,O
A5,2328,2330,O
suppresses,2331,2341,O
BDNF,2342,2346,O
induced,2347,2354,O
IEG,2355,2358,O
responses,2359,2368,O
MAP,2373,2376,O
kinase,2377,2383,O
signaling,2384,2393,O
Wild,2395,2399,O
type,2400,2404,O
cortical,2405,2413,B-Cell
neurons,2414,2421,I-Cell
mock,2423,2427,O
electroporated,2428,2442,O
black,2444,2449,O
bars,2450,2454,O
vector,2466,2472,O
expressing,2473,2483,O
constitutively,2484,2498,O
active,2499,2505,O
MEK1,2506,2510,O
white,2512,2517,O
bars,2518,2522,O
treated,2530,2537,O
guidance,2543,2551,O
cues,2552,2556,O
20,2561,2563,O
minutes,2564,2571,O
depicted,2575,2583,O
followed,2585,2593,O
mRNA,2597,2601,O
quantification,2602,2616,O
mock,2621,2625,O
electroporated,2626,2640,O
neurons,2641,2648,B-Cell
BDNF,2650,2654,O
induced,2655,2662,O
IEG,2666,2669,O
response,2670,2678,O
c,2682,2683,O
fos,2684,2687,O
Egr1,2693,2697,O
B,2699,2700,O
Egr2,2703,2707,O
C,2709,2710,O
Arc,2716,2719,O
D,2721,2722,O
Co,2725,2727,O
application,2728,2739,O
ephrin,2743,2749,O
A5,2750,2752,O
BDNF,2757,2761,O
reduced,2762,2769,O
mRNA,2770,2774,O
levels,2775,2781,O
IEGs,2794,2798,O
mock,2802,2806,O
electroporated,2807,2821,O
neurons,2822,2829,B-Cell
D,2833,2834,O
contrast,2840,2848,O
expression,2850,2860,O
constitutively,2864,2878,O
active,2879,2885,O
MEK1,2886,2890,O
prevented,2891,2900,O
Eph,2901,2904,O
forward,2905,2912,O
signaling,2913,2922,O
suppressing,2928,2939,O
BDNF,2940,2944,O
evoked,2945,2951,O
IEG,2952,2955,O
responses,2956,2965,O
evident,2981,2988,O
IEGs,2997,3001,O
Egr1,3002,3006,O
B,3008,3009,O
Egr2,3015,3019,O
C,3021,3022,O
analyzed,3042,3050,O
impact,3055,3061,O
MEK1,3068,3072,O
neurite,3076,3083,B-Cellular_component
outgrowth,3084,3093,O
ephrin,3098,3104,O
A5,3105,3107,O
mediated,3108,3116,O
growth,3117,3123,B-Cellular_component
cone,3124,3128,I-Cellular_component
responses,3129,3138,O
Fig,3140,3143,O
5,3145,3146,O
average,3153,3160,O
neurite,3161,3168,B-Cellular_component
length,3169,3175,O
neurons,3179,3186,B-Cell
overexpressing,3187,3201,O
MEK1,3205,3209,O
Fig,3211,3214,O
5B,3216,3218,O
clearly,3224,3231,O
reduced,3232,3239,O
compared,3240,3248,O
control,3252,3259,O
GFP,3260,3263,O
expressing,3264,3274,O
neurons,3275,3282,B-Cell
Fig,3284,3287,O
5A,3289,3291,O
quantification,3297,3311,O
G,3316,3317,O
Growth,3321,3327,B-Cellular_component
cones,3328,3333,I-Cellular_component
GFP,3337,3340,O
C,3342,3343,O
MEK1,3352,3356,O
expressing,3357,3367,O
neurons,3368,3375,B-Cell
similar,3381,3388,O
protruded,3393,3402,O
filopodia,3408,3417,B-Cellular_component
arrows,3419,3425,O
Fig,3429,3432,O
5C,3434,3436,O
F,3437,3438,O
MEK1,3444,3448,O
expression,3449,3459,O
growth,3463,3469,B-Cellular_component
cones,3470,3475,I-Cellular_component
confined,3480,3488,O
individual,3492,3502,O
dot,3503,3506,O
like,3507,3511,O
structures,3512,3522,O
arrowheads,3524,3534,O
Fig,3538,3541,O
5D,3543,3545,O
F,3547,3548,O
Ephrin,3551,3557,O
A5,3558,3560,O
application,3561,3572,O
GFP,3578,3581,O
expressing,3582,3592,O
control,3593,3600,O
growth,3601,3607,B-Cellular_component
cone,3608,3612,I-Cellular_component
Fig,3614,3617,O
5E,3619,3621,O
resulted,3623,3631,O
growth,3637,3643,B-Cellular_component
cone,3644,3648,I-Cellular_component
collapse,3649,3657,O
revealed,3661,3669,O
reduced,3673,3680,O
overall,3681,3688,O
growth,3689,3695,B-Cellular_component
cone,3696,3700,I-Cellular_component
area,3701,3705,O
filopodia,3710,3719,B-Cellular_component
number,3720,3726,O
quantified,3728,3738,O
Fig,3742,3745,O
5H,3747,3749,O
contrast,3758,3766,O
neurons,3771,3778,B-Cell
overexpressing,3779,3793,O
MEK1,3797,3801,O
Fig,3803,3806,O
5F,3808,3810,O
ephrin,3813,3819,O
A5,3820,3822,O
induced,3823,3830,O
partial,3838,3845,O
growth,3846,3852,B-Cellular_component
cone,3853,3857,I-Cellular_component
collapse,3858,3866,O
growth,3874,3880,B-Cellular_component
cone,3881,3885,I-Cellular_component
area,3886,3890,O
filopodia,3895,3904,B-Cellular_component
number,3905,3911,O
reduced,3921,3928,O
Fig,3934,3937,O
5H,3939,3941,O
result,3952,3958,O
suggests,3959,3967,O
ephrin,3976,3982,O
A5,3983,3985,O
induced,3986,3993,O
signaling,3994,4003,O
cascade,4004,4011,O
targets,4012,4019,O
MAP,4020,4023,O
kinase,4024,4030,O
signaling,4031,4040,O
exert,4044,4049,O
growth,4057,4063,B-Cellular_component
cone,4064,4068,I-Cellular_component
collapse,4069,4077,O
result,4084,4090,O
contrast,4097,4105,O
recent,4111,4117,O
report,4118,4124,O
46,4126,4128,O
excluded,4136,4144,O
ERK,4145,4148,O
signaling,4149,4158,O
downstream,4159,4169,O
ephrin,4176,4182,O
A5,4183,4185,O
mediated,4186,4194,O
growth,4195,4201,B-Cellular_component
cone,4202,4206,I-Cellular_component
collapse,4207,4215,O
tested,4226,4232,O
ephrin,4241,4247,O
A5,4248,4250,O
signaling,4251,4260,O
suppresses,4261,4271,O
ERK,4272,4275,O
kinase,4276,4282,O
signaling,4283,4292,O
interfere,4301,4310,O
BDNF,4316,4320,O
mediated,4321,4329,O
gene,4330,4334,O
expression,4335,4345,O
Fig,4347,4350,O
6,4352,4353,O
agreement,4359,4368,O
previous,4374,4382,O
results,4383,4390,O
Fig,4392,4395,O
4,4397,4398,O
mock,4404,4408,O
electroporated,4409,4423,O
neurons,4424,4431,B-Cell
ephrin,4433,4439,O
A5,4440,4442,O
incubation,4443,4453,O
reduced,4454,4461,O
BDNF,4466,4470,O
mediated,4471,4479,O
regulation,4483,4493,O
c,4497,4498,O
fos,4499,4502,O
Fig,4504,4507,O
6A,4509,4511,O
Egr1,4514,4518,O
Fig,4520,4523,O
6B,4525,4527,O
Egr2,4530,4534,O
Fig,4536,4539,O
6C,4541,4543,O
Arc,4549,4552,O
Fig,4554,4557,O
6D,4559,4561,O
mRNA,4563,4567,O
contrast,4572,4580,O
neurons,4585,4592,B-Cell
expressing,4598,4608,O
MEK1,4612,4616,O
ephrin,4618,4624,O
A5,4625,4627,O
suppress,4638,4646,O
BDNF,4647,4651,O
induced,4652,4659,O
IEG,4660,4663,O
responses,4664,4673,O
degree,4686,4692,O
Particularly,4694,4706,O
Egr1,4707,4711,O
Fig,4713,4716,O
6B,4718,4720,O
Egr2,4726,4730,O
Fig,4732,4735,O
6C,4737,4739,O
mRNA,4741,4745,O
levels,4746,4752,O
identical,4765,4774,O
comparing,4780,4789,O
neurons,4790,4797,B-Cell
treated,4798,4805,O
BDNF,4811,4815,O
neurons,4826,4833,B-Cell
BDNF,4839,4843,O
ephrin,4848,4854,O
A5,4855,4857,O
ephrin,4874,4880,O
A5,4881,4883,O
represses,4884,4893,O
gene,4894,4898,O
activity,4899,4907,O
elicited,4908,4916,O
BDNF,4920,4924,O
MAP,4946,4949,O
kinases,4950,4957,O
IEGs,4967,4971,O
inspected,4976,4985,O
influence,4990,4999,O
guidance,5008,5016,O
cues,5017,5021,O
cytoskeletal,5025,5037,B-Cellular_component
genes,5038,5043,O
gene,5051,5055,O
products,5056,5064,O
modulate,5071,5079,O
cytoskeletal,5080,5092,B-Cellular_component
dynamics,5093,5101,O
evoked,5102,5108,O
ephrin,5112,5118,O
neurotrophins,5129,5142,O
Fig,5144,5147,O
S4,5149,5151,O
filamentous,5169,5180,B-Cellular_component
actin,5181,5186,O
F,5188,5189,O
actin,5190,5195,O
stabilizing,5197,5208,O
tropomyosins,5209,5221,O
Tpm1,5223,5227,O
Tpm2,5232,5236,O
F,5243,5244,O
actin,5245,5250,O
cross,5251,5256,O
linker,5257,5263,O
alpha,5264,5269,O
actinin,5270,5277,O
1,5278,5279,O
Actn1,5281,5286,O
motor,5296,5301,O
protein,5302,5309,O
dynein,5310,5316,O
light,5317,5322,O
chain,5323,5328,O
1,5329,5330,O
Dnal1,5332,5337,O
analyzed,5344,5352,O
mRNA,5354,5358,O
levels,5359,5365,O
cytoskeletal,5375,5387,B-Cellular_component
genes,5388,5393,O
altered,5403,5410,O
guidance,5425,5433,O
cues,5434,5438,O
e,5442,5443,O
cofilin,5445,5452,O
filamin,5454,5461,O
mena,5465,5469,O
vinculin,5471,5479,O
smooth,5484,5490,B-Tissue
muscle,5491,5497,I-Tissue
actin,5498,5503,O
data,5505,5509,O
shown,5514,5519,O
Short,5522,5527,O
term,5528,5532,O
stimulation,5533,5544,O
guidance,5550,5558,O
cues,5559,5563,O
result,5572,5578,O
major,5582,5587,O
alterations,5588,5599,O
cytoskeletal,5603,5615,B-Cellular_component
mRNA,5616,5620,O
levels,5621,5627,O
upregulation,5639,5651,O
Tpm1,5655,5659,O
ephrin,5663,5669,O
A5,5670,5672,O
Fig,5674,5677,O
S4A,5679,5682,O
16h,5688,5691,O
incubation,5695,5705,O
tropomyosin,5712,5723,O
genes,5724,5729,O
induced,5735,5742,O
BDNF,5746,5750,O
ephrin,5755,5761,O
A5,5762,5764,O
Fig,5790,5793,O
S4B,5795,5798,O
D,5800,5801,O
Actn1,5804,5809,O
levels,5810,5816,O
induced,5822,5829,O
individual,5833,5843,O
application,5844,5855,O
ephrin,5859,5865,O
A5,5866,5868,O
BDNF,5873,5877,O
co,5885,5887,O
application,5888,5899,O
Fig,5909,5912,O
S4F,5914,5917,O
similar,5922,5929,O
profile,5930,5937,O
observed,5942,5950,O
dynein,5959,5965,O
light,5966,5971,O
chain,5972,5977,O
Fig,5979,5982,O
S4H,5984,5987,O
Taken,5990,5995,O
cytoskeletal,6006,6018,B-Cellular_component
gene,6019,6023,O
expression,6024,6034,O
modulated,6039,6048,O
ephrin,6052,6058,O
A5,6059,6061,O
BDNF,6066,6070,O
contrast,6075,6083,O
antagonistic,6091,6103,O
impact,6104,6110,O
IEG,6118,6121,O
gene,6122,6126,O
response,6127,6135,O
Figs,6137,6141,O
4,6143,6144,O
6,6149,6150,O
ephrin,6153,6159,O
A5,6160,6162,O
BDNF,6167,6171,O
resulted,6172,6180,O
synergistic,6191,6202,O
action,6203,6209,O
cytoskeletal,6213,6225,B-Cellular_component
gene,6226,6230,O
expression,6231,6241,O
difference,6248,6258,O
short,6275,6280,O
term,6281,6285,O
e,6289,6290,O
20,6292,6294,O
minutes,6295,6302,O
vs,6304,6306,O
long,6308,6312,O
term,6313,6317,O
e,6321,6322,O
16h,6324,6327,O
exposure,6329,6337,O
guidance,6346,6354,O
cues,6355,6359,O
IEG,6367,6370,O
cytoskeletal,6375,6387,B-Cellular_component
gene,6388,6392,O
response,6393,6401,O
respectively,6403,6415,O
Introduction,0,12,O
Yeast,13,18,O
infections,19,29,O
cause,30,35,O
significant,36,47,O
mortality,48,57,O
critically,61,71,O
ill,72,75,O
immunocompromised,80,97,O
patients,98,106,O
particular,111,121,O
Candida,123,130,O
species,131,138,O
4th,147,150,O
common,156,162,O
cause,163,168,O
nosocomial,172,182,O
bloodstream,183,194,B-Organism_substance
infections,195,205,O
United,213,219,O
States,220,226,O
Cryptococcus,232,244,O
neoformans,245,255,O
commonest,261,270,O
cause,271,276,O
fungal,280,286,O
meningitis,287,297,O
worldwide,298,307,O
1,309,310,O
2,314,315,O
Whilst,318,324,O
Candida,325,332,O
albicans,333,341,O
remains,342,349,O
leading,354,361,O
pathogenic,362,372,O
yeast,373,378,O
infections,380,390,O
non,398,401,O
C,402,403,O
albicans,405,413,O
species,414,421,O
Candida,430,437,O
glabrata,438,446,O
previously,459,469,O
rare,470,474,O
opportunists,475,487,O
Trichosporon,496,508,O
Geotrichum,513,523,O
species,524,531,O
increasingly,537,549,O
reported,550,558,O
1,560,561,O
3,565,566,O
6,569,570,O
Novel,573,578,O
pathogenic,579,589,O
Candida,590,597,O
species,598,605,O
Candida,614,621,O
nivariensis,622,633,O
Candida,638,645,O
bracarensis,646,657,O
described,673,682,O
7,684,685,O
non,699,702,O
C,703,704,O
albicans,706,714,O
Candida,715,722,O
non,727,730,O
Candida,731,738,O
yeasts,739,745,O
resistant,750,759,O
susceptible,768,779,O
antifungal,783,793,O
agents,794,800,O
rapid,802,807,O
accurate,808,816,O
species,817,824,O
identification,825,839,O
central,843,850,O
timely,854,860,O
effective,862,871,O
antifungal,872,882,O
therapy,883,890,O
3,892,893,O
6,896,897,O
8,901,902,O
9,906,907,O
Conventional,910,922,O
phenotypic,923,933,O
based,934,939,O
methods,940,947,O
yeast,952,957,O
identification,958,972,O
slow,987,991,O
24,993,995,O
72,996,998,O
h,999,1000,O
insensitive,1003,1014,O
unable,1025,1031,O
identify,1035,1043,O
unusual,1049,1056,O
species,1057,1064,O
molecular,1074,1083,O
techniques,1084,1094,O
including,1095,1104,O
real,1105,1109,O
time,1110,1114,O
PCR,1115,1118,O
DNA,1120,1123,O
sequence,1124,1132,O
analysis,1133,1141,O
microarray,1143,1153,O
analysis,1154,1162,O
fluorescence,1168,1180,O
situ,1184,1188,O
hybridization,1189,1202,O
provide,1203,1210,O
accurate,1211,1219,O
identification,1220,1234,O
10,1236,1238,O
11,1242,1244,O
expensive,1254,1263,O
require,1265,1272,O
substantial,1273,1284,O
specimen,1285,1293,O
processing,1294,1304,O
time,1305,1309,O
hours,1311,1316,O
day,1322,1325,O
easily,1339,1345,O
implemented,1346,1357,O
routine,1361,1368,O
techniques,1369,1379,O
clinical,1387,1395,O
laboratory,1396,1406,O
Matrix,1408,1414,O
assisted,1415,1423,O
laser,1424,1429,O
desorption,1430,1440,O
ionization,1441,1451,O
time,1452,1456,O
flight,1460,1466,O
mass,1467,1471,O
spectrometry,1472,1484,O
MALDI,1486,1491,O
TOF,1492,1495,O
MS,1496,1498,O
emerged,1504,1511,O
powerful,1517,1525,O
rapid,1530,1535,O
tool,1536,1540,O
identification,1549,1563,O
bacterial,1567,1576,O
yeast,1581,1586,O
pathogens,1587,1596,O
12,1598,1600,O
17,1603,1605,O
MALDI,1614,1619,O
TOF,1620,1623,O
MS,1624,1626,O
protein,1632,1639,O
spectral,1640,1648,O
fingerprint,1650,1661,O
isolate,1669,1676,O
compared,1680,1688,O
reference,1694,1703,O
spectral,1704,1712,O
database,1713,1721,O
identification,1726,1740,O
18,1742,1744,O
Previous,1747,1755,O
studies,1756,1763,O
reported,1769,1777,O
species,1778,1785,O
identification,1786,1800,O
rates,1801,1806,O
92,1810,1812,O
99,1813,1815,O
collections,1825,1836,O
yeasts,1840,1846,O
yeast,1851,1856,O
like,1857,1861,O
organisms,1862,1871,O
14,1873,1875,O
17,1878,1880,O
19,1884,1886,O
20,1890,1892,O
taken,1904,1909,O
collectively,1910,1922,O
results,1928,1935,O
directly,1947,1955,O
comparable,1956,1966,O
studies,1979,1986,O
different,1997,2006,O
approaches,2007,2017,O
assign,2021,2027,O
species,2028,2035,O
comparing,2043,2052,O
spectra,2053,2060,O
test,2066,2070,O
organisms,2071,2080,O
reference,2084,2093,O
spectra,2094,2101,O
MALDI,2105,2110,O
TOF,2111,2114,O
MS,2115,2117,O
databases,2118,2127,O
16,2129,2131,O
20,2135,2137,O
enhancing,2143,2152,O
databases,2159,2168,O
instances,2182,2191,O
developing,2192,2202,O
study,2203,2208,O
specific,2209,2217,O
databases,2218,2227,O
house,2238,2243,O
spectral,2245,2253,O
signatures,2254,2264,O
14,2266,2268,O
15,2272,2274,O
continuing,2293,2303,O
need,2304,2308,O
extend,2312,2318,O
repository,2323,2333,O
reference,2337,2346,O
spectra,2347,2354,O
MALDI,2358,2363,O
TOF,2364,2367,O
MS,2368,2370,O
databases,2371,2380,O
undertook,2395,2404,O
present,2409,2416,O
study,2417,2422,O
evaluate,2426,2434,O
utility,2439,2446,O
MALDI,2454,2459,O
Biotyper,2460,2468,O
2,2469,2470,O
0,2471,2472,O
Microflex,2473,2482,O
LT,2483,2485,O
spectrometer,2486,2498,O
Bruker,2500,2506,O
Daltonik,2507,2515,O
GmbH,2516,2520,O
Bremen,2522,2528,O
Germany,2530,2537,O
current,2548,2555,O
spectral,2556,2564,O
database,2565,2573,O
comparison,2577,2587,O
phenotypic,2593,2603,O
based,2604,2609,O
methods,2610,2617,O
identification,2626,2640,O
broad,2646,2651,O
range,2652,2657,O
yeasts,2661,2667,O
diagnostic,2673,2683,O
laboratory,2684,2694,O
study,2718,2723,O
comprised,2724,2733,O
testing,2734,2741,O
reference,2745,2754,O
clinical,2759,2767,O
strains,2768,2775,O
culture,2785,2792,O
collection,2793,2803,O
second,2809,2815,O
blinded,2822,2829,O
prospective,2830,2841,O
analysis,2842,2850,O
freshly,2854,2861,O
collected,2862,2871,O
yeast,2872,2877,O
isolates,2878,2886,O
recovered,2887,2896,O
routine,2904,2911,O
laboratory,2912,2922,O
work,2923,2927,O
flow,2928,2932,O
discrepant,2934,2944,O
results,2945,2952,O
MALDI,2961,2966,O
TOF,2967,2970,O
MS,2971,2973,O
phenotypic,2978,2988,O
methods,2989,2996,O
resolved,3002,3010,O
sequence,3017,3025,O
analysis,3026,3034,O
fungal,3042,3048,O
internal,3049,3057,O
transcribed,3058,3069,O
spacer,3070,3076,O
regions,3083,3090,O
21,3092,3094,O
22,3098,3100,O
Results,3103,3110,O
obtained,3111,3119,O
preparation,3123,3134,O
yeasts,3138,3144,O
extraction,3148,3158,O
fungal,3162,3168,O
proteins,3169,3177,O
direct,3185,3191,O
application,3192,3203,O
yeast,3207,3212,O
colonies,3213,3221,O
MALDI,3231,3236,O
TOF,3237,3240,O
MS,3241,3243,O
plate,3244,3249,O
compared,3260,3268,O
Classification,0,14,O
result,15,21,O
3,0,1,O
2,2,3,O
Molecular,5,14,O
Mechanisms,15,25,O
Mediating,26,35,O
Perinatal,40,49,O
Beta,50,54,B-Cell
Cell,55,59,I-Cell
Adaptive,60,68,O
Response,69,77,O
Early,81,86,O
Life,87,91,O
Stressors,92,101,O
Molecular,102,111,O
mechanisms,112,122,O
responsible,123,134,O
impaired,139,147,O
beta,148,152,B-Cell
cell,153,157,I-Cell
mass,158,162,O
formation,163,172,O
IUCR,179,183,O
IUPR,187,191,O
come,197,201,O
investigation,208,221,O
proposed,242,250,O
IUCR,256,260,O
result,265,271,O
reduction,277,286,O
embryonic,294,303,B-Cell
beta,304,308,I-Cell
cell,309,313,I-Cell
progenitor,314,324,O
pool,325,329,O
leading,330,337,O
inappropriate,341,354,O
postnatal,355,364,O
beta,365,369,B-Cell
cell,370,374,I-Cell
formation,375,384,O
Stanger,386,393,O
et,394,396,O
al,397,399,O
108,402,405,O
demonstrated,407,419,O
selective,425,434,O
genetic,435,442,O
reduction,443,452,O
size,460,464,O
PDX,468,471,O
1,472,473,O
pancreatic,475,485,B-Organ
progenitors,486,497,O
fetal,509,514,B-Developing_anatomical_structure
period,515,521,O
results,522,529,O
impaired,533,541,O
beta,542,546,B-Cell
cell,547,551,I-Cell
formation,552,561,O
postnatal,573,582,O
period,583,589,O
consequent,595,605,O
development,606,617,O
glucose,621,628,O
intolerance,629,640,O
adulthood,648,657,O
Consistent,659,669,O
maternal,681,689,O
food,690,694,O
restriction,695,706,O
leads,707,712,O
significant,716,727,O
reduction,728,737,O
PDX,741,744,O
1,745,746,O
neurogenin,752,762,O
3,763,764,O
pancreatic,766,776,B-Organ
precursors,777,787,O
embryonic,795,804,B-Developing_anatomical_structure
development,805,816,O
rats,820,824,O
diminished,826,836,O
postnatal,837,846,O
beta,847,851,B-Cell
cell,852,856,I-Cell
formation,857,866,O
inability,872,881,O
expand,885,891,O
beta,892,896,B-Cell
cell,897,901,I-Cell
mass,902,906,O
response,910,918,O
pregnancy,922,931,O
47,933,935,O
94,937,939,O
UPI,946,949,O
model,950,955,O
characterized,964,977,O
permanent,983,992,O
decrease,993,1001,O
islet,1005,1010,B-Multi-tissue_structure
PDX,1011,1014,O
1,1015,1016,O
mRNA,1017,1021,O
expression,1022,1032,O
decrease,1039,1047,O
recently,1052,1060,O
shown,1066,1071,O
progressive,1085,1096,O
epigenetic,1097,1107,O
silencing,1108,1117,O
Pdx1,1125,1129,O
gene,1130,1134,O
locus,1135,1140,O
secondary,1141,1150,O
proximal,1154,1162,O
promoter,1163,1171,O
methylation,1172,1183,O
69,1185,1187,O
109,1189,1192,O
responsible,1209,1220,O
decreased,1229,1238,O
rate,1239,1243,O
beta,1247,1251,B-Cell
cell,1252,1256,I-Cell
replication,1257,1268,O
inappropriate,1273,1286,O
postnatal,1287,1296,O
beta,1297,1301,B-Cell
cell,1302,1306,I-Cell
mass,1307,1311,O
development,1312,1323,O
69,1325,1327,O
110,1329,1332,O
way,1347,1350,O
thinking,1354,1362,O
studies,1364,1371,O
demonstrated,1377,1389,O
maintenance,1399,1410,O
methylated,1414,1424,O
histone,1425,1432,O
H3,1433,1435,O
Lys4,1436,1440,O
Set7,1444,1448,O
9,1449,1450,O
member,1454,1460,O
SET,1468,1471,O
methyltransferase,1472,1489,O
family,1490,1496,O
crucial,1501,1508,O
Pdx1,1512,1516,O
activity,1517,1525,O
beta,1529,1533,B-Cell
cell,1534,1538,I-Cell
lines,1539,1544,I-Cell
111,1546,1549,O
113,1550,1553,O
led,1561,1564,O
hypothesis,1572,1582,O
Set7,1588,1592,O
9,1593,1594,O
represent,1599,1608,O
novel,1611,1616,O
chromatin,1617,1626,O
modifying,1627,1636,O
protein,1637,1644,O
functions,1650,1659,O
recruitment,1680,1691,O
target,1695,1701,O
genes,1702,1707,O
cell,1711,1715,B-Cell
specific,1716,1724,O
transcription,1725,1738,O
factors,1739,1746,O
Pdx1,1755,1759,O
role,1775,1779,O
histone,1783,1790,O
methyl,1791,1797,O
transferases,1798,1810,O
particularly,1812,1824,O
set7,1825,1829,O
demonstrated,1845,1857,O
sustained,1865,1874,O
deleterious,1875,1886,O
effects,1887,1894,O
chronic,1898,1905,O
hyperglycemia,1906,1919,O
human,1923,1928,O
microvascular,1929,1942,B-Cell
endothelial,1943,1954,I-Cell
cells,1955,1960,I-Cell
114,1962,1965,O
epigenetic,1976,1986,O
change,1987,1993,O
potentially,2000,2011,O
involved,2015,2023,O
deleterious,2031,2042,O
effect,2043,2049,O
high,2053,2057,O
glucose,2058,2065,O
fetal,2075,2080,B-Organ
pancreas,2081,2089,I-Organ
IUED,2097,2101,O
models,2102,2108,O
mechanism,2118,2127,O
proposed,2128,2136,O
explain,2140,2147,O
reduced,2148,2155,O
beta,2156,2160,B-Cell
cell,2161,2165,I-Cell
formation,2166,2175,O
IUCR,2182,2186,O
related,2190,2197,O
prenatal,2201,2209,O
glucocorticoid,2210,2224,O
exposure,2225,2233,O
Administration,2235,2249,O
dexamethasone,2260,2273,O
carbenoxolone,2277,2290,O
inhibit,2295,2302,O
11,2303,2305,O
beta,2306,2310,O
hydroxysteroid,2311,2325,O
dehydrogenase,2326,2339,O
type,2340,2344,O
2,2345,2346,O
normal,2351,2357,O
pregnant,2358,2366,O
rats,2367,2371,O
causes,2377,2383,O
fetal,2384,2389,B-Developing_anatomical_structure
growth,2390,2396,O
retardation,2397,2408,O
adult,2417,2422,O
offspring,2423,2432,O
hypertensive,2437,2449,O
hyperglycemic,2454,2467,O
hyperactive,2474,2485,O
hypothalamic,2486,2498,B-Organ
pituitary,2499,2508,B-Organ
adrenal,2509,2516,B-Organ
axis,2517,2521,O
115,2523,2526,O
Maternal,2529,2537,O
undernutrition,2538,2552,O
significantly,2553,2566,O
increased,2567,2576,O
fetal,2582,2587,B-Developing_anatomical_structure
maternal,2592,2600,O
corticosterone,2601,2615,O
concentrations,2616,2630,O
rats,2634,2638,O
116,2640,2643,O
Subsequently,2646,2658,O
maternal,2660,2668,O
fetal,2676,2681,B-Developing_anatomical_structure
overexposure,2682,2694,O
glucocorticoids,2698,2713,O
administration,2719,2733,O
dexamethasone,2737,2750,O
impairs,2752,2759,O
fetal,2765,2770,B-Developing_anatomical_structure
postnatal,2775,2784,O
beta,2785,2789,B-Cell
cell,2790,2794,I-Cell
formation,2795,2804,O
rodents,2808,2815,O
nonhuman,2820,2828,O
primates,2829,2837,O
94,2839,2841,O
117,2843,2846,O
119,2847,2850,O
Seckl,2853,2858,O
et,2859,2861,O
al,2862,2864,O
115,2867,2870,O
shown,2877,2882,O
fetal,2888,2893,B-Developing_anatomical_structure
corticosterone,2894,2908,O
concentrations,2909,2923,O
inversely,2928,2937,O
correlated,2938,2948,O
fetal,2954,2959,B-Developing_anatomical_structure
insulin,2960,2967,O
content,2968,2975,O
postnatal,2980,2989,O
beta,2990,2994,B-Cell
cell,2995,2999,I-Cell
formation,3000,3009,O
rats,3013,3017,O
Evidence,3019,3027,O
suggests,3028,3036,O
glucocorticoids,3042,3057,O
exert,3062,3067,O
direct,3070,3076,O
effect,3077,3083,O
developing,3091,3101,O
fetal,3102,3107,B-Organ
pancreas,3108,3116,I-Organ
transcriptional,3121,3136,O
modulation,3137,3147,O
transcription,3151,3164,O
factors,3165,3172,O
involved,3173,3181,O
beta,3185,3189,B-Cell
cell,3190,3194,I-Cell
formation,3195,3204,O
differentiation,3209,3224,O
117,3226,3229,O
Glucocorticoid,3232,3246,O
receptors,3247,3256,O
present,3261,3268,O
pancreas,3276,3284,B-Organ
embryonic,3292,3301,B-Developing_anatomical_structure
development,3302,3313,O
rodents,3317,3324,O
humans,3329,3335,O
117,3337,3340,O
glucocorticoids,3347,3362,O
bind,3367,3371,O
Pdx1,3379,3383,O
promoter,3384,3392,O
suppress,3402,3410,O
fetal,3411,3416,B-Cell
endocrine,3417,3426,I-Cell
cell,3427,3431,I-Cell
differentiation,3432,3447,O
117,3449,3452,O
Glucocorticoid,3455,3469,O
treatment,3470,3479,O
shown,3489,3494,O
significantly,3498,3511,O
reduce,3512,3518,O
fetal,3519,3524,B-Developing_anatomical_structure
expression,3525,3535,O
key,3539,3542,O
endocrine,3543,3552,O
transcription,3553,3566,O
factors,3567,3574,O
Pdx1,3583,3587,O
Pax6,3592,3596,O
simultaneously,3601,3615,O
increase,3616,3624,O
expression,3625,3635,O
transcription,3639,3652,O
factors,3653,3660,O
regulate,3666,3674,O
development,3675,3686,O
exocrine,3694,3702,B-Organ
pancreas,3703,3711,I-Organ
119,3713,3716,O
demonstrated,3736,3748,O
UPI,3758,3761,O
low,3769,3772,O
protein,3773,3780,O
IUPR,3781,3785,O
offspring,3786,3795,O
experience,3796,3806,O
increased,3807,3816,O
oxidative,3817,3826,O
stress,3827,3833,O
impaired,3838,3846,O
mitochondrial,3847,3860,B-Cellular_component
function,3861,3869,O
96,3871,3873,O
120,3875,3878,O
mitochondrial,3885,3898,B-Cellular_component
dysfunction,3899,3910,O
limited,3919,3926,O
beta,3939,3943,B-Cell
cell,3944,3948,I-Cell
mitochondria,3953,3965,B-Cellular_component
liver,3980,3985,B-Organ
skeletal,3990,3998,B-Organ
muscle,3999,4005,I-Organ
exhibit,4006,4013,O
decreased,4014,4023,O
oxidation,4024,4033,O
pyruvate,4037,4045,O
subsequently,4047,4059,O
leading,4060,4067,O
development,4075,4086,O
features,4090,4098,O
commonly,4099,4107,O
found,4108,4113,O
T2D,4117,4120,O
100,4122,4125,O
121,4127,4130,O
exposure,4138,4146,O
Western,4152,4159,O
style,4160,4165,O
diet,4166,4170,O
pregnancy,4189,4198,O
IUEO,4203,4207,O
model,4208,4213,O
alters,4215,4221,O
redox,4226,4231,O
state,4232,4237,O
early,4241,4246,O
preimplantation,4250,4265,O
development,4266,4277,O
leading,4279,4286,O
mild,4290,4294,O
oxidative,4295,4304,O
stress,4305,4311,O
associated,4312,4322,O
inflammation,4328,4340,O
finding,4346,4353,O
administration,4359,4373,O
antioxidants,4377,4389,O
dam,4397,4400,O
reverses,4401,4409,O
oxidative,4410,4419,O
stress,4420,4426,O
completely,4431,4441,O
prevents,4442,4450,O
development,4455,4466,O
glucose,4470,4477,O
intolerance,4478,4489,O
increased,4494,4503,O
adiposity,4504,4513,O
adult,4521,4526,O
offspring,4527,4536,O
suggests,4537,4545,O
oxidative,4551,4560,O
stress,4561,4567,O
plays,4568,4573,O
important,4577,4586,O
role,4587,4591,O
development,4599,4610,O
adiposity,4614,4623,O
case,4632,4636,O
122,4638,4641,O
studies,4649,4656,O
low,4664,4667,O
protein,4668,4675,O
IUPR,4676,4680,O
model,4681,4686,O
demonstrated,4692,4704,O
oxidative,4710,4719,O
stress,4720,4726,O
limited,4734,4741,O
mitochondrial,4750,4763,B-Cellular_component
DNA,4764,4767,O
damage,4768,4774,O
genomic,4788,4795,O
DNA,4796,4799,O
impacting,4801,4810,O
cell,4811,4815,B-Cell
cycle,4816,4821,O
regulation,4822,4832,O
gene,4837,4841,O
expression,4842,4852,O
123,4854,4857,O
DNA,4866,4869,O
targeted,4879,4887,O
ROS,4902,4905,O
particular,4917,4927,O
regions,4928,4935,O
known,4945,4950,O
sensitive,4962,4971,O
ROS,4975,4978,O
mediated,4979,4987,O
damage,4988,4994,O
example,5000,5007,O
telomeres,5009,5018,O
Telomeres,5020,5029,O
comprise,5030,5038,O
GC,5039,5041,O
rich,5042,5046,O
repeats,5047,5054,O
found,5063,5068,O
ends,5076,5080,O
chromosome,5089,5099,O
known,5110,5115,O
shorten,5119,5126,O
cellular,5137,5145,B-Cell
division,5146,5154,O
act,5171,5174,O
mitotic,5180,5187,O
clock,5188,5193,O
registering,5195,5206,O
number,5211,5217,O
replicative,5221,5232,O
divisions,5233,5242,O
taken,5251,5256,O
place,5257,5262,O
cell,5274,5278,B-Cell
Investigations,5280,5294,O
IUPR,5304,5308,O
model,5309,5314,O
reported,5327,5335,O
decrease,5338,5346,O
longevity,5350,5359,O
offspring,5367,5376,O
123,5378,5381,O
124,5383,5386,O
accompanied,5388,5399,O
reduction,5403,5412,O
mitochondrial,5416,5429,B-Cellular_component
antioxidant,5430,5441,O
defences,5442,5450,O
96,5452,5454,O
125,5456,5459,O
telomere,5465,5473,O
length,5474,5480,O
islets,5484,5490,B-Multi-tissue_structure
125,5492,5495,O
Pancreatic,5498,5508,B-Multi-tissue_structure
islet,5509,5514,I-Multi-tissue_structure
development,5515,5526,O
shown,5536,5541,O
influenced,5548,5558,O
number,5564,5570,O
growth,5574,5580,O
factors,5581,5588,O
including,5589,5598,O
insulin,5603,5610,O
like,5611,5615,O
growth,5616,5622,O
factors,5623,5630,O
IGF,5632,5635,O
IGF,5642,5645,O
II,5646,5648,O
expression,5655,5665,O
utero,5669,5674,O
regulated,5678,5687,O
nutrient,5691,5699,O
hormone,5704,5711,O
concentrations,5712,5726,O
IUPR,5728,5732,O
modifies,5733,5741,O
expression,5742,5752,O
IGF,5761,5764,O
genes,5765,5770,O
variety,5776,5783,O
fetal,5787,5792,B-Tissue
tissues,5793,5800,I-Tissue
IUPR,5808,5812,O
rat,5813,5816,O
model,5817,5822,O
decreased,5830,5839,O
beta,5840,5844,B-Cell
cell,5845,5849,I-Cell
mass,5850,5854,O
beta,5859,5863,B-Cell
cell,5864,5868,I-Cell
replication,5869,5880,O
increased,5888,5897,O
rate,5898,5902,O
beta,5906,5910,B-Cell
cell,5911,5915,I-Cell
apoptosis,5916,5925,O
gene,5927,5931,O
expression,5932,5942,O
IGF,5947,5950,O
II,5951,5953,O
IGF,5962,5965,O
found,5972,5977,O
reduced,5978,5985,O
fetal,5993,5998,B-Organ
pancreas,5999,6007,I-Organ
126,6009,6012,O
different,6020,6029,O
IUPR,6030,6034,O
model,6035,6040,O
severe,6051,6057,O
global,6058,6064,O
food,6065,6069,O
restriction,6070,6081,O
induced,6088,6095,O
hyperinsulinemia,6096,6112,O
increase,6120,6128,O
beta,6132,6136,B-Cell
cell,6137,6141,I-Cell
mass,6142,6146,O
fetuses,6156,6163,B-Developing_anatomical_structure
90,6165,6167,O
fetal,6174,6179,B-Developing_anatomical_structure
phenotype,6180,6189,O
unexpectedly,6194,6206,O
associated,6207,6217,O
increase,6226,6234,O
pancreatic,6238,6248,B-Organ
IGF,6249,6252,O
expression,6255,6265,O
islet,6267,6272,B-Multi-tissue_structure
IGF,6273,6276,O
1R,6277,6279,O
91,6281,6283,O
IRS,6290,6293,O
2,6294,6295,O
92,6297,6299,O
fetal,6309,6314,B-Developing_anatomical_structure
GK,6315,6317,O
Par,6318,6321,O
rat,6322,6325,O
exposed,6326,6333,O
mild,6337,6341,O
hyperglycemia,6342,6355,O
gestation,6363,6372,O
model,6376,6381,O
IUED,6385,6389,O
data,6392,6396,O
group,6406,6411,O
suggest,6412,6419,O
beta,6429,6433,B-Cell
cell,6434,6438,I-Cell
deficit,6439,6446,O
reduced,6448,6455,O
50,6469,6471,O
starts,6474,6480,O
early,6484,6489,O
fetal,6493,6498,B-Developing_anatomical_structure
age,6499,6502,O
E16,6503,6506,O
reflects,6511,6519,O
decreased,6520,6529,O
beta,6530,6534,B-Cell
cell,6535,6539,I-Cell
proliferation,6540,6553,O
limitation,6557,6567,O
beta,6571,6575,B-Cell
cell,6576,6580,I-Cell
neogenesis,6581,6591,O
precursors,6597,6607,O
increased,6613,6622,O
apoptosis,6623,6632,O
beta,6641,6645,B-Cell
cells,6646,6651,I-Cell
precursors,6662,6672,O
86,6674,6676,O
Notably,6679,6686,O
Pdx1,6688,6692,O
Neurogenin3,6697,6708,O
expression,6709,6719,O
decreased,6725,6734,O
E18,6738,6741,O
normally,6746,6754,O
expressed,6755,6764,O
E13,6768,6771,O
86,6773,6775,O
Defective,6778,6787,O
signalling,6788,6798,O
Igf2,6811,6815,O
Igf1,6816,6820,O
R,6821,6822,O
pathway,6823,6830,O
represent,6835,6844,O
primary,6849,6856,O
instrumental,6857,6869,O
anomaly,6870,6877,O
Igf2,6884,6888,O
Igf1,6893,6897,O
R,6898,6899,O
protein,6900,6907,O
expressions,6908,6919,O
decreased,6932,6941,O
GK,6953,6955,O
Par,6956,6959,O
pancreatic,6960,6970,B-Organ
rudiment,6971,6979,I-Organ
E13,6983,6986,O
time,6993,6997,O
beta,7003,7007,B-Cell
cell,7008,7012,I-Cell
mass,7013,7017,O
wave,7025,7029,O
beta,7033,7037,B-Cell
cell,7038,7042,I-Cell
expansion,7043,7052,O
fact,7060,7064,O
normal,7065,7071,O
31,7073,7075,O
Low,7078,7081,O
levels,7082,7088,O
pancreatic,7092,7102,B-Organ
Igf2,7103,7107,O
associated,7108,7118,O
beta,7124,7128,B-Cell
cell,7129,7133,I-Cell
mass,7134,7138,O
deficiency,7139,7149,O
maintained,7154,7164,O
fetal,7187,7192,B-Organ
pancreas,7193,7201,I-Organ
87,7203,7205,O
Crossbreeding,7208,7221,O
protocols,7222,7231,O
nondiabetic,7240,7251,O
W,7252,7253,O
diabetic,7258,7266,O
GK,7267,7269,O
rats,7270,7274,O
showed,7275,7281,O
late,7291,7295,O
gestation,7296,7305,O
E18,7307,7310,O
pancreatic,7313,7323,B-Organ
Igf2,7324,7328,O
protein,7329,7336,O
expression,7337,7347,O
low,7355,7358,O
GKmother,7362,7370,O
GKfather,7371,7379,O
Wmother,7384,7391,O
GKfather,7392,7400,O
crosses,7401,7408,O
GKmother,7415,7423,O
GKfather,7424,7432,O
crosses,7433,7440,O
87,7442,7444,O
findings,7453,7461,O
support,7469,7476,O
hypothesis,7481,7491,O
pancreatic,7501,7511,B-Organ
Igf2,7512,7516,O
anomaly,7517,7524,O
GK,7532,7534,O
diabetic,7535,7543,O
model,7544,7549,O
linked,7553,7559,O
genetic,7565,7572,O
determinism,7573,7584,O
view,7591,7595,O
consistent,7604,7614,O
results,7624,7631,O
genetic,7635,7642,O
analyses,7643,7651,O
linked,7657,7663,O
locus,7666,7671,O
containing,7672,7682,O
gene,7687,7691,O
encoding,7692,7700,O
Igf2,7701,7705,O
diabetes,7709,7717,O
GK,7725,7727,O
rat,7728,7731,O
127,7733,7736,O
Igf2,7743,7747,O
gene,7748,7752,O
subjected,7756,7765,O
paternal,7769,7777,O
genomic,7778,7785,O
imprinting,7786,7796,O
Igf2,7819,7823,O
expression,7824,7834,O
similarly,7838,7847,O
affected,7848,7856,O
fetuses,7860,7867,B-Developing_anatomical_structure
regardless,7869,7879,O
father,7895,7901,O
W,7905,7906,O
GK,7910,7912,O
87,7914,7916,O
conclude,7929,7937,O
simple,7945,7951,O
change,7952,7958,O
Igf2,7962,7966,O
gene,7967,7971,O
imprinting,7972,7982,O
GK,7990,7992,O
rat,7993,7996,O
Finally,7998,8005,O
understanding,8011,8024,O
underlying,8032,8042,O
mechanisms,8043,8053,O
reduced,8058,8065,O
BCM,8066,8069,O
response,8073,8081,O
inappropriate,8085,8098,O
perinatal,8099,8108,O
nutrition,8109,8118,O
growing,8122,8129,O
rapidly,8130,8137,O
relative,8152,8160,O
contribution,8161,8173,O
intrinsic,8186,8195,O
extrinsic,8200,8209,O
factors,8210,8217,O
contribute,8224,8234,O
adaptive,8242,8250,O
response,8251,8259,O
developing,8267,8277,O
endocrine,8278,8287,B-Organ
pancreas,8288,8296,I-Organ
established,8312,8323,O
Refinement,0,10,O
R,11,12,O
F,13,14,O
2,15,16,O
2sigma,19,25,O
F,26,27,O
2,28,29,O
0,34,35,O
052,36,39,O
wR,40,42,O
F,43,44,O
2,45,46,O
0,50,51,O
132,52,55,O
S,56,57,O
1,60,61,O
02,62,64,O
3804,65,69,O
reflections,70,81,O
229,82,85,O
parameters,86,96,O
67,97,99,O
restraints,100,110,O
H,111,112,O
atom,113,117,O
parameters,118,128,O
constrained,129,140,O
Deltarhomax,141,152,O
0,155,156,O
56,157,159,O
e,160,161,O
3,164,165,O
Deltarhomin,166,177,O
0,181,182,O
38,183,185,O
e,186,187,O
3,190,191,O
Outcomes,0,8,O
primary,13,20,O
outcomes,21,29,O
study,38,43,O
smoking,48,55,O
abstinence,56,66,O
rates,67,72,O
post,73,77,O
release,78,85,O
number,97,103,O
days,107,111,O
cigarette,121,130,O
release,137,144,O
Seven,146,151,O
day,152,155,O
point,156,161,O
prevalence,162,172,O
abstinence,173,183,O
determined,192,202,O
combining,206,215,O
self,216,220,O
reported,221,229,O
tobacco,230,237,O
use,238,241,O
prior,251,256,O
seven,257,262,O
days,263,267,O
urine,272,277,B-Organism_substance
cotinine,278,286,O
assays,287,293,O
200,301,304,O
ng,305,307,O
ml,308,310,O
versus,311,317,O
200,318,321,O
Participants,333,345,O
self,351,355,O
reported,356,364,O
abstinence,365,375,O
cotinine,380,388,O
levels,389,395,O
cut,406,409,O
classified,422,432,O
abstinent,436,445,O
Participants,447,459,O
lost,460,464,O
follow,468,474,O
considered,486,496,O
non,497,500,O
abstinent,501,510,O
secondary,514,523,O
analysis,524,532,O
examine,538,545,O
effect,550,556,O
length,560,566,O
forced,570,576,O
abstinence,577,587,O
quit,591,595,O
rates,596,601,O
Abbreviations,0,13,O
ARDS,14,18,O
acute,20,25,O
respiratory,26,37,B-Anatomical_system
distress,38,46,O
syndrome,47,55,O
CMV,57,60,O
conventional,62,74,O
mechanical,75,85,O
ventilation,86,97,O
HFOV,99,103,O
high,105,109,O
frequency,110,119,O
oscillation,120,131,O
ventilation,132,143,O
LPS,145,148,O
lipopolysaccharide,150,168,O
PEEP,170,174,O
positive,176,184,O
end,185,188,O
expiratory,189,199,O
pressure,200,208,O
VILI,210,214,O
ventilator,216,226,O
induced,227,234,O
lung,235,239,B-Organ
injury,240,246,O
TxA2,1,5,O
generated,7,16,O
arachidonic,22,33,O
acid,34,38,O
cyclooxygenase,42,56,O
1,57,58,O
COX,60,63,O
1,64,65,O
Tx,71,73,O
synthase,74,82,O
amplifies,92,101,O
platelet,102,110,B-Cell
activation,111,121,O
COX,123,126,O
1,127,128,O
converts,129,137,O
arachidonic,138,149,O
acid,150,154,O
prostaglandin,160,173,O
endoperoxides,174,187,O
PGG2,188,192,O
PGH2,197,201,O
turn,224,228,O
transformed,230,241,O
Tx,245,247,O
synthase,248,256,O
TxA2,262,266,O
potent,270,276,O
amplifier,277,286,O
platelet,290,298,B-Cell
aggregation,299,310,O
vasoconstrictive,316,332,O
properties,333,343,O
site,352,356,O
atheroma,364,372,B-Pathological_formation
rupture,373,380,O
platelet,382,390,B-Cell
released,391,399,O
TxA2,400,404,O
leads,405,410,O
downstream,414,424,O
micro,425,430,B-Tissue
vessel,431,437,I-Tissue
contraction,438,449,O
thrombus,454,462,B-Organism_substance
propagation,463,474,O
7,476,477,O
addition,483,491,O
role,499,503,O
coagulation,507,518,O
thrombin,520,528,O
extremely,532,541,O
low,542,545,O
concentrations,546,560,O
major,575,580,O
platelet,581,589,B-Cell
activators,590,600,O
8,602,603,O
Human,606,611,O
platelets,612,621,B-Cell
express,622,629,O
cell,634,638,B-Cellular_component
surface,639,646,I-Cellular_component
G,647,648,O
protein,649,656,O
coupled,657,664,O
protease,665,673,O
activated,674,683,O
receptors,684,693,O
PARs,695,699,O
thrombin,705,713,O
PAR,715,718,O
1,719,720,O
PAR,725,728,O
4,729,730,O
binding,735,742,O
hirudin,747,754,O
like,755,759,O
extracellular,760,773,B-Immaterial_anatomical_entity
amino,774,779,O
terminal,780,788,O
domain,789,795,O
called,804,810,O
thrombin,811,819,O
receptor,820,828,O
thrombin,831,839,O
activates,840,849,O
platelets,850,859,B-Cell
smooth,864,870,B-Cell
muscle,871,877,I-Cell
cells,878,883,I-Cell
promoting,890,899,O
platelet,900,908,B-Cell
pro,909,912,O
coagulant,913,922,O
activity,923,931,O
shape,933,938,O
change,939,945,O
secretion,947,956,O
release,961,968,O
agonists,972,980,O
ADP,982,985,O
TxA2,990,994,O
expression,997,1007,O
P,1011,1012,O
selectin,1013,1021,O
activation,1023,1033,O
alphaIIbbeta3,1041,1054,O
integrin,1055,1063,O
receptor,1064,1072,O
aggregation,1078,1089,O
Thrombin,1091,1099,O
binds,1105,1110,O
GpIbalpha,1114,1123,O
surface,1131,1138,O
platelets,1142,1151,B-Cell
thought,1153,1160,O
act,1164,1167,O
co,1173,1175,O
factor,1176,1182,O
localizes,1188,1197,O
enzyme,1202,1208,O
platelet,1216,1224,B-Cellular_component
surface,1225,1232,I-Cellular_component
accelerates,1237,1248,O
hydrolysis,1253,1263,O
PAR,1267,1270,O
1,1271,1272,O
9,1274,1275,O
PAR,1278,1281,O
1,1282,1283,O
P2Y12,1288,1293,O
cross,1294,1299,O
react,1300,1305,O
platelet,1309,1317,B-Cell
activation,1318,1328,O
Galphaq,1334,1341,O
Galphai,1346,1353,O
coupled,1354,1361,O
receptors,1362,1371,O
involved,1376,1384,O
process,1393,1400,O
Thrombin,1402,1410,O
dependent,1411,1420,O
platelet,1421,1429,B-Cell
aggregation,1430,1441,O
mediated,1445,1453,O
secreted,1465,1473,O
ADP,1474,1477,O
acting,1479,1485,O
Galphai,1493,1500,O
linked,1501,1507,O
ADP,1508,1511,O
receptor,1512,1520,O
blocking,1525,1533,O
Galphaq,1534,1541,O
PAR,1546,1549,O
1,1550,1551,O
Gbetai,1556,1562,O
P2Y12,1567,1572,O
combined,1574,1582,O
inhibition,1583,1593,O
thrombin,1597,1605,O
P2Y12,1610,1615,O
receptors,1616,1625,O
leads,1626,1631,O
synergistic,1637,1648,O
inhibitory,1649,1659,O
effect,1660,1666,O
thrombin,1670,1678,O
induced,1679,1686,O
platelet,1687,1695,B-Cell
aggregation,1696,1707,O
10,1709,1711,O
5,1714,1715,O
HT,1716,1718,O
vasoconstrictor,1724,1739,O
agent,1740,1745,O
binds,1751,1756,O
5HT,1760,1763,O
2A,1764,1766,O
receptors,1767,1776,O
amplifies,1781,1790,O
platelet,1795,1803,B-Cell
response,1804,1812,O
stimulating,1816,1827,O
shape,1828,1833,O
change,1834,1840,O
enhancing,1845,1854,O
platelet,1855,1863,B-Cell
recruitment,1864,1875,O
sites,1879,1884,O
injury,1888,1894,O
3,1896,1897,O
play,1912,1916,O
pro,1919,1922,O
coagulant,1923,1932,O
role,1933,1937,O
promoting,1941,1950,O
retention,1955,1964,O
fibrinogen,1968,1978,O
thrombospondin,1983,1997,O
platelet,2005,2013,B-Cellular_component
surface,2014,2021,I-Cellular_component
Intraplatelet,2023,2036,B-Cell
5,2037,2038,O
HT,2039,2041,O
stores,2042,2048,O
implicated,2053,2063,O
shear,2067,2072,O
induced,2073,2080,O
platelet,2081,2089,B-Cell
aggregation,2090,2101,O
thrombus,2106,2114,B-Organism_substance
propagation,2115,2126,O
3,2128,2129,O
Methods,0,7,O
studied,11,18,O
3,19,20,O
574,21,24,O
Canadian,25,33,O
children,34,42,O
aged,44,48,O
7,49,50,O
8,51,52,O
yr,53,55,O
enrolled,57,65,O
population,71,81,O
based,82,87,O
birth,88,93,O
cohort,94,100,O
Standardized,102,114,O
questionnaires,115,129,O
completed,135,144,O
children,152,160,O
s,161,162,O
parents,163,170,O
data,176,180,O
analyzed,186,194,O
multivariate,198,210,O
logistic,211,219,O
regression,220,230,O
iii,1,4,O
HIV,6,9,O
testing,10,17,O
response,18,26,O
rate,27,31,O
educational,35,46,O
attainment,47,57,O
gender,62,68,O
Relative,0,8,O
phage,9,14,O
haplotype,15,24,O
frequencies,25,36,O
PAO1,40,44,O
samples,45,52,O
planktonic,58,68,O
B,71,72,O
biofilm,74,81,B-Cell
4,82,83,O
days,84,88,O
C,91,92,O
biofilm,94,101,B-Cell
11,102,104,O
days,105,109,O
Collaxa,0,7,O
BPEL,8,12,O
Server,13,19,O
Screenshot,20,30,O
Collaxa,34,41,O
s,42,43,O
bpelz,44,49,O
design,50,56,O
tool,57,61,O
building,63,71,O
choreography,74,86,O
GetHAPI,90,97,O
GetUMLS,102,109,O
web,110,113,O
services,114,122,O
Abbreviations,0,13,O
Ac,14,16,O
DEVD,17,21,O
AMC,22,25,O
N,28,29,O
acetyl,30,36,O
Asp,37,40,O
Glu,41,44,O
Val,45,48,O
Asp,49,52,O
7,53,54,O
amino,55,60,O
4,61,62,O
methylcoumarin,63,77,O
Ac,79,81,O
DEVD,82,86,O
CHO,87,90,O
N,93,94,O
acetyl,95,101,O
Asp,102,105,O
Glu,106,109,O
Val,110,113,O
Asp,114,117,O
aldehyde,118,126,O
COX,128,131,O
cyclooxygenase,134,148,O
Deltapsim,150,159,O
mitochondrial,162,175,B-Cellular_component
membrane,176,184,I-Cellular_component
potential,185,194,O
DAPI,196,200,O
4,203,204,O
6,206,207,O
diamidino,208,217,O
2,218,219,O
phenylindole,220,232,O
DMEM,234,238,O
Dulbecco,241,249,O
s,250,251,O
modified,252,260,O
Eagle,261,266,O
s,267,268,O
medium,269,275,O
ELISA,277,282,O
enzyme,285,291,O
linked,292,298,O
immunosorbent,299,312,O
assay,313,318,O
FCS,320,323,O
fetal,326,331,B-Developing_anatomical_structure
calf,332,336,O
serum,337,342,B-Organism_substance
FLS,344,347,B-Cell
fibroblast,350,360,B-Cell
like,361,365,I-Cell
synoviocytes,366,378,I-Cell
IL,380,382,O
interleukin,385,396,O
JC,398,400,O
1,401,402,O
5,405,406,O
5,407,408,O
6,410,411,O
6,412,413,O
tetrachloro,415,426,O
1,427,428,O
1,429,430,O
3,432,433,O
3,434,435,O
tetraethylbenzimidazole,437,460,O
carbocyanide,461,473,O
iodide,474,480,O
MTT,482,485,O
3,488,489,O
4,491,492,O
5,493,494,O
dimethylthiazol,495,510,O
2,511,512,O
yl,513,515,O
2,517,518,O
5,519,520,O
diphenyltetrazolium,521,540,O
bromide,541,548,O
PBS,550,553,O
phosphate,556,565,O
buffered,566,574,O
saline,575,581,O
PGE2,583,587,O
prostaglandin,590,603,O
E2,604,606,O
RA,608,610,O
rheumatoid,613,623,O
arthritis,624,633,O
Authors,0,7,O
contributions,9,22,O
FR,23,25,O
initiated,26,35,O
designed,40,48,O
research,53,61,O
collected,63,72,O
analyzed,77,85,O
data,90,94,O
wrote,99,104,O
paper,109,114,O
FO,116,118,O
main,127,131,O
supervisor,132,142,O
helped,144,150,O
analysis,154,162,O
revised,168,175,O
edited,180,186,O
drafts,191,197,O
MN,199,201,O
co,206,208,O
supervisor,210,220,O
revised,225,232,O
drafts,237,243,O
Conclusion,0,10,O
Artificial,11,21,O
addition,22,30,O
siderophores,34,46,O
HSLs,51,55,O
possible,65,73,O
method,74,80,O
aid,84,87,O
identification,95,109,O
isolation,114,123,O
marine,127,133,O
bacterial,134,143,O
species,144,151,O
thought,162,169,O
unknown,176,183,O
